<SEC-DOCUMENT>0000883984-22-000030.txt : 20220509
<SEC-HEADER>0000883984-22-000030.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509171522
ACCESSION NUMBER:		0000883984-22-000030
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		113
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICU MEDICAL INC/DE
		CENTRAL INDEX KEY:			0000883984
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330022692
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34634
		FILM NUMBER:		22906184

	BUSINESS ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
		BUSINESS PHONE:		949-366-2183

	MAIL ADDRESS:	
		STREET 1:		951 CALLE AMANECER
		CITY:			SAN CLEMENTE
		STATE:			CA
		ZIP:			92763-6212
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>icui-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:eb6bc161-64f3-45ef-8355-0537b049f0f7,g:1fc0d841-3e14-4a45-9a82-f075c6cb343a,d:8343a502cf1c465a8adfd72ff6994fce--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:icui="http://www.icumed.com/20220331" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>icui-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY18yLTEtMS0xLTIzMzk5_e1d9cbd7-31e6-434e-b157-9255bec4036e">0000883984</ix:nonNumeric><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY18zLTEtMS0xLTIzMzk5_ea6837fc-0e5b-493a-9db3-be70afdd413c">ICU MEDICAL INC/DE</ix:nonNumeric><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY180LTEtMS0xLTIzMzk5_cc0b3c27-66e9-474f-8b3b-2ed8d15cc1c4">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY181LTEtMS0xLTIzMzk5_ec6e2553-4a0b-4e3c-b5ad-506865f7ded1">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY182LTEtMS0xLTIzMzk5_3551e7a1-b29f-4f14-8803-952e9c735a99">2022</ix:nonNumeric><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY183LTEtMS0xLTIzMzk5_f16f2ce0-566b-46e8-9094-e5c2bf958900">Q1</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="icui-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4143f4321de483daeaf8422585b5992_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic739b9e6cfbd49928ba2becb10737a7b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5d868d49505419592afffab42bf0eb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64868371845d4e76bc447e71919e1983_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfc64c489cf04a69892f2bb79d05265d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6984b38e57b4cb9b7db8552e7a3fcaa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86236b5f9d4c43f5b952f83a321739b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee98598f2d5949e89f38dd5e926233ef_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17a81a7b494f4b9389f3416497deb3e2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d11403464e048ae8378f62edfc53cea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb961a439cc448229c94512348851dab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ffc6e2664094fdf93f1f351c76c317c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fe8dbdded6c47e5abc6e9b101c5276c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i691612597ddd469aa1e76c59b67248a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77dbdeb976b5481f9ae92bbf1102665e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cbe5a67bda441529efd0b011401173b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69c8c17a24744f9be803234128f6c24_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3a542e87e2f471ba2bf2af24b497b2e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbec71a052e34a628bdbc7874d90f523_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee88159d0ccf4a36be2cea91faa46dd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83d7811e874b43c3ac9eedf4ade5ff94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaa3308af1304da2922818b5e5b2203a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4bf3dd823004949bb668180e422e8b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70d5d4b789c14217a4637b71e3935b05_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9709296c43fd4879b1cc1f464dfaac3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6de1955a7159499e9b68b9b0daa91296_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie23ec980b5784615a4b1e1be6c1805d9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1dae3bb26454570acfeaff45f3e5b66_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e2dc9a5e24485b8f9b458a7172bbff_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cd3a8fb34fc4f0f9340555ab6074ee6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib569fc18582645668995f72d04a72816_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58b4154cd7374229b9e379d211fbefc5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i894ed5cd7131488eb00a9af8903195f4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i463ae5afe8854c50a81194644b397891_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i766a662d646644049de578ec36ca4f87_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93e818396f3f49a2ad987c721bf7dd83_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9086cf89d1247ba9e8c0d33a92d5450_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ida794f824cb94242bde5116941247684_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id513614e0fb644d7b5f9986414615ea1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9c19a0416554eb991a114156f302300_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">icui:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0f9607f3f64f179b6cf6d4462adc77_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bb7b402883540419226d3c255ed0ce0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31bdd76ac7d94b7da503fd63b93ae400_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7330ec69856e4bedab9881611ec4c66f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idced1370c58d496699456e82e999c739_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4421707804146808e8d82bd497823f1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id248bc190fef460ab54156ad628a9a09_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b01fe971840481cbc0118ca73113ed3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic31670f3190f4250afa50c949a969ee7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6940ef2009e4c4896a32c8c4aaf68d6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82d850d6caf542d5bb4c6d576c8debea_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a0e8abbc6647928fbf299a5ca9c5bc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icca9ac7dfc3a4aa489ff4d89527fdae9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80e0a0251974b428f96f3f717f4d8c6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i677c8e8ff77c48aa8ce2231709909edf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c2efe33dc8d4acd88c30e7d87d93647_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60182e4c96d44b05a31dbc6f360895df_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i910b191cc2064df1a370ea5673a067f8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99f317b22200400aa27ba28ee92de705_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fa0894a784543158f3f2b1d7c4de28c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica2afa04d4254f6bb80cb6e3672895e9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15c0bb3aed1b4706bc6fac56eab2c4cd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38ee104e0e7f45abbbb082a302c3fd84_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b4f448345b34a609c7840e89139cedb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6ffb2785f52491bb1b6d09817f187a4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5f91818e98e47c78b2642f077b41076_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b42d6a2aae43fb9961ff4e802256f1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib52844df4caf4174aa01d6d15e5ce18a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06dca36adccb4e6aa29a97ea62498b09_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461675ccf5e5457c93bc148a02ebef8f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94c6563557f14f0fa17a7b159d6942ec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic115301640614d36b47d9f6973156033_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31ba1716c4654d44b41229c3a3ba3502_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica6df5554552455890bb3e503c4ecaf7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10d0c665e84f4c42842d8354c9c251b1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice75ec9db3e341b6aef90d3334be1eb0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67d2154781164924b275843b993212d9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieffb1189d545486bb1d18d7d6120aa94_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i747977f101ff4d60a6662e14aeccca04_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9e71644be0d416286bfb1eca80a5bed_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaa7a333a6924010b053423c65083d92_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i590611035a394a67b144447f0765cc48_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66742bd27a76437d802c35ce2d1bb3f2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c8dc12807f14595a91b904cd714ee48_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2dd7ec8ea2a4048a06ea268924bf23a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5b1cec7abee4f76b35a418a82f45396_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8646fd65464c418fae83a8e61e4c8e4b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62db31deb9084936bafdeb3f3f63c809_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7963d1971572480fbd840e0d5474ceb0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic373291ce2a54c54bc47f9dc50e82a5e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CZK</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5be466fa5bc14021acd2af7f71cc4898_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aca8fbd4d9f46bd8abdb6dfa1bc52fa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:Srt_MultipleCurrencyAxisAxis">icui:OtherCurrenciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic788c207f74e4b2dafcf30292f3548ad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="mxn"><xbrli:measure>iso4217:MXN</xbrli:measure></xbrli:unit><xbrli:context id="i2cae28aee9a248c6992bfec3cecde803_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78dc0822a7604ba0b14a6be54c13e439_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge3MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7df84c8e6ce6476ba122f96383a99201_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f1ae97aae0424a80ff8ef2c5fe28de_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie951b51b46c24f91a76523e2ca109cf7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1565ea9c18f0446cac5355139ceb7865_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5480e0d4b9e94e3890f7f73f6ed47c70_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i315729be48514840b0d36c895155ff5e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8b0233d309c4ffcb68ad6044df3947b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7790dee9054ceca551b75f9663ebea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f4262eb928148c0bbdb719d4842c46e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47c493e4a240482e95f73b4965a6f972_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92d5fc92c6d7403f858073017410d73b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i442353a0995745d69a88c9e06d2b2e2b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f57e3739bad4f56b45c5af9ecd59b05_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ebbac56dc4f40cab230df979062a6fb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96528d11b19404186843078164bf0ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cb96a5a627a4f2c9fbf16b433a2a039_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32b4f49688b3453dabe1cbce3dac596e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if45f73643f964e8dad36acddabd4f6b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic809f3d4de8e4c4fa7ac38f6e35822f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i112e5d0a75164fdeb157a57239a63582_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa3affafd794a8aba01a0642e492edc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0aeb03074de41f4a5d5dadadbbef2d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5567182ccf4bf2afb2d97a18d3f46e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b68c68d4340458b97c555caf230716e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic64816f8cccb4c3aa043d7bda0ab7443_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1428c27386ca455990cd6a0836006bf5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59c249ecf14641feac25b572b32ac6c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55bf118e00554d2e9a4e30260c8c7917_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a0ebabf35b94de9b3494c8f98c35fcb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75dee15445a241d39eb89a15ed0d7674_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f597ec7d6d94442ad8c9951a802383c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d6c5a747f3646a5b3e9c6bcbaa397f8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c6a7c98f99c45a0af8e8a18126938ea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadccd508c3834cc2a5379622d5278846_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i768b7317377646e18a4f32bd2ab2443d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296eba7b2d0d407894537da13b4266d5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c66699e81d84448b3ba8cae1a7e7d61_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i030a14b9f87541e5a345d6f3f9d9e08d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib28660aeb4894aeabf3989dbe4367892_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a11d8ef901545fcbe623f7dd7ff571b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i099b2a7d616d421c860d4ddb8052bdab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27fd8cbeeab3426e97107930d3deb563_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i591e5151200040c0933b61638412feac_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52f666ba7ecd4b1e858ed6eed44de97d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b57ff5dbf448208328e971b35a3f90_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4ad65ae063d4e49821ad5b4dece8ece_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc7d2919e7140fa9c80f0f1d09a1728_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27bd3a8f9e2b4c90a09dc353bf7cbd60_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id15440599eac41b2b8dcbf173de1a069_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73db172d800a49ca831d1f3440d0a9a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01dc0feea8d540698b9fa442d8af1726_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia760ade7301b4ae091a97fbf0f60bae8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementinputadjustedEBITDAvolatilityDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae19c16d454a4da888fb439fac3a5955_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2eba1326445642438ae8479679188e72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1ddc2565fbb4bc9ac3f95f9e98205b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementInputMarketPriceofRiskDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97a07c4fb7834238809f74bc245a07e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625f2e9aec314e25b0c0699f19c11778_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d39ec8bd177421d91c1d78701f1ac51_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2dd58641ec4c47944780cf820a3c80_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893e8eee099341c480fec838d774cb74_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c3fa86ba23d4ca99c7c1d8b7d588cce_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08573f64c1804db985e0aed112395314_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia840f694db644720be6253993494b8e0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62a390f242ec4b708b42188ba1ed533a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8af3b131bc14d17a7571c2fdcc1af47_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c78732ffce9481d84d10a6eed768479_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id600755f8bb64800a5c3f7106c241dcf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56220f4e4fce4161bc7b4edbede836a0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92b9167994c04c478ad5b2e150315812_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf032587ff8047c4b9bb91de60bb0fa0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055211e4c3454a24b54386b6a7b21511_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97d55547e25c4f90a6a7c87dd4a11427_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id97f8182fd794fdaa58639212799a600_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d2d55b60f2e4d11a4d5ea598a1837be_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc848f2b140a428c9e22a6befc519c3d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1419702164fa4c2a834cca8d8c248f20_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0534e7808d42c69fc2180af5749efe_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia01d6c13756c4351b7acb497ed3f5adb_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3b4f8d61bc94efd8c535988f345c281_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c455c5698b743659c9158cd90d076a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i163dcce9674d46a2b3445bb6740cef0b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf12885b0a9c40079ede306096232146_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18ee0f7fc4e048ad942066fc6d02bb35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c21c453adc4f41a028e77788e381cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9346449d62a4bae80c04e42368902d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15baeddeabd64f0793f301a17f103c2f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic019a3f7c2aa41b3b60c36d8dc1afbdc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007e0b709a7948e9bfd7a77dfd33edca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8727c5088147f1815d1cbf94b178ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e231f7074be46edac627e3736610412_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff209c9c312842e6a5aa213e04c2dd43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib96b6effe9a345e6809e9a0242de4c6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i744f21c9656746cd8b7b2215b75ac43f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:AvailableforsaleDebtSecurityCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafc15da5318940b5a790f399b28e9e5a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab0337d3ad564247a1200aceefee3a92_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:AvailableforsaleDebtSecurityCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd1e48a37ce464490eb88d4e81041c1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e5193042f2c45bd83248a95c20e923d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708212e3ab134bbaab535bc663a5a479_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ba8683ccfb439d8c9bf26272861771_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i190b17e0f2b041758e8c0431e71dcc64_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id29aa22c8f0840b08bc18688167f63d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddf2d2aa8b564efc876aa1ba23936f52_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfb0aaca7e4e4381ac74739e433b7861_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c8a50a910984b9e86610a127c140e86_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c3826af64dd4f7db3fecffa7b173fc5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic439ddf48ef245c5b7e4afa06b2ebd93_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if65da200e05c4e4b9a561174b1bc7c23_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i731b7502508d4f8c8b50e49d76dc37ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e9016dd7b774b169ec2614f61542be9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71b6f20b81f44312800477e6da74fd8f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7e4ab57206c488b97acd961e65966ff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i912753928ea843239807436aa78d567d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aec3bdfaced4372b17ea0347c016398_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabdeca4cff6a4718b4f1dd649c39be64_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia17f985170954eb48428d61f36b19859_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if65467afecf74a8b93960ba983aa3d59_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b397229737456d84db63d3bf2f90df_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514d9e8e7edd4fa28d63ef9fccb34cd1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97a46089acbd4ff2aaeb2d2252ab6eb1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7205011397d3426281ae4bd434b15c77_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eb56f1821864a0db13d3ee2043d7dcd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide038f68482143e7bc6cead2e03b3248_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66bc748b1f3449e4a5e0f34ba0a23593_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02924cdb80304d2fbd0a1fd268de89a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfc7fd5a9dbe4432b60326ce95161345_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e310a8c7f034cd7853abf6100bc499e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5230a8d671ee4f5ab0953b698bff8639_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic17f4375ba33447ab41447690f328232_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if248896a740349349b9dc2c70a6c7362_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf4da5fb2b8244bca91159e192d1b9ee_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99c31a1bbc5e49dfba0d6f77e03b2107_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icedd39ede0a346b7935ed0db37bd69b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78ebe3443d494bd490f9f07d5202134d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ae4f3915f574485829c8127bbdd1797_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78b84b5657084d8e998eb611076dc5ab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icab58ddd66a140bc97118bd0a1be6cef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d03299aace54ed7ac0e3ac6f5fe2d8c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i148b265b5e2742bd83a80cbf70e476da_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i121a2aae16c14453b205c42847a26f54_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if626b886e63044aaa9c6735867a954ec_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic46418b7be58471cb3d15195cc4f5e2e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc6ce78ff0d54018b0f911617adafb8c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57b48a056c4f4370adbb6f193d7b4dd9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e374be09b9f4b79a626d3ea4af57397_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:GreaterThan275To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6781406cb9184964ac659cf86bf513a4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThan275To100Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9088e8033ac42c7978c4207a0f3bf01_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1cdbdaa242848b79d2fbe0b9504e9ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa110691e734492ebd77f89f72327112_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0afb2c7772cc49b1a684427d27a6856b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i338ce135c3964ade933cbd32298f936b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d6a1b5b0fc46539828a1892118c0d4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1994924f97d2435894c33f53b4e7eb17_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7b56bfd8ed46c2a062213becf7ccad_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48b83546156b4d78be0e3b72137bad96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a79558ef22f4c09ac5459ea71f37b04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i567486d5838948dd8530f75bf634afcd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i480060d5d0174855bf349ac2611a425d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95227b0013004393b99c2f868c8b0457_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd1bc723546d4451bd24a0afcc9a5ad0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63067cc116cb4e2baece3c78ca5225f7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i942bbd8143694f56aeaf956c380440e7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1114e70a57024459b1dd8837d9a8d9f3_I20220106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04278caae1d04e05aee4473287d6eb1f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide3f1af499ed4114bc7d8f8c83ec901a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000883984</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0zLTEtMS0yMzM5OQ_ced62afb-b606-4297-99ef-c3702478fb1a id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMy0xLTEtMjMzOTk_7aee2232-f5cc-4422-ac0b-acde2a7b22b0 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMy0xLTEtMjMzOTk_cc8b8dfd-f6dc-4ec6-ade4-50b9cede901b id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMy0xLTEtMjMzOTk_32d6c330-d912-4473-bc54-f1f72227b1fa id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMy0xLTEtMjMzOTk_98e9d6c1-3d9c-47ba-acef-9005f92f14af id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMy0xLTEtMjMzOTk_f3b68358-a167-4d1b-8af5-9ec10e8f8a00 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMy0xLTEtMjMzOTk_d1006863-ea7d-4d08-acaa-0dd139ce00e6 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMy0xLTEtMjMzOTk_3f6dcf20-b952-4de0-a9ee-232417604dbb id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMy0xLTEtMjMzOTk_329d35b3-51f6-4be3-bbcb-f409487a5d01 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMy0xLTEtMjMzOTk_1dbdf55a-a861-400c-aae6-f31012cdc0ee id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0zLTEtMS0yMzM5OQ_5cd22cf8-6283-40e8-bbc5-1bc602267a07 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMy0xLTEtMjMzOTk_95ae1fef-bd2e-4aa7-85d3-b39bcaf0be5e id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMy0xLTEtMjMzOTk_854504f5-7b4b-4a6e-a397-62f066a793aa id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0zLTEtMS0yMzM5OQ_7efa49ea-e092-413e-8751-a78ed1981b91 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMy0xLTEtMjMzOTk_a21ce225-4244-42ec-a068-e469ba3a1a67 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMy0xLTEtMjMzOTk_46bef57c-5157-447f-a499-70c305544b3d id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMy0xLTEtMjMzOTk_5d1b87c2-8fa3-4722-b2ef-4a2b0a6fbfa6 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMy0xLTEtMjMzOTk_e9fe34ae-66d8-4800-81fe-6664927fd088 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMy0xLTEtMjMzOTk_455e6497-8c50-4f7b-930c-dbbd2cdcd547 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMy0xLTEtMjMzOTk_536c1a7f-db16-4a10-bfbb-c97cfb71f07d id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMS0xLTEtMjMzOTk_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMy0xLTEtMjMzOTk_1d960f4e-b520-4e13-ac47-3d43057e8c38 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0zLTEtMS0yMzM5OQ_3144b2c3-7246-4a9a-b321-858926ddc79b id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMy0xLTEtMjMzOTk_73e25217-2337-4482-8f2c-9f7a801092f0 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMy0xLTEtMjMzOTk_4fb9c3bb-8931-450f-b3cf-01bdf5d961d5 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0zLTEtMS0yMzM5OQ_850e73c3-d686-46ed-ba31-c5a05b4446a4 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMy0xLTEtMjMzOTk_d7e34423-5f9a-44e2-9011-cd54a0587ee2 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMy0xLTEtMjMzOTk_0598d5f2-f50a-4a33-ac25-fbef7e76a68e id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMy0xLTEtMjMzOTk_e0b25fae-b7d7-48dd-8dfd-d1c3160c65c1 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMy0xLTEtMjMzOTk_73a62e42-584c-4dce-9927-9c26f4e79261 id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0zLTEtMS0yMzM5OQ_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i8343a502cf1c465a8adfd72ff6994fce_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgx_24da2f6b-28fe-4499-be59-fd82103b8368">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6YmU1YjU3NmVjMDA1NDM5NTg1YmQ3YjdkNDU2MWVlMWMvdGFibGVyYW5nZTpiZTViNTc2ZWMwMDU0Mzk1ODViZDdiN2Q0NTYxZWUxY18wLTAtMS0xLTIzMzk5_c3c50f52-5bc7-416f-b536-ae784b679d32">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xMjQ_ee345c25-b38c-44de-b69d-cc2e49e2d458">March&#160;31, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.465%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NTkwM2YyY2ZjNjc3NDQ3NWJjOTA5YmJhNTRlNWZkNzIvdGFibGVyYW5nZTo1OTAzZjJjZmM2Nzc0NDc1YmM5MDliYmE1NGU1ZmQ3Ml8wLTAtMS0xLTIzMzk5_2983145d-5490-4bbb-88f6-25e9dea36e2e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File No.:&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgy_6bb60dbd-2938-412a-9e56-001861cd3e96">001-34634</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:47.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6MjYxMjQwY2NkZjk3NDNiZGIxZGE1OWEwZjg1ZDcxYjQvdGFibGVyYW5nZToyNjEyNDBjY2RmOTc0M2JkYjFkYTU5YTBmODVkNzFiNF8wLTAtMS0xLTIzMzk5_5e364189-edfd-4cc5-a200-701d730035d4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6MjYxMjQwY2NkZjk3NDNiZGIxZGE1OWEwZjg1ZDcxYjQvdGFibGVyYW5nZToyNjEyNDBjY2RmOTc0M2JkYjFkYTU5YTBmODVkNzFiNF8wLTItMS0xLTIzMzk5_f12d48e6-8e6f-473d-aea9-922be618afab">33-0022692</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.043%"><tr><td style="width:1.0%"></td><td style="width:16.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.980%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.639%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.963%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTAtMS0xLTIzMzk5_5c90fe01-88b9-4bba-b09f-2d6e4d9e3293">951 Calle Amanecer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTItMS0xLTIzMzk5_a184e1b1-16c8-4672-9881-239fb024b539">San Clemente</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTQtMS0xLTIzMzk5_6e892a67-ea43-4cee-b98b-c6df98115b67">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTYtMS0xLTIzMzk5_7aada6c0-f8a4-4845-847c-bddbff8f6e87">92673</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgz_044219fb-a125-4a2f-baf6-61280d3ae459">949</ix:nonNumeric>) <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTg0_582ebb86-d879-4d52-a2b7-5b5ed9fa99fe">366-2183</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160; <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTg1_3cf8bf95-d13c-4849-aa1b-ecca538b466c">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160; <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTg2_f2e576ee-f32b-4094-9634-b304225482f5">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.059%"><tr><td style="width:1.0%"></td><td style="width:26.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6Y2NiZDc4MzkyMGZhNGVmZjhlNTYzNmUzZTc1YTdjZDEvdGFibGVyYW5nZTpjY2JkNzgzOTIwZmE0ZWZmOGU1NjM2ZTNlNzVhN2NkMV8wLTAtMS0xLTIzMzk5_365c3c9f-78ff-41ca-9136-a2659856d791">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6Y2NiZDc4MzkyMGZhNGVmZjhlNTYzNmUzZTc1YTdjZDEvdGFibGVyYW5nZTpjY2JkNzgzOTIwZmE0ZWZmOGU1NjM2ZTNlNzVhN2NkMV8yLTQtMS0xLTIzMzk5_43a7d8d2-ed8e-4cbe-a799-c2e3111b8917">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6Y2NiZDc4MzkyMGZhNGVmZjhlNTYzNmUzZTc1YTdjZDEvdGFibGVyYW5nZTpjY2JkNzgzOTIwZmE0ZWZmOGU1NjM2ZTNlNzVhN2NkMV80LTQtMS0xLTIzMzk5_47126e9f-b371-4d39-af07-7fb24e011a63">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act):&#160; Yes&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgw_e98cc6b4-6f99-4254-935b-48bab9018489">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:42.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NzljOTllYzM1YjZjNDgyNmExOWNjMTk0ZmEwZGFhZWQvdGFibGVyYW5nZTo3OWM5OWVjMzViNmM0ODI2YTE5Y2MxOTRmYTBkYWFlZF8xLTAtMS0xLTIzMzk5_34b8a5a5-c15b-4271-8d7f-0f1183a177be">Common stock, par value $0.10 per share</ix:nonNumeric></span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NzljOTllYzM1YjZjNDgyNmExOWNjMTk0ZmEwZGFhZWQvdGFibGVyYW5nZTo3OWM5OWVjMzViNmM0ODI2YTE5Y2MxOTRmYTBkYWFlZF8xLTEtMS0xLTIzMzk5_a79f54e8-8a7d-4522-aab6-f83240cf3000">ICUI</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NzljOTllYzM1YjZjNDgyNmExOWNjMTk0ZmEwZGFhZWQvdGFibGVyYW5nZTo3OWM5OWVjMzViNmM0ODI2YTE5Y2MxOTRmYTBkYWFlZF8xLTItMS0xLTIzMzk5_d5e90568-6f4a-4b3e-94e7-058411612d97">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Global Select Market)</span></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date:</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.908%"><tr><td style="width:1.0%"></td><td style="width:42.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.590%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding&#160;at April 30, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4143f4321de483daeaf8422585b5992_I20220430" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDM0YjhkNjg5OWYxNDBhZWJlYzQwYjIwOGYyM2JiYTIvdGFibGVyYW5nZTo0MzRiOGQ2ODk5ZjE0MGFlYmVjNDBiMjA4ZjIzYmJhMl8xLTItMS0xLTIzMzk5_8765f4c4-0972-4cf4-8e03-71ab48b64668">23,896,032</ix:nonFraction></span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2022</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.421%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;Number</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_10">Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_13">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_16">Condensed Consolidated Balance Sheets at March 31, 2022 and December&#160;31,&#160;2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_19">Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_22">Condensed Consolidated Statements of Comprehensive </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_22">(</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_22">L</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_22">oss) </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_22">Income for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_25">Condensed Consolidated Statements of Stockholders' Equity for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_28">Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_94">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_112">54</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_115">54</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PART II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_118">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_121">55</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_124">55</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_127">56</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_130">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_130">56</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_133">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_133">58</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.52pt;text-decoration:underline">Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands, except par value data)&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURRENT ASSETS:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0xLTEtMS0yMzM5OQ_8f223e2a-c7a3-45c2-b8c9-c02f9bc85e8b">329,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0zLTEtMS0yMzM5OQ_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776">552,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0xLTEtMS0yMzM5OQ_042a1c10-7f68-468c-a5f2-ec21530c78c3">14,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0zLTEtMS0yMzM5OQ_7efa49ea-e092-413e-8751-a78ed1981b91">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0xLTEtMS0yMzM5OQ_5cac9912-3b11-491d-bed4-d202c212cdb0">344,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0zLTEtMS0yMzM5OQ_ced62afb-b606-4297-99ef-c3702478fb1a">567,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmVmODBiYTVkMTE4ZjQyNTc4Y2VjYjBhYzc3YTE4NWQwXzY4_56a5c0c1-5b15-4de7-b108-bffac7f1fcc5">6,921</ix:nonFraction> at March&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmVmODBiYTVkMTE4ZjQyNTc4Y2VjYjBhYzc3YTE4NWQwXzgy_aa5a6e39-1e86-4eb9-880f-e855d2a8d8cf">7,038</ix:nonFraction> at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0xLTEtMS0yMzM5OQ_1783ed44-61fa-423e-b6d9-30b2616498d6">202,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0zLTEtMS0yMzM5OQ_3144b2c3-7246-4a9a-b321-858926ddc79b">105,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0xLTEtMS0yMzM5OQ_2e259d8f-d9d4-49de-aa52-8a8d0dcf7509">536,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0zLTEtMS0yMzM5OQ_5cd22cf8-6283-40e8-bbc5-1bc602267a07">290,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0xLTEtMS0yMzM5OQ_0f6960d9-049a-4b33-bec9-ed2473bdc25b">10,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0zLTEtMS0yMzM5OQ_850e73c3-d686-46ed-ba31-c5a05b4446a4">19,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMS0xLTEtMjMzOTk_29221140-b63d-4ea3-9114-83edc7057327">80,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMy0xLTEtMjMzOTk_98e9d6c1-3d9c-47ba-acef-9005f92f14af">46,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CURRENT ASSETS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMS0xLTEtMjMzOTk_6bbcbeff-3570-4869-8170-4039168b08b9">1,173,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMy0xLTEtMjMzOTk_455e6497-8c50-4f7b-930c-dbbd2cdcd547">1,029,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PROPERTY, PLANT AND EQUIPMENT, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMS0xLTEtMjMzOTk_bf574f23-40f6-4f51-b7f2-6ebaa3c93511">674,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMy0xLTEtMjMzOTk_d1006863-ea7d-4d08-acaa-0dd139ce00e6">468,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPERATING LEASE RIGHT-OF-USE ASSETS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMS0xLTEtMjMzOTk_7783218e-7891-4209-9c51-2efacc89438e">92,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMy0xLTEtMjMzOTk_f3b68358-a167-4d1b-8af5-9ec10e8f8a00">39,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LONG-TERM INVESTMENT SECURITIES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTgtMS0xLTEtMjMzOTk_a37bf520-05d4-4da8-b0e4-b06d7a0bf503">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTgtMy0xLTEtMjMzOTk_a01b21fa-ae9d-464d-b712-a89be39bf466">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GOODWILL</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMS0xLTEtMjMzOTk_aea7c300-2ee8-42bc-8f8e-68c24d5e3cad">1,526,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMy0xLTEtMjMzOTk_cc8b8dfd-f6dc-4ec6-ade4-50b9cede901b">43,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INTANGIBLE ASSETS, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMS0xLTEtMjMzOTk_4c928e13-9c1a-4c81-b7a8-a2b122c2b383">1,094,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMy0xLTEtMjMzOTk_1d960f4e-b520-4e13-ac47-3d43057e8c38">188,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjEtMS0xLTEtMjMzOTk_63e8dce3-e5ce-431f-ba91-47d9fbee08f8">77,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjEtMy0xLTEtMjMzOTk_118ed157-f4cb-439b-8e84-4893d6863033">42,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OTHER ASSETS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMS0xLTEtMjMzOTk_292a04ec-19b5-459d-ba96-0e8d914e07cc">104,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMy0xLTEtMjMzOTk_7aee2232-f5cc-4422-ac0b-acde2a7b22b0">63,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMS0xLTEtMjMzOTk_4d10a56b-609a-4723-af01-73eb394bf29f">4,746,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMy0xLTEtMjMzOTk_536c1a7f-db16-4a10-bfbb-c97cfb71f07d">1,880,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CURRENT LIABILITIES:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMS0xLTEtMjMzOTk_777b6f19-85c7-4931-bf62-9926a0d98a98">200,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMy0xLTEtMjMzOTk_32d6c330-d912-4473-bc54-f1f72227b1fa">81,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMS0xLTEtMjMzOTk_77184d0d-a829-4821-aeeb-495f082192dd">261,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMy0xLTEtMjMzOTk_d7e34423-5f9a-44e2-9011-cd54a0587ee2">118,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjktMS0xLTEtMjMzOTk_75053216-cfe1-41e6-a2b2-a4a8436babaa">13,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjktMy0xLTEtMjMzOTk_90f9957f-bf72-46ea-bc54-612412e6684a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMS0xLTEtMjMzOTk_05f5df22-0b2f-41fd-ab63-39121102b451">17,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMy0xLTEtMjMzOTk_4fb9c3bb-8931-450f-b3cf-01bdf5d961d5">1,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL CURRENT LIABILITIES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMS0xLTEtMjMzOTk_67f92a58-6c0d-46f4-b834-c384f08e9d0c">494,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMy0xLTEtMjMzOTk_0598d5f2-f50a-4a33-ac25-fbef7e76a68e">200,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CONTINGENT EARN-OUT LIABILITY</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMS0xLTEtMjMzOTk_8aabeb50-7166-4149-916b-cd6a192197c4">57,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMy0xLTEtMjMzOTk_73a62e42-584c-4dce-9927-9c26f4e79261">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LONG-TERM DEBT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzUtMS0xLTEtMjMzOTk_4ccd8e6a-00a4-4d67-b64a-46a3acaf57db">1,642,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzUtMy0xLTEtMjMzOTk_0940c759-8b82-4e41-bf73-bebc2e62c37b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OTHER LONG-TERM LIABILITIES</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzYtMS0xLTEtMjMzOTk_0bfad877-863b-465c-8708-1f2d9fca50df">134,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzYtMy0xLTEtMjMzOTk_6b8d70db-f3d1-4394-a8bb-e5dabb598e55">41,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">DEFERRED INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMS0xLTEtMjMzOTk_37c176c3-80df-4330-9217-8342e772413b">220,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMy0xLTEtMjMzOTk_a21ce225-4244-42ec-a068-e469ba3a1a67">1,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INCOME TAX LIABILITY</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMS0xLTEtMjMzOTk_b2b2179e-2d19-4e9f-a0ee-59e7d72f05cd">19,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMy0xLTEtMjMzOTk_5d1b87c2-8fa3-4722-b2ef-4a2b0a6fbfa6">18,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">COMMITMENTS AND CONTINGENCIES (Note 19)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMS0xLTEtMjMzOTk_7bdb1601-8a35-4347-b103-d518694bc2d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:CommitmentsAndContingencies" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMy0xLTEtMjMzOTk_73e25217-2337-4482-8f2c-9f7a801092f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">STOCKHOLDERS&#8217; EQUITY:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl8zMw_376fb228-85a8-4e9c-84e3-6f7ccc2f109c">1.00</ix:nonFraction> par value; Authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl81Nw_20e20338-a95c-46e6-8fef-1ed9e025c1a3">500</ix:nonFraction> shares; Issued and outstanding &#8212; <ix:nonFraction unitRef="shares" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_2f42a07f-0c52-4bf8-815d-321b0670a44f"><ix:nonFraction unitRef="shares" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_4741798e-0a03-4611-acaf-4a12eb78e72b"><ix:nonFraction unitRef="shares" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_980eb8e6-fc2a-4a46-95e5-0b43fd260535"><ix:nonFraction unitRef="shares" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_deddc23b-2ffc-4ddd-93a9-f9e415474685">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMS0xLTEtMjMzOTk_6d16ef22-2c67-4b58-b749-32f510187024">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMy0xLTEtMjMzOTk_e9fe34ae-66d8-4800-81fe-6664927fd088">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM18xOQ_e03f9b58-29c5-43e1-b6aa-00fc74555a55">0.10</ix:nonFraction> par value; Authorized &#8212; <ix:nonFraction unitRef="shares" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM180Ng_68664b0d-d8a1-4ddc-a8d4-807781be40dd">80,000</ix:nonFraction> shares; Issued &#8212; <ix:nonFraction unitRef="shares" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM182Ng_257315c0-fbcb-4157-b8e2-b72f8390054e">23,897</ix:nonFraction> shares at March&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM184Nw_cfb7c5b6-6b8c-41d6-98c0-490ded8cc89a">21,280</ix:nonFraction> shares at December&#160;31, 2021; and outstanding &#8212; <ix:nonFraction unitRef="shares" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM18xMjE_8a126408-28b2-4164-a02f-b7ad1a1c122c">23,884</ix:nonFraction> shares at March&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM18xNDI_a68b9cb1-e6d9-4703-b141-b3b64807d47d">21,280</ix:nonFraction> shares at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMS0xLTEtMjMzOTk_e48ee132-beec-4002-8c2c-174fb31b3d5f">2,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMy0xLTEtMjMzOTk_e0b25fae-b7d7-48dd-8dfd-d1c3160c65c1">2,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMS0xLTEtMjMzOTk_ae026f59-c364-4c1c-8fcb-542e9417ef0c">1,306,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMy0xLTEtMjMzOTk_3f6dcf20-b952-4de0-a9ee-232417604dbb">721,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="0" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjphMTEwYzZhOTQwMjc0MjdiYjlkNzVlNzVkZWIxMjE3N18yOQ_a065c0f7-8fef-403e-8497-7be8c12a6321">12,684</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="0" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjphMTEwYzZhOTQwMjc0MjdiYjlkNzVlNzVkZWIxMjE3N18zNg_9509bcca-1e4c-4fb2-9867-20451623f3e3">119</ix:nonFraction> shares, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMS0xLTEtMjMzOTk_7f1801cc-1268-4115-ba5f-93c4d613a90e">2,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMy0xLTEtMjMzOTk_1dbdf55a-a861-400c-aae6-f31012cdc0ee">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMS0xLTEtMjMzOTk_4afae006-708a-4552-9dbb-0da7dc8f336b">873,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMy0xLTEtMjMzOTk_95ae1fef-bd2e-4aa7-85d3-b39bcaf0be5e">911,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMS0xLTEtMjMzOTk_b0537436-48f3-420e-89d5-a1b4fa47c940">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMy0xLTEtMjMzOTk_854504f5-7b4b-4a6e-a397-62f066a793aa">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL STOCKHOLDERS' EQUITY</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMS0xLTEtMjMzOTk_4881f416-8c20-42c2-95e5-f911c4732a75">2,178,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMy0xLTEtMjMzOTk_329d35b3-51f6-4be3-bbcb-f409487a5d01">1,616,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMS0xLTEtMjMzOTk_6779b994-fdab-4501-be16-8cac7df2be1f">4,746,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMy0xLTEtMjMzOTk_46bef57c-5157-447f-a499-70c305544b3d">1,880,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453" footnoteRole="http://www.xbrl.org/2003/role/footnote">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</ix:footnote></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL REVENUES</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMi0xLTEtMS0yMzM5OQ_3fbc241c-9c48-4539-beec-1a8c32ec3b88">543,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMi0zLTEtMS0yMzM5OQ_3a491be6-cb0a-4de0-9503-2da593b368fa">318,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COST OF GOODS SOLD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMy0xLTEtMS0yMzM5OQ_55cb87c4-1ab2-4a42-85bd-aa6c8b9528fd">374,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMy0zLTEtMS0yMzM5OQ_1cccb4db-64c0-4efb-9b91-8bdaea293cd4">205,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GROSS PROFIT</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNC0xLTEtMS0yMzM5OQ_5ff8df05-7037-420f-bad0-09cfa8a09b00">168,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNC0zLTEtMS0yMzM5OQ_ff5f40f2-a9b3-481e-a193-65d38bd9a390">112,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATING EXPENSES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNi0xLTEtMS0yMzM5OQ_33cf3920-3c24-473b-9c0f-d48d1a6815bc">153,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNi0zLTEtMS0yMzM5OQ_38faddea-0d7c-479e-bfd4-b61ef51548af">72,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNy0xLTEtMS0yMzM5OQ_60ac384e-c89b-4589-ac33-9e3926d3c143">23,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNy0zLTEtMS0yMzM5OQ_f4e57751-9437-4339-8fec-5ed6236ece8d">10,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfOC0xLTEtMS0yMzM5OQ_90f03014-f1b6-4223-accb-b8cf5bd0bc95">33,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:Restructuringandstrategictransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfOC0zLTEtMS0yMzM5OQ_a952656f-724f-449a-988c-39fca1742f24">2,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:Contractsettlement" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTAtMS0xLTEtMjMzOTk_44e76da9-6d34-4a0b-a267-32b75ebc2f5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:Contractsettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTAtMy0xLTEtMjMzOTk_ecbee636-88d9-482d-a8ad-9b281b923eaf">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL OPERATING EXPENSES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTEtMS0xLTEtMjMzOTk_7747b104-5a9b-4b0d-a75d-51fd57047b8b">210,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTEtMy0xLTEtMjMzOTk_e0143547-c67b-471a-8fc2-5b005593d8ca">86,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(LOSS) INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTItMS0xLTEtMjMzOTk_eca3d082-59a7-4584-9933-b43c30bb99ce">42,161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTItMy0xLTEtMjMzOTk_389c79ea-d2f6-4d8c-86ee-30dfe40a1ed0">26,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTEREST EXPENSE</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTQtMS0xLTEtMjMzOTk_c2dec322-b84d-4ff8-ba88-2ee045e1d26f">13,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTQtMy0xLTEtMjMzOTk_902aa5bc-3cfc-445e-9a60-a4b750c7bf22">161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER INCOME, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTUtMS0xLTEtMjMzOTk_de0b792b-48ac-40ac-991c-8540eb3b1ae0">1,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTUtMy0xLTEtMjMzOTk_069cbdd6-e804-43a8-b619-5ea36bd617c7">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(LOSS) INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTYtMS0xLTEtMjMzOTk_ec36d0a1-efa1-4ee1-bb1a-bc16336b529e">54,801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTYtMy0xLTEtMjMzOTk_8e3985ff-8adb-434a-aa39-49e2213c1571">27,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BENEFIT (PROVISION) FOR INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTctMS0xLTEtMjMzOTk_ebf6c258-c750-4c02-93ea-d1c11b0cb8da">16,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTctMy0xLTEtMjMzOTk_8e0edcb1-8c48-49f4-9c57-1375f73a5ebb">3,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET (LOSS) INCOME</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTgtMS0xLTEtMjMzOTk_68615dee-bd61-407d-ba81-912725b657c6">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTgtMy0xLTEtMjMzOTk_a83511bf-c74f-410e-8362-a0f722e110f8">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET (LOSS) INCOME PER SHARE</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjAtMS0xLTEtMjMzOTk_d643da38-127c-4a2a-9be9-912b4ada2242">1.61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjAtMy0xLTEtMjMzOTk_f7fbcb2d-8fee-4d87-af34-a810a61cc269">1.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjEtMS0xLTEtMjMzOTk_673f2412-0a1f-47ba-8474-52baee72ec1e">1.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjEtMy0xLTEtMjMzOTk_71c6f6b4-e451-45c4-a29b-a673a70e9fd7">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">WEIGHTED AVERAGE NUMBER OF SHARES</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjMtMS0xLTEtMjMzOTk_2f69072f-b445-4602-8c3d-ea4a700ac797">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjMtMy0xLTEtMjMzOTk_6e80a370-1273-4167-8f19-35ac97d3fdd3">21,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjQtMS0xLTEtMjMzOTk_25b50bc0-f558-4484-b792-f3321eaa5651">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjQtMy0xLTEtMjMzOTk_32c11b28-52ed-4c71-9572-fed88200fb80">21,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NET (LOSS) INCOME</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfMi0xLTEtMS0yMzM5OQ_e30f038c-4e60-420c-9b66-1ae118369f42">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfMi0zLTEtMS0yMzM5OQ_bc2f94f8-f61e-47b9-a2f5-451ae607ddb1">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow hedge adjustments, net of tax of ($<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmI2NWRlNDgyNDkxODQ1MGViZWI2YzIwZDIwMzI2ZDYwXzQ5_c71799e3-addd-417b-992f-fa60aa282d42">7,312</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmI2NWRlNDgyNDkxODQ1MGViZWI2YzIwZDIwMzI2ZDYwXzU2_46bc91c1-4ce1-4aee-8179-b47ff74af45c">298</ix:nonFraction> for the three months ended March 31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0xLTEtMS0yMzM5OQ_ad73e19d-7673-4a81-9da0-c4ac9e914a62">23,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0zLTEtMS0yMzM5OQ_917f932b-5b3d-4d2f-9c2f-cc274baaa3b9">945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOjRjYjBiOTE1ODFkNjRmNTlhZDA2MzFlMzlmMDEzM2FlXzYx_5ae28854-c01c-4be4-bc48-a3f4dec29c67"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOjRjYjBiOTE1ODFkNjRmNTlhZDA2MzFlMzlmMDEzM2FlXzYx_875b80e6-a08a-4a11-b282-fb831edf7891">0</ix:nonFraction></ix:nonFraction> for all periods</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0xLTEtMS0yMzM5OQ_837799f1-9ea9-4634-a49c-ff4ab6ecf4ac">4,946</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0zLTEtMS0yMzM5OQ_f8533d45-bfd3-44d3-b729-b65381a0a6e3">7,458</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmQwYzAxZjQyNWFlNzQ1ODI4MzNjNGQxYjIwOGU3OTIyXzM5_dea1ebe9-32c3-4049-994e-6b9827379c5f"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmQwYzAxZjQyNWFlNzQ1ODI4MzNjNGQxYjIwOGU3OTIyXzM5_f1909a64-a1d0-4bee-b1f5-ae68e185e5c8">0</ix:nonFraction></ix:nonFraction> for all periods</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0xLTEtMS0yMzM5OQ_e22c59d8-e4b2-4410-b9e9-ab6e701cb923">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0zLTEtMS0yMzM5OQ_171c88d8-8eca-4210-931f-171c3c58a23b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNy0xLTEtMS0yMzM5OQ_199310b0-a349-447e-b15b-3cb8dd6a919b">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNy0zLTEtMS0yMzM5OQ_03026bca-26e4-4ba1-95df-6e9ee59be9d4">8,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPREHENSIVE (LOSS) INCOME</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfOC0xLTEtMS0yMzM5OQ_4407822f-708b-488a-b3ec-6b4d431c9247">19,427</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfOC0zLTEtMS0yMzM5OQ_4cfe52a6-d4f5-42da-810c-9e90d32c0657">15,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:38.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.902%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic739b9e6cfbd49928ba2becb10737a7b_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0yLTEtMS0yMzM5OQ_dbbf0bb8-f702-4be4-a3ff-e831d4de5ea3">21,280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5d868d49505419592afffab42bf0eb7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi00LTEtMS0yMzM5OQ_19a67c00-7d8f-4d28-899b-1a887ec35746">2,128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64868371845d4e76bc447e71919e1983_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi02LTEtMS0yMzM5OQ_2585f28a-05ca-4c98-94fc-8d83ea6b6eb7">721,412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfc64c489cf04a69892f2bb79d05265d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi04LTEtMS0yMzM5OQ_f24147ad-822d-42f5-9a96-2dcbca3829a6">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6984b38e57b4cb9b7db8552e7a3fcaa_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0xMC0xLTEtMjMzOTk_cbf8028a-1970-4dd2-b816-f87f151dec52">911,787</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86236b5f9d4c43f5b952f83a321739b1_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0xMi0xLTEtMjMzOTk_3d2a07a1-5191-4b1c-af1e-8602da137f2c">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0xNC0xLTEtMjMzOTk_faaeec9f-0b18-4a07-89c7-88bcfaf20e84">1,616,031</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee98598f2d5949e89f38dd5e926233ef_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy0yLTEtMS0yMzM5OQ_a542b5f5-db3f-4805-88e5-37dc893b2471">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a81a7b494f4b9389f3416497deb3e2_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy00LTEtMS0yMzM5OQ_5b9fdaa4-ab69-4ccf-8587-486e1838811c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy02LTEtMS0yMzM5OQ_a368e7b8-352b-43bd-9301-97af3dabc3cb">2,965</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d11403464e048ae8378f62edfc53cea_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy04LTEtMS0yMzM5OQ_dd433c8e-4eb0-4dda-a33e-9cbe86490b92">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy0xNC0xLTEtMjMzOTk_f547756c-0211-4f33-93d4-8456cd523488">2,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iee98598f2d5949e89f38dd5e926233ef_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNC0yLTEtMS0yMzM5OQ_f50d8223-8a83-4f14-9c05-e4b8584cf69d">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d11403464e048ae8378f62edfc53cea_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNC04LTEtMS0yMzM5OQ_12cf78d0-2890-47af-9470-7c5d818efa52">8,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNC0xNC0xLTEtMjMzOTk_fdb4057d-2737-4c6a-98ab-0b91eca8f9f6">8,743</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS0yLTEtMS04MzA3NQ_8bc2d8df-aa61-4bde-aedc-a2bd552fdcec">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a81a7b494f4b9389f3416497deb3e2_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS00LTEtMS04MzA3OA_1bd5497e-fa44-472f-a8f1-0d1131b55e82">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS02LTEtMS04MzA4MA_8fcbb2dd-dae0-4f1b-b151-402131153d27">575,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS0xNC0xLTEtODMwODM_5295b2bd-238b-42eb-bbdb-18510c5fa585">575,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS02LTEtMS0yMzM5OQ_24c1eddb-d054-42ef-b976-1bc9ad849744">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS0xNC0xLTEtMjMzOTk_eee8091c-9d30-4cfd-b8b1-60c0103ade4d">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb961a439cc448229c94512348851dab_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNi0xMi0xLTEtMjMzOTk_d32a77a0-9692-4ca1-b623-abdc2f4a2150">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNi0xNC0xLTEtMjMzOTk_33df5c6f-99be-4069-8ecc-5bf1816ac6d7">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ffc6e2664094fdf93f1f351c76c317c_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNy0xMC0xLTEtMjMzOTk_49d42a08-a466-44de-b41f-0a638dae1032">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNy0xNC0xLTEtMjMzOTk_6fcf52fe-a256-4ad2-8e22-76537ef4d81d">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fe8dbdded6c47e5abc6e9b101c5276c_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0yLTEtMS0yMzM5OQ_868063ad-dcc9-48f6-93f3-21c3c6fe4755">23,897</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i691612597ddd469aa1e76c59b67248a2_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC00LTEtMS0yMzM5OQ_734dd19f-ca29-47f8-b9db-4041e6294197">2,390</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77dbdeb976b5481f9ae92bbf1102665e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC02LTEtMS0yMzM5OQ_680efe93-def8-4eb6-99be-16b85255ed39">1,306,264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cbe5a67bda441529efd0b011401173b_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC04LTEtMS0yMzM5OQ_5b6ac48f-42b3-4895-af4b-1cdb86dc5a59">2,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69c8c17a24744f9be803234128f6c24_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0xMC0xLTEtMjMzOTk_ae08fd93-d436-4670-9da3-c7520e47db86">873,719</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a542e87e2f471ba2bf2af24b497b2e_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0xMi0xLTEtMjMzOTk_db52fbcb-5d34-4252-b18f-e6b866d9170f">628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0xNC0xLTEtMjMzOTk_cf24cf8c-d52e-462a-a5ec-5195f7affdef">2,178,902</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:38.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.902%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.280%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idbec71a052e34a628bdbc7874d90f523_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0yLTEtMS0yMzM5OQ_c474737c-590e-4f9d-9b78-e8cea9348fd7">21,058</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee88159d0ccf4a36be2cea91faa46dd6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi00LTEtMS0yMzM5OQ_ffe6356f-afef-4fdf-8297-4fe7bd283f72">2,106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83d7811e874b43c3ac9eedf4ade5ff94_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi02LTEtMS0yMzM5OQ_eebd16b2-29ae-4422-9400-5b92ed393cfa">693,068</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaa3308af1304da2922818b5e5b2203a_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi04LTEtMS0yMzM5OQ_39d93d85-b6a1-48b1-be1b-d206a627aa3a">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4bf3dd823004949bb668180e422e8b7_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0xMC0xLTEtMjMzOTk_286dc9e5-6ba2-4214-b986-b3f1f3395fd6">808,652</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d5d4b789c14217a4637b71e3935b05_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0xMi0xLTEtMjMzOTk_a2e0e79b-1b0a-4643-8ce9-2f226abe628b">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0xNC0xLTEtMjMzOTk_2b96084d-0b7a-49e5-b21a-92772ae4ad24">1,502,265</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock and exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6de1955a7159499e9b68b9b0daa91296_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy0yLTEtMS0yMzM5OQ_9595d7eb-0d26-4b75-b6c6-51a5ad27e3e8">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23ec980b5784615a4b1e1be6c1805d9_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy00LTEtMS0yMzM5OQ_75cb80c3-82d7-4275-956c-47de21ddf0ce">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dae3bb26454570acfeaff45f3e5b66_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy02LTEtMS0yMzM5OQ_b907134e-2059-4201-af09-18eacd67a6e6">2,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4e2dc9a5e24485b8f9b458a7172bbff_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy04LTEtMS0yMzM5OQ_16cb27ab-ef69-4a4e-88d5-62d4a7854abf">2,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy0xNC0xLTEtMjMzOTk_ef21eb33-1611-4825-9b8d-1fed631a4cfe">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6de1955a7159499e9b68b9b0daa91296_D20210101-20210331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNC0yLTEtMS0yMzM5OQ_a1094a7d-5645-4f75-b7bf-67f34e72337d">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4e2dc9a5e24485b8f9b458a7172bbff_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNC04LTEtMS0yMzM5OQ_ef9b0ce5-fa5d-41a5-96a5-939b1e4870e8">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNC0xNC0xLTEtMjMzOTk_390929dc-aeae-494b-8355-b53f96f22eeb">7,723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1dae3bb26454570acfeaff45f3e5b66_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNS02LTEtMS0yMzM5OQ_8fc503bf-0241-44ac-a0cc-a6e64cf99dd7">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNS0xNC0xLTEtMjMzOTk_fd00b81a-e5c4-4ccc-b0b1-6c150c862ba3">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5cd3a8fb34fc4f0f9340555ab6074ee6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNi0xMi0xLTEtMjMzOTk_064082bd-c97e-4dc3-aebd-4b5d88d61a60">8,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNi0xNC0xLTEtMjMzOTk_f1ed6d2b-84e2-49d8-9746-0b659c3ed1af">8,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib569fc18582645668995f72d04a72816_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNy0xMC0xLTEtMjMzOTk_fdaf1d9f-ff78-4000-aae2-0464231f5974">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNy0xNC0xLTEtMjMzOTk_9c17b1e6-a66d-458e-be11-7b529355d9dc">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58b4154cd7374229b9e379d211fbefc5_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0yLTEtMS0yMzM5OQ_32215ebd-d0d5-448f-a79d-e881cb8f98ae">21,219</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i894ed5cd7131488eb00a9af8903195f4_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC00LTEtMS0yMzM5OQ_8c772c7c-1779-4d6f-bd14-e001ce7eaad4">2,122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463ae5afe8854c50a81194644b397891_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC02LTEtMS0yMzM5OQ_9038bd54-36b1-476e-ab07-b0c599246d10">701,586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766a662d646644049de578ec36ca4f87_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC04LTEtMS0yMzM5OQ_add666bf-4c63-4d3d-9768-300ffe1cd513">5,410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93e818396f3f49a2ad987c721bf7dd83_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0xMC0xLTEtMjMzOTk_781519fc-042e-4121-b83d-e524a53e2de1">832,383</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9086cf89d1247ba9e8c0d33a92d5450_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0xMi0xLTEtMjMzOTk_4fcf2971-be2e-4d70-ba2d-56e1d52501dd">9,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0xNC0xLTEtMjMzOTk_35c8822e-532f-4528-8b4e-7b8faa799458">1,520,768</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMy0xLTEtMS0yMzM5OQ_dbf4a617-b6e9-4832-9789-90cc160185e6">38,068</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMy0zLTEtMS0yMzM5OQ_8c040a25-f314-4be9-90a0-9afff6d3fc69">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNS0xLTEtMS0yMzM5OQ_4220f00f-5221-4d42-a0f9-cb0f58911359">53,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNS0zLTEtMS0yMzM5OQ_d6ca2aee-c333-494b-979c-8c126f865cc3">22,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of inventory step-up</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:AmortizationOfInventoryStepUp" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0xLTEtMS03ODM5OA_aa5c395e-8aea-4407-9a7b-a641ca38c906">14,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:AmortizationOfInventoryStepUp" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0zLTEtMS03ODM5OA_79b14498-4c5b-4bf2-8491-1525df7c1ef6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0xLTEtMS0yMzM5OQ_ac23e570-2dd9-4522-9705-772fa0cad30f">5,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0zLTEtMS0yMzM5OQ_6a0c6ca9-d992-4f74-9c49-ac4c1df76204">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNy0xLTEtMS0yMzM5OQ_0f4bf77e-c595-4ccb-adb2-a352906bab6d">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNy0zLTEtMS0yMzM5OQ_3845bcd5-43f4-4717-a4eb-53d7448d55da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for warranty and returns</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:ProvisionForWarrantyAndReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOC0xLTEtMS0yMzM5OQ_ea700709-3f50-4433-bcb3-48cf77a43e4c">726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:ProvisionForWarrantyAndReturns" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOC0zLTEtMS0yMzM5OQ_b4cf7dac-988e-42d4-a221-3deccce9a4fe">209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOS0xLTEtMS0yMzM5OQ_de0e882c-84c4-4c24-985e-05ba06d2307e">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOS0zLTEtMS0yMzM5OQ_f58b1c1a-1049-4d50-87ac-eafd82cb44cb">6,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on disposal of property, plant and equipment and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTAtMS0xLTEtMjMzOTk_15773f4e-1211-4224-a952-467bd70089b6">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTAtMy0xLTEtMjMzOTk_bf50ed2d-9beb-424d-8286-77e75523d2d8">659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bond premium amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTEtMS0xLTEtMjMzOTk_e8740504-80b3-42a6-a6a1-8ecd5c14daff">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:InvestmentIncomeAmortizationOfPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTEtMy0xLTEtMjMzOTk_822541fc-21ba-449b-a3a4-d3aa98a9afb7">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTItMS0xLTEtMjMzOTk_a7962df2-2e03-43f5-9ede-55dbd1d37b4a">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTItMy0xLTEtMjMzOTk_f845f838-e0fb-467c-94ad-ba26bd7c3cbf">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Usage of spare parts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTUtMS0xLTEtMjMzOTk_bb5b7c01-e1b1-4bc8-a924-c006d22e389e">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:Sparepartsusage" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTUtMy0xLTEtMjMzOTk_9a5b75e0-25cb-422d-a30e-c6ae4e2aa2c3">2,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTYtMS0xLTEtMjMzOTk_5538607d-2de2-4e75-958e-6eedb13c44e4">1,649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTYtMy0xLTEtMjMzOTk_1a24d51b-4588-4652-95a6-23e221403e21">1,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of amounts acquired:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTgtMS0xLTEtMjMzOTk_547ac486-31d6-4d46-9e6b-3ffd10cc9f0d">22,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTgtMy0xLTEtMjMzOTk_f0cb7ef0-e054-4836-a098-5e06ec201852">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTktMS0xLTEtMjMzOTk_7769c256-008b-4001-8327-abb2483ce6a0">36,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTktMy0xLTEtMjMzOTk_5c4c0810-6e7e-4d86-b850-417484c5c250">13,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjAtMS0xLTEtMjMzOTk_85c6fff0-5fc6-489f-a342-187c572d4b27">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjAtMy0xLTEtMjMzOTk_78f91aa2-37c2-41d7-be86-a7fadca70ede">742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjEtMS0xLTEtMjMzOTk_76b599e9-0f50-4970-830d-ded4bdb09afe">14,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjEtMy0xLTEtMjMzOTk_16c7e48e-2509-4497-8df8-fbfcf6febf03">3,463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjItMS0xLTEtMjMzOTk_86ffedd2-b4ed-42dc-a5da-3e7a85211f4a">19,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjItMy0xLTEtMjMzOTk_b04766a0-b3fe-49ba-8cc1-abe6edcad626">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjMtMS0xLTEtMjMzOTk_8f70a698-d4f3-4317-9037-40dded42fa37">19,238</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjMtMy0xLTEtMjMzOTk_7563bed5-c22a-4673-8123-47d0b738fa46">19,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes, including excess tax benefits and deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjQtMS0xLTEtMjMzOTk_5c2385c1-67a5-420e-bc16-1005803c0f88">26,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjQtMy0xLTEtMjMzOTk_56b527f6-15bb-42b5-b404-af36caf1b650">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjUtMS0xLTEtMjMzOTk_23d77972-5f21-4a31-b8bf-073bd2049bc3">1,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjUtMy0xLTEtMjMzOTk_b4ef3e32-5153-4fd3-b73e-4e84f608b38e">51,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjctMS0xLTEtMjMzOTk_c9008c86-830b-4cd8-94d3-8212002bb762">23,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjctMy0xLTEtMjMzOTk_4e9fa866-6e22-497e-a5a2-944351f62186">14,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjgtMS0xLTEtMjMzOTk_9c51ff8f-e1f0-4bfb-a9b5-b15e3b13482a">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjgtMy0xLTEtMjMzOTk_bb42ae96-55b0-4c0b-9f11-046b5244345d">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjktMS0xLTEtMjMzOTk_7d586f35-dfc3-4e72-a0c6-b259b197c6ea">1,844,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjktMy0xLTEtMjMzOTk_7d82e179-84b3-47fe-8b14-529438d0e576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzAtMS0xLTEtMjMzOTk_9992a60b-ba78-4fb2-841f-e000cc25d4dd">2,387</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzAtMy0xLTEtMjMzOTk_f1c0f719-7170-4b74-a54f-3e442f04520c">1,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzItMS0xLTEtMjMzOTk_1804271f-67eb-4fbf-9b5f-f5092964db8a">1,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzItMy0xLTEtMjMzOTk_9d9e3efc-7e11-4098-8995-80b4eb7b7516">10,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzMtMS0xLTEtMjMzOTk_767c577e-141a-4f15-bdf4-06e1141c82a2">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzMtMy0xLTEtMjMzOTk_81e29548-ed66-4859-9e02-2969b94a96a2">7,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzQtMS0xLTEtMjMzOTk_6cb2b965-e3f6-470a-9843-ee6c262ed42c">1,867,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzQtMy0xLTEtMjMzOTk_c867fc16-2dcb-4fe2-9337-582d1d1078f6">18,881</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt, net of lender debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzYtMS0xLTEtMjMzOTk_a334ff59-e2ed-4c6c-be60-7783f892a8e2">1,672,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzYtMy0xLTEtMjMzOTk_7d14c37d-9095-4afa-9e53-683f1c3f16b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzctMS0xLTEtMjMzOTk_fe6d2992-9779-4b2c-b85c-fb0e3154300b">16,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzctMy0xLTEtMjMzOTk_c0aba7c9-8342-4457-9609-c2c47f4c78b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of third-party debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMS0xLTEtNzc0MTI_abd0fe19-0c32-4df2-b1dd-591609187153">1,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMy0xLTEtNzc0MTI_c48e58d7-cf82-4277-b393-8d330a153556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMS0xLTEtMjMzOTk_7f732b21-747f-4663-b211-d45767e2cf2d">2,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMy0xLTEtMjMzOTk_c3b800ed-0177-445f-b43f-a8f80842e7a4">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzktMS0xLTEtMjMzOTk_5b01dae7-517d-42b4-b5f1-66418146edf7">160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzktMy0xLTEtMjMzOTk_7a2a070d-387c-4a8c-9c1d-6812e6fac5ea">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDAtMS0xLTEtMjMzOTk_813d3c86-a3ef-41ea-a207-6218148ae034">8,743</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDAtMy0xLTEtMjMzOTk_bf4dc73d-7da2-4a86-8523-f2deb3ef983f">7,723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDEtMS0xLTEtMjMzOTk_7975406f-caba-42e9-b2ad-9922af618158">1,648,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDEtMy0xLTEtMjMzOTk_6ccf6b31-8bb8-41b7-be29-d6598eb72a70">3,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDItMS0xLTEtMjMzOTk_c92e3fde-e47a-49eb-9f91-66d7c235ca14">3,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDItMy0xLTEtMjMzOTk_3853d05f-2562-4302-8395-1a3bcb87e902">1,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDMtMS0xLTEtMjMzOTk_9fcdc25e-927c-46bc-9d1f-1cf2e08ab92d">223,399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDMtMy0xLTEtMjMzOTk_03c00b39-0957-4a41-9ceb-a1c751e1be91">28,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMS0xLTEtMjMzOTk_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776">552,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMy0xLTEtMjMzOTk_d475e045-ba25-4c52-b01b-ecadd868009e">396,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDUtMS0xLTEtMjMzOTk_2bc899dd-032f-44cd-8e62-b7bbb5147b21">329,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDUtMy0xLTEtMjMzOTk_fe531192-9bff-4151-b884-f9fc031824fc">424,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ICU MEDICAL,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:73.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.141%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Accounts payable for property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMy0xLTEtMS0yMzM5OQ_9645d35c-d331-4d3d-832a-9d97bf75aa8b">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMy0zLTEtMS0yMzM5OQ_3047d636-6539-4f69-b062-53add204054d">1,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Detail of assets acquired and liabilities assumed in acquisitions*:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:FairValueOfAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTEtMS0xLTEtODMxMDk_848fa656-f247-4b39-982a-8af23082484f">1,594,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTItMS0xLTEtODMxMTE_bc76399b-95f8-4fd3-a4ab-a1656a45fc39">1,844,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTMtMS0xLTEtODMxMTM_2459d989-7193-42d6-8ae9-cb0a12179474">575,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:ContingentConsiderationAllAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTQtMS0xLTEtODMxMTU_e6224a78-6aaf-46ed-913b-e599e44b4b72">55,158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill, acquired during period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:GoodwillAcquiredDuringPeriodAllAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTUtMS0xLTEtODMxMTc_15c0d975-1d12-41fa-a8ae-96606ddbde86">1,485,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities assumed/Adjustments to liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTYtMS0xLTEtODMxMTk_a320e858-4802-4c37-8a94-abf6a589c046">605,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*Includes amounts related to the acquisition of Smiths Medical 2020 Limited and measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_31"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_34"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.19pt"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8zNC9mcmFnOmZhNjQ1NzMxZTU4OTRkMWNhZmM2Nzg0NTJkODZiNmQzL3RleHRyZWdpb246ZmE2NDU3MzFlNTg5NGQxY2FmYzY3ODQ1MmQ4NmI2ZDNfMTczOQ_21a8361f-7e51-4a13-a353-ac23411292eb" continuedAt="i89fb66c3d0ff4ec28d214031fa82a8e5" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i89fb66c3d0ff4ec28d214031fa82a8e5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU Medical,&#160;Inc., ("ICU") a Delaware corporation, filed with the SEC for the year ended December&#160;31, 2021.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in the development, manufacturing and sale of innovative medical products used in infusion therapy and critical care applications.&#160;We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical 2020 Limited ("Smiths Medical"), see Note 3: Acquisitions. Our condensed consolidated statement of operations includes the results of operations for Smiths Medical from January 7, 2022 through March 26, 2022, which is the current end of their 4-4-5 accounting period.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8zNy9mcmFnOmNmYzk2NzQ5NzllYTRjYjJhMGYyYTQ5Yjc3YTc5MDRiL3RleHRyZWdpb246Y2ZjOTY3NDk3OWVhNGNiMmEwZjJhNDliNzdhNzkwNGJfMTc4OA_58c85ef3-c865-4e16-8ee9-1214a851813e" continuedAt="ie9cf1b226400412191a2fc775b2ff6c0" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie9cf1b226400412191a2fc775b2ff6c0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_91"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI3NQ_e14d21ea-d6d6-4f6d-8910-b63c30b19f9b" continuedAt="i97e36c89a5f94c1ba934b599cc444ee6" escape="true">Acquisitions</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i97e36c89a5f94c1ba934b599cc444ee6" continuedAt="i8c9679e62b1d4424946f1e7027b9a198"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired <ix:nonFraction unitRef="number" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="0" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMjE5OTAyMzI5MTQ3NQ_df51bb94-188d-4283-a074-a336868dea78">100.0</ix:nonFraction>% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash consideration for the acquisition was $<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="icui:BusinessCombinationConsiderationTransferredCash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfNDU3_67561b3a-03de-4ac0-b34e-16ee5f9c9b41">1.9</ix:nonFraction>&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of <ix:nonFraction unitRef="shares" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfNDg1_152fee50-3b7b-46a1-9480-f2bebe5d63b7">2.5</ix:nonFraction>&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the closing market price of our common stock on the acquisition date. Smiths may be entitled to an additional $<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfNjEx_df257995-1e34-4357-93e8-823ee4591a89">100.0</ix:nonFraction>&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="INF" name="icui:MinimumStockPriceTargetForEarnOutPayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzM0Nw_a60198f5-b1c6-4065-971b-f7bc979da013">300.00</ix:nonFraction> per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="INF" name="icui:MinimumStockPriceTargetForEarnOutPayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzM1Ng_75baa589-4b06-4e54-99d9-2b08b8fa4831">300.00</ix:nonFraction> per share (each a "Price Target"), and provided Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="1" name="icui:RequiredShareHoldingOfStockIssuedAtAcquisition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzM4MQ_45a57194-7035-49da-81d6-e03b105e3abd">50.0</ix:nonFraction>% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ1NDQwOA_df257995-1e34-4357-93e8-823ee4591a89">100.0</ix:nonFraction>&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preliminary Purchase Price Allocation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE1NA_2ba0a110-907d-4f2a-9130-a9374a759614" continuedAt="i85b33c33fbc34131a73f93dcba604f29" escape="true">The following table summarizes the preliminary purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i8c9679e62b1d4424946f1e7027b9a198" continuedAt="i5ca224d9eeeb4b208f79477f559cc493"><ix:continuation id="i85b33c33fbc34131a73f93dcba604f29"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMS0yLTEtMS04MzI3NA_181805dd-3781-4540-b0e5-083b85c79c34">53,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNC0yLTEtMS04MzI2Nw_1b98de30-e654-4aed-b80b-3f8b7c968b57">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNS0yLTEtMS04MzI3MA_802380c5-f7b1-4aa8-8592-affce38a2d6e">230.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNi0yLTEtMS04MzI3Mg_d2835194-0bac-4314-b0e8-504c71ccaf3a">575,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated consideration to be paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNy0yLTEtMS04MzI3Ng_2797d3bc-c144-400e-b488-4a5f356bcd5f">2,552,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTAtMi0xLTEtODMyNzg_c7ba5276-0f44-4a9e-8cdd-a33491541828">78,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTEtMi0xLTEtODMyODA_3b0c9b52-fa5b-43ae-a1bb-5194c141229f">120,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTItMi0xLTEtODMyODI_54609cfd-a8c2-45b8-b7c1-4c4e6d67124e">226,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTMtMi0xLTEtODMyODQ_ca24f570-d6b3-4130-af6e-cb5441039d34">34,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTQtMi0xLTEtODMyODY_526f943b-c626-4026-b457-96b8d689629e">210,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTUtMi0xLTEtODMyODg_fb01adf1-8c5a-4772-ab0b-df8b02c2dac2">57,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTYtMi0xLTEtODMyOTA_5ddd5e2c-2ac8-43da-8715-902be9efd2b8">925,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTctMi0xLTEtODMyOTI_7a436072-16cd-4d6c-8e0c-1f18f57deb8e">9,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTgtMi0xLTEtODMyOTQ_e41b01db-27d9-41fc-8c8c-9a4aecb5ab33">379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTktMi0xLTEtODMyOTY_982bc8a0-247c-472b-8554-36cbb7908798">105,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjAtMi0xLTEtODMyOTg_7e8045ad-65d9-43f2-a2d1-c0eeb5dfe169">175,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjEtMi0xLTEtODMzMDA_028f10fc-edf4-4323-af7c-4d1d1cc56854">24,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjItMi0xLTEtODMzMDI_8fa25786-7aa2-40b0-88d3-33b34f653819">85,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjMtMi0xLTEtODMzMDQ_071509ec-5359-4b8e-8a59-b516498c10a6">212,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjQtMi0xLTEtODMzMDY_502bc63f-d89e-4f45-86a5-81347fdccf3b">1,059,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-3" name="icui:BusinessCombinationGoodwillNonDeductible" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjUtMi0xLTEtODMzMTE_55f2d3d9-f95a-464c-96ee-7a21412cf89e">1,493,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjYtMi0xLTEtODMzMTM_b612703d-875b-4d76-9453-198bd7bbaeeb">2,552,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preliminary identifiable intangible assets include $<ix:nonFraction unitRef="usd" contextRef="id513614e0fb644d7b5f9986414615ea1_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzA3OA_e36172e7-bbf2-4211-8eca-88a506b56595">500.0</ix:nonFraction>&#160;million of customer relationships, $<ix:nonFraction unitRef="usd" contextRef="ib9c19a0416554eb991a114156f302300_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzA5NA_fe196299-f3b9-4845-aa97-122796b37394">420.0</ix:nonFraction>&#160;million of developed technology, and $<ix:nonFraction unitRef="usd" contextRef="i3e0f9607f3f64f179b6cf6d4462adc77_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzExMA_6427010d-2844-47a6-916a-4aed2f18d459">5.0</ix:nonFraction>&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately nine years, and, for each identifiable intangible asset is estimated as follows: eight years for customer relationships, ten years for developed technology, and six months for the trade mark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preliminary accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above purchase price and purchase price allocation are preliminary and subject to future revision as the acquired assets and liabilities assumed are dependent upon the finalization of the related valuations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The identifiable intangible assets and other long-lived assets acquired have been valued as Level 3 assets at fair value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i5ca224d9eeeb4b208f79477f559cc493" continuedAt="ic140d43c0f7042efaa59d78b5d0796af"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to March 31, 2022 were $<ix:nonFraction unitRef="usd" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzEyNA_eb05f855-535c-4dae-900f-a25d2fa03c25">214.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE0MA_2344cfda-77f9-499c-8993-d1d3325fc2f8">40.4</ix:nonFraction>&#160;million, respectively. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2021. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE1NQ_414b78de-55e4-4510-9120-c6baf288df5f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMi0xLTEtMS04MzM0Mw_37784eca-0656-4409-a1ce-ed77faed6b18">563,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:BusinessAcquisitionsProFormaRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMi0zLTEtMS04MzM0OQ_12b0c390-692c-4f04-8e8c-e0d7b2232fd4">594,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMy0xLTEtMS04MzM1MQ_bc66edc2-e78b-4bfb-a83f-a07927bc0300">34,994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMy0zLTEtMS04MzM1Mw_224f3387-1694-494b-8ed5-7e95a997060e">1,994</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:ProFormaAdjustmentAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE1Nw_7e8307c3-1345-4e18-9e6a-9ff7cde80c57">3.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:ProFormaAdjustmentAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE3MQ_0e5fe162-117a-402e-8126-16a39f39a953">26.3</ix:nonFraction>&#160;million for the three months ended March 31, 2022 and 2021, respectively, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Credit Facilities of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:ProFormaAdjustmentFinanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE4Ng_0ae874b8-67e0-4b7e-8bd9-4e7c7948a896">0.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:ProFormaAdjustmentFinanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzIwMA_13d7574a-f942-4d7e-b3f0-59a54a88d47d">12.6</ix:nonFraction>&#160;million for the three months ended March 31, 2022 and 2021, respectively; and a $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:ProFormaAdjustmentInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI0NQ_4cccac38-7511-4b7c-b4de-316cc23bc3a3">18.8</ix:nonFraction>&#160;million expense related to the increase in fair value of inventory for the three months ended March 31, 2021. In addition, there were non-recurring adjustments directly attributable to the business combination, including acquisition-related cost of $<ix:nonFraction unitRef="usd" contextRef="i6bb7b402883540419226d3c255ed0ce0_I20220331" decimals="-3" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI1OQ_914b7600-9341-4896-aa3e-85605b761ddf">13.5</ix:nonFraction>&#160;million for the three months ended March 31, 2021 and adjustments related to the extinguishment of related party loans receivable and payable equal to $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:ProFormaAdjustmentRelatedPartyLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzIxNQ_82930ed9-2de4-49b7-a050-41b3b54954f6">81.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:ProFormaAdjustmentRelatedPartyLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzIzMA_63d12b5f-32e9-4b3a-afc7-b5a690809f72">31.0</ix:nonFraction>&#160;million for the three months ended March 31, 2022 and 2021, respectively. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Acquisition</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic140d43c0f7042efaa59d78b5d0796af">During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTQ1NA_6b4c85c3-ffb7-4bda-825e-e8298df6436a">15.4</ix:nonFraction>&#160;million. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:BusinessCombinationConsiderationHoldbackLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzMyMA_53350510-0360-4b90-a193-ee14041e935c">0.5</ix:nonFraction>&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTQ4Mg_e5d004d0-089a-45c5-a2c3-1dc8c3670d9d">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTUwOQ_95ab2223-8b08-4c26-a98c-e0d307b40d8b">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTUzNg_a485c9e3-9c4e-4ffd-acb2-10b61373296b">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March 31, 2022, the total consideration which includes the acquisition date fair value of the contingent consideration was $<ix:nonFraction unitRef="usd" contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI2MQ_a0e022d3-5500-4d4d-9278-3d23125b8e39">17.1</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_40"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMjgzNA_62ae63d3-0e54-4f7e-b5c8-9cebcc439ce5" continuedAt="i0307f5b9aa46433c9314ed3d7bd15dc7" escape="true">Restructuring, Strategic Transaction and Integration</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0307f5b9aa46433c9314ed3d7bd15dc7" continuedAt="i4bebdde8a987498eb92b12ef6b33075f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTM3_772855e5-2615-44ca-b426-9a1af396916d">33.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="icui:Restructuringstrategictransactionandintegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTY0OTI2NzQ0NDUxMA_f6221196-f3ad-4757-9d88-25bb0b7edc4e">2.9</ix:nonFraction> million for the three months ended March 31, 2022 and 2021, respectively.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March 31, 2022, restructuring charges were $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:RestructuringCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfNjcz_89662d79-c2a8-4a70-bd7e-af98a5ee5a25">3.2</ix:nonFraction>&#160;million and were related to severance costs. Restructuring charges during the three months ended March 31, 2021 were not material.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMjg0Mg_2b6d94d2-7189-45c0-b531-e37990df7ba1" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended March&#160;31, 2022 (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.041%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Balance<br/>January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquired Restructuring Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges<br/>Incurred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency <br/>Translation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Balance<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance pay and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31bdd76ac7d94b7da503fd63b93ae400_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0xLTEtMS0yMzM5OQ_5fb7a51f-cf46-45cc-8be1-385f631e9353">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7330ec69856e4bedab9881611ec4c66f_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0zLTEtMS04Mzk3OQ_16fc140f-618a-4800-b2c8-9715ae5de449">5,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0zLTEtMS0yMzM5OQ_ae5d1006-6792-4acf-8b96-246132d70691">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS01LTEtMS0yMzM5OQ_315f2a5b-4d56-45d4-8be0-a24dcc00ae55">2,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS03LTEtMS0yMzM5OQ_72272bb4-0ea2-4f24-ba80-34b99bfca905">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7330ec69856e4bedab9881611ec4c66f_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0xMS0xLTEtMjMzOTk_85dfcbea-3658-4f65-9504-0ad8669256b1">7,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility closure expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idced1370c58d496699456e82e999c739_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0xLTEtMS0yMzM5OQ_02f92040-4cdd-4963-b15e-41fd07b1eb82">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4421707804146808e8d82bd497823f1_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0zLTEtMS04Mzk4Ng_46ac9ba0-368e-4a8f-ba83-d7871e494a77">1,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id248bc190fef460ab54156ad628a9a09_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0zLTEtMS0yMzM5OQ_75482fc1-dc9a-4db6-9168-02c413d4dab1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id248bc190fef460ab54156ad628a9a09_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy01LTEtMS0yMzM5OQ_45807a4e-2437-4e41-8ba3-f7a4f3decd44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id248bc190fef460ab54156ad628a9a09_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy03LTEtMS0yMzM5OQ_e9211f30-f7db-4999-9efc-c733ae0306f0">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4421707804146808e8d82bd497823f1_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0xMS0xLTEtMjMzOTk_57cbe14a-07d7-4e99-b169-8d350c62f157">1,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0xLTEtMS0yMzM5OQ_3d61e44a-c319-4664-ab4d-365d728e80c3">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0zLTEtMS04NDI4Mg_461b3893-8b5c-4849-aed2-bbc49716adcd">7,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0zLTEtMS0yMzM5OQ_abd0e571-f8eb-4f61-94f9-a0ea776cbebb">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRestructuring" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC01LTEtMS0yMzM5OQ_0c005458-b4d0-4603-97c4-1cf742afe906">2,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC03LTEtMS0yMzM5OQ_0c5e5624-077e-495e-bf1d-49482b7c7d64">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:RestructuringReserve" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0xMS0xLTEtMjMzOTk_415ed4b6-b625-4b6b-8805-50f0f926f234">9,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Transaction and Integration Expenses</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4bebdde8a987498eb92b12ef6b33075f">&#160;&#160;&#160;&#160;We incurred and expensed $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTU2MQ_fe2a0716-a130-4425-90fc-88b7fae12cce">30.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-5" name="icui:StrategicTransactionandIntegration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTY5NQ_fba94c5e-ac10-493c-9e27-02cb43e42e0d">2.9</ix:nonFraction> million in strategic transaction and integration expenses during the three months ended March 31, 2022 and 2021, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three months ended March 31, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 (see Note 3: Acquisitions) which primarily included legal expenses, bank fees, a United Kingdom stamp tax and employee costs. The strategic transaction and integration expenses for the three months ended March 31, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RleHRyZWdpb246YjE1MmM3NjJiODI1NGQ3Njg4NmQxMDFkZTE4Y2M2MDVfMzMyNA_acc53ce4-cc1d-4e6e-a97c-ca2c3e090ba1" continuedAt="i83a51bdbaaab4c2cb8bf3f15ac1c2356" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i83a51bdbaaab4c2cb8bf3f15ac1c2356" continuedAt="i7b6c60d0a6834d8799da2bc0c3d53257"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Following our acquisition of Smiths Medical, our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions, Critical Care, Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i7b6c60d0a6834d8799da2bc0c3d53257" continuedAt="i690a2cf1f2554f10b38b7546d82d76cf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b01fe971840481cbc0118ca73113ed3_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMi0xLTEtMS04MzEyOA_40dc05e8-0786-4dba-a9a8-df2d7792b2c3">140,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31670f3190f4250afa50c949a969ee7_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMi0zLTEtMS04MzEzMw_60cd8eb9-ad10-4ee1-8f0e-157b5f13f416">126,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6940ef2009e4c4896a32c8c4aaf68d6_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMy0xLTEtMS04MzEzMQ_f65cccb0-11a5-4964-9a22-c9569bfad6f0">87,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82d850d6caf542d5bb4c6d576c8debea_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMy0zLTEtMS04MzEzMw_14e8f2ce-16a7-4e0d-a86e-06544e41bef1">84,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05a0e8abbc6647928fbf299a5ca9c5bc_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNC0xLTEtMS04MzEzMQ_d612b1ce-1094-4a60-8624-31ecee1be940">88,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icca9ac7dfc3a4aa489ff4d89527fdae9_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNC0zLTEtMS04MzEzMw_9aa238c1-9adf-4740-b994-03c1dafca09b">94,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80e0a0251974b428f96f3f717f4d8c6_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNS0xLTEtMS04MzEzMQ_cee7db62-213e-414f-9198-3c3ae3e1b5c9">12,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i677c8e8ff77c48aa8ce2231709909edf_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNS0zLTEtMS04MzEzMw_9902a678-8d3b-4566-88bf-dc28109f24af">13,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c2efe33dc8d4acd88c30e7d87d93647_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNi0xLTEtMS04MzEzMQ_e2b05fb4-f435-4bf5-80cc-c301af4cfce7">66,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60182e4c96d44b05a31dbc6f360895df_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNi0zLTEtMS04MzEzMw_31f8706a-12ae-4f2d-89f3-ec0c7aea9fa1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular Access-Smiths Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i910b191cc2064df1a370ea5673a067f8_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNy0xLTEtMS04MzEzMQ_0a858e39-a9ac-4c84-8218-8ef253f7b352">79,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99f317b22200400aa27ba28ee92de705_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNy0zLTEtMS04MzEzMw_d48b8a67-c9c1-4614-8ccf-88d8dede9d24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vital Care-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa0894a784543158f3f2b1d7c4de28c_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOC0xLTEtMS04MzEzMQ_ae3d6a76-5bb2-4ffc-b62e-5634e4a6d192">69,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2afa04d4254f6bb80cb6e3672895e9_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOC0zLTEtMS04MzEzMw_8036b460-14c4-4b9e-b441-846d11505e3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOS0xLTEtMS04MzEzMQ_386255d7-daf3-4139-a7d8-54a833cc6060">543,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOS0zLTEtMS04MzEzMw_8926fd47-1c05-41d7-92b9-e668d15e4163">318,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical represent our newly integrated product lines following our acquisition of Smiths Medical on January 6, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RleHRyZWdpb246YjE1MmM3NjJiODI1NGQ3Njg4NmQxMDFkZTE4Y2M2MDVfMzMyNg_a40c2172-49de-4853-b5ea-d21666ce61b3" continuedAt="i77a8fc48edc44a2a96a7bb310205d878" escape="true">The following table represents our revenues disaggregated by geography (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i77a8fc48edc44a2a96a7bb310205d878"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c0bb3aed1b4706bc6fac56eab2c4cd_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfMi0xLTEtMS0yMzM5OQ_1f6c808b-c281-42bb-8370-ccf9394d9a4f">86,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38ee104e0e7f45abbbb082a302c3fd84_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfMi0zLTEtMS0yMzM5OQ_c9d809e4-398d-4c4c-a882-c1f54649929d">34,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b4f448345b34a609c7840e89139cedb_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNi0xLTEtMS0yMzM5OQ_0e439acd-1439-4640-bdae-cafe4f2661e0">109,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ffb2785f52491bb1b6d09817f187a4_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNi0zLTEtMS0yMzM5OQ_eee8e11d-be24-4095-b112-46aa2c4aaa69">55,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f91818e98e47c78b2642f077b41076_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNy0xLTEtMS0yMzM5OQ_cf6f63f4-e480-4658-923f-b39a4fc78918">195,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b42d6a2aae43fb9961ff4e802256f1_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNy0zLTEtMS0yMzM5OQ_40d05e28-f372-48d6-bc32-04d988fa639a">90,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib52844df4caf4174aa01d6d15e5ce18a_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOC0xLTEtMS0yMzM5OQ_aba0d283-709c-4616-95af-ccc1d88ed42f">347,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06dca36adccb4e6aa29a97ea62498b09_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOC0zLTEtMS0yMzM5OQ_cdd26749-c5cd-4b49-a88e-299895dd261b">227,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOS0xLTEtMS0yMzM5OQ_1f85bb72-2c94-47e6-98fb-51bd5a1dd211">543,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOS0zLTEtMS0yMzM5OQ_108f4e5f-5c4b-4788-a74d-8d310dece1b5">318,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i690a2cf1f2554f10b38b7546d82d76cf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RleHRyZWdpb246YjE1MmM3NjJiODI1NGQ3Njg4NmQxMDFkZTE4Y2M2MDVfMzMzMg_a6548c83-825d-4692-b9f5-7f076558ee6a" continuedAt="id93560b786b44413b34501b44ee0d7c5" escape="true">The following table presents the changes in our contract balances for the three months ended March 31, 2022 and 2021 (in thousands):</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="id93560b786b44413b34501b44ee0d7c5"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMS0xLTEtMS0yMzM5OQ_eefb4029-bc4e-4394-bfcb-e6674b1e40b6">7,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i461675ccf5e5457c93bc148a02ebef8f_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMi0xLTEtMS04MTA5OA_7e1c2971-cd3e-4497-b7ba-f3249fc43641">51,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c6563557f14f0fa17a7b159d6942ec_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMi0xLTEtMS0yMzM5OQ_d574f580-bb79-4415-987a-9f84b0fa1214">5,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94c6563557f14f0fa17a7b159d6942ec_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMy0xLTEtMS0yMzM5OQ_7600c79a-c037-4844-85ba-836dedf17108">3,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic115301640614d36b47d9f6973156033_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNC0xLTEtMS0yMzM5OQ_7f6d8c58-d20f-40ba-9f6a-ab13bd8ab059">4,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic115301640614d36b47d9f6973156033_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNS0xLTEtMS0yMzM5OQ_28438e1a-5a3f-4606-9679-567ef5199a0d">4,777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31ba1716c4654d44b41229c3a3ba3502_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNy0xLTEtMS04MTI1Nw_12cb65cc-a1f8-4eb9-a99f-1362b07c308a">2,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31ba1716c4654d44b41229c3a3ba3502_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOC0xLTEtMS04MTI2OQ_4a1d6990-5f78-4eec-8aa6-7de941dbdc7f">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica6df5554552455890bb3e503c4ecaf7_D20220101-20220331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOS0xLTEtMS04MTI4OQ_00299f29-7c20-45ef-b4c3-2b89bbe9a03f">767</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6df5554552455890bb3e503c4ecaf7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTAtMS0xLTEtODEyOTY_e1467b11-14bd-442a-a079-0ea569781efe">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNi0xLTEtMS0yMzM5OQ_cafe84c3-efa9-4b66-9d57-fd0d8bd99344">58,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOC0xLTEtMS0yMzM5OQ_f16a8104-4b10-4da6-a3f0-3b6bf7eb2ba3">6,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d0c665e84f4c42842d8354c9c251b1_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOS0xLTEtMS0yMzM5OQ_bf7862e7-6ed6-431f-87f0-c947c76c41ec">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10d0c665e84f4c42842d8354c9c251b1_D20210101-20210331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTAtMS0xLTEtMjMzOTk_b4cc4456-fb84-4caa-ac77-dc9cea8d1650">2,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice75ec9db3e341b6aef90d3334be1eb0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTEtMS0xLTEtMjMzOTk_28f12a81-b9f9-4f9c-a289-effbdaa522ec">1,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice75ec9db3e341b6aef90d3334be1eb0_D20210101-20210331" decimals="-3" name="us-gaap:DeferredRevenueAdditions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTItMS0xLTEtMjMzOTk_8783e9c8-83df-412e-a511-c65b63d4f8f4">1,794</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTMtMS0xLTEtMjMzOTk_cedcd825-a864-4558-84f2-18d1c835e2d3">8,888</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March 31, 2022, revenue from remaining performance obligations is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.516%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recognition Timing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&lt; 12 Months</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&gt; 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67d2154781164924b275843b993212d9_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMi0xLTEtMS04MjQ5Nw_2ef70f3c-86ad-41b5-8372-0cba0accb962">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieffb1189d545486bb1d18d7d6120aa94_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMi0zLTEtMS04MzE1Mw_9a995d4e-7b47-48b8-8c0c-57b8b077219f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747977f101ff4d60a6662e14aeccca04_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMy0xLTEtMS04MjQ5NA_709cc06f-5369-4300-888f-e5f43fefd23c">7.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9e71644be0d416286bfb1eca80a5bed_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMy0zLTEtMS04MzE1Mw_3efd7fe6-a972-4bd6-8d4e-022a0ab617e4">2.6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa7a333a6924010b053423c65083d92_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNC0xLTEtMS04MzE0Nw_865aafd3-443f-4fd8-98a3-8b59f9433831">1.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590611035a394a67b144447f0765cc48_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNC0zLTEtMS04MzE1Mw_605501a7-e1fa-46f1-8056-444b295abd24">12.8</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66742bd27a76437d802c35ce2d1bb3f2_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNS0xLTEtMS04MzE0Nw_39fa94c0-e8e7-46ff-bd19-979c8b1b7da9">2.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c8dc12807f14595a91b904cd714ee48_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNS0zLTEtMS04MzE1Mw_2fde12a0-34a6-45f8-b826-5b7bd89995e6">7.6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2dd7ec8ea2a4048a06ea268924bf23a_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNi0xLTEtMS04MzE0Nw_c77f6531-6cdb-41be-8b3c-d9fab8079925">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b1cec7abee4f76b35a418a82f45396_I20220331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNi0zLTEtMS04MzE1Mw_1d1eb42e-26fb-44dd-9094-74270fd8becd">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Other deferred revenue includes pump development programs, purchased training and extended warranty.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc4OQ_f64cd80a-a7d2-454a-a8a8-8ee32f2ad8b1" continuedAt="i8d0ab873bfe84a508186d556962cd001" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i8d0ab873bfe84a508186d556962cd001" continuedAt="i3df0b5cd80e84cc7b3b214a505e4dee0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities, and other long-term liabilities on our condensed consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i3df0b5cd80e84cc7b3b214a505e4dee0" continuedAt="i9b58b1190f014920a07b7e002dbea23f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of one year to <ix:nonNumeric contextRef="i8646fd65464c418fae83a8e61e4c8e4b_I20220331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMTUzNg_b1c47139-ec37-43ca-ab79-8353480edbe0">fifteen years</ix:nonNumeric>, some of which include options to extend the leases for up to an additional <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="icui:Optiontoextendinyears" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMTYxNQ_a99a23b1-4ce9-41dc-a2af-aa24bb629c66">five years</ix:nonNumeric>. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc5Nw_345be884-a828-4a51-950b-f370773687df" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMi0xLTEtMS0yMzM5OQ_69fb02c5-b413-44a0-8dbd-640dfd4bcd53">5,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMi0zLTEtMS0yMzM5OQ_d3bc3b59-9eb1-4ab3-96e9-5211ceaab2c2">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNC0xLTEtMS0yMzM5OQ_471d7d60-4214-4ba4-8b18-d1a572a491ba">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNC0zLTEtMS0yMzM5OQ_d5b91a9b-dea2-4975-bcca-2c1f441f7e9d">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNi0xLTEtMS0yMzM5OQ_0c0a830c-ec29-4e7e-81e0-276cb537718d">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNi0zLTEtMS0yMzM5OQ_7d4a2215-49e0-4252-8f35-67fd81bff0dc">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfOC0xLTEtMS0yMzM5OQ_76a08417-26ad-49c5-b885-372af069f729">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfOC0zLTEtMS0yMzM5OQ_83e17a58-3392-41a9-a9c7-ed452879a3b9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMTItMS0xLTEtMjMzOTk_3604a48f-146a-4683-b463-fb6c594eb275">5,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMTItMy0xLTEtMjMzOTk_a63dfc14-77b1-4921-9001-763f870dd3df">3,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in other income (expense), net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc5MQ_fbb9351b-c126-483e-bc9b-68b1ee12a555" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfMy0xLTEtMS0yMzM5OQ_4bf075f5-8695-4ce0-b939-99840f644130">6,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfMy0zLTEtMS0yMzM5OQ_5ecc1aea-e107-44a4-a232-6a36c0c0fb92">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNC0xLTEtMS0yMzM5OQ_4d61fc76-63d9-46bb-b1b0-3d9c1eda5986">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNC0zLTEtMS0yMzM5OQ_b37b1485-cabd-4cde-950e-7078be95e5e8">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNy0xLTEtMS0yMzM5OQ_78e018c8-9aa9-4525-9218-327d42749456">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNy0zLTEtMS0yMzM5OQ_ca8a6739-ecf1-4f1e-88dd-75a5ace9f970">1,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfOC0xLTEtMS0yMzM5OQ_ddf271f7-e297-45d9-998a-dea13e55902e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfOC0zLTEtMS0yMzM5OQ_96625c64-aed2-4671-81a5-e68bbfa11a97">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i9b58b1190f014920a07b7e002dbea23f" continuedAt="i82824ee8c8fc44309ba46ce5b2b04e03"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="icui:AssetsandLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjgwMA_87704c09-d761-4db5-a10b-44595ab1f4c7" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMi0xLTEtMS0yMzM5OQ_e376585a-6b59-4fbf-9bce-64eabb1c0a85">92,027</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMi0zLTEtMS0yMzM5OQ_e190b40d-381b-497a-babf-ae03f3fe2642">39,847</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNC0xLTEtMS0yMzM5OQ_920d74e3-0359-4397-a215-cb05f4be0e0a">20,786</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNC0zLTEtMS0yMzM5OQ_5bdbb41d-1665-434d-a580-f53ca321eb4b">9,009</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNS0xLTEtMS0yMzM5OQ_4d6081ef-358c-4f7a-8b9c-0ee08147ad05">73,391</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNS0zLTEtMS0yMzM5OQ_49394f29-d90e-4e2d-b9b0-5fad47dbe982">33,971</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNi0xLTEtMS0yMzM5OQ_8e4e24ad-53ce-4c53-bbbe-a5b42cc0d2e7">94,177</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNi0zLTEtMS0yMzM5OQ_345f80b9-cd40-487e-9467-d910a77913be">42,980</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfOS0xLTEtMS0yMzM5OQ_bddd6176-34ef-4f5a-a034-bb7227bf3f23">6.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfOS0zLTEtMS0yMzM5OQ_a1f38bb1-646a-4581-a635-6b0d22b55daf">5.9</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMTItMS0xLTEtMjMzOTk_68ec5617-132f-46da-8f93-349e4be40791">4.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMTItMy0xLTEtMjMzOTk_765b009b-b4c8-4cd5-bc4d-597f65783cd1">4.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMi0xLTEtMS0yMzM5OQ_73dd0add-c2ad-442e-8649-88491506f0d5">2,545</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMi0zLTEtMS0yMzM5OQ_da716474-4f82-454c-8dfd-fde0c4b45724">2,673</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNC0xLTEtMS0yMzM5OQ_282d04d6-27b1-467d-a591-17c7d3f5e6ba">669</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNC0zLTEtMS0yMzM5OQ_613b5616-ad3a-4598-a353-2874dc320c30">643</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNS0xLTEtMS0yMzM5OQ_fe49c5dc-66b5-4a89-bf05-5f80737d5604">1,923</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNS0zLTEtMS0yMzM5OQ_76146ae9-65d7-47c3-80df-f10f6ab8d800">2,067</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNi0xLTEtMS0yMzM5OQ_ba1cc55d-3810-4f6f-9389-019d8ceb6ee0">2,592</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNi0zLTEtMS0yMzM5OQ_3ffad43e-6fac-4a16-9ac2-09e344c54cdc">2,710</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfOS0xLTEtMS0yMzM5OQ_5335968c-3bca-417e-9a9b-010f1105c87f">5.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfOS0zLTEtMS0yMzM5OQ_e729b08a-9c6b-4e0c-9fa3-3a3cc6014531">5.6</ix:nonNumeric> years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMTItMS0xLTEtMjMzOTk_2ee22b7f-b4b6-4fa8-97a5-0025980baf59">4.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMTItMy0xLTEtMjMzOTk_7e60268c-b1ca-4846-bf8e-0090ffd214c8">4.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i82824ee8c8fc44309ba46ce5b2b04e03"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc5NQ_904fa11b-f72a-4b1b-8b4a-da0cd74ca173" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMS0xLTEtMS0yMzM5OQ_4c36bf70-4ee3-44ec-a9bf-92b429c9e7fc">18,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMS0zLTEtMS0yMzM5OQ_a4bc9b1c-fbc4-462b-aadf-c417d71c13e4">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMi0xLTEtMS0yMzM5OQ_7647cdb2-94e1-4051-b639-30ecb015d3bc">20,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMi0zLTEtMS0yMzM5OQ_295fbfdc-9e69-462f-97be-e61fd40bd094">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMy0xLTEtMS0yMzM5OQ_f7206f07-cfcd-4c85-9315-09a0f8ee7325">17,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMy0zLTEtMS0yMzM5OQ_84913190-6f2d-485f-9a07-b1ec8d17efef">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNC0xLTEtMS0yMzM5OQ_98af8bb2-58a0-4768-b14e-92e334ee1c7c">12,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNC0zLTEtMS0yMzM5OQ_a8c14ab8-1d14-4e80-9ba2-d99ee0a6e6de">267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNS0xLTEtMS0yMzM5OQ_b527685b-4b34-49b6-aa75-061110407e61">11,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNS0zLTEtMS0yMzM5OQ_a89a3e1c-fc39-4ea5-bbbb-b834b582e553">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNi0xLTEtMS0yMzM5OQ_a1d99bf9-cd29-4df5-ba11-c5ecf8e17ccf">7,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNi0zLTEtMS0yMzM5OQ_5230eeeb-ba07-46c7-a98e-271b3938b0c1">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNy0xLTEtMS0yMzM5OQ_a923b01d-6e21-490e-9b3f-6e4f52c06b46">18,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNy0zLTEtMS0yMzM5OQ_fcde7786-3d67-4b04-83af-cb6b0def28cd">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOC0xLTEtMS0yMzM5OQ_6f4d0931-e196-4fa5-b68f-d62fbdbeeda9">106,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOC0zLTEtMS0yMzM5OQ_12a40c52-1a20-41f7-bc49-e5efaef3d64e">2,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOS0xLTEtMS0yMzM5OQ_30fb9752-7e83-407d-9cae-ae382dbbfc9c">12,336</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOS0zLTEtMS0yMzM5OQ_c5013e13-c7d0-465b-9ed6-12fe7b96a8d4">314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMTAtMS0xLTEtMjMzOTk_c492ddbe-02a7-4232-b894-b7e425fba1d5">94,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMTAtMy0xLTEtMjMzOTk_646de9e5-79e3-4502-984e-17763181e111">2,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfMTA2Nw_33f93164-5589-47d9-b5d1-545a90513b54" continuedAt="idfb1ee7bc8fa4f3983ebc9ee34678b83" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="idfb1ee7bc8fa4f3983ebc9ee34678b83"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three months ended March 31, 2022, any potentially common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect, therefore basic and diluted net loss per share are equal for the period. There were <ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfNzEy_b9a4f335-621b-4460-b1be-69e2623836dc">nil</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfNzE5_1d6e8e13-2ac9-479c-a3b8-1deb2f7ae2d8">12,080</ix:nonFraction> anti-dilutive securities for the three months ended March&#160;31, 2022 and March 31, 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfMTA3Mw_479232cd-e50d-4d4a-a82c-a799096c7935" continuedAt="i180dffd9f0bd4a23945b714590846ab5" escape="true">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; </ix:nonNumeric></span></div><ix:continuation id="i180dffd9f0bd4a23945b714590846ab5"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMi0xLTEtMS0yMzM5OQ_e30f038c-4e60-420c-9b66-1ae118369f42">38,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMi0zLTEtMS0yMzM5OQ_bc2f94f8-f61e-47b9-a2f5-451ae607ddb1">23,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMy0xLTEtMS0yMzM5OQ_2f69072f-b445-4602-8c3d-ea4a700ac797">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMy0zLTEtMS0yMzM5OQ_6e80a370-1273-4167-8f19-35ac97d3fdd3">21,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNC0xLTEtMS0yMzM5OQ_6f3c3278-2c49-40a5-8fed-b46413215cb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNC0zLTEtMS0yMzM5OQ_4ed15e00-dc35-4c32-8479-156eed48a518">546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNS0xLTEtMS0yMzM5OQ_9449efea-7c2e-47a4-8893-256729786cd2">23,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNS0zLTEtMS0yMzM5OQ_47f4b78a-5d8b-4ded-996e-f6fdf8a67b1a">21,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNi0xLTEtMS0yMzM5OQ_e18e41b6-00b5-4051-a0c6-a90442b74a13">1.61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNi0zLTEtMS0yMzM5OQ_a651cd08-8950-49f4-9a9f-c7462a50330d">1.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNy0xLTEtMS0yMzM5OQ_625d60c6-7179-4281-8e9f-8295149d204b">1.61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNy0zLTEtMS0yMzM5OQ_70b7b7a2-74c7-4aea-9548-d79fef2efc28">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No dilutive effect for the three months ended March 31, 2022;  therefore, zero incremental shares included for the period.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTA5OTUxMTY2MTk5OA_70d5005d-4e92-4a5a-95ba-3844e77b26c9" continuedAt="icaa1598ef5aa4f7fa31452f3a05b0570" escape="true">Derivatives and Hedging Activities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icaa1598ef5aa4f7fa31452f3a05b0570" continuedAt="i4bcdd140200c4266afa87756153f059f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i4bcdd140200c4266afa87756153f059f" continuedAt="i02cdd0307ced4794af9fd70cbfd3f1cc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos, Euros, Czech Koruna and Japanese Yen, and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ1MzEzMA_8e1b6382-8002-4d5d-8810-b2b2733058f3">231.8</ix:nonFraction>&#160;million, which included the notional equivalent of $<ix:nonFraction unitRef="usd" contextRef="i62db31deb9084936bafdeb3f3f63c809_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTIwOA_0ebe66e7-0066-40e9-8f9b-8f9e3a1726c4">58.7</ix:nonFraction>&#160;million in Mexican Pesos, $<ix:nonFraction unitRef="usd" contextRef="i7963d1971572480fbd840e0d5474ceb0_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTIzOA_12139ed2-cc00-4084-b6b6-40806186a98d">42.4</ix:nonFraction>&#160;million in Euros, $<ix:nonFraction unitRef="usd" contextRef="ic373291ce2a54c54bc47f9dc50e82a5e_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTI1Mw_c6c80125-f9f6-4bbd-acc5-5460fd72b08e">23.5</ix:nonFraction>&#160;million in Czech Koruna, $<ix:nonFraction unitRef="usd" contextRef="i5be466fa5bc14021acd2af7f71cc4898_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ3Mzg5Mg_1e804189-42ff-4305-80cc-f8cc068c1257">22.2</ix:nonFraction>&#160;million in Japanese Yen and $<ix:nonFraction unitRef="usd" contextRef="i2aca8fbd4d9f46bd8abdb6dfa1bc52fa_I20220331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTI4Mw_65dc9e3c-149a-4632-a003-471402c9afed">85.0</ix:nonFraction>&#160;million in other foreign currencies, with terms currently through July 2023. We did not have such derivative contracts as of December 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-currency Par Forward Contracts</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in Mexican Pesos ("MXN"). These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of March&#160;31, 2022 and December 31, 2021 was approximately <ix:nonFraction unitRef="mxn" contextRef="ic788c207f74e4b2dafcf30292f3548ad_I20220331" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI1OTMzMA_74194547-e97b-4872-9b4f-6752a77510f0">311.6</ix:nonFraction> million MXN and <ix:nonFraction unitRef="mxn" contextRef="i2cae28aee9a248c6992bfec3cecde803_I20211231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ0NjE0Nw_86d48bda-8dbf-4423-aa06-20f00e166b81">413.1</ix:nonFraction>&#160;million MXN, respectively. The derivative instrument matures in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="ic788c207f74e4b2dafcf30292f3548ad_I20220331" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ0NTM5Mw_3b2cb24c-e4e9-495e-848b-79a14c6e62c3">21.60</ix:nonFraction> MXN/USD. Preceding this contract we had a one-year cross-currency par forward contract with a term from November 3, 2020 to December 1, 2021 that matured in equal monthly amounts at a fixed forward rate of <ix:nonFraction unitRef="number" contextRef="i78dc0822a7604ba0b14a6be54c13e439_I20211231" decimals="2" name="us-gaap:DerivativeForwardExchangeRate1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTYwNw_a942e684-65e1-446c-8861-bbddee89887b">24.26</ix:nonFraction> MXN/USD.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODczOA_68927ab9-4e10-45eb-ab6b-afacd6a693bd">300.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331" decimals="-6" name="icui:InterestRateSwapEndingNotionalValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc1NA_25daaa1f-93fc-4656-aadd-8381d70f31d0">150.0</ix:nonFraction>&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331" decimals="6" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc3Ng_d7f2c780-e613-4d1a-9338-153e63fa8e5d">1.32</ix:nonFraction>% and will receive the greater of 3-month USD SOFR or (<ix:nonFraction unitRef="number" contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331" decimals="4" sign="-" name="icui:DerivativeVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc3MA_ef9fb7c7-8ac8-4663-beef-d75111c3a3ee">0.15</ix:nonFraction>)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $<ix:nonFraction unitRef="usd" contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc4Mw_47a2d649-a5e9-4018-8698-c66cf6012083">750.0</ix:nonFraction>&#160;million, reducing to $<ix:nonFraction unitRef="usd" contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331" decimals="-3" name="icui:InterestRateSwapEndingNotionalValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc5OQ_14675f44-4e24-4964-93d1-40abfbbf812a">46.9</ix:nonFraction>&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of <ix:nonFraction unitRef="number" contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331" decimals="6" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODgxNA_1d66db6a-d2c3-44a3-80c3-4fe82ca9a8f8">1.17</ix:nonFraction>% and will receive the greater of 3-month USD SOFR or <ix:nonFraction unitRef="number" contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331" decimals="4" name="icui:DerivativeVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODgyMQ_11e26ce4-d102-4130-a254-c09d2ce0163a">0.35</ix:nonFraction>%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjcwNw_8fd39ba7-435e-4867-9c48-cec8e3d5a659" continuedAt="i5fe830aceabf4992bb3fd082c88f358c" escape="true">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i02cdd0307ced4794af9fd70cbfd3f1cc" continuedAt="i301a23b52e034626b5640c89ae9724fe"><ix:continuation id="i5fe830aceabf4992bb3fd082c88f358c" continuedAt="ic026f240eeb24ec9b93b8e9655ce759f"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f1ae97aae0424a80ff8ef2c5fe28de_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNC0yLTEtMS04MzU0Ng_3256bd52-5a9e-47d7-8cf3-a1d406ddc3c6">7,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie951b51b46c24f91a76523e2ca109cf7_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNC00LTEtMS04MzU0OQ_1af4af92-f88c-4773-9005-d1828cac0601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1565ea9c18f0446cac5355139ceb7865_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNC02LTEtMS04MzU1MQ_29f2c7a7-fefc-458a-9b91-f4344f75c7f5">7,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5480e0d4b9e94e3890f7f73f6ed47c70_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNS0yLTEtMS04MzU1Mw_6688674e-d8d1-42ac-8b5c-9ba5373c8b34">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315729be48514840b0d36c895155ff5e_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNS00LTEtMS04MzU1NQ_0f67c0d4-345b-409b-ac2a-dcfca8eae063">28,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b0233d309c4ffcb68ad6044df3947b_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNS02LTEtMS04MzU1Nw_3cd90c71-07d7-4a22-bbd5-5ff0d3fddfff">28,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7790dee9054ceca551b75f9663ebea_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNi0yLTEtMS04MzU1OQ_d4888f22-9b68-4253-874e-619f8dfe6e5d">7,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNi00LTEtMS04MzU2MQ_58b5cae2-2b50-4e26-a043-d33308ae36ad">28,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNi02LTEtMS04MzU2NA_58c7e185-b8fc-46e2-8b20-360b83f4fed0">36,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4262eb928148c0bbdb719d4842c46e_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOC0yLTEtMS04MzU3Mw_f252ae29-3f95-445d-8790-ba45ffeeeb38">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c493e4a240482e95f73b4965a6f972_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOC00LTEtMS04MzU3OA_3bc701ab-a985-4528-980a-fd2ac25728b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d5fc92c6d7403f858073017410d73b_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOC02LTEtMS04MzU4MA_a1abe308-8ffb-4c6e-b7f9-bed2b545454d">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i442353a0995745d69a88c9e06d2b2e2b_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOS0yLTEtMS04MzU4Ng_9503b47a-1701-4d7e-99aa-51336d06074a">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f57e3739bad4f56b45c5af9ecd59b05_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOS00LTEtMS04MzU4OA_12126381-4737-4071-a42a-15301dca546e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebbac56dc4f40cab230df979062a6fb_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOS02LTEtMS04MzU5MA_31e3c070-2e49-48d2-963f-37cea040b673">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e7790dee9054ceca551b75f9663ebea_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTAtMi0xLTEtODM1OTI_54825a12-3d6b-44af-bc7f-5c230b8209cb">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTAtNC0xLTEtODM1OTQ_a39f4399-9ec9-490c-a43a-7d7b094f5469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTAtNi0xLTEtODM1OTc_c77c5648-4a86-42d5-9d02-066e7ddb5ff2">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96528d11b19404186843078164bf0ff_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTMtMi0xLTEtODM1Njc_8430a7c1-665d-4ceb-907a-39785af36d75">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cb96a5a627a4f2c9fbf16b433a2a039_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTMtNC0xLTEtODM1Njk_6dd0ccb2-3710-4db0-86ee-132e08942960">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b4f49688b3453dabe1cbce3dac596e_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTMtNi0xLTEtODM1NzE_f2f3f2fb-81af-46c0-842c-e9d9d27fd7bd">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45f73643f964e8dad36acddabd4f6b0_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTQtMi0xLTEtODM1Njc_09b82e8b-4e9f-4d4f-9f98-91c8f8b9fd5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic809f3d4de8e4c4fa7ac38f6e35822f1_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTQtNC0xLTEtODM1Njk_658f2528-953d-43c3-9a11-5400b9cad6e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i112e5d0a75164fdeb157a57239a63582_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTQtNi0xLTEtODM1NzE_ac32061a-d3cb-47aa-a974-2afaba9cd8e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa3affafd794a8aba01a0642e492edc_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTUtMi0xLTEtODM1Njc_83ea6f9e-1be8-437c-b286-4e999b31bd2b">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0aeb03074de41f4a5d5dadadbbef2d1_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTUtNC0xLTEtODM1Njk_0e411063-22f0-4990-80bf-160052e41595">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTUtNi0xLTEtODM1NzE_11cfdddf-fdb2-436b-81b4-6a43adec4254">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5567182ccf4bf2afb2d97a18d3f46e_I20211231" decimals="-6" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTctMi0xLTEtODM1NzY_55f2580b-d861-4876-82ec-5f7114ed6bf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b68c68d4340458b97c555caf230716e_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTctNC0xLTEtODM1ODI_59680ec2-667b-47b9-8c40-9dc65881c276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic64816f8cccb4c3aa043d7bda0ab7443_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTctNi0xLTEtODM1ODQ_24e42a9b-e7d3-4d42-8924-c6efd04b2f65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1428c27386ca455990cd6a0836006bf5_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTgtMi0xLTEtODM1OTk_7f7315be-0f9d-4c28-bb45-2e9af18e50b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c249ecf14641feac25b572b32ac6c4_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTgtNC0xLTEtODM1OTk_4a9a7e37-7ff4-4ec5-b7e5-89b4ae9412d6">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55bf118e00554d2e9a4e30260c8c7917_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTgtNi0xLTEtODM1OTk_eebc4a6c-2190-4068-a169-817e0cfbd142">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa3affafd794a8aba01a0642e492edc_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTktMi0xLTEtODM1OTk_470e1d5a-f4f9-459f-b53a-18608ced6d01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0aeb03074de41f4a5d5dadadbbef2d1_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTktNC0xLTEtODM1OTk_2356f414-f289-4750-8a0f-5fc3462d061a">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTktNi0xLTEtODM1OTk_2f4da109-33f9-4e03-bc65-0c32b343e2eb">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a0ebabf35b94de9b3494c8f98c35fcb_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNS0yLTEtMS04MzYwMw_e7adad88-b269-47e2-9453-9d4d8f3c293c">3,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75dee15445a241d39eb89a15ed0d7674_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNS00LTEtMS04MzYxMA_1fc3776a-8625-4c46-b87c-4d1a138ff1a5">402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f597ec7d6d94442ad8c9951a802383c_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNi0yLTEtMS04MzYwNg_7f0f6964-c2ef-49be-88b3-801b23ee8873">30,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6c5a747f3646a5b3e9c6bcbaa397f8_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNi00LTEtMS04MzYxMA_06ca8e38-e654-450a-8f35-e9a71902c60d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNy0yLTEtMS04MzYwOA_6c085eea-db45-4f5b-96be-60522c2c5ebb">33,163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNy00LTEtMS04MzYxMA_ecf94a04-5677-472d-b2cf-9575fbbe0b12">402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i301a23b52e034626b5640c89ae9724fe" continuedAt="i47153b3708b943f9b14612cbded536a9"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic026f240eeb24ec9b93b8e9655ce759f">The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</ix:continuation></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjcxNA_5d95e631-9ff5-46e9-aae0-671d217934c5" continuedAt="i87387f0069d84708b9578224a6b90ee6" escape="true"><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.707%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c6a7c98f99c45a0af8e8a18126938ea_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS00LTEtMS04MzYxMg_1266cadf-5323-4fce-bdba-8694b38b8fe1">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadccd508c3834cc2a5379622d5278846_D20210101-20210331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS02LTEtMS04MzYxNg_3fbd8d2c-26bc-4a79-b8bf-a66f07841706">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i768b7317377646e18a4f32bd2ab2443d_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS04LTEtMS0yMzM5OQ_ed734df9-cfe2-4bba-98bd-3edea3c86130">513</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296eba7b2d0d407894537da13b4266d5_D20210101-20210331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS0xMC0xLTEtMjMzOTk_9ce5a11f-3441-4374-bcce-a036a92002f6">841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c66699e81d84448b3ba8cae1a7e7d61_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNy00LTEtMS04MzYxNA_895e30e7-ede7-4063-bbce-bf1a2bea5f50">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i030a14b9f87541e5a345d6f3f9d9e08d_D20210101-20210331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNy02LTEtMS04MzYxNg_280d3a8f-eb6f-4fee-9bf8-421f81841e77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib28660aeb4894aeabf3989dbe4367892_D20220101-20220331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNi04LTEtMS0yMzM5OQ_0e3f4793-78de-4c59-9968-69f5d2823e20">2,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a11d8ef901545fcbe623f7dd7ff571b_D20210101-20210331" decimals="-3" name="us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNi0xMC0xLTEtMjMzOTk_343bfd8b-666c-4e61-957e-efd4aa93230a">841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i47153b3708b943f9b14612cbded536a9"><ix:continuation id="i87387f0069d84708b9578224a6b90ee6">As of March&#160;31, 2022, we expect an estimated $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2OTUwMA_815659aa-73c1-4802-9112-c19bd0c4e14d">1.9</ix:nonFraction>&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ1OTk1NQ_8728b9e9-24b1-4f85-8f4f-4ddfbdef394b">3.9</ix:nonFraction>&#160;million in deferred losses on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</ix:continuation></ix:continuation>&#160;&#160;&#160;&#160;</span></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:19.736%"><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_55"></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.736%"></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.736%"></div><div style="display:inline-block;max-width:7.017%;min-width:6.684%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:19.741%"></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDcyNw_18d08f4e-13b5-4c1e-ab2c-b43d61c88eb4" continuedAt="ice2661af988449b4aca9b3dc1534850c" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="ice2661af988449b4aca9b3dc1534850c" continuedAt="icdc923b068fd4c7ab18182394290519f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Earn-out Liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $<ix:nonFraction unitRef="usd" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1NTU5OQ_9a09cdb2-06bb-4585-8475-9a7aba67e6dd">100.0</ix:nonFraction>&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="8" name="icui:OwnershipRequirementForEarnoutPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMjE5OTAyMzI3MTU2OA_4d629360-625c-4917-917c-f00753a570e2">50.0</ix:nonFraction>% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1NTg1Ng_3d306c79-1c9b-49a5-9923-67084caf3f23">53.5</ix:nonFraction>&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="icdc923b068fd4c7ab18182394290519f" continuedAt="i56ca8115a1e645939f5e04129ddef8a3"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjc0Mw_9fe422a3-3638-4458-a052-e3d4a4b27dbb">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjc3MA_bba804e3-eb3f-4fe5-9116-5bf3d451957b">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjc5Nw_a309faad-e2ff-4e4b-aab8-e853a2051a45">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March 31, 2022, the estimated fair value of the total contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i099b2a7d616d421c860d4ddb8052bdab_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjg1NQ_d235c744-c670-4713-8ff6-65b1618dde6a">1.6</ix:nonFraction>&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $<ix:nonFraction unitRef="usd" contextRef="i27fd8cbeeab3426e97107930d3deb563_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTI5MQ_a227bd7a-8cae-406c-a0ec-186f9414a721">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both March 31, 2022 and December 31, 2021, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i591e5151200040c0933b61638412feac_I20220331" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY5Nw_95e6f607-5af7-4801-8a95-4ef78ed6b8c4">2.6</ix:nonFraction>&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit Vascular, Inc. ("Pursuit"). Pursuit's former equity holders were entitled up to $<ix:nonFraction unitRef="usd" contextRef="i52f666ba7ecd4b1e858ed6eed44de97d_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMjA5NA_74846702-71e7-423c-9190-5c7ef4239d3e">50.0</ix:nonFraction> million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $<ix:nonFraction unitRef="usd" contextRef="i52f666ba7ecd4b1e858ed6eed44de97d_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMjM4NA_fafb815b-6658-45a0-8abb-0ceabec38d82">50.0</ix:nonFraction> million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $<ix:nonFraction unitRef="usd" contextRef="ia1b57ff5dbf448208328e971b35a3f90_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMzMyMw_6e2cedfa-1c22-42f6-87ef-489ef098cbcb">26.3</ix:nonFraction>&#160;million. The $<ix:nonFraction unitRef="usd" contextRef="ia1b57ff5dbf448208328e971b35a3f90_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMzMzMQ_b3aae195-8094-4266-8b80-c1f786f840b7">26.3</ix:nonFraction>&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDcyOQ_83efbcb1-2bc1-488f-93ae-d796da16fc6f" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfMS0yLTEtMS0yMzM5OQ_ccbcaaef-7df5-42ec-ae01-7d258a93874c">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfMi0yLTEtMS04MzIxNw_274e9ec4-ba8e-4efd-a0f8-ec0f2bb56983">55,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="icui:CurrencyTranslationOnEarnOut" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfNC0yLTEtMS04MzIyMA_f0fb2d1d-245d-4cc7-9ee2-dfe376475ba6">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4ad65ae063d4e49821ad5b4dece8ece_I20210930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfNC0yLTEtMS0yMzM5OQ_20cebdb6-5591-42eb-8b2a-4a3e6479aba8">57,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions). </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc7d2919e7140fa9c80f0f1d09a1728_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjlmZDc3MzFiOTc4MzRjNTJhMzc4MmFmYTAyYjNhYWE5L3RhYmxlcmFuZ2U6OWZkNzczMWI5NzgzNGM1MmEzNzgyYWZhMDJiM2FhYTlfMS0yLTEtMS0yMzM5OQ_348df728-4d45-4cd9-8d79-e4e37d5c33fa">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27bd3a8f9e2b4c90a09dc353bf7cbd60_D20200701-20200930" decimals="-3" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjlmZDc3MzFiOTc4MzRjNTJhMzc4MmFmYTAyYjNhYWE5L3RhYmxlcmFuZ2U6OWZkNzczMWI5NzgzNGM1MmEzNzgyYWZhMDJiM2FhYTlfMy0yLTEtMS0yMzM5OQ_15258ccf-2772-4c38-919c-a9004ab4e2ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id15440599eac41b2b8dcbf173de1a069_I20200930" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjlmZDc3MzFiOTc4MzRjNTJhMzc4MmFmYTAyYjNhYWE5L3RhYmxlcmFuZ2U6OWZkNzczMWI5NzgzNGM1MmEzNzgyYWZhMDJiM2FhYTlfNC0yLTEtMS0yMzM5OQ_da8e3bbc-6cdc-472e-b344-24199bb871f6">26,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDczMQ_e9e3c5a2-3edc-42cf-bf7e-f3078c92dae2" continuedAt="i9baf91096b2744339da2fd052eebc7f2" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i56ca8115a1e645939f5e04129ddef8a3" continuedAt="i6e7f4ae52cae4aa1adbf86bcfcfba923"><ix:continuation id="i9baf91096b2744339da2fd052eebc7f2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>January 6, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73db172d800a49ca831d1f3440d0a9a8_I20220331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmI3MjMzYzU4ZGI4MzRmOGU4OGVhOWJjN2RjYTE3OGY3L3RhYmxlcmFuZ2U6YjcyMzNjNThkYjgzNGY4ZTg4ZWE5YmM3ZGNhMTc4ZjdfMS0yLTEtMS04MzIyMg_960cac72-3506-41ff-af35-63772787a0f5">37.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01dc0feea8d540698b9fa442d8af1726_I20220331" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmI3MjMzYzU4ZGI4MzRmOGU4OGVhOWJjN2RjYTE3OGY3L3RhYmxlcmFuZ2U6YjcyMzNjNThkYjgzNGY4ZTg4ZWE5YmM3ZGNhMTc4ZjdfMi0yLTEtMS04MzIyNA_d67cb770-b9d1-459d-b3fe-df522b731627">1.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia760ade7301b4ae091a97fbf0f60bae8_I20211231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfMS0yLTEtMS0yMzM5OQ_7e778632-87f2-4f73-b645-2092aa5554c8">25.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae19c16d454a4da888fb439fac3a5955_I20211231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfMi0yLTEtMS0yMzM5OQ_52621628-1009-41bc-ab8a-cfbec2ee6f35">12.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2eba1326445642438ae8479679188e72_I20211231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfMy0yLTEtMS0yMzM5OQ_32d53bc7-949b-4410-b88a-03bc526009a1">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id1ddc2565fbb4bc9ac3f95f9e98205b2_I20211231" decimals="4" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfNC0yLTEtMS0yMzM5OQ_f9898db2-5b9a-43b3-bfef-0458be6bc7a2">3.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Exchange Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our investments, which consist of corporate bonds, is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDc1Mw_e8e14955-5fd7-429f-b3da-f8cc01a2da44" continuedAt="i253c89de846e46cda0fc473cdc118309" escape="true">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i6e7f4ae52cae4aa1adbf86bcfcfba923"><ix:continuation id="i253c89de846e46cda0fc473cdc118309"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC0xLTEtMS0yMzM5OQ_7df11abb-67e5-4138-9f44-88cf689fc47e">14,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC0zLTEtMS0yMzM5OQ_797b65c9-320d-4d58-a553-ff001ba17ae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a07c4fb7834238809f74bc245a07e1_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC01LTEtMS0yMzM5OQ_77679704-4f21-4fb9-b376-9e42fc0658bd">14,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625f2e9aec314e25b0c0699f19c11778_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC03LTEtMS0yMzM5OQ_b75d803e-487b-49cf-b2cb-963e6e64981e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS0xLTEtMS0yMzM5OQ_c81cbdf4-f6ac-4ec8-bc00-0b93031c6f67">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS0zLTEtMS0yMzM5OQ_7209081d-a6cf-4747-ae9c-f9b7e9790d72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a07c4fb7834238809f74bc245a07e1_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS01LTEtMS0yMzM5OQ_b6f76ab9-cce6-478c-85df-213f38bb36a5">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625f2e9aec314e25b0c0699f19c11778_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS03LTEtMS0yMzM5OQ_74f060d0-b9cd-4aed-8ef6-54beee40c735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1565ea9c18f0446cac5355139ceb7865_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy0xLTEtMS04MzIyOA_8fd3670c-54fb-482d-965e-7433df5f6a4f">7,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d39ec8bd177421d91c1d78701f1ac51_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy0zLTEtMS04MzIzMA_85ce1af8-7def-4f2d-a62f-18c9d3c2803c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2dd58641ec4c47944780cf820a3c80_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy01LTEtMS04MzIzMg_df76a9b3-ce20-442b-af05-3d3f501e6609">7,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i893e8eee099341c480fec838d774cb74_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy03LTEtMS04MzIzNA_75b60856-4469-4175-a5c3-b9e991853ba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b0233d309c4ffcb68ad6044df3947b_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0xLTEtMS04MzIyOA_b062c29b-db8b-403f-a58c-46f52b86025b">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3fa86ba23d4ca99c7c1d8b7d588cce_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0zLTEtMS04MzIzMA_1690ddea-903b-4aac-b76c-00f23c761993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08573f64c1804db985e0aed112395314_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC01LTEtMS04MzIzMg_6ca6caea-60f8-4056-bcb6-87a07da2fc4e">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia840f694db644720be6253993494b8e0_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC03LTEtMS04MzIzNA_e03ed455-3c10-45ab-9b9d-fe9d0cbf2dbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b0233d309c4ffcb68ad6044df3947b_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0xLTEtMS0yMzM5OQ_30a08faa-1010-48fb-943d-b0a19effde8a">28,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3fa86ba23d4ca99c7c1d8b7d588cce_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0zLTEtMS0yMzM5OQ_10640e7d-56c2-4e2d-832a-25de704067ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08573f64c1804db985e0aed112395314_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC01LTEtMS0yMzM5OQ_4c35908f-a4c5-4673-9f9a-7bd489650455">28,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia840f694db644720be6253993494b8e0_I20220331" decimals="-3" name="us-gaap:InterestRateDerivativeAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC03LTEtMS0yMzM5OQ_dd2f0071-5615-4ff1-bb8a-53d60855d709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS0xLTEtMS0yMzM5OQ_50df29c7-2786-4f2d-a44c-2d4f0564fb3a">53,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS0zLTEtMS0yMzM5OQ_eefce338-0e6f-4804-b95b-7feb49f284b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a07c4fb7834238809f74bc245a07e1_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS01LTEtMS0yMzM5OQ_0bc137c2-c9d3-418b-b32b-728e43827939">53,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i625f2e9aec314e25b0c0699f19c11778_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS03LTEtMS0yMzM5OQ_44690fb7-356e-430f-9d65-640a493271f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a390f242ec4b708b42188ba1ed533a_I20220331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItMS0xLTEtMjMzOTk_d02c9ad0-52f7-4942-b5a3-44e01ed1f49b">57,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8af3b131bc14d17a7571c2fdcc1af47_I20220331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItMy0xLTEtMjMzOTk_c9755067-e075-4aa1-ae96-d14f4bd692ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c78732ffce9481d84d10a6eed768479_I20220331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItNS0xLTEtMjMzOTk_6f548230-489b-4cde-aad7-28fb6a486f13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id600755f8bb64800a5c3f7106c241dcf_I20220331" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItNy0xLTEtMjMzOTk_532db989-2c66-4c13-956a-ce1bd5e6f643">57,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92d5fc92c6d7403f858073017410d73b_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtMS0xLTEtMjMzOTk_31953381-bf13-4036-b1eb-2c1b6d79c693">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56220f4e4fce4161bc7b4edbede836a0_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtMy0xLTEtMjMzOTk_0e0ba769-9404-4a84-a7c2-6afae49617d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92b9167994c04c478ad5b2e150315812_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtNS0xLTEtMjMzOTk_17c19670-666f-4a9e-8454-331169d6b7dc">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf032587ff8047c4b9bb91de60bb0fa0_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtNy0xLTEtMjMzOTk_35d9d43e-aa87-487f-9131-1d1f8084d5cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055211e4c3454a24b54386b6a7b21511_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtMS0xLTEtMjMzOTk_9a731a0a-a5a5-43d8-83c9-cc1729d1f3d0">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d55547e25c4f90a6a7c87dd4a11427_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtMy0xLTEtMjMzOTk_529d5569-e4bf-4784-a107-06b79f88380a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id97f8182fd794fdaa58639212799a600_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtNS0xLTEtMjMzOTk_526b2a70-0f1a-4505-a7ea-bbf446f2db7d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d2d55b60f2e4d11a4d5ea598a1837be_I20220331" decimals="-3" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtNy0xLTEtMjMzOTk_b3e6f7c3-2e70-40e3-b8d4-14c99cb64f91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc848f2b140a428c9e22a6befc519c3d_I20220331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtMS0xLTEtMjMzOTk_8684e2ea-4921-4aa7-9f14-dcb857406be7">58,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1419702164fa4c2a834cca8d8c248f20_I20220331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtMy0xLTEtMjMzOTk_9a2b0da5-e67d-44d5-ba31-73e1f1ee9fe8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0534e7808d42c69fc2180af5749efe_I20220331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtNS0xLTEtMjMzOTk_2d7887f4-1b8c-4495-80c0-5d0ebb77c040">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia01d6c13756c4351b7acb497ed3f5adb_I20220331" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtNy0xLTEtMjMzOTk_181f2382-abf0-4ee8-99a9-a5df814f4d4a">57,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC0xLTEtMS0yMzM5OQ_3136e164-c092-42f4-a181-7579a5f36f79">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b4f8d61bc94efd8c535988f345c281_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC0zLTEtMS0yMzM5OQ_b345c25f-4e75-4b22-a0a0-da1a9f3e1b73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c455c5698b743659c9158cd90d076a5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC01LTEtMS0yMzM5OQ_4b842840-e817-4cca-b8c4-8055e4a4bd93">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i163dcce9674d46a2b3445bb6740cef0b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC03LTEtMS0yMzM5OQ_bea6fd45-4108-484f-9345-db577f958012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS0xLTEtMS0yMzM5OQ_6619f4d1-d318-4fac-b3fa-e53070032911">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b4f8d61bc94efd8c535988f345c281_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS0zLTEtMS0yMzM5OQ_0fa0bf22-a27e-4d14-9913-19fe3eab26bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c455c5698b743659c9158cd90d076a5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS01LTEtMS0yMzM5OQ_df3af80f-c011-4fdc-b591-0f29ab9216ff">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i163dcce9674d46a2b3445bb6740cef0b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS03LTEtMS0yMzM5OQ_fd23906e-09ec-414a-bb40-4e51eddb53b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency par forward contract:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32b4f49688b3453dabe1cbce3dac596e_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy0xLTEtMS0yMzM5OQ_1a63f93f-faf1-4f66-a829-b92f50e89cbb">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf12885b0a9c40079ede306096232146_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy0zLTEtMS0yMzM5OQ_35f0fc63-54e1-496e-aa38-861d0652c73e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18ee0f7fc4e048ad942066fc6d02bb35_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy01LTEtMS0yMzM5OQ_9bc8ded2-9ed3-49ab-abac-28e93d57b179">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c21c453adc4f41a028e77788e381cf_I20211231" decimals="-3" name="us-gaap:ForeignCurrencyContractAssetFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy03LTEtMS0yMzM5OQ_6d2ad885-05de-494e-b43c-5593c5bd7f9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS0xLTEtMS0yMzM5OQ_981e575a-0bbe-44cc-9aab-77e4336801ea">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3b4f8d61bc94efd8c535988f345c281_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS0zLTEtMS0yMzM5OQ_da5a80f0-197b-4db5-ae13-97fb2c39dd6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c455c5698b743659c9158cd90d076a5_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS01LTEtMS0yMzM5OQ_168c3e8d-dd6d-4b84-9326-4b939455009f">20,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i163dcce9674d46a2b3445bb6740cef0b_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS03LTEtMS0yMzM5OQ_9761c711-2efc-4b6c-bc29-956d2efd0244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9346449d62a4bae80c04e42368902d7_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItMS0xLTEtMjMzOTk_44fc35a2-f844-4543-a2b6-d62075d93916">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15baeddeabd64f0793f301a17f103c2f_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItMy0xLTEtMjMzOTk_cf9ac7d1-5f32-439a-84b2-ff7b9f97c017">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic019a3f7c2aa41b3b60c36d8dc1afbdc_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItNS0xLTEtMjMzOTk_5f628ffb-adf8-4fa0-bcce-5f4668737968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007e0b709a7948e9bfd7a77dfd33edca_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItNy0xLTEtMjMzOTk_8ad53b31-1060-4315-8fc9-ab2c532bf450">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8727c5088147f1815d1cbf94b178ca_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtMS0xLTEtMjMzOTk_6339e884-595f-4b92-986a-e5c67437c806">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e231f7074be46edac627e3736610412_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtMy0xLTEtMjMzOTk_2b2e0609-37f3-4e01-9e11-9eb61835c870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff209c9c312842e6a5aa213e04c2dd43_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtNS0xLTEtMjMzOTk_aef20ce2-a027-4dc7-aebe-fb27b153334c">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96b6effe9a345e6809e9a0242de4c6f_I20211231" decimals="-3" name="us-gaap:NonfinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtNy0xLTEtMjMzOTk_62b1ca87-83f9-4b34-a72f-75c581681bf9">2,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_58"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzcyOQ_3a476142-e608-4c35-a01d-dc40c919b04c" continuedAt="i5a39856f19f74d848063e99851c31976" escape="true">Investment Securities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5a39856f19f74d848063e99851c31976" continuedAt="i939deb58e8eb47f8b818ca5d4e51454b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds and are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of March 31, 2022 or December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been <ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-6" name="us-gaap:GainLossOnSaleOfInvestments" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzczMg_70e451e9-b798-45f6-bd24-775ab1f0e357">no</ix:nonFraction> realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzcyNA_ccf1d6be-d280-4338-a363-033d03d7156c" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.301%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMi0xLTEtMS0yMzM5OQ_9d90fb84-4902-42f3-8aec-87a1f29e941b">14,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744f21c9656746cd8b7b2215b75ac43f_D20220101-20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMi0zLTEtMS0yMzM5OQ_4d87cf6e-1440-45a8-955f-8d5b2cfdacab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMi01LTEtMS0yMzM5OQ_2f255641-5a36-4fb6-a72e-9557b3156555">14,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMy0xLTEtMS0yMzM5OQ_b55f3161-1527-436a-8496-cb044e1a2a83">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMy0zLTEtMS0yMzM5OQ_4d41f952-6f95-4194-b21d-b5ab9d47f733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMy01LTEtMS0yMzM5OQ_a08cb36e-ff05-4f90-8d38-a79ac14f9d16">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfNC0xLTEtMS0yMzM5OQ_34bb2e48-100c-45a7-95f2-facf397c73ce">17,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfNC0zLTEtMS0yMzM5OQ_621ca732-e511-4306-88ec-3dd47d38db0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfNC01LTEtMS0yMzM5OQ_1fb6d314-550e-43b1-a589-4bb1712cdbc2">17,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOC0xLTEtMS0yMzM5OQ_351bbaad-8c08-402b-ade7-b495e599e3a6">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0337d3ad564247a1200aceefee3a92_D20210101-20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOC0zLTEtMS0yMzM5OQ_2052d82b-71af-4fb1-9230-410b4c643e2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOC01LTEtMS0yMzM5OQ_6bb817f2-00b7-49cb-b2d2-186d9383d8d2">14,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOS0xLTEtMS0yMzM5OQ_573f660b-980b-42f0-b0ff-7843c9f1594b">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOS0zLTEtMS0yMzM5OQ_49fff893-cccf-45f0-8df2-cca1c768d4d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOS01LTEtMS0yMzM5OQ_a442b1d6-6378-4946-94f8-a68c84e33392">4,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMTAtMS0xLTEtMjMzOTk_acc22656-87b8-449d-b30d-8d3692cf4b76">19,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMTAtMy0xLTEtMjMzOTk_1ac5f598-4a1b-4da2-8d4b-9a7981327ba2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMTAtNS0xLTEtMjMzOTk_bcf578ef-596b-454b-8e21-813f65275201">19,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired approximately a <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="1" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMTY0OTI2NzQ0OTI1MQ_00da0b00-04d3-439b-9624-cfbb14b9483b">20.0</ix:nonFraction>% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMTY0OTI2NzQ0OTI1Nw_61a2a7f0-8ce3-45a3-a341-d12144f8a4f9">3.3</ix:nonFraction>&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i939deb58e8eb47f8b818ca5d4e51454b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the period ended March 31, 2022. We did not receive any dividend distributions from this investment during the period ended March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzcyNw_d8a2a0f3-8547-45d3-84bc-20d06e10714b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOjk1NTY2M2UyODI2ZDQ0Njk4OWVkN2Y0OTgxNDIxOGI5L3RhYmxlcmFuZ2U6OTU1NjYzZTI4MjZkNDQ2OTg5ZWQ3ZjQ5ODE0MjE4YjlfMS0yLTEtMS0yMzM5OQ_02780a0f-9c4e-4bc6-971c-d101256092f0">3,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOjk1NTY2M2UyODI2ZDQ0Njk4OWVkN2Y0OTgxNDIxOGI5L3RhYmxlcmFuZ2U6OTU1NjYzZTI4MjZkNDQ2OTg5ZWQ3ZjQ5ODE0MjE4YjlfMS00LTEtMS0yMzM5OQ_3c23d4ad-c82a-4cc2-9d78-fe64eb2384dc">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RleHRyZWdpb246NDgwODViNmQzMjM1NDI0MWI0MTU1YWJiNmNkMzY2YmNfMjE3_af41bfd3-c5be-4749-8a0c-3cfb20cdaefe" continuedAt="i90ff02aca2c1421eba40e84455b9fa92" escape="true">Prepaid Expenses and Other Current Assets and Other Assets</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i90ff02aca2c1421eba40e84455b9fa92"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RleHRyZWdpb246NDgwODViNmQzMjM1NDI0MWI0MTU1YWJiNmNkMzY2YmNfMjE5_04711f52-7b84-42f9-836c-015a49ef04f9" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMS0yLTEtMS0yMzM5OQ_37a85796-4375-4ee5-adaf-ff6c16f63dc3">29,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMS00LTEtMS0yMzM5OQ_250dd83f-b294-4cc3-ac0a-500825dcccdb">14,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMi0yLTEtMS0yMzM5OQ_76f1bbf9-0fde-44db-b32e-cf15d41ad711">9,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DeferredCostsAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMi00LTEtMS0yMzM5OQ_8775c730-fceb-4f76-afed-d1d140d2783b">12,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMy0yLTEtMS0yMzM5OQ_b4f765ee-5c5c-4c4f-9607-a2d41f2a379a">19,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Prepaidinsuranceandpropertytaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMy00LTEtMS0yMzM5OQ_075df269-d88f-4615-90a2-bd320ad19f9a">6,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNC0yLTEtMS0yMzM5OQ_c26951f0-d6b9-4aee-bed7-30039703d92b">3,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Prepaidothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNC00LTEtMS0yMzM5OQ_13c3c3b3-9054-40da-be81-08624a65bd9f">4,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNS0yLTEtMS0yMzM5OQ_93df0e43-412d-4c35-90ce-ed253f6a1a9e">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Deferredtaxcharge" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNS00LTEtMS0yMzM5OQ_c40f904b-6bf4-4b32-959a-ebe0e2fddf25">4,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNi0yLTEtMS0yMzM5OQ_98fc1e78-abb2-4f5d-ab28-c7311de11afc">7,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DerivativeAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNi00LTEtMS0yMzM5OQ_1cf03c64-453c-423a-a196-9635ac2ad52f">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNy0yLTEtMS0yMzM5OQ_34f43121-542c-4184-ba7d-112a71f61360">1,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:DepositAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNy00LTEtMS0yMzM5OQ_fbf8bfc1-188b-49de-bf8d-f1a9529808ed">1,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOC0yLTEtMS0yMzM5OQ_8d70f0e6-2d3e-4a28-b640-8683d78a9dc7">3,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOC00LTEtMS0yMzM5OQ_7976f15d-26de-4107-bd40-a3448abdb8a2">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOS0yLTEtMS0yMzM5OQ_82155472-01df-4ba9-9b78-c5322d439fd7">80,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOS00LTEtMS0yMzM5OQ_0eb52cd9-a2e3-48e1-a8a9-0fe663a9b368">46,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RleHRyZWdpb246NDgwODViNmQzMjM1NDI0MWI0MTU1YWJiNmNkMzY2YmNfMjIx_bf40d2ba-65e2-4156-904e-98b46843ce40" escape="true"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMS0yLTEtMS0yMzM5OQ_fdf3e217-644f-4c56-a915-adb73abe87f4">27,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMS00LTEtMS0yMzM5OQ_a5773a27-1bed-4f16-8403-00e36490e561">25,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMi0yLTEtMS0yMzM5OQ_6435a784-83c8-47be-933f-2a331961c7b8">32,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:SpareParts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMi00LTEtMS0yMzM5OQ_99f071b1-af08-4a05-bedc-404f4e5f0748">28,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMy0yLTEtMS0yMzM5OQ_102f1282-7749-49d2-98bf-cf397f7c39e3">3,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMy00LTEtMS0yMzM5OQ_27dc79c7-a88b-422d-8335-e924751737c5">3,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS0yLTEtMS02MzMxOA_34427584-d48c-4db0-96cc-f1e21e10f1b2">6,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS00LTEtMS02MzMwOA_919ef840-72b8-4802-a243-e3112ca255d1">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNC0yLTEtMS0yMzM5OQ_04581712-74ae-44a3-a093-240ffc69f26e">2,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNC00LTEtMS0yMzM5OQ_75dde50e-e2c9-4af5-b5a5-030a4b33bbc8">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNy0yLTEtMS02MzMxOA_d9457157-2fc4-4141-a426-c3822f527455">28,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bd1e48a37ce464490eb88d4e81041c1_I20210331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNy00LTEtMS02MzMwOA_fdeb18c2-9719-4d1f-bec9-526dca86d5cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfOC0yLTEtMS03OTYzNw_c94bf1c5-f517-4103-a52e-71b206291de1">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5193042f2c45bd83248a95c20e923d_I20210331" decimals="-3" name="us-gaap:DerivativeAssetsNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfOC00LTEtMS03OTYzNw_b5c56686-86c0-48c7-8808-5f2ccb8a01f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS0yLTEtMS0yMzM5OQ_66cbb7ef-2f2a-4c7c-8a94-30de64f1f9e1">4,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS00LTEtMS0yMzM5OQ_f0887d8e-295e-4dd5-aa0c-c44ba927f5ce">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNi0yLTEtMS0yMzM5OQ_da6aef28-855a-4692-9451-6d7e7262962f">104,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNi00LTEtMS0yMzM5OQ_96ac44e0-ae13-4877-a55b-3eec03ddfae4">63,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RleHRyZWdpb246YWU3ZTliYWRiMmQwNGI2OTg0ZjEyZDM2NDBlZmQ4NzFfMzc3_f24dd6cc-1d72-41d8-b6fb-f2bb9e2d93e8" continuedAt="i9db712275e72466d945dd920284ade83" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="i9db712275e72466d945dd920284ade83" continuedAt="i86184f22035142cf8b1ba2de1be42aaf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RleHRyZWdpb246YWU3ZTliYWRiMmQwNGI2OTg0ZjEyZDM2NDBlZmQ4NzFfMzgw_139a9b76-5efb-4b97-9905-ec380cca48fa" continuedAt="i4f2795a8e7f445cc9f23be816cb10744" escape="true">Inventories consist of the following (in thousands):&#160;</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i86184f22035142cf8b1ba2de1be42aaf"><ix:continuation id="i4f2795a8e7f445cc9f23be816cb10744"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMS0xLTEtMS0yMzM5OQ_6a4e5fd4-59b8-4350-839c-ed9336c10463">232,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMS0zLTEtMS0yMzM5OQ_488d68ca-ccae-43cf-8393-bae1e47c402c">135,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMi0xLTEtMS0yMzM5OQ_ecf1bb07-fe12-41c7-89a5-2d7b83948ec8">74,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMi0zLTEtMS0yMzM5OQ_59fa85d2-99db-439d-93d9-0b4e2314f5f7">36,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMy0xLTEtMS0yMzM5OQ_90119c71-8c6a-4a5d-836c-cc19c28ce16f">229,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMy0zLTEtMS0yMzM5OQ_1fa03e02-89ec-4b80-8dd6-5c8af6b8fab8">118,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfNC0xLTEtMS0yMzM5OQ_9bde016e-ef9a-40d4-bbe4-b3803d221918">536,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfNC0zLTEtMS0yMzM5OQ_2d9bdf43-2278-4672-a6ff-a50a518a010a">290,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 3: Acquisitions).</span></div></ix:continuation></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfNDkz_d71573cb-6610-4f10-a63c-e4cd504bf1cb" continuedAt="i2ac2f3e7afab4682b2dd105b6a473300" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2ac2f3e7afab4682b2dd105b6a473300"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfNDg4_97c44bf9-1b1a-4097-ac29-885ceead391b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMS0xLTEtMS0yMzM5OQ_3494bb0a-9bf7-450f-b137-acbbc1d194a7">432,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMS0zLTEtMS0yMzM5OQ_91e476d4-a43f-4ffe-9727-6f8982372a99">321,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708212e3ab134bbaab535bc663a5a479_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMi0xLTEtMS0yMzM5OQ_e241b2af-f20c-44b5-a93c-a6054be19b10">289,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ba8683ccfb439d8c9bf26272861771_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMi0zLTEtMS0yMzM5OQ_269492f3-96dc-4b87-85f2-729f42220e02">243,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i190b17e0f2b041758e8c0431e71dcc64_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMy0xLTEtMS0yMzM5OQ_c9bd8619-fb76-4a5a-b4cd-80511e07e222">60,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id29aa22c8f0840b08bc18688167f63d5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMy0zLTEtMS0yMzM5OQ_805567fb-a7f8-4141-9bcc-bb4faf35486c">60,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddf2d2aa8b564efc876aa1ba23936f52_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNC0xLTEtMS0yMzM5OQ_e90c9ce5-a867-4f45-b5d9-b1d28d7756f2">112,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb0aaca7e4e4381ac74739e433b7861_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNC0zLTEtMS0yMzM5OQ_3fd11332-1975-42e2-bb0e-7870be3a6197">102,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNS0xLTEtMS0yMzM5OQ_5409e4c8-dad7-4d2f-ab7e-dd1c35f5c411">10,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FurnitureAndFixturesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNS0zLTEtMS0yMzM5OQ_5d436fbf-1027-431f-a208-487668ab110a">7,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c8a50a910984b9e86610a127c140e86_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNi0xLTEtMS0yMzM5OQ_a8e4f429-bef3-4ca3-8647-ee145d45b681">103,257</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3826af64dd4f7db3fecffa7b173fc5_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNi0zLTEtMS0yMzM5OQ_654729d2-d683-42f6-b93a-502c3bdbdc31">97,384</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNy0xLTEtMS0yMzM5OQ_30b59439-058a-4f72-8796-4b3135df506e">123,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNy0zLTEtMS0yMzM5OQ_22d889f1-74c1-46ed-95b6-db0f45fc2021">72,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOC0xLTEtMS0yMzM5OQ_44022310-3034-464e-9661-b3187c8053dc">1,133,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOC0zLTEtMS0yMzM5OQ_06740d1f-2552-46c8-8ca4-094a63d25b8b">905,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOS0xLTEtMS0yMzM5OQ_cff48f52-ef3d-469b-a426-1a91a1ce4d0a">458,614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOS0zLTEtMS0yMzM5OQ_395b0d84-ba7e-4093-bf89-578f364d7463">436,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMTAtMS0xLTEtMjMzOTk_1d60c3da-f33c-4982-b88b-42b5ab0e0b93">674,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMTAtMy0xLTEtMjMzOTk_8ee91103-b80b-46c6-9095-9d6e3458836e">468,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfMzAx_178857e3-83ac-4d96-b9cf-41b005c0a5b9">21.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfMzk2_f80568ef-b8f4-49ea-bddd-5f6a5eb654c3">16.3</ix:nonFraction>&#160;million for the three months ended March 31, 2022 and 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2022, property, plant and equipment and related depreciation expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTExOA_671db673-1d82-4801-8bbe-bdfa96c4df79" continuedAt="id620e486dcd84941848df6e79c5a699c" escape="true">Goodwill and Intangible Assets, Net</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id620e486dcd84941848df6e79c5a699c" continuedAt="i199459b7880644c4b29b36871d73226b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTEyMQ_bb01cdc5-bde6-4bcd-9029-77296f38124b" continuedAt="i281be6c952854bd1ad9d4827f2c76385" escape="true">The following table presents the changes in the carrying amount of our goodwill (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i281be6c952854bd1ad9d4827f2c76385" continuedAt="i082159f5a8b04e0ca1a409a39c6ba463"><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfMS0yLTEtMS0yMzM5OQ_8ce3c81b-c2c2-419a-ae11-46c9173333c3">43,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfMi0yLTEtMS0yMzM5OQ_efb1cf55-dc23-4b0d-ad38-741faacc109e">1,493,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfMy0yLTEtMS0yMzM5OQ_429ad652-269a-477f-acdf-df4c84655cbf">7,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfNC0yLTEtMS0yMzM5OQ_12b30994-6f32-46b6-966a-9210be75a4c4">2,560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfNS0yLTEtMS0yMzM5OQ_5513e417-073c-427b-a667-dc00bf0c170f">1,526,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to Smiths Medical acquired on January 6, 2022.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i199459b7880644c4b29b36871d73226b" continuedAt="i956dfa3dfdab476e8e822d66e8c1e200"><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><ix:continuation id="i082159f5a8b04e0ca1a409a39c6ba463"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other relates to measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTEzMg_d9c10c84-e33a-4cbd-8f78-aed4fa90712c" continuedAt="i4b1f5abd95f54c25bb81e0d3062ad8d5" escape="true">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i4b1f5abd95f54c25bb81e0d3062ad8d5"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic439ddf48ef245c5b7e4afa06b2ebd93_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi0yLTEtMS0yMzM5OQ_3057c2aa-a21b-48f3-a69a-2d2ece93273c">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65da200e05c4e4b9a561174b1bc7c23_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi00LTEtMS0yMzM5OQ_90b2f3bc-8daa-4ea3-bb21-99b2ec2109d8">28,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65da200e05c4e4b9a561174b1bc7c23_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi02LTEtMS0yMzM5OQ_7a12b2ae-c6b5-498c-af0f-7bd629c6f201">17,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if65da200e05c4e4b9a561174b1bc7c23_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi04LTEtMS0yMzM5OQ_47f1455a-dc14-46a4-857e-036f86f83e4c">10,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i731b7502508d4f8c8b50e49d76dc37ee_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy0yLTEtMS0yMzM5OQ_89a45bcf-01d2-421e-8f39-13003b22f78e">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy00LTEtMS0yMzM5OQ_bb43f8ab-755c-453f-ac5f-c2ee477ff0c6">10,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy02LTEtMS0yMzM5OQ_d562f244-4bc3-4722-9da8-3a1095c6a505">6,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy04LTEtMS0yMzM5OQ_88b50a9b-4301-4533-9265-5983f4c98e61">4,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1e9016dd7b774b169ec2614f61542be9_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC0yLTEtMS0yMzM5OQ_70bc1165-303e-4ba8-8d44-aa1a85fc6d18">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b6f20b81f44312800477e6da74fd8f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC00LTEtMS0yMzM5OQ_97431411-1dc2-4512-859c-dc2e97652827">558,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b6f20b81f44312800477e6da74fd8f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC02LTEtMS0yMzM5OQ_70734105-825b-467f-a254-fce1d1684ce8">47,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b6f20b81f44312800477e6da74fd8f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC04LTEtMS0yMzM5OQ_bb4629cf-e55f-472a-a80f-940d54a2ecef">510,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib7e4ab57206c488b97acd961e65966ff_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS0yLTEtMS0yMzM5OQ_e3b6eac6-1e19-4900-bc2e-e712351de569">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS00LTEtMS0yMzM5OQ_18863699-0165-4841-8e50-0c00d656401b">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS02LTEtMS0yMzM5OQ_8a5bd8f1-5dca-429f-924d-e17a38f2e27b">2,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS04LTEtMS0yMzM5OQ_ff6bfa70-b501-4b11-ae08-f2089f02d6ec">3,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i912753928ea843239807436aa78d567d_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi0yLTEtMS0yMzM5OQ_d0744d3c-1b44-45a0-b332-9b293a607d83">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aec3bdfaced4372b17ea0347c016398_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi00LTEtMS0yMzM5OQ_906c93ac-1067-4478-b279-b8e885fbb9ca">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aec3bdfaced4372b17ea0347c016398_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi02LTEtMS0yMzM5OQ_f4af65a7-7b71-443d-a660-b8de286bc428">5,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aec3bdfaced4372b17ea0347c016398_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi04LTEtMS0yMzM5OQ_90eadf72-92be-4ef4-a8c6-7f308161aa78">13,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iabdeca4cff6a4718b4f1dd649c39be64_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy0yLTEtMS0yMzM5OQ_ec2724c3-a322-4f6f-a921-d06bde0197c0">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17f985170954eb48428d61f36b19859_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy00LTEtMS0yMzM5OQ_0a09ca50-8040-4018-9ea8-ce7ae646fb42">581,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17f985170954eb48428d61f36b19859_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy02LTEtMS0yMzM5OQ_f3238abd-553a-4e87-bb50-f1d78f51ee02">62,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17f985170954eb48428d61f36b19859_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy04LTEtMS0yMzM5OQ_3f4de97d-06ea-4d3a-a9ad-0fdf63599b37">519,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if65467afecf74a8b93960ba983aa3d59_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC0yLTEtMS0yMzM5OQ_60b9b9cf-64c6-46fc-9cba-33715b72acf3">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b397229737456d84db63d3bf2f90df_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC00LTEtMS0yMzM5OQ_03cd97b4-6205-4978-951e-8e96c9a81e88">9,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b397229737456d84db63d3bf2f90df_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC02LTEtMS0yMzM5OQ_d979fed4-b324-41e0-b096-f7dbffb11531">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b397229737456d84db63d3bf2f90df_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC04LTEtMS0yMzM5OQ_bb0e230c-5cd1-4e86-9e91-650a1b43091c">5,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOS00LTEtMS0yMzM5OQ_19300e01-ffbe-4ad3-9dc4-9663d63215dd">1,211,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOS02LTEtMS0yMzM5OQ_1298261d-596e-4bee-a472-ff4b0b57b74e">144,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOS04LTEtMS0yMzM5OQ_ca7f6501-1923-4e81-b410-c88e92f8ae13">1,067,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTEtNC0xLTEtMjMzOTk_73d87545-5cff-449f-8dcc-ae235f5d78db">27,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTEtOC0xLTEtMjMzOTk_cbff7ad8-3657-49dd-9462-78154ddaa485">27,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTMtNC0xLTEtMjMzOTk_3e1afa61-517f-4ceb-ba46-3ac4db5db0f0">1,238,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTMtNi0xLTEtMjMzOTk_11a87a3b-0832-4aa2-9a90-e854cd117f1d">144,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTMtOC0xLTEtMjMzOTk_467c71f3-0b15-4080-bb79-146af76aae1a">1,094,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i514d9e8e7edd4fa28d63ef9fccb34cd1_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi0yLTEtMS0yMzM5OQ_addd357d-b42b-4e51-8c75-fbd281e636f5">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi00LTEtMS0yMzM5OQ_17308bb4-933c-4c31-b692-81c4056137da">27,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi02LTEtMS0yMzM5OQ_67d35e14-dc35-4e89-90c4-edcd5c8ab8c1">16,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi04LTEtMS0yMzM5OQ_486f8af7-894c-4eab-ab84-bee821386605">10,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i97a46089acbd4ff2aaeb2d2252ab6eb1_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy0yLTEtMS0yMzM5OQ_84cd81d4-4651-4f8f-8432-711cfc639e79">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7205011397d3426281ae4bd434b15c77_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy00LTEtMS0yMzM5OQ_3ef8ee79-8ff6-42f7-a733-3920b4d549b3">10,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7205011397d3426281ae4bd434b15c77_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy02LTEtMS0yMzM5OQ_2f4232b8-3f62-4df4-a865-cfb7097cbbc7">6,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7205011397d3426281ae4bd434b15c77_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy04LTEtMS0yMzM5OQ_d0a238b7-ca7a-4d1e-8933-63870e05eb29">4,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5eb56f1821864a0db13d3ee2043d7dcd_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC0yLTEtMS0yMzM5OQ_47b3c378-3e4d-4ecf-8090-a1b27e7d643c">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide038f68482143e7bc6cead2e03b3248_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC00LTEtMS0yMzM5OQ_01ed2a9f-2e80-4bf3-bb01-3683b0dac7c1">57,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide038f68482143e7bc6cead2e03b3248_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC02LTEtMS0yMzM5OQ_9aab2dcd-6944-411e-8cbf-007873d286ba">33,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide038f68482143e7bc6cead2e03b3248_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC04LTEtMS0yMzM5OQ_d59f2dc9-ba97-4ede-bbcb-9927b9f6ad86">24,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i66bc748b1f3449e4a5e0f34ba0a23593_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS0yLTEtMS0yMzM5OQ_c3e1a33a-8e74-4b41-8b6c-ddd29b565645">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02924cdb80304d2fbd0a1fd268de89a3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS00LTEtMS0yMzM5OQ_a33e3712-8e68-44a2-a20b-18d1829bfe46">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02924cdb80304d2fbd0a1fd268de89a3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS02LTEtMS0yMzM5OQ_429570e9-3c98-480d-9549-45259db6573b">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02924cdb80304d2fbd0a1fd268de89a3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS04LTEtMS0yMzM5OQ_158aac85-e536-4752-9c06-6e4234e3a65d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibfc7fd5a9dbe4432b60326ce95161345_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi0yLTEtMS0yMzM5OQ_6e5a8aa9-2e71-4e92-947a-4acdd6ab3f85">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e310a8c7f034cd7853abf6100bc499e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi00LTEtMS0yMzM5OQ_8421c14e-edea-4547-ae70-d657ed0d8078">18,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e310a8c7f034cd7853abf6100bc499e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi02LTEtMS0yMzM5OQ_d06e33b4-8ff0-4566-8408-5217bff920f6">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e310a8c7f034cd7853abf6100bc499e_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi04LTEtMS0yMzM5OQ_9865a5c7-aa36-4fdd-8fc3-c44e433c5b5e">13,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5230a8d671ee4f5ab0953b698bff8639_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy0yLTEtMS0yMzM5OQ_504d5d6c-a3f6-4f0c-ae3c-e6edc71c5e30">13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17f4375ba33447ab41447690f328232_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy00LTEtMS0yMzM5OQ_4f20865b-775d-442c-9ad2-0d3afbf76297">152,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17f4375ba33447ab41447690f328232_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy02LTEtMS0yMzM5OQ_ec4d7501-2850-42c0-98c1-ba76b0ffb22a">49,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17f4375ba33447ab41447690f328232_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy04LTEtMS0yMzM5OQ_b1f0f36d-57cb-4e21-ae99-d36e08ce9295">103,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if248896a740349349b9dc2c70a6c7362_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC0yLTEtMS0yMzM5OQ_4f600ed9-530e-4fc9-a701-55b58d96c97c">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC00LTEtMS0yMzM5OQ_6d6f14d6-99d3-4b4e-ac8b-47d020b5f2da">9,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC02LTEtMS0yMzM5OQ_ea019936-3b98-4d67-bd32-fbc358237f62">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC04LTEtMS0yMzM5OQ_3801a529-6ce8-4cb7-bbdb-75e4fd4db39b">6,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOS00LTEtMS0yMzM5OQ_c8e93ef4-35ee-47f2-a6ab-6582de6477e3">275,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOS02LTEtMS0yMzM5OQ_4a7c3572-4ae3-4c31-ac4f-0b578ee2b22b">112,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOS04LTEtMS0yMzM5OQ_a885609a-fc90-4e4a-98f6-dd87690441e7">162,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTEtNC0xLTEtMjMzOTk_cd29d848-7b2c-4361-ab16-37a4d5b1a8e7">25,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTEtOC0xLTEtMjMzOTk_14c9b66a-b936-4f34-9720-4d9fb98d2111">25,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTMtNC0xLTEtMjMzOTk_d1a31317-8a36-4ce4-95de-609bf8b175c4">301,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTMtNi0xLTEtMjMzOTk_5e7a9daa-fefa-4e4b-9a2f-367943689fb7">112,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTMtOC0xLTEtMjMzOTk_dc6f41dc-92b8-4715-81c6-8f5e8688403a">188,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended March&#160;31, 2022 and 2021, intangible asset amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfODY1_01391e8e-3387-457c-a6d8-c98850f15267">31.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfOTA1_39e2e9e6-7ae3-43e0-8eb9-bb7c5fecd8f3">5.8</ix:nonFraction> million, respectively. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2022, intangible assets and related amortization expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i956dfa3dfdab476e8e822d66e8c1e200"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTEzMQ_71564848-afad-4b87-92f8-a1aa7bf44894" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMC0yLTEtMS0yMzM5OQ_580c4739-a809-4ac2-bb16-e571c48fdc55">104,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMS0yLTEtMS0yMzM5OQ_a922e47a-f5fc-46a9-8929-bd72ff32671d">132,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMi0yLTEtMS0yMzM5OQ_2cffa45b-5c39-46e4-b823-dd0a6583eec7">132,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMy0yLTEtMS0yMzM5OQ_caeb0eaf-4393-492d-a87d-78d3f0f68993">124,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNC0yLTEtMS0yMzM5OQ_50ef94b2-786e-4dd4-978b-b07b40b54708">123,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNS0yLTEtMS0yMzM5OQ_5185cdd2-9805-4830-bce6-25d856e16ceb">116,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNi0yLTEtMS0yMzM5OQ_6256cb18-f186-4712-93cf-9945b3d11887">333,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNy0yLTEtMS0yMzM5OQ_3a0194b3-7d31-4e34-beb9-0d14f383d73f">1,067,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RleHRyZWdpb246OWYxMDQ5MDRhYzlmNDE3YTg5MTY2YTk5MDBlMzBlNmNfMjEx_d06b09b4-da9e-4fb8-8e8e-3f64fa9ae217" continuedAt="i68575d5c58bc4af2ad8f824454b1d4e6" escape="true">Accrued Liabilities and Other Long-Term Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i68575d5c58bc4af2ad8f824454b1d4e6" continuedAt="i62aed2ad283944e4acee3ad030a354af"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RleHRyZWdpb246OWYxMDQ5MDRhYzlmNDE3YTg5MTY2YTk5MDBlMzBlNmNfMjA3_e6b88f8b-d9ef-47a0-97d6-84902ffdf76d" continuedAt="ib9120500f42541b3a88ff07909b06c08" escape="true">Accrued liabilities consist of the following (in thousands):&#160;</ix:nonNumeric></span></div><ix:continuation id="ib9120500f42541b3a88ff07909b06c08" continuedAt="i50453b51b4ce498fb7e989916e503d89"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMS0xLTEtMS0yMzM5OQ_70f052fd-af62-406d-8ee3-bc8acf05f6c4">47,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:AccruedSalariesAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMS0zLTEtMS0yMzM5OQ_58de87eb-5653-41e6-b7e4-3850081d378e">27,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMi0xLTEtMS0yMzM5OQ_7041382c-5270-4395-8ed9-bb09a409f3a6">19,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedBonusesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMi0zLTEtMS0yMzM5OQ_349c8e42-f502-405e-9dd5-b2279bee2797">33,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfNC0xLTEtMS0yMzM5OQ_8ebd40c4-bd6e-4f8e-b444-6aeef148ed34">20,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfNC0zLTEtMS0yMzM5OQ_7dcadc56-55da-46b3-bb04-344bbd2daeec">9,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOC0xLTEtMS0yMzM5OQ_64ac18e5-7c79-41ac-b571-9bba34b47a70">7,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOC0zLTEtMS0yMzM5OQ_4b0d0de4-e958-43db-bd85-881d93375a20">1,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:RestructuringReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOS0xLTEtMS0yMzM5OQ_96252081-fff5-4082-9fde-1ae218ca05fc">2,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOS0zLTEtMS0yMzM5OQ_d26720bf-9ba2-4bef-a854-1cb77251bbdc">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:UnfavorablecontractliabilityST" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTEtMS0xLTEtMjMzOTk_ad7ce96d-9689-4ce9-aa72-76adc1e2b10c">40,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:UnfavorablecontractliabilityST" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTEtMy0xLTEtMjMzOTk_fc695162-215c-4cff-8011-67cbc97d58d8">12,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTItMS0xLTEtMjMzOTk_29386317-7cab-438a-89e5-ca88575e266d">1,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Accruedothertaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTItMy0xLTEtMjMzOTk_95bf1b1f-c64f-4a7a-aadc-f82f67800efc">4,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTMtMS0xLTEtMjMzOTk_c81f4ff5-b1d5-48da-98be-eda5c9d4035b">16,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTMtMy0xLTEtMjMzOTk_ed4ab9cb-3637-4064-a457-100888dc905d">773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Accruedlegalfees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTQtMS0xLTEtMjMzOTk_d3ed3b21-1972-49a0-bcea-dee35e255940">3,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Accruedlegalfees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTQtMy0xLTEtMjMzOTk_9ac9c3a3-9954-469e-af91-309eaa02b9a6">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTYtMS0xLTEtMjMzOTk_4ea4563b-cf87-4b15-b6d4-d79736e4a425">21,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Outsidesalescommissions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTYtMy0xLTEtMjMzOTk_995f60e1-875e-40a4-9e92-d6d69cdc622e">5,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTctMS0xLTEtMjMzOTk_9d38b1fd-b994-47ff-8159-3613d8fd4da8">31,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTctMy0xLTEtMjMzOTk_7020271a-bf7b-4ba3-afb3-d01a138c407b">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTgtMS0xLTEtMjMzOTk_b021a9c0-1d82-4835-8f83-ec6ea957122d">10,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Accruedfreight" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTgtMy0xLTEtMjMzOTk_546bf1ac-b8b4-4c06-8abc-bbb346a835e2">9,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjAtMS0xLTEtNjk5NzE_7828cc00-8d9b-47da-8647-0203a13ad0cc">895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5193042f2c45bd83248a95c20e923d_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjAtMy0xLTEtNjk5NzE_f4b54162-c523-4261-869b-0476c06329e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired restructuring liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:AcquiredRestructuringLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjEtMS0xLTEtMjMzOTk_bf95e6f0-f251-4532-8165-48b9ee7961f1">6,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331" decimals="-5" name="icui:AcquiredRestructuringLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjEtMy0xLTEtMjMzOTk_aed28218-dfa7-43bf-b802-cf148c4f31ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued transaction/integration costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:AccruedTransactionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMS0xLTEtODQwNDU_8fc8ee01-c2ee-4021-9fad-897faf282da4">8,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:AccruedTransactionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMy0xLTEtODQwNjY_9d6142cd-8ef4-430e-a40a-28c9902386b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:AccruedAuditFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjUtMS0xLTEtODQwNTI_e0c12b3f-3e41-4985-a2e0-b5bf37693b33">3,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:AccruedAuditFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjUtMy0xLTEtODQwNTk_f751be3b-0144-48be-ac11-0b809393fa3a">1,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMS0xLTEtODIwOTI_3b2b21c7-04e1-4199-b747-70023e1de5b2">2,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331" decimals="-5" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMy0xLTEtODIwOTk_55fffe9a-8ab0-4744-bea6-b49300f77068">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjMtMS0xLTEtMjMzOTk_fc4be422-e752-4b5e-96f9-3b267c6b099c">15,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjMtMy0xLTEtMjMzOTk_fa12a7e3-35d0-4530-86fa-cee03d8bd7fe">8,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMS0xLTEtMjMzOTk_08e57882-9ba1-4428-a13f-cd77e57f3bcc">261,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMy0xLTEtMjMzOTk_3b00ee63-673b-495c-8dca-0c8da16be919">118,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $<ix:nonFraction unitRef="usd" contextRef="ic2dd7ec8ea2a4048a06ea268924bf23a_I20220331" decimals="-5" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RleHRyZWdpb246OWYxMDQ5MDRhYzlmNDE3YTg5MTY2YTk5MDBlMzBlNmNfMTA5OTUxMTYyODk2NA_7f62d86c-72c3-4618-818a-d6893665b4c8">31.3</ix:nonFraction>&#160;million of estimated remediation costs related to a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i62aed2ad283944e4acee3ad030a354af" continuedAt="ifadb34fdd9514aeeb7f1751050588047"><ix:continuation id="i50453b51b4ce498fb7e989916e503d89" continuedAt="ieeb5e3ddfc764cfb970728862e479219">Other long-term liabilities consist of the following (in thousands):&#160;</ix:continuation></ix:continuation></span></div><div style="margin-bottom:3pt;margin-top:5pt"><ix:continuation id="ifadb34fdd9514aeeb7f1751050588047"><ix:continuation id="ieeb5e3ddfc764cfb970728862e479219"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMy0xLTEtMS0yMzM5OQ_ccbf8ffb-e267-4576-8ef6-f942626e6984">73,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMy0zLTEtMS0yMzM5OQ_7d320084-a07b-40b9-ac1a-14ea162e1f39">33,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNC0xLTEtMS0yMzM5OQ_8b50e06b-8ea9-437a-bc4f-46db64c562c4">1,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNC0zLTEtMS0yMzM5OQ_540b8f3b-153e-4f45-8ff9-632db695689b">1,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNS0xLTEtMS0yMzM5OQ_7a655156-842d-47ec-b21c-93eff91a1984">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:AccruedRentCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNS0zLTEtMS0yMzM5OQ_25d49aa2-e50c-4d8c-a9e7-5cf1ee14909c">1,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="icui:Liabilitiesforcontracts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNi0xLTEtMS0yMzM5OQ_ba4e51c3-ff9e-4f51-877f-04aa4e95614d">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="icui:Liabilitiesforcontracts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNi0zLTEtMS0yMzM5OQ_7fd80eb2-19d0-478f-bf23-1c9a3defdcef">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0xLTEtMS02NDA2Mg_80190eee-1b2a-4de7-8638-d1805f7792c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331" decimals="-3" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0zLTEtMS02NDA2Mg_ba4defc8-17de-4ade-b01c-9f7ff745c0eb">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0xLTEtMS03ODk2MQ_9721fce2-dbe7-4843-8807-1441f6dbdc92">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e5193042f2c45bd83248a95c20e923d_I20210331" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0zLTEtMS03ODk2MQ_986fbcf4-3964-46f2-8516-28a8d02626c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0xLTEtMS0yMzM5OQ_d8e00191-1db4-40b2-8101-c452d3c60e21">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0zLTEtMS0yMzM5OQ_529d5d04-1908-4473-bd22-352188847d08">2,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOS0xLTEtMS0yMzM5OQ_338bab05-d1eb-44d4-9224-2905251a64ff">22,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOS0zLTEtMS0yMzM5OQ_ec42d63d-5974-4d40-954a-8e71a5f1e00b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b1cec7abee4f76b35a418a82f45396_I20220331" decimals="-3" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTItMS0xLTEtODE3ODE_c8d08913-dddc-49c2-97bd-70b8ea80a30e">23,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf4da5fb2b8244bca91159e192d1b9ee_I20210331" decimals="-3" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTItMy0xLTEtODE3ODg_d6228173-00e9-464c-8163-a714357e4e2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTAtMS0xLTEtMjMzOTk_d01014b7-f265-4c70-afd3-96292443d9a0">9,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTAtMy0xLTEtMjMzOTk_3eaf2698-57ae-48c8-bf0c-5faede01e4ee">1,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTEtMS0xLTEtMjMzOTk_1a229b70-ef5c-40a7-974e-823c014560a6">134,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTEtMy0xLTEtMjMzOTk_f27e5418-30aa-45b8-ba6a-68debcf4257d">41,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consists of contracts with customers and suppliers that were valued at below market at the time of the Hospira Infusion Systems acquisition.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-term portion of the estimated remediation costs related to a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTk5Ng_af02782b-5b44-467a-bac5-88e31cd823d0" continuedAt="i8d2a608da4364546b03e87b943341443" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i8d2a608da4364546b03e87b943341443"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes were accrued at an estimated effective tax rate of <ix:nonFraction unitRef="number" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfOTY_fa82219b-e2ac-4533-9c2b-1d0d5c30761f">31</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTkx_3b53aa66-7f3a-47d4-8b73-0ccb3a494655">12</ix:nonFraction>% for the three months ended March 31, 2022 and 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMzU1_793958d3-869e-4377-9a74-cf5f4ed46593">21</ix:nonFraction>% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the three months ended March 31, 2022 of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfNzg5_012bf9e5-3135-459e-be57-e782138aa3a0">2.6</ix:nonFraction>&#160;million.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2021 differs from the federal statutory rate of <ix:nonFraction unitRef="number" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTE3MA_98b6ef9c-40f0-4739-b205-bb184c819ead">21</ix:nonFraction>% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low taxed income ("GILTI"), FDII and tax credits. The effective tax rate during the three months ended March 31, 2021 included a discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTUyNQ_3409a25c-23ba-4b2a-aa30-3aff82e980bf">1.8</ix:nonFraction>&#160;million related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span></div></ix:continuation><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMzA5OA_303eed1e-04df-4941-b732-7d840e02cd22" continuedAt="i6497db8c423e492a94157e992afe7734" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6497db8c423e492a94157e992afe7734" continuedAt="ie5bde78d60314887a653f192304b493d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-6" name="icui:TotalSeniorSecuredCreditFacility" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0NDk2MQ_cd2997d2-1fc2-4605-9c9c-93fcbf6be46b">2.2</ix:nonFraction>&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $<ix:nonFraction unitRef="usd" contextRef="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0Njg4Nw_de2ec5cb-5d69-4841-86e0-07240b46133a">850.0</ix:nonFraction>&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $<ix:nonFraction unitRef="usd" contextRef="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0NjkwMw_f427e247-4449-46a2-8409-2ab0f4c5b1d9">850.0</ix:nonFraction>&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i99c31a1bbc5e49dfba0d6f77e03b2107_I20220331" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0NjkxOQ_2dcaab8f-7a39-4d1c-8d9b-f6098d7d90b6">500.0</ix:nonFraction>&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-6" name="icui:RevolverSubLimits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ5NTkwMA_197d8327-2714-4f68-9cfb-33ac1f4c709d">50.0</ix:nonFraction>&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="ie5bde78d60314887a653f192304b493d" continuedAt="i3efb83b9631a4c52a88b9a55e22479c2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODE5MQ_ea89d7c3-42ad-41e0-93a2-76237b1bbd13">37.8</ix:nonFraction> million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $<ix:nonFraction unitRef="usd" contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODIyMg_89297a6b-dbf8-4e57-9446-8ded46d7892c">15.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODI0Mg_ce17cd52-50dd-4224-a8de-a1cfcdfee288">13.4</ix:nonFraction> million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $<ix:nonFraction unitRef="usd" contextRef="i99c31a1bbc5e49dfba0d6f77e03b2107_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODI2Mg_49ab5d22-0a1b-45b4-9abe-8ea6907b732b">8.7</ix:nonFraction> million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $<ix:nonFraction unitRef="usd" contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODI4MQ_0a9d1ba0-a4c5-4ad2-a023-fd8d7a2fecd6">834.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMwMg_87ab9c0e-3123-47a7-81e3-89f5f662b9d2">836.6</ix:nonFraction> million, respectively.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity Dates</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date for the Term Loan A and the Revolving Credit Facility is <ix:nonNumeric contextRef="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwMjQ3Ng_f1b2ead5-5e4d-4c31-99a8-078b14b8ac78">January 6, 2027</ix:nonNumeric>, and the maturity date for the Term Loan B is <ix:nonNumeric contextRef="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwMjQ5Mw_31767190-0354-449d-b4a1-82779b63432b">January 6, 2029</ix:nonNumeric>. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="3" name="icui:InterestPercentageAddedToFederalFundsRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxMTg1NA_1242d266-1dcc-40db-8d4e-4a85220a5069">0.50</ix:nonFraction>% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, plus <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="2" name="icui:InterestPercentageAddedToBaseRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxMjMyNQ_f2fd6db0-164b-4565-b8a2-cd5316276197">1.00</ix:nonFraction>%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Term SOFR is the rate per annum equal to (a) Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="3" name="icui:TerSOFRInterestRateAdjustmentForBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxNjYyNQ_a3c57553-49ad-42e0-bee8-baafbca29f49">0.10</ix:nonFraction>% for Base Rate Loans and between <ix:nonFraction unitRef="number" contextRef="i78ebe3443d494bd490f9f07d5202134d_I20220331" decimals="3" name="icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxNjYzMg_5c0edb43-83b7-4b22-802f-10b830005011">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8646fd65464c418fae83a8e61e4c8e4b_I20220331" decimals="8" name="icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxNjYzOQ_98f069c5-2670-49e6-bfb8-bb295a070cad">0.25</ix:nonFraction>% for Term SOFR Loans based on the applicable interest period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility has a per annum commitment fee at an initial rate of <ix:nonFraction unitRef="number" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwMDIxOA_bc96ce56-4806-4e9e-886c-ed91b9386087">0.25</ix:nonFraction>% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of <ix:nonFraction unitRef="number" contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwNjM1NA_817e02a6-9ffe-4615-8751-fa592af6a9cd">0.75</ix:nonFraction>% per annum for Base Rate Loans and <ix:nonFraction unitRef="number" contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwOTUxMw_2969fc52-b1c5-452b-95ab-1136a9151a35">1.75</ix:nonFraction>% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxMw_9874ab50-1e71-4492-a486-802fd2fe3072" continuedAt="ifd8abcfb670043d3b66c60e7e2f11b30" escape="true">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i3efb83b9631a4c52a88b9a55e22479c2" continuedAt="i3296f183f5214a9997e269c226c9e6c0"><div style="text-align:center;text-indent:36pt"><ix:continuation id="ifd8abcfb670043d3b66c60e7e2f11b30"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ae4f3915f574485829c8127bbdd1797_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMS0xLTEtMS04Mzg4Nw_693a765b-23b5-4e5d-acde-2056b73e3d1e">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9ae4f3915f574485829c8127bbdd1797_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMS0yLTEtMS04Mzg4OQ_4e84fd85-191f-4b51-a3be-04b0e8eb3c68">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i78b84b5657084d8e998eb611076dc5ab_D20220101-20220331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMS0zLTEtMS04Mzg5NA_1fd2c4c4-485b-4eae-bcca-ef8b2a6f8053">0.35</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icab58ddd66a140bc97118bd0a1be6cef_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMi0xLTEtMS04Mzg5Mg_1a4ff9a9-8716-4790-b269-7a2ef68d2b4e">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icab58ddd66a140bc97118bd0a1be6cef_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMi0yLTEtMS04Mzg4OQ_3fd089f3-d72b-4402-86c4-ff0373484d89">1.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d03299aace54ed7ac0e3ac6f5fe2d8c_D20220101-20220331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMi0zLTEtMS04Mzg5NA_6c1dc68c-f80c-4416-9972-e6cbddf95851">0.30</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i148b265b5e2742bd83a80cbf70e476da_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMy0xLTEtMS04Mzg5Mg_d102ce6f-0f47-49d0-bb94-d4f8182193ef">1.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i148b265b5e2742bd83a80cbf70e476da_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMy0yLTEtMS04Mzg4OQ_49273537-080a-442c-aef6-0f8e5aa122dc">0.75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i121a2aae16c14453b205c42847a26f54_D20220101-20220331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMy0zLTEtMS04Mzg5NA_9017b65b-6bcf-4011-bc89-ccfcdee248ec">0.25</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if626b886e63044aaa9c6735867a954ec_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNC0xLTEtMS04Mzg5Mg_51e122a7-ffea-4437-bc90-d0b596de4828">1.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if626b886e63044aaa9c6735867a954ec_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNC0yLTEtMS04Mzg4OQ_55a1395a-c21e-46e9-af08-00b1e61a2159">0.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic46418b7be58471cb3d15195cc4f5e2e_D20220101-20220331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNC0zLTEtMS04Mzg5NA_d646ab30-f806-4cd6-97c0-303a6720d9ff">0.20</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc6ce78ff0d54018b0f911617adafb8c_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNS0xLTEtMS04Mzg5Mg_1ec187c5-a110-46b7-9966-7ae5a810abe7">1.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc6ce78ff0d54018b0f911617adafb8c_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNS0yLTEtMS04Mzg4OQ_25d18833-566c-4529-94bf-edde0484cff5">0.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57b48a056c4f4370adbb6f193d7b4dd9_D20220101-20220331" decimals="4" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNS0zLTEtMS04Mzg5NA_0dadb25f-0422-4f64-bb0f-4390721f9ad1">0.15</ix:nonFraction>%</span></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B has an initial applicable margin of <ix:nonFraction unitRef="number" contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMjE5OTAyMzMyMzA5NQ_45351cf6-bb9b-44dc-904a-abfe3094bfe9">1.5</ix:nonFraction>% per annum for Base Rate Loans and <ix:nonFraction unitRef="number" contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwOTgxMg_c952e26d-420c-4096-b089-f29c7a38ee54">2.5</ix:nonFraction>% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.368%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e374be09b9f4b79a626d3ea4af57397_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMS0xLTEtMS04Mzg5OQ_066fbb1c-c4bc-480c-bea7-81c618e67e5f">2.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e374be09b9f4b79a626d3ea4af57397_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMS0yLTEtMS04MzkwMg_19b34d78-6250-401d-9ddb-42ecc531bf21">1.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6781406cb9184964ac659cf86bf513a4_I20220331" decimals="4" name="icui:ApplicableMarginTermSOFRLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMi0xLTEtMS04MzkwNA_d531fe92-7e2b-435c-8e6a-295ad9366382">2.25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6781406cb9184964ac659cf86bf513a4_I20220331" decimals="4" name="icui:ApplicableMarginBaseRateLoans" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMi0yLTEtMS04MzkwNw_f4bff7e1-5a10-4ee2-9d70-9b4c43b348b0">1.25</ix:nonFraction>%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="3" name="icui:TermAPrincipalPaymentFirst2Years" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxOTc1NQ_1ed2f298-34d9-437d-8404-4018bdff9d7b">2.50</ix:nonFraction>% of the original principal amount in each of the first two years, <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="8" name="icui:TermAPrincipalPaymentYear3And4" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUyMDQyMQ_50f14474-7d4f-49dc-a956-03fd9ba918cf">5.00</ix:nonFraction>% in each of the third and fourth years and <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="3" name="icui:TermAPrincipalPaymentInYear5" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUyMDU0NA_6e5a5a31-bdb7-48e7-9f38-aefe01dc64c8">7.50</ix:nonFraction>% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="4" name="icui:TermLoanBPrincipalPayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMjE5OTAyMzMzNjU2Mg_3c046f9d-68f0-4a83-b406-7e3aa3e269e3">0.25</ix:nonFraction>% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2022, we prepaid $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMyNw_fdde98a1-c220-4704-9006-1c237b608997">16.0</ix:nonFraction> million in principal payments on the Term Loan A principal balance.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i3296f183f5214a9997e269c226c9e6c0" continuedAt="i0ce0d3f4442148f28f36f048d5d23fc9"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Leverage Ratio is defined, at any such date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-6" name="icui:LeverageRatioCalculationCeilingSubtractedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUyNjEyMg_65c10a84-359b-49f8-b768-a3eb9c3313d6">500.0</ix:nonFraction>&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interest Coverage ratio is defined, at any such date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants as of March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTky_806f0a40-7cdc-4f31-b7b2-4f785abff735">150.0</ix:nonFraction> million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMjE5OTAyMzI5ODU1Mg_cfe22a44-1830-4eb7-a87c-c6ce362e5ffb">November 8, 2022</ix:nonNumeric>, was terminated in connection with entering into the Credit Agreement on January 6, 2022. There were <ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-5" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ4NjUyOQ_3fc51293-be74-414b-8ba1-3abd9cdc9ecf">no</ix:nonFraction> borrowings outstanding under the Prior Credit Facility at that date or at December 31, 2021. The remaining unamortized deferred debt issuance costs related to the Prior Credit Facility were not material and were expensed in connection with its termination. See further details of the terms of the Prior Credit Facility in Note 11 in Part II, Item 8, of our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxNA_9a010423-41d2-4941-b09f-bdaabf501ab9" continuedAt="ib0771b8da3e44f2db481535a287895af" escape="true">The carrying values of our long-term debt consist of the following (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i0ce0d3f4442148f28f36f048d5d23fc9"><ix:continuation id="ib0771b8da3e44f2db481535a287895af"><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfMy0xLTEtMS04Mzg3MQ_15559a9c-a695-4575-91a8-f6c2972a9471">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfMy0zLTEtMS04Mzc1MA_4d3a19af-b931-49d4-abda-57d0f01965bd">834,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNC0xLTEtMS04Mzg3Mw_6ecdac8f-24b9-441e-b3f9-7b54d4a93c19">5.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNC0zLTEtMS04MzgxNw_68bbed7f-9116-4f16-9d41-83e575429665">850,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib9088e8033ac42c7978c4207a0f3bf01_D20220101-20220331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNS0xLTEtMS04Mzg3Ng_66a693fb-db3b-48e5-9314-fd32e8dd4b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNS0zLTEtMS04MzgxOQ_ac9083a0-487e-4fd8-997f-fb581d067a21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="INF" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNi0zLTEtMS04MzgyMQ_50c13a0b-2e0e-456e-8831-8cf898c9d608">28,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNy0zLTEtMS04MzgyMw_2db4fc10-cccf-4848-99d8-e8bc612bd7fe">1,655,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfOC0zLTEtMS04MzgyNQ_f27cab39-da5d-4066-819a-885da14bc79b">13,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfOS0zLTEtMS04MzgyNw_5e50d798-26b7-4488-bc51-e7dfa5e39f32">1,642,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $<ix:nonFraction unitRef="usd" contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331" decimals="INF" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODM0OQ_2595807e-e119-4196-aba1-8ad4d4bd6876">15.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331" decimals="INF" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODM2NA_e4f4ec59-f53d-41f7-a98d-99c9cac26992">13.0</ix:nonFraction> million relating to the Term Loan A and the Term Loan B, respectively.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxNQ_4017ad6f-74fd-4136-bea7-9660e2c3a366" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMC0yLTEtMS04Mzc1NA_92656462-d7f6-4317-8533-b1d0dcd66ea2">6,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMS0zLTEtMS00NjYyOA_d24c6138-3328-466f-b9c2-58e5a28a3bde">29,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMi0yLTEtMS04Mzc1OQ_ce9e26c4-c7cd-4a1a-88cc-bcd86af64c61">51,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMy0yLTEtMS04Mzc2MQ_99c6c9ed-7919-4670-9bfb-70d0c01007e9">51,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNC0yLTEtMS04Mzc2Mw_426c2adc-e638-449d-b9c0-7f736f35795e">72,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNS0yLTEtMS04Mzc2NQ_468e4d9b-4e45-469a-9832-e61bfd2cd4e0">672,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNi0yLTEtMS04Mzc2Nw_e9eb6289-4028-4dbc-ab52-cd20ad5f91b2">801,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNy0yLTEtMS04Mzc2OQ_d4591164-3735-4190-870b-c11265e3f314">1,684,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="icui:InterestExpenseOnLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxNg_662225ab-5ac7-4449-a7e5-b383b9f0cbc3" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total interest expense related to our long-term debt (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMi0xLTEtMS04Mzc3Mw_b4b330c3-5b8d-4d46-a40e-431fc2e7cef9">10,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="INF" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMi0zLTEtMS04Mzc4Mg_800743a1-8022-4c4d-aed7-f56132151671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMy0xLTEtMS04Mzc3Ng_566a8440-6b2d-463f-b5ed-107127817bde">1,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="INF" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMy0zLTEtMS04Mzc4Mg_d805010a-e9ad-406c-b951-645885639d27">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNC0xLTEtMS04Mzc3OA_0d55d2ae-d972-4f17-bd41-c98f46773d94">351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNC0zLTEtMS04Mzc4Mg_96a6906c-3c4b-46f5-8c88-6cc368bfc4c9">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="INF" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNS0xLTEtMS04Mzc4MA_6b7b5160-7aa0-449e-bb6f-5b9908c9b651">12,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="INF" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNS0zLTEtMS04Mzc4Mg_05149d4c-5323-42d0-bd54-2ada18f67022">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMTQwNA_0b4ffe30-467d-4094-aba7-ee28c4f7ffce" continuedAt="i76048c8396424fcfac0203f5b442e356" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i76048c8396424fcfac0203f5b442e356" continuedAt="i7d1ccd6ea5444ee4ac33f85fc4031620"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholders Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owns approximately <ix:nonFraction unitRef="number" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="3" name="icui:SmithsGroupOwnershipAcquisitionSharesIssued" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMjE5OTAyMzI2MTMwNA_aed12629-8966-4fa8-a03e-6e7d622e8bce">10.5</ix:nonFraction>% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least <ix:nonFraction unitRef="number" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="2" name="icui:SmithsGroupOwnershipRequiredForBoardRepresentation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMjE5OTAyMzI2MTM4MQ_2a4da476-0839-4813-9967-478b4e4669af">5.0</ix:nonFraction>% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i7d1ccd6ea5444ee4ac33f85fc4031620"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pursuant to the Shareholders Agreement who will stand for election to the Board at the 2022 Annual Meeting of Stockholders to be held in May 2022. This appointment expands the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-5" name="icui:TreasuryStockPurchasePlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMTQ3_a0fcfa77-3af0-415d-923c-96db35254a4d">100.0</ix:nonFraction> million of our common stock. This plan has no expiration date. During the three months ended March&#160;31, 2022, we did not purchase any shares of our common stock under our share purchase plan. As of March&#160;31, 2022, all of the $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMzcz_ee094dca-716e-4c7b-a0f2-ee3337594020">100.0</ix:nonFraction> million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  </span></div><div><span><br/></span></div><div><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, we withheld <ix:nonFraction unitRef="shares" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfNjI0_88bc6a89-95df-42b3-ac8a-64a0368c0296">37,279</ix:nonFraction> shares of our common stock from employee vested restricted stock units in consideration for $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfNzE5_96465006-62d8-4ff2-96dc-d6e8540282ec">8.7</ix:nonFraction> million in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. For the three months ended March 31, 2021, we withheld&#160;<ix:nonFraction unitRef="shares" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfODg3_f0e8ac51-d499-4ada-8f13-265bea85aee0">37,423</ix:nonFraction>&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$<ix:nonFraction unitRef="usd" contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfOTgy_95ea2367-f5e3-46fe-a10b-b8ddc7762ced">7.7</ix:nonFraction> million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMTQxNA_1a4dd690-56cf-4ba4-9c34-60d92cc76515" continuedAt="i301fe4580bb349e1ab22bbe55a05b367" escape="true">The components of AOCI, net of tax, were as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i301fe4580bb349e1ab22bbe55a05b367"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1cdbdaa242848b79d2fbe0b9504e9ca_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS0yLTEtMS0yMzM5OQ_4e613981-fd67-4eb5-8035-a54ba8b92509">19,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa110691e734492ebd77f89f72327112_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS00LTEtMS0yMzM5OQ_7c114136-1e63-4ee5-a8b8-cd04d38f176c">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afb2c7772cc49b1a684427d27a6856b_I20211231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS02LTEtMS0yMzM5OQ_4aeb03ca-2217-47bb-89f7-bcbc461017d3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS04LTEtMS0yMzM5OQ_47c44f01-a161-4058-a450-3cee8c0f6c73">19,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi0yLTEtMS0yMzM5OQ_a7cfb0fe-b92c-45e2-8feb-2623f9a895fe">4,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi00LTEtMS0yMzM5OQ_f02d0c93-8013-4165-9d26-755b5bdf3944">25,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi02LTEtMS0yMzM5OQ_8960598d-21c5-4240-8c9e-9f19cfd108f8">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338ce135c3964ade933cbd32298f936b_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi04LTEtMS0yMzM5OQ_83c595f2-fbda-48b7-b283-f210adba7c29">20,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy0yLTEtMS0yMzM5OQ_cb9c15b2-d5a1-4f29-b5d6-11ea2e83074b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy00LTEtMS0yMzM5OQ_1e9c7f0f-7b38-4cac-8b44-9e3011d8e9cb">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy02LTEtMS0yMzM5OQ_260fbda5-8236-478a-bdfd-b5af3a4fa596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i338ce135c3964ade933cbd32298f936b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy04LTEtMS0yMzM5OQ_e7bae5fd-4592-4824-b42a-6d8a5aaea760">2,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC0yLTEtMS0yMzM5OQ_45b429eb-484b-4dbd-b3a1-288ef0dbf6c5">4,946</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC00LTEtMS0yMzM5OQ_77b56c02-9cd3-4e23-bab1-5e75c83fbf69">23,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC02LTEtMS0yMzM5OQ_98d679c0-7f9c-48c0-be72-97f24bbc585e">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i338ce135c3964ade933cbd32298f936b_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC04LTEtMS0yMzM5OQ_4d5c7ae6-a1a5-487d-a598-9c8ef7dd8203">18,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85d6a1b5b0fc46539828a1892118c0d4_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS0yLTEtMS0yMzM5OQ_2b735417-2162-4f79-8d6f-e80ecda4e62b">23,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1994924f97d2435894c33f53b4e7eb17_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS00LTEtMS0yMzM5OQ_045ea32c-a90a-4c5c-b2a2-2e683440a002">23,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7b56bfd8ed46c2a062213becf7ccad_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS02LTEtMS0yMzM5OQ_75997a99-3c97-4943-8d20-21637360294c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4ad65ae063d4e49821ad5b4dece8ece_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS04LTEtMS0yMzM5OQ_3e1ca7ae-9183-4e3f-828d-62c5e6bdc35c">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:39.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48b83546156b4d78be0e3b72137bad96_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS0yLTEtMS0yMzM5OQ_02cb4440-3f92-4f71-b71a-7244437942b6">4,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a79558ef22f4c09ac5459ea71f37b04_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS00LTEtMS0yMzM5OQ_5c2e5490-5bab-4eae-9a68-6f30b2e812b5">2,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i567486d5838948dd8530f75bf634afcd_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS02LTEtMS0yMzM5OQ_8e23ae93-f6ab-4f4a-bdce-39567ebab46d">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS04LTEtMS0yMzM5OQ_ce5ed612-4394-4af9-b6dd-636d9bfc8e95">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi0yLTEtMS0yMzM5OQ_68a376a4-6736-49af-a4a9-ef7309cdc574">7,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi00LTEtMS0yMzM5OQ_63d11792-53b1-4317-88e9-8f6396173a59">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi02LTEtMS0yMzM5OQ_a930aa91-1168-4b1b-8281-149e7f112a98">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i480060d5d0174855bf349ac2611a425d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi04LTEtMS0yMzM5OQ_32760467-8042-4cad-851e-7da5b0f61cfb">7,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy0yLTEtMS0yMzM5OQ_8f8eac25-dffc-49b4-b594-0f2caf1c7dc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy00LTEtMS0yMzM5OQ_4769da29-2b54-4e86-ba80-32fa86e28ac2">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy02LTEtMS0yMzM5OQ_7302bc55-6b1d-462c-9fdc-dd679425fd46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i480060d5d0174855bf349ac2611a425d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy04LTEtMS0yMzM5OQ_fbc4d984-e07e-4dc5-b507-cfb3465257a0">639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC0yLTEtMS0yMzM5OQ_d3b29a11-bcc6-4d01-8707-440a3579d05e">7,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC00LTEtMS0yMzM5OQ_9b9a5b1e-1b65-4c1e-b957-602d3a45270f">945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC02LTEtMS0yMzM5OQ_52aa1409-f5f5-49c3-80e0-f6885883fe6f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i480060d5d0174855bf349ac2611a425d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC04LTEtMS0yMzM5OQ_fbac193b-2492-4edd-beaf-2964118ed2bc">8,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95227b0013004393b99c2f868c8b0457_I20200930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS0yLTEtMS0yMzM5OQ_31b0f158-b080-44ac-be4d-b16c3847996b">11,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd1bc723546d4451bd24a0afcc9a5ad0_I20200930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS00LTEtMS0yMzM5OQ_a33ee7f0-a833-41cc-9deb-06a957aec12e">1,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63067cc116cb4e2baece3c78ca5225f7_I20200930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS02LTEtMS0yMzM5OQ_aac215b7-ca24-482a-b72f-afe9ad46fbbc">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i942bbd8143694f56aeaf956c380440e7_I20200930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS04LTEtMS0yMzM5OQ_89e5ced8-4b51-4fc9-8aff-a13522bf8da0">9,913</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19:  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMzM0OA_81194a40-fb9a-4945-bcea-7dd96ec757d0" continuedAt="i1dd18b1d45344e5290db963d497ac4a9" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1dd18b1d45344e5290db963d497ac4a9" continuedAt="i06da86221fec4f05b18a7f8c0ad07e46"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><ix:continuation id="i06da86221fec4f05b18a7f8c0ad07e46" continuedAt="ibfc074f597154c72a8312b46dd49cd47"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $<ix:nonFraction unitRef="usd" contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0ODYxMA_8d3f3082-4909-47a7-87c8-5d08f5c83696">100.0</ix:nonFraction>&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from the closing date to either the third or fourth anniversary of closing. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331" decimals="-4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0ODYyOQ_d196577a-58dd-464b-9a58-47118f0a1186">53.5</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $<ix:nonFraction unitRef="usd" contextRef="i1114e70a57024459b1dd8837d9a8d9f3_I20220106" decimals="-5" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ1MDQ2OQ_421905b3-44c3-4090-a33d-7806ed409ee2">55.1</ix:nonFraction>&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at March 31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-5" name="us-gaap:ProductLiabilityAccrualComponentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTA5OTUxMTYzNjg2NA_ba3d3e07-40c3-4349-9fec-6a368564e990">54.7</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $<ix:nonFraction unitRef="usd" contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzM0Nw_53eaee76-e1f7-4529-ac7e-2d4b4757b42f">2.5</ix:nonFraction>&#160;million, consisting of (i) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-6" name="icui:ContingentConsiderationGrossST" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzM3NA_23a98fc8-df36-4439-bbbd-95a22ac38acd">1.0</ix:nonFraction>&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $<ix:nonFraction unitRef="usd" contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" decimals="-5" name="icui:ContingentConsiderationGrossLT" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzQwMQ_29dede25-0318-40b8-8e39-69f91899ce25">1.5</ix:nonFraction>&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="i099b2a7d616d421c860d4ddb8052bdab_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzQ1OQ_fb81e433-c185-4139-b1d7-aa8747179284">1.6</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $<ix:nonFraction unitRef="usd" contextRef="i04278caae1d04e05aee4473287d6eb1f_D20220101-20220331" decimals="-5" name="icui:Contingentconsiderationgross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTI3Mw_3081a915-3ce7-40ab-b0ce-89858451f327">6.0</ix:nonFraction>&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $<ix:nonFraction unitRef="usd" contextRef="ide3f1af499ed4114bc7d8f8c83ec901a_I20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY3OQ_ff60f0a6-b9a3-4fd8-885b-ca708f957112">2.6</ix:nonFraction>&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ibfc074f597154c72a8312b46dd49cd47" continuedAt="ia758583d87f74dfa80e7a80930ab29c4">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia758583d87f74dfa80e7a80930ab29c4">We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).</ix:continuation> </span></div><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 20:&#160;&#160;&#160;&#160;  <ix:nonNumeric contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84OC9mcmFnOjZjODE3MTU5Yzg0OTQ4YTJhZTE3YTMwMDViMjM4YTEyL3RleHRyZWdpb246NmM4MTcxNTljODQ5NDhhMmFlMTdhMzAwNWIyMzhhMTJfMTQxOA_02458c38-15e3-401a-9401-9cbd06390267" continuedAt="i5106a3d92f044e228fae6cc71d54a17f" escape="true">Collaborative and Other Arrangements</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5106a3d92f044e228fae6cc71d54a17f" continuedAt="i27b0b58fa629430d8f629c01640de042">&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ICU MEDICAL, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i27b0b58fa629430d8f629c01640de042">minimum purchase obligation of $<ix:nonFraction unitRef="usd" contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331" decimals="-5" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84OC9mcmFnOjZjODE3MTU5Yzg0OTQ4YTJhZTE3YTMwMDViMjM4YTEyL3RleHRyZWdpb246NmM4MTcxNTljODQ5NDhhMmFlMTdhMzAwNWIyMzhhMTJfMTY0OTI2NzQ0MzgyOQ_c2247560-5ddf-4525-86f4-7d845272dd83">29.6</ix:nonFraction>&#160;million and expires on November 30, 2022. As of March 31, 2022, we had satisfied the minimum purchase obligations under the Product Addendum.</ix:continuation> </span></div><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_94"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following information should be read in conjunction with the condensed consolidated financial statements and accompanying notes in this Form 10-Q, as well as the audited consolidated financial statements and related notes for the fiscal year ended December 31, 2021 included in our Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;When used in this report, the terms &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to ICU Medical, Inc ("ICU") and its subsidiaries included in our condensed consolidated financial statements unless context requires otherwise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Developments</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022 we completed the acquisition of Smiths Medical 2020 Limited ("Smiths Medical"), the holding company of Smiths Group plc's global medical device business. See "Acquisitions" in the remainder of this item for additional detail regarding the acquisition transaction. Smiths Medical is engaged in the development, manufacture and sale of syringe and ambulatory infusion devices, vascular access, and vital care products used in hospital, emergency, home and alternative care settings. Our acquisition of Smiths Medical was strategic and increases our focus and scale in infusion therapy globally which we believe will enhance our competitive position as a leader within the industry.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination of ICU and Smiths Medical brings together two highly complementary product portfolios to create a comprehensive range of offerings utilized in the infusion therapy care continuum. Our existing product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needlefree connectors designed to help meet clinical, safety and workflow goals. In addition, we manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for preparing and administering hazardous IV drugs, and cardiac monitoring systems for critically ill patients. The acquisition of Smiths Medical broadened our product portfolio to include syringe and ambulatory pumps, peripheral IV catheters, fluid warming and respiratory devices, silicone and PVC tracheotomy tubes, among other products. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Smiths Medical acquisition, we are initially presenting the following product lines in addition to our legacy product lines: Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. See "Products" in the remainder of this item for a list of our primary products included in each line. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary customers are acute care hospitals, wholesalers, ambulatory clinics and alternate site facilities, such as clinics, home health care providers and long-term care facilities. With the addition of Smiths Medical we sell our products in more than 90 countries throughout the world.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information is additional to and not a substitute for the Business section under Part I, Item 1 of our Annual Report on Form 10-K for the year ended December 31, 2021 and should be read in conjunction with that filing:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacturing Changes</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of the Smiths Medical business, we now operate additional manufacturing facilities including five facilities in the United States ("U.S."), two facilities in Mexico and two in the UK, and one facility in the Czech Republic, Italy and China.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service Centers</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of the Smiths Medical business, we now operate additional service and repair facilities in the U.S., Canada, two locations in Europe and four locations in Asia. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distribution Changes</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Smiths Medical acquisition, we operate two additional main distribution centers, one in the U.S. supporting the Americas and International and one in the Netherlands mainly supporting EMEA. We have a further eleven smaller distribution centers globally three of which are in the U.S., two centers in EMEA and China, and one center in Canada, the U.K., Japan and India.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competition Changes</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Infusion Systems product line of Smiths Medical competes with many of the same competitors as those referenced in Part I, Item 1. "Business" of our 2021 Annual Report on Form 10-K as well as additional competitors such as Moog Medical and QCOR.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Vascular Access product line of Smith Medicals competes with many of the same competitors as those referenced in Part I, Item 1. "Business" of our 2021 Annual Report on Form 10-K as well as additional competitors such Angio Dynamics, Greiner Bio-One, and Teleflex Incorporated. Our ability to remain competitive in this market will depend on our ability to focus on demonstrable patient outcomes by differentiating our products by improving device functionality and by providing successful customer training programs on the use and maintenance of our products. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Vital Care product line of Smith Medical competes with numerous competitors due its wide range of business. Those include multinational competitors such as Medtronic and Philips Healthcare as well as smaller more focused competitors such as Belmont and Intersurgical plc. Our ability to compete in this market will depend on our ability to continue to make technological advances to our products, thereby increasing customer efficiency and by providing product support that improves clinical decision-making that ultimately enhances patient safety.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Products</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, our primary product offerings by product line are listed below. We have presented our financial results in accordance with these product lines: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Consumables</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion therapy sets, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient&#8217;s vein, that may or may not be used with an IV pump.&#160; Our primary Infusion Consumable products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Clave&#8482; needlefree products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including the MicroClave, MicroClave Clear, and NanoClave&#8482; brand of connectors, accessories, extension and administration sets used for the administration of IV fluids and medications and the Neutron catheter patency device, used to help maintain patency of central venous catheters;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">SwabCap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and SwabTip disinfecting caps, used to protect and disinfect any needlefree connector, including competitive brands of connectors, and male luers; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ClearGuard HD </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">antimicrobial barrier caps for hemodialysis catheters; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Tego</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Closed System Transfer Devices ("CSTD") and hazardous drug compounding systems</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are used to prepare and deliver hazardous IV medications such as those used in chemotherapy, which, if released, can have harmful effects on the healthcare worker and environment.&#160;Our products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoLock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CSTD, which utilizes a proprietary needlefree connection method, is used for the preparation and administration of hazardous drugs. ChemoLock is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ChemoClave</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an ISO Connection standard and universally compatible CSTD used for the preparation and administration of hazardous drugs. ChemoClave utilizes standard ISO luer locking connections, making it compatible with all brands of needlefree connectors and pump delivery systems. ChemoClave also is used to limit the escape of hazardous drug or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminate the risk of needlestick injury; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Diana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hazardous drug compounding system, an automated sterile compounding system that incorporates ChemoClave and ChemoLock CSTD consumables and IV workflow technology for the accurate, safe, and efficient preparation of hazardous drugs. It is a user-controlled automated system that provides repeatable accuracy of drug mixes and minimizes clinician exposure to hazardous drugs while helping to maintain the sterility of the drugs being mixed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of hazardous drugs typically takes place in a pharmacy where drugs are removed from vials and prepared for delivery to a patient. Those prepared drugs are then transferred to a nursing unit where the chemotherapy is administered via an infusion pump set to a patient. Components of the ChemoClave and ChemoLock product lines are used both in pharmacies and on the nursing floors for the preparation and administration of hazardous drugs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We offer a wide range of infusion pumps, dedicated IV sets, software and professional services. Our primary Infusion System products are dedicated IV sets and the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Pump Hardware:</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Plum 360&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plum 360&#8482; infusion pump is an ICU Medical MedNet&#8482; ready large volume infusion pump with an extensive drug library and wireless capability. Plum 360 was named the 2018, 2019 and 2020 Best in KLAS winner as top-performing IV smart pump and was the first medical device to be awarded UL Cybersecurity Assurance Program Certification. Also, in 2021 and 2022, the Plum 360 won the award as the top-performing Smart Pump EMR-Integrated; and</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">LifeCare PCA&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The LifeCare PCA infusion pump is an ICU Medical MedNet&#8482; ready patient-controlled analgesia pump ("PCA"), providing complete IV Electronic Health Record ("IV-EHR") interoperability since 2016.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV Medication Safety Software:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">ICU Medical MedNet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;: ICU Medical MedNet is an enterprise-class medication management platform for any sized healthcare system that can help reduce medication errors, improve quality of care, streamline workflows and maximize revenue capture. ICU Medical MedNet connects our industry-leading smart pumps to a hospital&#8217;s EHR, asset tracking systems, and alarm notification platforms with the largest array of integration partners. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Professional Services: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In addition to the products above, our teams of clinical, information technology, and professional services experts work with customers to develop and deliver safe and efficient infusion systems, providing customized and personalized configuration, implementation, and data analytics services to complement our infusion hardware and software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We provide a broad portfolio of IV solutions to meet our customers&#8217; clinical needs, providing a consistent supply of IV solutions, irrigation, and nutritionals to help provide safe and effective patient care. Our primary IV Solutions products are:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IV Therapy and Diluents:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride, Dextrose, Balanced Electrolyte Solutions, Lactated Ringer's, Ringer's, Mannitol, Sodium Chloride/Dextrose and Sterile Water.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irrigation:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Including Sodium Chloride Irrigation, Sterile Water Irrigation, Physiologic Solutions, Ringer's Irrigation, Acetic Acid Irrigation, Glycine Irrigation, Sorbitol-Mannitol Irrigation, Flexible Containers and Pour Bottle Options.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our Critical Care products help clinicians get accurate real-time access to patients&#8217; hemodynamic and cardiac status with an extensive portfolio of monitoring systems and advanced sensors &amp; catheters.&#160;Measurements provided by our systems help clinicians determine how well the heart is pumping blood and how efficiently oxygen from the blood is being used by the tissues. Our primary Critical Care products are:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cogent&#8482; 2-in-1 hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioFlo&#8482; hemodynamic monitoring system;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TDQ&#8482; and OptiQ&#8482; cardiac output monitoring catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">TriOx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venous oximetry catheters;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Transpac&#8482; blood pressure transducers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SafeSet&#8482; closed blood sampling and conservation system.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems-Smiths Medical </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a wide range of infusion pumps, disposables and safety software for use in both hospital and home settings. These products participate in adjacent categories to the legacy ICU Medical Infusion Systems segment.  The primary Infusion Systems-Smith Medical products are:</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ambulatory Infusion Hardware:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">CADD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ambulatory infusion pumps and disposables, including administration sets and medication cassette reservoirs, support a variety of IV pain management therapies across clinical care areas from hospital to outpatient treatment. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Syringe Infusion Hardware:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medfusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> syringe infusion pumps are designed for the administration of fluids and medication requiring precisely controlled infusion rates from a variety of syringe sizes in acute care settings. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Infusion Software:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;padding-left:14.5pt">PharmGuard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> Medication Safety Software</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Medfusion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4000 syringe and CADD&#8482; Solis pumps allows for customized drug libraries to support the standardization of protocols for medication administration throughout the facility. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vascular Access-Smiths Medical</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Vascular Access-Smiths Medical products allow clinicians to safely access the patients' bloodstream to deliver fluids and medication or to obtain blood samples. Vascular Access products are often used in conjunction with Consumables and Infusion Systems devices. Our primary Vascular Access products are:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Jelco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> safety and conventional peripheral IV catheters, sharps safety devices for hypodermic injection, and venipuncture blood collection and peripheral IV catheters designed to help prevent needlestick injury and to reduce the risks associated with blood exposure and contamination while reducing patients' risk of infection;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">DELTEC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">implantable ports and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GRIPPER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> non-coring needles for portal access; </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> arterial blood sampling syringes, anesthesia trays and kits for pain management;</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Powerwand</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> midline catheters; and</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">MEDEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> LogiCal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pressure Monitoring System and components.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vital Care-Smiths Medical</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a range of devices and systems to maintain patients' airways and maintain body temperature before, during and after surgery. Our primary Vital Care products are:  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> temperature management systems used in perioperative and critical care settings to help monitor and regulate patient temperature through rapid infusion, routine blood and fluid warming, irrigation warming and convective warming.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">acapella</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bronchial hygiene products used to mobilize pulmonary secretions to facilitate the opening of airways in patients with chronic respiratory diseases such as chronic obstructive pulmonary disease, or COPD, asthma and cystic fibrosis.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Portex</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bivona</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tracheostomy tubes in PVC and silicone construction that provide a secure airway for both surgical and percutaneous procedures. Our silicone tracheostomy tubes are customizable to accommodate unique patient requirements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S. a substantial amount of our products are sold to group purchasing organization member hospitals. We believe that as healthcare providers continue to either consolidate or join major buying organizations, the success of our products will depend, in part, on our ability, either independently or through strategic relationships to secure long-term contracts with large healthcare providers and major buying organizations.&#160;Although we believe that we are not dependent on any single distributor, large healthcare provider or major buying organization for distribution of our products, the loss of a strategic relationship with any one of these organizations or a decline in the demand for our products could have a material adverse effect on our operating results.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that achievement of our growth objectives worldwide will require increased efforts by us in sales and marketing and product acquisition and development; however, there is no assurance that we will be successful in implementing our growth strategy. Product development or acquisition efforts may not succeed, and even if we do develop or acquire additional products, there is no assurance that we will achieve profitable sales of such products.&#160;Increased expenditures for sales and marketing and product acquisition and development may not yield desired results when expected, or at all.&#160;While we have taken steps to control these risks, there are certain risks that may be outside of our control, and there is no assurance that steps we have taken will succeed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality/Quarterly Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There are no significant seasonal aspects to our business. We can experience fluctuations in net sales as a result of variations in the ordering patterns of our largest customers, which may be driven more by the novel coronavirus and its variants (&#8220;COVID-19&#8221;) pandemic surges and its impact on hospital admissions and procedure volumes along with production scheduling and customer inventory levels, and less by seasonality.&#160;Our expenses often do not fluctuate in the same manner as net sales, which may cause fluctuations in operating income that are disproportionate to fluctuations in our revenue.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired 100% of the equity interests in Smiths Medical from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;) for cash consideration of $1.9 billion and the issuance of 2.5 million shares of our common stock valued at $576.0 million. We funded the cash portion of the consideration paid with a combination of proceeds from a Credit Agreement dated January 6, 2022 (the "Credit Agreement") and our cash and cash equivalents. The fair value of the common shares issued to Smiths was determined based on the closing market price of our common stock on the acquisition date. Smiths may be entitled to a potential contingent earn-out payment of $100.0 million based on our common stock achieving certain price targets on or prior to the third or fourth anniversary of closing. See Note 3, Acquisitions in our accompanying condensed consolidated financial statements for further details on the acquisition. See "Liquidity and Capital Resources" in the remainder of this item and Note 17 in our accompanying condensed consolidated financial statements for additional information regarding the Credit Agreement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COVID-19</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;COVID-19 continues to have an impact on our business operations. Our manufacturing, distribution and pump service facilities continue to operate under our business continuity plan and our precautionary safety measures implemented to maximize the safety of our employees and mitigate disruption to our business remain in effect. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we continually monitor the ongoing and evolving impact of the effect of the COVID-19 pandemic on our operations the overall impact will not be fully reflected in our results of operations until future periods.&#160;The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be fully predicted at this time, as such, the impact of the pandemic on our overall financial performance remain uncertain and cannot as yet be quantified. For discussion of the risks and uncertainties we face associated with the COVID-19 pandemic, see Part I, Item 1A. "Risk Factors" of our 2021 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We present income statement data in Part I, Item 1. "Financial Statements." The following table shows, for the three months ended March&#160;31, 2022 and 2021, the percentages of each income statement caption in relation to total revenue:&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, strategic transaction and integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract settlement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit (provision) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to comparing changes in revenue on a U.S. GAAP basis, we also compare the changes in revenue from one period to another using constant currency. We provide constant currency information to enhance the visibility of underlying business trends, excluding the effects of changes in foreign currency translation rates. To calculate our constant currency results, we apply the average exchange rate for revenues from the prior year to the current year results. These results should be considered in addition to, not as a substitute for, results reported in accordance with GAAP. Results on a constant currency basis, as we present them, may not be comparable to similarly titled measures used by other companies and are not measures of performance presented in accordance with GAAP.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Consumables</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Consumables revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:57.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.463%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Infusion Consumables revenue increased for the three months ended March&#160;31, 2022, as compared to the same period in the prior year, due to growth in our global core infusion, global oncology, renal and specialty products.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On a constant currency basis, Infusion Consumables revenue would have been $142.5 million for the three months ended March 31, 2022, an increase of $16.1 million or 12.7%, as compared to the same period in the prior year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Systems revenue (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Infusion Systems revenue increased for the three months ended March&#160;31, 2022, as compared to the same period in the prior year, due to higher large volume pump ("LVP") dedicated set sales driven by larger install base of LVPs, offset partially by lower sales related to our non-LVP products. On a constant currency basis, Infusion Systems revenue would have been $88.7 million for the three months ended March 31, 2022, an increase of $4.4 million or 5.2%, as compared to the same period in the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IV Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total IV Solutions revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">IV Solutions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IV Solutions revenue decreased for the three months ended March&#160;31, 2022, as compared to the same period in the prior year, primarily due to lower contract manufacturing sales to Pfizer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Care</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Critical Care revenue (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Critical Care</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Critical Care revenue slightly decreased for the three months ended March&#160;31, 2022, as compared to the same period in the prior year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Infusion Systems-Smiths Medical</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Infusion Systems-Smiths Medical revenue (in millions):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Infusion Systems-Smiths Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Infusion Systems-Smiths Medical revenue is a result of the acquisition of Smiths Medical. The amount in the table above represents approximately three months of revenue from the closing date of the transaction to the end of the quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vascular Access-Smiths Medical</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes our total Vascular Access revenue (in millions):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vascular Access-Smiths Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vascular Access-Smiths Medical revenue is a result of the acquisition of Smiths Medical. The amount in the table above represents approximately three months of revenue from the closing date of the transaction to the end of the quarter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vital Care-Smiths Medical</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vital Care-Smiths Medical</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">nm</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Vital Care-Smiths Medical revenue is a result of the acquisition of Smiths Medical. The amount in the table above represents approximately three months of revenue from the closing date of the transaction to the end of the quarter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2022 and 2021, gross margins were 31.1% and 35.4%, respectively. The decrease in gross margins for the three months ended March 31, 2022, as compared to the same period in the prior year, was primarily due to the acquisition of Smiths Medical. Smiths Medical gross margins are lower than historical ICU margins for the quarter due to: $13.2 million spending on quality systems and product-related remediation costs; lower manufacturing absorption due to supply chain disruptions; and the impact of inflation and higher freight expediting costs. Legacy ICU gross margins for the quarter were generally consistent with prior year and reflected improvement due to increased sales of higher margin consumables, offset by lower absorption in our Austin manufacturing plant from lower volumes and inflation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative (&#8220;SG&amp;A&#8221;) Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total SG&amp;A Expenses (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SG&amp;A</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses increased for the three months&#160;ended March&#160;31, 2022, as compared to the same period in the prior year, primarily due to a $72.7 million impact from the acquisition of Smiths Medical, which consisted primarily of $28.0 million of salaries and benefits, $25.1 million of depreciation and amortization expense. Expenses that increased aside from the Smiths Medical acquisition included $5.9 million in stock based compensation. Stock based compensation increased due to a change in the probability of shares expected to be earned. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total R&amp;D Expenses (in millions):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">R&amp;D</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">123.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expenses increased for the three months ended March&#160;31, 2022, as compared to the same period in the prior year primarily due to the acquisition of Smiths Medical. The increase included $11.8 million related to Smiths Medical R&amp;D expenses. R&amp;D expenses during both periods primarily relate to compensation and related benefit expenses on current R&amp;D projects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring, Strategic Transaction and Integration Expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, strategic transaction and integration expenses were $33.9 million and $2.9 million for the three months ended March 31, 2022 and 2021, respectively.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring charges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring charges were $3.2 million for the three months ended March 31, 2022 related to severance costs. We expect to pay unpaid restructuring charges as of March 31, 2022 by the end of 2022.  There were no restructuring charges for the three months ended March 31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic transaction and integration expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Strategic transaction and integration expenses were $30.7 million and $2.9 million for the three months ended March 31, 2022 and 2021, respectively. The strategic transaction and integration expenses during the three months ended March 31, 2022 were primarily related to our acquisition of Smiths Medical which primarily included legal expenses, bank fees, a United Kingdom stamp tax and employee costs. The strategic transaction and integration expenses during the three months ended March 31, 2021 were primarily related to integration costs associated with previous acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Settlement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not incur contract settlement expense for the three months ended March 31, 2022. For the three months ended March 31, 2021, we recorded $0.1 million in contract settlement expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $13.6 million and $0.2 million for the three months ended March 31, 2022 and 2021, respectively.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three months ended March 31, 2022 includes the contractual interest incurred on borrowings under the Credit Agreement, the per annum commitment fee charged on the available amount of the revolving credit facility contained in the Credit Agreement and the amortization of debt issuance costs incurred in connection with entering into the Credit Agreement (see Note 17: Long-Term Debt in our accompanying condensed consolidated financial statements for additional information). </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three months ended March 31, 2021 includes the per annum commitment fee charged on the unused portion of the revolver under our 2017 Credit Facility (the "Prior Credit Facility") and the amortization of financing costs that were incurred in 2017 in connection with entering into the Prior Credit Facility. The Prior Credit Facility was terminated in connection with entering into the Credit Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other income netted to $1.0 million and $0.7 million for the three months ended March 31, 2022 and 2021, respectively. For the three months ended March 31, 2022, other income, net was related to $0.6 million of interest income, $0.5 million of miscellaneous income and $0.2 million in foreign exchange gains, partially offset by $0.3 million of loss from disposed assets. For the three months ended March 31, 2021, other income, net was related to $0.7 million of interest income, $0.5 million in foreign exchange gains and $0.2 million of miscellaneous income, partially offset by $0.7 million of loss from disposed assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March 31, 2022 and 2021, income taxes were accrued at an estimated effective tax rate of 31% and 12%, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits. The effective tax rate during the three months ended March 31, 2022 included the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period of $2.6 million.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2021 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, GILTI, FDII and tax credits. The effective tax rate during the three months ended March 31, 2021 included a tax benefit of $1.8 million related to the excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our liquidity and capital resources, including our access to external capital, to ensure we can adequately meet our principal cash requirements, which include working capital requirements, planned capital investments in our business, commitments, acquisition restructuring and integration expenses, investments in quality systems and quality compliance objectives, payment of interest expense, repayment of outstanding borrowings, income tax obligations and acquisition opportunities in accordance with our growth strategy.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash and cash equivalents, our short-term investment portfolio, cash flows from our operations and access to borrowing arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds generated from operations are held in cash and cash equivalents and investment securities. During the three months ended March 31, 2022, our cash and cash equivalents and short-term investment securities decreased by $223.0 million from $567.2 million at December&#160;31, 2021 to $344.3 million at March&#160;31, 2022, which was primarily due to our use of existing cash balances to partially fund the Smiths Medical acquisition in January 2022. Our short-term investment portfolio consists of investment-grade corporate bonds and is primarily intended to facilitate capital preservation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement and Access to Capital</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into the Credit Agreement with various lenders on January 6, 2022 in connection with the closing of the Smiths Medical acquisition. The Credit Agreement provides for a five-year term loan A facility of $850.0 million (the "Term Loan A"), a seven-year term loan B facility of $850.0 million (the "Term Loan B") and a five-year revolving credit facility of $500.0 million (the "Revolving Credit Facility") (collectively, the "Senior Secured Credit Facilities"). The proceeds from the term loans were used to finance a portion of the cash consideration for the Smiths Medical acquisition. The outstanding aggregate principal amount of the term loans is $1.7 billion as of March 31, 2022, which includes the Term Loan A that will mature in January 2027 and the Term Loan B that will mature in January 2029. The proceeds of future borrowings under the Revolving Credit Facility, which expires in January 2027, may be used as a source of liquidity to support our ongoing working capital requirements and other general corporate purposes. There are no outstanding borrowings under the Revolving Credit Facility as of March 31, 2022. As part of entering into the Senior Secured Credit Facilities, we were assigned issuer and Term Loan B credit ratings. At the date of issuance of this report, our issuer and Term Loan B credit ratings assigned and outlook were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuer/Term Loan B <br/>Credit Ratings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Moody's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ba3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fitch</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB/BBB-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard &amp; Poor's</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BB/BB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stable</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains financial covenants that pertain to the Term Loan A and the Revolving Credit Facility. Specifically, we are required to maintain a Senior Secured Leverage Ratio of no more than 4.50 to 1.00 until June 30, 2024, with stepdowns to 4.00 to 1.00 thereafter, and an Interest Coverage Ratio of no less than 3.00 to 1.00 (defined and discussed in greater detail in Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements). We were in compliance with these financial covenants as of March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 8, 2017, we entered into a five-year revolving credit facility with various lenders for $150.0 million (the "Prior Credit Facility"). The Prior Credit Facility, which was set to expire in November 2022, was terminated upon entering into the new Senior Secured Credit Facilities. There were no outstanding borrowings under the Prior Credit Facility at the time of its termination.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents along with cash flows expected to be generated from future operations and the funds received and accessible under the Senior Secured Credit Facilities will provide us with sufficient liquidity to finance our cash requirements for the next twelve months. In the event that we experience downturns, cyclical fluctuations in our business that are more severe or longer than anticipated, fail to achieve anticipated revenue and expense levels, or have significant unplanned cash expenditures, we may need to obtain or seek alternative sources of capital or financing, and we can provide no assurances that the terms of such capital or financing will be available to us on favorable terms, if at all. Our ability to generate cash flows from operations, issue debt or enter into other financing arrangements on acceptable terms could be adversely affected if there is a material decline in the demand for our products or in the solvency of our customers or suppliers, deterioration in our key financial ratios or credit ratings or other significantly unfavorable changes in conditions. See Part I. Item 1A. "Risk Factors&#8221; in our 2021 Annual Report on Form 10-K for discussion of the risks and uncertainties associated with our debt financing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uses of Liquidity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Expenditures</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, there have been no material changes to our estimate for 2022 planned capital expenditures, as previously disclosed in our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal commitments at March 31, 2022 include both short and long-term future obligations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating lease agreements where we are contractually obligated for certain lease payment amounts. We assumed additional operating leases as a result of our acquisition of Smiths Medical. For more information regarding our operating lease obligations, (see Note 6: Leases to our accompanying condensed consolidated financial statements). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Debt</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, in January 2022, we incurred borrowings under Senior Secured Credit Facilities. The principal repayment obligations and estimated interest payments on the term loans and estimated commitment fee payments on the revolver are estimated in the table below. Interest payments on the term loans were estimated using an Adjusted Term SOFR rate and an initial applicable margin of 1.75% for Term Loan A and 2.50% for Term Loan B and the revolver commitment fees were estimated using the initial rate of 0.25%. The applicable margin rate and commitment fee rate will change from time to time in accordance with a preset pricing grid based on the leverage ratio (see Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements for pricing grids related to the Senior Secured Credit Facilities). We expect to fund these obligations with our existing cash and cash equivalents and cash generated from our future operations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Principal Payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Principal Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B Interest Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Commitment Fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Minimum Purchase Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our Manufacturing and Supply Agreements to supply us with additional product subject to certain time and pricing terms and conditions (see Note 20: Collaborative and Other Arrangements to our accompanying condensed consolidated financial statements for additional information). As of March 31, 2022, we had satisfied the minimum purchase obligations under the Product Addendum. The Product Addendum expires on November 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Future Capital Investments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March 31, 2022, there have been no material changes to our estimate for restructuring and integration expenses along with spending to support quality systems and quality compliance objectives, as previously disclosed in our 2021 Annual Report on Form 10-K. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnifications </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters related to sales of our products. There is no maximum limit on the indemnification that may be required under these agreements.&#160;Although we can provide no assurances, we have never incurred, nor do we expect to incur, any liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Historical Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash used in operations for the three months ended March&#160;31, 2022 was $1.3 million. Net income plus adjustments for non-cash net expenses contributed $49.9 million. Net cash used in operations as a result of changes in operating assets and liabilities was $51.3 million.&#160;The changes in operating assets and liabilities included a $36.2 million increase in inventories, a $14.4 million increase in other assets, a $19.2 million decrease in accrued liabilities and $26.1 million in net changes in income taxes, including excess tax benefits and deferred income taxes. Offsetting these amounts was a $22.5 million decrease in accounts receivable, a $2.6 million decrease in prepaid expenses and other current assets and a $19.5 million increase in accounts payable. The increase in inventory was primarily due to the increase in safety stock. The increase in other assets was due to the purchase of spare parts and the capitalization of debt issuance costs allocated to the revolving credit facility. The decrease in accrued liabilities was primarily due to the payout of annual bonuses. The net changes in income taxes was a result of the timing of payments. The decrease in accounts receivable is primarily due to collection efforts and the timing of revenue. The net decrease in prepaid expenses and other current assets was primarily due to a decrease in deferred costs mostly offset by capitalized debt issuance costs allocated to the revolving credit facility. The increase in accounts payable was due to the timing of payments.       </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash provided by operations for the three months ended March&#160;31, 2021 was $51.3 million. Net income plus adjustments for non-cash net expenses contributed $56.9 million. Net cash used in operations as a result of changes in operating assets and liabilities was $5.6 million. The changes in operating assets and liabilities included a $20.0 million decrease in accrued liabilities, a $3.5 million increase in other assets and a $0.7 million increase in prepaid expenses and other assets. Offsetting these amounts was a $13.2 million decrease in inventories, a $2.4 million increase in accounts payable, a $1.5 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million decrease in accounts receivable and $1.4 million in net changes in income taxes, including excess tax benefits and deferred income taxes. The decrease in accrued liabilities was primarily due to the payment of annual bonuses. The net increase in prepaid expenses and other current assets was primarily due to the payment of annual software renewals, offset by the amortization of prepaid insurance and property taxes. The increase in other assets was due to the purchase of spare parts. The</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decrease in inventory was primarily due to the timing of production and customer purchases combined with the reduction in capitalized manufacturing variances. The increase in accounts payable was due to the timing of payments. The decrease in accounts receivable is primarily due to collection efforts. The net changes in income taxes was a result of the timing of payments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table summarizes the changes in our investing cash flows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,578)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,844,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,844,164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,874)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,034)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,867,750)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,881)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,848,869)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Our purchases of property, plant and equipment increased during the quarter due to the acquisition of Smiths Medical and will also vary from period to period based on additional investments needed to support new and existing products and expansion of our manufacturing facilities.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Our business acquisitions will vary from period to period based upon our current growth strategy and our ability to execute on desirable target companies. On January 6, 2022, we completed the acquisition of Smiths Medical. The cash consideration for the transaction was $1.9 billion, which was financed with existing cash balances and borrowings under the Credit Agreement. Acquired cash was $78.8 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our purchases of investment securities will vary from period to period based on current cash needs, planning for known future transactions and changes in our investment strategy. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Proceeds from the sale of our investment securities will vary from period to period based on the maturity dates of the investments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in our financing cash flows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i8343a502cf1c465a8adfd72ff6994fce_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Cash Flows:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt, net of lender debt issuance costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of third-party debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,890)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax withholding payments related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,723)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,020)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648,917&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651,917&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we borrowed an aggregate of $1.7 billion under Senior Secured Credit Facilities contained in the Credit Agreement to partially finance our acquisition of Smiths Medical (see Note 17: Long-Term Debt to our accompanying condensed consolidated financial statements for additional information). The proceeds are net of $27.3 million in payments of lender debt issuance costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment of $16.0 million of principal payments on the Senior Secured Credit Facilities and $1.9 million in third-party debt issuance costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Proceeds from the exercise of stock options will vary from period to period based on the volume of options exercised and the exercise price of the specific options exercised.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2022, our employees surrendered 37,279 shares of our common stock from vested restricted stock awards as consideration for approximately $8.7 million in minimum statutory withholding obligations paid on their behalf. During the three months ended March 31, 2021, our employees surrendered 37,423 shares of our common stock from vested restricted stock awards as consideration for approximately $7.7 million in minimum statutory withholding obligations paid on their behalf.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was approved by our Board of Directors in August 2019. This plan has no expiration date.&#160;As of March&#160;31, 2022, all of the $100.0 million available for purchase was remaining under the plan. </span></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our 2021 Annual Report on Form 10-K, we identified the critical accounting policies which affect our more significant estimates and assumptions used in preparing our consolidated financial statements. There have been no material changes to our critical accounting policies from those previously disclosed in our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2: New Accounting Pronouncements in Part&#160;I,&#160;Item 1. "Financial Statements."</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various portions of this Quarterly Report on Form&#160;10-Q, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, and documents referenced herein, describe trends in our business and finances that we perceive and state some of our expectations and beliefs about our future. These statements about the future are &#8220;forward-looking statements,&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, and we may identify them by using words such as "anticipate," "believe," "expect," "estimate," "intend," "plan," "will," "continue," "could," "may," and by similar expressions and statements about aims, goals and plans. The forward-looking statements are based on the best information currently available to us and assumptions that we believe are reasonable, but we do not intend the statements to be representations as to future results. They include, without limitation, statements about:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future growth; future operating results and various elements of operating results, including future expenditures and effects with respect to sales and marketing and product development and acquisition efforts; future sales and unit volumes of products; expected increases and decreases in sales; deferred revenue; accruals for restructuring charges, future license, royalty and revenue share income; production costs; gross margins; litigation expense; future SG&amp;A and R&amp;D expenses; manufacturing expenses; future costs of expanding our business; income; losses; cash flow; amortization; source of funds for capital purchases and operations; future tax rates; alternative sources of capital or financing; changes in working capital items such as receivables and inventory; selling prices; and income taxes;</span></div><div style="padding-left:72pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">factors affecting operating results, such as shipments to specific customers; reduced dependence on current proprietary products; loss of a strategic relationship; change in demand; domestic and international sales; expansion in international markets, selling prices; future increases or decreases in sales of certain products and in certain markets and distribution channels; maintaining strategic relationships and securing long-term and multi-product contracts with large healthcare providers and major buying organizations; increases in systems capabilities; introduction, development and sales of new products, acquisition and integration of businesses and product lines (including Smiths Medical); benefits of our products over competing systems; qualification of our new products for the expedited Section 510(k) clearance procedure; possibility of lengthier clearance process for new products; planned increases in marketing; warranty claims; rebates; product returns; bad debt expense; amortization expense; inventory requirements; lives of property and equipment; manufacturing efficiencies and cost savings; unit manufacturing costs; establishment or expansion of production facilities inside or outside of the United States; planned new orders for semi-automated or fully automated assembly machines for new products; adequacy of production capacity; results of R&amp;D; our plans to repurchase shares of our common stock; asset impairment losses; relocation of manufacturing facilities and personnel; effect of expansion of manufacturing facilities on production efficiencies and resolution of production inefficiencies; the effect of costs to customers and delivery times; business seasonality and fluctuations in quarterly results; customer ordering patterns and the effects of new accounting pronouncements; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new or extended contracts with manufacturers and buying organizations; dependence on a small number of customers; loss of larger distributors and the ability to locate other distributors; impact of our recently completed acquisition of the Smiths Medical business; the outcome of our strategic initiatives; regulatory approvals and compliance; including the work necessary to achieve regulatory clearance with respect to the Smiths Medical Warning Letter; outcome of litigation; patent protection and intellectual property landscape; patent infringement claims and the impact of newly issued patents on other medical devices; competitive and market factors, including continuing development of competing products by other manufacturers; improved production processes and higher volume production; innovation requirements; consolidation of the healthcare provider market and downward pressure on selling prices; distribution or financial capabilities of competitors; healthcare reform legislation; use of treasury stock; working capital requirements; liquidity and realizable value of our investment securities; future investment alternatives; foreign currency denominated financial instruments; foreign exchange risk; commodity price risk; our expectations regarding liquidity and capital resources over the next twelve months; capital expenditures; plans to convert existing space; acquisitions of other businesses or product lines, indemnification liabilities and contractual liabilities. </span></div><div style="padding-left:72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Forward-looking statements involve certain risks and uncertainties, which may cause actual results to differ materially from those discussed in each such statement.&#160; First, one should consider the factors and risks described in the statements themselves or otherwise discussed herein. Those factors are uncertain, and if one or more of them turn out differently than we currently expect, our operating results may differ materially from our current expectations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Second, investors should read the forward-looking statements in conjunction with the Risk Factors discussed in Part&#160;I,&#160;Item 1A of our Annual Report on Form&#160;10-K for the year ended December 31, 2021, Part II, Item 1A of this Quarterly Report on Form 10-Q and our other reports filed with the Securities and Exchange Commission ("SEC").&#160; Also, actual future operating results are subject to other important factors and risks that we cannot predict or control, including without limitation, the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impacts of the COVID-19 pandemic on us, our business and on domestic and global economies generally;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the integration of Smiths Medical being more difficult, time-consuming or costly than expected;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions, both in the U.S. and internationally;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected changes in our arrangements with Pfizer or our other large customers;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">outcome of litigation;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in foreign exchange rates and other risks of doing business internationally;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased competition for skilled workers;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in availability of the raw materials needed to manufacture our products;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of price and safety considerations on the healthcare industry;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitive factors, such as product innovation, new technologies, marketing and distribution strength and price erosion;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the successful development and marketing of new products;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated market shifts and trends;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of legislation affecting government reimbursement of healthcare costs;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes by our major customers and independent distributors in their strategies that might affect their efforts to market  our products;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effects of additional governmental regulations;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated production problems;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisition and integration expenses (including as it relates to the Smiths Medical acquisition);</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of patent protection and the cost of enforcing and of defending patent claims;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters and outbreak of disease or illness;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supply chain constraints or disruptions;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact of inflation on raw materials, freight charges and labor, especially in the U.S.; and</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interest rate increases.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this report are subject to additional risks and uncertainties, including those detailed from time to time in our other filings with the SEC. These forward-looking statements are made only as of the date hereof and, except as required by law, we undertake no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_112"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Quantitative and Qualitative Disclosures about Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Smiths Medical acquisition on January 6, 2022 we entered into the Senior Secured Credit Facilities totaling approximately $2.2 billion consisting of a variable-rate term loan A facility of $850.0 million, a variable-rate term loan B facility of $850.0 million and a revolving credit facility of $500.0 million. We are exposed to changes in interest rates on all of these variable-rate debt instruments. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term loan A facility currently bears interest based on Adjusted Term SOFR plus an initial applicable margin of 1.75% per year. The term loan B facility currently bears interest based on Adjusted Term SOFR subject to a 0.50% floor plus an initial applicable margin of 2.5%. We used a sensitivity analyses to measure our interest rate risk exposure. If the SOFR rate increases or decreases 1% from March 31, 2022, the additional annual interest expense or savings related to the term loans would amount to approximately $17.0 million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to mitigate and offset a portion of this interest rate risk exposure associated with these debt instruments we entered into interest rate swaps to achieve a targeted mix of fixed and variable-rate debt. The term loan A swap has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027 and we will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. The term loan B swap has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026 and we will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. See Note 8: Derivatives and Hedging Activities to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We transact business globally in multiple currencies, some of which are considered volatile. Our international revenues and expenses and working capital positions denominated in these foreign currencies expose us to the risk of fluctuations in foreign currency exchange rates against the U.S. dollar. As the receiver of foreign currencies we are adversely affected by the strengthening of the U.S. dollar and other currencies relative to the operating unit functional currency. Our hedging policy attempts to manage these risks to an acceptable level. We manage our foreign currency exposures on a consolidated basis to take advantage of net exposures and natural offsets, which are then further reduced by the gains and losses of our hedging instruments. Gains and losses on the hedging instruments offset gains and losses on the hedged forecasted transactions and reduce the earnings volatility related to foreign exchange, however we do not hedge our entire foreign exchange exposure and are still subject to earnings volatility due to foreign exchange risk.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign exchange forward contracts hedge a portion of our forecasted foreign currency-denominated revenues and expenses (principally Mexican Pesos, Euros, Czech Koruna and Japanese Yen) that differ from the functional currency of the operating unit. These derivative contracts are designated and qualify as cash flow hedges (see Note 8: Derivatives and Hedging Activities to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q). We performed a sensitivity analysis to estimate changes in the fair value of our foreign exchange derivatives due to potential changes in near-term foreign exchange rates. At March 31, 2022, the effect of a hypothetical 10% weakening in the actual foreign exchange rates used for the applicable currencies would result in an estimated increase in the fair value of these outstanding derivatives contracts by approximately $1.0 million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_115"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive officer and principal financial officer have concluded, based on their evaluation of our disclosure controls and procedures (as defined in Rules&#160;13a-15(e)&#160;and 15d-15(e)&#160;under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Report, that our disclosure controls and procedures are effective to ensure that the information we are required to disclose in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure and that such information is recorded, processed, summarized and reported within the time periods specified in the rules&#160;and forms of the SEC.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we completed our acquisition of Smiths Medical and we continue to integrate the acquired operations. As the acquisition occurred in the first quarter of 2022, the scope of our evaluation of the effectiveness of internal control over financial reporting does not include Smiths Medical. This exclusion is in accordance with the SEC's general guidance that an assessment of a recently acquired business may be omitted from our scope for a period not to exceed one year from the date of the acquisition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in our internal control over financial reporting during the quarter ended March&#160;31, 2022 that has materially affected or is reasonably likely to materially affect our internal control over financial reporting, except as mentioned above. </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II - OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_121"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Certain legal proceedings in which we are involved are discussed in Part I, Item 1. "Financial Statements" of this Form 10-Q in Note 19. Commitments and Contingencies to the Condensed Consolidated Financial Statements, and is incorporated herein by reference. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_124"></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.8pt;text-decoration:underline">Risk Factors</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In evaluating an investment in our common stock, investors should consider carefully, among other things, the risk factors previously disclosed in Part&#160;I,&#160;Item 1A of our Annual Report on Form&#160;10-K filed with the SEC for the year ended December&#160;31, 2021, as well as the information contained in this Quarterly Report and our other reports and registration statements filed with the SEC.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Smiths Medical acquisition completed in the period has resulted in organizational changes and significant growth to our business. If we fail to effectively manage this growth and change to our business in a manner that preserves our reputation with customers and the key aspects of our corporate culture, our business, financial condition and results of operations could be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Smiths Medical acquisition has resulted in significant growth in our personnel and operations, adding approximately 6,700 employees to our headcount, bringing our total headcount as of March 31, 2031 to approximately 15,300 employees. We will continue to incur significant expenditures and the allocation of management time to assimilate the Smiths Medical employees in a manner that preserves the key aspects of our corporate culture, including a focus on strong customer satisfaction, but there can be no assurance that we will be successful in our efforts. If we do not effectively integrate, train and manage our combined employee base and maintain strong customer relationships, our corporate culture could be undermined, the quality of our products and customer service could suffer, and our reputation could be harmed, each of which could adversely impact our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Smiths Medical acquisition is a significant acquisition for us and the product offerings within Smiths Medical are not product offerings that we previously offered. The success of our business will depend, in part, on our ability to realize our anticipated benefits, opportunities and synergies from combining our legacy businesses and Smiths Medical. We can provide no assurance that the anticipated benefits of the Smiths Medical acquisition will be fully realized in the time frame anticipated or at all. Integrating the operations of Smiths Medical with that of our legacy business will be a complex, costly and time-consuming process. The integration process may disrupt the businesses and, if implemented ineffectively, would restrict the realization of the full expected benefits. The failure to meet the challenges involved in integrating the two businesses could cause an interruption of, or a loss of momentum in, the activities of the combined businesses and could adversely affect the results of operations of the combined businesses. Potential difficulties that may be encountered in the integration process include the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">challenges in preserving important strategic customer and other third-party relationships of both businesses;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the diversion of management&#8217;s attention to integration matters;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">challenges in maintaining employee morale and retaining or attracting key employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">potential incompatibility of corporate cultures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">changes in the combined business due to potential divestitures or requirements imposed by antitrust regulators;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">costs, delays and other difficulties consolidating corporate and administrative infrastructures and information systems and in implementing common systems and procedures including, in particular, our internal controls over financial reporting; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">coordinating and integrating a geographically dispersed organization, including operations in jurisdictions we currently do not operate in.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any one or all of these factors may increase operating costs or lower anticipated financial performance. Achieving the anticipated benefits and the potential benefits underlying our reasons for the Smiths Medical business acquisition will depend on successful integration of the businesses. Because of the significance of the Smiths Medical business acquisition to us, our failure to successfully integrate the Smiths Medical business with that of our own could have a material adverse impact on our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no other material changes in the risk factors other than those mentioned above from those previously disclosed under &#8220;Risk Factors&#8221; in Part I, Item 1A of our Annual Report on Form 10-K with the SEC for the year ended December 31, 2021.</span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_127"></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Sales of Unregistered Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, as part of the consideration for the acquisition of Smiths Medical, we issued 2.5 million unregistered shares of our common stock to Smiths Group International Holdings Limited.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of these shares to Smiths Medical in accordance with the terms and subject to the conditions set forth in a shareholders agreement was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act and/or the private offering safe harbor provision of Rule 506 of Regulation D promulgated thereunder, as transactions not involving a public offering.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase of Equity Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following is a summary of our stock repurchasing activity during the first quarter of 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares<br/>purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>price&#160;paid<br/>per&#160;share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total number of shares<br/>purchased&#160;as<br/>part&#160;of&#160;a<br/>publicly<br/>announced<br/>program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">dollar&#160;value&#160;that</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">may&#160;yet&#160;be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">purchased&#160;under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">the&#160;program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">01/01/2022 &#8212; 01/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/01/2022 &#8212; 02/28/2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/01/2022 &#8212; 03/31/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First quarter of 2022 total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was authorized by our Board of Directors and publicly announced in August, 2019.&#160;This plan has no expiration date.  We are not obligated to make any purchases under our stock purchase program. Subject to applicable state and federal corporate and securities laws, purchases under a stock purchase program may be made at such times and in such amounts as we deem appropriate. Purchases made under our stock purchase program can be discontinued at any time we feel additional purchases are not warranted.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div id="i8343a502cf1c465a8adfd72ff6994fce_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item 6.  Exhibits</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See the Exhibit Index following the signature page to this Quarterly Report on Form 10-Q for a list of exhibits filed or furnished with this report, which Exhibit Index is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signature</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICU Medical,&#160;Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.146%"><tr><td style="width:1.0%"></td><td style="width:64.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brian M. Bonnell</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i8343a502cf1c465a8adfd72ff6994fce_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit&#160;Index</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.490%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/883984/000088398422000026/exhibit101_41522.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Executive Employment Agreement, dated as of April 15, 2022, by and between ICU Medical, Inc. and Vivek Jain. Filed as an Exhibit to Registrant's Current Report on Form 8-K filed April 20, 2022, and incorporated herein by reference.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex31133122.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex31233122.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="icui-ex32133122.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - this instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit&#160;101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>icui-ex31133122.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i481b5a2370cf4eb08f5af64146baf26d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vivek Jain, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form&#160;10-Q of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:108pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:72pt;text-indent:40.5pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.728%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>icui-ex31233122.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic47a7ca7cedb41aab15cec9ed38e881c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian M. Bonnell, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%;padding-left:24pt">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this quarterly report on Form&#160;10-Q of ICU Medical,&#160;Inc.&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24pt"> The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.74pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.17pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:4.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.265%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right;text-indent:36pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>icui-ex32133122.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2374e3cd63e449de924349a9fb620e9c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Vivek Jain, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vivek Jain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivek Jain</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of ICU Medical,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Brian M. Bonnell, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167;&#160;1350, as adopted pursuant to &#167;&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brian M. Bonnell</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian M. Bonnell</font></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>icui-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eb6bc161-64f3-45ef-8355-0537b049f0f7,g:1fc0d841-3e14-4a45-9a82-f075c6cb343a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:icui="http://www.icumed.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.icumed.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="icui-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DEIDocument" roleURI="http://www.icumed.com/role/DEIDocument">
        <link:definition>0001001 - Document - DEI Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofIncome" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityStatement" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.icumed.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.icumed.com/role/NewAccountingPronouncements">
        <link:definition>2102102 - Disclosure - New Accounting Pronouncements:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" roleURI="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies">
        <link:definition>2203201 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements Adopted (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitions" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions">
        <link:definition>2104103 - Disclosure - Business Combinations and Asset Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsTables" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables">
        <link:definition>2305301 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails">
        <link:definition>2406401 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails">
        <link:definition>2407402 - Disclosure - Business Combinations and Asset Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails">
        <link:definition>2408403 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails">
        <link:definition>2409404 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationNotes" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes">
        <link:definition>2110104 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationTables" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables">
        <link:definition>2311302 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationRestructuringDetails" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails">
        <link:definition>2412405 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringStrategicTransactionandIntegrationLiabilityDetails" roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails">
        <link:definition>2413406 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StrategicTransactionandIntegrationDetails" roleURI="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails">
        <link:definition>2414407 - Disclosure - Strategic Transaction and Integration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNotes" roleURI="http://www.icumed.com/role/RevenueNotes">
        <link:definition>2115105 - Disclosure - Revenue (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.icumed.com/role/RevenueTables">
        <link:definition>2316303 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDetails" roleURI="http://www.icumed.com/role/RevenueDetails">
        <link:definition>2417408 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregatedRevenuebyGeographyDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails">
        <link:definition>2418409 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregatedRevenuebyProductLineDetails" roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails">
        <link:definition>2419410 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractLiabilitiesDetails" roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails">
        <link:definition>2420411 - Disclosure - Revenue Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNotes" roleURI="http://www.icumed.com/role/LeasesNotes">
        <link:definition>2121106 - Disclosure - Leases (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.icumed.com/role/LeasesTables">
        <link:definition>2322304 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTextDetails" roleURI="http://www.icumed.com/role/LeasesTextDetails">
        <link:definition>2423412 - Disclosure - Leases Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesDetails" roleURI="http://www.icumed.com/role/LeasesDetails">
        <link:definition>2424413 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesCashFlowOperatingActivitiesLesseeDetails" roleURI="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails">
        <link:definition>2425414 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAssetsandLiabilitiesLesseeDetails" roleURI="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails">
        <link:definition>2426415 - Disclosure - Leases Assets and Liabilities, Lessee (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityDetails" roleURI="http://www.icumed.com/role/LeasesMaturityDetails">
        <link:definition>2427416 - Disclosure - Leases Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.icumed.com/role/NetIncomePerShare">
        <link:definition>2128107 - Disclosure - Net Income Per Share:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.icumed.com/role/NetIncomePerShareTables">
        <link:definition>2329305 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails" roleURI="http://www.icumed.com/role/NetIncomePerShareDetails">
        <link:definition>2430417 - Disclosure - Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareDetails1" roleURI="http://www.icumed.com/role/NetIncomePerShareDetails1">
        <link:definition>2431418 - Disclosure - Net Income Per Share (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsNotes" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes">
        <link:definition>2132108 - Disclosure - Derivative Financial Instruments (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>2333306 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails">
        <link:definition>2434419 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails">
        <link:definition>2435420 - Disclosure - Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsInterestRateSwapsDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails">
        <link:definition>2436421 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails">
        <link:definition>2437422 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2438423 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails">
        <link:definition>2439424 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresNotes" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes">
        <link:definition>2140109 - Disclosure - Fair Value Measures and Disclosures (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresTables" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables">
        <link:definition>2341307 - Disclosure - Fair Value Measures and Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails">
        <link:definition>2442425 - Disclosure - Fair Value Measures and Disclosures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails">
        <link:definition>2443426 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails">
        <link:definition>2444427 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails">
        <link:definition>2445428 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails">
        <link:definition>2446429 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesNotes" roleURI="http://www.icumed.com/role/InvestmentSecuritiesNotes">
        <link:definition>2147110 - Disclosure - Investment Securities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTables" roleURI="http://www.icumed.com/role/InvestmentSecuritiesTables">
        <link:definition>2348308 - Disclosure - Investment Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesDetails" roleURI="http://www.icumed.com/role/InvestmentSecuritiesDetails">
        <link:definition>2449430 - Disclosure - Investment Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTableDetails" roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails">
        <link:definition>2450431 - Disclosure - Investment Securities Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityMethodInvestmentsDetails" roleURI="http://www.icumed.com/role/EquityMethodInvestmentsDetails">
        <link:definition>2451432 - Disclosure - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsNotes" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes">
        <link:definition>2152111 - Disclosure - Prepaids and Other Current Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsTables" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables">
        <link:definition>2353309 - Disclosure - Prepaids and Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails">
        <link:definition>2454433 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsNoncurrentDetails" roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails">
        <link:definition>2455434 - Disclosure - Other Assets Noncurrent(Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.icumed.com/role/Inventories">
        <link:definition>2156112 - Disclosure - Inventories:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.icumed.com/role/InventoriesTables">
        <link:definition>2357310 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.icumed.com/role/InventoriesDetails">
        <link:definition>2458435 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.icumed.com/role/PropertyandEquipment">
        <link:definition>2159113 - Disclosure - Property and Equipment:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.icumed.com/role/PropertyandEquipmentTables">
        <link:definition>2360311 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails">
        <link:definition>2461436 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTextDetails" roleURI="http://www.icumed.com/role/PropertyandEquipmentTextDetails">
        <link:definition>2462437 - Disclosure - Property and Equipment Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNotes" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes">
        <link:definition>2163114 - Disclosure - Goodwill and Intangible Assets (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTables" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables">
        <link:definition>2364312 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsGoodwillTableDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails">
        <link:definition>2465438 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsIntangiblesTableDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails">
        <link:definition>2466439 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsTextDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails">
        <link:definition>2467440 - Disclosure - Goodwill and Intangible Assets Text (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssets5YearAmortizationDetails" roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails">
        <link:definition>2468441 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesNotes" roleURI="http://www.icumed.com/role/AccruedLiabilitiesNotes">
        <link:definition>2169115 - Disclosure - Accrued Liabilities (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.icumed.com/role/AccruedLiabilitiesTables">
        <link:definition>2370313 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails">
        <link:definition>2471442 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesLongtermliabilitiesDetails" roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails">
        <link:definition>2472443 - Disclosure - Accrued Liabilities Long-term liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.icumed.com/role/IncomeTaxes">
        <link:definition>2173116 - Disclosure - Income Taxes:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectivetaxrateDetails" roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails">
        <link:definition>2474444 - Disclosure - Income Taxes Effective tax rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsNotes" roleURI="http://www.icumed.com/role/LongTermObligationsNotes">
        <link:definition>2175117 - Disclosure - Long-Term Obligations (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTables" roleURI="http://www.icumed.com/role/LongTermObligationsTables">
        <link:definition>2376314 - Disclosure - Long-Term Obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsDetails" roleURI="http://www.icumed.com/role/LongTermObligationsDetails">
        <link:definition>2477445 - Disclosure - Long-Term Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsInterestRateTermsDetails" roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails">
        <link:definition>2478446 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTerminatedCreditAgreementDetails" roleURI="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails">
        <link:definition>2479447 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsTableDetails" roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails">
        <link:definition>2480448 - Disclosure - Long-Term Obligations Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsScheduleofMaturitiesDetails" roleURI="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails">
        <link:definition>2481449 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsInterestExpenseDetails" roleURI="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails">
        <link:definition>2482450 - Disclosure - Long-Term Obligations Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermObligationsPrincipalPaymentDetails" roleURI="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails">
        <link:definition>2483451 - Disclosure - Long-Term Obligations Principal Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.icumed.com/role/CommitmentsandContingencies">
        <link:definition>2184118 - Disclosure - Commitments and Contingencies:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesContingencyDetails" roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails">
        <link:definition>2485452 - Disclosure - Commitments and Contingencies Contingency (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsNotes" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes">
        <link:definition>2186119 - Disclosure - Collaborative and Other Arrangements (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsTables" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables">
        <link:definition>2387315 - Disclosure - Collaborative and Other Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborativeandOtherArrangementsDetails" roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails">
        <link:definition>2488453 - Disclosure - Collaborative and Other Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.icumed.com/role/Equity">
        <link:definition>2189120 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.icumed.com/role/EquityTables">
        <link:definition>2390316 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityDetails" roleURI="http://www.icumed.com/role/EquityDetails">
        <link:definition>2491454 - Disclosure - Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2492455 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="icui_Contingentconsiderationgross" abstract="false" name="Contingentconsiderationgross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_StrategicTransactionandIntegration" abstract="false" name="StrategicTransactionandIntegration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Accruedlegalfees" abstract="false" name="Accruedlegalfees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Prepaidinsuranceandpropertytaxes" abstract="false" name="Prepaidinsuranceandpropertytaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" abstract="false" name="IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Srt_MultipleCurrencyAxisDomain" abstract="true" name="Srt_MultipleCurrencyAxisDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Srt_MultipleCurrencyAxisAxis" abstract="true" name="Srt_MultipleCurrencyAxisAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" abstract="false" name="PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_AmortizationOfInventoryStepUp" abstract="false" name="AmortizationOfInventoryStepUp" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Outsidesalescommissions" abstract="false" name="Outsidesalescommissions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TimingAxis" abstract="true" name="TimingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_InternationalDistributorMember" abstract="true" name="InternationalDistributorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" abstract="false" name="ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Hedge3MemberMember" abstract="true" name="Hedge3MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Accruedothertaxes" abstract="false" name="Accruedothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_AccruedAuditFees" abstract="false" name="AccruedAuditFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InfusionConsumablesMember" abstract="true" name="InfusionConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Hedge2Member" abstract="true" name="Hedge2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentFirst2Years" abstract="false" name="TermAPrincipalPaymentFirst2Years" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_RevolverSubLimits" abstract="false" name="RevolverSubLimits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_BusinessCombinationConsiderationTransferredCash" abstract="false" name="BusinessCombinationConsiderationTransferredCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Accruedfreight" abstract="false" name="Accruedfreight" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" abstract="false" name="TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_ProFormaAdjustmentInventory" abstract="false" name="ProFormaAdjustmentInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_EquipmentrevenueMember" abstract="true" name="EquipmentrevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_RequiredShareHoldingOfStockIssuedAtAcquisition" abstract="false" name="RequiredShareHoldingOfStockIssuedAtAcquisition" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_VascularAccessMember" abstract="true" name="VascularAccessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LOngTermObligationsDisclosureAbstract" abstract="true" name="LOngTermObligationsDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_CriticalCareMember" abstract="true" name="CriticalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentInYear5" abstract="false" name="TermAPrincipalPaymentInYear5" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_ApplicableMarginTermSOFRLoans" abstract="false" name="ApplicableMarginTermSOFRLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_GoodwillAcquiredDuringPeriodAllAcquisitions" abstract="false" name="GoodwillAcquiredDuringPeriodAllAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InterestRateSwapEndingNotionalValue" abstract="false" name="InterestRateSwapEndingNotionalValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TotalSeniorSecuredCreditFacility" abstract="false" name="TotalSeniorSecuredCreditFacility" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ProFormaAdjustmentAmortization" abstract="false" name="ProFormaAdjustmentAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_MeasurementinputadjustedEBITDAvolatilityDomain" abstract="true" name="MeasurementinputadjustedEBITDAvolatilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_MinimumStockPriceTargetForEarnOutPayment" abstract="false" name="MinimumStockPriceTargetForEarnOutPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TimingDomain" abstract="true" name="TimingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InterestExpenseOnLongTermDebtTableTextBlock" abstract="false" name="InterestExpenseOnLongTermDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_ContingentConsiderationGrossLT" abstract="false" name="ContingentConsiderationGrossLT" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ContingentConsiderationGrossST" abstract="false" name="ContingentConsiderationGrossST" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_UnfavorablecontractliabilityST" abstract="false" name="UnfavorablecontractliabilityST" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_LongTermMember" abstract="true" name="LongTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Prepaidothertaxes" abstract="false" name="Prepaidothertaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Greaterthan400to100Member" abstract="true" name="Greaterthan400to100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermAPrincipalPaymentYear3And4" abstract="false" name="TermAPrincipalPaymentYear3And4" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_Contractsettlement" abstract="false" name="Contractsettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_AssetsandLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsandLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_LessThanOrEqualTo200To100Member" abstract="true" name="LessThanOrEqualTo200To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_GovernmentGrantRevenueMember" abstract="true" name="GovernmentGrantRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ProFormaAdjustmentFinanceCosts" abstract="false" name="ProFormaAdjustmentFinanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesLineItems" abstract="true" name="ContractassetandliabilitybalancesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_ForeignInfusionSystemSupplierMember" abstract="true" name="ForeignInfusionSystemSupplierMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_OwnershipRequirementForEarnoutPayment" abstract="false" name="OwnershipRequirementForEarnoutPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_LessThanOrEqual300To100ButGreaterThan250to100Member" abstract="true" name="LessThanOrEqual300To100ButGreaterThan250to100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AccruedTransactionCosts" abstract="false" name="AccruedTransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ContractassetandliabilitybalancesTable" abstract="true" name="ContractassetandliabilitybalancesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" abstract="false" name="InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_TermLoanBMember" abstract="true" name="TermLoanBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AcquiredRestructuringLiabilityCurrent" abstract="false" name="AcquiredRestructuringLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InterestPercentageAddedToFederalFundsRate" abstract="false" name="InterestPercentageAddedToFederalFundsRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_InfusionConsumablesSmithsMedicalMember" abstract="true" name="InfusionConsumablesSmithsMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InfusionSystemsMember" abstract="true" name="InfusionSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" abstract="false" name="BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_OtherDeferredRevenueMember" abstract="true" name="OtherDeferredRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_IVSolutionsMember" abstract="true" name="IVSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_PursuitVascularInc.Member" abstract="true" name="PursuitVascularInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SpareParts" abstract="false" name="SpareParts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_MoldsMember" abstract="true" name="MoldsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Optiontoextendinyears" abstract="false" name="Optiontoextendinyears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioLineItems" abstract="true" name="ApplicableMarginBasedOnLeverageRatioLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="icui_SmithsMedicalMember" abstract="true" name="SmithsMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_BusinessCombinationConsiderationHoldbackLiability" abstract="false" name="BusinessCombinationConsiderationHoldbackLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Sparepartsusage" abstract="false" name="Sparepartsusage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_EarnoutliabilityMember" abstract="true" name="EarnoutliabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LeverageRatioLevelAxis" abstract="true" name="LeverageRatioLevelAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_LessThan275To100Member" abstract="true" name="LessThan275To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_VitalCareMember" abstract="true" name="VitalCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_DerivativeVariableRateFloor" abstract="false" name="DerivativeVariableRateFloor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_BusinessCombinationGoodwillNonDeductible" abstract="false" name="BusinessCombinationGoodwillNonDeductible" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Deferredtaxcharge" abstract="false" name="Deferredtaxcharge" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ForeignMember" abstract="true" name="ForeignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SmithsGroupOwnershipRequiredForBoardRepresentation" abstract="false" name="SmithsGroupOwnershipRequiredForBoardRepresentation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_AvailableforsaleDebtSecurityCurrentMember" abstract="true" name="AvailableforsaleDebtSecurityCurrentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioTable" abstract="true" name="ApplicableMarginBasedOnLeverageRatioTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="icui_TermLoanBPrincipalPayment" abstract="false" name="TermLoanBPrincipalPayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_LeverageRatioCalculationCeilingSubtractedAmount" abstract="false" name="LeverageRatioCalculationCeilingSubtractedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_Liabilitiesforcontracts" abstract="false" name="Liabilitiesforcontracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Restructuringandstrategictransaction" abstract="false" name="Restructuringandstrategictransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_ShortTermMember" abstract="true" name="ShortTermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LeverageRatioLevelDomain" abstract="true" name="LeverageRatioLevelDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_MeasurementInputMarketPriceofRiskDomain" abstract="true" name="MeasurementInputMarketPriceofRiskDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_SoftwarerevenueMember" abstract="true" name="SoftwarerevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" abstract="false" name="ApplicableMarginBasedOnLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="icui_ProFormaAdjustmentRelatedPartyLoans" abstract="false" name="ProFormaAdjustmentRelatedPartyLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TreasuryStockPurchasePlan" abstract="false" name="TreasuryStockPurchasePlan" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_GreaterThan275To100Member" abstract="true" name="GreaterThan275To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_AccruedSalariesAndBenefits" abstract="false" name="AccruedSalariesAndBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_CommonStockSharesMember" abstract="true" name="CommonStockSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_InterestPercentageAddedToBaseRate" abstract="false" name="InterestPercentageAddedToBaseRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_SmithsGroupOwnershipAcquisitionSharesIssued" abstract="false" name="SmithsGroupOwnershipAcquisitionSharesIssued" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_ContingentConsiderationAllAcquisitions" abstract="false" name="ContingentConsiderationAllAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" abstract="false" name="TerSOFRInterestRateAdjustmentForBaseRateLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_OtherforeigncountriesMember" abstract="true" name="OtherforeigncountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" abstract="true" name="LessThanOrEqualTo400To100ButGreaterThan300To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_TermLoanDomain" abstract="true" name="TermLoanDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_OtherCurrenciesMember" abstract="true" name="OtherCurrenciesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" abstract="true" name="LessThanOrEqualTo250To100ButGreaterThan200To100Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_CurrencyTranslationOnEarnOut" abstract="false" name="CurrencyTranslationOnEarnOut" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_Restructuringstrategictransactionandintegration" abstract="false" name="Restructuringstrategictransactionandintegration" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_InstrumentsPlacedwithCustomersMember" abstract="true" name="InstrumentsPlacedwithCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ApplicableMarginBaseRateLoans" abstract="false" name="ApplicableMarginBaseRateLoans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="icui_LongtermInvestmentsDomain" abstract="true" name="LongtermInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="icui_ProvisionForWarrantyAndReturns" abstract="false" name="ProvisionForWarrantyAndReturns" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="icui_TermLoanAxis" abstract="true" name="TermLoanAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>icui-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eb6bc161-64f3-45ef-8355-0537b049f0f7,g:1fc0d841-3e14-4a45-9a82-f075c6cb343a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bfaeb20d-1aa0-47c1-9834-8a3cf542ce2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_AssetsCurrent_bfaeb20d-1aa0-47c1-9834-8a3cf542ce2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_62bb8d8e-2661-4278-80fb-f2ff41f51827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_62bb8d8e-2661-4278-80fb-f2ff41f51827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_158cc3ee-f1de-4a59-a3b4-8cf444948dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_158cc3ee-f1de-4a59-a3b4-8cf444948dd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_f3a47ca7-e46d-4732-94ea-f98d63e1b9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_f3a47ca7-e46d-4732-94ea-f98d63e1b9ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0a8f8c73-e454-46fe-b11f-daaebbf8a430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_Goodwill_0a8f8c73-e454-46fe-b11f-daaebbf8a430" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6972f791-dabf-4797-8cfc-18c7cc15a82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6972f791-dabf-4797-8cfc-18c7cc15a82f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5ce0e0b9-a293-44d4-833c-e9b32337c872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5ce0e0b9-a293-44d4-833c-e9b32337c872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d5afe4b8-e998-4d9c-8549-9ff74d8ba28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f8a22255-ae15-4d5e-b818-129d43a85708" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d5afe4b8-e998-4d9c-8549-9ff74d8ba28c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_71975cb4-59ea-49ca-90e2-2c47f0714e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2eb2c4c8-74b7-4810-97fc-8ec6dbf69bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_71975cb4-59ea-49ca-90e2-2c47f0714e35" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2eb2c4c8-74b7-4810-97fc-8ec6dbf69bf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fdd99fb5-3b3d-4181-a7a6-7fc05bff0b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_71975cb4-59ea-49ca-90e2-2c47f0714e35" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fdd99fb5-3b3d-4181-a7a6-7fc05bff0b76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3b8efe3d-1cab-4989-9279-f07b8b731cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_dbfaf406-fe4f-4293-84f3-ad94204bda97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3b8efe3d-1cab-4989-9279-f07b8b731cd9" xlink:to="loc_us-gaap_AccountsPayableCurrent_dbfaf406-fe4f-4293-84f3-ad94204bda97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1bca7977-ceae-4178-adfc-f8f7f2eaf90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3b8efe3d-1cab-4989-9279-f07b8b731cd9" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1bca7977-ceae-4178-adfc-f8f7f2eaf90c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1f4cb38e-fc6c-46cf-a5c8-1753caa36f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3b8efe3d-1cab-4989-9279-f07b8b731cd9" xlink:to="loc_us-gaap_LongTermDebtCurrent_1f4cb38e-fc6c-46cf-a5c8-1753caa36f25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_1b6550d4-ec63-41de-9e25-062dc54debed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3b8efe3d-1cab-4989-9279-f07b8b731cd9" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_1b6550d4-ec63-41de-9e25-062dc54debed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8361f140-e6c0-4556-bc39-c3bced1924f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:to="loc_us-gaap_LiabilitiesCurrent_8361f140-e6c0-4556-bc39-c3bced1924f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_be6dac7f-e903-477f-af0b-916967563cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_be6dac7f-e903-477f-af0b-916967563cfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a357747f-abde-4ab4-bcbc-3092eed1442e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a357747f-abde-4ab4-bcbc-3092eed1442e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_67145082-77e1-4cfd-8afd-46eac608f540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_67145082-77e1-4cfd-8afd-46eac608f540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eec5f04f-96ad-450c-8e6d-5c80c4efa7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_eec5f04f-96ad-450c-8e6d-5c80c4efa7b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_609eb5d4-ab11-42f6-8ea8-c034ea71c8d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_609eb5d4-ab11-42f6-8ea8-c034ea71c8d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd695daa-a48c-4741-be39-e233aaaeb594" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f9c2a39f-d468-48be-8e0f-237f026ab7aa" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bd695daa-a48c-4741-be39-e233aaaeb594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d8666f9f-54ef-44a7-83bc-12c894c3192a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_df8595da-3a29-4b08-afc7-a6ef161e4a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d8666f9f-54ef-44a7-83bc-12c894c3192a" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_df8595da-3a29-4b08-afc7-a6ef161e4a73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_447da38e-3164-400e-9395-504cb7477ba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d8666f9f-54ef-44a7-83bc-12c894c3192a" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_447da38e-3164-400e-9395-504cb7477ba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c93ba12e-372f-4d91-842d-4819b7c8b020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d8666f9f-54ef-44a7-83bc-12c894c3192a" xlink:to="loc_us-gaap_InventoryNet_c93ba12e-372f-4d91-842d-4819b7c8b020" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_da4d1868-797c-468b-995a-ff2217478a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d8666f9f-54ef-44a7-83bc-12c894c3192a" xlink:to="loc_us-gaap_PrepaidTaxes_da4d1868-797c-468b-995a-ff2217478a6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16e30fdd-dcc9-4b82-ae20-3df2c27c9816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d8666f9f-54ef-44a7-83bc-12c894c3192a" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16e30fdd-dcc9-4b82-ae20-3df2c27c9816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b68415-84a1-49f2-88d1-9cb333a7bdd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_b518bdbd-7905-44f9-9ccf-09041626f98e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b68415-84a1-49f2-88d1-9cb333a7bdd0" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_b518bdbd-7905-44f9-9ccf-09041626f98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d4ef3690-c6f2-475d-ad5e-54dbcb6860c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b68415-84a1-49f2-88d1-9cb333a7bdd0" xlink:to="loc_us-gaap_CommonStockValue_d4ef3690-c6f2-475d-ad5e-54dbcb6860c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fa8aff7e-7007-4b19-9589-eeb59a754134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b68415-84a1-49f2-88d1-9cb333a7bdd0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fa8aff7e-7007-4b19-9589-eeb59a754134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d3489d05-68be-464f-a634-0bdde0655001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b68415-84a1-49f2-88d1-9cb333a7bdd0" xlink:to="loc_us-gaap_TreasuryStockValue_d3489d05-68be-464f-a634-0bdde0655001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dd435abf-053c-416a-b82d-2848151314a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b68415-84a1-49f2-88d1-9cb333a7bdd0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dd435abf-053c-416a-b82d-2848151314a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b82c856d-07a2-44bd-a740-4ea9fe312c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44b68415-84a1-49f2-88d1-9cb333a7bdd0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b82c856d-07a2-44bd-a740-4ea9fe312c42" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6dcea4a8-fe2c-4491-9ef6-a188b9cfdb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_581f1025-3598-41c5-825b-4ba792eb5d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6dcea4a8-fe2c-4491-9ef6-a188b9cfdb25" xlink:to="loc_us-gaap_OperatingIncomeLoss_581f1025-3598-41c5-825b-4ba792eb5d1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2c94394e-eb12-41e1-8665-9660dc507ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6dcea4a8-fe2c-4491-9ef6-a188b9cfdb25" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2c94394e-eb12-41e1-8665-9660dc507ce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c61f4790-0bf0-4514-b39a-9f3846c2161b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6dcea4a8-fe2c-4491-9ef6-a188b9cfdb25" xlink:to="loc_us-gaap_InterestExpense_c61f4790-0bf0-4514-b39a-9f3846c2161b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_07131280-b6c3-42c5-90a2-375cc77e067c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f1bd03d-70c3-4331-aa9c-8a4fffed0dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_07131280-b6c3-42c5-90a2-375cc77e067c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f1bd03d-70c3-4331-aa9c-8a4fffed0dc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ffe7091b-6f47-47fd-bdaf-8893a7f2073d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_07131280-b6c3-42c5-90a2-375cc77e067c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ffe7091b-6f47-47fd-bdaf-8893a7f2073d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_881678de-8701-4df4-b130-7210735fa81e" xlink:href="icui-20220331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_07131280-b6c3-42c5-90a2-375cc77e067c" xlink:to="loc_icui_Restructuringandstrategictransaction_881678de-8701-4df4-b130-7210735fa81e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement_a9dea0a6-84ba-470a-8338-9c6545357a3d" xlink:href="icui-20220331.xsd#icui_Contractsettlement"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_07131280-b6c3-42c5-90a2-375cc77e067c" xlink:to="loc_icui_Contractsettlement_a9dea0a6-84ba-470a-8338-9c6545357a3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_308d6d0a-97f9-410d-a5a5-7f8cff325515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6022a482-fb53-40ea-8ee1-6e91fe9a2736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_308d6d0a-97f9-410d-a5a5-7f8cff325515" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6022a482-fb53-40ea-8ee1-6e91fe9a2736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3fa2d8af-6746-4fde-a4c8-d7f922aeba11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_308d6d0a-97f9-410d-a5a5-7f8cff325515" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3fa2d8af-6746-4fde-a4c8-d7f922aeba11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_605a8c88-c663-414d-b3de-8e49b1658324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e5d0342-8982-4443-b761-09ef5650f90f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_605a8c88-c663-414d-b3de-8e49b1658324" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e5d0342-8982-4443-b761-09ef5650f90f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_0cb2bab6-4a39-4f16-b061-18dd8203c61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_605a8c88-c663-414d-b3de-8e49b1658324" xlink:to="loc_us-gaap_CostOfRevenue_0cb2bab6-4a39-4f16-b061-18dd8203c61f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_17705452-c24b-4280-98d8-78581929bb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6912c02b-6900-41dd-9c49-5ee5c75dd32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_17705452-c24b-4280-98d8-78581929bb13" xlink:to="loc_us-gaap_GrossProfit_6912c02b-6900-41dd-9c49-5ee5c75dd32e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_67bf7436-7a47-403a-bb0e-2f4127eca4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_17705452-c24b-4280-98d8-78581929bb13" xlink:to="loc_us-gaap_OperatingExpenses_67bf7436-7a47-403a-bb0e-2f4127eca4df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c912ece-9bd8-4f00-953f-d535cb85b063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5201a75a-6016-435c-b7a8-e877158c5233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c912ece-9bd8-4f00-953f-d535cb85b063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_5201a75a-6016-435c-b7a8-e877158c5233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f20668a5-06ff-4bc1-b293-7851359104c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c912ece-9bd8-4f00-953f-d535cb85b063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f20668a5-06ff-4bc1-b293-7851359104c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4bad5a1f-d2bd-4500-ae41-3790aa9bd7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2c912ece-9bd8-4f00-953f-d535cb85b063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4bad5a1f-d2bd-4500-ae41-3790aa9bd7e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4e51a09c-fbb5-49b3-8154-d6ad315803ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ca0fdd16-3f7c-423c-86fd-b88f90a017f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4e51a09c-fbb5-49b3-8154-d6ad315803ab" xlink:to="loc_us-gaap_ProfitLoss_ca0fdd16-3f7c-423c-86fd-b88f90a017f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_94aa8876-8a12-4e02-9923-5a731e300afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4e51a09c-fbb5-49b3-8154-d6ad315803ab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_94aa8876-8a12-4e02-9923-5a731e300afc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_00d06c66-0ff1-4a36-8dc7-575db1a5eb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c3d24dea-2775-4a90-90af-e2bbbc7fa093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_00d06c66-0ff1-4a36-8dc7-575db1a5eb62" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c3d24dea-2775-4a90-90af-e2bbbc7fa093" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_0cd19855-fa2e-4a65-87a9-85edef3cbe78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_00d06c66-0ff1-4a36-8dc7-575db1a5eb62" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_0cd19855-fa2e-4a65-87a9-85edef3cbe78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_545f09a3-cb9f-4024-8724-d96c63b5089d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_00d06c66-0ff1-4a36-8dc7-575db1a5eb62" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_545f09a3-cb9f-4024-8724-d96c63b5089d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_31558741-ca42-4feb-b542-f3cc0d1dfe0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_00d06c66-0ff1-4a36-8dc7-575db1a5eb62" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_31558741-ca42-4feb-b542-f3cc0d1dfe0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8c50482d-133e-4761-bfcd-1c98758d5168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_00d06c66-0ff1-4a36-8dc7-575db1a5eb62" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_8c50482d-133e-4761-bfcd-1c98758d5168" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1f4a1f8b-0115-4963-aae7-9bff0376b187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_00d06c66-0ff1-4a36-8dc7-575db1a5eb62" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1f4a1f8b-0115-4963-aae7-9bff0376b187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0b2c00ec-6a94-4c41-98a3-1079d8bea9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_ProfitLoss_0b2c00ec-6a94-4c41-98a3-1079d8bea9df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b6e0cb68-0fb2-4502-9aa3-ef27be649be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b6e0cb68-0fb2-4502-9aa3-ef27be649be6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_ab146e27-2ddf-486f-96c1-98fa5d28e629" xlink:href="icui-20220331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_icui_AmortizationOfInventoryStepUp_ab146e27-2ddf-486f-96c1-98fa5d28e629" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_aedf46fa-5d4d-449e-b709-589765dbc4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_aedf46fa-5d4d-449e-b709-589765dbc4c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_cf5e5199-5a13-4875-b30b-a4d98d0bd972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_cf5e5199-5a13-4875-b30b-a4d98d0bd972" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_2401d715-273e-463e-b278-2b50c73a38cf" xlink:href="icui-20220331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_2401d715-273e-463e-b278-2b50c73a38cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9bbe5ef7-3d23-40b1-a34f-a0c59c1ad49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_ShareBasedCompensation_9bbe5ef7-3d23-40b1-a34f-a0c59c1ad49f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b53a44cd-848a-40f4-b42f-183033991b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b53a44cd-848a-40f4-b42f-183033991b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_75d778a6-1ebf-4e28-affe-7402c78facb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_75d778a6-1ebf-4e28-affe-7402c78facb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_757d44cb-a73c-4fcd-9534-3c4a6d426244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_757d44cb-a73c-4fcd-9534-3c4a6d426244" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_e7f881d0-4b1c-4ed3-919d-647109ab9045" xlink:href="icui-20220331.xsd#icui_Sparepartsusage"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_icui_Sparepartsusage_e7f881d0-4b1c-4ed3-919d-647109ab9045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_a41017e6-f9a7-438f-bdb6-f6180880388b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_a41017e6-f9a7-438f-bdb6-f6180880388b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4f3744d7-7d56-49cc-aa1b-821903437b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4f3744d7-7d56-49cc-aa1b-821903437b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_71581d20-fe5f-4c3b-a69e-2de6e9f71f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_71581d20-fe5f-4c3b-a69e-2de6e9f71f6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cbeb7f8f-2777-45ed-8577-8273e9b5ed3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cbeb7f8f-2777-45ed-8577-8273e9b5ed3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c899d43f-39a7-44e2-9735-eb861c4129c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c899d43f-39a7-44e2-9735-eb861c4129c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e9a40c47-e0b2-43ac-94cc-5aa324c96224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e9a40c47-e0b2-43ac-94cc-5aa324c96224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_11523ad2-f747-45dc-8705-51badf7a113b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_11523ad2-f747-45dc-8705-51badf7a113b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_314fab80-aaaa-4970-943b-01e8fe36829e" xlink:href="icui-20220331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d3ca8496-aab0-4d8f-9794-bdc257157285" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_314fab80-aaaa-4970-943b-01e8fe36829e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d461185a-30c0-4ab7-ae02-1488ba2681fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_007ac916-4644-4519-94a9-e56d459eb936" xlink:href="icui-20220331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d461185a-30c0-4ab7-ae02-1488ba2681fd" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_007ac916-4644-4519-94a9-e56d459eb936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_34d629fb-8f43-47fe-9874-51bec49f9b98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d461185a-30c0-4ab7-ae02-1488ba2681fd" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_34d629fb-8f43-47fe-9874-51bec49f9b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1b08bb1a-eef2-4a77-8b7d-f2e3033a14e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d461185a-30c0-4ab7-ae02-1488ba2681fd" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_1b08bb1a-eef2-4a77-8b7d-f2e3033a14e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_01c81df0-5197-4856-8c81-9c2434442b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d461185a-30c0-4ab7-ae02-1488ba2681fd" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_01c81df0-5197-4856-8c81-9c2434442b2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_9b6e7c56-f952-4ce2-ade9-281a7d65e488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d461185a-30c0-4ab7-ae02-1488ba2681fd" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_9b6e7c56-f952-4ce2-ade9-281a7d65e488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5009ccc8-d075-44b5-bd67-d66cc82ab7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d461185a-30c0-4ab7-ae02-1488ba2681fd" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5009ccc8-d075-44b5-bd67-d66cc82ab7c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_138a4011-1225-49c2-9c07-8f1ed737ebab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13481781-e4ed-4437-8f22-52e676d524f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_138a4011-1225-49c2-9c07-8f1ed737ebab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13481781-e4ed-4437-8f22-52e676d524f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c9a0a28-7996-4dd0-9c8d-69fd5c75fcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_138a4011-1225-49c2-9c07-8f1ed737ebab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5c9a0a28-7996-4dd0-9c8d-69fd5c75fcc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be5ce73b-2ae2-4d17-910d-d5b3c133b9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_138a4011-1225-49c2-9c07-8f1ed737ebab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_be5ce73b-2ae2-4d17-910d-d5b3c133b9ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_4c284f07-2283-46d4-977a-0dd9072a035e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_138a4011-1225-49c2-9c07-8f1ed737ebab" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_4c284f07-2283-46d4-977a-0dd9072a035e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ce6a67bd-80ab-4163-b94d-e001def224fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f6fc87a4-8ee5-4f35-92a0-8a2940893c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ce6a67bd-80ab-4163-b94d-e001def224fd" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f6fc87a4-8ee5-4f35-92a0-8a2940893c0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_661c8ca8-b326-4391-8db4-4c552c8ffcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ce6a67bd-80ab-4163-b94d-e001def224fd" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_661c8ca8-b326-4391-8db4-4c552c8ffcaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d6ad38a3-061c-4bd6-ae5d-1a472d55bd18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ce6a67bd-80ab-4163-b94d-e001def224fd" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d6ad38a3-061c-4bd6-ae5d-1a472d55bd18" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0f07d4b3-6011-4b19-8605-b7b59a72fc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5f500e10-f667-4205-915a-1d40a58f0b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0f07d4b3-6011-4b19-8605-b7b59a72fc98" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5f500e10-f667-4205-915a-1d40a58f0b8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_edfd4f0b-a4f4-426e-a8d4-a27577e4fe26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_0f07d4b3-6011-4b19-8605-b7b59a72fc98" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_edfd4f0b-a4f4-426e-a8d4-a27577e4fe26" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>icui-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eb6bc161-64f3-45ef-8355-0537b049f0f7,g:1fc0d841-3e14-4a45-9a82-f075c6cb343a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i62e4c8cd9a2649089b1b8ce49aada6f8_CondensedConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:to="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7254ef9d-1147-41f2-947b-11189b29ba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7254ef9d-1147-41f2-947b-11189b29ba5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6a240cb2-0b42-40cf-a2e6-61abfdc7be75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6a240cb2-0b42-40cf-a2e6-61abfdc7be75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_cae6fefe-37ae-47f7-aec0-cf1d135ea8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_cae6fefe-37ae-47f7-aec0-cf1d135ea8d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cf23b31e-8624-400e-9d20-b928874f5729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cf23b31e-8624-400e-9d20-b928874f5729" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cc2e93e5-ef6b-4254-8064-1b743d40fefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_InventoryNet_cc2e93e5-ef6b-4254-8064-1b743d40fefd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_fba9d33c-e7fb-4610-bdfd-a38e89dbbe82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_PrepaidTaxes_fba9d33c-e7fb-4610-bdfd-a38e89dbbe82" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7137fbaa-2349-4b15-839a-98adbe2e66ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7137fbaa-2349-4b15-839a-98adbe2e66ec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_25491c16-842e-4ea3-9b74-88227c74c87a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_AssetsCurrent_25491c16-842e-4ea3-9b74-88227c74c87a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_051715ca-c174-4e5e-b6a5-42f9ff75a972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_051715ca-c174-4e5e-b6a5-42f9ff75a972" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7730cb4b-faab-45f9-91e5-a3d517b8cd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7730cb4b-faab-45f9-91e5-a3d517b8cd9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e77fa760-f656-4745-8690-40642766ee86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e77fa760-f656-4745-8690-40642766ee86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ac64d8ab-b1ec-4284-aac9-2f6bb1d82951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_Goodwill_ac64d8ab-b1ec-4284-aac9-2f6bb1d82951" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9719a352-1ffe-4df8-beb7-c9f9cca3f262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9719a352-1ffe-4df8-beb7-c9f9cca3f262" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bbdaa80d-559b-45a5-9652-32dcfc783110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bbdaa80d-559b-45a5-9652-32dcfc783110" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_81e3fdbf-915d-420a-a5df-4f9754bfc377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_81e3fdbf-915d-420a-a5df-4f9754bfc377" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b9f93c1b-4685-40dd-bc80-29fa7ee5588b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_Assets_b9f93c1b-4685-40dd-bc80-29fa7ee5588b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ab7294ee-6de7-488f-a135-aee1ae8987fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_AccountsPayableCurrent_ab7294ee-6de7-488f-a135-aee1ae8987fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4b9a4c0e-6918-4e69-bb3b-cac962114b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4b9a4c0e-6918-4e69-bb3b-cac962114b54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_936271c5-fa4b-4543-96e6-e069506df8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_LongTermDebtCurrent_936271c5-fa4b-4543-96e6-e069506df8c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_198a02f4-58fa-41a1-8fce-81d4aa634ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_198a02f4-58fa-41a1-8fce-81d4aa634ca6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_59d0d44f-0e60-42ec-bfe1-df3cb0529871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_LiabilitiesCurrent_59d0d44f-0e60-42ec-bfe1-df3cb0529871" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_52c890d0-a80b-4cba-b82c-c2920ca6536f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_52c890d0-a80b-4cba-b82c-c2920ca6536f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_862940ef-aa21-4a98-9bbd-32e7cb7a8009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_862940ef-aa21-4a98-9bbd-32e7cb7a8009" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_74954bda-d654-4f67-8995-6c0bd4ab6a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_74954bda-d654-4f67-8995-6c0bd4ab6a63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4933ce16-8a70-47f9-b521-b74f6067ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4933ce16-8a70-47f9-b521-b74f6067ff5a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0dcba0e8-7840-4733-bf44-c5922abf7bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0dcba0e8-7840-4733-bf44-c5922abf7bdc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c55fc8f5-c3b7-4488-9726-995e8122959e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c55fc8f5-c3b7-4488-9726-995e8122959e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_aae814f2-cc4a-4a10-8d4a-91ddaa874a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_aae814f2-cc4a-4a10-8d4a-91ddaa874a86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d9779a57-1343-4d0a-926b-d85afd9773ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_CommonStockValue_d9779a57-1343-4d0a-926b-d85afd9773ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1c7555e8-d585-4e2b-8f75-6b459d888fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1c7555e8-d585-4e2b-8f75-6b459d888fbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2582a186-b056-486c-ba83-83bd356431c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_TreasuryStockValue_2582a186-b056-486c-ba83-83bd356431c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_792828ea-8df0-47c1-bac6-72c7d61f5c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_792828ea-8df0-47c1-bac6-72c7d61f5c2a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dbf28fd7-e92c-4101-a738-e3855e6463f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dbf28fd7-e92c-4101-a738-e3855e6463f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0a2d3ee3-605e-4a90-b68a-883f2985bad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0a2d3ee3-605e-4a90-b68a-883f2985bad2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_35a31d6d-0af9-48bc-bbfc-4c42506319fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_35a31d6d-0af9-48bc-bbfc-4c42506319fc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_88e4696c-38bb-455a-95c9-14ab2f092dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:to="loc_us-gaap_StatementTable_88e4696c-38bb-455a-95c9-14ab2f092dc2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_88e4696c-38bb-455a-95c9-14ab2f092dc2" xlink:to="loc_srt_StatementScenarioAxis_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4182b620-4bc0-49ff-ad06-aaee5b0e775e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4182b620-4bc0-49ff-ad06-aaee5b0e775e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended" id="i64b5da97f36f49608cc869b430283b27_CondensedConsolidatedStatementsofIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db937ee0-1ec1-4c94-aada-1ecb46838fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db937ee0-1ec1-4c94-aada-1ecb46838fbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_a1e504ee-d592-4933-918b-ab8de226a849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:to="loc_us-gaap_CostOfRevenue_a1e504ee-d592-4933-918b-ab8de226a849" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2c960ca2-4e53-4c22-8d99-d1c69393a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:to="loc_us-gaap_GrossProfit_2c960ca2-4e53-4c22-8d99-d1c69393a6ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2a835e2-c0a0-47b8-b1dc-850d9e9b1c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2a835e2-c0a0-47b8-b1dc-850d9e9b1c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a647ec89-ab9e-4748-9d00-820333878815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a647ec89-ab9e-4748-9d00-820333878815" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_6478c85e-e001-4b2e-9044-7dca431889e3" xlink:href="icui-20220331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_icui_Restructuringandstrategictransaction_6478c85e-e001-4b2e-9044-7dca431889e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement_47c7ae3e-5976-483f-a5cf-96b4026250f8" xlink:href="icui-20220331.xsd#icui_Contractsettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_icui_Contractsettlement_47c7ae3e-5976-483f-a5cf-96b4026250f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a5d88a6c-4e78-471a-9ec3-310b187244b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_us-gaap_OperatingExpenses_a5d88a6c-4e78-471a-9ec3-310b187244b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1cea31bc-4502-4217-9b0d-b80694c28bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_OperatingIncomeLoss_1cea31bc-4502-4217-9b0d-b80694c28bed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3ff22c51-85ee-47ac-b948-3241a2d04aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_InterestExpense_3ff22c51-85ee-47ac-b948-3241a2d04aba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_eb26e384-90c7-4283-9015-1960e7dacd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_eb26e384-90c7-4283-9015-1960e7dacd4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c1535476-b929-4435-9209-233f96afe88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c1535476-b929-4435-9209-233f96afe88c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_26fbfc7c-efa3-43fe-aeb4-90db3c26ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_26fbfc7c-efa3-43fe-aeb4-90db3c26ed1d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c9a598c5-e7d7-418a-92e5-c9eb2c0782fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_ProfitLoss_c9a598c5-e7d7-418a-92e5-c9eb2c0782fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d652bae3-7960-4245-8167-0caf061a1f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:to="loc_us-gaap_EarningsPerShareBasic_d652bae3-7960-4245-8167-0caf061a1f01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_847de671-50ed-42c5-baa8-bf6ba62906e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_847de671-50ed-42c5-baa8-bf6ba62906e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ab321a0-35b5-45c7-b77f-a9c0e8236f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ab321a0-35b5-45c7-b77f-a9c0e8236f07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_950d4417-7ab8-45a7-b0b9-49c8abbf233d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_950d4417-7ab8-45a7-b0b9-49c8abbf233d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8b77114e-385d-48eb-a500-ba01bb6cf92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_StatementTable_8b77114e-385d-48eb-a500-ba01bb6cf92a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8b77114e-385d-48eb-a500-ba01bb6cf92a" xlink:to="loc_srt_ProductOrServiceAxis_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495" xlink:to="loc_srt_ProductsAndServicesDomain_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_16f4c176-d6d3-48ee-bfdd-88064f9b0b34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495" xlink:to="loc_srt_ProductsAndServicesDomain_16f4c176-d6d3-48ee-bfdd-88064f9b0b34" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i0dbf9202e28b4befb29ae4697fc51bbb_CondensedConsolidatedStatementsofComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_80ab9bd9-c800-4f88-934f-59070be8571a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:to="loc_us-gaap_ProfitLoss_80ab9bd9-c800-4f88-934f-59070be8571a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a810f087-9419-4e5a-9628-04604b7ab332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a810f087-9419-4e5a-9628-04604b7ab332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c10bd3e0-6227-4121-9613-3665b72993e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c10bd3e0-6227-4121-9613-3665b72993e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d4fbb81a-b930-4822-8dea-d6a005f300c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d4fbb81a-b930-4822-8dea-d6a005f300c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_51e94e39-bf97-4f6b-b113-aabee0470e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_51e94e39-bf97-4f6b-b113-aabee0470e2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_36becdbd-6743-4f82-92e1-bc8a4bf1eb99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_36becdbd-6743-4f82-92e1-bc8a4bf1eb99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93622a6c-80a5-4e6a-b8fa-0b6291381620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:to="loc_us-gaap_StatementTable_93622a6c-80a5-4e6a-b8fa-0b6291381620" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d11c6e88-9c35-4e34-89a7-affed4da110e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_93622a6c-80a5-4e6a-b8fa-0b6291381620" xlink:to="loc_srt_StatementScenarioAxis_d11c6e88-9c35-4e34-89a7-affed4da110e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d11c6e88-9c35-4e34-89a7-affed4da110e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_d11c6e88-9c35-4e34-89a7-affed4da110e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d11c6e88-9c35-4e34-89a7-affed4da110e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ae58b134-c18a-4f8c-88f0-d2346e2f678e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_d11c6e88-9c35-4e34-89a7-affed4da110e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ae58b134-c18a-4f8c-88f0-d2346e2f678e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofStockholdersEquityStatement"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="extended" id="ib0cb9ec1beae429fb9340be02e4bc0e7_CondensedConsolidatedStatementsofStockholdersEquityStatement">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_34a22aba-11db-48f6-8bd7-b8a7d2f7bcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_34a22aba-11db-48f6-8bd7-b8a7d2f7bcc5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b0d9a2e6-16cc-4ee0-acfa-a3b79a52b125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b0d9a2e6-16cc-4ee0-acfa-a3b79a52b125" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9a6cdbbb-fdc8-4135-b6af-d90ac845bfca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockholdersEquity_9a6cdbbb-fdc8-4135-b6af-d90ac845bfca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8975de65-93a4-44bd-824a-6f89efd482f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8975de65-93a4-44bd-824a-6f89efd482f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_404107a0-0174-4128-b2da-1e9dfcec8b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_404107a0-0174-4128-b2da-1e9dfcec8b53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e3659c4c-df43-493c-b143-1af9f06e8490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e3659c4c-df43-493c-b143-1af9f06e8490" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_28ef0db6-ae63-489d-a1ed-5adbf0491245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_28ef0db6-ae63-489d-a1ed-5adbf0491245" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0f0dea0e-fa54-4800-98c5-0affd903535a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0f0dea0e-fa54-4800-98c5-0affd903535a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4247037c-e5e8-4fbe-b1ed-3b3f868016d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4247037c-e5e8-4fbe-b1ed-3b3f868016d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_59e9c9dc-79a4-49bc-8f4f-c7c92e242554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_59e9c9dc-79a4-49bc-8f4f-c7c92e242554" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e0ba106b-1b00-4f8c-9c2f-a8e0d7aa065f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e0ba106b-1b00-4f8c-9c2f-a8e0d7aa065f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_232f6cee-4d6b-4467-8f9c-4be4e1650642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_232f6cee-4d6b-4467-8f9c-4be4e1650642" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8c267532-c82f-40fd-8d88-51c44439ccb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_NetIncomeLoss_8c267532-c82f-40fd-8d88-51c44439ccb0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_130a2f6c-3b41-444f-b8b3-63b09deccffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c6ed15ac-3ee0-4e4c-9b69-63974b091016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7c0d83fe-5bb2-43ce-a5fd-21878050d41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7c0d83fe-5bb2-43ce-a5fd-21878050d41f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12ec75f3-a0c1-41b8-939d-e334e0fd9afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_34a22aba-11db-48f6-8bd7-b8a7d2f7bcc5" xlink:to="loc_us-gaap_StatementTable_12ec75f3-a0c1-41b8-939d-e334e0fd9afa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cee2e9b0-eae4-431b-91e1-e13053d1c6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_12ec75f3-a0c1-41b8-939d-e334e0fd9afa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cee2e9b0-eae4-431b-91e1-e13053d1c6a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cee2e9b0-eae4-431b-91e1-e13053d1c6a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cee2e9b0-eae4-431b-91e1-e13053d1c6a6" xlink:to="loc_us-gaap_EquityComponentDomain_cee2e9b0-eae4-431b-91e1-e13053d1c6a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cee2e9b0-eae4-431b-91e1-e13053d1c6a6" xlink:to="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_119348a7-7cbe-4288-a0be-9d5c4b8e6c6c" xlink:href="icui-20220331.xsd#icui_CommonStockSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_icui_CommonStockSharesMember_119348a7-7cbe-4288-a0be-9d5c4b8e6c6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_66b78d87-e033-4305-b568-d06c28b735e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_CommonStockMember_66b78d87-e033-4305-b568-d06c28b735e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0edf2923-5311-432d-8327-0d6602999b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0edf2923-5311-432d-8327-0d6602999b61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_97abbda3-966a-4d58-85bc-acee21e0ceba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_TreasuryStockMember_97abbda3-966a-4d58-85bc-acee21e0ceba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eea5c911-a25f-416b-9bac-562f74111885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_RetainedEarningsMember_eea5c911-a25f-416b-9bac-562f74111885" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2a90722-da4b-4213-b275-fd4191e5ed2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2a90722-da4b-4213-b275-fd4191e5ed2c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="ib11609fa6065403dbb00dd6de87ea1ba_CondensedConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:to="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c7909c91-2f57-414f-8ab7-f8dc50e5c8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_ProfitLoss_c7909c91-2f57-414f-8ab7-f8dc50e5c8d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_78623660-277e-47aa-83a2-6e2c081be434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_78623660-277e-47aa-83a2-6e2c081be434" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_229d9250-b004-4ffb-8094-4964e7b06ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_229d9250-b004-4ffb-8094-4964e7b06ede" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_80d5ea72-701d-4b78-9c7d-407a59706e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_80d5ea72-701d-4b78-9c7d-407a59706e57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c15b90db-b557-45b1-b052-fc67ef20223e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c15b90db-b557-45b1-b052-fc67ef20223e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f232833d-fd49-43ca-97d2-df2fe2541092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f232833d-fd49-43ca-97d2-df2fe2541092" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_023b6f73-1190-4ddf-870c-bb625b1fdd60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_023b6f73-1190-4ddf-870c-bb625b1fdd60" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_ae984c65-e540-414c-a2ee-250bcfbc2c34" xlink:href="icui-20220331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_ae984c65-e540-414c-a2ee-250bcfbc2c34" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d619d71d-7a58-4ccd-9bb2-cac962d6eb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d619d71d-7a58-4ccd-9bb2-cac962d6eb6f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_65c31c74-a462-499e-8c1b-03ca08eac099" xlink:href="icui-20220331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_AmortizationOfInventoryStepUp_65c31c74-a462-499e-8c1b-03ca08eac099" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c141e5f4-3613-4022-a229-4c20ebf8c64a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c141e5f4-3613-4022-a229-4c20ebf8c64a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_3577aee7-9def-408f-9d82-09ebccd19a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_3577aee7-9def-408f-9d82-09ebccd19a63" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_756a4452-6da8-4506-93a6-60710455a112" xlink:href="icui-20220331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_756a4452-6da8-4506-93a6-60710455a112" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e88d453d-ec12-4134-b4c1-408beaa73719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_ShareBasedCompensation_e88d453d-ec12-4134-b4c1-408beaa73719" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ee39ad6f-45b1-4a8f-9ebf-ca225e7cfacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ee39ad6f-45b1-4a8f-9ebf-ca225e7cfacf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_5a4d546b-f5af-401b-9d2f-2908f72031bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_5a4d546b-f5af-401b-9d2f-2908f72031bb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_20c91fda-d55f-452b-b4cb-f06c7c30e4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_20c91fda-d55f-452b-b4cb-f06c7c30e4f5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_83f04fad-b575-4ef3-9381-1d627089b7b3" xlink:href="icui-20220331.xsd#icui_Sparepartsusage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_Sparepartsusage_83f04fad-b575-4ef3-9381-1d627089b7b3" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e68413de-bc19-4fe6-a031-4c4aeeb2aca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e68413de-bc19-4fe6-a031-4c4aeeb2aca7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88b3b4cd-fff3-4d08-a6aa-7ddfe3fcbd67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88b3b4cd-fff3-4d08-a6aa-7ddfe3fcbd67" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80d1ba6b-d2e3-4071-8ca7-2997bbe629ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80d1ba6b-d2e3-4071-8ca7-2997bbe629ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d1849604-fa85-4f67-aa5b-440a47da89fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d1849604-fa85-4f67-aa5b-440a47da89fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4857fc6d-3513-4f69-91a5-193c4fc9c5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4857fc6d-3513-4f69-91a5-193c4fc9c5fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f1cd59a9-9639-4959-b0b7-91edc3e55c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f1cd59a9-9639-4959-b0b7-91edc3e55c57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d354702a-8673-4a0b-86e3-f29337704a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d354702a-8673-4a0b-86e3-f29337704a05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad79188-8d50-494c-9392-d9d9c787376c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad79188-8d50-494c-9392-d9d9c787376c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_a1b7ee77-8f5c-42d6-8ea4-103989f118c8" xlink:href="icui-20220331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_a1b7ee77-8f5c-42d6-8ea4-103989f118c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_726ac97c-5f4d-4cc2-ad3b-0c3cb8109c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_726ac97c-5f4d-4cc2-ad3b-0c3cb8109c9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3c57acc5-a317-4d4c-89d4-486750abbeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3c57acc5-a317-4d4c-89d4-486750abbeb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b74230b1-9a11-42c7-a06c-095f0c6e3d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b74230b1-9a11-42c7-a06c-095f0c6e3d88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_9c3daba2-fc9a-4492-ba7f-772290e5ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_9c3daba2-fc9a-4492-ba7f-772290e5ef30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b9dbd601-4ea4-4d68-9db5-249a4bf8a8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b9dbd601-4ea4-4d68-9db5-249a4bf8a8b0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3034d98-b375-414b-a689-4e123ed86474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3034d98-b375-414b-a689-4e123ed86474" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_bd7e2e84-7753-4215-96d7-878a6fe813c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_bd7e2e84-7753-4215-96d7-878a6fe813c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_f45af9e8-e3d1-4c70-af1c-e7cbb584c2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_bd7e2e84-7753-4215-96d7-878a6fe813c9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_f45af9e8-e3d1-4c70-af1c-e7cbb584c2b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f01bd0f3-b3d4-4cf0-8fda-700edf410b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f01bd0f3-b3d4-4cf0-8fda-700edf410b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ebfcbfd3-7022-44e5-9077-fc4b34c46568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ebfcbfd3-7022-44e5-9077-fc4b34c46568" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d2ccab67-7283-4d57-afe2-205c8917d986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d2ccab67-7283-4d57-afe2-205c8917d986" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_703e7d4f-9a80-4619-b347-715ef28f5c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d2ccab67-7283-4d57-afe2-205c8917d986" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_703e7d4f-9a80-4619-b347-715ef28f5c41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_bd0cd037-d38e-4e17-bcae-d8e3c6c21b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_bd0cd037-d38e-4e17-bcae-d8e3c6c21b74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a0c7a302-d589-4828-822b-6e3824eb3e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a0c7a302-d589-4828-822b-6e3824eb3e27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_9eebfee2-be77-47f3-ab0d-d9d80f6c7735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_9eebfee2-be77-47f3-ab0d-d9d80f6c7735" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationAllAcquisitions_b6bea2ba-1386-4aa4-8921-0c40da217602" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationAllAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_icui_ContingentConsiderationAllAcquisitions_b6bea2ba-1386-4aa4-8921-0c40da217602" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_ef8655d3-7deb-4e03-8efa-2d105f3d5da1" xlink:href="icui-20220331.xsd#icui_GoodwillAcquiredDuringPeriodAllAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_ef8655d3-7deb-4e03-8efa-2d105f3d5da1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_6158b62a-3a0f-4b95-ab09-1c70e93441ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_LiabilitiesAssumed1_6158b62a-3a0f-4b95-ab09-1c70e93441ca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0a6bd7a5-6f17-490c-acba-7968ce928da0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:to="loc_srt_StatementScenarioAxis_0a6bd7a5-6f17-490c-acba-7968ce928da0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0a6bd7a5-6f17-490c-acba-7968ce928da0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0a6bd7a5-6f17-490c-acba-7968ce928da0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0a6bd7a5-6f17-490c-acba-7968ce928da0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8ce2fa46-9b12-4a81-a9b3-3fa0147c63d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0a6bd7a5-6f17-490c-acba-7968ce928da0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8ce2fa46-9b12-4a81-a9b3-3fa0147c63d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_01decb7f-e365-454d-b5d5-f6ac2c61fc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_01decb7f-e365-454d-b5d5-f6ac2c61fc9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01decb7f-e365-454d-b5d5-f6ac2c61fc9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_01decb7f-e365-454d-b5d5-f6ac2c61fc9e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_01decb7f-e365-454d-b5d5-f6ac2c61fc9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cface4c3-f2e0-4e78-9b4e-fa9b19fb98a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_01decb7f-e365-454d-b5d5-f6ac2c61fc9e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cface4c3-f2e0-4e78-9b4e-fa9b19fb98a2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="extended" id="i50c5bd18b93d4e049765c9fecd8d2e26_BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d43a9f3d-bcc7-4ae6-9089-6d077f2b0d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d43a9f3d-bcc7-4ae6-9089-6d077f2b0d61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_92da397a-8068-4420-9f19-ef5e61cc5917" xlink:href="icui-20220331.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_Contingentconsiderationgross_92da397a-8068-4420-9f19-ef5e61cc5917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_175521f7-f2ed-4c99-842f-f7d2144079b6" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_ContingentConsiderationGrossST_175521f7-f2ed-4c99-842f-f7d2144079b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_8a1c4247-9250-4593-95d4-d07c22687189" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_ContingentConsiderationGrossLT_8a1c4247-9250-4593-95d4-d07c22687189" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationHoldbackLiability_4854cbb8-6315-4031-881d-148d30ca2064" xlink:href="icui-20220331.xsd#icui_BusinessCombinationConsiderationHoldbackLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_BusinessCombinationConsiderationHoldbackLiability_4854cbb8-6315-4031-881d-148d30ca2064" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9ad13ef3-a315-41e3-9c96-19f44f666679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9ad13ef3-a315-41e3-9c96-19f44f666679" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_19e622cd-2ffb-4325-840d-1f090515ce75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_19e622cd-2ffb-4325-840d-1f090515ce75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e78e5f6a-f3df-4868-a62f-e51b0c6bae47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_19e622cd-2ffb-4325-840d-1f090515ce75" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e78e5f6a-f3df-4868-a62f-e51b0c6bae47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e78e5f6a-f3df-4868-a62f-e51b0c6bae47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e78e5f6a-f3df-4868-a62f-e51b0c6bae47" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e78e5f6a-f3df-4868-a62f-e51b0c6bae47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64cd4fe6-62b0-4fea-9bfd-f954588769be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e78e5f6a-f3df-4868-a62f-e51b0c6bae47" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64cd4fe6-62b0-4fea-9bfd-f954588769be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_c983fc36-ddff-475c-9ce1-fac9dac2ef7c" xlink:href="icui-20220331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64cd4fe6-62b0-4fea-9bfd-f954588769be" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_c983fc36-ddff-475c-9ce1-fac9dac2ef7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="extended" id="i4bfee16ad4c2454ba26a5bb780f1888f_BusinessCombinationsandAssetAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a561e857-955b-4286-ba97-d70918dc8cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a561e857-955b-4286-ba97-d70918dc8cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash_b3815df7-cf9b-48b9-8c32-6d6caa2eedb0" xlink:href="icui-20220331.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_icui_BusinessCombinationConsiderationTransferredCash_b3815df7-cf9b-48b9-8c32-6d6caa2eedb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_bffbc939-8411-47b2-b5d9-6f5b3b3f32fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_bffbc939-8411-47b2-b5d9-6f5b3b3f32fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_de431c1e-a1fe-4865-8b9c-dd4195c74e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_de431c1e-a1fe-4865-8b9c-dd4195c74e3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment_9dd3429b-6461-4237-b0b8-ea0072297b2b" xlink:href="icui-20220331.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_icui_MinimumStockPriceTargetForEarnOutPayment_9dd3429b-6461-4237-b0b8-ea0072297b2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_fe290f27-c7c7-4d92-ae23-906f720ff471" xlink:href="icui-20220331.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_fe290f27-c7c7-4d92-ae23-906f720ff471" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af9985d9-fdb9-46a1-8772-f8c37770a848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af9985d9-fdb9-46a1-8772-f8c37770a848" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a403b674-f2e9-42fb-a00c-e746cad9b65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af9985d9-fdb9-46a1-8772-f8c37770a848" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a403b674-f2e9-42fb-a00c-e746cad9b65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a403b674-f2e9-42fb-a00c-e746cad9b65e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a403b674-f2e9-42fb-a00c-e746cad9b65e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a403b674-f2e9-42fb-a00c-e746cad9b65e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98011959-287a-438d-aded-0deea35b2190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a403b674-f2e9-42fb-a00c-e746cad9b65e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98011959-287a-438d-aded-0deea35b2190" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_f844b24d-6e49-4425-be0a-92f8c61715e4" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98011959-287a-438d-aded-0deea35b2190" xlink:to="loc_icui_SmithsMedicalMember_f844b24d-6e49-4425-be0a-92f8c61715e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="extended" id="i6dd479af2e7e407fa0bec514ec27574f_BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_454bc27f-713d-42ee-8fd2-4a208d587fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_454bc27f-713d-42ee-8fd2-4a208d587fea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_9845680b-a75e-47bd-b67b-aeb2f1fc113f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_9845680b-a75e-47bd-b67b-aeb2f1fc113f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_910be676-b08a-40c5-b063-c083feac08a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_910be676-b08a-40c5-b063-c083feac08a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_a69f8308-3071-4d05-a7da-f4f8d0c37f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_a69f8308-3071-4d05-a7da-f4f8d0c37f6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_32be385e-740a-449e-aed4-cb76dd5d611c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_32be385e-740a-449e-aed4-cb76dd5d611c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1229d1c0-0728-47b6-a593-3596be7f917f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1229d1c0-0728-47b6-a593-3596be7f917f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a0410568-1a8f-40dc-96ab-d26e6d55193b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a0410568-1a8f-40dc-96ab-d26e6d55193b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_51eaa169-37b0-454c-af82-9debcc9d6f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_51eaa169-37b0-454c-af82-9debcc9d6f05" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ba6544f3-45bd-46da-8f1c-dfe7e3cef302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ba6544f3-45bd-46da-8f1c-dfe7e3cef302" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_51452a1e-20ef-4c13-813b-6f4b56f6e974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_51452a1e-20ef-4c13-813b-6f4b56f6e974" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_f0cd72e5-9bf0-4814-a5a3-8eb7cb2699af" xlink:href="icui-20220331.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_f0cd72e5-9bf0-4814-a5a3-8eb7cb2699af" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e32000ff-aecf-4b26-90eb-700186c0124e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e32000ff-aecf-4b26-90eb-700186c0124e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_ae4010c3-3cf0-42eb-8052-ad14a5fcfb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_ae4010c3-3cf0-42eb-8052-ad14a5fcfb4b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_501d1d94-21e5-4fdb-8b6f-1a61dd332304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_501d1d94-21e5-4fdb-8b6f-1a61dd332304" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fdb2e3ce-18ba-4ff8-8c0e-84adec783780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fdb2e3ce-18ba-4ff8-8c0e-84adec783780" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b8f682e0-8883-4ce3-bc68-299815fc758b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b8f682e0-8883-4ce3-bc68-299815fc758b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_39b2c40f-2256-4438-b1a9-1110fda89f8d" xlink:href="icui-20220331.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_39b2c40f-2256-4438-b1a9-1110fda89f8d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4daf7a3c-998f-4ab5-9720-770ec441a50c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4daf7a3c-998f-4ab5-9720-770ec441a50c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_51a5b115-f609-4e64-84d2-bedc0ae7f597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_51a5b115-f609-4e64-84d2-bedc0ae7f597" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_665d1eb5-9739-4add-ae12-11047adbeac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_665d1eb5-9739-4add-ae12-11047adbeac6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible_d1375867-5080-465b-b6e7-b5812e520d21" xlink:href="icui-20220331.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_icui_BusinessCombinationGoodwillNonDeductible_d1375867-5080-465b-b6e7-b5812e520d21" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35b5091e-cf71-4d98-9a13-636d80deebb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35b5091e-cf71-4d98-9a13-636d80deebb8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_787cf311-ade7-48ee-a59a-f2b556f1cc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_787cf311-ade7-48ee-a59a-f2b556f1cc2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_787cf311-ade7-48ee-a59a-f2b556f1cc2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_787cf311-ade7-48ee-a59a-f2b556f1cc2b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_787cf311-ade7-48ee-a59a-f2b556f1cc2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b15c071f-bfec-4098-9173-44bf8dbf759f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_787cf311-ade7-48ee-a59a-f2b556f1cc2b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b15c071f-bfec-4098-9173-44bf8dbf759f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_89117ddc-5005-4341-a6cf-e1a0fa46a584" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b15c071f-bfec-4098-9173-44bf8dbf759f" xlink:to="loc_icui_SmithsMedicalMember_89117ddc-5005-4341-a6cf-e1a0fa46a584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0615ce28-c87d-423e-90b3-824680f67311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0615ce28-c87d-423e-90b3-824680f67311" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0615ce28-c87d-423e-90b3-824680f67311_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0615ce28-c87d-423e-90b3-824680f67311" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0615ce28-c87d-423e-90b3-824680f67311_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0615ce28-c87d-423e-90b3-824680f67311" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6b1ba9a4-123f-4a07-ab01-97c180849429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6b1ba9a4-123f-4a07-ab01-97c180849429" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember_4ca9933b-46f2-4c1d-9849-cc01fe5fb015" xlink:href="icui-20220331.xsd#icui_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:to="loc_icui_DevelopedTechnologyMember_4ca9933b-46f2-4c1d-9849-cc01fe5fb015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_040493a5-7008-4dc4-b247-be68397d5d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_040493a5-7008-4dc4-b247-be68397d5d58" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="extended" id="i510cf2768265411d914a567f667c2434_BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b4cd73b4-1528-4652-99f9-9a4b01b7f41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:to="loc_us-gaap_Revenues_b4cd73b4-1528-4652-99f9-9a4b01b7f41e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a436352b-a7b7-49e4-aabc-7e6568fa6566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:to="loc_us-gaap_ProfitLoss_a436352b-a7b7-49e4-aabc-7e6568fa6566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_957ccc43-7a34-4649-a6d6-ea27aca8a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_957ccc43-7a34-4649-a6d6-ea27aca8a4ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d8efb276-0405-4487-b738-1f30f541e50a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d8efb276-0405-4487-b738-1f30f541e50a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d8efb276-0405-4487-b738-1f30f541e50a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d8efb276-0405-4487-b738-1f30f541e50a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d8efb276-0405-4487-b738-1f30f541e50a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f94a64f-df78-4b5c-914a-e15d57af6180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d8efb276-0405-4487-b738-1f30f541e50a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f94a64f-df78-4b5c-914a-e15d57af6180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_92f44008-e82e-4083-98fe-42168461046a" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f94a64f-df78-4b5c-914a-e15d57af6180" xlink:to="loc_icui_SmithsMedicalMember_92f44008-e82e-4083-98fe-42168461046a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_687ca6cb-5e52-4548-b1bf-32565b6e839f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_687ca6cb-5e52-4548-b1bf-32565b6e839f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_687ca6cb-5e52-4548-b1bf-32565b6e839f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_687ca6cb-5e52-4548-b1bf-32565b6e839f" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_687ca6cb-5e52-4548-b1bf-32565b6e839f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_4fe6e398-a264-4cb3-9077-6ccd2fae6216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_687ca6cb-5e52-4548-b1bf-32565b6e839f" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_4fe6e398-a264-4cb3-9077-6ccd2fae6216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_8d1b4b32-94de-4d8d-b972-33b0dca2679a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_4fe6e398-a264-4cb3-9077-6ccd2fae6216" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_8d1b4b32-94de-4d8d-b972-33b0dca2679a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RestructuringStrategicTransactionandIntegrationLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="extended" id="if647b24f563f4810a62d006f5a5048e4_RestructuringStrategicTransactionandIntegrationLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_22b945c7-7328-46aa-b4da-7fc207b71475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_RestructuringReserve_22b945c7-7328-46aa-b4da-7fc207b71475" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f76e8062-8344-4bc0-8e9f-e92aac733349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_RestructuringCharges_f76e8062-8344-4bc0-8e9f-e92aac733349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f075c821-0aa9-4d84-b2f1-b7167b0f0d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_PaymentsForRestructuring_f075c821-0aa9-4d84-b2f1-b7167b0f0d2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_60655d9f-fa01-4144-91d5-d9777b9507ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_60655d9f-fa01-4144-91d5-d9777b9507ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2f26eddd-46b0-42cf-824e-88b2be3b1472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_cfeac958-1872-4ea2-b07c-666977e2a47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_cfeac958-1872-4ea2-b07c-666977e2a47d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fa61ba3d-8a39-4618-8f24-73fcd8fdbf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fa61ba3d-8a39-4618-8f24-73fcd8fdbf71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_653f36fb-54d7-40d3-a04d-3f173cd95966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fa61ba3d-8a39-4618-8f24-73fcd8fdbf71" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_653f36fb-54d7-40d3-a04d-3f173cd95966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_653f36fb-54d7-40d3-a04d-3f173cd95966_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_653f36fb-54d7-40d3-a04d-3f173cd95966" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_653f36fb-54d7-40d3-a04d-3f173cd95966_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_653f36fb-54d7-40d3-a04d-3f173cd95966" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6c626e92-19e9-4cb8-8c6f-ed58619dabf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:to="loc_us-gaap_EmployeeSeveranceMember_6c626e92-19e9-4cb8-8c6f-ed58619dabf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_119de4dd-da35-4a09-acbe-15d48338a1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:to="loc_us-gaap_FacilityClosingMember_119de4dd-da35-4a09-acbe-15d48338a1e2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDetails" xlink:type="extended" id="i1dfdb0bf166047929d8c96bce836d9ef_RevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_853bc8a7-5aaa-485b-9a58-8bc78c693493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5cd50d8a-929d-4b18-8260-cc876aa00169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_853bc8a7-5aaa-485b-9a58-8bc78c693493" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5cd50d8a-929d-4b18-8260-cc876aa00169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ae7a5cb3-af47-4147-806c-bc09ae50874f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_853bc8a7-5aaa-485b-9a58-8bc78c693493" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ae7a5cb3-af47-4147-806c-bc09ae50874f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b76e90f3-b8da-4e1a-8235-e2b3f82a10db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae7a5cb3-af47-4147-806c-bc09ae50874f" xlink:to="loc_srt_ProductOrServiceAxis_b76e90f3-b8da-4e1a-8235-e2b3f82a10db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b76e90f3-b8da-4e1a-8235-e2b3f82a10db_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b76e90f3-b8da-4e1a-8235-e2b3f82a10db" xlink:to="loc_srt_ProductsAndServicesDomain_b76e90f3-b8da-4e1a-8235-e2b3f82a10db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b76e90f3-b8da-4e1a-8235-e2b3f82a10db" xlink:to="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_7eaca74e-d611-4663-b22d-c78bff767158" xlink:href="icui-20220331.xsd#icui_InfusionSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:to="loc_icui_InfusionSystemsMember_7eaca74e-d611-4663-b22d-c78bff767158" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_b185b171-258a-43ed-8a67-50fadfe024b6" xlink:href="icui-20220331.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:to="loc_icui_EquipmentrevenueMember_b185b171-258a-43ed-8a67-50fadfe024b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_3de29b1e-8f62-443d-86b1-29cca64e4a9f" xlink:href="icui-20220331.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:to="loc_icui_SoftwarerevenueMember_3de29b1e-8f62-443d-86b1-29cca64e4a9f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueDisaggregatedRevenuebyGeographyDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="extended" id="i56d74748802e4aa383752f3821cc12cd_RevenueDisaggregatedRevenuebyGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_577a900e-c912-47cd-8fb2-9bce19319ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b45fe5dd-a57d-45b6-a95c-35f2e6adf20b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_577a900e-c912-47cd-8fb2-9bce19319ca2" xlink:to="loc_us-gaap_Revenues_b45fe5dd-a57d-45b6-a95c-35f2e6adf20b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_69383135-1346-4c63-90e7-1fae8f4f1e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_577a900e-c912-47cd-8fb2-9bce19319ca2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_69383135-1346-4c63-90e7-1fae8f4f1e31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_292fb9a0-f4af-4879-b5e0-44b350de31e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_69383135-1346-4c63-90e7-1fae8f4f1e31" xlink:to="loc_srt_StatementGeographicalAxis_292fb9a0-f4af-4879-b5e0-44b350de31e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_292fb9a0-f4af-4879-b5e0-44b350de31e8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_292fb9a0-f4af-4879-b5e0-44b350de31e8" xlink:to="loc_srt_SegmentGeographicalDomain_292fb9a0-f4af-4879-b5e0-44b350de31e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_292fb9a0-f4af-4879-b5e0-44b350de31e8" xlink:to="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_2f1d78d0-da74-48d1-92fe-bd57d17d874d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_us-gaap_EMEAMember_2f1d78d0-da74-48d1-92fe-bd57d17d874d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_a24ffe15-adcf-40b5-94b0-9ecf3f45402c" xlink:href="icui-20220331.xsd#icui_OtherforeigncountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_icui_OtherforeigncountriesMember_a24ffe15-adcf-40b5-94b0-9ecf3f45402c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_4994ec34-c241-494e-8c5c-828b3eefd9d1" xlink:href="icui-20220331.xsd#icui_ForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_icui_ForeignMember_4994ec34-c241-494e-8c5c-828b3eefd9d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a8c60026-c8b8-4020-bfe4-05be022a1e2a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_country_US_a8c60026-c8b8-4020-bfe4-05be022a1e2a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueDisaggregatedRevenuebyProductLineDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="extended" id="i8af2122212d8474c8eaf89b8daff10da_RevenueDisaggregatedRevenuebyProductLineDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_101add8c-6855-4b9f-a61a-227d048829be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_65585075-114a-453d-bdd4-21287e5f6cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_101add8c-6855-4b9f-a61a-227d048829be" xlink:to="loc_us-gaap_Revenues_65585075-114a-453d-bdd4-21287e5f6cb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ef5397b3-1250-4ee5-94fd-30ad6fb95846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_101add8c-6855-4b9f-a61a-227d048829be" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ef5397b3-1250-4ee5-94fd-30ad6fb95846" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a3e58776-6677-4dc8-acd8-8d0fe4d35d79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef5397b3-1250-4ee5-94fd-30ad6fb95846" xlink:to="loc_srt_ProductOrServiceAxis_a3e58776-6677-4dc8-acd8-8d0fe4d35d79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a3e58776-6677-4dc8-acd8-8d0fe4d35d79_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a3e58776-6677-4dc8-acd8-8d0fe4d35d79" xlink:to="loc_srt_ProductsAndServicesDomain_a3e58776-6677-4dc8-acd8-8d0fe4d35d79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a3e58776-6677-4dc8-acd8-8d0fe4d35d79" xlink:to="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_e2d1a306-6aaa-4ca6-a913-e636dd489977" xlink:href="icui-20220331.xsd#icui_InfusionConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_InfusionConsumablesMember_e2d1a306-6aaa-4ca6-a913-e636dd489977" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_74294216-93dc-4573-9d03-b97ff5b22f0a" xlink:href="icui-20220331.xsd#icui_InfusionSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_InfusionSystemsMember_74294216-93dc-4573-9d03-b97ff5b22f0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember_d17d7fe5-a589-4d1f-9870-70e8454fc3c8" xlink:href="icui-20220331.xsd#icui_IVSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_IVSolutionsMember_d17d7fe5-a589-4d1f-9870-70e8454fc3c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember_ebf3dc46-93c3-478d-a4d3-054cbe3105c5" xlink:href="icui-20220331.xsd#icui_CriticalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_CriticalCareMember_ebf3dc46-93c3-478d-a4d3-054cbe3105c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesSmithsMedicalMember_bd31c93c-5a4c-4b3e-9af7-9a10484b1dad" xlink:href="icui-20220331.xsd#icui_InfusionConsumablesSmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_InfusionConsumablesSmithsMedicalMember_bd31c93c-5a4c-4b3e-9af7-9a10484b1dad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VascularAccessMember_b1967680-d9ce-42ab-ba2f-76d78124b89a" xlink:href="icui-20220331.xsd#icui_VascularAccessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_VascularAccessMember_b1967680-d9ce-42ab-ba2f-76d78124b89a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember_56b0057e-c78a-461a-8dce-cae017546742" xlink:href="icui-20220331.xsd#icui_VitalCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_VitalCareMember_56b0057e-c78a-461a-8dce-cae017546742" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended" id="if0247be7eb39470fa84b1ce8f7fc357b_RevenueContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:href="icui-20220331.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward_d3c034a7-fffe-47c4-a0ed-1ccd6d3a4800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_MovementInDeferredRevenueRollForward_d3c034a7-fffe-47c4-a0ed-1ccd6d3a4800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_eb3c86a0-eaab-4a55-af15-cbfac741d525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_ContractWithCustomerLiability_eb3c86a0-eaab-4a55-af15-cbfac741d525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_9e61c1a9-2747-472c-9ee5-997c45e366b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_9e61c1a9-2747-472c-9ee5-997c45e366b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_96d8af1f-5659-4567-ac0f-5242d6a97832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_DeferredRevenueAdditions_96d8af1f-5659-4567-ac0f-5242d6a97832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7a489708-79f0-45de-9792-c881df852d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_61bb726f-8f91-4e04-98e0-e4a3dd36268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_61bb726f-8f91-4e04-98e0-e4a3dd36268c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:href="icui-20220331.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_509aa0dc-b058-4c27-af41-7fc9558e8174" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:to="loc_srt_ProductOrServiceAxis_509aa0dc-b058-4c27-af41-7fc9558e8174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_509aa0dc-b058-4c27-af41-7fc9558e8174_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_509aa0dc-b058-4c27-af41-7fc9558e8174" xlink:to="loc_srt_ProductsAndServicesDomain_509aa0dc-b058-4c27-af41-7fc9558e8174_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_509aa0dc-b058-4c27-af41-7fc9558e8174" xlink:to="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_b42b1489-6c18-45f2-ae3d-b8fc1bcbae8e" xlink:href="icui-20220331.xsd#icui_EquipmentrevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_EquipmentrevenueMember_b42b1489-6c18-45f2-ae3d-b8fc1bcbae8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_a99fb34b-1bfd-499f-b2a2-17ea22adb6c5" xlink:href="icui-20220331.xsd#icui_SoftwarerevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_SoftwarerevenueMember_a99fb34b-1bfd-499f-b2a2-17ea22adb6c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember_a7ce9e8d-c40a-44c5-9c89-03c487993b17" xlink:href="icui-20220331.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_GovernmentGrantRevenueMember_a7ce9e8d-c40a-44c5-9c89-03c487993b17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember_563dd622-d446-4397-8cfc-5ab2feb31178" xlink:href="icui-20220331.xsd#icui_OtherDeferredRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_OtherDeferredRevenueMember_563dd622-d446-4397-8cfc-5ab2feb31178" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_44bf5876-89e3-474f-ac84-085d562bc5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_44bf5876-89e3-474f-ac84-085d562bc5ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44bf5876-89e3-474f-ac84-085d562bc5ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_44bf5876-89e3-474f-ac84-085d562bc5ed" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44bf5876-89e3-474f-ac84-085d562bc5ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_843e6e56-ff3b-4716-a13e-27e5c73ea9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_44bf5876-89e3-474f-ac84-085d562bc5ed" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_843e6e56-ff3b-4716-a13e-27e5c73ea9ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_7389347e-e3a8-4fc8-9bff-768ef183c930" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_843e6e56-ff3b-4716-a13e-27e5c73ea9ef" xlink:to="loc_icui_SmithsMedicalMember_7389347e-e3a8-4fc8-9bff-768ef183c930" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a" xlink:href="icui-20220331.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:to="loc_icui_TimingAxis_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a_default" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a" xlink:to="loc_icui_TimingDomain_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a" xlink:to="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_74617887-6835-4f21-9c92-6173837dce72" xlink:href="icui-20220331.xsd#icui_ShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:to="loc_icui_ShortTermMember_74617887-6835-4f21-9c92-6173837dce72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_b8cb41cd-11c9-4308-b9c4-ad6bf6ea15cc" xlink:href="icui-20220331.xsd#icui_LongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:to="loc_icui_LongTermMember_b8cb41cd-11c9-4308-b9c4-ad6bf6ea15cc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTextDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesTextDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LeasesTextDetails" xlink:type="extended" id="i59d43c29ad6d43dfa7933364516730dd_LeasesTextDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_9119e24d-d044-4309-8ea0-6362e5c6583a" xlink:href="icui-20220331.xsd#icui_Optiontoextendinyears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:to="loc_icui_Optiontoextendinyears_9119e24d-d044-4309-8ea0-6362e5c6583a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd4ca983-d898-47cf-a190-ac8e847ad9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd4ca983-d898-47cf-a190-ac8e847ad9b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f4841762-9106-4cd8-bb0a-b904c069f678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f4841762-9106-4cd8-bb0a-b904c069f678" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_49b528bb-e150-44c7-a007-c19bb203567b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f4841762-9106-4cd8-bb0a-b904c069f678" xlink:to="loc_srt_RangeAxis_49b528bb-e150-44c7-a007-c19bb203567b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_49b528bb-e150-44c7-a007-c19bb203567b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_49b528bb-e150-44c7-a007-c19bb203567b" xlink:to="loc_srt_RangeMember_49b528bb-e150-44c7-a007-c19bb203567b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_186ab9c7-42aa-42b7-9b1d-f9a551e75a91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_49b528bb-e150-44c7-a007-c19bb203567b" xlink:to="loc_srt_RangeMember_186ab9c7-42aa-42b7-9b1d-f9a551e75a91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c78c621d-7886-4c88-9e0e-3870fb00b8ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_186ab9c7-42aa-42b7-9b1d-f9a551e75a91" xlink:to="loc_srt_MaximumMember_c78c621d-7886-4c88-9e0e-3870fb00b8ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#NetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="extended" id="i498f2001361645279e6b5305b4e8f0e7_NetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6548fabe-f8b7-4414-ac36-be0805f36d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6548fabe-f8b7-4414-ac36-be0805f36d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1ea4232-22b1-4299-82d4-f65ee4af7173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_ProfitLoss_c1ea4232-22b1-4299-82d4-f65ee4af7173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1f992f4c-f113-41a1-83b6-dbb2830b65a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1f992f4c-f113-41a1-83b6-dbb2830b65a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d2f8b223-7cf4-4ebc-96a6-b0a2625f9bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d2f8b223-7cf4-4ebc-96a6-b0a2625f9bf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1398c0b4-d37d-49f1-89b9-26670329ebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1398c0b4-d37d-49f1-89b9-26670329ebfc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_90b2ec47-0507-4a2c-9568-cbf2f0d90c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_EarningsPerShareBasic_90b2ec47-0507-4a2c-9568-cbf2f0d90c68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_16a2dd01-1f03-40af-a571-551e0f7cf8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_16a2dd01-1f03-40af-a571-551e0f7cf8ce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a9d25d9d-d4ff-4750-b590-b45137f0f108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a9d25d9d-d4ff-4750-b590-b45137f0f108" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2e5894ad-b432-4a3a-882c-232058ca87fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a9d25d9d-d4ff-4750-b590-b45137f0f108" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2e5894ad-b432-4a3a-882c-232058ca87fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2e5894ad-b432-4a3a-882c-232058ca87fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2e5894ad-b432-4a3a-882c-232058ca87fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2e5894ad-b432-4a3a-882c-232058ca87fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_af25965c-d9e2-44d2-bbb9-ce58493061fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2e5894ad-b432-4a3a-882c-232058ca87fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_af25965c-d9e2-44d2-bbb9-ce58493061fb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="extended" id="i6753f303ce0b4c1d902aab0a87e3e8fb_DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5a006f59-64ad-4349-b4af-4bf63365aa40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8cf150d5-0041-487f-a762-1696de4a67a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5a006f59-64ad-4349-b4af-4bf63365aa40" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8cf150d5-0041-487f-a762-1696de4a67a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5a006f59-64ad-4349-b4af-4bf63365aa40" xlink:to="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_9750ed7b-86c9-4929-abc0-30951fcc7282" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:to="loc_srt_CurrencyAxis_9750ed7b-86c9-4929-abc0-30951fcc7282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_9750ed7b-86c9-4929-abc0-30951fcc7282_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_9750ed7b-86c9-4929-abc0-30951fcc7282" xlink:to="loc_currency_AllCurrenciesDomain_9750ed7b-86c9-4929-abc0-30951fcc7282_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_9750ed7b-86c9-4929-abc0-30951fcc7282" xlink:to="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_6bcc7eba-1309-4ca3-93e7-b8290a0e8ba6" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_MXN_6bcc7eba-1309-4ca3-93e7-b8290a0e8ba6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_76ddf558-ade5-49d2-b4a7-a65e7fed21c1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_EUR_76ddf558-ade5-49d2-b4a7-a65e7fed21c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK_46c85034-0f6b-450f-9a47-5be9a30c36d1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CZK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_CZK_46c85034-0f6b-450f-9a47-5be9a30c36d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_0b5c4dbf-6e12-48cc-9e99-e243ff908330" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_JPY_0b5c4dbf-6e12-48cc-9e99-e243ff908330" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis_569b37ea-0d3e-422f-a017-23ea171da364" xlink:href="icui-20220331.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:to="loc_icui_Srt_MultipleCurrencyAxisAxis_569b37ea-0d3e-422f-a017-23ea171da364" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_569b37ea-0d3e-422f-a017-23ea171da364_default" xlink:href="icui-20220331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_569b37ea-0d3e-422f-a017-23ea171da364" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_569b37ea-0d3e-422f-a017-23ea171da364_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_848dbeae-c46c-4f9d-aa19-301a010f38a4" xlink:href="icui-20220331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_569b37ea-0d3e-422f-a017-23ea171da364" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_848dbeae-c46c-4f9d-aa19-301a010f38a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember_bdc48979-58f3-470e-bb7f-5a280fbf8a88" xlink:href="icui-20220331.xsd#icui_OtherCurrenciesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain_848dbeae-c46c-4f9d-aa19-301a010f38a4" xlink:to="loc_icui_OtherCurrenciesMember_bdc48979-58f3-470e-bb7f-5a280fbf8a88" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="extended" id="if0e34107469948a2b9b39ca673a389ad_DerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_2655941c-b905-4235-a71d-645e7ed8f7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_2655941c-b905-4235-a71d-645e7ed8f7a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d3f55de4-bb7e-465b-a522-d81d7947e887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d3f55de4-bb7e-465b-a522-d81d7947e887" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_16e2e105-8316-4729-906b-6b47de7a4cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_16e2e105-8316-4729-906b-6b47de7a4cf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e4ca71e9-a127-4f85-b8e4-bd4a13143875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:to="loc_us-gaap_DerivativeTable_e4ca71e9-a127-4f85-b8e4-bd4a13143875" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f751d2-b821-4e26-b664-977f78ca02f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e4ca71e9-a127-4f85-b8e4-bd4a13143875" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f751d2-b821-4e26-b664-977f78ca02f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d3f751d2-b821-4e26-b664-977f78ca02f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f751d2-b821-4e26-b664-977f78ca02f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d3f751d2-b821-4e26-b664-977f78ca02f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f751d2-b821-4e26-b664-977f78ca02f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_9ffd7d60-e97b-46ae-a67b-0c007d60e743" xlink:href="icui-20220331.xsd#icui_Hedge2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:to="loc_icui_Hedge2Member_9ffd7d60-e97b-46ae-a67b-0c007d60e743" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember_c4fb6489-1cab-4002-b93e-c8ff3ff89799" xlink:href="icui-20220331.xsd#icui_Hedge3MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:to="loc_icui_Hedge3MemberMember_c4fb6489-1cab-4002-b93e-c8ff3ff89799" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsInterestRateSwapsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="extended" id="i4b084eb6b2774e3e87e8bbc4fa3733ac_DerivativeFinancialInstrumentsInterestRateSwapsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3656ae5e-a138-48c5-bbfd-a0b914f05d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3656ae5e-a138-48c5-bbfd-a0b914f05d44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue_56a370be-9902-4599-b1ef-46acf7779cf6" xlink:href="icui-20220331.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_icui_InterestRateSwapEndingNotionalValue_56a370be-9902-4599-b1ef-46acf7779cf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_ca7b7042-0168-490d-9e77-027ceeff200a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_ca7b7042-0168-490d-9e77-027ceeff200a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor_a63d600b-ed00-42db-8a80-93a595f69f02" xlink:href="icui-20220331.xsd#icui_DerivativeVariableRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_icui_DerivativeVariableRateFloor_a63d600b-ed00-42db-8a80-93a595f69f02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9802d576-cc36-4aeb-8c44-71e31e9d6089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9802d576-cc36-4aeb-8c44-71e31e9d6089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9802d576-cc36-4aeb-8c44-71e31e9d6089_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9802d576-cc36-4aeb-8c44-71e31e9d6089" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9802d576-cc36-4aeb-8c44-71e31e9d6089_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b8b0bc3a-e6db-4388-a773-82d6db57d284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9802d576-cc36-4aeb-8c44-71e31e9d6089" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b8b0bc3a-e6db-4388-a773-82d6db57d284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_28bb3a20-d22e-4e46-8fab-3f5a9bed702d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b8b0bc3a-e6db-4388-a773-82d6db57d284" xlink:to="loc_us-gaap_InterestRateSwapMember_28bb3a20-d22e-4e46-8fab-3f5a9bed702d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_b9c246d6-2997-48d3-a988-8fa938880a84" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:to="loc_icui_TermLoanAxis_b9c246d6-2997-48d3-a988-8fa938880a84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_b9c246d6-2997-48d3-a988-8fa938880a84_default" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_b9c246d6-2997-48d3-a988-8fa938880a84" xlink:to="loc_icui_TermLoanDomain_b9c246d6-2997-48d3-a988-8fa938880a84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_b9c246d6-2997-48d3-a988-8fa938880a84" xlink:to="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_7464711c-a9b8-4cda-aa31-958e2b3b5fa2" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:to="loc_icui_TermLoanAMember_7464711c-a9b8-4cda-aa31-958e2b3b5fa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_859ca917-e04a-4800-9f25-045df850b699" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:to="loc_icui_TermLoanBMember_859ca917-e04a-4800-9f25-045df850b699" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="extended" id="i8b8b54b182da42cb8eea7d34db17a910_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_4e8f09c9-0e88-4ab8-8014-c9298c7933cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeAssets_4e8f09c9-0e88-4ab8-8014-c9298c7933cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_f58c67f4-961e-45fe-926e-bad7ad5d1e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_f58c67f4-961e-45fe-926e-bad7ad5d1e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_a01d0e86-3ea7-4049-bd16-d9ebb76187d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_a01d0e86-3ea7-4049-bd16-d9ebb76187d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_85c448f0-ea07-4df7-b072-fce9ad42a08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_85c448f0-ea07-4df7-b072-fce9ad42a08c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_08604ddc-2aeb-4e55-ae5c-3b9eef280909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_08604ddc-2aeb-4e55-ae5c-3b9eef280909" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_b562c786-ef77-4f3a-ae62-a9298e5fc30e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeLiabilities_b562c786-ef77-4f3a-ae62-a9298e5fc30e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7460d039-c593-477b-8262-202cbb12c657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7460d039-c593-477b-8262-202cbb12c657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7460d039-c593-477b-8262-202cbb12c657_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7460d039-c593-477b-8262-202cbb12c657" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7460d039-c593-477b-8262-202cbb12c657_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7460d039-c593-477b-8262-202cbb12c657" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_238f576e-701c-41b6-a5e0-16b2eecb4feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:to="loc_us-gaap_ForeignExchangeContractMember_238f576e-701c-41b6-a5e0-16b2eecb4feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_889af754-e39d-4b36-81c6-f01cb3cfdecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:to="loc_us-gaap_InterestRateSwapMember_889af754-e39d-4b36-81c6-f01cb3cfdecc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a032060c-c5b3-4d8a-926a-0635731125df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a032060c-c5b3-4d8a-926a-0635731125df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a032060c-c5b3-4d8a-926a-0635731125df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a032060c-c5b3-4d8a-926a-0635731125df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a032060c-c5b3-4d8a-926a-0635731125df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a032060c-c5b3-4d8a-926a-0635731125df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_824c952e-78ac-43fa-878f-d5bb8550198c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_824c952e-78ac-43fa-878f-d5bb8550198c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_6ab2cc3e-e485-4bc5-b33d-0d9331c35571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_OtherAssetsMember_6ab2cc3e-e485-4bc5-b33d-0d9331c35571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_d15708bf-73a0-47ae-b08f-a7f42ed4916f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_d15708bf-73a0-47ae-b08f-a7f42ed4916f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_e4f250f7-4bfa-4034-bb4b-d519f207a2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_OtherLiabilitiesMember_e4f250f7-4bfa-4034-bb4b-d519f207a2dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f3a8e8d2-4d10-4483-825e-f004b446560b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f3a8e8d2-4d10-4483-825e-f004b446560b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f3a8e8d2-4d10-4483-825e-f004b446560b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f3a8e8d2-4d10-4483-825e-f004b446560b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f3a8e8d2-4d10-4483-825e-f004b446560b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_13a99627-d2fc-453b-9ef8-f5ec317ecc21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f3a8e8d2-4d10-4483-825e-f004b446560b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_13a99627-d2fc-453b-9ef8-f5ec317ecc21" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i71cbdb6abfb64eef9692d4928d4473f9_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2d93b9fe-d5a0-4020-ac8a-93c2329d8865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_6a6e4b08-bf04-4916-bf29-d3543cf3f115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2d93b9fe-d5a0-4020-ac8a-93c2329d8865" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_6a6e4b08-bf04-4916-bf29-d3543cf3f115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f19d7164-bf85-48d0-800c-f5f608efc75f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2d93b9fe-d5a0-4020-ac8a-93c2329d8865" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f19d7164-bf85-48d0-800c-f5f608efc75f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e8430bde-f8f3-4deb-90b6-f6007e005e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f19d7164-bf85-48d0-800c-f5f608efc75f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e8430bde-f8f3-4deb-90b6-f6007e005e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e8430bde-f8f3-4deb-90b6-f6007e005e36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e8430bde-f8f3-4deb-90b6-f6007e005e36" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e8430bde-f8f3-4deb-90b6-f6007e005e36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e8430bde-f8f3-4deb-90b6-f6007e005e36" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ea14f127-7170-4aab-90c1-d4212de17d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ea14f127-7170-4aab-90c1-d4212de17d58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d360f372-b6d6-4fb6-8cf8-7b15974943b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:to="loc_us-gaap_InterestRateSwapMember_d360f372-b6d6-4fb6-8cf8-7b15974943b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="extended" id="ia616f880cfe4492c925946f7bdde57b9_DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_1e859ca1-c741-4aa5-a69f-eb4bba74982e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_1e859ca1-c741-4aa5-a69f-eb4bba74982e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a18e1e4f-183c-40f2-8456-e2bdd5588691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a18e1e4f-183c-40f2-8456-e2bdd5588691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_df30c0e4-2d5f-403d-92bb-906c0ddf1ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_df30c0e4-2d5f-403d-92bb-906c0ddf1ee7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8741f6fa-c959-4c0f-8945-42e3cbf84b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8741f6fa-c959-4c0f-8945-42e3cbf84b77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8741f6fa-c959-4c0f-8945-42e3cbf84b77_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8741f6fa-c959-4c0f-8945-42e3cbf84b77" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8741f6fa-c959-4c0f-8945-42e3cbf84b77_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8741f6fa-c959-4c0f-8945-42e3cbf84b77" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_933713de-0924-4e55-96f3-f70035b03388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_933713de-0924-4e55-96f3-f70035b03388" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5badede2-faaa-480a-b5b3-d3fb9d2a26d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:to="loc_us-gaap_InterestRateSwapMember_5badede2-faaa-480a-b5b3-d3fb9d2a26d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e14b9bba-0a2c-46a3-b948-ee757061762b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e14b9bba-0a2c-46a3-b948-ee757061762b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e14b9bba-0a2c-46a3-b948-ee757061762b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e14b9bba-0a2c-46a3-b948-ee757061762b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e14b9bba-0a2c-46a3-b948-ee757061762b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e14b9bba-0a2c-46a3-b948-ee757061762b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember_49a62213-680d-4216-aa91-7660cb3d2fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:to="loc_us-gaap_TradingRevenueMember_49a62213-680d-4216-aa91-7660cb3d2fe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d8dcc51c-6f5c-4042-8d02-dfe340dcdafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:to="loc_us-gaap_CostOfSalesMember_d8dcc51c-6f5c-4042-8d02-dfe340dcdafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f1fc14ed-b72e-4c4c-a5d6-bb615cbab1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:to="loc_us-gaap_InterestExpenseMember_f1fc14ed-b72e-4c4c-a5d6-bb615cbab1cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0cb328ea-3ceb-4d5f-9d07-38365fdb8782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_HedgingDesignationAxis_0cb328ea-3ceb-4d5f-9d07-38365fdb8782" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0cb328ea-3ceb-4d5f-9d07-38365fdb8782_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0cb328ea-3ceb-4d5f-9d07-38365fdb8782" xlink:to="loc_us-gaap_HedgingDesignationDomain_0cb328ea-3ceb-4d5f-9d07-38365fdb8782_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0cd6edf-06fc-4b50-bb63-c78ba2acb51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0cb328ea-3ceb-4d5f-9d07-38365fdb8782" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0cd6edf-06fc-4b50-bb63-c78ba2acb51e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697a22d9-b63a-47c8-a542-a0d17b29f4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697a22d9-b63a-47c8-a542-a0d17b29f4e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_697a22d9-b63a-47c8-a542-a0d17b29f4e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697a22d9-b63a-47c8-a542-a0d17b29f4e8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_697a22d9-b63a-47c8-a542-a0d17b29f4e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4569e39b-cd5d-4ef6-8703-a13e0ccbd7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697a22d9-b63a-47c8-a542-a0d17b29f4e8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4569e39b-cd5d-4ef6-8703-a13e0ccbd7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ce2ad121-bf54-4d8f-b008-8fd8e5d57959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4569e39b-cd5d-4ef6-8703-a13e0ccbd7fb" xlink:to="loc_us-gaap_CashFlowHedgingMember_ce2ad121-bf54-4d8f-b008-8fd8e5d57959" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended" id="i3ed99db6041f437aa45958a1acc9338d_FairValueMeasuresandDisclosuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_46ed7a9e-7f07-4fc9-be45-df875f5076f7" xlink:href="icui-20220331.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_Contingentconsiderationgross_46ed7a9e-7f07-4fc9-be45-df875f5076f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_630cc4ad-c966-4c85-bf8c-2d59e9d0f476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_630cc4ad-c966-4c85-bf8c-2d59e9d0f476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_c52a8c5b-2997-4587-9737-463dfdaa8368" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_ContingentConsiderationGrossST_c52a8c5b-2997-4587-9737-463dfdaa8368" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_26236e42-cbe9-4cab-8934-25ad85ce5a78" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_ContingentConsiderationGrossLT_26236e42-cbe9-4cab-8934-25ad85ce5a78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ab3f36ff-8543-425d-be85-fe5dca368582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ab3f36ff-8543-425d-be85-fe5dca368582" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment_08e55804-5f17-4362-83c0-b024d99f15e0" xlink:href="icui-20220331.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_OwnershipRequirementForEarnoutPayment_08e55804-5f17-4362-83c0-b024d99f15e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0670cb67-fc3e-48cc-aa85-4f95a686e886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0670cb67-fc3e-48cc-aa85-4f95a686e886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0670cb67-fc3e-48cc-aa85-4f95a686e886_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0670cb67-fc3e-48cc-aa85-4f95a686e886" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0670cb67-fc3e-48cc-aa85-4f95a686e886_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0670cb67-fc3e-48cc-aa85-4f95a686e886" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_f94bf7b1-020d-454f-95bb-c3d93e9542a8" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:to="loc_icui_PursuitVascularInc.Member_f94bf7b1-020d-454f-95bb-c3d93e9542a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_f39ae178-e4ca-4f47-af2a-d6f1f731f884" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:to="loc_icui_SmithsMedicalMember_f39ae178-e4ca-4f47-af2a-d6f1f731f884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_cbab7adc-ba83-42db-945d-0b36c80264ac" xlink:href="icui-20220331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_cbab7adc-ba83-42db-945d-0b36c80264ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_229ffe85-2789-42c2-aed0-1671f349b9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_229ffe85-2789-42c2-aed0-1671f349b9c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_229ffe85-2789-42c2-aed0-1671f349b9c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_229ffe85-2789-42c2-aed0-1671f349b9c5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_229ffe85-2789-42c2-aed0-1671f349b9c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c0ff982e-d868-43d9-8516-981ea81d1ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_229ffe85-2789-42c2-aed0-1671f349b9c5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c0ff982e-d868-43d9-8516-981ea81d1ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_f9a15c11-2662-4040-884b-afaf42e3077c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_c0ff982e-d868-43d9-8516-981ea81d1ce6" xlink:to="loc_us-gaap_LiabilityMember_f9a15c11-2662-4040-884b-afaf42e3077c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="extended" id="i0c4c4987b7824c6793fbc31b39e72716_FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4ed6f98a-a1e5-4dcb-af9e-359a210e4ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4ed6f98a-a1e5-4dcb-af9e-359a210e4ca9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e8706bbb-8bc8-4b6c-820c-56a1d87467ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e8706bbb-8bc8-4b6c-820c-56a1d87467ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_c04f671f-30be-4c27-b98b-d1b37aaf2f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_c04f671f-30be-4c27-b98b-d1b37aaf2f0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_708588b7-e3f4-4782-9482-e9247158fabc" xlink:href="icui-20220331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_708588b7-e3f4-4782-9482-e9247158fabc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_157e8dc7-1273-487e-bdef-725e05f6c1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_157e8dc7-1273-487e-bdef-725e05f6c1f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_faff6494-f35e-4ffd-b521-d9fe464ce5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_157e8dc7-1273-487e-bdef-725e05f6c1f9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_faff6494-f35e-4ffd-b521-d9fe464ce5f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faff6494-f35e-4ffd-b521-d9fe464ce5f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_faff6494-f35e-4ffd-b521-d9fe464ce5f7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_faff6494-f35e-4ffd-b521-d9fe464ce5f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e8a6ec-5d13-46c2-9d84-fcef54b0683e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_faff6494-f35e-4ffd-b521-d9fe464ce5f7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e8a6ec-5d13-46c2-9d84-fcef54b0683e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_dfc4e174-741e-4f4d-bc3e-4f5b3cedc30f" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e8a6ec-5d13-46c2-9d84-fcef54b0683e" xlink:to="loc_icui_PursuitVascularInc.Member_dfc4e174-741e-4f4d-bc3e-4f5b3cedc30f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="extended" id="id1ceef7a332c414e86634cb0fc280c2b_FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f794efbc-b394-433e-a0fc-0d928f2d44b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f794efbc-b394-433e-a0fc-0d928f2d44b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_8122802d-eb2a-4860-a9da-14419903b5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_8122802d-eb2a-4860-a9da-14419903b5e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ef44c0f9-9589-44eb-bdbf-210f87047071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ef44c0f9-9589-44eb-bdbf-210f87047071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ef44c0f9-9589-44eb-bdbf-210f87047071_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ef44c0f9-9589-44eb-bdbf-210f87047071" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ef44c0f9-9589-44eb-bdbf-210f87047071_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc96884d-1778-4362-8161-41b7e2b3f830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ef44c0f9-9589-44eb-bdbf-210f87047071" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc96884d-1778-4362-8161-41b7e2b3f830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_3a494bcb-0519-4af0-8313-f24f4d14b48e" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc96884d-1778-4362-8161-41b7e2b3f830" xlink:to="loc_icui_PursuitVascularInc.Member_3a494bcb-0519-4af0-8313-f24f4d14b48e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2919031b-8026-42f0-bc99-269c09ba6799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2919031b-8026-42f0-bc99-269c09ba6799" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2919031b-8026-42f0-bc99-269c09ba6799_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2919031b-8026-42f0-bc99-269c09ba6799" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2919031b-8026-42f0-bc99-269c09ba6799_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a8ca76e7-bde4-40ec-8c6c-d0f27a95739c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2919031b-8026-42f0-bc99-269c09ba6799" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a8ca76e7-bde4-40ec-8c6c-d0f27a95739c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8b613099-686e-4f74-a73f-b6f2ab2d2a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8b613099-686e-4f74-a73f-b6f2ab2d2a1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8b613099-686e-4f74-a73f-b6f2ab2d2a1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8b613099-686e-4f74-a73f-b6f2ab2d2a1c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_8b613099-686e-4f74-a73f-b6f2ab2d2a1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6dfa8b2b-a025-49f6-8511-2b592c58062c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8b613099-686e-4f74-a73f-b6f2ab2d2a1c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6dfa8b2b-a025-49f6-8511-2b592c58062c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_53ede3fb-f7bc-4ea2-95ac-d342d31303f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_53ede3fb-f7bc-4ea2-95ac-d342d31303f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_53ede3fb-f7bc-4ea2-95ac-d342d31303f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_53ede3fb-f7bc-4ea2-95ac-d342d31303f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_53ede3fb-f7bc-4ea2-95ac-d342d31303f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_27781bfe-9c2c-4321-9d69-a6b89849e8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_53ede3fb-f7bc-4ea2-95ac-d342d31303f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_27781bfe-9c2c-4321-9d69-a6b89849e8da" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="extended" id="i343f088b6b9c4f79a0718481e2ce1a8d_FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_dce44732-2e8c-472c-9579-6314f8c419a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_da409fa1-596e-417e-890c-e5fbb85abc90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_dce44732-2e8c-472c-9579-6314f8c419a8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_da409fa1-596e-417e-890c-e5fbb85abc90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_dce44732-2e8c-472c-9579-6314f8c419a8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0f1f2dc1-5d1b-4faf-b503-36087516c3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0f1f2dc1-5d1b-4faf-b503-36087516c3d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f1f2dc1-5d1b-4faf-b503-36087516c3d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f1f2dc1-5d1b-4faf-b503-36087516c3d5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0f1f2dc1-5d1b-4faf-b503-36087516c3d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f1f2dc1-5d1b-4faf-b503-36087516c3d5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_5653e3fd-dd12-4bda-9d49-a479b57f2403" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:to="loc_icui_PursuitVascularInc.Member_5653e3fd-dd12-4bda-9d49-a479b57f2403" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_e563d30b-c03a-4648-822e-6e795e8ecb4b" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:to="loc_icui_SmithsMedicalMember_e563d30b-c03a-4648-822e-6e795e8ecb4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_726e2338-064f-40eb-86b0-77a80075c359" xlink:href="icui-20220331.xsd#icui_MeasurementinputadjustedEBITDAvolatilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_726e2338-064f-40eb-86b0-77a80075c359" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_79c4c575-705d-4361-aba7-099e57918de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_79c4c575-705d-4361-aba7-099e57918de4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_499d01fd-aa53-4aad-8f36-c990c3770309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_499d01fd-aa53-4aad-8f36-c990c3770309" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementInputMarketPriceofRiskDomain_b4ab1952-6f02-4587-a195-5e84392aedf9" xlink:href="icui-20220331.xsd#icui_MeasurementInputMarketPriceofRiskDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_icui_MeasurementInputMarketPriceofRiskDomain_b4ab1952-6f02-4587-a195-5e84392aedf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_4f45f5e3-7fd7-4358-b60e-bd7d973c01ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_4f45f5e3-7fd7-4358-b60e-bd7d973c01ec" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="extended" id="i486672837c394c58910b7b2aec37a4ed_FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fc04846f-57b8-4119-b40e-a187d339a580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fc04846f-57b8-4119-b40e-a187d339a580" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_4f5b89c0-0f68-456c-81b5-9c92e4ceccfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_4f5b89c0-0f68-456c-81b5-9c92e4ceccfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a65cca0c-e732-434f-bf48-b6985a0e6caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a65cca0c-e732-434f-bf48-b6985a0e6caa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_d7024c01-2d84-4243-9f9f-3070895383d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_d7024c01-2d84-4243-9f9f-3070895383d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_15bd8897-ea5d-4d3a-a4ef-1783095fcfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_15bd8897-ea5d-4d3a-a4ef-1783095fcfa2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_56f0f30e-e6cf-4bc2-b0e6-dd2b255e233d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_56f0f30e-e6cf-4bc2-b0e6-dd2b255e233d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4d9033a1-3e85-4128-a550-dd7b7cebabfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4d9033a1-3e85-4128-a550-dd7b7cebabfa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_631a9423-782b-47a5-ae2b-100ceda105b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_631a9423-782b-47a5-ae2b-100ceda105b2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c78efca9-4518-475c-971f-3a7f5e9a942d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c78efca9-4518-475c-971f-3a7f5e9a942d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c78efca9-4518-475c-971f-3a7f5e9a942d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c78efca9-4518-475c-971f-3a7f5e9a942d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c78efca9-4518-475c-971f-3a7f5e9a942d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c78efca9-4518-475c-971f-3a7f5e9a942d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8255a319-dd02-4c4e-b7bd-35daaed543bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8255a319-dd02-4c4e-b7bd-35daaed543bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6d084e8d-83c1-482b-ad68-a847682a8615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6d084e8d-83c1-482b-ad68-a847682a8615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d45e2535-154e-4bf5-a75d-474e9a379ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d45e2535-154e-4bf5-a75d-474e9a379ba3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6fe258e6-6f78-46cf-89b2-e153afb6d6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6fe258e6-6f78-46cf-89b2-e153afb6d6b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6fe258e6-6f78-46cf-89b2-e153afb6d6b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6fe258e6-6f78-46cf-89b2-e153afb6d6b7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6fe258e6-6f78-46cf-89b2-e153afb6d6b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6fe258e6-6f78-46cf-89b2-e153afb6d6b7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9b22f302-ddba-4fbc-9d84-1c3b9fb8ac23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9b22f302-ddba-4fbc-9d84-1c3b9fb8ac23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_76f00939-5031-4506-bfa4-8832e1ff8d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_76f00939-5031-4506-bfa4-8832e1ff8d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0da5c124-b672-42ff-be77-f13ac63806ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0da5c124-b672-42ff-be77-f13ac63806ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_d675b00c-9927-4d65-964b-7928febcb88e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_OtherAssetsMember_d675b00c-9927-4d65-964b-7928febcb88e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d97fdc79-f596-4bcc-a737-756d58ac9c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d97fdc79-f596-4bcc-a737-756d58ac9c07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdc79-f596-4bcc-a737-756d58ac9c07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d97fdc79-f596-4bcc-a737-756d58ac9c07" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_d97fdc79-f596-4bcc-a737-756d58ac9c07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d97fdc79-f596-4bcc-a737-756d58ac9c07" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_a58600e3-a93d-470b-af99-16acfaeddbf6" xlink:href="icui-20220331.xsd#icui_EarnoutliabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:to="loc_icui_EarnoutliabilityMember_a58600e3-a93d-470b-af99-16acfaeddbf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_0f528a96-9c6c-4f29-81da-e394d0ddf358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:to="loc_us-gaap_LiabilitiesTotalMember_0f528a96-9c6c-4f29-81da-e394d0ddf358" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#InvestmentSecuritiesTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="extended" id="i0be38552f3254f8e883640a4ab35e908_InvestmentSecuritiesTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_31083723-505d-4bc3-9870-3735ecec0616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_31083723-505d-4bc3-9870-3735ecec0616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_3d75bf43-1acd-4de5-979a-b324f1d000f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_3d75bf43-1acd-4de5-979a-b324f1d000f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_20c5e56b-d8c9-4661-b9e2-c918364232a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_20c5e56b-d8c9-4661-b9e2-c918364232a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a754fa6c-3acd-4dee-ada0-1475829a2ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a754fa6c-3acd-4dee-ada0-1475829a2ca0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_ce08517f-0ea6-4cc8-bee8-f15c64a0d719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_ce08517f-0ea6-4cc8-bee8-f15c64a0d719" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_09d07a28-28fa-4f28-81e5-40fbab4f6bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_09d07a28-28fa-4f28-81e5-40fbab4f6bd4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8a61ce51-97c6-470d-82f6-684ae9de75d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8a61ce51-97c6-470d-82f6-684ae9de75d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_58192355-3a7a-471a-8262-748ef105af67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_58192355-3a7a-471a-8262-748ef105af67" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b5199ee0-7497-43f3-8df6-5b8a3b9d4949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b5199ee0-7497-43f3-8df6-5b8a3b9d4949" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_fc75c329-c74a-416e-8a49-11f193e1224c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b5199ee0-7497-43f3-8df6-5b8a3b9d4949" xlink:to="loc_us-gaap_InvestmentTypeAxis_fc75c329-c74a-416e-8a49-11f193e1224c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_fc75c329-c74a-416e-8a49-11f193e1224c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_fc75c329-c74a-416e-8a49-11f193e1224c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_fc75c329-c74a-416e-8a49-11f193e1224c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_fc75c329-c74a-416e-8a49-11f193e1224c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AvailableforsaleDebtSecurityCurrentMember_97b9fe04-84e4-4bd9-aed3-e7df324224a0" xlink:href="icui-20220331.xsd#icui_AvailableforsaleDebtSecurityCurrentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:to="loc_icui_AvailableforsaleDebtSecurityCurrentMember_97b9fe04-84e4-4bd9-aed3-e7df324224a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain_1f7d2923-ce3a-47ed-8e41-ca6ae17fe623" xlink:href="icui-20220331.xsd#icui_LongtermInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:to="loc_icui_LongtermInvestmentsDomain_1f7d2923-ce3a-47ed-8e41-ca6ae17fe623" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#OtherAssetsNoncurrentDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="extended" id="i43d57b96abfb43e3b898f7e339d0d228_OtherAssetsNoncurrentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c7e944dc-1e47-400c-919e-85265b8d7d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_7aefbef2-b906-49a9-b842-2db3a48da10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c7e944dc-1e47-400c-919e-85265b8d7d27" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_7aefbef2-b906-49a9-b842-2db3a48da10d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_249ac518-89b7-4238-b367-b5810ce94f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_c7e944dc-1e47-400c-919e-85265b8d7d27" xlink:to="loc_us-gaap_DerivativeTable_249ac518-89b7-4238-b367-b5810ce94f68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_249ac518-89b7-4238-b367-b5810ce94f68" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_77a8dcbb-54d5-4f62-b427-26f0f1f750b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:to="loc_us-gaap_InterestRateSwapMember_77a8dcbb-54d5-4f62-b427-26f0f1f750b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_7e40e5f9-e6ab-4bac-b1b9-f0df492ce97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:to="loc_us-gaap_ForeignExchangeMember_7e40e5f9-e6ab-4bac-b1b9-f0df492ce97f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#PropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended" id="i6c22bad9dece471c80aba92d1904f128_PropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_868ec711-8242-4b56-8e07-ae98f52a8f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_868ec711-8242-4b56-8e07-ae98f52a8f17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e5f89a45-6336-4b70-a8d6-2e88e684b4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e5f89a45-6336-4b70-a8d6-2e88e684b4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_52795b66-83d6-479d-9870-12f17edd11ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_52795b66-83d6-479d-9870-12f17edd11ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_6a82acae-ca68-4447-b96a-adfdb573d4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_6a82acae-ca68-4447-b96a-adfdb573d4a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_2d1f7328-12c2-43b6-a95a-e1a8182e5ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_2d1f7328-12c2-43b6-a95a-e1a8182e5ce5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_fcfc80c9-f7ce-4ba6-8502-b5f126300987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_ConstructionInProgressGross_fcfc80c9-f7ce-4ba6-8502-b5f126300987" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b59f1c8a-1ed6-4a6b-8f50-9333803a4950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b59f1c8a-1ed6-4a6b-8f50-9333803a4950" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6779a748-154f-4d10-8a5c-a4081a604223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b59f1c8a-1ed6-4a6b-8f50-9333803a4950" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6779a748-154f-4d10-8a5c-a4081a604223" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6779a748-154f-4d10-8a5c-a4081a604223_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6779a748-154f-4d10-8a5c-a4081a604223" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6779a748-154f-4d10-8a5c-a4081a604223_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6779a748-154f-4d10-8a5c-a4081a604223" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_9d8551f8-88a9-4114-9fd5-9e79149f3759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_9d8551f8-88a9-4114-9fd5-9e79149f3759" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_d9e281c3-db25-405f-907d-31d98477b87a" xlink:href="icui-20220331.xsd#icui_MoldsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_icui_MoldsMember_d9e281c3-db25-405f-907d-31d98477b87a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_c13471bc-c164-488a-8321-d284061be1ce" xlink:href="icui-20220331.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_c13471bc-c164-488a-8321-d284061be1ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_d7c252a3-3970-4844-91bc-32fb1a726815" xlink:href="icui-20220331.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_d7c252a3-3970-4844-91bc-32fb1a726815" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#GoodwillandIntangibleAssetsIntangiblesTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="extended" id="i713877c0ed9a4e548414affe289db714_GoodwillandIntangibleAssetsIntangiblesTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05c4f581-74bc-4119-8905-b1e195327c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05c4f581-74bc-4119-8905-b1e195327c46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c9cfba3-8eed-480d-98dc-787761fc1257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c9cfba3-8eed-480d-98dc-787761fc1257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2def289a-1d90-4478-9180-9df0997655b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2def289a-1d90-4478-9180-9df0997655b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7cc2b19b-dc3a-43a7-b459-98e505878fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7cc2b19b-dc3a-43a7-b459-98e505878fba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e4812a49-89d9-4c5e-9ca7-1ba62e9e21bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e4812a49-89d9-4c5e-9ca7-1ba62e9e21bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2329d8f0-f659-4937-b7dc-531d3839a066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2329d8f0-f659-4937-b7dc-531d3839a066" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b7073efa-c386-46af-ae1f-6e9af8a75db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b7073efa-c386-46af-ae1f-6e9af8a75db3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_7594e372-1815-4883-89fc-536469630e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_PatentsMember_7594e372-1815-4883-89fc-536469630e3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_e86477f6-1f67-4a81-9ab1-a636bc376958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_CustomerContractsMember_e86477f6-1f67-4a81-9ab1-a636bc376958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_a3af7114-f421-4b36-914c-ad8b05828776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_a3af7114-f421-4b36-914c-ad8b05828776" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_788e55a1-b22c-4c4a-a83b-533db1724da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_TrademarksMember_788e55a1-b22c-4c4a-a83b-533db1724da7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3f8f0333-b3bd-4699-8ed0-e321f07e44bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_TradeNamesMember_3f8f0333-b3bd-4699-8ed0-e321f07e44bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_d1122e39-b8c8-49f2-9d50-d07292459e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_d1122e39-b8c8-49f2-9d50-d07292459e5e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_08f4bdcc-9289-43f5-aef3-3fc135c39c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_08f4bdcc-9289-43f5-aef3-3fc135c39c98" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_srt_ConsolidationItemsAxis_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad" xlink:to="loc_srt_ConsolidationItemsDomain_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e665463b-7d25-44ff-9511-e7ecd9a66732" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad" xlink:to="loc_srt_ConsolidationItemsDomain_e665463b-7d25-44ff-9511-e7ecd9a66732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_10bb3279-9b4f-4261-befe-3f951246ff49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_10bb3279-9b4f-4261-befe-3f951246ff49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_10bb3279-9b4f-4261-befe-3f951246ff49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_10bb3279-9b4f-4261-befe-3f951246ff49" xlink:to="loc_us-gaap_SegmentDomain_10bb3279-9b4f-4261-befe-3f951246ff49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2e44c106-9b32-48d1-9573-3ed647c6405b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_10bb3279-9b4f-4261-befe-3f951246ff49" xlink:to="loc_us-gaap_SegmentDomain_2e44c106-9b32-48d1-9573-3ed647c6405b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a195ae60-43b4-4d95-9b44-92285735e2a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_srt_RangeAxis_a195ae60-43b4-4d95-9b44-92285735e2a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a195ae60-43b4-4d95-9b44-92285735e2a4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a195ae60-43b4-4d95-9b44-92285735e2a4" xlink:to="loc_srt_RangeMember_a195ae60-43b4-4d95-9b44-92285735e2a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_370cd97e-e66b-467f-bedc-77f3dd772163" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a195ae60-43b4-4d95-9b44-92285735e2a4" xlink:to="loc_srt_RangeMember_370cd97e-e66b-467f-bedc-77f3dd772163" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#AccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="extended" id="i6faeeecfd8e44082be015b322e1871e9_AccruedLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a6b76fa6-a966-4f70-a2f5-8969c9031cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_75b2bf60-e39c-459d-a3cf-a1f6b47e52b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a6b76fa6-a966-4f70-a2f5-8969c9031cf4" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_75b2bf60-e39c-459d-a3cf-a1f6b47e52b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3b834736-b389-44c8-abc4-a9095a555c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_a6b76fa6-a966-4f70-a2f5-8969c9031cf4" xlink:to="loc_us-gaap_DerivativeTable_3b834736-b389-44c8-abc4-a9095a555c62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6efc2a4f-38c9-4e10-a605-3ebf70595db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_3b834736-b389-44c8-abc4-a9095a555c62" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6efc2a4f-38c9-4e10-a605-3ebf70595db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6efc2a4f-38c9-4e10-a605-3ebf70595db3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6efc2a4f-38c9-4e10-a605-3ebf70595db3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6efc2a4f-38c9-4e10-a605-3ebf70595db3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c59c7b86-efea-425c-9c31-6395629cba4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6efc2a4f-38c9-4e10-a605-3ebf70595db3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c59c7b86-efea-425c-9c31-6395629cba4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_9ea130f7-d497-4afe-8918-92a81f79b556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c59c7b86-efea-425c-9c31-6395629cba4e" xlink:to="loc_us-gaap_ForeignExchangeMember_9ea130f7-d497-4afe-8918-92a81f79b556" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_c1d1f835-80c5-41f5-b59a-e88002dce73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7a0c7b98-d4a9-4611-8100-8130d224ca0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_c1d1f835-80c5-41f5-b59a-e88002dce73c" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7a0c7b98-d4a9-4611-8100-8130d224ca0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_e030dddb-517d-4878-bfb4-22c8516168f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_c1d1f835-80c5-41f5-b59a-e88002dce73c" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_e030dddb-517d-4878-bfb4-22c8516168f2" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_0a7a2059-0a83-4dcb-a879-16fb8ac70661" xlink:href="icui-20220331.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_e030dddb-517d-4878-bfb4-22c8516168f2" xlink:to="loc_icui_TimingAxis_0a7a2059-0a83-4dcb-a879-16fb8ac70661" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_0a7a2059-0a83-4dcb-a879-16fb8ac70661_default" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_0a7a2059-0a83-4dcb-a879-16fb8ac70661" xlink:to="loc_icui_TimingDomain_0a7a2059-0a83-4dcb-a879-16fb8ac70661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_a6121b59-cfb7-408d-a754-4405494ff5d5" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_0a7a2059-0a83-4dcb-a879-16fb8ac70661" xlink:to="loc_icui_TimingDomain_a6121b59-cfb7-408d-a754-4405494ff5d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_26cfe82c-1f0b-45ef-b0fe-21f4313d42ca" xlink:href="icui-20220331.xsd#icui_ShortTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_a6121b59-cfb7-408d-a754-4405494ff5d5" xlink:to="loc_icui_ShortTermMember_26cfe82c-1f0b-45ef-b0fe-21f4313d42ca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#AccruedLiabilitiesLongtermliabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="extended" id="if1e8a01cb4cd454f870ff1ff7912eb1b_AccruedLiabilitiesLongtermliabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7dd5fc71-441c-40fe-8a81-6b7eb94d8cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7dd5fc71-441c-40fe-8a81-6b7eb94d8cdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_65f95c35-0dda-42ee-aab7-b6ff3ff4341a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_65f95c35-0dda-42ee-aab7-b6ff3ff4341a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_8602d682-2420-48ba-9263-669128155413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_8602d682-2420-48ba-9263-669128155413" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_834da5a2-f484-456e-8814-48e4a240c671" xlink:href="icui-20220331.xsd#icui_TimingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_8602d682-2420-48ba-9263-669128155413" xlink:to="loc_icui_TimingAxis_834da5a2-f484-456e-8814-48e4a240c671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_834da5a2-f484-456e-8814-48e4a240c671_default" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TimingAxis_834da5a2-f484-456e-8814-48e4a240c671" xlink:to="loc_icui_TimingDomain_834da5a2-f484-456e-8814-48e4a240c671_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_a501312f-640a-4ed0-b967-b2c662341c62" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TimingAxis_834da5a2-f484-456e-8814-48e4a240c671" xlink:to="loc_icui_TimingDomain_a501312f-640a-4ed0-b967-b2c662341c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_7f5a4675-d51d-42c8-91c8-e6875a74f308" xlink:href="icui-20220331.xsd#icui_LongTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TimingDomain_a501312f-640a-4ed0-b967-b2c662341c62" xlink:to="loc_icui_LongTermMember_7f5a4675-d51d-42c8-91c8-e6875a74f308" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_37a62734-6dd4-4548-8b03-ef71a6affff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fb02ffac-bfe6-4210-a259-146fbcccd914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_37a62734-6dd4-4548-8b03-ef71a6affff4" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fb02ffac-bfe6-4210-a259-146fbcccd914" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d3a4b865-c993-47e2-8c20-5eaae46a8b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_37a62734-6dd4-4548-8b03-ef71a6affff4" xlink:to="loc_us-gaap_DerivativeTable_d3a4b865-c993-47e2-8c20-5eaae46a8b44" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ebd21deb-9ae6-4599-9f2d-fe3351361d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d3a4b865-c993-47e2-8c20-5eaae46a8b44" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ebd21deb-9ae6-4599-9f2d-fe3351361d23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ebd21deb-9ae6-4599-9f2d-fe3351361d23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ebd21deb-9ae6-4599-9f2d-fe3351361d23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ebd21deb-9ae6-4599-9f2d-fe3351361d23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72956afa-f61d-4a4e-9c78-6a20deab7495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ebd21deb-9ae6-4599-9f2d-fe3351361d23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72956afa-f61d-4a4e-9c78-6a20deab7495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_b4c1f993-7fae-425a-8d84-44ae01c943b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72956afa-f61d-4a4e-9c78-6a20deab7495" xlink:to="loc_us-gaap_ForeignExchangeMember_b4c1f993-7fae-425a-8d84-44ae01c943b8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended" id="i00f7c506d11449839f966952a3a673c6_LongTermObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility_d87df326-754e-4e39-8a32-a70a17328be5" xlink:href="icui-20220331.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_icui_TotalSeniorSecuredCreditFacility_d87df326-754e-4e39-8a32-a70a17328be5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_d5063708-0d98-4997-a5f9-b6c7bf370a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_d5063708-0d98-4997-a5f9-b6c7bf370a21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_24e6092e-0cdb-4cc3-beb5-5ad7e9f7e8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_24e6092e-0cdb-4cc3-beb5-5ad7e9f7e8bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits_5562588e-904b-48e7-9da5-1830c40206cf" xlink:href="icui-20220331.xsd#icui_RevolverSubLimits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_icui_RevolverSubLimits_5562588e-904b-48e7-9da5-1830c40206cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_96096b92-6f7a-4a0b-aba2-a325ebfa182b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_96096b92-6f7a-4a0b-aba2-a325ebfa182b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_93c953d4-5452-4173-af85-d01263103a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_LongTermDebt_93c953d4-5452-4173-af85-d01263103a94" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_67390cfb-4d58-4378-a301-22d71f8eb2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_67390cfb-4d58-4378-a301-22d71f8eb2f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_3f3f29a7-3fc8-4ff3-bb44-94fc25cbdfd2" xlink:href="icui-20220331.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_3f3f29a7-3fc8-4ff3-bb44-94fc25cbdfd2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4c3190a5-1349-4c4c-a91a-0414c856950b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4c3190a5-1349-4c4c-a91a-0414c856950b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4c3190a5-1349-4c4c-a91a-0414c856950b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c3190a5-1349-4c4c-a91a-0414c856950b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4c3190a5-1349-4c4c-a91a-0414c856950b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5cd67d49-c57d-449c-83ca-3facbe43fe89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c3190a5-1349-4c4c-a91a-0414c856950b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5cd67d49-c57d-449c-83ca-3facbe43fe89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b4c99ea7-63ff-4990-a863-e70b7837068f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5cd67d49-c57d-449c-83ca-3facbe43fe89" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b4c99ea7-63ff-4990-a863-e70b7837068f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_d3f7f152-e59d-4c25-9160-c577e9c9c016" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:to="loc_icui_TermLoanAxis_d3f7f152-e59d-4c25-9160-c577e9c9c016" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_d3f7f152-e59d-4c25-9160-c577e9c9c016_default" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_d3f7f152-e59d-4c25-9160-c577e9c9c016" xlink:to="loc_icui_TermLoanDomain_d3f7f152-e59d-4c25-9160-c577e9c9c016_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_d3f7f152-e59d-4c25-9160-c577e9c9c016" xlink:to="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_ade1f07c-fb07-4b9e-b055-cf9e7c0fc9da" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:to="loc_icui_TermLoanAMember_ade1f07c-fb07-4b9e-b055-cf9e7c0fc9da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_927c1405-e848-4be7-9d0e-b3a17075bf83" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:to="loc_icui_TermLoanBMember_927c1405-e848-4be7-9d0e-b3a17075bf83" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsInterestRateTermsDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="extended" id="i06fdf3ac32074667ad96bb9cedab2dd5_LongTermObligationsInterestRateTermsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_3fe4f185-c706-4ad9-9381-1678e1cfb5b7" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_3fe4f185-c706-4ad9-9381-1678e1cfb5b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_b9c9f001-d111-4a00-8652-8287fbc78a03" xlink:href="icui-20220331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_b9c9f001-d111-4a00-8652-8287fbc78a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b79db158-0ae7-49c7-80d6-219602d25fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b79db158-0ae7-49c7-80d6-219602d25fc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_62c7e672-a074-48dc-9145-993e7274b428" xlink:href="icui-20220331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_62c7e672-a074-48dc-9145-993e7274b428" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_b9908362-d257-4828-8c0c-e1359ebcb6fa" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:to="loc_icui_TermLoanAxis_b9908362-d257-4828-8c0c-e1359ebcb6fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_b9908362-d257-4828-8c0c-e1359ebcb6fa_default" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_b9908362-d257-4828-8c0c-e1359ebcb6fa" xlink:to="loc_icui_TermLoanDomain_b9908362-d257-4828-8c0c-e1359ebcb6fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_b9908362-d257-4828-8c0c-e1359ebcb6fa" xlink:to="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_b03137c2-5df5-4ec2-a551-769926b6054a" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:to="loc_icui_TermLoanAMember_b03137c2-5df5-4ec2-a551-769926b6054a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_280100b5-8dbf-4e03-9766-f6ebe14ce81b" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:to="loc_icui_TermLoanBMember_280100b5-8dbf-4e03-9766-f6ebe14ce81b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis_130c4923-eb71-4782-85ee-e85e1dec6516" xlink:href="icui-20220331.xsd#icui_LeverageRatioLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:to="loc_icui_LeverageRatioLevelAxis_130c4923-eb71-4782-85ee-e85e1dec6516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_130c4923-eb71-4782-85ee-e85e1dec6516_default" xlink:href="icui-20220331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_LeverageRatioLevelAxis_130c4923-eb71-4782-85ee-e85e1dec6516" xlink:to="loc_icui_LeverageRatioLevelDomain_130c4923-eb71-4782-85ee-e85e1dec6516_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:href="icui-20220331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_LeverageRatioLevelAxis_130c4923-eb71-4782-85ee-e85e1dec6516" xlink:to="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member_ae64bc02-fa6f-46a0-a797-ee0dcac2ea08" xlink:href="icui-20220331.xsd#icui_Greaterthan400to100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_Greaterthan400to100Member_ae64bc02-fa6f-46a0-a797-ee0dcac2ea08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_ba0cee51-36a7-49b0-a767-2a4dd93a50fe" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_ba0cee51-36a7-49b0-a767-2a4dd93a50fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_b5e7aa2d-b7fc-41db-8866-ccee8f709eec" xlink:href="icui-20220331.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_b5e7aa2d-b7fc-41db-8866-ccee8f709eec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_af4dfd1e-823d-4d91-8b5c-9082204fcb7b" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_af4dfd1e-823d-4d91-8b5c-9082204fcb7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member_3ae02ee4-1ac2-4cf5-b05a-77c04bf19cca" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqualTo200To100Member_3ae02ee4-1ac2-4cf5-b05a-77c04bf19cca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member_62ac7adb-8041-40bf-ac44-452ccbd642d3" xlink:href="icui-20220331.xsd#icui_GreaterThan275To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_GreaterThan275To100Member_62ac7adb-8041-40bf-ac44-452ccbd642d3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member_ed11ac49-e6a0-4ad3-94d6-81d06f03d827" xlink:href="icui-20220331.xsd#icui_LessThan275To100Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThan275To100Member_ed11ac49-e6a0-4ad3-94d6-81d06f03d827" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_614017a1-6b15-463e-a859-e78e45c9cd46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:to="loc_srt_RangeAxis_614017a1-6b15-463e-a859-e78e45c9cd46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_614017a1-6b15-463e-a859-e78e45c9cd46_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_614017a1-6b15-463e-a859-e78e45c9cd46" xlink:to="loc_srt_RangeMember_614017a1-6b15-463e-a859-e78e45c9cd46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_614017a1-6b15-463e-a859-e78e45c9cd46" xlink:to="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_98490953-e769-4e59-8589-3132ae0445ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:to="loc_srt_MaximumMember_98490953-e769-4e59-8589-3132ae0445ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2fd8e960-8ff8-41ce-8df8-cbf94e6046df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:to="loc_srt_MinimumMember_2fd8e960-8ff8-41ce-8df8-cbf94e6046df" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsTableDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="extended" id="ib268cb1f23e14fec94dca603a45dac1d_LongTermObligationsTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_896d0064-486b-449c-a357-b55ad6d26d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_896d0064-486b-449c-a357-b55ad6d26d0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_18c65468-20f5-4ce0-8729-c3fdc48a82b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_18c65468-20f5-4ce0-8729-c3fdc48a82b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_aa2519be-4e12-46ba-b3eb-eabd02de0217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_aa2519be-4e12-46ba-b3eb-eabd02de0217" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_a622bf2b-9cdd-4dd1-a7bf-c55189f2e882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_a622bf2b-9cdd-4dd1-a7bf-c55189f2e882" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_46e8968c-fa02-4582-ab5c-c6876896d382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtCurrent_46e8968c-fa02-4582-ab5c-c6876896d382" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_01cd1d77-f62e-499c-90f4-34399d513de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_01cd1d77-f62e-499c-90f4-34399d513de3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_db717f4b-5a66-4e1c-a68c-3688fe430811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_db717f4b-5a66-4e1c-a68c-3688fe430811" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_e3e9f52a-4425-43e8-a9d0-eaa820af1a93" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:to="loc_icui_TermLoanAxis_e3e9f52a-4425-43e8-a9d0-eaa820af1a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_e3e9f52a-4425-43e8-a9d0-eaa820af1a93_default" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_icui_TermLoanAxis_e3e9f52a-4425-43e8-a9d0-eaa820af1a93" xlink:to="loc_icui_TermLoanDomain_e3e9f52a-4425-43e8-a9d0-eaa820af1a93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_icui_TermLoanAxis_e3e9f52a-4425-43e8-a9d0-eaa820af1a93" xlink:to="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_56a23503-a6c4-4583-9b92-b5772b71e07b" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:to="loc_icui_TermLoanAMember_56a23503-a6c4-4583-9b92-b5772b71e07b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_ad17b6e9-e957-49f8-a118-d56f79968e01" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:to="loc_icui_TermLoanBMember_ad17b6e9-e957-49f8-a118-d56f79968e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ff6423d0-3aa4-4dca-80c0-ee1095d30957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ff6423d0-3aa4-4dca-80c0-ee1095d30957" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ff6423d0-3aa4-4dca-80c0-ee1095d30957_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff6423d0-3aa4-4dca-80c0-ee1095d30957" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ff6423d0-3aa4-4dca-80c0-ee1095d30957_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3c9f2e63-7ce3-444d-b882-12973110e77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff6423d0-3aa4-4dca-80c0-ee1095d30957" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3c9f2e63-7ce3-444d-b882-12973110e77a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6985caf7-4d15-4294-b69d-11ad63a84f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3c9f2e63-7ce3-444d-b882-12973110e77a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6985caf7-4d15-4294-b69d-11ad63a84f04" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#CommitmentsandContingenciesContingencyDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="extended" id="ife58b4a706634a2e984ffa0a1b06692a_CommitmentsandContingenciesContingencyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_ddc4f808-2e0d-4230-945d-8c2dee6c77d0" xlink:href="icui-20220331.xsd#icui_Contingentconsiderationgross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_icui_Contingentconsiderationgross_ddc4f808-2e0d-4230-945d-8c2dee6c77d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_fffe307c-a194-46d4-b411-e5437ca3205a" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_icui_ContingentConsiderationGrossST_fffe307c-a194-46d4-b411-e5437ca3205a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_c6cee085-9fc7-4fa3-b2cd-1b9a66ade992" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_icui_ContingentConsiderationGrossLT_c6cee085-9fc7-4fa3-b2cd-1b9a66ade992" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1377aa0e-a7da-4c01-88fe-093335e99311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1377aa0e-a7da-4c01-88fe-093335e99311" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_58e18ad2-b941-4d8a-976c-854ee10eec64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_58e18ad2-b941-4d8a-976c-854ee10eec64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_71098062-308f-4c3b-bcd1-6e8d88aec01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_71098062-308f-4c3b-bcd1-6e8d88aec01c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_236d8c8e-169a-4220-9576-d615bcbe2264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_71098062-308f-4c3b-bcd1-6e8d88aec01c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_236d8c8e-169a-4220-9576-d615bcbe2264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_236d8c8e-169a-4220-9576-d615bcbe2264_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_236d8c8e-169a-4220-9576-d615bcbe2264" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_236d8c8e-169a-4220-9576-d615bcbe2264_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_236d8c8e-169a-4220-9576-d615bcbe2264" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_32376de9-a648-4520-91cb-f9ed09f3e399" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:to="loc_icui_SmithsMedicalMember_32376de9-a648-4520-91cb-f9ed09f3e399" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_4434cbcb-a481-43d5-8a65-ba0a1bcf3ba5" xlink:href="icui-20220331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_4434cbcb-a481-43d5-8a65-ba0a1bcf3ba5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_ba25dead-6484-4a70-a70d-4d6bb2205350" xlink:href="icui-20220331.xsd#icui_InternationalDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:to="loc_icui_InternationalDistributorMember_ba25dead-6484-4a70-a70d-4d6bb2205350" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#EquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="ic974fc1a95bd416eabc7140d2552dc48_EquityAccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e69e789-190b-48c7-b7df-e1651f1546d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e69e789-190b-48c7-b7df-e1651f1546d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4d1384b6-537d-40eb-8ee3-0b3e87200f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4d1384b6-537d-40eb-8ee3-0b3e87200f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_673cddf8-b873-48b5-975a-c507ddcfc195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_673cddf8-b873-48b5-975a-c507ddcfc195" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_051b12f9-9d28-4590-8cbf-655e525ea954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_051b12f9-9d28-4590-8cbf-655e525ea954" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6dd1a99d-a237-4b63-91aa-c67c62822c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6dd1a99d-a237-4b63-91aa-c67c62822c48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8239fd6-1d09-428e-bed3-853740c16173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8239fd6-1d09-428e-bed3-853740c16173" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_110e4e56-5259-48d1-af4f-23674bea2ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8239fd6-1d09-428e-bed3-853740c16173" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_110e4e56-5259-48d1-af4f-23674bea2ab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_110e4e56-5259-48d1-af4f-23674bea2ab8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_110e4e56-5259-48d1-af4f-23674bea2ab8" xlink:to="loc_us-gaap_EquityComponentDomain_110e4e56-5259-48d1-af4f-23674bea2ab8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_110e4e56-5259-48d1-af4f-23674bea2ab8" xlink:to="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d7864ccd-5529-46d5-8197-5a16d99956ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d7864ccd-5529-46d5-8197-5a16d99956ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_a535e07b-01cc-4b97-94dd-ddcd1daac5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_a535e07b-01cc-4b97-94dd-ddcd1daac5f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ce89983f-fa36-4d98-b60c-753c9bd804ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ce89983f-fa36-4d98-b60c-753c9bd804ad" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>icui-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eb6bc161-64f3-45ef-8355-0537b049f0f7,g:1fc0d841-3e14-4a45-9a82-f075c6cb343a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_cb997425-8d51-4652-bfc0-96bc5f583ce8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_326b1104-2c51-4dda-999d-e039dbae0740_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_341b3d44-5f9e-4280-84e7-579339c3a2ee_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThan275To100Member_ee6b3355-e677-49d2-b31b-f65c1e53ae57_terseLabel_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthan2point75to1</link:label>
    <link:label id="lab_icui_LessThan275To100Member_label_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than 2.75 to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThan275To100Member_documentation_en-US" xlink:label="lab_icui_LessThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than 2.75:1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member" xlink:href="icui-20220331.xsd#icui_LessThan275To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThan275To100Member" xlink:to="lab_icui_LessThan275To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_5363eee7-4555-4f1f-86d7-c53304e3a9c8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedfreight_8f90d130-5f63-4d0d-859b-5ed395e58e42_terseLabel_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_label_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:label id="lab_icui_Accruedfreight_documentation_en-US" xlink:label="lab_icui_Accruedfreight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued freight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight" xlink:href="icui-20220331.xsd#icui_Accruedfreight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedfreight" xlink:to="lab_icui_Accruedfreight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_58663da1-a043-4689-9fda-a319dcda7afb_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e9ea39ab-ceb2-457c-a971-b301960316fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_191039bc-8f05-45b1-8714-8ab7e589fa0b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_90218b9f-661e-4887-b19d-f38695fb34dc_terseLabel_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_label_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:label id="lab_icui_TermLoanBPrincipalPayment_documentation_en-US" xlink:label="lab_icui_TermLoanBPrincipalPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B Principal Payment %</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBPrincipalPayment" xlink:href="icui-20220331.xsd#icui_TermLoanBPrincipalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBPrincipalPayment" xlink:to="lab_icui_TermLoanBPrincipalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8a969ad6-a34a-4b27-8471-9ff2474f88f5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0bed2269-95bf-443b-b556-df24dd355d65_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f0c9d29b-ca74-46f8-8ce5-f45397bb24d7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, outstanding shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InternationalDistributorMember_9bad943e-850c-401c-ad46-89187012a091_terseLabel_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_label_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:label id="lab_icui_InternationalDistributorMember_documentation_en-US" xlink:label="lab_icui_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember" xlink:href="icui-20220331.xsd#icui_InternationalDistributorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InternationalDistributorMember" xlink:to="lab_icui_InternationalDistributorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_607b212c-9f4e-4dc8-adc3-c61832542bd2_terseLabel_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</link:label>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</link:label>
    <link:label id="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_documentation_en-US" xlink:label="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">investments in Debt and Marketable Equity Securities and Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:href="icui-20220331.xsd#icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:to="lab_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_70595725-c843-4179-b3e5-14beafde0776_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f41259e0-fbb0-4101-8c99-92afa8f47a31_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f643f93c-8089-4a52-bd3d-a49c9832d198_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_da92ced5-cf20-4237-8f6b-c6b42eaef747_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_97618e6d-1a9f-4cc2-9ae3-b958a80bce7e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_48d1e9f0-966d-4eb7-b1be-0ff3901bcaa9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7d5c503c-1127-4e84-9906-05ecd6fa238e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_bdf4515a-d2c5-4b5d-a22c-fae69843a55a_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_80f0a0da-e0b7-4a23-a911-32a665ae3781_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of asset</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d9b2c741-fe6c-49bb-8836-eabf51071294_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_8cd00b9a-ba65-4a63-97ff-b99d30cf6e32_terseLabel_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_label_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:label id="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_documentation_en-US" xlink:label="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:href="icui-20220331.xsd#icui_TerSOFRInterestRateAdjustmentForBaseRateLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:to="lab_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_dec8374f-75a2-4286-9d30-6b4aa1f5d386_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_68736cc7-509d-4377-ae16-e4d91b324d9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2184e40a-6439-484e-ad50-0f64184c6d21_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_fe21421c-b050-44c1-99c1-f5fcecdac49a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_69debe9c-3fee-4ee5-8825-4580eb65e644_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_678b8486-820a-461f-aadd-a5dfa11ee796_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherCurrenciesMember_ec3bd462-d0e5-4e31-b169-79e5e90c0ee8_terseLabel_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies</link:label>
    <link:label id="lab_icui_OtherCurrenciesMember_label_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies [Member]</link:label>
    <link:label id="lab_icui_OtherCurrenciesMember_documentation_en-US" xlink:label="lab_icui_OtherCurrenciesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">other currencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember" xlink:href="icui-20220331.xsd#icui_OtherCurrenciesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherCurrenciesMember" xlink:to="lab_icui_OtherCurrenciesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_150e55dc-02d2-411c-ba62-7858fc712bc0_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_5cbd639d-de18-424b-b081-6ed2df96a78b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedAuditFees_0c949f45-fbc2-4912-a681-b98d2a5f7f72_terseLabel_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:label id="lab_icui_AccruedAuditFees_label_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:label id="lab_icui_AccruedAuditFees_documentation_en-US" xlink:label="lab_icui_AccruedAuditFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued audit fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedAuditFees" xlink:href="icui-20220331.xsd#icui_AccruedAuditFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedAuditFees" xlink:to="lab_icui_AccruedAuditFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_357933a8-75a2-4fc3-b692-eda45066897d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_33cfdc22-bd86-46ab-8331-6e9328a60593_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_7b6d9b4a-c496-4702-9855-812200a48348_terseLabel_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_label_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:label id="lab_icui_InterestRateSwapEndingNotionalValue_documentation_en-US" xlink:label="lab_icui_InterestRateSwapEndingNotionalValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap Ending Notional Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue" xlink:href="icui-20220331.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestRateSwapEndingNotionalValue" xlink:to="lab_icui_InterestRateSwapEndingNotionalValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d03271aa-d41b-4f9e-98d9-cb3090b77a80_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6b960400-81cc-419f-a9d2-c37a68b8c1bf_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2eb5d851-2de2-4a3d-96b7-1fe7969a3def_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_2ee522a3-f8a7-4139-8b0c-7dc4d6f10722_negatedTerseLabel_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_label_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:label id="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_documentation_en-US" xlink:label="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:href="icui-20220331.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:to="lab_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_843e0557-71c5-4f47-a506-a26f15252b67_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_7e92bbb5-5ed7-4dff-8922-0ad8b013c39b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SoftwarerevenueMember_727f8853-b8ec-4276-98b0-9e3d3c442a4c_terseLabel_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_label_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:label id="lab_icui_SoftwarerevenueMember_documentation_en-US" xlink:label="lab_icui_SoftwarerevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember" xlink:href="icui-20220331.xsd#icui_SoftwarerevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SoftwarerevenueMember" xlink:to="lab_icui_SoftwarerevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_399d5102-b18c-42fb-85a8-9f369593ef0b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_913fb95b-6e35-4a13-abaf-43d44ec9608b_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incentive compensation</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_85b4edaf-57c6-4131-832b-0b9eaed8876b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_5fb1bff1-8815-4dd1-b6e3-52f016d97011_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_418d1329-990f-412d-ad42-9b22d61f8979_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_792a8aad-a007-4b69-adf0-0cc8f35da9f6_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_cde75f55-74cb-4169-ae13-192998ea4233_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionContingentConsiderationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0dc7d335-696b-487c-bea5-f9584f8165c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_9d0f4578-b5ff-423f-849c-8d591749fce0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b6907033-32a1-4f81-824a-f6e73f903b2d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_65f450fe-105f-4b5d-878b-3ff9c1c2f768_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_ce26bcc8-ee1f-4940-9325-7ffee77be7a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_b7c7fdac-8a2e-4cad-b03f-3fb9de439a75_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_92efc9e7-9917-40e2-becc-cdf8d3c967ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_e0904ad2-ed0c-4b19-816f-e32de316a216_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_88d89fdf-1927-4756-9b85-a2eb5535946c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b3e013f6-2db7-45ab-b665-1377bdea5399_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_26d3dbab-4f7c-4aa0-9e1e-27cf5d91c1d6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_aadf87c5-68e1-4c52-a58e-a712c2bd76ed_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_018d3539-c294-4782-92c3-8955ea90744e_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_43a21d92-a6c6-4091-9130-497606436981_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_e057d5c6-476c-4198-bcab-1615664b8a12_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1c58164a-373b-4e54-b336-e73e28f6520c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_16b33638-40a2-4fb9-b4fd-d6972aa9a4db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0566e8ca-4bf2-45dc-a042-547ba564e634_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Deferredtaxcharge_237de909-8d4e-4502-a577-2c41ecdeb35d_terseLabel_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_label_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:label id="lab_icui_Deferredtaxcharge_documentation_en-US" xlink:label="lab_icui_Deferredtaxcharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge" xlink:href="icui-20220331.xsd#icui_Deferredtaxcharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Deferredtaxcharge" xlink:to="lab_icui_Deferredtaxcharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_cccbac3b-4451-4366-a0fb-dc444e709aeb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2c32165e-0b76-4b66-bc28-d5853a8266a2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9e33f101-7404-46cb-b93c-636cf6bb1fdc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_61ce44c5-8530-4205-8176-7c2fcfff959b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_eb8cb8df-2032-42cf-9a7e-9fb2ffcdb5d5_terseLabel_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_label_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToBaseRate_documentation_en-US" xlink:label="lab_icui_InterestPercentageAddedToBaseRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Base Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToBaseRate" xlink:href="icui-20220331.xsd#icui_InterestPercentageAddedToBaseRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestPercentageAddedToBaseRate" xlink:to="lab_icui_InterestPercentageAddedToBaseRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_494e02ae-56cb-4be6-81af-b264f0ef4836_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_50a1c865-cb44-488f-b1c0-ff48ae77dc36_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ba529389-dcdc-408c-9d1f-a1051783d4ce_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b99b7465-e801-4ab7-bba4-432f9932ddde_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_983ab8db-2617-4b8e-ad72-688b6414602b_terseLabel_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_label_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:label id="lab_icui_TreasuryStockPurchasePlan_documentation_en-US" xlink:label="lab_icui_TreasuryStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TreasuryStockPurchasePlan" xlink:href="icui-20220331.xsd#icui_TreasuryStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TreasuryStockPurchasePlan" xlink:to="lab_icui_TreasuryStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b350caf3-14b4-49d5-964a-eb7524562ffc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_fdf5e0ec-78f9-4755-98e3-7443f148182b_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequal3to1butgreaterthan2point5to1</link:label>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal 3.00 to 1.00 but greater than 2.50to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal 3.00 to 1.00 but greater than 2.50to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:href="icui-20220331.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:to="lab_icui_LessThanOrEqual300To100ButGreaterThan250to100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Restructuringandstrategictransaction_9c4375b4-af34-4197-a0d4-38f945d006ff_terseLabel_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransaction_label_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction</link:label>
    <link:label id="lab_icui_Restructuringandstrategictransaction_documentation_en-US" xlink:label="lab_icui_Restructuringandstrategictransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and strategic transaction expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction" xlink:href="icui-20220331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Restructuringandstrategictransaction" xlink:to="lab_icui_Restructuringandstrategictransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_88982fc7-b009-41a5-8072-ce23ca86c053_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies [Text Block]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_766bfddf-99a5-42a9-be31-b15f44877407_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_98ea3b34-fc5f-45d9-a682-6fa25048be0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EarnoutliabilityMember_346a8b52-6b6f-4987-b91b-2258bf07dfa9_terseLabel_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_label_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:label id="lab_icui_EarnoutliabilityMember_documentation_en-US" xlink:label="lab_icui_EarnoutliabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember" xlink:href="icui-20220331.xsd#icui_EarnoutliabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EarnoutliabilityMember" xlink:to="lab_icui_EarnoutliabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_4a7044d4-a51d-4659-893f-38c4daecf203_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9132dae1-911c-4fbd-a005-29bf91b483b4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_f8ee8095-1d03-4184-a8bc-044b86338d6a_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d4f5e04e-62cb-434b-9812-603b65915f7d_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_7f9b939c-9080-4759-8ecd-fd3a98901bc2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_090c832e-03ee-4a31-a1bf-acc1e42ab8eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d2e9c979-5c95-41d0-84b2-27d41b0c8d3c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_9baf3c69-5e68-4893-8b5e-3b3d2a496e5e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_36974455-7be9-4719-b946-911f48ea058d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_CZK_c4417bb1-2d9e-4cab-90b1-267f9c7e72a5_terseLabel_en-US" xlink:label="lab_currency_CZK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Czech Republic, Koruny</link:label>
    <link:label id="lab_currency_CZK_label_en-US" xlink:label="lab_currency_CZK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Czech Republic, Koruny</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CZK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_CZK" xlink:to="lab_currency_CZK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6ffdede3-49e6-4e40-8a57-5ca86adee57b_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_3ed13f28-c9a6-4ebf-b93e-c266cdf84cdd_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_951dea47-8a46-4188-92a8-e0d46c48f096_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cabe700c-efc1-45da-99d2-aa8fb3a8f6aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_329719a7-08a8-401f-97c7-c3d75528a93d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_51e536a8-135c-41d0-b2b3-26643492eea0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_5e45d754-5d94-4433-9a2f-9ac78b5865b8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_aedd3c60-12cd-44ca-93e3-87bb6abf3d07_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_8aa493a4-8d57-4cd6-bfa6-7b9768d592ac_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_dc9f6497-8c05-4558-9393-1c750233885a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_917be0d3-6041-4922-b8b3-a85a9233c5cd_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EPS - basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_6459a509-b651-48b2-9e13-ffe74815f55e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Other Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8eab1983-6971-49ee-8aba-04f2f676fda9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_2b02e051-a7aa-4397-b64c-ec6a928c5a6c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Outsidesalescommissions_91007dcb-8fe3-47fc-bf5f-ee7c398e5b18_terseLabel_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Fees</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_label_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:label id="lab_icui_Outsidesalescommissions_documentation_en-US" xlink:label="lab_icui_Outsidesalescommissions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside sales commissions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions" xlink:href="icui-20220331.xsd#icui_Outsidesalescommissions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Outsidesalescommissions" xlink:to="lab_icui_Outsidesalescommissions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_7fe100de-7c1a-4a93-95aa-0232a3fad65e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_1df13dc4-55ce-4276-8a70-c28d2c4b223a_terseLabel_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_label_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued_documentation_en-US" xlink:label="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Acquisition Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:href="icui-20220331.xsd#icui_SmithsGroupOwnershipAcquisitionSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:to="lab_icui_SmithsGroupOwnershipAcquisitionSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_d862b519-aa69-417c-b73a-c37e98141530_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTINGENT EARN-OUT LIABILITY</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_92504c59-3ce0-495d-9605-894ea603a632_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_000f32bd-ea42-4a2d-a46c-b1566231532d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_56024c07-4957-4f34-a489-ac6d2821488b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_7eae0ed9-5c72-45d3-afb1-669b2a982ded_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_3a369b08-5fcc-47f7-a669-389179503f44_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_97659aa2-b113-4897-8288-9c24f2f932a3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0d447db5-c612-4e8c-97bd-d17c6e10b9f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_05b9af42-1957-4cab-abf1-85275dad26ef_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_4668ae7b-2ddc-40f5-8f82-ae23a8fb5805_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_47079df2-ce7f-4c40-a897-f8b511c10de6_terseLabel_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonfinancial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_NonfinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanBMember_275153ea-e994-4e64-8bf6-0092339c29f9_terseLabel_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:label id="lab_icui_TermLoanBMember_label_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B [Member]</link:label>
    <link:label id="lab_icui_TermLoanBMember_documentation_en-US" xlink:label="lab_icui_TermLoanBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanBMember" xlink:to="lab_icui_TermLoanBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b573c8f8-3999-413c-9323-49b5f8cf5ecc_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_23506219-3911-4340-ac1b-a9cb9077ac3a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_64753c58-e35a-4425-b690-754614724af1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionConsumablesMember_c733e4e6-d206-4690-a2d5-628274f21c3a_terseLabel_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_label_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesMember_documentation_en-US" xlink:label="lab_icui_InfusionConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember" xlink:href="icui-20220331.xsd#icui_InfusionConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionConsumablesMember" xlink:to="lab_icui_InfusionConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_5471fedf-34f4-4e1c-860e-b920f263d246_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_8559ebd4-cba4-4e0f-8c0d-d84a11e9b5fa_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_3472d0db-d8e7-434a-ae0c-d307127460cc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c0c75e6b-5dd7-4b7f-b7c5-a3259468b665_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_d96e8cac-fad3-42a1-ae02-2ea0583c4742_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_90dd2e4b-ea74-45b8-8944-d220acbe63f0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_d4c40fd2-c9f6-42b7-aed1-bc2463acdb0c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_8db64db8-d48d-4f38-b0c0-ddec27aebf28_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c8e55374-006e-4228-a598-b131948c7f7f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_cce3a2dc-3ff5-454c-bec1-5f2f6042bcab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherDeferredRevenueMember_ac19da11-6071-4492-9f28-cbd3cdbaa237_terseLabel_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:label id="lab_icui_OtherDeferredRevenueMember_label_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue [Member]</link:label>
    <link:label id="lab_icui_OtherDeferredRevenueMember_documentation_en-US" xlink:label="lab_icui_OtherDeferredRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other deferred revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember" xlink:href="icui-20220331.xsd#icui_OtherDeferredRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherDeferredRevenueMember" xlink:to="lab_icui_OtherDeferredRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_a5814243-7565-423c-be40-9e426efd1d9b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_a1691216-aa4f-4e75-8043-5509bd86444b_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_eb8ae80d-b183-47ac-b863-97a314c9f970_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_7795a907-fbd3-4e4e-9e56-4a376e665ba8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAbstract_43f244b6-bcc9-4fe5-b1c8-70d808d02bbe_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash [Abstract]</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAbstract_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4980c0b6-c6a6-4abe-ac89-cd61d607f03f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_8b301118-b7a7-4b3c-a61d-6ebf0696fdeb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_57c3fae1-9646-4382-9829-dbe9dbea58d9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_995086bf-4bd5-42b9-8a03-327a565194f9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b47be058-1b1d-43c5-9c55-f72d614e5efe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_b087e77f-8d5f-44ca-995d-03cef8485526_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_429ac850-9f4e-4d43-9dc7-a5ba93782d54_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_7006650e-6e9d-4329-adae-b50858a1ecd7_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_c19ed37d-9c92-42ff-b1c2-2adde553bc26_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_2b5221a6-ae1a-4617-9306-b2af13d9843c_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_label_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:label id="lab_icui_BusinessCombinationGoodwillNonDeductible_documentation_en-US" xlink:label="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, goodwill- non deductible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible" xlink:href="icui-20220331.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationGoodwillNonDeductible" xlink:to="lab_icui_BusinessCombinationGoodwillNonDeductible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_ea67b048-aa40-412a-842d-c9821c35c19f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_45d6542d-eb74-469d-8f0b-92f52455a417_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f24c420f-1e04-4a71-a399-d484c28a5ba7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_StrategicTransactionandIntegration_e9d36b80-d5ec-490e-a11b-e252b5ab7c26_terseLabel_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_label_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:label id="lab_icui_StrategicTransactionandIntegration_documentation_en-US" xlink:label="lab_icui_StrategicTransactionandIntegration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Transaction and Integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration" xlink:href="icui-20220331.xsd#icui_StrategicTransactionandIntegration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_StrategicTransactionandIntegration" xlink:to="lab_icui_StrategicTransactionandIntegration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_52f5966c-af83-435b-acdc-51dd8bb2dec3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_6ebfa99a-ae70-4f9f-994f-064e15fda9ad_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_57f8e616-49b1-4e22-a601-51f033aa8ba7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_937a30b1-22d9-47d2-8599-0e1fe1999f07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_cc90e220-44e4-4625-98d4-4141820567b3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_7dcd68ff-df0b-4084-8b6e-25a0bb320f7f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d9d3350a-4dd7-4045-a1ff-3497322e06d3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_581feead-15a4-4ba4-9928-8e729f7cc226_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_c34e7e2d-29c3-4043-8dec-2929bcde69ed_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5778d371-c340-44bc-9b00-07badafcccc1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_5dd4c71c-ee44-4516-8db0-3ed6f29e5a2c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_a4426cef-36a2-41a4-966b-e9f7dfcafc42_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cf84484b-0747-4c65-b34a-06e23f7fa440_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_668ced6f-1a97-4859-9d7f-e78b2b648a3b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_06272a42-77c0-46ed-85b6-c8e6b7e71dcb_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentDomain_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain" xlink:to="lab_us-gaap_NonrecurringAdjustmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_db8d3e84-f15c-4375-9cbd-2d1194d82cf4_terseLabel_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets [Text Block]</link:label>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_label_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets [Text Block]</link:label>
    <link:label id="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_documentation_en-US" xlink:label="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids, other current assets and other noncurrent assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:href="icui-20220331.xsd#icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:to="lab_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_3ccae34f-7482-47ba-9e7c-3ce26794d343_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentRelatedPartyLoans_b61c2253-bf9c-4c0f-8b49-61cd89d86ff6_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Related Party Loans</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentRelatedPartyLoans_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Related Party Loans</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentRelatedPartyLoans_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Related Party Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentRelatedPartyLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:to="lab_icui_ProFormaAdjustmentRelatedPartyLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongtermInvestmentsDomain_f03f5071-2261-48cc-8229-378e24e7a9c0_terseLabel_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:label id="lab_icui_LongtermInvestmentsDomain_label_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:label id="lab_icui_LongtermInvestmentsDomain_documentation_en-US" xlink:label="lab_icui_LongtermInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain" xlink:href="icui-20220331.xsd#icui_LongtermInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongtermInvestmentsDomain" xlink:to="lab_icui_LongtermInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ShortTermMember_b40cd2a6-1b7c-48c7-8414-648ab72d3723_terseLabel_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term</link:label>
    <link:label id="lab_icui_ShortTermMember_label_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term [Member]</link:label>
    <link:label id="lab_icui_ShortTermMember_documentation_en-US" xlink:label="lab_icui_ShortTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember" xlink:href="icui-20220331.xsd#icui_ShortTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ShortTermMember" xlink:to="lab_icui_ShortTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_c5007ef0-c334-4323-b1cc-4700ce0567ce_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f65be315-5adb-42ed-b8e8-f9f5206d850c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_b6783338-dfe9-4a59-a31a-534ad1931d80_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_886db3df-da92-4abe-96cd-1ecf1794c2eb_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_cd14d113-fbd1-4936-8b80-83726985c318_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, authorized shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_7e86d312-12fc-459b-a51c-b96da5a0f637_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_label_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:label id="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount_documentation_en-US" xlink:label="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Calculation Ceiling Subtracted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:href="icui-20220331.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:to="lab_icui_LeverageRatioCalculationCeilingSubtractedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1a1adaab-670a-4a7e-a136-aa32c1196afe_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_46e88154-ade5-4f16-8868-d172d913f02c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:to="lab_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_ec492464-abd5-4df6-8ab5-a99f1cc16d58_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsCurrent" xlink:to="lab_us-gaap_DerivativeAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fbab81da-9bcd-406d-969b-1d8ee72908e2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OtherforeigncountriesMember_824a961b-b66e-408e-9cdb-55f0f62cdf17_terseLabel_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_label_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_icui_OtherforeigncountriesMember_documentation_en-US" xlink:label="lab_icui_OtherforeigncountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember" xlink:href="icui-20220331.xsd#icui_OtherforeigncountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OtherforeigncountriesMember" xlink:to="lab_icui_OtherforeigncountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_3ce9d75f-7222-4f76-b3b0-d43dc3519c41_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_6c37dda4-7127-4fad-8960-775aca91877e_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_ff217b44-6beb-4b30-9678-00aacc824210_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentAmortization_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentAmortization" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentAmortization" xlink:to="lab_icui_ProFormaAdjustmentAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_60f242ec-b37e-4792-9cb8-412a86cdb26c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AvailableforsaleDebtSecurityCurrentMember_bb88a187-1b4c-4208-93ff-a62ad4709ed6_terseLabel_en-US" xlink:label="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Debt Security Current [Member]</link:label>
    <link:label id="lab_icui_AvailableforsaleDebtSecurityCurrentMember_label_en-US" xlink:label="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Debt Security Current [Member]</link:label>
    <link:label id="lab_icui_AvailableforsaleDebtSecurityCurrentMember_documentation_en-US" xlink:label="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Debt Security Current [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:href="icui-20220331.xsd#icui_AvailableforsaleDebtSecurityCurrentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:to="lab_icui_AvailableforsaleDebtSecurityCurrentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_102e597d-9dd1-47f5-9ca7-45c270c04314_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_14d361c1-3efe-4ba5-970d-186b46562fae_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GreaterThan275To100Member_cab121cf-7235-400f-8646-5b4ae6b4ce59_terseLabel_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan2point75to1</link:label>
    <link:label id="lab_icui_GreaterThan275To100Member_label_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greater than 2.75 to1.00 [Member]</link:label>
    <link:label id="lab_icui_GreaterThan275To100Member_documentation_en-US" xlink:label="lab_icui_GreaterThan275To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greater than 2.75 to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member" xlink:href="icui-20220331.xsd#icui_GreaterThan275To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GreaterThan275To100Member" xlink:to="lab_icui_GreaterThan275To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_c2026c39-5986-4013-a396-d06fd1398893_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b70e4a5f-2248-4fe6-9b31-f0d3ec904387_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_cb6ad181-9a0a-46ce-99dc-4f425980113d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_9af588e3-1c92-4b87-8cd9-1ff7bf8b76c1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2433f01c-8d94-4302-be7b-708f09db0f4e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_e7eab03f-806b-4340-8e61-8f19b86bdf15_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CriticalCareMember_f1fa9070-a827-4222-8a8e-9e3b4ac4cf57_terseLabel_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_icui_CriticalCareMember_label_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:label id="lab_icui_CriticalCareMember_documentation_en-US" xlink:label="lab_icui_CriticalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Critical Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember" xlink:href="icui-20220331.xsd#icui_CriticalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CriticalCareMember" xlink:to="lab_icui_CriticalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_79e431c3-159e-46de-a6f3-e5886a040225_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_18c974f1-7795-40e3-8348-d21edc1db369_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_0820e575-cc99-41a9-97b3-58df6a063ea9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_31bbd0e1-dd7d-46d4-9e2c-9bd980541592_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_8601ff5b-8077-4e3e-a4f8-92f585171017_terseLabel_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:label id="lab_us-gaap_NonrecurringAdjustmentAxis_label_en-US" xlink:label="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring Adjustment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis" xlink:to="lab_us-gaap_NonrecurringAdjustmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_0661f3ec-cc8b-4b85-81d6-82a116b9a8e3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationDomain_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f3876b8a-c12a-4729-9b44-ffa53ac70e29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MeasurementInputMarketPriceofRiskDomain_98d1ae08-b7a5-4b57-bb97-23628e015087_terseLabel_en-US" xlink:label="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Price of Risk [Domain]</link:label>
    <link:label id="lab_icui_MeasurementInputMarketPriceofRiskDomain_label_en-US" xlink:label="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Price of Risk [Domain]</link:label>
    <link:label id="lab_icui_MeasurementInputMarketPriceofRiskDomain_documentation_en-US" xlink:label="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Price of Risk [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementInputMarketPriceofRiskDomain" xlink:href="icui-20220331.xsd#icui_MeasurementInputMarketPriceofRiskDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MeasurementInputMarketPriceofRiskDomain" xlink:to="lab_icui_MeasurementInputMarketPriceofRiskDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_626d3b4e-6dad-4ff3-96bd-b0706e53fca5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories [Text Block]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d1cc31fa-362e-4173-8d7f-f93f2b6b7943_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_6686d1e3-5665-45bf-9662-b9e9a5b22b05_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentFirst2Years_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A principal payment % First 2 Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentFirst2Years" xlink:href="icui-20220331.xsd#icui_TermAPrincipalPaymentFirst2Years"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentFirst2Years" xlink:to="lab_icui_TermAPrincipalPaymentFirst2Years" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_544608b0-bb86-44c6-b622-767a5598463a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_bdc2dc77-0f41-4df1-9728-2b1d55cc1e16_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioLevelDomain_ef6d1099-0f16-4186-a8f6-ace92c358790_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelDomain_label_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelDomain_documentation_en-US" xlink:label="lab_icui_LeverageRatioLevelDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain" xlink:href="icui-20220331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioLevelDomain" xlink:to="lab_icui_LeverageRatioLevelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_70759485-dfb6-40ce-ab46-b1712e668dcf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_ad08b411-e558-439a-aa53-47db3679bce6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ec4bad43-632d-42ba-bce2-4ad3dce71e7a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_481ad0d5-e733-4e7d-9593-63ac906c856f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,897 shares at March 31,2022 and 21,280 shares at December 31, 2021 and outstanding 23,884 shares at March 31, 2022 and 21,280 shares at December 31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_64ca1de7-39e7-4bbe-906c-fe391613287b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ba3d183a-2c5e-4789-9abb-b7650ae8f8fe_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_9b5cd2dd-8e2e-4a8f-8ab7-2f40c912fdb9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_d23fb6f5-5d68-48e8-9f7c-26515cfd9ba2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bond premium amortization</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeAmortizationOfPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Amortization of Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:to="lab_us-gaap_InvestmentIncomeAmortizationOfPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9d233fc1-9746-4adb-a824-44afcc2537c9_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME (EXPENSE), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_ea14848a-d33d-4d47-a670-360a0155b229_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_134070f3-d7bc-415c-bec0-b8c7b42a642c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2ded688e-cad0-4df7-b59a-6511e705977a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1c057c64-d659-4068-be13-a8a505372719_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_cf05cd14-bd0d-484c-8269-b9ad94aa450a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_bcf21d17-c0d6-4fc5-9e7e-954d00e08413_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_86b134b9-6b63-4897-93ea-92e6e3f6237e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositAssets_1dabe9ce-3e73-4c94-aa21-38e23554b864_terseLabel_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:label id="lab_us-gaap_DepositAssets_label_en-US" xlink:label="lab_us-gaap_DepositAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositAssets" xlink:to="lab_us-gaap_DepositAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_8eed73f7-89cf-4c9d-85e5-f92940138e37_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAX LIABILITY</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b4b93a6e-7229-4ae6-a7a7-ca157f1f1166_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_VitalCareMember_d60a4627-f165-431f-81a8-267436e00d56_terseLabel_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care</link:label>
    <link:label id="lab_icui_VitalCareMember_label_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care [Member]</link:label>
    <link:label id="lab_icui_VitalCareMember_documentation_en-US" xlink:label="lab_icui_VitalCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vital Care</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember" xlink:href="icui-20220331.xsd#icui_VitalCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_VitalCareMember" xlink:to="lab_icui_VitalCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_3b288aca-ffd3-4526-a193-04d9f539beca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_45365a3f-7b7d-43c8-ad5a-084bf3e31d72_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_b1c9e864-49f4-40dd-a829-9e840e67f9c3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_3608a594-a311-4484-8a06-5f4a0423ff3e_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTable_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_092b002f-0bbb-43c1-9222-93c4bade059c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge3MemberMember_325a626c-969e-4b24-bf43-68c083c7252a_terseLabel_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member] [Member]</link:label>
    <link:label id="lab_icui_Hedge3MemberMember_label_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member] [Member]</link:label>
    <link:label id="lab_icui_Hedge3MemberMember_documentation_en-US" xlink:label="lab_icui_Hedge3MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember" xlink:href="icui-20220331.xsd#icui_Hedge3MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge3MemberMember" xlink:to="lab_icui_Hedge3MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_383103ac-fe3a-4c62-bdc9-df18c1a6aba4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent[TableTextBlock]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_829cf353-2926-48a7-9077-21a36ea76e39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_175389b0-0de9-4eed-9d7c-c0605a69e309_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_e6b7906f-230e-409f-b3e8-5ed68de3b318_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0e05684a-efcb-4df8-93f3-7fffd15c1857_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive securities</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_a6fd7dd0-816e-4900-83da-55901e1010ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4169f046-5cfe-42ec-b556-0c04c3f0562a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_58c48c4f-eba9-4ce1-9168-b1f14e5c36f0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_084528f0-f03a-4bdc-b0a9-9c0ffd06a03c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_c063d506-1501-44f6-9513-333e6d22ee19_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionRelatedCostsMember_label_en-US" xlink:label="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionRelatedCostsMember" xlink:to="lab_us-gaap_AcquisitionRelatedCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_f4370da8-ae6c-40f7-ab76-8ccefa3b3935_terseLabel_en-US" xlink:label="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired during period</link:label>
    <link:label id="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_label_en-US" xlink:label="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired during period - All acquisitions</link:label>
    <link:label id="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_documentation_en-US" xlink:label="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, acquired during period - All acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:href="icui-20220331.xsd#icui_GoodwillAcquiredDuringPeriodAllAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:to="lab_icui_GoodwillAcquiredDuringPeriodAllAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_6ddc1322-f04d-43ba-b356-fcd36293d0cb_terseLabel_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_LandBuildingsAndImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandBuildingsAndImprovementsMember" xlink:to="lab_us-gaap_LandBuildingsAndImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_38d20ff3-a5e0-49ac-b11b-beb05c405dc2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_76fe8170-9a9f-46bd-80a7-46f94c02c0d4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsMedicalMember_602f3d5f-89d9-41cc-830c-addc78a87bcb_terseLabel_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_label_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical [Member]</link:label>
    <link:label id="lab_icui_SmithsMedicalMember_documentation_en-US" xlink:label="lab_icui_SmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SmithsMedical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsMedicalMember" xlink:to="lab_icui_SmithsMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_0086dc8e-33ac-4863-9c90-08a74549bdda_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cd5cc99b-c4dc-4f25-a58a-ed6a021ec0d2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Contingentconsiderationgross_1452d0f9-d8ae-4fdd-af78-790c98de8fd4_terseLabel_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_label_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:label id="lab_icui_Contingentconsiderationgross_documentation_en-US" xlink:label="lab_icui_Contingentconsiderationgross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contingent consideration gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross" xlink:href="icui-20220331.xsd#icui_Contingentconsiderationgross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Contingentconsiderationgross" xlink:to="lab_icui_Contingentconsiderationgross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_71b7c09f-62f5-4539-81ce-05446d3bc318_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_9be1543c-7aed-4257-b5f4-0b1031cd0e82_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_413799f3-f6aa-436a-916b-18a24cff45e3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6d611228-bcda-4aba-aa1a-a1941e8d435d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_bf26bae0-4784-4492-ba37-4d064a4c431d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3db06cc9-b411-436c-a5fe-c959fb0ce237_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_b6e229c9-c362-41b2-873d-22d943cc1aa2_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_label_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginTermSOFRLoans_documentation_en-US" xlink:label="lab_icui_ApplicableMarginTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Term SOFR Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans" xlink:href="icui-20220331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginTermSOFRLoans" xlink:to="lab_icui_ApplicableMarginTermSOFRLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_88067011-bba0-4e56-849f-f7c19884068b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_62ced25d-6e04-4bc8-95c8-fc81de89f1fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_25ef4260-b695-4d69-aa2b-c6662921fbbd_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_52a46ee7-c5ec-49b9-af1e-70da8ae3a39b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_3651819f-6fb1-4b73-9320-e73be7e061b5_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_adf47f03-3e59-4b26-949d-1369a711c233_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c877a964-d68e-41b5-8794-345bdd6b44f0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_c9d9ceda-5d59-4fac-8fb0-be8a74692386_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d95840a7-acd5-477e-88ec-ddabfea3d6a9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_1f2b5491-a30c-43a4-be3e-cf1a0df463fa_terseLabel_en-US" xlink:label="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_label_en-US" xlink:label="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:to="lab_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_c4059c3b-a2ee-4a80-9c21-77d04d85d36c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent</link:label>
    <link:label id="lab_us-gaap_AccruedRentCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedRentCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a3008d0a-1ab5-42c0-83f8-25196af9e536_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a815d46d-3d67-41be-9d64-d20e6e98740c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_19731cbe-a8ad-4144-a20d-ba329dbec0c8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_95e6d57c-50ee-44c0-bd84-2a7b5d33d275_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_22682a20-c0cb-4b43-b128-05e8dca0c0eb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_36addacf-bdec-40dc-ae74-aa49a0b02669_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_602be7f5-0e2b-4c49-bfd1-1aecdf22d844_terseLabel_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_label_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in income taxes, including excess tax benefits and deferred income taxes</link:label>
    <link:label id="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_documentation_en-US" xlink:label="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:href="icui-20220331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:to="lab_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d6ee5cfe-5522-47bf-9ed2-5ff9094cc8bc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ed12fba7-5b30-4199-beee-92bacd21e0cb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_2fc3af17-86f4-48f7-8dbe-4978b4199377_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_d8c46185-6dac-4805-b5e7-497f37a22c04_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3a2e8b47-f855-490a-b796-5d28f9eecced_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e94ee0c2-f5ba-48d3-b4b2-fe447982aaf1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c563473a-e94f-48d8-888b-7b47779808fd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_b79567d9-6cf2-4d17-b60b-06c850445c73_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_9e405825-9dbf-4427-ae5d-0210650773ef_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_5bf1b9b0-5003-464c-8e99-ad318d2095f6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_71ba0d1c-2e0d-4e54-940f-baad83e19652_terseLabel_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_label_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:label id="lab_icui_InterestPercentageAddedToFederalFundsRate_documentation_en-US" xlink:label="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Percentage Added to Federal Funds Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToFederalFundsRate" xlink:href="icui-20220331.xsd#icui_InterestPercentageAddedToFederalFundsRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestPercentageAddedToFederalFundsRate" xlink:to="lab_icui_InterestPercentageAddedToFederalFundsRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_7ae5f48b-9418-4cc4-8ecd-230efc1eb7c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_6f29a081-5109-46be-8e50-80f400e58bb1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_13c24b58-b05e-453e-9419-20ba3db4a653_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_81125cd2-57ca-4963-9463-f0ad7cbe7831_terseLabel_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_label_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:label id="lab_icui_Restructuringstrategictransactionandintegration_documentation_en-US" xlink:label="lab_icui_Restructuringstrategictransactionandintegration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, strategic transaction and integration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringstrategictransactionandintegration" xlink:href="icui-20220331.xsd#icui_Restructuringstrategictransactionandintegration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Restructuringstrategictransactionandintegration" xlink:to="lab_icui_Restructuringstrategictransactionandintegration" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_df46361f-c681-494d-8230-4af17fcf3c4f_terseLabel_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Axis]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_label_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Axis]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisAxis_documentation_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis" xlink:href="icui-20220331.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis" xlink:to="lab_icui_Srt_MultipleCurrencyAxisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_04759a15-6eb8-4de7-83fe-04df2da11334_terseLabel_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_label_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:label id="lab_icui_TotalSeniorSecuredCreditFacility_documentation_en-US" xlink:label="lab_icui_TotalSeniorSecuredCreditFacility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TotalSeniorSecuredCreditFacility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility" xlink:href="icui-20220331.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TotalSeniorSecuredCreditFacility" xlink:to="lab_icui_TotalSeniorSecuredCreditFacility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dcd744ea-d46b-48dc-9bd3-7e0004281ee7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_c01e55fb-cd20-4192-9b41-f88f29cfd1fc_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FacilityClosingMember_562f52fe-6e8d-4ed9-ac6d-2b691004a35c_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember" xlink:to="lab_us-gaap_FacilityClosingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_83b1f442-aaf4-492c-a399-21e6cb7518e5_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_IVSolutionsMember_0297b821-412a-4f4e-b084-68a0aaca85ca_terseLabel_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:label id="lab_icui_IVSolutionsMember_label_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:label id="lab_icui_IVSolutionsMember_documentation_en-US" xlink:label="lab_icui_IVSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IV Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember" xlink:href="icui-20220331.xsd#icui_IVSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_IVSolutionsMember" xlink:to="lab_icui_IVSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_f5f84f1e-8127-4bdc-9534-a874b239520d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_PursuitVascularInc.Member_aebe8854-9db4-4aea-ba95-eb6dac92c046_terseLabel_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_label_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member]</link:label>
    <link:label id="lab_icui_PursuitVascularInc.Member_documentation_en-US" xlink:label="lab_icui_PursuitVascularInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pursuit Vascular, Inc. [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_PursuitVascularInc.Member" xlink:to="lab_icui_PursuitVascularInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_ddab8307-0e64-4691-a1be-f02b4b2e757c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0fece0e1-3bed-4a28-a508-82e377403bd8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_af1820e0-6ac7-49fb-bdd1-77631913ed27_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a60ba97d-3d84-44f3-a3a8-9a9391c97866_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_af813961-ed21-4f81-a2c3-aa933af77eb5_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_f01b0876-40d9-457a-9851-f29204a54a4d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e6695052-95ad-44b3-8c8f-c7c2f978bf1d_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_4a363475-d78d-4e33-b336-af1c7ec20ee6_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8ffedf55-2504-48b2-9e44-e4891e927ead_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_40434dac-72cd-40f2-9c1d-992340612c5a_terseLabel_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_label_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:label id="lab_icui_AmortizationOfInventoryStepUp_documentation_en-US" xlink:label="lab_icui_AmortizationOfInventoryStepUp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Inventory Step-up</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp" xlink:href="icui-20220331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AmortizationOfInventoryStepUp" xlink:to="lab_icui_AmortizationOfInventoryStepUp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_979b2e42-deee-41bc-8e2a-1e20d8c60ea9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, issued shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_40872458-01c7-4dbd-b193-6b2d1dddb737_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualComponentAmount_b4e45ac4-53f7-4dbc-8363-48ffd34ab948_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Component Amount</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualComponentAmount_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Component Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:to="lab_us-gaap_ProductLiabilityAccrualComponentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ecbed1c0-738e-476f-a150-b7468db27136_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5e120627-8266-4a52-8e6e-d8d59fe57011_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4bc345a6-c8d4-4e2e-a339-7f2dbbc6612f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_b3373df8-5313-4d0e-aba5-0a1a00423538_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequalto2to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.00 to 1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo200To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo200To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.00 to 1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo200To100Member" xlink:to="lab_icui_LessThanOrEqualTo200To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_6e05c29c-dc1e-4ccf-b39f-ae97e3e8362e_terseLabel_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_label_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:label id="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_documentation_en-US" xlink:label="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:href="icui-20220331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:to="lab_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_076696d0-26d4-43b9-b78f-38c539672988_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TimingAxis_7b3dc1a8-519d-445b-be27-b927e3853050_terseLabel_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Axis]</link:label>
    <link:label id="lab_icui_TimingAxis_label_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Axis]</link:label>
    <link:label id="lab_icui_TimingAxis_documentation_en-US" xlink:label="lab_icui_TimingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis" xlink:href="icui-20220331.xsd#icui_TimingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TimingAxis" xlink:to="lab_icui_TimingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_942d8fb0-cd0f-4f8a-acfa-9d1f1b9c19d3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Optiontoextendinyears_a386656e-2f12-4dfb-97e7-c56710421571_terseLabel_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_label_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:label id="lab_icui_Optiontoextendinyears_documentation_en-US" xlink:label="lab_icui_Optiontoextendinyears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Optiontoextendinyears</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears" xlink:href="icui-20220331.xsd#icui_Optiontoextendinyears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Optiontoextendinyears" xlink:to="lab_icui_Optiontoextendinyears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d91e0e64-13d2-469c-8021-af484b9ff4a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d04eae26-75c0-4a3b-a6d1-dab5991876fc_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NON-CASH INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeMember_cc401eee-dc81-47f0-a44e-34a10ba88194_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeMember" xlink:to="lab_us-gaap_ForeignExchangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CommonStockSharesMember_915d195c-a420-4c89-b14f-ee08b9baaad4_terseLabel_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_label_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:label id="lab_icui_CommonStockSharesMember_documentation_en-US" xlink:label="lab_icui_CommonStockSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember" xlink:href="icui-20220331.xsd#icui_CommonStockSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CommonStockSharesMember" xlink:to="lab_icui_CommonStockSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_69fc3709-ca57-4f72-95f8-0d0b02385bed_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c795c910-0f22-44d5-b0e0-7d45f4b93027_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_68300126-b80a-446e-b246-a3e8994782d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_f5035d22-b32f-4906-8b43-5670648a87b1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_aee48ba5-dd95-4314-ad3f-c4dee34cf486_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_c7fea1e7-1ab7-4e03-99b6-1602e340c11f_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_label_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:label id="lab_icui_ApplicableMarginBaseRateLoans_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBaseRateLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Base Rate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBaseRateLoans" xlink:to="lab_icui_ApplicableMarginBaseRateLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedothertaxes_3067752a-f65c-4b73-a937-3b6f5dab813c_terseLabel_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_label_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:label id="lab_icui_Accruedothertaxes_documentation_en-US" xlink:label="lab_icui_Accruedothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes" xlink:href="icui-20220331.xsd#icui_Accruedothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedothertaxes" xlink:to="lab_icui_Accruedothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_2376a477-9230-448f-8b9f-86b5ddb21b21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_acd9ac08-829b-436c-a16a-e087c0779633_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_e1b98860-660e-4e63-8028-0819a0587672_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MoldsMember_f76af40d-a9dc-4118-8043-f9c736d0a721_terseLabel_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_label_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:label id="lab_icui_MoldsMember_documentation_en-US" xlink:label="lab_icui_MoldsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember" xlink:href="icui-20220331.xsd#icui_MoldsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MoldsMember" xlink:to="lab_icui_MoldsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_9c559282-bde2-4f08-989a-f60a530c47ff_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_84738a5a-9b21-4f8b-91a6-00a26cf53622_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_692b58ce-33b7-47fb-adcb-7ad46a2877fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_364b5a1d-a925-4c87-9d82-b4da7da2f8a0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d15dac02-74ba-42fa-b07b-25980cafe345_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_fcacbb10-7545-4f04-9d57-f683f678b138_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_64bb552d-3ed2-4abc-aa53-480ced6525a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_bb1c92eb-c1d4-4383-b56c-d427ce926307_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_6ebcc2a1-6403-45e5-9a5f-6e8d5ae24bbd_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_5077bc5e-07c3-4629-adfb-5046dfe25e7e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_11b672da-0205-4355-b7c6-2df29add35bf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_faac6d10-74dc-48f5-85bd-4ff6f978b15a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_81741e6b-5339-407b-ad2d-714bd3503884_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_09611b07-f25d-4197-9fbf-14faf9d8b8af_verboseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_72bf8671-e8a4-48f9-a74b-efb7621e2d01_terseLabel_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_icui_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_icui_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DocumentAndEntityInformationAbstract" xlink:href="icui-20220331.xsd#icui_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DocumentAndEntityInformationAbstract" xlink:to="lab_icui_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_135378dd-66c0-4953-aaec-ebcbecd5b095_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0fcde78f-a2ed-4d9c-9316-72479e321e1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_de4f572a-7269-4f3b-b7db-570e8bdc329b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_6c9c83fb-f384-4d3e-996f-3628215979a7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_204370b0-17f0-451b-9a86-b619f6d9bded_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f478b03f-21cb-4802-849e-6d4b3db57136_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TimingDomain_decef345-f2ab-42bf-8947-09c74bb69d27_terseLabel_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:label id="lab_icui_TimingDomain_label_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:label id="lab_icui_TimingDomain_documentation_en-US" xlink:label="lab_icui_TimingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TimingDomain" xlink:to="lab_icui_TimingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4f4fa1fd-c6ae-4eb5-8e8f-61d3343b7f68_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_8271b237-bb8e-4087-bc2d-16b9c2904699_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_ea4503b3-4d75-4118-9285-4eab27bcb4f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_bbade740-cfe0-4157-8153-5ff8156747eb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e2fbd084-1bc3-40c9-8871-ed8985ba7564_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROVISION FOR INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_56649e2b-016b-4e19-96e6-9bc9f126d5d9_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_38897d41-4f6f-4f42-89e6-bf9f0e04b02e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d0104b41-22a7-4dd4-90fc-fb15e8b096b8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e7e96753-8d48-417e-93c6-175dbacb1ef3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_69faf0d7-e864-48de-aaf9-ec005d6b3dfe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_47d6f536-9c45-4004-8446-49b538b782c5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_01bd7036-cf75-4fa2-a804-bb8940f24bad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_45564fff-bc05-488e-8e7c-48326cd02017_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d7a55339-e8c4-4396-940e-dce96ccfbdf3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_fd7023c3-2e66-417b-8a1a-c84fce858663_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_16cf8feb-4b30-4dcc-a262-efb705fdaf04_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_517a6bc0-4fd0-42d1-a6ba-9fac32b47426_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f11e381a-822e-44f0-9652-52e459530586_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_4b9b2c57-6754-4ef0-990b-4f12ecd2c830_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_7f2e6b88-af75-43ba-810c-a2a526fca0f5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_ffa7bb0c-89f3-4c16-b967-22d669e9584a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_4246c4d1-97b1-489e-ac3f-2c1baec0fe21_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_cb513a02-e670-4525-b489-886f83e22ea9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_6aa03937-e970-4b88-a781-5811c8c25413_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Year Five</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_e1dc55a9-d9c3-4ae6-82db-c69734bc5f4d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_MXN_1c50a95f-7748-47ed-b13f-01ee5f701abf_terseLabel_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:label id="lab_currency_MXN_label_en-US" xlink:label="lab_currency_MXN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mexico, Pesos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_MXN" xlink:to="lab_currency_MXN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_5a91f291-26c0-46df-8296-ce47a87264b1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-Out Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_7f05a181-e9a3-4f04-b340-129284b9a653_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_ccf66d01-1bac-4c8d-94dd-21b86d177db8_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_be18d89f-1c3d-4d33-b046-3e3a378d8e00_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_42221231-6eec-4018-ac53-00deabcdc70c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_8abf71fd-df4d-4665-8598-f25e446a2819_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d6f447b7-d25d-42f4-823e-50469be6d000_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_aaf987c7-c3e4-4fa5-97dd-0ae87677f95d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_4bc1d7e2-6793-4672-a20a-9df37b68e424_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_8aa906f2-5c27-4615-ae76-5ee6ba4c1b53_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d94d1e64-c535-4904-acca-cf56f9833fc1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b105ba83-b5d8-4bba-9c10-cd7d99e6e341_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment, net of taxes of $0 for all periods</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationConsiderationHoldbackLiability_6a1518dd-66db-47a3-b4f2-217148a1f206_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration, Holdback liability</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationHoldbackLiability_label_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration, Holdback liability</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationHoldbackLiability_documentation_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration, Holdback liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:href="icui-20220331.xsd#icui_BusinessCombinationConsiderationHoldbackLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:to="lab_icui_BusinessCombinationConsiderationHoldbackLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_701ac4ed-cbfa-4fb6-b820-100d118cf45d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4fe3430f-c44a-4453-a4be-7b130186dc0f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_5f7d7812-636b-458e-92ab-6a4667cdfaf1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationGrossST_d2e1bf09-7e7c-4a53-88eb-2811010a9fb6_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossST_label_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossST_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationGrossST" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross ST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationGrossST" xlink:to="lab_icui_ContingentConsiderationGrossST" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_cda4245d-2a5c-4f4e-8c4e-153da0fb0316_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_c07b5a1f-4f7a-44c6-b7d3-111c91b4835b_negatedTerseLabel_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_label_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:label id="lab_icui_CurrencyTranslationOnEarnOut_documentation_en-US" xlink:label="lab_icui_CurrencyTranslationOnEarnOut" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation on earn-out</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut" xlink:href="icui-20220331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_CurrencyTranslationOnEarnOut" xlink:to="lab_icui_CurrencyTranslationOnEarnOut" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8b67e9cc-ab1e-48c6-a3ce-4cc602b71aca_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_a399ca7c-f8c1-4207-86e3-4e466b71e5d6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_325acc1e-c546-49ef-8eae-5aba873d5035_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_b3981bf7-6ee9-4da6-97ce-1aa4ca46124a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_1d8e3139-74dc-4371-a3c7-9bfe0bdf418e_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyTable_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable" xlink:to="lab_us-gaap_ProductLiabilityContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bd22aa0b-6d76-4650-8dfb-827a5dae7142_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_780dbf14-3d4e-4910-a053-8b65451a54d1_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_f4a330c6-dc03-4be9-9721-4771601753f0_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesTable_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable" xlink:href="icui-20220331.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesTable" xlink:to="lab_icui_ContractassetandliabilitybalancesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a1ac2da4-e73a-420a-84ef-a5f760ec400f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_305a7ee0-6c4b-4592-b5d0-c20488bc03a3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_2b2a4eb9-5953-4ac4-99e5-f41238f0479c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_92fa6512-e494-4bc9-b8db-e087f4ec2ff4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_768fce8c-64da-4101-9a41-0e94c2da12e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c6673ded-2866-4705-b206-e7ecc8dae9d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AcquiredRestructuringLiabilityCurrent_95ec2e36-0f96-47d3-b1ab-1e48fc336d40_terseLabel_en-US" xlink:label="lab_icui_AcquiredRestructuringLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired restructuring liability, current</link:label>
    <link:label id="lab_icui_AcquiredRestructuringLiabilityCurrent_label_en-US" xlink:label="lab_icui_AcquiredRestructuringLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired restructuring liability, current</link:label>
    <link:label id="lab_icui_AcquiredRestructuringLiabilityCurrent_documentation_en-US" xlink:label="lab_icui_AcquiredRestructuringLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired restructuring liability, current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AcquiredRestructuringLiabilityCurrent" xlink:href="icui-20220331.xsd#icui_AcquiredRestructuringLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AcquiredRestructuringLiabilityCurrent" xlink:to="lab_icui_AcquiredRestructuringLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_0c3644b9-ce8d-461d-a200-9d72c8f140ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_83c7ebca-be60-4f85-a3ff-7f592e82f189_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_5478bd77-f3ab-4288-80b2-e682c0a0d44a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_a04bed7f-0648-4435-b2da-4429cba3b9cd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_a9860c28-c1b9-4ebc-8dda-3982507be341_terseLabel_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_label_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:label id="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_documentation_en-US" xlink:label="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt, net of lender debt issuance costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:href="icui-20220331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:to="lab_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_a6ebd6c9-6fbe-434d-ae71-206713833bdc_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_dfaf2bd4-c967-40d3-ba31-965d04f3ee95_terseLabel_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue</link:label>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_label_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue [Member]</link:label>
    <link:label id="lab_icui_GovernmentGrantRevenueMember_documentation_en-US" xlink:label="lab_icui_GovernmentGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember" xlink:href="icui-20220331.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_GovernmentGrantRevenueMember" xlink:to="lab_icui_GovernmentGrantRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Greaterthan400to100Member_b84ec531-bf1b-4aff-8a8e-60371c14c2f7_terseLabel_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan 4to1</link:label>
    <link:label id="lab_icui_Greaterthan400to100Member_label_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan4.00to1.00 [Member]</link:label>
    <link:label id="lab_icui_Greaterthan400to100Member_documentation_en-US" xlink:label="lab_icui_Greaterthan400to100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">greaterthan4.00to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member" xlink:href="icui-20220331.xsd#icui_Greaterthan400to100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Greaterthan400to100Member" xlink:to="lab_icui_Greaterthan400to100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a8c9033a-9c14-4ff3-8d32-1b1e0ef8d0da_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_361e4f3b-462a-4195-99d4-15896a640b52_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_709b907a-c0a1-4142-a819-8bbe9a9d65b6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_3cc310d6-8280-4ecc-bca3-2749a7800d1a_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_9447c783-1a1c-4a16-be10-c83b3cb7c916_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_d3710614-d7d7-4dcb-bd4d-198f7ed6bab8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_8bb1ae5c-a07c-42e7-a158-31e095bec04e_terseLabel_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_label_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:label id="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_documentation_en-US" xlink:label="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required Share Holding Of Stock Issued At Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:href="icui-20220331.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:to="lab_icui_RequiredShareHoldingOfStockIssuedAtAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_75b8cff0-4cdd-405d-9f52-1434d8ed4e3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_259f04e5-3287-479e-b98f-6584d1b85f3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bf1c91d7-97e8-446a-be2a-d00927752d2e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_01b07866-f9e0-4084-b6ed-4d4cfc1edab0_terseLabel_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_label_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:label id="lab_icui_LOngTermObligationsDisclosureAbstract_documentation_en-US" xlink:label="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOng-Term Obligations Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract" xlink:href="icui-20220331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract" xlink:to="lab_icui_LOngTermObligationsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c7d438be-1289-425c-b2e1-3907857228e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_9f761da9-ea71-440a-a185-35473b3ec0cf_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_1a3dbae7-7b6b-44ab-b642-2bd6316c164e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionConsumablesSmithsMedicalMember_ecb854d7-36be-4ccb-8c0c-78690bebff5c_terseLabel_en-US" xlink:label="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables-Smiths Medical</link:label>
    <link:label id="lab_icui_InfusionConsumablesSmithsMedicalMember_label_en-US" xlink:label="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables-Smiths Medical [Member]</link:label>
    <link:label id="lab_icui_InfusionConsumablesSmithsMedicalMember_documentation_en-US" xlink:label="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Consumables-Smiths Medical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesSmithsMedicalMember" xlink:href="icui-20220331.xsd#icui_InfusionConsumablesSmithsMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionConsumablesSmithsMedicalMember" xlink:to="lab_icui_InfusionConsumablesSmithsMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9400c83b-df03-497d-80e4-d368e514391a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4497b2cb-61fe-4b8e-9cd9-68e78536fc97_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3e5e2074-4bb6-4cb6-93f1-670b280da6ab_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_2ade104d-7913-4bc5-84c6-d3597c20b818_terseLabel_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_label_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:label id="lab_icui_Srt_MultipleCurrencyAxisDomain_documentation_en-US" xlink:label="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">srt_MultipleCurrencyAxis [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain" xlink:href="icui-20220331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain" xlink:to="lab_icui_Srt_MultipleCurrencyAxisDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d68cbcb3-eb13-4493-a819-b71ea87078a0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_dbba9bbf-b868-4fe1-8181-46e01c2f01da_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Liabilitiesforcontracts_ce996fbf-816e-47da-82d9-37e9c485a67c_terseLabel_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:label id="lab_icui_Liabilitiesforcontracts_label_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:label id="lab_icui_Liabilitiesforcontracts_documentation_en-US" xlink:label="lab_icui_Liabilitiesforcontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities for contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Liabilitiesforcontracts" xlink:href="icui-20220331.xsd#icui_Liabilitiesforcontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Liabilitiesforcontracts" xlink:to="lab_icui_Liabilitiesforcontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_80d2bf54-de66-4a07-9a6a-7b379ed8209e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain_6ece979e-8aee-4a45-b07c-fb1293f54b06_terseLabel_en-US" xlink:label="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeasurementinputadjustedEBITDAvolatility [Domain]</link:label>
    <link:label id="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain_label_en-US" xlink:label="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeasurementinputadjustedEBITDAvolatility [Domain]</link:label>
    <link:label id="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain_documentation_en-US" xlink:label="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MeasurementinputadjustedEBITDAvolatility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:href="icui-20220331.xsd#icui_MeasurementinputadjustedEBITDAvolatilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:to="lab_icui_MeasurementinputadjustedEBITDAvolatilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_1dfc10a9-5929-4e76-902e-07ddb9087d9a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignMember_c83b1f12-303e-41ec-a6db-d37450ee52e5_terseLabel_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:label id="lab_icui_ForeignMember_label_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:label id="lab_icui_ForeignMember_documentation_en-US" xlink:label="lab_icui_ForeignMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember" xlink:href="icui-20220331.xsd#icui_ForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignMember" xlink:to="lab_icui_ForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_61d7ef67-0380-49b9-aa4e-7696489396a6_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAMember_1d47bdf1-83ca-4767-bb92-0ef3be830e78_terseLabel_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_icui_TermLoanAMember_label_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_icui_TermLoanAMember_documentation_en-US" xlink:label="lab_icui_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAMember" xlink:to="lab_icui_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_7515eb08-b50c-4823-9019-d749e7163f97_terseLabel_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt</link:label>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt [Table Text Block]</link:label>
    <link:label id="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock_documentation_en-US" xlink:label="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on long term debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:href="icui-20220331.xsd#icui_InterestExpenseOnLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:to="lab_icui_InterestExpenseOnLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_de9f2bf1-4468-43f5-812d-690e97d79e86_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_319fe859-c70a-45f8-af28-216f8a8f8f31_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_44a0db41-fdec-4471-bea1-f34a98885752_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_4f17fd07-799f-4940-9a9e-d25bcc16c045_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_984551f3-36e5-42d8-9268-dd2b31c63de4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:to="lab_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_b9ff3811-5aa4-42b7-b43f-9fd168c31970_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentFinanceCosts_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Finance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentFinanceCosts" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentFinanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentFinanceCosts" xlink:to="lab_icui_ProFormaAdjustmentFinanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_45b4f750-b978-42a7-834b-dcf27baceb1f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsAndOtherAssets" xlink:to="lab_us-gaap_DeferredCostsAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_694e0055-bcd6-4444-bee6-10a1c15c2340_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_90265cfd-b412-4f0c-a735-c5245cddee58_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0dfe467d-66ff-433f-8e87-2a627c7a25a0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_487dadd6-8178-4b66-ae1c-a90f60929949_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding (for basic calculation)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_b901249b-474a-4e0d-bab6-751300deae44_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1ba43e82-3216-4905-ba78-c2e19b891b60_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (In dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_3d6ba635-4212-43e6-b4f9-de6964d79075_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationDate1_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_7cc8d6d7-bc66-4bfa-913a-407f629de8fc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fb03baed-b135-499b-9666-42f65256de7c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4671e13b-5d2d-4cef-8af8-0f678e0db934_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_378bb15b-a781-41d4-b90b-5422bed7e467_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_ee387e7d-9b23-4775-9529-7dec8915f25b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_92d55ce7-613c-491f-ab11-595d3f4d15db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_142648a9-0124-4b6e-9478-d6dd30531acf_terseLabel_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_label_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:label id="lab_icui_MinimumStockPriceTargetForEarnOutPayment_documentation_en-US" xlink:label="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Stock Price Target for Earn-out Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:href="icui-20220331.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:to="lab_icui_MinimumStockPriceTargetForEarnOutPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_3d1204dd-c8db-4b0a-8b16-c5e43a1b4e18_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cf158e4d-53e6-4cdb-971d-7db9a84e2964_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_461df404-bd9a-4ae8-8219-a307bf66d35b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_6582637a-6bbc-4417-b01c-245a5e069ae8_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTANGIBLE ASSETS, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_9fb261b9-62f8-411e-812a-67048fec06b5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_74507bc2-36da-4605-bf7b-d6334a96b31f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_224aaec1-e4b9-452d-bee2-4d354f65b538_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_d60e1b74-af53-455c-a1e9-6c32e16ffa9b_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_86c32dfa-bf63-4ad3-b825-1ac755477bd4_terseLabel_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_label_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:label id="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_documentation_en-US" xlink:label="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smiths Group Ownership % Required for Board Representation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:href="icui-20220331.xsd#icui_SmithsGroupOwnershipRequiredForBoardRepresentation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:to="lab_icui_SmithsGroupOwnershipRequiredForBoardRepresentation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_6966be8c-24c3-4a01-b66c-9f3bfe4596d1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring accrual</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c35b8a79-55ef-41ce-b91d-6abae8a3a4b8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ee54b4bf-8350-417a-9271-80ef344b95cc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_361b3183-d18d-4b25-b77d-220fe8765c77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at cost (12,684 and 119 shares, respectively)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_215878a8-e72f-4aa7-8dc2-8944b270ca4d_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems" xlink:to="lab_us-gaap_ProductLiabilityContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a6100190-7a4a-4909-bf7a-25cc1dd24cea_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_a3383ea2-8ae0-4ddf-97c8-a4d6389e658e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_d3df45c2-2579-4f63-bdb0-73a51604860c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_57c8eb75-4cb7-4199-a1af-2099abe61856_terseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales taxes</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Excise Tax Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_3fd2d06c-dae6-4069-ab4a-f09c487cb346_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_0be097ae-ece9-4df6-a3c2-fa5993bf4a33_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_4670aad7-4325-4931-8841-5c3433b572b1_terseLabel_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_label_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:label id="lab_icui_UnfavorablecontractliabilityST_documentation_en-US" xlink:label="lab_icui_UnfavorablecontractliabilityST" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnfavorablecontractliabilityST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnfavorablecontractliabilityST" xlink:href="icui-20220331.xsd#icui_UnfavorablecontractliabilityST"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_UnfavorablecontractliabilityST" xlink:to="lab_icui_UnfavorablecontractliabilityST" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_377b1cf8-5fc4-4c02-b9eb-e6d7c91855f8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanAxis_e05d6cba-5345-4276-b817-c5c99f95f61b_terseLabel_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAxis_label_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Axis]</link:label>
    <link:label id="lab_icui_TermLoanAxis_documentation_en-US" xlink:label="lab_icui_TermLoanAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanAxis" xlink:to="lab_icui_TermLoanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_920cc080-2199-449b-9227-9c09f0354a3d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DerivativeVariableRateFloor_7a78444c-72cf-4b58-aac8-b5fbad8e7aa1_terseLabel_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:label id="lab_icui_DerivativeVariableRateFloor_label_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:label id="lab_icui_DerivativeVariableRateFloor_documentation_en-US" xlink:label="lab_icui_DerivativeVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">derivative variable rate floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor" xlink:href="icui-20220331.xsd#icui_DerivativeVariableRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DerivativeVariableRateFloor" xlink:to="lab_icui_DerivativeVariableRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a6b76c5d-1de4-46f8-8094-a76fe60c9851_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0391a683-e878-4e6a-9063-df9f5c8deb73_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_fc48565f-1702-4ee9-b940-ceb04b05dcb5_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1092fc84-40a0-49cc-9248-8e3e3047cf5b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Hedge2Member_9a7ff7a7-ab8b-4025-8b0b-8e533bc34aaa_terseLabel_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_label_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:label id="lab_icui_Hedge2Member_documentation_en-US" xlink:label="lab_icui_Hedge2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member" xlink:href="icui-20220331.xsd#icui_Hedge2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Hedge2Member" xlink:to="lab_icui_Hedge2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_4f2b3687-e091-49e3-b4e0-dc9dbcd7c67f_terseLabel_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_label_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:label id="lab_icui_InstrumentsPlacedwithCustomersMember_documentation_en-US" xlink:label="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments Placed with Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:href="icui-20220331.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InstrumentsPlacedwithCustomersMember" xlink:to="lab_icui_InstrumentsPlacedwithCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_2ac1644e-58c3-4f5c-8da2-dcced3db1909_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Derivative Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_81aa94c7-746e-4979-8e53-1d4e3615104d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_2d7dcc4e-58f1-4350-92dd-834530b21c69_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthanorequalto2point5to1butgreaterthan2to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.50 to1.00 but greater than 2.00 to1.00 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 2.50 to1.00 but greater than 2.00 to1.00</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:to="lab_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_28b8bf30-6186-40e1-9f54-3ec9d69d541c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c0276712-428e-49db-a5ad-d605403e87df_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_c73d6263-06d2-454f-841c-240c83f9e485_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_901a09bb-a9fa-4d55-9ed3-e44e5ee3f897_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_f467db7c-3f64-4ad4-8b94-13dbe7ccdc83_terseLabel_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_label_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier [Member]</link:label>
    <link:label id="lab_icui_ForeignInfusionSystemSupplierMember_documentation_en-US" xlink:label="lab_icui_ForeignInfusionSystemSupplierMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Infusion System Supplier</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember" xlink:href="icui-20220331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ForeignInfusionSystemSupplierMember" xlink:to="lab_icui_ForeignInfusionSystemSupplierMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e262aae7-2750-4968-b8d7-791567e2d998_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a89f08b9-38f8-45de-89ea-577829fbc149_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_8834d979-7d71-4797-a035-c564282d4984_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_bbfdef57-e466-4696-9682-124ef928d256_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_e1c57574-c80f-4943-baea-7fe2e6ea57a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_8d31aba8-f90f-4898-bc5e-ce6e528d3dc7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_e8613a60-d669-4d92-9694-e310246ad952_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_7dcb6568-6803-484c-9563-6a9bd8c1eca9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Current</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_d4d3efb0-4288-4e4e-b4c4-92320e238733_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_198275ca-1bc0-4fcc-8577-4c17eff7fc07_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f1396b2e-7c04-4c8a-bc35-fc04db9f36fd_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_c8d890bf-4ca1-4059-9179-9fcb2f0a0594_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranties and returns</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_f6d6b2cd-7410-4878-8ba6-f2ae90936145_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_label_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:label id="lab_icui_BusinessCombinationConsiderationTransferredCash_documentation_en-US" xlink:label="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash" xlink:href="icui-20220331.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationConsiderationTransferredCash" xlink:to="lab_icui_BusinessCombinationConsiderationTransferredCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_63c5d0ef-3c8d-40e4-abff-3a0d5c3711c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets additions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_ea9effbd-4dfc-4207-a4bf-b32d3564d825_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:to="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_eb10c1e3-3f3e-445e-b541-41ea312c387c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_EquipmentrevenueMember_86a7c3a6-0830-4f9e-8829-e8f911291387_terseLabel_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_label_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:label id="lab_icui_EquipmentrevenueMember_documentation_en-US" xlink:label="lab_icui_EquipmentrevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember" xlink:href="icui-20220331.xsd#icui_EquipmentrevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_EquipmentrevenueMember" xlink:to="lab_icui_EquipmentrevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0afca37b-070d-4c5e-ba68-b17dec3d2d80_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInDeferredRevenueRollForward_8aa028d6-6729-4088-a5c9-cdd5c733671e_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Deferred Revenue [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInDeferredRevenueRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Deferred Revenue [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInDeferredRevenueRollForward" xlink:to="lab_us-gaap_MovementInDeferredRevenueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_34d956ba-274b-444c-a42c-dedf875cec0d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_1a8140cb-623c-4865-acb0-64e369c72a3d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3f8ee599-4a2a-4fac-9d87-2bdafd865178_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ac63491c-ed0e-4d0d-8613-a245f7287777_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_0d53c9c0-63f4-4901-a35f-7d1ebbacc0a2_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_9f334587-dc2c-4b1f-b47a-c8054f5a70f0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_7c185be1-60be-4a90-8ea7-2fa26315dca7_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_ca0bb8d1-854e-4e71-91dd-baf6069053f1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ef3494dd-4e84-4fa1-b506-7168b9a4b5dc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4cbdd64b-be60-4d66-afd5-b3c4a5b58aeb_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_0643307e-d32a-4c1c-91fe-86c2285cfccb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment [Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_ff6b2ef0-9421-460e-83d8-7276e939bd41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_6bb12ed1-688a-4a65-9ea2-c6cd24809aa0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_SpareParts_53d3700c-f8c2-478c-9d93-75d2949f1456_terseLabel_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_label_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:label id="lab_icui_SpareParts_documentation_en-US" xlink:label="lab_icui_SpareParts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spare parts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts" xlink:href="icui-20220331.xsd#icui_SpareParts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_SpareParts" xlink:to="lab_icui_SpareParts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8022e5dd-4974-4f80-958e-c6ff17e25bfa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_d542f60e-005c-4401-9e34-11d20cec6be3_terseLabel_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_icui_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:href="icui-20220331.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ComputerEquipmentAndSoftwareMember" xlink:to="lab_icui_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_1bb8a348-1bd9-45b0-b317-0e6b6b389e8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_73a14e03-ae7e-41db-8556-a80f8cfa6820_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_870eaa45-c60a-4764-a248-ef0a26a51555_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c5fda5d1-95a6-4880-bd08-7190ba466945_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_42a3b1a1-43b5-4976-9285-c7eddaf0e627_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_7875123c-8e96-40ee-ab24-6b14295fd169_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_4c653226-4d5e-428e-9e8f-86780b05a07b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_53fd0c30-bdfb-4ba3-a814-81235eec1e09_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_f6275e10-f16b-41d7-9d02-86eaeaeef6a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_b55ab608-fd7f-44f5-9530-af9e6c8dc4a9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_abec1465-bdd6-4d5b-b7db-8082d467154a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_49a96901-436b-4b75-982b-54c5e7882e64_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_74a65bd9-2ace-473d-89b6-e2bfe7ba7758_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_47eb9f9e-acb2-4474-8e1c-4a6c98228620_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_45bb8159-51af-4751-ab3a-901f5fde2f45_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_2bcf2576-f9b5-482a-9930-934d8f133baf_terseLabel_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:label id="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities, Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:href="icui-20220331.xsd#icui_AssetsandLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:to="lab_icui_AssetsandLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProFormaAdjustmentInventory_f9b660cf-3caf-4ba7-8022-c01ccb3e42e7_terseLabel_en-US" xlink:label="lab_icui_ProFormaAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Inventory</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentInventory_label_en-US" xlink:label="lab_icui_ProFormaAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Inventory</link:label>
    <link:label id="lab_icui_ProFormaAdjustmentInventory_documentation_en-US" xlink:label="lab_icui_ProFormaAdjustmentInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma Adjustment - Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentInventory" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProFormaAdjustmentInventory" xlink:to="lab_icui_ProFormaAdjustmentInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_b872d9e7-11fa-4961-b730-1191494a4bde_terseLabel_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_label_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:label id="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_documentation_en-US" xlink:label="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">business combination, recognized identifiable asset acquired and liability assumed,</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:href="icui-20220331.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:to="lab_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_5942c781-78ba-441f-bbc8-2aa460f048de_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_2b284a76-6c36-4afa-9b6a-39b82326ae8c_terseLabel_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_label_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:label id="lab_icui_ProvisionForWarrantyAndReturns_documentation_en-US" xlink:label="lab_icui_ProvisionForWarrantyAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for warranty and returns</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns" xlink:href="icui-20220331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ProvisionForWarrantyAndReturns" xlink:to="lab_icui_ProvisionForWarrantyAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_34aef39b-683f-4110-b8ff-4f0ba3f05737_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_21f06036-704e-4a03-8099-c882a9076c37_terseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_label_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:label id="lab_icui_ContingentConsiderationGrossLT_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationGrossLT" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Gross LT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationGrossLT" xlink:to="lab_icui_ContingentConsiderationGrossLT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_4dc85a0c-bdb3-4e35-9a3f-ead0e137720b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_ebc09867-2ad1-4aa6-9031-88f2521391a0_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_73bb115f-7a2b-44d6-8cd3-9ce93df9c0c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLocationAxis_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_b7d0075f-fbf7-4f82-b809-39c338d73aad_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_40c64a33-a7cd-4419-a0df-e98b76c48680_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_af988bcd-7463-4252-96b6-abbcb60c09da_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb5175bc-2d07-40ac-87be-b94f0b138e6e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d4a45e29-2f87-4733-8ac3-bcf617e5c166_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5b735f46-fe0c-498f-9c65-386c1ddd0630_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_8ceabe1d-bb62-45c7-beb8-b1c9f041f74a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_40ae0a29-86a0-4b58-9de4-d8027a67d307_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_28011673-9b40-47ce-a33e-4c2aa1fe0f13_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_b323c84c-9fbb-40ca-9292-5f82e66809a1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_80cf46af-c2f8-4515-b638-cc322d90e0c1_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_227b4ae8-a510-4f1d-a4fa-fe3e12a2019d_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_InfusionSystemsMember_ebdcf409-22d1-4581-95a9-2c5a86962d9a_terseLabel_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_label_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:label id="lab_icui_InfusionSystemsMember_documentation_en-US" xlink:label="lab_icui_InfusionSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infusion Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember" xlink:href="icui-20220331.xsd#icui_InfusionSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_InfusionSystemsMember" xlink:to="lab_icui_InfusionSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Sparepartsusage_31ecedf3-5ec5-4b5a-b45f-b916485d7cac_terseLabel_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_label_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:label id="lab_icui_Sparepartsusage_documentation_en-US" xlink:label="lab_icui_Sparepartsusage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sparepartsusage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage" xlink:href="icui-20220331.xsd#icui_Sparepartsusage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Sparepartsusage" xlink:to="lab_icui_Sparepartsusage" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_bad7b371-79d7-45ba-ba77-97d6f24312e2_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f74c5e72-eb8d-4d1a-9404-783612a84fce_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_cf7ed5b9-4e7d-42ce-b28f-f9c0f03ac5d0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_717718fd-5a51-43e1-a4f8-b59cbb481489_terseLabel_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_label_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:label id="lab_icui_Prepaidinsuranceandpropertytaxes_documentation_en-US" xlink:label="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance and property taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:href="icui-20220331.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidinsuranceandpropertytaxes" xlink:to="lab_icui_Prepaidinsuranceandpropertytaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_RevolverSubLimits_b12d24df-ef66-406c-981b-90cf04e98ee2_terseLabel_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:label id="lab_icui_RevolverSubLimits_label_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:label id="lab_icui_RevolverSubLimits_documentation_en-US" xlink:label="lab_icui_RevolverSubLimits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Sub limits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits" xlink:href="icui-20220331.xsd#icui_RevolverSubLimits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_RevolverSubLimits" xlink:to="lab_icui_RevolverSubLimits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ee2fe92a-aadd-4d64-8bc8-84626f056d0a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_02a7af9f-e0d2-4f98-982f-53f1faf39c84_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_fb5fbccb-54e3-4d52-81c5-d320ee513f09_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_c4d77862-f7c4-40e0-b0aa-744ee8a51189_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_8d29ad7a-f109-460e-9234-1d26f4137689_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_edfcd744-97c1-4caf-aee3-de5160ef1a48_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContingentConsiderationAllAcquisitions_0480e186-8274-4720-a562-0c2108ffc1be_negatedTerseLabel_en-US" xlink:label="lab_icui_ContingentConsiderationAllAcquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration all Acquisitions</link:label>
    <link:label id="lab_icui_ContingentConsiderationAllAcquisitions_label_en-US" xlink:label="lab_icui_ContingentConsiderationAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration all Acquisitions</link:label>
    <link:label id="lab_icui_ContingentConsiderationAllAcquisitions_documentation_en-US" xlink:label="lab_icui_ContingentConsiderationAllAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration all Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationAllAcquisitions" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationAllAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContingentConsiderationAllAcquisitions" xlink:to="lab_icui_ContingentConsiderationAllAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_67cec296-6ccc-4d57-92d4-df81c1225071_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LongTermMember_5e3f8c6a-a24d-4c65-a920-024601fc6f23_terseLabel_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term</link:label>
    <link:label id="lab_icui_LongTermMember_label_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term [Member]</link:label>
    <link:label id="lab_icui_LongTermMember_documentation_en-US" xlink:label="lab_icui_LongTermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember" xlink:href="icui-20220331.xsd#icui_LongTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LongTermMember" xlink:to="lab_icui_LongTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0a3a5034-5a64-48aa-bcab-515e469dda80_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_2aa86de3-bec8-4ba4-83d7-6161da65adaa_terseLabel_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">lessthan4to1butgreaterthan3to1</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_label_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 4.00 to 1.00 but greater than 3.00 to100 [Member]</link:label>
    <link:label id="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_documentation_en-US" xlink:label="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">less than or equal to 4.00 to 1.00 but greater than 3.00 to100</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:to="lab_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_d80012bc-5c54-45af-8e06-9264c9fd9cbf_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentInYear5_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentInYear5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % in Year 5</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentInYear5" xlink:href="icui-20220331.xsd#icui_TermAPrincipalPaymentInYear5"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentInYear5" xlink:to="lab_icui_TermAPrincipalPaymentInYear5" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5522d95b-b6a5-470c-955b-22fad029a569_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_66295c65-8610-41eb-8087-c02d55dc619b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive income (loss), net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_c9dcedf1-fd9d-48b6-bfcd-4056ee145e43_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Contractsettlement_4e658dc7-bab7-4c61-b0fb-531dadee8551_terseLabel_en-US" xlink:label="lab_icui_Contractsettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contract settlement</link:label>
    <link:label id="lab_icui_Contractsettlement_label_en-US" xlink:label="lab_icui_Contractsettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contract settlement</link:label>
    <link:label id="lab_icui_Contractsettlement_documentation_en-US" xlink:label="lab_icui_Contractsettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">contract settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement" xlink:href="icui-20220331.xsd#icui_Contractsettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Contractsettlement" xlink:to="lab_icui_Contractsettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_084b7556-3218-4017-bea3-a7dd97e41ebb_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_3c3d37c8-53d8-4628-a973-8f89ca130287_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_44c017de-7f33-45b5-b471-d959adf6ed15_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_2df49cdf-fa11-4f4c-a8ef-f3c1386c2af8_terseLabel_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable Margin Based on Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:to="lab_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_967edf08-2a56-403b-9c72-2ccc38ca9268_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_90fa56b1-7d19-440b-9dd4-94e28796a44d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingRevenueMember_849ba43f-b50f-4e1a-98af-c0c9d07dbdce_terseLabel_en-US" xlink:label="lab_us-gaap_TradingRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Revenue</link:label>
    <link:label id="lab_us-gaap_TradingRevenueMember_label_en-US" xlink:label="lab_us-gaap_TradingRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingRevenueMember" xlink:to="lab_us-gaap_TradingRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7922ca9c-a165-4855-ae01-e10b6d1b1dda_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8aae88a0-be05-4618-9d28-64b694399a23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_faf6d10c-f644-4111-93cf-3d6e8062f08b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2f677748-ce90-4cbf-8ecd-a79acbbf7e23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_70921e57-2054-41c1-92bb-37b2fe128e38_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_7b660956-e586-46f4-8106-a5fac3583458_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3964bfc6-f57e-476f-8df2-3b27269c095b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_23ad8466-bd67-487b-8e46-c7a59bddae2a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_71e5b628-076f-44e0-b568-f9766809199e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_0cedc1b1-4631-443e-84ee-ea7c864ace78_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:to="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermLoanDomain_af747f3e-65c6-4901-bd49-5d0ee774204a_terseLabel_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:label id="lab_icui_TermLoanDomain_label_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:label id="lab_icui_TermLoanDomain_documentation_en-US" xlink:label="lab_icui_TermLoanDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermLoanDomain" xlink:to="lab_icui_TermLoanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_1fd784ea-5894-4cee-ac84-7a443da4f672_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_624af8eb-d4eb-45d3-be95-6df29d6635f2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8f1f2b8a-18d8-4057-bc4f-2736817cc77f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_e38354d3-2da8-4d93-b41a-2212a487cb4f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_aa6fbfa1-dc05-4e6d-9654-31281ae717b9_terseLabel_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_label_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:label id="lab_icui_OwnershipRequirementForEarnoutPayment_documentation_en-US" xlink:label="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership requirement for Earnout Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment" xlink:href="icui-20220331.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_OwnershipRequirementForEarnoutPayment" xlink:to="lab_icui_OwnershipRequirementForEarnoutPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_9f13840b-c311-440c-bba1-a931b37a69fa_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f40d73fd-a6c2-4476-a00d-d9596efb448c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_cba8c7f9-147a-4287-ac16-a76cd62ce8ba_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_a48cf9bb-546f-482a-a757-fafb7e8f69ba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Accruedlegalfees_1eea6044-39c6-4d76-8f5c-f68ed0fe9065_terseLabel_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal accrual</link:label>
    <link:label id="lab_icui_Accruedlegalfees_label_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:label id="lab_icui_Accruedlegalfees_documentation_en-US" xlink:label="lab_icui_Accruedlegalfees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees" xlink:href="icui-20220331.xsd#icui_Accruedlegalfees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Accruedlegalfees" xlink:to="lab_icui_Accruedlegalfees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_f2091d9b-3788-4b2b-a64d-0a5c7bf7cc85_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a20cc653-b70f-4ba5-8aed-acc773710723_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_ef1f2796-c2e9-42c2-8f9b-47acc4bcf36b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c66d8d04-356d-44de-ac72-ce299fec6327_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_9ae7103d-7aea-48a1-ae65-dc1e22fcef91_terseLabel_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_label_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:label id="lab_icui_AccruedSalariesAndBenefits_documentation_en-US" xlink:label="lab_icui_AccruedSalariesAndBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salaries and benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits" xlink:href="icui-20220331.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedSalariesAndBenefits" xlink:to="lab_icui_AccruedSalariesAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_Prepaidothertaxes_6cdf8df2-99bc-48fb-a056-6b75669a69be_terseLabel_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_label_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:label id="lab_icui_Prepaidothertaxes_documentation_en-US" xlink:label="lab_icui_Prepaidothertaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid other taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes" xlink:href="icui-20220331.xsd#icui_Prepaidothertaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_Prepaidothertaxes" xlink:to="lab_icui_Prepaidothertaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_3f9ee2fb-851d-40ac-99e0-fdb559909154_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_fe1b347a-ad5d-40d7-8a17-434e4a193c29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ffc3cc81-dd3e-405f-80c0-a0185051c12e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_f40984ea-2b7b-4d0a-a75c-83a16f8bd150_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_90c776f7-cc80-44f7-9df0-d1cb7a554975_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_dae1d491-ab53-45b1-8a45-361ef85486d6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_69778bc1-18d3-4a5d-b7d3-8993fa1d3e24_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_fb41eb01-1f85-4316-93c9-ba1fdd43c986_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_35b93267-f17b-4745-9e24-c4cebab4c553_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeForwardExchangeRate1_label_en-US" xlink:label="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Forward Exchange Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeForwardExchangeRate1" xlink:to="lab_us-gaap_DerivativeForwardExchangeRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_e6416db2-7e05-4bba-ae1a-c306af50b575_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e54686e6-5b5d-418a-a932-d7362e0ddb71_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_90ddcf03-d633-4816-9cc3-c5e8dcaeca90_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_c3744934-b45f-4b65-9b23-2e432661c3ac_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesTotalMember_label_en-US" xlink:label="lab_us-gaap_LiabilitiesTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Total [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesTotalMember" xlink:to="lab_us-gaap_LiabilitiesTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_a1d763a7-9cb6-486b-a4ca-0be3155eaf0d_terseLabel_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_label_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:label id="lab_icui_TermAPrincipalPaymentYear3And4_documentation_en-US" xlink:label="lab_icui_TermAPrincipalPaymentYear3And4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term A Principal Payment % Year 3 and 4</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentYear3And4" xlink:href="icui-20220331.xsd#icui_TermAPrincipalPaymentYear3And4"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_TermAPrincipalPaymentYear3And4" xlink:to="lab_icui_TermAPrincipalPaymentYear3And4" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_971c477d-1d0d-40bd-988a-41891a9d2ca0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_bd1d304b-dcd5-4392-9ef7-ae1febed2efc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_9a9743a3-33a0-4604-9994-5ce7718665b2_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_d62d4b03-3b1c-44a8-9095-38f510841b87_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_LeverageRatioLevelAxis_153139b1-cf48-447a-853d-b91e663756ab_terseLabel_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Axis]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelAxis_label_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level [Axis]</link:label>
    <link:label id="lab_icui_LeverageRatioLevelAxis_documentation_en-US" xlink:label="lab_icui_LeverageRatioLevelAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Level</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis" xlink:href="icui-20220331.xsd#icui_LeverageRatioLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_LeverageRatioLevelAxis" xlink:to="lab_icui_LeverageRatioLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_DevelopedTechnologyMember_d11e16a7-2bac-46db-b6a7-c11157418964_terseLabel_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology</link:label>
    <link:label id="lab_icui_DevelopedTechnologyMember_label_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology [Member]</link:label>
    <link:label id="lab_icui_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_icui_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">developed technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember" xlink:href="icui-20220331.xsd#icui_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_DevelopedTechnologyMember" xlink:to="lab_icui_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_cf152c6f-d739-445c-9cf5-ca620e5e56f2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax liability</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_f96bb145-e106-4ed3-bd3b-cecba6e84850_terseLabel_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_label_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset and liability balances [Line Items]</link:label>
    <link:label id="lab_icui_ContractassetandliabilitybalancesLineItems_documentation_en-US" xlink:label="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Contract asset and liability balances [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:href="icui-20220331.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems" xlink:to="lab_icui_ContractassetandliabilitybalancesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_a027d827-c51a-4b00-b7c9-6d0448973590_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_43ca4b3c-b88f-4081-8288-5eb58b65ebe5_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_AccruedTransactionCosts_74661176-ac42-47b5-8f7b-d76d375ccb7a_terseLabel_en-US" xlink:label="lab_icui_AccruedTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued transaction costs</link:label>
    <link:label id="lab_icui_AccruedTransactionCosts_label_en-US" xlink:label="lab_icui_AccruedTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued transaction costs</link:label>
    <link:label id="lab_icui_AccruedTransactionCosts_documentation_en-US" xlink:label="lab_icui_AccruedTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued transaction costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedTransactionCosts" xlink:href="icui-20220331.xsd#icui_AccruedTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_AccruedTransactionCosts" xlink:to="lab_icui_AccruedTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_719a0492-f6c7-43ff-af71-c2abe14508af_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_03fbb698-7b17-4e59-9620-5727fd8b8265_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_3ae59c9a-0fe1-4534-9be3-f37f675370f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueAdditions_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueAdditions" xlink:to="lab_us-gaap_DeferredRevenueAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_icui_VascularAccessMember_5935dfd3-49a3-467a-b955-7d252cb56b74_terseLabel_en-US" xlink:label="lab_icui_VascularAccessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vascular Access</link:label>
    <link:label id="lab_icui_VascularAccessMember_label_en-US" xlink:label="lab_icui_VascularAccessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vascular Access [Member]</link:label>
    <link:label id="lab_icui_VascularAccessMember_documentation_en-US" xlink:label="lab_icui_VascularAccessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vascular Access</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VascularAccessMember" xlink:href="icui-20220331.xsd#icui_VascularAccessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_icui_VascularAccessMember" xlink:to="lab_icui_VascularAccessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_822a3861-789c-4f25-ae1e-3652ec0233dc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8d70a376-c47f-4dce-9758-1b5b8c159d6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_f46e46c0-1dab-4afa-ad79-ff67e60c5e4c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>icui-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eb6bc161-64f3-45ef-8355-0537b049f0f7,g:1fc0d841-3e14-4a45-9a82-f075c6cb343a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.icumed.com/role/DEIDocument" xlink:type="simple" xlink:href="icui-20220331.xsd#DEIDocument"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DEIDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:href="icui-20220331.xsd#icui_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d1a0ff6d-842d-498a-a7ff-59e1d7154958" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_DocumentType_d1a0ff6d-842d-498a-a7ff-59e1d7154958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_63deef42-7b97-44c3-a2f7-6843e45449c0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_DocumentQuarterlyReport_63deef42-7b97-44c3-a2f7-6843e45449c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0fe71983-8556-4b13-83c6-e9d846637f9e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_DocumentPeriodEndDate_0fe71983-8556-4b13-83c6-e9d846637f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_74380009-9555-4b51-ae6b-ee7977b4f649" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_DocumentTransitionReport_74380009-9555-4b51-ae6b-ee7977b4f649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_353a3b97-3291-45fc-a1c4-22fd2995de25" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityFileNumber_353a3b97-3291-45fc-a1c4-22fd2995de25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2ce9e6a8-e6e0-4b3a-a579-7130d57d5529" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2ce9e6a8-e6e0-4b3a-a579-7130d57d5529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_9148713f-3101-46f0-a827-d2025277d06c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityTaxIdentificationNumber_9148713f-3101-46f0-a827-d2025277d06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c822f99a-8fda-4e39-9671-4bbece7b310e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityAddressAddressLine1_c822f99a-8fda-4e39-9671-4bbece7b310e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b5d88563-ec6f-4365-b142-865f2253cee2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityAddressCityOrTown_b5d88563-ec6f-4365-b142-865f2253cee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b5d36041-3069-4202-a3e8-8fa3db2291e5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityAddressStateOrProvince_b5d36041-3069-4202-a3e8-8fa3db2291e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e7696bf9-4c1a-4798-a97b-3c28927dbecf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityAddressPostalZipCode_e7696bf9-4c1a-4798-a97b-3c28927dbecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_84256068-54ee-4e11-b92b-40c03f531ac3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_CityAreaCode_84256068-54ee-4e11-b92b-40c03f531ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_576741c7-d33c-47f0-9180-e5b0b1d5eeb0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_LocalPhoneNumber_576741c7-d33c-47f0-9180-e5b0b1d5eeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4adb04f5-350c-4874-bc25-f92a52dcd01d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityCurrentReportingStatus_4adb04f5-350c-4874-bc25-f92a52dcd01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_00e81c21-a187-42b5-86ff-e55ff2a7d0cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityInteractiveDataCurrent_00e81c21-a187-42b5-86ff-e55ff2a7d0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_74aa7f3e-83bd-41f4-9b2d-204a78e1ce2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityFilerCategory_74aa7f3e-83bd-41f4-9b2d-204a78e1ce2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a73af377-a4ed-41ff-a4cf-ebdca9ff65b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntitySmallBusiness_a73af377-a4ed-41ff-a4cf-ebdca9ff65b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ec52dcd6-a5b3-4d7d-807b-26d62c0b8572" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityEmergingGrowthCompany_ec52dcd6-a5b3-4d7d-807b-26d62c0b8572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2887c761-4f2e-4411-85df-cab53a75f082" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityShellCompany_2887c761-4f2e-4411-85df-cab53a75f082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_583d515b-b2c9-4338-a689-d0e2ecb51bc5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_Security12bTitle_583d515b-b2c9-4338-a689-d0e2ecb51bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_47b5b659-92ee-4f5b-ac11-db69f39c6216" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_TradingSymbol_47b5b659-92ee-4f5b-ac11-db69f39c6216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_90bf90ce-d3f6-40d6-91f7-047c424be6dd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_SecurityExchangeName_90bf90ce-d3f6-40d6-91f7-047c424be6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ef30bfa8-c1f2-4b0f-b15b-e491b9402580" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ef30bfa8-c1f2-4b0f-b15b-e491b9402580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a971823b-f995-4a6e-a9f4-13d1a466749c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityCentralIndexKey_a971823b-f995-4a6e-a9f4-13d1a466749c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8e9a9701-033c-4de3-95a2-e18d0ff0c224" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_EntityRegistrantName_8e9a9701-033c-4de3-95a2-e18d0ff0c224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_205f65fc-122a-4c2c-ac12-dfacee1512c6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_AmendmentFlag_205f65fc-122a-4c2c-ac12-dfacee1512c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4e3c6c1d-e520-4550-ae57-8e5e1e5c8881" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_CurrentFiscalYearEndDate_4e3c6c1d-e520-4550-ae57-8e5e1e5c8881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e20f6bd3-f299-4dfd-8d2f-740925e8531f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_DocumentFiscalYearFocus_e20f6bd3-f299-4dfd-8d2f-740925e8531f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_379e9b4a-a41e-477e-a17d-a9bf1ab606e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_DocumentAndEntityInformationAbstract_9913c2ef-d060-460b-b168-2f3bcc38ab31" xlink:to="loc_dei_DocumentFiscalPeriodFocus_379e9b4a-a41e-477e-a17d-a9bf1ab606e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_025d56cf-daf5-4064-82d6-5773bd5acfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_88e4696c-38bb-455a-95c9-14ab2f092dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_025d56cf-daf5-4064-82d6-5773bd5acfa6" xlink:to="loc_us-gaap_StatementTable_88e4696c-38bb-455a-95c9-14ab2f092dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_88e4696c-38bb-455a-95c9-14ab2f092dc2" xlink:to="loc_srt_StatementScenarioAxis_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4182b620-4bc0-49ff-ad06-aaee5b0e775e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7d5b2c0e-fa2b-4b2a-bbf8-f8e2be8bddb7" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4182b620-4bc0-49ff-ad06-aaee5b0e775e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_88e4696c-38bb-455a-95c9-14ab2f092dc2" xlink:to="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:to="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7254ef9d-1147-41f2-947b-11189b29ba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7254ef9d-1147-41f2-947b-11189b29ba5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6a240cb2-0b42-40cf-a2e6-61abfdc7be75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6a240cb2-0b42-40cf-a2e6-61abfdc7be75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_cae6fefe-37ae-47f7-aec0-cf1d135ea8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_cae6fefe-37ae-47f7-aec0-cf1d135ea8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cf23b31e-8624-400e-9d20-b928874f5729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cf23b31e-8624-400e-9d20-b928874f5729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cc2e93e5-ef6b-4254-8064-1b743d40fefd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_InventoryNet_cc2e93e5-ef6b-4254-8064-1b743d40fefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_fba9d33c-e7fb-4610-bdfd-a38e89dbbe82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_PrepaidTaxes_fba9d33c-e7fb-4610-bdfd-a38e89dbbe82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7137fbaa-2349-4b15-839a-98adbe2e66ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7137fbaa-2349-4b15-839a-98adbe2e66ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_25491c16-842e-4ea3-9b74-88227c74c87a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_b4001299-6a2d-440f-a229-5eedbd8ceb82" xlink:to="loc_us-gaap_AssetsCurrent_25491c16-842e-4ea3-9b74-88227c74c87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_051715ca-c174-4e5e-b6a5-42f9ff75a972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_051715ca-c174-4e5e-b6a5-42f9ff75a972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7730cb4b-faab-45f9-91e5-a3d517b8cd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7730cb4b-faab-45f9-91e5-a3d517b8cd9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e77fa760-f656-4745-8690-40642766ee86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e77fa760-f656-4745-8690-40642766ee86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ac64d8ab-b1ec-4284-aac9-2f6bb1d82951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_Goodwill_ac64d8ab-b1ec-4284-aac9-2f6bb1d82951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9719a352-1ffe-4df8-beb7-c9f9cca3f262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9719a352-1ffe-4df8-beb7-c9f9cca3f262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bbdaa80d-559b-45a5-9652-32dcfc783110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bbdaa80d-559b-45a5-9652-32dcfc783110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_81e3fdbf-915d-420a-a5df-4f9754bfc377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_81e3fdbf-915d-420a-a5df-4f9754bfc377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b9f93c1b-4685-40dd-bc80-29fa7ee5588b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_78d11733-a850-4f3a-b751-c1dcd7d1835f" xlink:to="loc_us-gaap_Assets_b9f93c1b-4685-40dd-bc80-29fa7ee5588b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_168953ce-a904-44de-baf9-05ba12de9d58" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ab7294ee-6de7-488f-a135-aee1ae8987fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_AccountsPayableCurrent_ab7294ee-6de7-488f-a135-aee1ae8987fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4b9a4c0e-6918-4e69-bb3b-cac962114b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4b9a4c0e-6918-4e69-bb3b-cac962114b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_936271c5-fa4b-4543-96e6-e069506df8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_LongTermDebtCurrent_936271c5-fa4b-4543-96e6-e069506df8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_198a02f4-58fa-41a1-8fce-81d4aa634ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_198a02f4-58fa-41a1-8fce-81d4aa634ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_59d0d44f-0e60-42ec-bfe1-df3cb0529871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_cac007c8-72ca-44d3-aa05-88f11c0c0db4" xlink:to="loc_us-gaap_LiabilitiesCurrent_59d0d44f-0e60-42ec-bfe1-df3cb0529871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_52c890d0-a80b-4cba-b82c-c2920ca6536f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_52c890d0-a80b-4cba-b82c-c2920ca6536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_862940ef-aa21-4a98-9bbd-32e7cb7a8009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_862940ef-aa21-4a98-9bbd-32e7cb7a8009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_74954bda-d654-4f67-8995-6c0bd4ab6a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_74954bda-d654-4f67-8995-6c0bd4ab6a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4933ce16-8a70-47f9-b521-b74f6067ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4933ce16-8a70-47f9-b521-b74f6067ff5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0dcba0e8-7840-4733-bf44-c5922abf7bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_0dcba0e8-7840-4733-bf44-c5922abf7bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c55fc8f5-c3b7-4488-9726-995e8122959e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c55fc8f5-c3b7-4488-9726-995e8122959e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_aae814f2-cc4a-4a10-8d4a-91ddaa874a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_aae814f2-cc4a-4a10-8d4a-91ddaa874a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d9779a57-1343-4d0a-926b-d85afd9773ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_CommonStockValue_d9779a57-1343-4d0a-926b-d85afd9773ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1c7555e8-d585-4e2b-8f75-6b459d888fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1c7555e8-d585-4e2b-8f75-6b459d888fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2582a186-b056-486c-ba83-83bd356431c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_TreasuryStockValue_2582a186-b056-486c-ba83-83bd356431c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_792828ea-8df0-47c1-bac6-72c7d61f5c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_792828ea-8df0-47c1-bac6-72c7d61f5c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dbf28fd7-e92c-4101-a738-e3855e6463f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dbf28fd7-e92c-4101-a738-e3855e6463f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0a2d3ee3-605e-4a90-b68a-883f2985bad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_d05020c8-b378-4ab4-b977-49b24b3d07e6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0a2d3ee3-605e-4a90-b68a-883f2985bad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_35a31d6d-0af9-48bc-bbfc-4c42506319fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3ab0e334-f046-4089-ae93-45959538ded9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_35a31d6d-0af9-48bc-bbfc-4c42506319fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_320f440a-5b47-4d3a-a45f-9889edc2461b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_320f440a-5b47-4d3a-a45f-9889edc2461b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8849c7d1-07f8-492a-b941-b1aac08f3cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8849c7d1-07f8-492a-b941-b1aac08f3cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_75e4a8e2-aa20-4058-bb8d-87d2c8f7567c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_75e4a8e2-aa20-4058-bb8d-87d2c8f7567c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_47ef558f-c94f-4248-a95e-ad1bf72b8b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_PreferredStockSharesIssued_47ef558f-c94f-4248-a95e-ad1bf72b8b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_35162e5a-e6d2-46de-b919-797487d47c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_35162e5a-e6d2-46de-b919-797487d47c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_78260126-0504-4824-a012-29885932589f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_78260126-0504-4824-a012-29885932589f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_30e40713-f503-4d20-805a-4b66c0976a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_30e40713-f503-4d20-805a-4b66c0976a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d59c5cd8-d7b8-407b-8bb4-3a8a2668e88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_CommonStockSharesIssued_d59c5cd8-d7b8-407b-8bb4-3a8a2668e88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bb5df95a-a129-47ff-814f-da062b71aa38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bb5df95a-a129-47ff-814f-da062b71aa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_abfd5e6f-cb7f-4a45-b244-1f65b1a88e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c331eede-36cd-4ff1-a539-6a1e7e0a9064" xlink:to="loc_us-gaap_TreasuryStockShares_abfd5e6f-cb7f-4a45-b244-1f65b1a88e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_557dd783-4d52-4e5b-a074-2bd9340b5bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8b77114e-385d-48eb-a500-ba01bb6cf92a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_557dd783-4d52-4e5b-a074-2bd9340b5bde" xlink:to="loc_us-gaap_StatementTable_8b77114e-385d-48eb-a500-ba01bb6cf92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8b77114e-385d-48eb-a500-ba01bb6cf92a" xlink:to="loc_srt_ProductOrServiceAxis_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_16f4c176-d6d3-48ee-bfdd-88064f9b0b34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6da3c60f-e40a-4b1c-8b42-6d50b0eb5495" xlink:to="loc_srt_ProductsAndServicesDomain_16f4c176-d6d3-48ee-bfdd-88064f9b0b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8b77114e-385d-48eb-a500-ba01bb6cf92a" xlink:to="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db937ee0-1ec1-4c94-aada-1ecb46838fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_db937ee0-1ec1-4c94-aada-1ecb46838fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_a1e504ee-d592-4933-918b-ab8de226a849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:to="loc_us-gaap_CostOfRevenue_a1e504ee-d592-4933-918b-ab8de226a849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2c960ca2-4e53-4c22-8d99-d1c69393a6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_243ee714-6e03-40e8-b562-9a13857fdc9e" xlink:to="loc_us-gaap_GrossProfit_2c960ca2-4e53-4c22-8d99-d1c69393a6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2a835e2-c0a0-47b8-b1dc-850d9e9b1c0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e2a835e2-c0a0-47b8-b1dc-850d9e9b1c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a647ec89-ab9e-4748-9d00-820333878815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a647ec89-ab9e-4748-9d00-820333878815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringandstrategictransaction_6478c85e-e001-4b2e-9044-7dca431889e3" xlink:href="icui-20220331.xsd#icui_Restructuringandstrategictransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_icui_Restructuringandstrategictransaction_6478c85e-e001-4b2e-9044-7dca431889e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contractsettlement_47c7ae3e-5976-483f-a5cf-96b4026250f8" xlink:href="icui-20220331.xsd#icui_Contractsettlement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_icui_Contractsettlement_47c7ae3e-5976-483f-a5cf-96b4026250f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a5d88a6c-4e78-471a-9ec3-310b187244b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb6fc609-1f57-41f0-a61d-8a59c4fa5266" xlink:to="loc_us-gaap_OperatingExpenses_a5d88a6c-4e78-471a-9ec3-310b187244b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1cea31bc-4502-4217-9b0d-b80694c28bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_OperatingIncomeLoss_1cea31bc-4502-4217-9b0d-b80694c28bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3ff22c51-85ee-47ac-b948-3241a2d04aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_InterestExpense_3ff22c51-85ee-47ac-b948-3241a2d04aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_eb26e384-90c7-4283-9015-1960e7dacd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_eb26e384-90c7-4283-9015-1960e7dacd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c1535476-b929-4435-9209-233f96afe88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c1535476-b929-4435-9209-233f96afe88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_26fbfc7c-efa3-43fe-aeb4-90db3c26ed1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_26fbfc7c-efa3-43fe-aeb4-90db3c26ed1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c9a598c5-e7d7-418a-92e5-c9eb2c0782fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_ProfitLoss_c9a598c5-e7d7-418a-92e5-c9eb2c0782fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d652bae3-7960-4245-8167-0caf061a1f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:to="loc_us-gaap_EarningsPerShareBasic_d652bae3-7960-4245-8167-0caf061a1f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_847de671-50ed-42c5-baa8-bf6ba62906e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0fe7dd02-1958-4f0b-b4f9-1bfdb2c51ab5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_847de671-50ed-42c5-baa8-bf6ba62906e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_450d454b-0500-4939-8f17-c3aac2f9fc9d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ab321a0-35b5-45c7-b77f-a9c0e8236f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2ab321a0-35b5-45c7-b77f-a9c0e8236f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_950d4417-7ab8-45a7-b0b9-49c8abbf233d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_40a93114-f2c2-4930-9ad4-cb453278c86c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_950d4417-7ab8-45a7-b0b9-49c8abbf233d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d23e0787-115d-4547-b649-2eeec406f6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93622a6c-80a5-4e6a-b8fa-0b6291381620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d23e0787-115d-4547-b649-2eeec406f6f2" xlink:to="loc_us-gaap_StatementTable_93622a6c-80a5-4e6a-b8fa-0b6291381620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d11c6e88-9c35-4e34-89a7-affed4da110e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93622a6c-80a5-4e6a-b8fa-0b6291381620" xlink:to="loc_srt_StatementScenarioAxis_d11c6e88-9c35-4e34-89a7-affed4da110e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ae58b134-c18a-4f8c-88f0-d2346e2f678e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_d11c6e88-9c35-4e34-89a7-affed4da110e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ae58b134-c18a-4f8c-88f0-d2346e2f678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93622a6c-80a5-4e6a-b8fa-0b6291381620" xlink:to="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_80ab9bd9-c800-4f88-934f-59070be8571a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:to="loc_us-gaap_ProfitLoss_80ab9bd9-c800-4f88-934f-59070be8571a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a810f087-9419-4e5a-9628-04604b7ab332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_a810f087-9419-4e5a-9628-04604b7ab332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c10bd3e0-6227-4121-9613-3665b72993e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c10bd3e0-6227-4121-9613-3665b72993e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d4fbb81a-b930-4822-8dea-d6a005f300c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d4fbb81a-b930-4822-8dea-d6a005f300c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_51e94e39-bf97-4f6b-b113-aabee0470e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e22368bb-4fe0-43c2-a4b3-b0df2ada678f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_51e94e39-bf97-4f6b-b113-aabee0470e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_36becdbd-6743-4f82-92e1-bc8a4bf1eb99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_09105196-6f8e-4ce5-88be-835307683af9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_36becdbd-6743-4f82-92e1-bc8a4bf1eb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3e5e0ef8-c474-4d03-871b-c7fae48296c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_da265979-3501-436d-a72c-90ba207edb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3e5e0ef8-c474-4d03-871b-c7fae48296c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_da265979-3501-436d-a72c-90ba207edb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_f8b81a23-38c3-42e2-9bce-45cfbe0c4fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3e5e0ef8-c474-4d03-871b-c7fae48296c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_f8b81a23-38c3-42e2-9bce-45cfbe0c4fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_607e3f16-8635-4fba-bce0-0ab318a830b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_3e5e0ef8-c474-4d03-871b-c7fae48296c7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_607e3f16-8635-4fba-bce0-0ab318a830b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofStockholdersEquityStatement"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_92d9ed8f-3226-41ac-8e08-6a67f030645c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12ec75f3-a0c1-41b8-939d-e334e0fd9afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_92d9ed8f-3226-41ac-8e08-6a67f030645c" xlink:to="loc_us-gaap_StatementTable_12ec75f3-a0c1-41b8-939d-e334e0fd9afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_cee2e9b0-eae4-431b-91e1-e13053d1c6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12ec75f3-a0c1-41b8-939d-e334e0fd9afa" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_cee2e9b0-eae4-431b-91e1-e13053d1c6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_cee2e9b0-eae4-431b-91e1-e13053d1c6a6" xlink:to="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CommonStockSharesMember_119348a7-7cbe-4288-a0be-9d5c4b8e6c6c" xlink:href="icui-20220331.xsd#icui_CommonStockSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_icui_CommonStockSharesMember_119348a7-7cbe-4288-a0be-9d5c4b8e6c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_66b78d87-e033-4305-b568-d06c28b735e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_CommonStockMember_66b78d87-e033-4305-b568-d06c28b735e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0edf2923-5311-432d-8327-0d6602999b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0edf2923-5311-432d-8327-0d6602999b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_97abbda3-966a-4d58-85bc-acee21e0ceba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_TreasuryStockMember_97abbda3-966a-4d58-85bc-acee21e0ceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_eea5c911-a25f-416b-9bac-562f74111885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_RetainedEarningsMember_eea5c911-a25f-416b-9bac-562f74111885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2a90722-da4b-4213-b275-fd4191e5ed2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cde70f75-a330-4d9e-b7d1-68be959dca16" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c2a90722-da4b-4213-b275-fd4191e5ed2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_34a22aba-11db-48f6-8bd7-b8a7d2f7bcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12ec75f3-a0c1-41b8-939d-e334e0fd9afa" xlink:to="loc_us-gaap_StatementLineItems_34a22aba-11db-48f6-8bd7-b8a7d2f7bcc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_34a22aba-11db-48f6-8bd7-b8a7d2f7bcc5" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b0d9a2e6-16cc-4ee0-acfa-a3b79a52b125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b0d9a2e6-16cc-4ee0-acfa-a3b79a52b125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9a6cdbbb-fdc8-4135-b6af-d90ac845bfca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockholdersEquity_9a6cdbbb-fdc8-4135-b6af-d90ac845bfca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8975de65-93a4-44bd-824a-6f89efd482f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8975de65-93a4-44bd-824a-6f89efd482f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_404107a0-0174-4128-b2da-1e9dfcec8b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_404107a0-0174-4128-b2da-1e9dfcec8b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e3659c4c-df43-493c-b143-1af9f06e8490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_e3659c4c-df43-493c-b143-1af9f06e8490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_28ef0db6-ae63-489d-a1ed-5adbf0491245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_28ef0db6-ae63-489d-a1ed-5adbf0491245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0f0dea0e-fa54-4800-98c5-0affd903535a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0f0dea0e-fa54-4800-98c5-0affd903535a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4247037c-e5e8-4fbe-b1ed-3b3f868016d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4247037c-e5e8-4fbe-b1ed-3b3f868016d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_59e9c9dc-79a4-49bc-8f4f-c7c92e242554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_59e9c9dc-79a4-49bc-8f4f-c7c92e242554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e0ba106b-1b00-4f8c-9c2f-a8e0d7aa065f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e0ba106b-1b00-4f8c-9c2f-a8e0d7aa065f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_232f6cee-4d6b-4467-8f9c-4be4e1650642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_232f6cee-4d6b-4467-8f9c-4be4e1650642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8c267532-c82f-40fd-8d88-51c44439ccb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_NetIncomeLoss_8c267532-c82f-40fd-8d88-51c44439ccb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_130a2f6c-3b41-444f-b8b3-63b09deccffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_StockholdersEquity_130a2f6c-3b41-444f-b8b3-63b09deccffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c6ed15ac-3ee0-4e4c-9b69-63974b091016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c6ed15ac-3ee0-4e4c-9b69-63974b091016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7c0d83fe-5bb2-43ce-a5fd-21878050d41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_98f2449a-6f54-4e53-a1dc-e2db4ae2c93a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7c0d83fe-5bb2-43ce-a5fd-21878050d41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="icui-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4555ea3e-1a1a-4d06-bdb8-76cf7ee16445" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4555ea3e-1a1a-4d06-bdb8-76cf7ee16445" xlink:to="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0a6bd7a5-6f17-490c-acba-7968ce928da0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:to="loc_srt_StatementScenarioAxis_0a6bd7a5-6f17-490c-acba-7968ce928da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_8ce2fa46-9b12-4a81-a9b3-3fa0147c63d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0a6bd7a5-6f17-490c-acba-7968ce928da0" xlink:to="loc_srt_ScenarioUnspecifiedDomain_8ce2fa46-9b12-4a81-a9b3-3fa0147c63d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_01decb7f-e365-454d-b5d5-f6ac2c61fc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_01decb7f-e365-454d-b5d5-f6ac2c61fc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cface4c3-f2e0-4e78-9b4e-fa9b19fb98a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_01decb7f-e365-454d-b5d5-f6ac2c61fc9e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cface4c3-f2e0-4e78-9b4e-fa9b19fb98a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_017182ee-265d-4f22-9f03-fde89b981cc1" xlink:to="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:to="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c7909c91-2f57-414f-8ab7-f8dc50e5c8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_ProfitLoss_c7909c91-2f57-414f-8ab7-f8dc50e5c8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_78623660-277e-47aa-83a2-6e2c081be434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_78623660-277e-47aa-83a2-6e2c081be434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_229d9250-b004-4ffb-8094-4964e7b06ede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_229d9250-b004-4ffb-8094-4964e7b06ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_80d5ea72-701d-4b78-9c7d-407a59706e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_80d5ea72-701d-4b78-9c7d-407a59706e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c15b90db-b557-45b1-b052-fc67ef20223e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c15b90db-b557-45b1-b052-fc67ef20223e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f232833d-fd49-43ca-97d2-df2fe2541092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f232833d-fd49-43ca-97d2-df2fe2541092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_023b6f73-1190-4ddf-870c-bb625b1fdd60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_023b6f73-1190-4ddf-870c-bb625b1fdd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_ae984c65-e540-414c-a2ee-250bcfbc2c34" xlink:href="icui-20220331.xsd#icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes_ae984c65-e540-414c-a2ee-250bcfbc2c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_d619d71d-7a58-4ccd-9bb2-cac962d6eb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_d619d71d-7a58-4ccd-9bb2-cac962d6eb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AmortizationOfInventoryStepUp_65c31c74-a462-499e-8c1b-03ca08eac099" xlink:href="icui-20220331.xsd#icui_AmortizationOfInventoryStepUp"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_AmortizationOfInventoryStepUp_65c31c74-a462-499e-8c1b-03ca08eac099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c141e5f4-3613-4022-a229-4c20ebf8c64a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c141e5f4-3613-4022-a229-4c20ebf8c64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_3577aee7-9def-408f-9d82-09ebccd19a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_3577aee7-9def-408f-9d82-09ebccd19a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProvisionForWarrantyAndReturns_756a4452-6da8-4506-93a6-60710455a112" xlink:href="icui-20220331.xsd#icui_ProvisionForWarrantyAndReturns"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_ProvisionForWarrantyAndReturns_756a4452-6da8-4506-93a6-60710455a112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e88d453d-ec12-4134-b4c1-408beaa73719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_ShareBasedCompensation_e88d453d-ec12-4134-b4c1-408beaa73719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ee39ad6f-45b1-4a8f-9ebf-ca225e7cfacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_ee39ad6f-45b1-4a8f-9ebf-ca225e7cfacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_5a4d546b-f5af-401b-9d2f-2908f72031bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfPremium"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_InvestmentIncomeAmortizationOfPremium_5a4d546b-f5af-401b-9d2f-2908f72031bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_20c91fda-d55f-452b-b4cb-f06c7c30e4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_20c91fda-d55f-452b-b4cb-f06c7c30e4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Sparepartsusage_83f04fad-b575-4ef3-9381-1d627089b7b3" xlink:href="icui-20220331.xsd#icui_Sparepartsusage"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_icui_Sparepartsusage_83f04fad-b575-4ef3-9381-1d627089b7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e68413de-bc19-4fe6-a031-4c4aeeb2aca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e68413de-bc19-4fe6-a031-4c4aeeb2aca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88b3b4cd-fff3-4d08-a6aa-7ddfe3fcbd67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1ec3229a-4629-4b63-8dda-357052edbbb8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_88b3b4cd-fff3-4d08-a6aa-7ddfe3fcbd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80d1ba6b-d2e3-4071-8ca7-2997bbe629ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80d1ba6b-d2e3-4071-8ca7-2997bbe629ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d1849604-fa85-4f67-aa5b-440a47da89fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d1849604-fa85-4f67-aa5b-440a47da89fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4857fc6d-3513-4f69-91a5-193c4fc9c5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4857fc6d-3513-4f69-91a5-193c4fc9c5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f1cd59a9-9639-4959-b0b7-91edc3e55c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_f1cd59a9-9639-4959-b0b7-91edc3e55c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d354702a-8673-4a0b-86e3-f29337704a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_d354702a-8673-4a0b-86e3-f29337704a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad79188-8d50-494c-9392-d9d9c787376c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a5e6da52-2859-450d-bd1e-713d13ae2113" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3ad79188-8d50-494c-9392-d9d9c787376c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract_752d3a09-14f7-499f-81ee-adc4ea559101" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_a1b7ee77-8f5c-42d6-8ea4-103989f118c8" xlink:href="icui-20220331.xsd#icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts_a1b7ee77-8f5c-42d6-8ea4-103989f118c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_726ac97c-5f4d-4cc2-ad3b-0c3cb8109c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_726ac97c-5f4d-4cc2-ad3b-0c3cb8109c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3c57acc5-a317-4d4c-89d4-486750abbeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_3c57acc5-a317-4d4c-89d4-486750abbeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b74230b1-9a11-42c7-a06c-095f0c6e3d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b74230b1-9a11-42c7-a06c-095f0c6e3d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_9c3daba2-fc9a-4492-ba7f-772290e5ef30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_9c3daba2-fc9a-4492-ba7f-772290e5ef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b9dbd601-4ea4-4d68-9db5-249a4bf8a8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b9dbd601-4ea4-4d68-9db5-249a4bf8a8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3034d98-b375-414b-a689-4e123ed86474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ed59633-ea9e-4868-ae3f-874627ed3261" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3034d98-b375-414b-a689-4e123ed86474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_bd7e2e84-7753-4215-96d7-878a6fe813c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_e9b15309-69c6-4c41-bcc9-4a03b4250e67" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_bd7e2e84-7753-4215-96d7-878a6fe813c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_f45af9e8-e3d1-4c70-af1c-e7cbb584c2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAbstract_bd7e2e84-7753-4215-96d7-878a6fe813c9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations_f45af9e8-e3d1-4c70-af1c-e7cbb584c2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f01bd0f3-b3d4-4cf0-8fda-700edf410b35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f01bd0f3-b3d4-4cf0-8fda-700edf410b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ebfcbfd3-7022-44e5-9077-fc4b34c46568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ebfcbfd3-7022-44e5-9077-fc4b34c46568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d2ccab67-7283-4d57-afe2-205c8917d986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d2ccab67-7283-4d57-afe2-205c8917d986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_703e7d4f-9a80-4619-b347-715ef28f5c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d2ccab67-7283-4d57-afe2-205c8917d986" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_703e7d4f-9a80-4619-b347-715ef28f5c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a5484a79-4f38-4e50-9a86-e6a647894312" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_bd0cd037-d38e-4e17-bcae-d8e3c6c21b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_bd0cd037-d38e-4e17-bcae-d8e3c6c21b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a0c7a302-d589-4828-822b-6e3824eb3e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a0c7a302-d589-4828-822b-6e3824eb3e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_9eebfee2-be77-47f3-ab0d-d9d80f6c7735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_9eebfee2-be77-47f3-ab0d-d9d80f6c7735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationAllAcquisitions_b6bea2ba-1386-4aa4-8921-0c40da217602" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationAllAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_icui_ContingentConsiderationAllAcquisitions_b6bea2ba-1386-4aa4-8921-0c40da217602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_ef8655d3-7deb-4e03-8efa-2d105f3d5da1" xlink:href="icui-20220331.xsd#icui_GoodwillAcquiredDuringPeriodAllAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_icui_GoodwillAcquiredDuringPeriodAllAcquisitions_ef8655d3-7deb-4e03-8efa-2d105f3d5da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_6158b62a-3a0f-4b95-ab09-1c70e93441ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9bfc0e61-3528-47ce-8eb0-144a9e282bd8" xlink:to="loc_us-gaap_LiabilitiesAssumed1_6158b62a-3a0f-4b95-ab09-1c70e93441ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BasisofPresentation" xlink:type="simple" xlink:href="icui-20220331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bd1c82ba-9276-44ac-9585-cc78a7a48567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_de704442-efbd-4b03-b97c-1b1b0bd555ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bd1c82ba-9276-44ac-9585-cc78a7a48567" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_de704442-efbd-4b03-b97c-1b1b0bd555ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="icui-20220331.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_6e041aed-29d2-4e9f-b5f1-5c9f2f5fc7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_cc4245bc-2d3f-41c8-89b1-456657939ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_6e041aed-29d2-4e9f-b5f1-5c9f2f5fc7ac" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_cc4245bc-2d3f-41c8-89b1-456657939ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_02e4f05e-2b5c-4b6c-8dfa-da8e7bb56ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" xlink:type="simple" xlink:href="icui-20220331.xsd#NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NewAccountingPronouncementsNewAccountingPronouncementsAdoptedPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitions"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6cce67fe-e32b-4f56-8c6d-2e8b1df40ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a10612e0-8ba8-402f-8258-7d6dd284135e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_6cce67fe-e32b-4f56-8c6d-2e8b1df40ee0" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a10612e0-8ba8-402f-8258-7d6dd284135e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d0fdb691-0cbb-4aad-a007-9ac45786ff68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_63ff8483-dfc0-4db7-9339-290c2711a7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d0fdb691-0cbb-4aad-a007-9ac45786ff68" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_63ff8483-dfc0-4db7-9339-290c2711a7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_ed1026f1-4b4d-44df-a9fe-db2785edcece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d0fdb691-0cbb-4aad-a007-9ac45786ff68" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_ed1026f1-4b4d-44df-a9fe-db2785edcece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eefb246e-4a45-4121-95d7-e54b78e865aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_19e622cd-2ffb-4325-840d-1f090515ce75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eefb246e-4a45-4121-95d7-e54b78e865aa" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_19e622cd-2ffb-4325-840d-1f090515ce75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e78e5f6a-f3df-4868-a62f-e51b0c6bae47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_19e622cd-2ffb-4325-840d-1f090515ce75" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e78e5f6a-f3df-4868-a62f-e51b0c6bae47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64cd4fe6-62b0-4fea-9bfd-f954588769be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e78e5f6a-f3df-4868-a62f-e51b0c6bae47" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64cd4fe6-62b0-4fea-9bfd-f954588769be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_c983fc36-ddff-475c-9ce1-fac9dac2ef7c" xlink:href="icui-20220331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64cd4fe6-62b0-4fea-9bfd-f954588769be" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_c983fc36-ddff-475c-9ce1-fac9dac2ef7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_19e622cd-2ffb-4325-840d-1f090515ce75" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d43a9f3d-bcc7-4ae6-9089-6d077f2b0d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d43a9f3d-bcc7-4ae6-9089-6d077f2b0d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_92da397a-8068-4420-9f19-ef5e61cc5917" xlink:href="icui-20220331.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_Contingentconsiderationgross_92da397a-8068-4420-9f19-ef5e61cc5917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_175521f7-f2ed-4c99-842f-f7d2144079b6" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_ContingentConsiderationGrossST_175521f7-f2ed-4c99-842f-f7d2144079b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_8a1c4247-9250-4593-95d4-d07c22687189" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_ContingentConsiderationGrossLT_8a1c4247-9250-4593-95d4-d07c22687189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationHoldbackLiability_4854cbb8-6315-4031-881d-148d30ca2064" xlink:href="icui-20220331.xsd#icui_BusinessCombinationConsiderationHoldbackLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_icui_BusinessCombinationConsiderationHoldbackLiability_4854cbb8-6315-4031-881d-148d30ca2064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9ad13ef3-a315-41e3-9c96-19f44f666679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_89f64707-20c3-4c0e-8b15-4c75b8ef9722" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9ad13ef3-a315-41e3-9c96-19f44f666679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e7f19c54-d16e-41a0-9f92-b2da9fd09c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af9985d9-fdb9-46a1-8772-f8c37770a848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e7f19c54-d16e-41a0-9f92-b2da9fd09c62" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af9985d9-fdb9-46a1-8772-f8c37770a848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a403b674-f2e9-42fb-a00c-e746cad9b65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af9985d9-fdb9-46a1-8772-f8c37770a848" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a403b674-f2e9-42fb-a00c-e746cad9b65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98011959-287a-438d-aded-0deea35b2190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a403b674-f2e9-42fb-a00c-e746cad9b65e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98011959-287a-438d-aded-0deea35b2190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_f844b24d-6e49-4425-be0a-92f8c61715e4" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98011959-287a-438d-aded-0deea35b2190" xlink:to="loc_icui_SmithsMedicalMember_f844b24d-6e49-4425-be0a-92f8c61715e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_af9985d9-fdb9-46a1-8772-f8c37770a848" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a561e857-955b-4286-ba97-d70918dc8cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a561e857-955b-4286-ba97-d70918dc8cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationConsiderationTransferredCash_b3815df7-cf9b-48b9-8c32-6d6caa2eedb0" xlink:href="icui-20220331.xsd#icui_BusinessCombinationConsiderationTransferredCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_icui_BusinessCombinationConsiderationTransferredCash_b3815df7-cf9b-48b9-8c32-6d6caa2eedb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_bffbc939-8411-47b2-b5d9-6f5b3b3f32fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_bffbc939-8411-47b2-b5d9-6f5b3b3f32fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_de431c1e-a1fe-4865-8b9c-dd4195c74e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_de431c1e-a1fe-4865-8b9c-dd4195c74e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MinimumStockPriceTargetForEarnOutPayment_9dd3429b-6461-4237-b0b8-ea0072297b2b" xlink:href="icui-20220331.xsd#icui_MinimumStockPriceTargetForEarnOutPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_icui_MinimumStockPriceTargetForEarnOutPayment_9dd3429b-6461-4237-b0b8-ea0072297b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_fe290f27-c7c7-4d92-ae23-906f720ff471" xlink:href="icui-20220331.xsd#icui_RequiredShareHoldingOfStockIssuedAtAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_bf131d60-6ba5-4a0e-9980-6c19d170f082" xlink:to="loc_icui_RequiredShareHoldingOfStockIssuedAtAcquisition_fe290f27-c7c7-4d92-ae23-906f720ff471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8cbc4f28-6b72-4d67-b173-b3ec1c6f813d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8cbc4f28-6b72-4d67-b173-b3ec1c6f813d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_787cf311-ade7-48ee-a59a-f2b556f1cc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_787cf311-ade7-48ee-a59a-f2b556f1cc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b15c071f-bfec-4098-9173-44bf8dbf759f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_787cf311-ade7-48ee-a59a-f2b556f1cc2b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b15c071f-bfec-4098-9173-44bf8dbf759f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_89117ddc-5005-4341-a6cf-e1a0fa46a584" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b15c071f-bfec-4098-9173-44bf8dbf759f" xlink:to="loc_icui_SmithsMedicalMember_89117ddc-5005-4341-a6cf-e1a0fa46a584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0615ce28-c87d-423e-90b3-824680f67311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0615ce28-c87d-423e-90b3-824680f67311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0615ce28-c87d-423e-90b3-824680f67311" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6b1ba9a4-123f-4a07-ab01-97c180849429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6b1ba9a4-123f-4a07-ab01-97c180849429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DevelopedTechnologyMember_4ca9933b-46f2-4c1d-9849-cc01fe5fb015" xlink:href="icui-20220331.xsd#icui_DevelopedTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:to="loc_icui_DevelopedTechnologyMember_4ca9933b-46f2-4c1d-9849-cc01fe5fb015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_040493a5-7008-4dc4-b247-be68397d5d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bf5e1b5c-f354-4f6a-a54e-e39424792789" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_040493a5-7008-4dc4-b247-be68397d5d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_40476f78-7630-44a0-b611-a443c745ea05" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_454bc27f-713d-42ee-8fd2-4a208d587fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_454bc27f-713d-42ee-8fd2-4a208d587fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_9845680b-a75e-47bd-b67b-aeb2f1fc113f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_9845680b-a75e-47bd-b67b-aeb2f1fc113f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_910be676-b08a-40c5-b063-c083feac08a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_910be676-b08a-40c5-b063-c083feac08a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_a69f8308-3071-4d05-a7da-f4f8d0c37f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_a69f8308-3071-4d05-a7da-f4f8d0c37f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_32be385e-740a-449e-aed4-cb76dd5d611c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_32be385e-740a-449e-aed4-cb76dd5d611c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1229d1c0-0728-47b6-a593-3596be7f917f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1229d1c0-0728-47b6-a593-3596be7f917f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a0410568-1a8f-40dc-96ab-d26e6d55193b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a0410568-1a8f-40dc-96ab-d26e6d55193b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_51eaa169-37b0-454c-af82-9debcc9d6f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_51eaa169-37b0-454c-af82-9debcc9d6f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ba6544f3-45bd-46da-8f1c-dfe7e3cef302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_ba6544f3-45bd-46da-8f1c-dfe7e3cef302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_51452a1e-20ef-4c13-813b-6f4b56f6e974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_51452a1e-20ef-4c13-813b-6f4b56f6e974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_f0cd72e5-9bf0-4814-a5a3-8eb7cb2699af" xlink:href="icui-20220331.xsd#icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed_f0cd72e5-9bf0-4814-a5a3-8eb7cb2699af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e32000ff-aecf-4b26-90eb-700186c0124e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_e32000ff-aecf-4b26-90eb-700186c0124e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_ae4010c3-3cf0-42eb-8052-ad14a5fcfb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_ae4010c3-3cf0-42eb-8052-ad14a5fcfb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_501d1d94-21e5-4fdb-8b6f-1a61dd332304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_501d1d94-21e5-4fdb-8b6f-1a61dd332304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fdb2e3ce-18ba-4ff8-8c0e-84adec783780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_fdb2e3ce-18ba-4ff8-8c0e-84adec783780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b8f682e0-8883-4ce3-bc68-299815fc758b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_b8f682e0-8883-4ce3-bc68-299815fc758b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_39b2c40f-2256-4438-b1a9-1110fda89f8d" xlink:href="icui-20220331.xsd#icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable_39b2c40f-2256-4438-b1a9-1110fda89f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4daf7a3c-998f-4ab5-9720-770ec441a50c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_4daf7a3c-998f-4ab5-9720-770ec441a50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_51a5b115-f609-4e64-84d2-bedc0ae7f597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_51a5b115-f609-4e64-84d2-bedc0ae7f597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_665d1eb5-9739-4add-ae12-11047adbeac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_665d1eb5-9739-4add-ae12-11047adbeac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_BusinessCombinationGoodwillNonDeductible_d1375867-5080-465b-b6e7-b5812e520d21" xlink:href="icui-20220331.xsd#icui_BusinessCombinationGoodwillNonDeductible"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_icui_BusinessCombinationGoodwillNonDeductible_d1375867-5080-465b-b6e7-b5812e520d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35b5091e-cf71-4d98-9a13-636d80deebb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8d9f9dcd-ab86-415f-9950-5b84d51b82b6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_35b5091e-cf71-4d98-9a13-636d80deebb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5fbc606-7fc0-45d6-b991-ba82229e7a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_92067dd6-adca-46d6-b29a-09700f71f00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5fbc606-7fc0-45d6-b991-ba82229e7a7c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_92067dd6-adca-46d6-b29a-09700f71f00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_92067dd6-adca-46d6-b29a-09700f71f00f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d8efb276-0405-4487-b738-1f30f541e50a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d8efb276-0405-4487-b738-1f30f541e50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f94a64f-df78-4b5c-914a-e15d57af6180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d8efb276-0405-4487-b738-1f30f541e50a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f94a64f-df78-4b5c-914a-e15d57af6180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_92f44008-e82e-4083-98fe-42168461046a" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2f94a64f-df78-4b5c-914a-e15d57af6180" xlink:to="loc_icui_SmithsMedicalMember_92f44008-e82e-4083-98fe-42168461046a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_687ca6cb-5e52-4548-b1bf-32565b6e839f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_687ca6cb-5e52-4548-b1bf-32565b6e839f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_4fe6e398-a264-4cb3-9077-6ccd2fae6216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_687ca6cb-5e52-4548-b1bf-32565b6e839f" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_4fe6e398-a264-4cb3-9077-6ccd2fae6216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_8d1b4b32-94de-4d8d-b972-33b0dca2679a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_4fe6e398-a264-4cb3-9077-6ccd2fae6216" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_8d1b4b32-94de-4d8d-b972-33b0dca2679a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5411bc31-4483-404d-a55b-50bdb1f7b701" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b4cd73b4-1528-4652-99f9-9a4b01b7f41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:to="loc_us-gaap_Revenues_b4cd73b4-1528-4652-99f9-9a4b01b7f41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a436352b-a7b7-49e4-aabc-7e6568fa6566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:to="loc_us-gaap_ProfitLoss_a436352b-a7b7-49e4-aabc-7e6568fa6566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_957ccc43-7a34-4649-a6d6-ea27aca8a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8abbb9f3-c304-4b20-9160-9b187be7256e" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_957ccc43-7a34-4649-a6d6-ea27aca8a4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ee0ae9c9-e23d-42f6-bbcd-17b8ac7e2170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5fbc606-7fc0-45d6-b991-ba82229e7a7c" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ee0ae9c9-e23d-42f6-bbcd-17b8ac7e2170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentAmortization_64839ff6-ff6d-49a1-a775-a9683d3d17b2" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5fbc606-7fc0-45d6-b991-ba82229e7a7c" xlink:to="loc_icui_ProFormaAdjustmentAmortization_64839ff6-ff6d-49a1-a775-a9683d3d17b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentFinanceCosts_7182814c-28d3-4181-8b0b-08afbccf4b4f" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentFinanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5fbc606-7fc0-45d6-b991-ba82229e7a7c" xlink:to="loc_icui_ProFormaAdjustmentFinanceCosts_7182814c-28d3-4181-8b0b-08afbccf4b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentInventory_0e287629-8472-431e-901e-3993b44ec9e3" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5fbc606-7fc0-45d6-b991-ba82229e7a7c" xlink:to="loc_icui_ProFormaAdjustmentInventory_0e287629-8472-431e-901e-3993b44ec9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ProFormaAdjustmentRelatedPartyLoans_2edd483b-131b-4950-88c1-742a86092d12" xlink:href="icui-20220331.xsd#icui_ProFormaAdjustmentRelatedPartyLoans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5fbc606-7fc0-45d6-b991-ba82229e7a7c" xlink:to="loc_icui_ProFormaAdjustmentRelatedPartyLoans_2edd483b-131b-4950-88c1-742a86092d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#RestructuringStrategicTransactionandIntegrationNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4eabf788-0cad-4315-9245-4519f007753f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_4f16d0b1-53d7-45bd-91d4-d75dc346f715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4eabf788-0cad-4315-9245-4519f007753f" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_4f16d0b1-53d7-45bd-91d4-d75dc346f715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables" xlink:type="simple" xlink:href="icui-20220331.xsd#RestructuringStrategicTransactionandIntegrationTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1eba662d-fdef-4cb3-a999-43f949706425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_75e66acd-bd87-4a1f-8f30-9dd14f426868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_1eba662d-fdef-4cb3-a999-43f949706425" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_75e66acd-bd87-4a1f-8f30-9dd14f426868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RestructuringStrategicTransactionandIntegrationRestructuringDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a9f113ad-d5b3-4e41-984b-cf037c6a44e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Restructuringstrategictransactionandintegration_87363964-a684-4141-a7b7-68868e3ed1df" xlink:href="icui-20220331.xsd#icui_Restructuringstrategictransactionandintegration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a9f113ad-d5b3-4e41-984b-cf037c6a44e6" xlink:to="loc_icui_Restructuringstrategictransactionandintegration_87363964-a684-4141-a7b7-68868e3ed1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_63293736-9e4a-44d6-bb91-0f8cdf9daf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_a9f113ad-d5b3-4e41-984b-cf037c6a44e6" xlink:to="loc_us-gaap_RestructuringCosts_63293736-9e4a-44d6-bb91-0f8cdf9daf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RestructuringStrategicTransactionandIntegrationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_73607b9d-1035-48c5-b2fe-ac5d8f6e048a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fa61ba3d-8a39-4618-8f24-73fcd8fdbf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_73607b9d-1035-48c5-b2fe-ac5d8f6e048a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fa61ba3d-8a39-4618-8f24-73fcd8fdbf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_653f36fb-54d7-40d3-a04d-3f173cd95966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fa61ba3d-8a39-4618-8f24-73fcd8fdbf71" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_653f36fb-54d7-40d3-a04d-3f173cd95966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_653f36fb-54d7-40d3-a04d-3f173cd95966" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_6c626e92-19e9-4cb8-8c6f-ed58619dabf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:to="loc_us-gaap_EmployeeSeveranceMember_6c626e92-19e9-4cb8-8c6f-ed58619dabf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FacilityClosingMember_119de4dd-da35-4a09-acbe-15d48338a1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FacilityClosingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d2fe0046-1384-466a-9041-9410a924d738" xlink:to="loc_us-gaap_FacilityClosingMember_119de4dd-da35-4a09-acbe-15d48338a1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_fa61ba3d-8a39-4618-8f24-73fcd8fdbf71" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_22b945c7-7328-46aa-b4da-7fc207b71475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_RestructuringReserve_22b945c7-7328-46aa-b4da-7fc207b71475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_f76e8062-8344-4bc0-8e9f-e92aac733349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_RestructuringCharges_f76e8062-8344-4bc0-8e9f-e92aac733349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f075c821-0aa9-4d84-b2f1-b7167b0f0d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_PaymentsForRestructuring_f075c821-0aa9-4d84-b2f1-b7167b0f0d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_60655d9f-fa01-4144-91d5-d9777b9507ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_60655d9f-fa01-4144-91d5-d9777b9507ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_2f26eddd-46b0-42cf-824e-88b2be3b1472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_RestructuringReserve_2f26eddd-46b0-42cf-824e-88b2be3b1472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_cfeac958-1872-4ea2-b07c-666977e2a47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_bb8d0229-86c6-4597-aff0-a151c72d2112" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities_cfeac958-1872-4ea2-b07c-666977e2a47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#StrategicTransactionandIntegrationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/StrategicTransactionandIntegrationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aff5878c-f9dd-4b2c-b382-04df697f9409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_StrategicTransactionandIntegration_011f5333-6ddb-49fa-924c-625c661c4038" xlink:href="icui-20220331.xsd#icui_StrategicTransactionandIntegration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_aff5878c-f9dd-4b2c-b382-04df697f9409" xlink:to="loc_icui_StrategicTransactionandIntegration_011f5333-6ddb-49fa-924c-625c661c4038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0993e0ba-74b3-41f9-96f9-b5d65b661e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_302194af-ca79-406f-9d99-4bb8ea02307a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0993e0ba-74b3-41f9-96f9-b5d65b661e51" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_302194af-ca79-406f-9d99-4bb8ea02307a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueTables" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_798f38a2-c8ec-4ff8-b1b6-19e99e144b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_eb583d6c-f3f8-458b-b328-04500f1b60a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_798f38a2-c8ec-4ff8-b1b6-19e99e144b8c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_eb583d6c-f3f8-458b-b328-04500f1b60a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d3870d9b-70a9-4a58-b0f2-97f4ffd5f29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_798f38a2-c8ec-4ff8-b1b6-19e99e144b8c" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d3870d9b-70a9-4a58-b0f2-97f4ffd5f29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d2409996-b737-438e-9ddb-edf3bc66804a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ae7a5cb3-af47-4147-806c-bc09ae50874f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d2409996-b737-438e-9ddb-edf3bc66804a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ae7a5cb3-af47-4147-806c-bc09ae50874f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b76e90f3-b8da-4e1a-8235-e2b3f82a10db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae7a5cb3-af47-4147-806c-bc09ae50874f" xlink:to="loc_srt_ProductOrServiceAxis_b76e90f3-b8da-4e1a-8235-e2b3f82a10db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b76e90f3-b8da-4e1a-8235-e2b3f82a10db" xlink:to="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_7eaca74e-d611-4663-b22d-c78bff767158" xlink:href="icui-20220331.xsd#icui_InfusionSystemsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:to="loc_icui_InfusionSystemsMember_7eaca74e-d611-4663-b22d-c78bff767158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_b185b171-258a-43ed-8a67-50fadfe024b6" xlink:href="icui-20220331.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:to="loc_icui_EquipmentrevenueMember_b185b171-258a-43ed-8a67-50fadfe024b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_3de29b1e-8f62-443d-86b1-29cca64e4a9f" xlink:href="icui-20220331.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1d9d0798-c686-4660-8a97-456144f871d7" xlink:to="loc_icui_SoftwarerevenueMember_3de29b1e-8f62-443d-86b1-29cca64e4a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_853bc8a7-5aaa-485b-9a58-8bc78c693493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae7a5cb3-af47-4147-806c-bc09ae50874f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_853bc8a7-5aaa-485b-9a58-8bc78c693493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5cd50d8a-929d-4b18-8260-cc876aa00169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_853bc8a7-5aaa-485b-9a58-8bc78c693493" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5cd50d8a-929d-4b18-8260-cc876aa00169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueDisaggregatedRevenuebyGeographyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9414cbc1-ed7b-4080-b1bc-5dc958876f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_69383135-1346-4c63-90e7-1fae8f4f1e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9414cbc1-ed7b-4080-b1bc-5dc958876f4a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_69383135-1346-4c63-90e7-1fae8f4f1e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_292fb9a0-f4af-4879-b5e0-44b350de31e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_69383135-1346-4c63-90e7-1fae8f4f1e31" xlink:to="loc_srt_StatementGeographicalAxis_292fb9a0-f4af-4879-b5e0-44b350de31e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_292fb9a0-f4af-4879-b5e0-44b350de31e8" xlink:to="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_2f1d78d0-da74-48d1-92fe-bd57d17d874d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_us-gaap_EMEAMember_2f1d78d0-da74-48d1-92fe-bd57d17d874d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherforeigncountriesMember_a24ffe15-adcf-40b5-94b0-9ecf3f45402c" xlink:href="icui-20220331.xsd#icui_OtherforeigncountriesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_icui_OtherforeigncountriesMember_a24ffe15-adcf-40b5-94b0-9ecf3f45402c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignMember_4994ec34-c241-494e-8c5c-828b3eefd9d1" xlink:href="icui-20220331.xsd#icui_ForeignMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_icui_ForeignMember_4994ec34-c241-494e-8c5c-828b3eefd9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a8c60026-c8b8-4020-bfe4-05be022a1e2a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_44903123-4a74-462f-999c-94130d76e0b5" xlink:to="loc_country_US_a8c60026-c8b8-4020-bfe4-05be022a1e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_577a900e-c912-47cd-8fb2-9bce19319ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_69383135-1346-4c63-90e7-1fae8f4f1e31" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_577a900e-c912-47cd-8fb2-9bce19319ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b45fe5dd-a57d-45b6-a95c-35f2e6adf20b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_577a900e-c912-47cd-8fb2-9bce19319ca2" xlink:to="loc_us-gaap_Revenues_b45fe5dd-a57d-45b6-a95c-35f2e6adf20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueDisaggregatedRevenuebyProductLineDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4ebb145-2f10-4e7a-b6ab-1cf5d3303973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ef5397b3-1250-4ee5-94fd-30ad6fb95846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4ebb145-2f10-4e7a-b6ab-1cf5d3303973" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ef5397b3-1250-4ee5-94fd-30ad6fb95846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a3e58776-6677-4dc8-acd8-8d0fe4d35d79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef5397b3-1250-4ee5-94fd-30ad6fb95846" xlink:to="loc_srt_ProductOrServiceAxis_a3e58776-6677-4dc8-acd8-8d0fe4d35d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a3e58776-6677-4dc8-acd8-8d0fe4d35d79" xlink:to="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesMember_e2d1a306-6aaa-4ca6-a913-e636dd489977" xlink:href="icui-20220331.xsd#icui_InfusionConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_InfusionConsumablesMember_e2d1a306-6aaa-4ca6-a913-e636dd489977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionSystemsMember_74294216-93dc-4573-9d03-b97ff5b22f0a" xlink:href="icui-20220331.xsd#icui_InfusionSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_InfusionSystemsMember_74294216-93dc-4573-9d03-b97ff5b22f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_IVSolutionsMember_d17d7fe5-a589-4d1f-9870-70e8454fc3c8" xlink:href="icui-20220331.xsd#icui_IVSolutionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_IVSolutionsMember_d17d7fe5-a589-4d1f-9870-70e8454fc3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CriticalCareMember_ebf3dc46-93c3-478d-a4d3-054cbe3105c5" xlink:href="icui-20220331.xsd#icui_CriticalCareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_CriticalCareMember_ebf3dc46-93c3-478d-a4d3-054cbe3105c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InfusionConsumablesSmithsMedicalMember_bd31c93c-5a4c-4b3e-9af7-9a10484b1dad" xlink:href="icui-20220331.xsd#icui_InfusionConsumablesSmithsMedicalMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_InfusionConsumablesSmithsMedicalMember_bd31c93c-5a4c-4b3e-9af7-9a10484b1dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VascularAccessMember_b1967680-d9ce-42ab-ba2f-76d78124b89a" xlink:href="icui-20220331.xsd#icui_VascularAccessMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_VascularAccessMember_b1967680-d9ce-42ab-ba2f-76d78124b89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_VitalCareMember_56b0057e-c78a-461a-8dce-cae017546742" xlink:href="icui-20220331.xsd#icui_VitalCareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_826f8bd7-54b2-41c1-8391-a87e77ea12e3" xlink:to="loc_icui_VitalCareMember_56b0057e-c78a-461a-8dce-cae017546742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_101add8c-6855-4b9f-a61a-227d048829be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef5397b3-1250-4ee5-94fd-30ad6fb95846" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_101add8c-6855-4b9f-a61a-227d048829be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_65585075-114a-453d-bdd4-21287e5f6cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_101add8c-6855-4b9f-a61a-227d048829be" xlink:to="loc_us-gaap_Revenues_65585075-114a-453d-bdd4-21287e5f6cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#RevenueContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/RevenueContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ca7941e8-eaf5-4e29-819b-77f27da4c540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:href="icui-20220331.xsd#icui_ContractassetandliabilitybalancesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ca7941e8-eaf5-4e29-819b-77f27da4c540" xlink:to="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_509aa0dc-b058-4c27-af41-7fc9558e8174" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:to="loc_srt_ProductOrServiceAxis_509aa0dc-b058-4c27-af41-7fc9558e8174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_509aa0dc-b058-4c27-af41-7fc9558e8174" xlink:to="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EquipmentrevenueMember_b42b1489-6c18-45f2-ae3d-b8fc1bcbae8e" xlink:href="icui-20220331.xsd#icui_EquipmentrevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_EquipmentrevenueMember_b42b1489-6c18-45f2-ae3d-b8fc1bcbae8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SoftwarerevenueMember_a99fb34b-1bfd-499f-b2a2-17ea22adb6c5" xlink:href="icui-20220331.xsd#icui_SoftwarerevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_SoftwarerevenueMember_a99fb34b-1bfd-499f-b2a2-17ea22adb6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GovernmentGrantRevenueMember_a7ce9e8d-c40a-44c5-9c89-03c487993b17" xlink:href="icui-20220331.xsd#icui_GovernmentGrantRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_GovernmentGrantRevenueMember_a7ce9e8d-c40a-44c5-9c89-03c487993b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherDeferredRevenueMember_563dd622-d446-4397-8cfc-5ab2feb31178" xlink:href="icui-20220331.xsd#icui_OtherDeferredRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8baf8d66-c40e-4beb-ac76-01f0f4fae980" xlink:to="loc_icui_OtherDeferredRevenueMember_563dd622-d446-4397-8cfc-5ab2feb31178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_44bf5876-89e3-474f-ac84-085d562bc5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_44bf5876-89e3-474f-ac84-085d562bc5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_843e6e56-ff3b-4716-a13e-27e5c73ea9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_44bf5876-89e3-474f-ac84-085d562bc5ed" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_843e6e56-ff3b-4716-a13e-27e5c73ea9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_7389347e-e3a8-4fc8-9bff-768ef183c930" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_843e6e56-ff3b-4716-a13e-27e5c73ea9ef" xlink:to="loc_icui_SmithsMedicalMember_7389347e-e3a8-4fc8-9bff-768ef183c930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a" xlink:href="icui-20220331.xsd#icui_TimingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:to="loc_icui_TimingAxis_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_4b75ec7e-d3a7-47b4-85b0-b43d4a8f5a5a" xlink:to="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_74617887-6835-4f21-9c92-6173837dce72" xlink:href="icui-20220331.xsd#icui_ShortTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:to="loc_icui_ShortTermMember_74617887-6835-4f21-9c92-6173837dce72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_b8cb41cd-11c9-4308-b9c4-ad6bf6ea15cc" xlink:href="icui-20220331.xsd#icui_LongTermMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_52a575e4-7f59-4f36-af1e-8b2cd68e08d4" xlink:to="loc_icui_LongTermMember_b8cb41cd-11c9-4308-b9c4-ad6bf6ea15cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:href="icui-20220331.xsd#icui_ContractassetandliabilitybalancesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesTable_a56d67b5-2dfa-49f8-9cfa-8918922e8717" xlink:to="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInDeferredRevenueRollForward_d3c034a7-fffe-47c4-a0ed-1ccd6d3a4800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInDeferredRevenueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_MovementInDeferredRevenueRollForward_d3c034a7-fffe-47c4-a0ed-1ccd6d3a4800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_eb3c86a0-eaab-4a55-af15-cbfac741d525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_ContractWithCustomerLiability_eb3c86a0-eaab-4a55-af15-cbfac741d525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_9e61c1a9-2747-472c-9ee5-997c45e366b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_9e61c1a9-2747-472c-9ee5-997c45e366b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueAdditions_96d8af1f-5659-4567-ac0f-5242d6a97832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueAdditions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_DeferredRevenueAdditions_96d8af1f-5659-4567-ac0f-5242d6a97832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7a489708-79f0-45de-9792-c881df852d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7a489708-79f0-45de-9792-c881df852d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_61bb726f-8f91-4e04-98e0-e4a3dd36268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ContractassetandliabilitybalancesLineItems_6109b192-5115-4afe-bcd4-e73bb3931eb8" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_61bb726f-8f91-4e04-98e0-e4a3dd36268c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_95cebccc-c087-4db1-b0a0-f6ed41e18dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_cbe11008-5434-4ccd-8c15-e2f1a5421d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_95cebccc-c087-4db1-b0a0-f6ed41e18dc5" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_cbe11008-5434-4ccd-8c15-e2f1a5421d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTables" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_28b1c75a-265c-4a96-996a-3044719214af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_fedfc1ed-59de-4544-9bf0-20f5ec0fa1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28b1c75a-265c-4a96-996a-3044719214af" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_fedfc1ed-59de-4544-9bf0-20f5ec0fa1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_49f96178-304d-43f6-92f1-407a4515fe6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28b1c75a-265c-4a96-996a-3044719214af" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_49f96178-304d-43f6-92f1-407a4515fe6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock_9313a638-3a55-41f1-a4b0-fddeb9c200b2" xlink:href="icui-20220331.xsd#icui_AssetsandLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28b1c75a-265c-4a96-996a-3044719214af" xlink:to="loc_icui_AssetsandLiabilitiesLeasesTableTextBlock_9313a638-3a55-41f1-a4b0-fddeb9c200b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f735fe45-27a7-447e-be34-b8dc35d9c9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_28b1c75a-265c-4a96-996a-3044719214af" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f735fe45-27a7-447e-be34-b8dc35d9c9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesTextDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0a6e15c1-1f1d-4994-83d3-aeb18dbc66b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f4841762-9106-4cd8-bb0a-b904c069f678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a6e15c1-1f1d-4994-83d3-aeb18dbc66b3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f4841762-9106-4cd8-bb0a-b904c069f678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_49b528bb-e150-44c7-a007-c19bb203567b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f4841762-9106-4cd8-bb0a-b904c069f678" xlink:to="loc_srt_RangeAxis_49b528bb-e150-44c7-a007-c19bb203567b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_186ab9c7-42aa-42b7-9b1d-f9a551e75a91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_49b528bb-e150-44c7-a007-c19bb203567b" xlink:to="loc_srt_RangeMember_186ab9c7-42aa-42b7-9b1d-f9a551e75a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c78c621d-7886-4c88-9e0e-3870fb00b8ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_186ab9c7-42aa-42b7-9b1d-f9a551e75a91" xlink:to="loc_srt_MaximumMember_c78c621d-7886-4c88-9e0e-3870fb00b8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f4841762-9106-4cd8-bb0a-b904c069f678" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Optiontoextendinyears_9119e24d-d044-4309-8ea0-6362e5c6583a" xlink:href="icui-20220331.xsd#icui_Optiontoextendinyears"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:to="loc_icui_Optiontoextendinyears_9119e24d-d044-4309-8ea0-6362e5c6583a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd4ca983-d898-47cf-a190-ac8e847ad9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a124c80b-bc1d-41ca-b514-934140c6fac0" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd4ca983-d898-47cf-a190-ac8e847ad9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_62254b43-2d91-4718-baba-e37de83b5998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_22d58b35-919c-497c-9fd4-6af3d5d5a4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_62254b43-2d91-4718-baba-e37de83b5998" xlink:to="loc_us-gaap_OperatingLeaseCost_22d58b35-919c-497c-9fd4-6af3d5d5a4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ecb3331e-603d-4ea7-aa9e-324819f19003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_62254b43-2d91-4718-baba-e37de83b5998" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ecb3331e-603d-4ea7-aa9e-324819f19003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a3b8997f-aca3-463f-9285-a9cd01714624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_62254b43-2d91-4718-baba-e37de83b5998" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a3b8997f-aca3-463f-9285-a9cd01714624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_638db6cd-1878-410d-8895-e53cfdc30194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_62254b43-2d91-4718-baba-e37de83b5998" xlink:to="loc_us-gaap_ShortTermLeaseCost_638db6cd-1878-410d-8895-e53cfdc30194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_95fcd6d8-abd8-4d2b-bcad-874596942e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_62254b43-2d91-4718-baba-e37de83b5998" xlink:to="loc_us-gaap_LeaseCost_95fcd6d8-abd8-4d2b-bcad-874596942e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesCashFlowOperatingActivitiesLesseeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_64375aa8-2821-40d7-bc97-0b43419c0dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_5af60ab2-a2d1-42c8-ac2d-74b8f0d24d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_64375aa8-2821-40d7-bc97-0b43419c0dad" xlink:to="loc_us-gaap_OperatingLeasePayments_5af60ab2-a2d1-42c8-ac2d-74b8f0d24d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9d99163a-acdd-4781-aeff-9cd74b4959e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_64375aa8-2821-40d7-bc97-0b43419c0dad" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9d99163a-acdd-4781-aeff-9cd74b4959e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4dc6d034-d982-486b-b832-009e5b7dd7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_64375aa8-2821-40d7-bc97-0b43419c0dad" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4dc6d034-d982-486b-b832-009e5b7dd7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_68734104-f1a4-4d00-a7cd-27d2d89f7ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_64375aa8-2821-40d7-bc97-0b43419c0dad" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_68734104-f1a4-4d00-a7cd-27d2d89f7ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesAssetsandLiabilitiesLesseeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bebd0863-c30a-4da5-8b3a-4be5635887c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bebd0863-c30a-4da5-8b3a-4be5635887c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f74b0e0d-eb0d-45c4-84a2-840312496c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f74b0e0d-eb0d-45c4-84a2-840312496c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_996bf012-6e68-4a96-a592-c859740caee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_996bf012-6e68-4a96-a592-c859740caee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_504fda88-09e3-42cc-9f2b-ee8c9f186806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_OperatingLeaseLiability_504fda88-09e3-42cc-9f2b-ee8c9f186806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1f8dafb8-1488-4e24-848d-ae852a51e3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1f8dafb8-1488-4e24-848d-ae852a51e3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_da3e7b2b-9a25-49a1-ba0b-178050652eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_da3e7b2b-9a25-49a1-ba0b-178050652eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_078faba6-08d5-409d-ba93-7fc39dd3e7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_078faba6-08d5-409d-ba93-7fc39dd3e7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c1ad61df-8079-4a29-acc2-13d6ed457e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c1ad61df-8079-4a29-acc2-13d6ed457e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_82efeac1-9b0e-4076-a6d0-82e62c43c361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_82efeac1-9b0e-4076-a6d0-82e62c43c361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b3b29f57-9d09-4759-9284-c5afbe1c2378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_FinanceLeaseLiability_b3b29f57-9d09-4759-9284-c5afbe1c2378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_eb383430-d471-4cfe-b7d2-d2d7b294e9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_eb383430-d471-4cfe-b7d2-d2d7b294e9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b9f15186-8a52-4a54-b372-5a8cb721840d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2f91cc07-5a6e-411d-ba82-fde93d85045f" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b9f15186-8a52-4a54-b372-5a8cb721840d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LeasesMaturityDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LeasesMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LeasesMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_733e33f4-2653-474b-9466-d05e6ab7893d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_733e33f4-2653-474b-9466-d05e6ab7893d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4db38d6b-cfe6-405e-a160-74b2e498eaef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4db38d6b-cfe6-405e-a160-74b2e498eaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_752bd56c-8d7b-46fa-a3ed-36072ce77aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_752bd56c-8d7b-46fa-a3ed-36072ce77aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f0555d42-97f0-4e3d-9599-10219f3173b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f0555d42-97f0-4e3d-9599-10219f3173b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_97ab1956-edd0-4bc6-9ac3-b053b756af80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_97ab1956-edd0-4bc6-9ac3-b053b756af80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_583504b2-bc62-4ba2-a7f6-b7ccb0f01888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_583504b2-bc62-4ba2-a7f6-b7ccb0f01888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5a03bda8-8e1e-4558-a273-101124732b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5a03bda8-8e1e-4558-a273-101124732b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_09787726-5ead-49ed-8a53-2945c84f4ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_09787726-5ead-49ed-8a53-2945c84f4ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d5fe302c-e4e2-4d31-874f-af76bdcde018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d5fe302c-e4e2-4d31-874f-af76bdcde018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8134c1bb-82e7-4d1e-bd27-d55797e320c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_OperatingLeaseLiability_8134c1bb-82e7-4d1e-bd27-d55797e320c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6393ddca-c885-489d-9c9f-68e420f56503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_6393ddca-c885-489d-9c9f-68e420f56503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cbeef072-e904-41ef-bf99-bf8132adc3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cbeef072-e904-41ef-bf99-bf8132adc3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3b02d3b9-209a-4653-b304-46d97ad1a17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3b02d3b9-209a-4653-b304-46d97ad1a17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_dc9bd48f-6f67-4cd3-a951-a8ff1cf887a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_dc9bd48f-6f67-4cd3-a951-a8ff1cf887a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_815635f2-5ac7-4b56-bcc3-5f060695ab0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_815635f2-5ac7-4b56-bcc3-5f060695ab0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f305349c-c3dd-4588-9b8d-2362725e9ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_f305349c-c3dd-4588-9b8d-2362725e9ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_470aa751-5d08-47d1-8dc5-fea5e9fc810a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_470aa751-5d08-47d1-8dc5-fea5e9fc810a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_708ee674-1f3a-4680-bf83-40eb11e3a487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_708ee674-1f3a-4680-bf83-40eb11e3a487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f2b15c69-65ef-4480-a4e4-27c3d1a7d932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f2b15c69-65ef-4480-a4e4-27c3d1a7d932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c575284c-144f-47f7-8f92-92769dbe0d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4785b27e-8319-417a-9b6a-c4bccdae2880" xlink:to="loc_us-gaap_FinanceLeaseLiability_c575284c-144f-47f7-8f92-92769dbe0d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="icui-20220331.xsd#NetIncomePerShare"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_08c3a647-fb49-42c8-bc71-b4ec503bb251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7cceabe4-8c3a-49c6-863b-b8d61260b9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_08c3a647-fb49-42c8-bc71-b4ec503bb251" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7cceabe4-8c3a-49c6-863b-b8d61260b9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="icui-20220331.xsd#NetIncomePerShareTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2338b1dc-0a81-4ec8-9b7c-b22e65aab917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_832c20fc-c533-4bfc-a3c2-fec98555f5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2338b1dc-0a81-4ec8-9b7c-b22e65aab917" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_832c20fc-c533-4bfc-a3c2-fec98555f5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#NetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2404cbb3-052c-4d20-b451-504c99297211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a9d25d9d-d4ff-4750-b590-b45137f0f108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2404cbb3-052c-4d20-b451-504c99297211" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a9d25d9d-d4ff-4750-b590-b45137f0f108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2e5894ad-b432-4a3a-882c-232058ca87fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a9d25d9d-d4ff-4750-b590-b45137f0f108" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2e5894ad-b432-4a3a-882c-232058ca87fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_af25965c-d9e2-44d2-bbb9-ce58493061fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2e5894ad-b432-4a3a-882c-232058ca87fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_af25965c-d9e2-44d2-bbb9-ce58493061fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a9d25d9d-d4ff-4750-b590-b45137f0f108" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6548fabe-f8b7-4414-ac36-be0805f36d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6548fabe-f8b7-4414-ac36-be0805f36d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1ea4232-22b1-4299-82d4-f65ee4af7173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_ProfitLoss_c1ea4232-22b1-4299-82d4-f65ee4af7173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1f992f4c-f113-41a1-83b6-dbb2830b65a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1f992f4c-f113-41a1-83b6-dbb2830b65a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d2f8b223-7cf4-4ebc-96a6-b0a2625f9bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d2f8b223-7cf4-4ebc-96a6-b0a2625f9bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1398c0b4-d37d-49f1-89b9-26670329ebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1398c0b4-d37d-49f1-89b9-26670329ebfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_90b2ec47-0507-4a2c-9568-cbf2f0d90c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_EarningsPerShareBasic_90b2ec47-0507-4a2c-9568-cbf2f0d90c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_16a2dd01-1f03-40af-a571-551e0f7cf8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_06eb9010-16a7-4fb1-812a-795d897077b7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_16a2dd01-1f03-40af-a571-551e0f7cf8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/NetIncomePerShareDetails1" xlink:type="simple" xlink:href="icui-20220331.xsd#NetIncomePerShareDetails1"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/NetIncomePerShareDetails1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_18c68be6-4194-4eb4-a53d-36914b17c936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bdfd394b-987e-4f97-ae86-b3709cedc9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_18c68be6-4194-4eb4-a53d-36914b17c936" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bdfd394b-987e-4f97-ae86-b3709cedc9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9b1aa266-982f-496f-a87e-d632f162b654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_18c68be6-4194-4eb4-a53d-36914b17c936" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9b1aa266-982f-496f-a87e-d632f162b654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8a380fc6-0f1a-4def-bc0b-2dd0c922e4a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_18c68be6-4194-4eb4-a53d-36914b17c936" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8a380fc6-0f1a-4def-bc0b-2dd0c922e4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ef6971ee-46a7-44a2-838d-54b8b0c4f7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_18c68be6-4194-4eb4-a53d-36914b17c936" xlink:to="loc_us-gaap_EarningsPerShareBasic_ef6971ee-46a7-44a2-838d-54b8b0c4f7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ae85f014-58f4-41fa-a296-376b15bb87f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_18c68be6-4194-4eb4-a53d-36914b17c936" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ae85f014-58f4-41fa-a296-376b15bb87f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_30f0896d-2281-471d-bd9a-a48333b2f7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0419f4af-93ba-4c33-a10b-769e968b6f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_30f0896d-2281-471d-bd9a-a48333b2f7b7" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_0419f4af-93ba-4c33-a10b-769e968b6f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11db28e3-3a5b-45ff-bdc1-c970765caef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1e4840e2-3b99-4f6b-932f-a2a545df04bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11db28e3-3a5b-45ff-bdc1-c970765caef5" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1e4840e2-3b99-4f6b-932f-a2a545df04bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_081b5a54-1ec3-4db3-a26e-dc5ae94f3d84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11db28e3-3a5b-45ff-bdc1-c970765caef5" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_081b5a54-1ec3-4db3-a26e-dc5ae94f3d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d160ccf8-014c-46b3-b5b9-627bdf300f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d160ccf8-014c-46b3-b5b9-627bdf300f8f" xlink:to="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_9750ed7b-86c9-4929-abc0-30951fcc7282" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:to="loc_srt_CurrencyAxis_9750ed7b-86c9-4929-abc0-30951fcc7282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_9750ed7b-86c9-4929-abc0-30951fcc7282" xlink:to="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_MXN_6bcc7eba-1309-4ca3-93e7-b8290a0e8ba6" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_MXN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_MXN_6bcc7eba-1309-4ca3-93e7-b8290a0e8ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_76ddf558-ade5-49d2-b4a7-a65e7fed21c1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_EUR_76ddf558-ade5-49d2-b4a7-a65e7fed21c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_CZK_46c85034-0f6b-450f-9a47-5be9a30c36d1" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_CZK"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_CZK_46c85034-0f6b-450f-9a47-5be9a30c36d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_0b5c4dbf-6e12-48cc-9e99-e243ff908330" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_461509bf-a256-4582-a3ad-f7673d29d0e2" xlink:to="loc_currency_JPY_0b5c4dbf-6e12-48cc-9e99-e243ff908330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisAxis_569b37ea-0d3e-422f-a017-23ea171da364" xlink:href="icui-20220331.xsd#icui_Srt_MultipleCurrencyAxisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:to="loc_icui_Srt_MultipleCurrencyAxisAxis_569b37ea-0d3e-422f-a017-23ea171da364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Srt_MultipleCurrencyAxisDomain_848dbeae-c46c-4f9d-aa19-301a010f38a4" xlink:href="icui-20220331.xsd#icui_Srt_MultipleCurrencyAxisDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_Srt_MultipleCurrencyAxisAxis_569b37ea-0d3e-422f-a017-23ea171da364" xlink:to="loc_icui_Srt_MultipleCurrencyAxisDomain_848dbeae-c46c-4f9d-aa19-301a010f38a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OtherCurrenciesMember_bdc48979-58f3-470e-bb7f-5a280fbf8a88" xlink:href="icui-20220331.xsd#icui_OtherCurrenciesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_Srt_MultipleCurrencyAxisDomain_848dbeae-c46c-4f9d-aa19-301a010f38a4" xlink:to="loc_icui_OtherCurrenciesMember_bdc48979-58f3-470e-bb7f-5a280fbf8a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5a006f59-64ad-4349-b4af-4bf63365aa40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_faabfca1-c1df-4542-a6f3-772b12aba7e4" xlink:to="loc_us-gaap_DerivativeLineItems_5a006f59-64ad-4349-b4af-4bf63365aa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8cf150d5-0041-487f-a762-1696de4a67a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5a006f59-64ad-4349-b4af-4bf63365aa40" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8cf150d5-0041-487f-a762-1696de4a67a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_86fea584-5df7-4587-9a36-d700ea5eac8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e4ca71e9-a127-4f85-b8e4-bd4a13143875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_86fea584-5df7-4587-9a36-d700ea5eac8a" xlink:to="loc_us-gaap_DerivativeTable_e4ca71e9-a127-4f85-b8e4-bd4a13143875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f751d2-b821-4e26-b664-977f78ca02f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e4ca71e9-a127-4f85-b8e4-bd4a13143875" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f751d2-b821-4e26-b664-977f78ca02f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_d3f751d2-b821-4e26-b664-977f78ca02f1" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge2Member_9ffd7d60-e97b-46ae-a67b-0c007d60e743" xlink:href="icui-20220331.xsd#icui_Hedge2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:to="loc_icui_Hedge2Member_9ffd7d60-e97b-46ae-a67b-0c007d60e743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Hedge3MemberMember_c4fb6489-1cab-4002-b93e-c8ff3ff89799" xlink:href="icui-20220331.xsd#icui_Hedge3MemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ddc55e4b-02c0-4303-95b8-7d8ff96580aa" xlink:to="loc_icui_Hedge3MemberMember_c4fb6489-1cab-4002-b93e-c8ff3ff89799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e4ca71e9-a127-4f85-b8e4-bd4a13143875" xlink:to="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeForwardExchangeRate1_2655941c-b905-4235-a71d-645e7ed8f7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeForwardExchangeRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:to="loc_us-gaap_DerivativeForwardExchangeRate1_2655941c-b905-4235-a71d-645e7ed8f7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_d3f55de4-bb7e-465b-a522-d81d7947e887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_d3f55de4-bb7e-465b-a522-d81d7947e887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_16e2e105-8316-4729-906b-6b47de7a4cf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b8d5877c-8d7a-40ba-bde5-a3c3807c7ae2" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_16e2e105-8316-4729-906b-6b47de7a4cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsInterestRateSwapsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d2086646-2d41-44f5-8be4-545a89c5b56c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d2086646-2d41-44f5-8be4-545a89c5b56c" xlink:to="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9802d576-cc36-4aeb-8c44-71e31e9d6089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9802d576-cc36-4aeb-8c44-71e31e9d6089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b8b0bc3a-e6db-4388-a773-82d6db57d284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9802d576-cc36-4aeb-8c44-71e31e9d6089" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b8b0bc3a-e6db-4388-a773-82d6db57d284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_28bb3a20-d22e-4e46-8fab-3f5a9bed702d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b8b0bc3a-e6db-4388-a773-82d6db57d284" xlink:to="loc_us-gaap_InterestRateSwapMember_28bb3a20-d22e-4e46-8fab-3f5a9bed702d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_b9c246d6-2997-48d3-a988-8fa938880a84" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:to="loc_icui_TermLoanAxis_b9c246d6-2997-48d3-a988-8fa938880a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_b9c246d6-2997-48d3-a988-8fa938880a84" xlink:to="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_7464711c-a9b8-4cda-aa31-958e2b3b5fa2" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:to="loc_icui_TermLoanAMember_7464711c-a9b8-4cda-aa31-958e2b3b5fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_859ca917-e04a-4800-9f25-045df850b699" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5fcb4d40-b6a7-4423-a6fd-4eed8ff651bf" xlink:to="loc_icui_TermLoanBMember_859ca917-e04a-4800-9f25-045df850b699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_797c6d10-053d-4b62-b486-10df985567ca" xlink:to="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3656ae5e-a138-48c5-bbfd-a0b914f05d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3656ae5e-a138-48c5-bbfd-a0b914f05d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestRateSwapEndingNotionalValue_56a370be-9902-4599-b1ef-46acf7779cf6" xlink:href="icui-20220331.xsd#icui_InterestRateSwapEndingNotionalValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_icui_InterestRateSwapEndingNotionalValue_56a370be-9902-4599-b1ef-46acf7779cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_ca7b7042-0168-490d-9e77-027ceeff200a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_ca7b7042-0168-490d-9e77-027ceeff200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_DerivativeVariableRateFloor_a63d600b-ed00-42db-8a80-93a595f69f02" xlink:href="icui-20220331.xsd#icui_DerivativeVariableRateFloor"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_8ec4375e-d71a-4d82-8136-c5c823cc8aab" xlink:to="loc_icui_DerivativeVariableRateFloor_a63d600b-ed00-42db-8a80-93a595f69f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_20421300-060c-444f-bbfd-15ae20688901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_20421300-060c-444f-bbfd-15ae20688901" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7460d039-c593-477b-8262-202cbb12c657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7460d039-c593-477b-8262-202cbb12c657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7460d039-c593-477b-8262-202cbb12c657" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_238f576e-701c-41b6-a5e0-16b2eecb4feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:to="loc_us-gaap_ForeignExchangeContractMember_238f576e-701c-41b6-a5e0-16b2eecb4feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_889af754-e39d-4b36-81c6-f01cb3cfdecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_fa7dbfda-9590-48be-8370-4d1f3502a252" xlink:to="loc_us-gaap_InterestRateSwapMember_889af754-e39d-4b36-81c6-f01cb3cfdecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a032060c-c5b3-4d8a-926a-0635731125df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a032060c-c5b3-4d8a-926a-0635731125df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a032060c-c5b3-4d8a-926a-0635731125df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_824c952e-78ac-43fa-878f-d5bb8550198c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_824c952e-78ac-43fa-878f-d5bb8550198c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_6ab2cc3e-e485-4bc5-b33d-0d9331c35571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_OtherAssetsMember_6ab2cc3e-e485-4bc5-b33d-0d9331c35571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_d15708bf-73a0-47ae-b08f-a7f42ed4916f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_d15708bf-73a0-47ae-b08f-a7f42ed4916f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_e4f250f7-4bfa-4034-bb4b-d519f207a2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a90dfee6-816e-407a-9b87-6c903eedc526" xlink:to="loc_us-gaap_OtherLiabilitiesMember_e4f250f7-4bfa-4034-bb4b-d519f207a2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f3a8e8d2-4d10-4483-825e-f004b446560b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f3a8e8d2-4d10-4483-825e-f004b446560b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_13a99627-d2fc-453b-9ef8-f5ec317ecc21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_f3a8e8d2-4d10-4483-825e-f004b446560b" xlink:to="loc_us-gaap_HedgingRelationshipDomain_13a99627-d2fc-453b-9ef8-f5ec317ecc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d06f3813-701f-4626-9072-f6f8c5e8f860" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_4e8f09c9-0e88-4ab8-8014-c9298c7933cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeAssets_4e8f09c9-0e88-4ab8-8014-c9298c7933cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_f58c67f4-961e-45fe-926e-bad7ad5d1e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_f58c67f4-961e-45fe-926e-bad7ad5d1e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_a01d0e86-3ea7-4049-bd16-d9ebb76187d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_a01d0e86-3ea7-4049-bd16-d9ebb76187d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_85c448f0-ea07-4df7-b072-fce9ad42a08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_85c448f0-ea07-4df7-b072-fce9ad42a08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_08604ddc-2aeb-4e55-ae5c-3b9eef280909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_08604ddc-2aeb-4e55-ae5c-3b9eef280909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_b562c786-ef77-4f3a-ae62-a9298e5fc30e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_f7a278f2-fe6f-4cc0-b527-8d88e15224a5" xlink:to="loc_us-gaap_DerivativeLiabilities_b562c786-ef77-4f3a-ae62-a9298e5fc30e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb627c26-4054-4df7-a65d-2af88166a929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f19d7164-bf85-48d0-800c-f5f608efc75f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_cb627c26-4054-4df7-a65d-2af88166a929" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f19d7164-bf85-48d0-800c-f5f608efc75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e8430bde-f8f3-4deb-90b6-f6007e005e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f19d7164-bf85-48d0-800c-f5f608efc75f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e8430bde-f8f3-4deb-90b6-f6007e005e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e8430bde-f8f3-4deb-90b6-f6007e005e36" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ea14f127-7170-4aab-90c1-d4212de17d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ea14f127-7170-4aab-90c1-d4212de17d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_d360f372-b6d6-4fb6-8cf8-7b15974943b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4051b99c-7f7e-4668-9f6c-d96fe72cdeaf" xlink:to="loc_us-gaap_InterestRateSwapMember_d360f372-b6d6-4fb6-8cf8-7b15974943b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2d93b9fe-d5a0-4020-ac8a-93c2329d8865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_f19d7164-bf85-48d0-800c-f5f608efc75f" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2d93b9fe-d5a0-4020-ac8a-93c2329d8865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_6a6e4b08-bf04-4916-bf29-d3543cf3f115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_2d93b9fe-d5a0-4020-ac8a-93c2329d8865" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_6a6e4b08-bf04-4916-bf29-d3543cf3f115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8989512e-81cb-425e-a244-fe42a085b279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8989512e-81cb-425e-a244-fe42a085b279" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8741f6fa-c959-4c0f-8945-42e3cbf84b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8741f6fa-c959-4c0f-8945-42e3cbf84b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8741f6fa-c959-4c0f-8945-42e3cbf84b77" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_933713de-0924-4e55-96f3-f70035b03388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:to="loc_us-gaap_ForeignExchangeContractMember_933713de-0924-4e55-96f3-f70035b03388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_5badede2-faaa-480a-b5b3-d3fb9d2a26d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_a132e385-8e54-462f-a28a-a602bc701ef9" xlink:to="loc_us-gaap_InterestRateSwapMember_5badede2-faaa-480a-b5b3-d3fb9d2a26d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e14b9bba-0a2c-46a3-b948-ee757061762b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e14b9bba-0a2c-46a3-b948-ee757061762b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e14b9bba-0a2c-46a3-b948-ee757061762b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingRevenueMember_49a62213-680d-4216-aa91-7660cb3d2fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:to="loc_us-gaap_TradingRevenueMember_49a62213-680d-4216-aa91-7660cb3d2fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_d8dcc51c-6f5c-4042-8d02-dfe340dcdafd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:to="loc_us-gaap_CostOfSalesMember_d8dcc51c-6f5c-4042-8d02-dfe340dcdafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_f1fc14ed-b72e-4c4c-a5d6-bb615cbab1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bbaeb05a-b8da-493c-99a8-ca350ab007ed" xlink:to="loc_us-gaap_InterestExpenseMember_f1fc14ed-b72e-4c4c-a5d6-bb615cbab1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0cb328ea-3ceb-4d5f-9d07-38365fdb8782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_HedgingDesignationAxis_0cb328ea-3ceb-4d5f-9d07-38365fdb8782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0cd6edf-06fc-4b50-bb63-c78ba2acb51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0cb328ea-3ceb-4d5f-9d07-38365fdb8782" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0cd6edf-06fc-4b50-bb63-c78ba2acb51e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697a22d9-b63a-47c8-a542-a0d17b29f4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697a22d9-b63a-47c8-a542-a0d17b29f4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4569e39b-cd5d-4ef6-8703-a13e0ccbd7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_697a22d9-b63a-47c8-a542-a0d17b29f4e8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4569e39b-cd5d-4ef6-8703-a13e0ccbd7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ce2ad121-bf54-4d8f-b008-8fd8e5d57959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_4569e39b-cd5d-4ef6-8703-a13e0ccbd7fb" xlink:to="loc_us-gaap_CashFlowHedgingMember_ce2ad121-bf54-4d8f-b008-8fd8e5d57959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ccd34e4d-5b11-4548-9db5-7ff0bf957420" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_1e859ca1-c741-4aa5-a69f-eb4bba74982e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion_1e859ca1-c741-4aa5-a69f-eb4bba74982e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a18e1e4f-183c-40f2-8456-e2bdd5588691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:to="loc_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months_a18e1e4f-183c-40f2-8456-e2bdd5588691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_df30c0e4-2d5f-403d-92bb-906c0ddf1ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_52a01dc6-fbdb-4b11-ae26-0fc91516ed3c" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_df30c0e4-2d5f-403d-92bb-906c0ddf1ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1b59ffac-4350-4fc4-9611-b727bff71078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_43962ac7-112e-4c21-ab35-171db887859b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1b59ffac-4350-4fc4-9611-b727bff71078" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_43962ac7-112e-4c21-ab35-171db887859b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cbc99cbe-fbaa-45e1-b1e2-1792592d66e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c0a3252c-a4bc-4b53-b5b9-17ea1fb24565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cbc99cbe-fbaa-45e1-b1e2-1792592d66e4" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c0a3252c-a4bc-4b53-b5b9-17ea1fb24565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ef865818-ed62-4a1c-8570-afb56a62f5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cbc99cbe-fbaa-45e1-b1e2-1792592d66e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ef865818-ed62-4a1c-8570-afb56a62f5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_4b21fc85-422f-4478-a848-f3e566df1566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cbc99cbe-fbaa-45e1-b1e2-1792592d66e4" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_4b21fc85-422f-4478-a848-f3e566df1566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7a706768-d776-43d7-8eb3-8d39912e6bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7a706768-d776-43d7-8eb3-8d39912e6bd3" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0670cb67-fc3e-48cc-aa85-4f95a686e886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0670cb67-fc3e-48cc-aa85-4f95a686e886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0670cb67-fc3e-48cc-aa85-4f95a686e886" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_f94bf7b1-020d-454f-95bb-c3d93e9542a8" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:to="loc_icui_PursuitVascularInc.Member_f94bf7b1-020d-454f-95bb-c3d93e9542a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_f39ae178-e4ca-4f47-af2a-d6f1f731f884" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:to="loc_icui_SmithsMedicalMember_f39ae178-e4ca-4f47-af2a-d6f1f731f884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_cbab7adc-ba83-42db-945d-0b36c80264ac" xlink:href="icui-20220331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a5d848b-5ad8-499f-852e-c3560932b7ee" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_cbab7adc-ba83-42db-945d-0b36c80264ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_229ffe85-2789-42c2-aed0-1671f349b9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_229ffe85-2789-42c2-aed0-1671f349b9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c0ff982e-d868-43d9-8516-981ea81d1ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_229ffe85-2789-42c2-aed0-1671f349b9c5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c0ff982e-d868-43d9-8516-981ea81d1ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_f9a15c11-2662-4040-884b-afaf42e3077c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_c0ff982e-d868-43d9-8516-981ea81d1ce6" xlink:to="loc_us-gaap_LiabilityMember_f9a15c11-2662-4040-884b-afaf42e3077c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_ea78b9db-c6bc-47cf-a16b-b7a3d409f0d5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_46ed7a9e-7f07-4fc9-be45-df875f5076f7" xlink:href="icui-20220331.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_Contingentconsiderationgross_46ed7a9e-7f07-4fc9-be45-df875f5076f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_630cc4ad-c966-4c85-bf8c-2d59e9d0f476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_630cc4ad-c966-4c85-bf8c-2d59e9d0f476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_c52a8c5b-2997-4587-9737-463dfdaa8368" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_ContingentConsiderationGrossST_c52a8c5b-2997-4587-9737-463dfdaa8368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_26236e42-cbe9-4cab-8934-25ad85ce5a78" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_ContingentConsiderationGrossLT_26236e42-cbe9-4cab-8934-25ad85ce5a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ab3f36ff-8543-425d-be85-fe5dca368582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ab3f36ff-8543-425d-be85-fe5dca368582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_OwnershipRequirementForEarnoutPayment_08e55804-5f17-4362-83c0-b024d99f15e0" xlink:href="icui-20220331.xsd#icui_OwnershipRequirementForEarnoutPayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_a7e50f44-ff58-49d3-bf21-a1bc9b4639f6" xlink:to="loc_icui_OwnershipRequirementForEarnoutPayment_08e55804-5f17-4362-83c0-b024d99f15e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e4dc50c1-12b0-486a-bb9e-7558aabb0f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_157e8dc7-1273-487e-bdef-725e05f6c1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e4dc50c1-12b0-486a-bb9e-7558aabb0f16" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_157e8dc7-1273-487e-bdef-725e05f6c1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_faff6494-f35e-4ffd-b521-d9fe464ce5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_157e8dc7-1273-487e-bdef-725e05f6c1f9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_faff6494-f35e-4ffd-b521-d9fe464ce5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e8a6ec-5d13-46c2-9d84-fcef54b0683e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_faff6494-f35e-4ffd-b521-d9fe464ce5f7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e8a6ec-5d13-46c2-9d84-fcef54b0683e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_dfc4e174-741e-4f4d-bc3e-4f5b3cedc30f" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61e8a6ec-5d13-46c2-9d84-fcef54b0683e" xlink:to="loc_icui_PursuitVascularInc.Member_dfc4e174-741e-4f4d-bc3e-4f5b3cedc30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_157e8dc7-1273-487e-bdef-725e05f6c1f9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4ed6f98a-a1e5-4dcb-af9e-359a210e4ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4ed6f98a-a1e5-4dcb-af9e-359a210e4ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e8706bbb-8bc8-4b6c-820c-56a1d87467ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e8706bbb-8bc8-4b6c-820c-56a1d87467ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_c04f671f-30be-4c27-b98b-d1b37aaf2f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_c04f671f-30be-4c27-b98b-d1b37aaf2f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_CurrencyTranslationOnEarnOut_708588b7-e3f4-4782-9482-e9247158fabc" xlink:href="icui-20220331.xsd#icui_CurrencyTranslationOnEarnOut"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_d52e034b-e31d-4aae-9a95-fe14b16a3fc9" xlink:to="loc_icui_CurrencyTranslationOnEarnOut_708588b7-e3f4-4782-9482-e9247158fabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_563ccf46-bd07-465c-b703-12bab9019885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_563ccf46-bd07-465c-b703-12bab9019885" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ef44c0f9-9589-44eb-bdbf-210f87047071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ef44c0f9-9589-44eb-bdbf-210f87047071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc96884d-1778-4362-8161-41b7e2b3f830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ef44c0f9-9589-44eb-bdbf-210f87047071" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc96884d-1778-4362-8161-41b7e2b3f830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_3a494bcb-0519-4af0-8313-f24f4d14b48e" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bc96884d-1778-4362-8161-41b7e2b3f830" xlink:to="loc_icui_PursuitVascularInc.Member_3a494bcb-0519-4af0-8313-f24f4d14b48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2919031b-8026-42f0-bc99-269c09ba6799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2919031b-8026-42f0-bc99-269c09ba6799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a8ca76e7-bde4-40ec-8c6c-d0f27a95739c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2919031b-8026-42f0-bc99-269c09ba6799" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a8ca76e7-bde4-40ec-8c6c-d0f27a95739c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_8b613099-686e-4f74-a73f-b6f2ab2d2a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_8b613099-686e-4f74-a73f-b6f2ab2d2a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6dfa8b2b-a025-49f6-8511-2b592c58062c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_8b613099-686e-4f74-a73f-b6f2ab2d2a1c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6dfa8b2b-a025-49f6-8511-2b592c58062c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_53ede3fb-f7bc-4ea2-95ac-d342d31303f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_53ede3fb-f7bc-4ea2-95ac-d342d31303f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_27781bfe-9c2c-4321-9d69-a6b89849e8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLocationAxis_53ede3fb-f7bc-4ea2-95ac-d342d31303f1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLocationDomain_27781bfe-9c2c-4321-9d69-a6b89849e8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c81cf01f-29cb-4b0c-8f8f-03e274ff8690" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f794efbc-b394-433e-a0fc-0d928f2d44b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f794efbc-b394-433e-a0fc-0d928f2d44b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_8122802d-eb2a-4860-a9da-14419903b5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_8cdcb75e-b4cf-4e17-8061-31e750d8a153" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_8122802d-eb2a-4860-a9da-14419903b5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ddf87b2a-80a5-4843-9e2f-b42833909473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ddf87b2a-80a5-4843-9e2f-b42833909473" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0f1f2dc1-5d1b-4faf-b503-36087516c3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0f1f2dc1-5d1b-4faf-b503-36087516c3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0f1f2dc1-5d1b-4faf-b503-36087516c3d5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PursuitVascularInc.Member_5653e3fd-dd12-4bda-9d49-a479b57f2403" xlink:href="icui-20220331.xsd#icui_PursuitVascularInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:to="loc_icui_PursuitVascularInc.Member_5653e3fd-dd12-4bda-9d49-a479b57f2403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_e563d30b-c03a-4648-822e-6e795e8ecb4b" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0fe8aa98-9587-4956-ad4c-0d967394e9d1" xlink:to="loc_icui_SmithsMedicalMember_e563d30b-c03a-4648-822e-6e795e8ecb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_5a38e319-39d9-47ab-bd2e-b3d0995a0d0b" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_726e2338-064f-40eb-86b0-77a80075c359" xlink:href="icui-20220331.xsd#icui_MeasurementinputadjustedEBITDAvolatilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_icui_MeasurementinputadjustedEBITDAvolatilityDomain_726e2338-064f-40eb-86b0-77a80075c359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_79c4c575-705d-4361-aba7-099e57918de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_79c4c575-705d-4361-aba7-099e57918de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_499d01fd-aa53-4aad-8f36-c990c3770309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_499d01fd-aa53-4aad-8f36-c990c3770309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MeasurementInputMarketPriceofRiskDomain_b4ab1952-6f02-4587-a195-5e84392aedf9" xlink:href="icui-20220331.xsd#icui_MeasurementInputMarketPriceofRiskDomain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_icui_MeasurementInputMarketPriceofRiskDomain_b4ab1952-6f02-4587-a195-5e84392aedf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_4f45f5e3-7fd7-4358-b60e-bd7d973c01ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c5a152e0-949a-4e7a-b09f-63129232f227" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_4f45f5e3-7fd7-4358-b60e-bd7d973c01ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_dce44732-2e8c-472c-9579-6314f8c419a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5ff9e7b1-d147-48d0-b698-b0b0d538b4c2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_dce44732-2e8c-472c-9579-6314f8c419a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_da409fa1-596e-417e-890c-e5fbb85abc90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_dce44732-2e8c-472c-9579-6314f8c419a8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_da409fa1-596e-417e-890c-e5fbb85abc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_64e91968-9da7-458c-b7b8-7604ce86b836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_64e91968-9da7-458c-b7b8-7604ce86b836" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c78efca9-4518-475c-971f-3a7f5e9a942d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c78efca9-4518-475c-971f-3a7f5e9a942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c78efca9-4518-475c-971f-3a7f5e9a942d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8255a319-dd02-4c4e-b7bd-35daaed543bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8255a319-dd02-4c4e-b7bd-35daaed543bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_6d084e8d-83c1-482b-ad68-a847682a8615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_6d084e8d-83c1-482b-ad68-a847682a8615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d45e2535-154e-4bf5-a75d-474e9a379ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5e0ff5d7-bf52-4941-b1fc-a04d6da2eb91" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d45e2535-154e-4bf5-a75d-474e9a379ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6fe258e6-6f78-46cf-89b2-e153afb6d6b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6fe258e6-6f78-46cf-89b2-e153afb6d6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6fe258e6-6f78-46cf-89b2-e153afb6d6b7" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9b22f302-ddba-4fbc-9d84-1c3b9fb8ac23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_9b22f302-ddba-4fbc-9d84-1c3b9fb8ac23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_76f00939-5031-4506-bfa4-8832e1ff8d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_76f00939-5031-4506-bfa4-8832e1ff8d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0da5c124-b672-42ff-be77-f13ac63806ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0da5c124-b672-42ff-be77-f13ac63806ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_d675b00c-9927-4d65-964b-7928febcb88e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c065f7cd-2dd4-49ae-a687-90843cba9372" xlink:to="loc_us-gaap_OtherAssetsMember_d675b00c-9927-4d65-964b-7928febcb88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_d97fdc79-f596-4bcc-a737-756d58ac9c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_d97fdc79-f596-4bcc-a737-756d58ac9c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_d97fdc79-f596-4bcc-a737-756d58ac9c07" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_EarnoutliabilityMember_a58600e3-a93d-470b-af99-16acfaeddbf6" xlink:href="icui-20220331.xsd#icui_EarnoutliabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:to="loc_icui_EarnoutliabilityMember_a58600e3-a93d-470b-af99-16acfaeddbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesTotalMember_0f528a96-9c6c-4f29-81da-e394d0ddf358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesTotalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_97d1fc84-e37c-467b-8c7c-263c85ac1a69" xlink:to="loc_us-gaap_LiabilitiesTotalMember_0f528a96-9c6c-4f29-81da-e394d0ddf358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18c6fc6f-16d4-4e31-84b6-1ce7eee7dc41" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fc04846f-57b8-4119-b40e-a187d339a580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_fc04846f-57b8-4119-b40e-a187d339a580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_4f5b89c0-0f68-456c-81b5-9c92e4ceccfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_InterestRateDerivativeAssetsAtFairValue_4f5b89c0-0f68-456c-81b5-9c92e4ceccfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a65cca0c-e732-434f-bf48-b6985a0e6caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_a65cca0c-e732-434f-bf48-b6985a0e6caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_d7024c01-2d84-4243-9f9f-3070895383d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonfinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_NonfinancialLiabilitiesFairValueDisclosure_d7024c01-2d84-4243-9f9f-3070895383d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_15bd8897-ea5d-4d3a-a4ef-1783095fcfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_15bd8897-ea5d-4d3a-a4ef-1783095fcfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_56f0f30e-e6cf-4bc2-b0e6-dd2b255e233d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_56f0f30e-e6cf-4bc2-b0e6-dd2b255e233d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4d9033a1-3e85-4128-a550-dd7b7cebabfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_4d9033a1-3e85-4128-a550-dd7b7cebabfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_631a9423-782b-47a5-ae2b-100ceda105b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8da8155e-2ba9-4a9e-a967-c7997d3694a0" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_631a9423-782b-47a5-ae2b-100ceda105b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#InvestmentSecuritiesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1be10cd4-5ad4-4688-97e5-d1e0d5bf6bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_95435db0-a1e7-4bc9-9f65-974a08c70d73" xlink:href="icui-20220331.xsd#icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1be10cd4-5ad4-4688-97e5-d1e0d5bf6bdd" xlink:to="loc_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock_95435db0-a1e7-4bc9-9f65-974a08c70d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTables" xlink:type="simple" xlink:href="icui-20220331.xsd#InvestmentSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8a981d1-1dfb-4a4e-9b18-1a6e15a05272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_8983ab29-d9b3-4b4d-9b8f-a5f4d747332a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8a981d1-1dfb-4a4e-9b18-1a6e15a05272" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_8983ab29-d9b3-4b4d-9b8f-a5f4d747332a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_9292ad28-0a6e-4792-8fbf-99f16fa04db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8a981d1-1dfb-4a4e-9b18-1a6e15a05272" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_9292ad28-0a6e-4792-8fbf-99f16fa04db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#InvestmentSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_465ed965-c176-474a-963a-eeb5f12f583e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfInvestments_7bece3e3-dd4e-4bee-8982-d5f59f57672c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_465ed965-c176-474a-963a-eeb5f12f583e" xlink:to="loc_us-gaap_GainLossOnSaleOfInvestments_7bece3e3-dd4e-4bee-8982-d5f59f57672c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#InvestmentSecuritiesTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InvestmentSecuritiesTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_37ce54f6-8ddd-4555-9529-75a7898d4ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b5199ee0-7497-43f3-8df6-5b8a3b9d4949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_37ce54f6-8ddd-4555-9529-75a7898d4ff3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b5199ee0-7497-43f3-8df6-5b8a3b9d4949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_fc75c329-c74a-416e-8a49-11f193e1224c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b5199ee0-7497-43f3-8df6-5b8a3b9d4949" xlink:to="loc_us-gaap_InvestmentTypeAxis_fc75c329-c74a-416e-8a49-11f193e1224c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_fc75c329-c74a-416e-8a49-11f193e1224c" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AvailableforsaleDebtSecurityCurrentMember_97b9fe04-84e4-4bd9-aed3-e7df324224a0" xlink:href="icui-20220331.xsd#icui_AvailableforsaleDebtSecurityCurrentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:to="loc_icui_AvailableforsaleDebtSecurityCurrentMember_97b9fe04-84e4-4bd9-aed3-e7df324224a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongtermInvestmentsDomain_1f7d2923-ce3a-47ed-8e41-ca6ae17fe623" xlink:href="icui-20220331.xsd#icui_LongtermInvestmentsDomain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_e491d674-d7e1-4435-9dc1-497f222ef158" xlink:to="loc_icui_LongtermInvestmentsDomain_1f7d2923-ce3a-47ed-8e41-ca6ae17fe623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_b5199ee0-7497-43f3-8df6-5b8a3b9d4949" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_31083723-505d-4bc3-9870-3735ecec0616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_31083723-505d-4bc3-9870-3735ecec0616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_3d75bf43-1acd-4de5-979a-b324f1d000f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_3d75bf43-1acd-4de5-979a-b324f1d000f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_20c5e56b-d8c9-4661-b9e2-c918364232a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_20c5e56b-d8c9-4661-b9e2-c918364232a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a754fa6c-3acd-4dee-ada0-1475829a2ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a754fa6c-3acd-4dee-ada0-1475829a2ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_ce08517f-0ea6-4cc8-bee8-f15c64a0d719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_ce08517f-0ea6-4cc8-bee8-f15c64a0d719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_09d07a28-28fa-4f28-81e5-40fbab4f6bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_09d07a28-28fa-4f28-81e5-40fbab4f6bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8a61ce51-97c6-470d-82f6-684ae9de75d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8a61ce51-97c6-470d-82f6-684ae9de75d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_58192355-3a7a-471a-8262-748ef105af67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_92874018-34b7-4874-b5c1-4e7916c08b3b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_58192355-3a7a-471a-8262-748ef105af67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#EquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4453f109-f1a0-4b93-8c13-ab0eb714e71d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_76ddf899-9f5a-46d2-84c0-270a156aeb31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4453f109-f1a0-4b93-8c13-ab0eb714e71d" xlink:to="loc_us-gaap_EquityMethodInvestments_76ddf899-9f5a-46d2-84c0-270a156aeb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_97a951eb-b254-40dd-8fcf-9f98308c2fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4453f109-f1a0-4b93-8c13-ab0eb714e71d" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_97a951eb-b254-40dd-8fcf-9f98308c2fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dc2b3196-7139-4dad-ad97-6b19d9458dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4453f109-f1a0-4b93-8c13-ab0eb714e71d" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_dc2b3196-7139-4dad-ad97-6b19d9458dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#PrepaidsandOtherCurrentAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9aea2d7a-7b34-4d5f-b296-dd8c99545872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_4d9f6bbb-fbb5-40b1-90ba-02ecb9f1e35a" xlink:href="icui-20220331.xsd#icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_9aea2d7a-7b34-4d5f-b296-dd8c99545872" xlink:to="loc_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_4d9f6bbb-fbb5-40b1-90ba-02ecb9f1e35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="icui-20220331.xsd#PrepaidsandOtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_774c1c58-51c7-4b2b-93bf-14fa985ac339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_ed91c21b-b240-41d8-a6d5-594ecc3f4de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_774c1c58-51c7-4b2b-93bf-14fa985ac339" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_ed91c21b-b240-41d8-a6d5-594ecc3f4de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_6b88091f-316b-4f8f-9753-09f03fd8366e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_774c1c58-51c7-4b2b-93bf-14fa985ac339" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_6b88091f-316b-4f8f-9753-09f03fd8366e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_3f880e5f-a3fc-48d5-ba19-2cc0db3f128b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_3f880e5f-a3fc-48d5-ba19-2cc0db3f128b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsAndOtherAssets_958b3582-1c18-4e1b-b3dc-eded56ff2518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCostsAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_us-gaap_DeferredCostsAndOtherAssets_958b3582-1c18-4e1b-b3dc-eded56ff2518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidinsuranceandpropertytaxes_1dd31850-275f-4897-9808-f7367ae066c8" xlink:href="icui-20220331.xsd#icui_Prepaidinsuranceandpropertytaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_icui_Prepaidinsuranceandpropertytaxes_1dd31850-275f-4897-9808-f7367ae066c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Prepaidothertaxes_d24c4d77-b255-41d9-b999-f32104b769e2" xlink:href="icui-20220331.xsd#icui_Prepaidothertaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_icui_Prepaidothertaxes_d24c4d77-b255-41d9-b999-f32104b769e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Deferredtaxcharge_2000d31a-a0ae-4a48-ab28-3cd6df9d9828" xlink:href="icui-20220331.xsd#icui_Deferredtaxcharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_icui_Deferredtaxcharge_2000d31a-a0ae-4a48-ab28-3cd6df9d9828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsCurrent_b1203f27-7174-4123-be40-f3876741d07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_us-gaap_DerivativeAssetsCurrent_b1203f27-7174-4123-be40-f3876741d07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositAssets_038ecee6-2722-47a4-a75d-289b838d3a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_us-gaap_DepositAssets_038ecee6-2722-47a4-a75d-289b838d3a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1cef4890-5178-4339-ad64-ba114ab74103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_us-gaap_OtherAssetsCurrent_1cef4890-5178-4339-ad64-ba114ab74103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50c1909a-f3c5-43a8-8dd2-d8d63b3f3228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_dfcb16f4-a3a4-4b00-80ab-5761a2f0e605" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_50c1909a-f3c5-43a8-8dd2-d8d63b3f3228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#OtherAssetsNoncurrentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/OtherAssetsNoncurrentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_249ac518-89b7-4238-b367-b5810ce94f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_DerivativeTable_249ac518-89b7-4238-b367-b5810ce94f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_249ac518-89b7-4238-b367-b5810ce94f68" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_b3a4ab24-9b10-491e-a6aa-26f2a8c92bb5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_77a8dcbb-54d5-4f62-b427-26f0f1f750b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:to="loc_us-gaap_InterestRateSwapMember_77a8dcbb-54d5-4f62-b427-26f0f1f750b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_7e40e5f9-e6ab-4bac-b1b9-f0df492ce97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee1057e0-5d37-4ac5-bb02-03a878773a41" xlink:to="loc_us-gaap_ForeignExchangeMember_7e40e5f9-e6ab-4bac-b1b9-f0df492ce97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c7e944dc-1e47-400c-919e-85265b8d7d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_249ac518-89b7-4238-b367-b5810ce94f68" xlink:to="loc_us-gaap_DerivativeLineItems_c7e944dc-1e47-400c-919e-85265b8d7d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_7aefbef2-b906-49a9-b842-2db3a48da10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c7e944dc-1e47-400c-919e-85265b8d7d27" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_7aefbef2-b906-49a9-b842-2db3a48da10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_998a0a2f-3ed0-4af9-8a85-17270f492c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_998a0a2f-3ed0-4af9-8a85-17270f492c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SpareParts_600b3699-5e46-48a4-b08a-4dffac186041" xlink:href="icui-20220331.xsd#icui_SpareParts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_icui_SpareParts_600b3699-5e46-48a4-b08a-4dffac186041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_45143c00-b38b-4be3-9912-8a6566b57b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_EquityMethodInvestments_45143c00-b38b-4be3-9912-8a6566b57b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_0c36e632-2eac-4825-be1c-3f1791fcb15a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_0c36e632-2eac-4825-be1c-3f1791fcb15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_7535c966-83c2-4908-882d-60c4508da743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_7535c966-83c2-4908-882d-60c4508da743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_e2035f0e-e09f-480d-8dde-28246557a5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_e2035f0e-e09f-480d-8dde-28246557a5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_51e87aef-df1c-45da-92ac-42200e04dbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_51e87aef-df1c-45da-92ac-42200e04dbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9160cc2b-8a6e-4bbe-bb86-9d7a7c7da3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsAbstract_51b72d3f-546c-45dc-8dc1-6bfec4139e8c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9160cc2b-8a6e-4bbe-bb86-9d7a7c7da3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/Inventories" xlink:type="simple" xlink:href="icui-20220331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8dc9b6d6-28b7-429f-a51f-b770f33d2e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_b51c71b4-8a09-41e1-8f1f-31fc75256f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8dc9b6d6-28b7-429f-a51f-b770f33d2e23" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_b51c71b4-8a09-41e1-8f1f-31fc75256f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesTables" xlink:type="simple" xlink:href="icui-20220331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_a58f882f-e9d1-4d06-8797-865a0d0bbffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_edad54b8-e2e7-4de3-802d-ceadc592141a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a58f882f-e9d1-4d06-8797-865a0d0bbffe" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_edad54b8-e2e7-4de3-802d-ceadc592141a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/InventoriesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e82ec53a-df34-4dd9-874b-34a9c244220c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_178b09ed-ec3c-464a-a788-130e0ac24cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e82ec53a-df34-4dd9-874b-34a9c244220c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_178b09ed-ec3c-464a-a788-130e0ac24cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_79caf369-3f35-4355-8a3d-33fba9d631b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e82ec53a-df34-4dd9-874b-34a9c244220c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_79caf369-3f35-4355-8a3d-33fba9d631b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_06ec7865-a1b0-4361-825b-dbf901e60a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e82ec53a-df34-4dd9-874b-34a9c244220c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_06ec7865-a1b0-4361-825b-dbf901e60a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_39e777c2-e395-4238-a190-1ff5e100f8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e82ec53a-df34-4dd9-874b-34a9c244220c" xlink:to="loc_us-gaap_InventoryNet_39e777c2-e395-4238-a190-1ff5e100f8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="icui-20220331.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5ab4f74d-bc58-4870-bab2-b02b90cc65e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_80cb0d2b-360e-4102-b846-4c47411df58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5ab4f74d-bc58-4870-bab2-b02b90cc65e0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_80cb0d2b-360e-4102-b846-4c47411df58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="icui-20220331.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_12763f9c-cf04-46e7-ae1b-f5de148124ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c6f2bd2c-8dee-4bd9-9893-daad04dd4eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_12763f9c-cf04-46e7-ae1b-f5de148124ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c6f2bd2c-8dee-4bd9-9893-daad04dd4eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_98feda4f-be8b-4d91-9ba0-e6d91f0c9c96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b59f1c8a-1ed6-4a6b-8f50-9333803a4950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_98feda4f-be8b-4d91-9ba0-e6d91f0c9c96" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b59f1c8a-1ed6-4a6b-8f50-9333803a4950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6779a748-154f-4d10-8a5c-a4081a604223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b59f1c8a-1ed6-4a6b-8f50-9333803a4950" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6779a748-154f-4d10-8a5c-a4081a604223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6779a748-154f-4d10-8a5c-a4081a604223" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandBuildingsAndImprovementsMember_9d8551f8-88a9-4114-9fd5-9e79149f3759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandBuildingsAndImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_us-gaap_LandBuildingsAndImprovementsMember_9d8551f8-88a9-4114-9fd5-9e79149f3759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_MoldsMember_d9e281c3-db25-405f-907d-31d98477b87a" xlink:href="icui-20220331.xsd#icui_MoldsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_icui_MoldsMember_d9e281c3-db25-405f-907d-31d98477b87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ComputerEquipmentAndSoftwareMember_c13471bc-c164-488a-8321-d284061be1ce" xlink:href="icui-20220331.xsd#icui_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_icui_ComputerEquipmentAndSoftwareMember_c13471bc-c164-488a-8321-d284061be1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InstrumentsPlacedwithCustomersMember_d7c252a3-3970-4844-91bc-32fb1a726815" xlink:href="icui-20220331.xsd#icui_InstrumentsPlacedwithCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d61287ac-188c-4613-bbf0-7a71df4d7d48" xlink:to="loc_icui_InstrumentsPlacedwithCustomersMember_d7c252a3-3970-4844-91bc-32fb1a726815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b59f1c8a-1ed6-4a6b-8f50-9333803a4950" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_868ec711-8242-4b56-8e07-ae98f52a8f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_868ec711-8242-4b56-8e07-ae98f52a8f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e5f89a45-6336-4b70-a8d6-2e88e684b4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e5f89a45-6336-4b70-a8d6-2e88e684b4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_52795b66-83d6-479d-9870-12f17edd11ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_52795b66-83d6-479d-9870-12f17edd11ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_6a82acae-ca68-4447-b96a-adfdb573d4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_6a82acae-ca68-4447-b96a-adfdb573d4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_2d1f7328-12c2-43b6-a95a-e1a8182e5ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_2d1f7328-12c2-43b6-a95a-e1a8182e5ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_fcfc80c9-f7ce-4ba6-8502-b5f126300987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_6a474a5a-65e4-466e-92e6-9e4ba905d544" xlink:to="loc_us-gaap_ConstructionInProgressGross_fcfc80c9-f7ce-4ba6-8502-b5f126300987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/PropertyandEquipmentTextDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#PropertyandEquipmentTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/PropertyandEquipmentTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ac4f19e-2837-41de-8a6d-b36e39554eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2a716d17-7652-47ef-8151-03a428d2db61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6ac4f19e-2837-41de-8a6d-b36e39554eab" xlink:to="loc_us-gaap_Depreciation_2a716d17-7652-47ef-8151-03a428d2db61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#GoodwillandIntangibleAssetsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d0641a6-68c2-4c5f-adf8-68448d270e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_874e20e3-7a7e-455e-a89b-562333f045bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1d0641a6-68c2-4c5f-adf8-68448d270e3d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_874e20e3-7a7e-455e-a89b-562333f045bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="icui-20220331.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_10219635-a375-495c-8609-af298b56dd1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_3c4cbc55-2de3-4461-bfa4-aa3d8a8656a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_10219635-a375-495c-8609-af298b56dd1a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_3c4cbc55-2de3-4461-bfa4-aa3d8a8656a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_58346f36-f543-4269-b99b-97ce5230ee52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_10219635-a375-495c-8609-af298b56dd1a" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_58346f36-f543-4269-b99b-97ce5230ee52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8e3fe321-d13d-4e05-a1b3-5a95e2d5638f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_10219635-a375-495c-8609-af298b56dd1a" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8e3fe321-d13d-4e05-a1b3-5a95e2d5638f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#GoodwillandIntangibleAssetsGoodwillTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1a975169-922c-474c-8fbd-3b0cb4eee787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a311369d-02e8-4939-a4e3-11469aa871e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1a975169-922c-474c-8fbd-3b0cb4eee787" xlink:to="loc_us-gaap_Goodwill_a311369d-02e8-4939-a4e3-11469aa871e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8445e4e4-8a56-4016-9be4-71ad04e14bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1a975169-922c-474c-8fbd-3b0cb4eee787" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8445e4e4-8a56-4016-9be4-71ad04e14bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d2e7d893-03a0-4e88-87a3-063ca34c7e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1a975169-922c-474c-8fbd-3b0cb4eee787" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_d2e7d893-03a0-4e88-87a3-063ca34c7e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_fefcb629-14a1-4901-9f13-c0115bb5ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1a975169-922c-474c-8fbd-3b0cb4eee787" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_fefcb629-14a1-4901-9f13-c0115bb5ba41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#GoodwillandIntangibleAssetsIntangiblesTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12a69cc0-e0d6-42b4-84f3-23e30f632691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12a69cc0-e0d6-42b4-84f3-23e30f632691" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5938ebd6-53c5-4f39-bba8-1d9f2abb05ad" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_7594e372-1815-4883-89fc-536469630e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_PatentsMember_7594e372-1815-4883-89fc-536469630e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_e86477f6-1f67-4a81-9ab1-a636bc376958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_CustomerContractsMember_e86477f6-1f67-4a81-9ab1-a636bc376958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_a3af7114-f421-4b36-914c-ad8b05828776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_a3af7114-f421-4b36-914c-ad8b05828776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_788e55a1-b22c-4c4a-a83b-533db1724da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_TrademarksMember_788e55a1-b22c-4c4a-a83b-533db1724da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3f8f0333-b3bd-4699-8ed0-e321f07e44bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_TradeNamesMember_3f8f0333-b3bd-4699-8ed0-e321f07e44bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_d1122e39-b8c8-49f2-9d50-d07292459e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_d1122e39-b8c8-49f2-9d50-d07292459e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_08f4bdcc-9289-43f5-aef3-3fc135c39c98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d08e50c3-3733-4f27-bbd3-037bf862bd01" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_08f4bdcc-9289-43f5-aef3-3fc135c39c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_srt_ConsolidationItemsAxis_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e665463b-7d25-44ff-9511-e7ecd9a66732" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_ddaef8e3-df1b-4a30-aaf7-e2bfbf329cad" xlink:to="loc_srt_ConsolidationItemsDomain_e665463b-7d25-44ff-9511-e7ecd9a66732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_10bb3279-9b4f-4261-befe-3f951246ff49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_10bb3279-9b4f-4261-befe-3f951246ff49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2e44c106-9b32-48d1-9573-3ed647c6405b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_10bb3279-9b4f-4261-befe-3f951246ff49" xlink:to="loc_us-gaap_SegmentDomain_2e44c106-9b32-48d1-9573-3ed647c6405b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a195ae60-43b4-4d95-9b44-92285735e2a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_srt_RangeAxis_a195ae60-43b4-4d95-9b44-92285735e2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_370cd97e-e66b-467f-bedc-77f3dd772163" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a195ae60-43b4-4d95-9b44-92285735e2a4" xlink:to="loc_srt_RangeMember_370cd97e-e66b-467f-bedc-77f3dd772163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a5cd3bba-5a27-4246-a181-ceaf5727e84f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05c4f581-74bc-4119-8905-b1e195327c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05c4f581-74bc-4119-8905-b1e195327c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c9cfba3-8eed-480d-98dc-787761fc1257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c9cfba3-8eed-480d-98dc-787761fc1257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2def289a-1d90-4478-9180-9df0997655b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2def289a-1d90-4478-9180-9df0997655b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7cc2b19b-dc3a-43a7-b459-98e505878fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7cc2b19b-dc3a-43a7-b459-98e505878fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e4812a49-89d9-4c5e-9ca7-1ba62e9e21bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e4812a49-89d9-4c5e-9ca7-1ba62e9e21bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2329d8f0-f659-4937-b7dc-531d3839a066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2329d8f0-f659-4937-b7dc-531d3839a066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b7073efa-c386-46af-ae1f-6e9af8a75db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9193ecab-2aa3-4cf1-90e0-b9e5ae7bb48a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b7073efa-c386-46af-ae1f-6e9af8a75db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#GoodwillandIntangibleAssetsTextDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_acfc8b5c-4172-49b0-911d-eab2dbb3f5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5e297e75-5ce0-48cb-b3dd-f161a5a3f573" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_acfc8b5c-4172-49b0-911d-eab2dbb3f5f9" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5e297e75-5ce0-48cb-b3dd-f161a5a3f573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#GoodwillandIntangibleAssets5YearAmortizationDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_37a69a34-e53b-43aa-83f0-b14c0e082669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_37a69a34-e53b-43aa-83f0-b14c0e082669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5489850c-46ba-4451-8b40-b184601305c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5489850c-46ba-4451-8b40-b184601305c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6a96a745-07e4-4317-bde9-8f6331e2f4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6a96a745-07e4-4317-bde9-8f6331e2f4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f77cc6d4-0d6f-40b7-a953-290f58ad87f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f77cc6d4-0d6f-40b7-a953-290f58ad87f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f8dbd37c-54a5-44d9-bdf1-96318f0e35ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_f8dbd37c-54a5-44d9-bdf1-96318f0e35ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0efa9e75-e914-443f-ae3c-3dc1fc49336c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0efa9e75-e914-443f-ae3c-3dc1fc49336c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_d538e6e7-9ba0-46f5-8fa3-af0b249f0f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_d538e6e7-9ba0-46f5-8fa3-af0b249f0f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_55866efd-0396-4109-b368-604c26dfb2df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b347239-222d-469b-ac62-43c78a5fcd29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_55866efd-0396-4109-b368-604c26dfb2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#AccruedLiabilitiesNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d2598b1b-2d33-45a2-8c44-76be8fc3532d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_691a2e53-9ee1-4f17-bcb3-c2214fb6d6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_d2598b1b-2d33-45a2-8c44-76be8fc3532d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_691a2e53-9ee1-4f17-bcb3-c2214fb6d6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="icui-20220331.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_6d65d832-8af0-43a8-ab3f-812cb1ca0108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3fb0c5a8-762b-4c9d-a662-f792ba1720f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_6d65d832-8af0-43a8-ab3f-812cb1ca0108" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3fb0c5a8-762b-4c9d-a662-f792ba1720f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedSalariesAndBenefits_f1c40dad-ed23-4a04-b379-e054b6e5e481" xlink:href="icui-20220331.xsd#icui_AccruedSalariesAndBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_AccruedSalariesAndBenefits_f1c40dad-ed23-4a04-b379-e054b6e5e481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_83f5f7e5-5d93-4c4a-a1de-244361b25e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_AccruedBonusesCurrent_83f5f7e5-5d93-4c4a-a1de-244361b25e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b691547c-162b-4fde-90af-4480adf88462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b691547c-162b-4fde-90af-4480adf88462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_ecd32bca-fd69-4785-b181-f7a282df30dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_ecd32bca-fd69-4785-b181-f7a282df30dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_bdd4e694-6fae-47a1-b252-4711cc12c353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_RestructuringReserveCurrent_bdd4e694-6fae-47a1-b252-4711cc12c353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_UnfavorablecontractliabilityST_471c0bdb-a163-4003-80fa-7a5a10181e61" xlink:href="icui-20220331.xsd#icui_UnfavorablecontractliabilityST"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_UnfavorablecontractliabilityST_471c0bdb-a163-4003-80fa-7a5a10181e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedothertaxes_17a1168e-2e1d-4dcf-b0de-3c5714dc5f73" xlink:href="icui-20220331.xsd#icui_Accruedothertaxes"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_Accruedothertaxes_17a1168e-2e1d-4dcf-b0de-3c5714dc5f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_616196f9-d3ee-4184-a080-4a92a7fd6b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_616196f9-d3ee-4184-a080-4a92a7fd6b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedlegalfees_a5e240f7-bf48-4bf3-bee6-f7822854093f" xlink:href="icui-20220331.xsd#icui_Accruedlegalfees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_Accruedlegalfees_a5e240f7-bf48-4bf3-bee6-f7822854093f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Outsidesalescommissions_9dc970ff-c983-4ece-abdb-0f1b60634c56" xlink:href="icui-20220331.xsd#icui_Outsidesalescommissions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_Outsidesalescommissions_9dc970ff-c983-4ece-abdb-0f1b60634c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_673a4700-3d30-4302-8c05-84a1b3def5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_673a4700-3d30-4302-8c05-84a1b3def5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Accruedfreight_d9e450cb-e7bc-4c13-9416-0d5e66372cf2" xlink:href="icui-20220331.xsd#icui_Accruedfreight"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_Accruedfreight_d9e450cb-e7bc-4c13-9416-0d5e66372cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_32ce5789-53b6-4cbb-a3b4-ad767115993f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_32ce5789-53b6-4cbb-a3b4-ad767115993f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_60344bcb-f3c5-4393-a784-c5d3e5f2e83e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_60344bcb-f3c5-4393-a784-c5d3e5f2e83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bd7f9f0f-a2a3-4029-a2e5-554537b6a12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bd7f9f0f-a2a3-4029-a2e5-554537b6a12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_efb94c98-0131-4322-9dec-8bf94e21f709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_efb94c98-0131-4322-9dec-8bf94e21f709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AcquiredRestructuringLiabilityCurrent_eb4c82b2-e06d-4c9a-82ce-16b6f0e8d054" xlink:href="icui-20220331.xsd#icui_AcquiredRestructuringLiabilityCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_AcquiredRestructuringLiabilityCurrent_eb4c82b2-e06d-4c9a-82ce-16b6f0e8d054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedTransactionCosts_aa06ff77-ab23-4d4d-8112-1e602e245fa4" xlink:href="icui-20220331.xsd#icui_AccruedTransactionCosts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_AccruedTransactionCosts_aa06ff77-ab23-4d4d-8112-1e602e245fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_AccruedAuditFees_ac05c4c0-4271-4c40-8b41-5a65d7fa28e4" xlink:href="icui-20220331.xsd#icui_AccruedAuditFees"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_icui_AccruedAuditFees_ac05c4c0-4271-4c40-8b41-5a65d7fa28e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_3b834736-b389-44c8-abc4-a9095a555c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_DerivativeTable_3b834736-b389-44c8-abc4-a9095a555c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6efc2a4f-38c9-4e10-a605-3ebf70595db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b834736-b389-44c8-abc4-a9095a555c62" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6efc2a4f-38c9-4e10-a605-3ebf70595db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c59c7b86-efea-425c-9c31-6395629cba4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6efc2a4f-38c9-4e10-a605-3ebf70595db3" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c59c7b86-efea-425c-9c31-6395629cba4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_9ea130f7-d497-4afe-8918-92a81f79b556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c59c7b86-efea-425c-9c31-6395629cba4e" xlink:to="loc_us-gaap_ForeignExchangeMember_9ea130f7-d497-4afe-8918-92a81f79b556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a6b76fa6-a966-4f70-a2f5-8969c9031cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_3b834736-b389-44c8-abc4-a9095a555c62" xlink:to="loc_us-gaap_DerivativeLineItems_a6b76fa6-a966-4f70-a2f5-8969c9031cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_75b2bf60-e39c-459d-a3cf-a1f6b47e52b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a6b76fa6-a966-4f70-a2f5-8969c9031cf4" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_75b2bf60-e39c-459d-a3cf-a1f6b47e52b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_e030dddb-517d-4878-bfb4-22c8516168f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_0a7f9016-3c5a-4480-b054-680135d11b09" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_e030dddb-517d-4878-bfb4-22c8516168f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_0a7a2059-0a83-4dcb-a879-16fb8ac70661" xlink:href="icui-20220331.xsd#icui_TimingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_e030dddb-517d-4878-bfb4-22c8516168f2" xlink:to="loc_icui_TimingAxis_0a7a2059-0a83-4dcb-a879-16fb8ac70661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_a6121b59-cfb7-408d-a754-4405494ff5d5" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_0a7a2059-0a83-4dcb-a879-16fb8ac70661" xlink:to="loc_icui_TimingDomain_a6121b59-cfb7-408d-a754-4405494ff5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ShortTermMember_26cfe82c-1f0b-45ef-b0fe-21f4313d42ca" xlink:href="icui-20220331.xsd#icui_ShortTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_a6121b59-cfb7-408d-a754-4405494ff5d5" xlink:to="loc_icui_ShortTermMember_26cfe82c-1f0b-45ef-b0fe-21f4313d42ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_c1d1f835-80c5-41f5-b59a-e88002dce73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_e030dddb-517d-4878-bfb4-22c8516168f2" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_c1d1f835-80c5-41f5-b59a-e88002dce73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7a0c7b98-d4a9-4611-8100-8130d224ca0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_c1d1f835-80c5-41f5-b59a-e88002dce73c" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7a0c7b98-d4a9-4611-8100-8130d224ca0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#AccruedLiabilitiesLongtermliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d74fc9e4-eded-465a-a2c5-f9cef35dcabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d74fc9e4-eded-465a-a2c5-f9cef35dcabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_b18dd380-285d-43d1-958c-a26a7ace04ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent_b18dd380-285d-43d1-958c-a26a7ace04ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRentCurrentAndNoncurrent_1e712682-083a-4b06-98c8-ffac1c0b9e85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRentCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_AccruedRentCurrentAndNoncurrent_1e712682-083a-4b06-98c8-ffac1c0b9e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Liabilitiesforcontracts_197c70c0-fa73-4883-9100-86e5687c7898" xlink:href="icui-20220331.xsd#icui_Liabilitiesforcontracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_icui_Liabilitiesforcontracts_197c70c0-fa73-4883-9100-86e5687c7898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_bff2b569-8024-445e-93a7-5fa85522f241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateDerivativeLiabilitiesAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue_bff2b569-8024-445e-93a7-5fa85522f241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_43bbdcec-e5df-4bd5-92ea-9dfc97928cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_43bbdcec-e5df-4bd5-92ea-9dfc97928cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3ed96cf9-2df6-4398-a096-1b6a7a1ddd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3ed96cf9-2df6-4398-a096-1b6a7a1ddd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_dfe274cd-4518-4e63-98dc-d20de0249411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_dfe274cd-4518-4e63-98dc-d20de0249411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_57f6ee40-bf7a-4131-9a84-f19d5cc0f6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_57f6ee40-bf7a-4131-9a84-f19d5cc0f6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_ce717f84-7f3b-410b-80aa-eefb7615f9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_ce717f84-7f3b-410b-80aa-eefb7615f9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyTable_8602d682-2420-48ba-9263-669128155413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_ProductLiabilityContingencyTable_8602d682-2420-48ba-9263-669128155413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingAxis_834da5a2-f484-456e-8814-48e4a240c671" xlink:href="icui-20220331.xsd#icui_TimingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_8602d682-2420-48ba-9263-669128155413" xlink:to="loc_icui_TimingAxis_834da5a2-f484-456e-8814-48e4a240c671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TimingDomain_a501312f-640a-4ed0-b967-b2c662341c62" xlink:href="icui-20220331.xsd#icui_TimingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingAxis_834da5a2-f484-456e-8814-48e4a240c671" xlink:to="loc_icui_TimingDomain_a501312f-640a-4ed0-b967-b2c662341c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LongTermMember_7f5a4675-d51d-42c8-91c8-e6875a74f308" xlink:href="icui-20220331.xsd#icui_LongTermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TimingDomain_a501312f-640a-4ed0-b967-b2c662341c62" xlink:to="loc_icui_LongTermMember_7f5a4675-d51d-42c8-91c8-e6875a74f308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyTable_8602d682-2420-48ba-9263-669128155413" xlink:to="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7dd5fc71-441c-40fe-8a81-6b7eb94d8cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_7dd5fc71-441c-40fe-8a81-6b7eb94d8cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_65f95c35-0dda-42ee-aab7-b6ff3ff4341a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductLiabilityContingencyLineItems_f8246c7f-dc97-4690-b1c9-c066f25436e5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_65f95c35-0dda-42ee-aab7-b6ff3ff4341a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d3a4b865-c993-47e2-8c20-5eaae46a8b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_e85488fc-141b-445a-b50c-260de8c5ff20" xlink:to="loc_us-gaap_DerivativeTable_d3a4b865-c993-47e2-8c20-5eaae46a8b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ebd21deb-9ae6-4599-9f2d-fe3351361d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d3a4b865-c993-47e2-8c20-5eaae46a8b44" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ebd21deb-9ae6-4599-9f2d-fe3351361d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72956afa-f61d-4a4e-9c78-6a20deab7495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ebd21deb-9ae6-4599-9f2d-fe3351361d23" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72956afa-f61d-4a4e-9c78-6a20deab7495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeMember_b4c1f993-7fae-425a-8d84-44ae01c943b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_72956afa-f61d-4a4e-9c78-6a20deab7495" xlink:to="loc_us-gaap_ForeignExchangeMember_b4c1f993-7fae-425a-8d84-44ae01c943b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_37a62734-6dd4-4548-8b03-ef71a6affff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d3a4b865-c993-47e2-8c20-5eaae46a8b44" xlink:to="loc_us-gaap_DerivativeLineItems_37a62734-6dd4-4548-8b03-ef71a6affff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fb02ffac-bfe6-4210-a259-146fbcccd914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_37a62734-6dd4-4548-8b03-ef71a6affff4" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_fb02ffac-bfe6-4210-a259-146fbcccd914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxes" xlink:type="simple" xlink:href="icui-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c7e7e3fe-e173-48a3-998f-5b249f0e3235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_a646544d-3f6d-4915-81f5-58ce46a10534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c7e7e3fe-e173-48a3-998f-5b249f0e3235" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_a646544d-3f6d-4915-81f5-58ce46a10534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#IncomeTaxesEffectivetaxrateDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dcf1f301-177a-44ee-8493-fbccc1d3fb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1a4da80d-8e89-4f5d-8d94-a4a996b5f811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcf1f301-177a-44ee-8493-fbccc1d3fb9f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1a4da80d-8e89-4f5d-8d94-a4a996b5f811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3782af06-720c-4645-9dad-ac5bbfd821d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcf1f301-177a-44ee-8493-fbccc1d3fb9f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3782af06-720c-4645-9dad-ac5bbfd821d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0575ce70-f0c8-43b0-bfb0-9986eb30c793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dcf1f301-177a-44ee-8493-fbccc1d3fb9f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0575ce70-f0c8-43b0-bfb0-9986eb30c793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_598616a0-367c-48b5-8ac7-f77a8a4e03c4" xlink:href="icui-20220331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_5c5c6ef6-c17f-4cfc-a432-d4905f4f56d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_598616a0-367c-48b5-8ac7-f77a8a4e03c4" xlink:to="loc_us-gaap_LongTermDebtTextBlock_5c5c6ef6-c17f-4cfc-a432-d4905f4f56d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_4e7d80dc-d3f1-4732-9aa7-6ca833bc98ac" xlink:href="icui-20220331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0bcf0203-69bb-4c17-a5fb-37605a09eb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_4e7d80dc-d3f1-4732-9aa7-6ca833bc98ac" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0bcf0203-69bb-4c17-a5fb-37605a09eb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8252a08e-9d17-4171-979a-8b0ef3a00d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_4e7d80dc-d3f1-4732-9aa7-6ca833bc98ac" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_8252a08e-9d17-4171-979a-8b0ef3a00d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock_e5a31cba-8936-4ae9-b44e-a515b6de3f20" xlink:href="icui-20220331.xsd#icui_InterestExpenseOnLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_4e7d80dc-d3f1-4732-9aa7-6ca833bc98ac" xlink:to="loc_icui_InterestExpenseOnLongTermDebtTableTextBlock_e5a31cba-8936-4ae9-b44e-a515b6de3f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_090df557-9883-4cc2-b45a-a11e1f45e9fa" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_4e7d80dc-d3f1-4732-9aa7-6ca833bc98ac" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock_090df557-9883-4cc2-b45a-a11e1f45e9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_f01f59b8-044f-4e9a-a22c-02b250cc482f" xlink:href="icui-20220331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_f01f59b8-044f-4e9a-a22c-02b250cc482f" xlink:to="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4c3190a5-1349-4c4c-a91a-0414c856950b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4c3190a5-1349-4c4c-a91a-0414c856950b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5cd67d49-c57d-449c-83ca-3facbe43fe89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c3190a5-1349-4c4c-a91a-0414c856950b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5cd67d49-c57d-449c-83ca-3facbe43fe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b4c99ea7-63ff-4990-a863-e70b7837068f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5cd67d49-c57d-449c-83ca-3facbe43fe89" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b4c99ea7-63ff-4990-a863-e70b7837068f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_d3f7f152-e59d-4c25-9160-c577e9c9c016" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:to="loc_icui_TermLoanAxis_d3f7f152-e59d-4c25-9160-c577e9c9c016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_d3f7f152-e59d-4c25-9160-c577e9c9c016" xlink:to="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_ade1f07c-fb07-4b9e-b055-cf9e7c0fc9da" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:to="loc_icui_TermLoanAMember_ade1f07c-fb07-4b9e-b055-cf9e7c0fc9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_927c1405-e848-4be7-9d0e-b3a17075bf83" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_5c259f91-a318-4bbd-a2ff-f59df08cd609" xlink:to="loc_icui_TermLoanBMember_927c1405-e848-4be7-9d0e-b3a17075bf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5474dd65-54b2-4ee0-a8e8-04d0cf1080ce" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TotalSeniorSecuredCreditFacility_d87df326-754e-4e39-8a32-a70a17328be5" xlink:href="icui-20220331.xsd#icui_TotalSeniorSecuredCreditFacility"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_icui_TotalSeniorSecuredCreditFacility_d87df326-754e-4e39-8a32-a70a17328be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_d5063708-0d98-4997-a5f9-b6c7bf370a21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_d5063708-0d98-4997-a5f9-b6c7bf370a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_24e6092e-0cdb-4cc3-beb5-5ad7e9f7e8bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_24e6092e-0cdb-4cc3-beb5-5ad7e9f7e8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_RevolverSubLimits_5562588e-904b-48e7-9da5-1830c40206cf" xlink:href="icui-20220331.xsd#icui_RevolverSubLimits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_icui_RevolverSubLimits_5562588e-904b-48e7-9da5-1830c40206cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_96096b92-6f7a-4a0b-aba2-a325ebfa182b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_96096b92-6f7a-4a0b-aba2-a325ebfa182b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_93c953d4-5452-4173-af85-d01263103a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_LongTermDebt_93c953d4-5452-4173-af85-d01263103a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_67390cfb-4d58-4378-a301-22d71f8eb2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_67390cfb-4d58-4378-a301-22d71f8eb2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_3f3f29a7-3fc8-4ff3-bb44-94fc25cbdfd2" xlink:href="icui-20220331.xsd#icui_LeverageRatioCalculationCeilingSubtractedAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2b2aef0-b314-4403-b676-ad11d0bcd8db" xlink:to="loc_icui_LeverageRatioCalculationCeilingSubtractedAmount_3f3f29a7-3fc8-4ff3-bb44-94fc25cbdfd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsInterestRateTermsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToFederalFundsRate_b7a6d867-d5fc-45c7-8f16-e8c618abec89" xlink:href="icui-20220331.xsd#icui_InterestPercentageAddedToFederalFundsRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_icui_InterestPercentageAddedToFederalFundsRate_b7a6d867-d5fc-45c7-8f16-e8c618abec89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InterestPercentageAddedToBaseRate_8f6d7e01-37f4-48c0-9311-a33cc1554934" xlink:href="icui-20220331.xsd#icui_InterestPercentageAddedToBaseRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_icui_InterestPercentageAddedToBaseRate_8f6d7e01-37f4-48c0-9311-a33cc1554934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_02aabe92-3a6e-447c-bc4f-c7425be0c3e7" xlink:href="icui-20220331.xsd#icui_TerSOFRInterestRateAdjustmentForBaseRateLoans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans_02aabe92-3a6e-447c-bc4f-c7425be0c3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_2c854f24-bd30-4d1e-a90c-71b0dcfec8f7" xlink:href="icui-20220331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_2c854f24-bd30-4d1e-a90c-71b0dcfec8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_11fac744-7077-4971-b851-44935b8cc679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_11fac744-7077-4971-b851-44935b8cc679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_e9fe097a-0b4c-4b05-85e7-944b5690333c" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_e9fe097a-0b4c-4b05-85e7-944b5690333c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_91aa0873-8ce5-48c5-9a28-5d513719a7ed" xlink:href="icui-20220331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_91aa0873-8ce5-48c5-9a28-5d513719a7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f3162051-5181-43f8-b431-4eded5860045" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_b9908362-d257-4828-8c0c-e1359ebcb6fa" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:to="loc_icui_TermLoanAxis_b9908362-d257-4828-8c0c-e1359ebcb6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_b9908362-d257-4828-8c0c-e1359ebcb6fa" xlink:to="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_b03137c2-5df5-4ec2-a551-769926b6054a" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:to="loc_icui_TermLoanAMember_b03137c2-5df5-4ec2-a551-769926b6054a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_280100b5-8dbf-4e03-9766-f6ebe14ce81b" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_e314aed2-3035-4444-ae2f-4225b0707921" xlink:to="loc_icui_TermLoanBMember_280100b5-8dbf-4e03-9766-f6ebe14ce81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelAxis_130c4923-eb71-4782-85ee-e85e1dec6516" xlink:href="icui-20220331.xsd#icui_LeverageRatioLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:to="loc_icui_LeverageRatioLevelAxis_130c4923-eb71-4782-85ee-e85e1dec6516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:href="icui-20220331.xsd#icui_LeverageRatioLevelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelAxis_130c4923-eb71-4782-85ee-e85e1dec6516" xlink:to="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Greaterthan400to100Member_ae64bc02-fa6f-46a0-a797-ee0dcac2ea08" xlink:href="icui-20220331.xsd#icui_Greaterthan400to100Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_Greaterthan400to100Member_ae64bc02-fa6f-46a0-a797-ee0dcac2ea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_ba0cee51-36a7-49b0-a767-2a4dd93a50fe" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member_ba0cee51-36a7-49b0-a767-2a4dd93a50fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_b5e7aa2d-b7fc-41db-8866-ccee8f709eec" xlink:href="icui-20220331.xsd#icui_LessThanOrEqual300To100ButGreaterThan250to100Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqual300To100ButGreaterThan250to100Member_b5e7aa2d-b7fc-41db-8866-ccee8f709eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_af4dfd1e-823d-4d91-8b5c-9082204fcb7b" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member_af4dfd1e-823d-4d91-8b5c-9082204fcb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThanOrEqualTo200To100Member_3ae02ee4-1ac2-4cf5-b05a-77c04bf19cca" xlink:href="icui-20220331.xsd#icui_LessThanOrEqualTo200To100Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThanOrEqualTo200To100Member_3ae02ee4-1ac2-4cf5-b05a-77c04bf19cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_GreaterThan275To100Member_62ac7adb-8041-40bf-ac44-452ccbd642d3" xlink:href="icui-20220331.xsd#icui_GreaterThan275To100Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_GreaterThan275To100Member_62ac7adb-8041-40bf-ac44-452ccbd642d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_LessThan275To100Member_ed11ac49-e6a0-4ad3-94d6-81d06f03d827" xlink:href="icui-20220331.xsd#icui_LessThan275To100Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LeverageRatioLevelDomain_8d065499-be6c-4ada-baff-2b233ad4cc73" xlink:to="loc_icui_LessThan275To100Member_ed11ac49-e6a0-4ad3-94d6-81d06f03d827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_614017a1-6b15-463e-a859-e78e45c9cd46" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:to="loc_srt_RangeAxis_614017a1-6b15-463e-a859-e78e45c9cd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_614017a1-6b15-463e-a859-e78e45c9cd46" xlink:to="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_98490953-e769-4e59-8589-3132ae0445ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:to="loc_srt_MaximumMember_98490953-e769-4e59-8589-3132ae0445ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2fd8e960-8ff8-41ce-8df8-cbf94e6046df" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9f152ef0-1b8a-41fa-896d-0497a7245584" xlink:to="loc_srt_MinimumMember_2fd8e960-8ff8-41ce-8df8-cbf94e6046df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBasedOnLeverageRatioLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioTable_a225ff01-baac-42f5-865e-92735fd7ee64" xlink:to="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginBaseRateLoans_3fe4f185-c706-4ad9-9381-1678e1cfb5b7" xlink:href="icui-20220331.xsd#icui_ApplicableMarginBaseRateLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_icui_ApplicableMarginBaseRateLoans_3fe4f185-c706-4ad9-9381-1678e1cfb5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ApplicableMarginTermSOFRLoans_b9c9f001-d111-4a00-8652-8287fbc78a03" xlink:href="icui-20220331.xsd#icui_ApplicableMarginTermSOFRLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_icui_ApplicableMarginTermSOFRLoans_b9c9f001-d111-4a00-8652-8287fbc78a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b79db158-0ae7-49c7-80d6-219602d25fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b79db158-0ae7-49c7-80d6-219602d25fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_62c7e672-a074-48dc-9145-993e7274b428" xlink:href="icui-20220331.xsd#icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_ApplicableMarginBasedOnLeverageRatioLineItems_22e59866-e1da-4789-88c9-2b73e93a4c71" xlink:to="loc_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans_62c7e672-a074-48dc-9145-993e7274b428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsTerminatedCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5c133f7f-2a4a-4491-8f7f-4d6ed011da4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d92f92bf-6aa2-4875-ad22-5f70befcd854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c133f7f-2a4a-4491-8f7f-4d6ed011da4b" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d92f92bf-6aa2-4875-ad22-5f70befcd854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationDate1_ce7b424b-b5af-4ddd-8297-f0ba58c1cb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c133f7f-2a4a-4491-8f7f-4d6ed011da4b" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationDate1_ce7b424b-b5af-4ddd-8297-f0ba58c1cb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_d31e2b38-0fce-4545-992d-43bbda4dcec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c133f7f-2a4a-4491-8f7f-4d6ed011da4b" xlink:to="loc_us-gaap_LinesOfCreditCurrent_d31e2b38-0fce-4545-992d-43bbda4dcec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsTableDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4d8c098a-2324-4684-ba7f-ca363dd8fd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4d8c098a-2324-4684-ba7f-ca363dd8fd49" xlink:to="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAxis_e3e9f52a-4425-43e8-a9d0-eaa820af1a93" xlink:href="icui-20220331.xsd#icui_TermLoanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:to="loc_icui_TermLoanAxis_e3e9f52a-4425-43e8-a9d0-eaa820af1a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:href="icui-20220331.xsd#icui_TermLoanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanAxis_e3e9f52a-4425-43e8-a9d0-eaa820af1a93" xlink:to="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanAMember_56a23503-a6c4-4583-9b92-b5772b71e07b" xlink:href="icui-20220331.xsd#icui_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:to="loc_icui_TermLoanAMember_56a23503-a6c4-4583-9b92-b5772b71e07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBMember_ad17b6e9-e957-49f8-a118-d56f79968e01" xlink:href="icui-20220331.xsd#icui_TermLoanBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_TermLoanDomain_940b7633-28bc-4d4e-a3dd-e7023fa5a538" xlink:to="loc_icui_TermLoanBMember_ad17b6e9-e957-49f8-a118-d56f79968e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ff6423d0-3aa4-4dca-80c0-ee1095d30957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ff6423d0-3aa4-4dca-80c0-ee1095d30957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3c9f2e63-7ce3-444d-b882-12973110e77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ff6423d0-3aa4-4dca-80c0-ee1095d30957" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3c9f2e63-7ce3-444d-b882-12973110e77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6985caf7-4d15-4294-b69d-11ad63a84f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3c9f2e63-7ce3-444d-b882-12973110e77a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6985caf7-4d15-4294-b69d-11ad63a84f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a01f3764-b09a-49e3-ad40-99eee80b0471" xlink:to="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_896d0064-486b-449c-a357-b55ad6d26d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_896d0064-486b-449c-a357-b55ad6d26d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_18c65468-20f5-4ce0-8729-c3fdc48a82b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_18c65468-20f5-4ce0-8729-c3fdc48a82b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_aa2519be-4e12-46ba-b3eb-eabd02de0217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_aa2519be-4e12-46ba-b3eb-eabd02de0217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_a622bf2b-9cdd-4dd1-a7bf-c55189f2e882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_a622bf2b-9cdd-4dd1-a7bf-c55189f2e882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_46e8968c-fa02-4582-ab5c-c6876896d382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtCurrent_46e8968c-fa02-4582-ab5c-c6876896d382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_01cd1d77-f62e-499c-90f4-34399d513de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_01cd1d77-f62e-499c-90f4-34399d513de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_db717f4b-5a66-4e1c-a68c-3688fe430811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_63839bd5-5b00-42da-9dfd-85d2c41232ce" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_db717f4b-5a66-4e1c-a68c-3688fe430811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:href="icui-20220331.xsd#icui_LOngTermObligationsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_e8a4c6b2-82cd-4551-9477-16cc80b3448f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_e8a4c6b2-82cd-4551-9477-16cc80b3448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_76b39383-78a6-4974-a90b-e8e1955a95a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_76b39383-78a6-4974-a90b-e8e1955a95a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4629cadc-8010-4639-af9a-171b42b56e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4629cadc-8010-4639-af9a-171b42b56e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_68e60cd3-260b-4501-b52f-9e3bf1dc1d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_68e60cd3-260b-4501-b52f-9e3bf1dc1d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e42f0a9d-15ba-4fdd-ae84-0950a30efddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e42f0a9d-15ba-4fdd-ae84-0950a30efddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0081467e-c469-466d-958c-c57b69d62d42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0081467e-c469-466d-958c-c57b69d62d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d587ac17-33ea-4d84-ac6f-429aa1e5eb67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d587ac17-33ea-4d84-ac6f-429aa1e5eb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_583d84aa-23e9-41a5-ba11-492cead99777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_icui_LOngTermObligationsDisclosureAbstract_d918d40a-e282-4caf-941c-6c5a34e5aebd" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_583d84aa-23e9-41a5-ba11-492cead99777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cac1e1bd-9834-425a-84c3-7a5d2fa93f45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b5bb74dd-bf1d-49f6-bfe7-810629ea020d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cac1e1bd-9834-425a-84c3-7a5d2fa93f45" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_b5bb74dd-bf1d-49f6-bfe7-810629ea020d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d7a49024-0089-4beb-b09b-135a547e5030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cac1e1bd-9834-425a-84c3-7a5d2fa93f45" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d7a49024-0089-4beb-b09b-135a547e5030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_ee85032f-3f79-4167-8543-cbc8e100029a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cac1e1bd-9834-425a-84c3-7a5d2fa93f45" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_ee85032f-3f79-4167-8543-cbc8e100029a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_841815de-83c6-4bea-acc8-1957e54c3fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cac1e1bd-9834-425a-84c3-7a5d2fa93f45" xlink:to="loc_us-gaap_InterestExpenseDebt_841815de-83c6-4bea-acc8-1957e54c3fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#LongTermObligationsPrincipalPaymentDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a7a667d0-d747-4c65-8290-3c926f2ac1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentFirst2Years_3c79fc1f-ea54-42e3-b41e-a41150a928be" xlink:href="icui-20220331.xsd#icui_TermAPrincipalPaymentFirst2Years"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a7a667d0-d747-4c65-8290-3c926f2ac1e0" xlink:to="loc_icui_TermAPrincipalPaymentFirst2Years_3c79fc1f-ea54-42e3-b41e-a41150a928be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentYear3And4_976e9153-e402-452c-b1ab-38f257879641" xlink:href="icui-20220331.xsd#icui_TermAPrincipalPaymentYear3And4"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a7a667d0-d747-4c65-8290-3c926f2ac1e0" xlink:to="loc_icui_TermAPrincipalPaymentYear3And4_976e9153-e402-452c-b1ab-38f257879641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermAPrincipalPaymentInYear5_ede7c8ec-ca4c-4a76-a9ed-1a7f35c33eac" xlink:href="icui-20220331.xsd#icui_TermAPrincipalPaymentInYear5"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a7a667d0-d747-4c65-8290-3c926f2ac1e0" xlink:to="loc_icui_TermAPrincipalPaymentInYear5_ede7c8ec-ca4c-4a76-a9ed-1a7f35c33eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TermLoanBPrincipalPayment_6e178a49-b3a5-4407-a192-b9eeb5033eb1" xlink:href="icui-20220331.xsd#icui_TermLoanBPrincipalPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a7a667d0-d747-4c65-8290-3c926f2ac1e0" xlink:to="loc_icui_TermLoanBPrincipalPayment_6e178a49-b3a5-4407-a192-b9eeb5033eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_bd3ac693-80ef-4b24-86cb-441b8cda74d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a7a667d0-d747-4c65-8290-3c926f2ac1e0" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_bd3ac693-80ef-4b24-86cb-441b8cda74d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="icui-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6fa5fa81-7d74-40cf-ad69-ed0db74d5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_364dc444-241a-4c2d-90ae-a2ae89f217a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6fa5fa81-7d74-40cf-ad69-ed0db74d5f3a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_364dc444-241a-4c2d-90ae-a2ae89f217a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#CommitmentsandContingenciesContingencyDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_99668a9a-aa61-4e97-a6e6-44304f71882c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_71098062-308f-4c3b-bcd1-6e8d88aec01c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_99668a9a-aa61-4e97-a6e6-44304f71882c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_71098062-308f-4c3b-bcd1-6e8d88aec01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_236d8c8e-169a-4220-9576-d615bcbe2264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_71098062-308f-4c3b-bcd1-6e8d88aec01c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_236d8c8e-169a-4220-9576-d615bcbe2264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_236d8c8e-169a-4220-9576-d615bcbe2264" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsMedicalMember_32376de9-a648-4520-91cb-f9ed09f3e399" xlink:href="icui-20220331.xsd#icui_SmithsMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:to="loc_icui_SmithsMedicalMember_32376de9-a648-4520-91cb-f9ed09f3e399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ForeignInfusionSystemSupplierMember_4434cbcb-a481-43d5-8a65-ba0a1bcf3ba5" xlink:href="icui-20220331.xsd#icui_ForeignInfusionSystemSupplierMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:to="loc_icui_ForeignInfusionSystemSupplierMember_4434cbcb-a481-43d5-8a65-ba0a1bcf3ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_InternationalDistributorMember_ba25dead-6484-4a70-a70d-4d6bb2205350" xlink:href="icui-20220331.xsd#icui_InternationalDistributorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e400c90c-e99d-498f-aae7-7a5bf1baee18" xlink:to="loc_icui_InternationalDistributorMember_ba25dead-6484-4a70-a70d-4d6bb2205350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionContingentConsiderationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable_71098062-308f-4c3b-bcd1-6e8d88aec01c" xlink:to="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_Contingentconsiderationgross_ddc4f808-2e0d-4230-945d-8c2dee6c77d0" xlink:href="icui-20220331.xsd#icui_Contingentconsiderationgross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_icui_Contingentconsiderationgross_ddc4f808-2e0d-4230-945d-8c2dee6c77d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossST_fffe307c-a194-46d4-b411-e5437ca3205a" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossST"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_icui_ContingentConsiderationGrossST_fffe307c-a194-46d4-b411-e5437ca3205a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_ContingentConsiderationGrossLT_c6cee085-9fc7-4fa3-b2cd-1b9a66ade992" xlink:href="icui-20220331.xsd#icui_ContingentConsiderationGrossLT"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_icui_ContingentConsiderationGrossLT_c6cee085-9fc7-4fa3-b2cd-1b9a66ade992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1377aa0e-a7da-4c01-88fe-093335e99311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_1377aa0e-a7da-4c01-88fe-093335e99311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualComponentAmount_58e18ad2-b941-4d8a-976c-854ee10eec64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualComponentAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionContingentConsiderationLineItems_d8d3ec27-6d50-4115-9676-6cdb930a8f4c" xlink:to="loc_us-gaap_ProductLiabilityAccrualComponentAmount_58e18ad2-b941-4d8a-976c-854ee10eec64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="simple" xlink:href="icui-20220331.xsd#CollaborativeandOtherArrangementsNotes"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5ac62f84-bd11-417f-9989-9b60b868e08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5948f825-0581-426a-a24a-980179c420b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5ac62f84-bd11-417f-9989-9b60b868e08e" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_5948f825-0581-426a-a24a-980179c420b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="simple" xlink:href="icui-20220331.xsd#CollaborativeandOtherArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#CollaborativeandOtherArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_53d415ea-8568-4729-9a6e-814bd2a0ab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_f838ac8d-55f3-49d4-9592-17c06d85e09d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_53d415ea-8568-4729-9a6e-814bd2a0ab4e" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_f838ac8d-55f3-49d4-9592-17c06d85e09d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/Equity" xlink:type="simple" xlink:href="icui-20220331.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f4f517fe-0d6c-43e9-b089-b726d9dc5ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2e697bdd-e864-44e5-8c18-81660ee65364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f4f517fe-0d6c-43e9-b089-b726d9dc5ab4" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2e697bdd-e864-44e5-8c18-81660ee65364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityTables" xlink:type="simple" xlink:href="icui-20220331.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b8c4f4fb-a117-4635-982c-12cf27d49824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8f50ce1c-afa0-4086-9b03-dea14ca5701d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b8c4f4fb-a117-4635-982c-12cf27d49824" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8f50ce1c-afa0-4086-9b03-dea14ca5701d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#EquityDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bf628174-9e97-4b75-ac55-2521bfa0912c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_TreasuryStockPurchasePlan_f46dfca1-511e-4681-aaee-4dc01411223e" xlink:href="icui-20220331.xsd#icui_TreasuryStockPurchasePlan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf628174-9e97-4b75-ac55-2521bfa0912c" xlink:to="loc_icui_TreasuryStockPurchasePlan_f46dfca1-511e-4681-aaee-4dc01411223e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_69a873f2-c96b-4d03-94ef-b89984a80bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf628174-9e97-4b75-ac55-2521bfa0912c" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_69a873f2-c96b-4d03-94ef-b89984a80bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_03b3a804-a196-4774-a467-20075ecd16c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf628174-9e97-4b75-ac55-2521bfa0912c" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_03b3a804-a196-4774-a467-20075ecd16c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_dee5fed1-f560-4368-99c5-62aa5b754c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf628174-9e97-4b75-ac55-2521bfa0912c" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_dee5fed1-f560-4368-99c5-62aa5b754c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued_0f8d41cd-0bf5-4b27-acba-26845069c1f6" xlink:href="icui-20220331.xsd#icui_SmithsGroupOwnershipAcquisitionSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf628174-9e97-4b75-ac55-2521bfa0912c" xlink:to="loc_icui_SmithsGroupOwnershipAcquisitionSharesIssued_0f8d41cd-0bf5-4b27-acba-26845069c1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_ce749588-2e38-4466-9759-dcd692ae85ac" xlink:href="icui-20220331.xsd#icui_SmithsGroupOwnershipRequiredForBoardRepresentation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bf628174-9e97-4b75-ac55-2521bfa0912c" xlink:to="loc_icui_SmithsGroupOwnershipRequiredForBoardRepresentation_ce749588-2e38-4466-9759-dcd692ae85ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="icui-20220331.xsd#EquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_16444c95-36f1-4cd8-aaab-cbf76a33c927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8239fd6-1d09-428e-bed3-853740c16173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_16444c95-36f1-4cd8-aaab-cbf76a33c927" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8239fd6-1d09-428e-bed3-853740c16173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_110e4e56-5259-48d1-af4f-23674bea2ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8239fd6-1d09-428e-bed3-853740c16173" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_110e4e56-5259-48d1-af4f-23674bea2ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_110e4e56-5259-48d1-af4f-23674bea2ab8" xlink:to="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d7864ccd-5529-46d5-8197-5a16d99956ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d7864ccd-5529-46d5-8197-5a16d99956ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_a535e07b-01cc-4b97-94dd-ddcd1daac5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_a535e07b-01cc-4b97-94dd-ddcd1daac5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ce89983f-fa36-4d98-b60c-753c9bd804ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e8470d4a-3926-45b4-a00b-f098a7dcce31" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_ce89983f-fa36-4d98-b60c-753c9bd804ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e8239fd6-1d09-428e-bed3-853740c16173" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e69e789-190b-48c7-b7df-e1651f1546d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6e69e789-190b-48c7-b7df-e1651f1546d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4d1384b6-537d-40eb-8ee3-0b3e87200f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4d1384b6-537d-40eb-8ee3-0b3e87200f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_673cddf8-b873-48b5-975a-c507ddcfc195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_673cddf8-b873-48b5-975a-c507ddcfc195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_051b12f9-9d28-4590-8cbf-655e525ea954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_051b12f9-9d28-4590-8cbf-655e525ea954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6dd1a99d-a237-4b63-91aa-c67c62822c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_93a3d2d8-3dc7-45e9-b9c1-a4f8e3cf970c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6dd1a99d-a237-4b63-91aa-c67c62822c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511389459768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEI Document - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0022692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Calle Amanecer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Clemente<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">366-2183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.10 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ICUI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,896,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000883984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ICU MEDICAL INC/DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511388589736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">$ 329,428<span></span>
</td>
<td class="nump">$ 552,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">14,864<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES</a></td>
<td class="nump">344,292<span></span>
</td>
<td class="nump">567,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts</a></td>
<td class="nump">202,897<span></span>
</td>
<td class="nump">105,894<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">536,314<span></span>
</td>
<td class="nump">290,235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">10,219<span></span>
</td>
<td class="nump">19,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">80,273<span></span>
</td>
<td class="nump">46,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">1,173,995<span></span>
</td>
<td class="nump">1,029,809<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, net</a></td>
<td class="nump">674,412<span></span>
</td>
<td class="nump">468,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">92,027<span></span>
</td>
<td class="nump">39,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">1,526,866<span></span>
</td>
<td class="nump">43,439<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">1,094,710<span></span>
</td>
<td class="nump">188,311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred Income Tax Assets</a></td>
<td class="nump">77,566<span></span>
</td>
<td class="nump">42,604<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">OTHER ASSETS</a></td>
<td class="nump">104,617<span></span>
</td>
<td class="nump">63,743<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,746,732<span></span>
</td>
<td class="nump">1,880,738<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">200,991<span></span>
</td>
<td class="nump">81,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">261,820<span></span>
</td>
<td class="nump">118,195<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="nump">13,813<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax liability</a></td>
<td class="nump">17,491<span></span>
</td>
<td class="nump">1,454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">494,115<span></span>
</td>
<td class="nump">200,777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">57,701<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,642,171<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">134,208<span></span>
</td>
<td class="nump">41,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">DEFERRED INCOME TAXES</a></td>
<td class="nump">220,628<span></span>
</td>
<td class="nump">1,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">INCOME TAX LIABILITY</a></td>
<td class="nump">19,007<span></span>
</td>
<td class="nump">18,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue', window );">Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,897 shares at March 31,2022 and 21,280 shares at December 31, 2021 and outstanding 23,884 shares at March 31, 2022 and 21,280 shares at December 31, 2021</a></td>
<td class="nump">2,390<span></span>
</td>
<td class="nump">2,128<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,306,264<span></span>
</td>
<td class="nump">721,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, at cost (12,684 and 119 shares, respectively)</a></td>
<td class="num">(2,843)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">873,719<span></span>
</td>
<td class="nump">911,787<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(628)<span></span>
</td>
<td class="num">(19,269)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">TOTAL STOCKHOLDERS' EQUITY</a></td>
<td class="nump">2,178,902<span></span>
</td>
<td class="nump">1,616,031<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 4,746,732<span></span>
</td>
<td class="nump">$ 1,880,738<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511389391832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts Receivable, Allowance for Credit Loss</a></td>
<td class="nump">$ 6,921<span></span>
</td>
<td class="nump">$ 7,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible preferred stock, par value</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible preferred stock, authorized shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible preferred stock, issued shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible preferred stock, outstanding shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">23,897,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">23,884,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">12,684<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391154280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">$ 543,122<span></span>
</td>
<td class="nump">$ 318,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="nump">374,295<span></span>
</td>
<td class="nump">205,366<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">168,827<span></span>
</td>
<td class="nump">112,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">153,212<span></span>
</td>
<td class="nump">72,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">23,871<span></span>
</td>
<td class="nump">10,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Restructuringandstrategictransaction', window );">Restructuring, strategic transaction and integration</a></td>
<td class="nump">33,905<span></span>
</td>
<td class="nump">2,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contractsettlement', window );">contract settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">TOTAL OPERATING EXPENSES</a></td>
<td class="nump">210,988<span></span>
</td>
<td class="nump">86,110<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME FROM OPERATIONS</a></td>
<td class="num">(42,161)<span></span>
</td>
<td class="nump">26,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(13,644)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">OTHER INCOME (EXPENSE), net</a></td>
<td class="nump">1,004<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</a></td>
<td class="num">(54,801)<span></span>
</td>
<td class="nump">27,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">PROVISION FOR INCOME TAXES</a></td>
<td class="nump">16,733<span></span>
</td>
<td class="num">(3,361)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="num">$ (38,068)<span></span>
</td>
<td class="nump">$ 23,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET INCOME PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>WEIGHTED AVERAGE NUMBER OF SHARES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">23,646<span></span>
</td>
<td class="nump">21,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">23,646<span></span>
</td>
<td class="nump">21,695<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contractsettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contract settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contractsettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringandstrategictransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and strategic transaction expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringandstrategictransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392019832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="num">$ (38,068)<span></span>
</td>
<td class="nump">$ 23,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="nump">23,572<span></span>
</td>
<td class="num">(945)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment, net of taxes of $0 for all periods</a></td>
<td class="num">(4,946)<span></span>
</td>
<td class="num">(7,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Other Comprehensive Income (Loss), Other Adjustments, after Tax</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of taxes</a></td>
<td class="nump">18,641<span></span>
</td>
<td class="num">(8,391)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="num">$ (19,427)<span></span>
</td>
<td class="nump">$ 15,340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392330344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Paranthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="nump">$ 7,312<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386008712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock Shares [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,058,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2020</a></td>
<td class="nump">$ 1,502,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,106<span></span>
</td>
<td class="nump">$ 693,068<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="nump">$ 808,652<span></span>
</td>
<td class="num">$ (1,522)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 4,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to Additional Paid in Capital, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="num">(37,423)<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">$ (7,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,723)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">6,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="num">(8,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="nump">23,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2021</a></td>
<td class="nump">1,520,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">701,586<span></span>
</td>
<td class="num">(5,410)<span></span>
</td>
<td class="nump">832,383<span></span>
</td>
<td class="num">(9,913)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,219,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="num">$ (8,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,391)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Dec. 31, 2021</a></td>
<td class="nump">21,280,000<span></span>
</td>
<td class="nump">21,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Dec. 31, 2021</a></td>
<td class="nump">$ 1,616,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">721,412<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="nump">911,787<span></span>
</td>
<td class="num">(19,269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock Issued During Period, Shares, New Issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Stock Issued During Period, Value, New Issues</a></td>
<td class="nump">$ 2,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Adjustments to Additional Paid in Capital, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,965)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="num">(37,279)<span></span>
</td>
<td class="num">(37,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</a></td>
<td class="num">$ (8,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Stock Issued During Period, Value, Acquisitions</a></td>
<td class="nump">$ 575,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">575,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Stock Issued During Period, Shares, Acquisitions</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</a></td>
<td class="nump">$ 12,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</a></td>
<td class="nump">18,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income Attributable to Parent</a></td>
<td class="num">(38,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38,068)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent at Mar. 31, 2022</a></td>
<td class="nump">$ 2,178,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,390<span></span>
</td>
<td class="nump">$ 1,306,264<span></span>
</td>
<td class="num">$ (2,843)<span></span>
</td>
<td class="nump">$ 873,719<span></span>
</td>
<td class="num">(628)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding at Mar. 31, 2022</a></td>
<td class="nump">23,884,000<span></span>
</td>
<td class="nump">23,897,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">$ 18,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,641<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511388698296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="num">$ (38,068)<span></span>
</td>
<td class="nump">$ 23,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">22,489<span></span>
</td>
<td class="nump">1,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(36,170)<span></span>
</td>
<td class="nump">13,208<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">2,607<span></span>
</td>
<td class="num">(742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase (Decrease) in Other Operating Assets</a></td>
<td class="num">(14,371)<span></span>
</td>
<td class="num">(3,463)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">19,504<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(19,238)<span></span>
</td>
<td class="num">(19,965)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes', window );">Income taxes, including excess tax benefits and deferred income taxes</a></td>
<td class="num">(26,102)<span></span>
</td>
<td class="nump">1,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">53,138<span></span>
</td>
<td class="nump">22,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AmortizationOfInventoryStepUp', window );">Amortization of Inventory Step-up</a></td>
<td class="nump">14,370<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Operating Lease, Right-of-Use Asset, Amortization Expense</a></td>
<td class="nump">5,286<span></span>
</td>
<td class="nump">2,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="num">(548)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProvisionForWarrantyAndReturns', window );">Provision for warranty and returns</a></td>
<td class="nump">726<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock compensation</a></td>
<td class="nump">12,092<span></span>
</td>
<td class="nump">6,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfPremium', window );">Bond premium amortization</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Debt Issuance Costs amortization</a></td>
<td class="nump">1,643<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Sparepartsusage', window );">Sparepartsusage</a></td>
<td class="nump">2,223<span></span>
</td>
<td class="nump">2,825<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other Noncash Income (Expense)</a></td>
<td class="num">(1,649)<span></span>
</td>
<td class="num">(1,287)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="num">(1,342)<span></span>
</td>
<td class="nump">51,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(23,606)<span></span>
</td>
<td class="num">(14,028)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of asset</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Intangible assets additions</a></td>
<td class="num">(2,387)<span></span>
</td>
<td class="num">(1,874)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of investment securities</a></td>
<td class="num">(1,993)<span></span>
</td>
<td class="num">(10,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of investment securities</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,867,750)<span></span>
</td>
<td class="num">(18,881)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts', window );">Proceeds from issuance of long-term debt, net of lender debt issuance costs</a></td>
<td class="nump">1,672,698<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="nump">16,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="num">(1,852)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">2,974<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance Lease, Principal Payments</a></td>
<td class="num">(160)<span></span>
</td>
<td class="num">(141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="nump">8,743<span></span>
</td>
<td class="nump">7,723<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="nump">1,648,917<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAbstract', window );"><strong>Effect of Exchange Rate on Cash [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations', window );">Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations</a></td>
<td class="num">(3,224)<span></span>
</td>
<td class="num">(1,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="num">(223,399)<span></span>
</td>
<td class="nump">28,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="nump">329,428<span></span>
</td>
<td class="nump">424,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital Expenditures Incurred but Not yet Paid</a></td>
<td class="nump">5,178<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>NON-CASH INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair Value of Assets Acquired</a></td>
<td class="nump">1,594,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to Acquire Businesses, Net of Cash Acquired</a></td>
<td class="num">(1,844,164)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</a></td>
<td class="num">(575,975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationAllAcquisitions', window );">Contingent consideration all Acquisitions</a></td>
<td class="num">(55,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_GoodwillAcquiredDuringPeriodAllAcquisitions', window );">Goodwill, acquired during period</a></td>
<td class="nump">1,485,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Liabilities Assumed</a></td>
<td class="num">$ (605,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AmortizationOfInventoryStepUp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Inventory Step-up</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AmortizationOfInventoryStepUp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationAllAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration all Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationAllAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_GoodwillAcquiredDuringPeriodAllAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, acquired during period - All acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_GoodwillAcquiredDuringPeriodAllAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of long-term debt, net of lender debt issuance costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProvisionForWarrantyAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for warranty and returns</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProvisionForWarrantyAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Sparepartsusage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sparepartsusage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Sparepartsusage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash balances in continuing operations held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of purchase premium on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391861112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation [Text Block]</a></td>
<td class="text">Basis of Presentation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU Medical,&#160;Inc., ("ICU") a Delaware corporation, filed with the SEC for the year ended December&#160;31, 2021.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged in the development, manufacturing and sale of innovative medical products used in infusion therapy and critical care applications.&#160;We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical 2020 Limited ("Smiths Medical"), see Note 3: Acquisitions. Our condensed consolidated statement of operations includes the results of operations for Smiths Medical from January 7, 2022 through March 26, 2022, which is the current end of their 4-4-5 accounting period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392190888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</a></td>
<td class="text">New Accounting Pronouncements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391863064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination Disclosure</a></td>
<td class="text">Acquisitions<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Acquisition</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired 100.0% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#8220;Smiths&#8221;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash consideration for the acquisition was $1.9&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of 2.5&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the closing market price of our common stock on the acquisition date. Smiths may be entitled to an additional $100.0&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share (each a "Price Target"), and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $100.0&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Preliminary Purchase Price Allocation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the preliminary purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated consideration to be paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212,950)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493,115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preliminary identifiable intangible assets include $500.0&#160;million of customer relationships, $420.0&#160;million of developed technology, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately nine years, and, for each identifiable intangible asset is estimated as follows: eight years for customer relationships, ten years for developed technology, and six months for the trade mark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preliminary accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above purchase price and purchase price allocation are preliminary and subject to future revision as the acquired assets and liabilities assumed are dependent upon the finalization of the related valuations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The identifiable intangible assets and other long-lived assets acquired have been valued as Level 3 assets at fair value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unaudited Pro Forma Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to March 31, 2022 were $214.9&#160;million and $40.4&#160;million, respectively. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2021. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $3.3&#160;million and $26.3&#160;million for the three months ended March 31, 2022 and 2021, respectively, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Credit Facilities of $0.8&#160;million and $12.6&#160;million for the three months ended March 31, 2022 and 2021, respectively; and a $18.8&#160;million expense related to the increase in fair value of inventory for the three months ended March 31, 2021. In addition, there were non-recurring adjustments directly attributable to the business combination, including acquisition-related cost of $13.5&#160;million for the three months ended March 31, 2021 and adjustments related to the extinguishment of related party loans receivable and payable equal to $81.0&#160;million and $31.0&#160;million for the three months ended March 31, 2022 and 2021, respectively. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Acquisition</span></div>During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $15.4&#160;million. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $0.5&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March 31, 2022, the total consideration which includes the acquisition date fair value of the contingent consideration was $17.1&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511507666888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure</a></td>
<td class="text">Restructuring, Strategic Transaction and Integration<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $33.9 million and $2.9 million for the three months ended March 31, 2022 and 2021, respectively.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March 31, 2022, restructuring charges were $3.2&#160;million and were related to severance costs. Restructuring charges during the three months ended March 31, 2021 were not material.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended March&#160;31, 2022 (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Balance<br/>January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquired Restructuring Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges<br/>Incurred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency <br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Balance<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance pay and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility closure expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Strategic Transaction and Integration Expenses</span></div>&#160;&#160;&#160;&#160;We incurred and expensed $30.7 million and $2.9 million in strategic transaction and integration expenses during the three months ended March 31, 2022 and 2021, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three months ended March 31, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 (see Note 3: Acquisitions) which primarily included legal expenses, bank fees, a United Kingdom stamp tax and employee costs. The strategic transaction and integration expenses for the three months ended March 31, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397066568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text">Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Following our acquisition of Smiths Medical, our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions, Critical Care, Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue disaggregated</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents our revenues disaggregated by product line (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product line</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Consumables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Critical Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infusion Systems-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular Access-Smiths Medical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vital Care-Smiths Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,046&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical represent our newly integrated product lines following our acquisition of Smiths Medical on January 6, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table represents our revenues disaggregated by geography (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract balances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the changes in our contract balances for the three months ended March 31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,236)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,794)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,888)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March 31, 2022, revenue from remaining performance obligations is as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.516%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Recognition Timing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&lt; 12 Months</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&gt; 12 Months</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Other deferred revenue includes pump development programs, purchased training and extended warranty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397074920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Lessee, Operating Leases [Text Block]</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities, and other long-term liabilities on our condensed consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,020&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on our finance leases is included in other income (expense), net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,847</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,786</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,177</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,545</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391848744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share [Text Block]</a></td>
<td class="text">Net Income Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three months ended March 31, 2022, any potentially common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect, therefore basic and diluted net loss per share are equal for the period. There were nil and 12,080 anti-dilutive securities for the three months ended March&#160;31, 2022 and March 31, 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,068)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.12&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No dilutive effect for the three months ended March 31, 2022;  therefore, zero incremental shares included for the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392171640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging Activities Disclosure [Text Block]</a></td>
<td class="text">Derivatives and Hedging Activities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedge Accounting and Hedging Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos, Euros, Czech Koruna and Japanese Yen, and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of March&#160;31, 2022 was $231.8&#160;million, which included the notional equivalent of $58.7&#160;million in Mexican Pesos, $42.4&#160;million in Euros, $23.5&#160;million in Czech Koruna, $22.2&#160;million in Japanese Yen and $85.0&#160;million in other foreign currencies, with terms currently through July 2023. We did not have such derivative contracts as of December 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cross-currency Par Forward Contracts</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in Mexican Pesos ("MXN"). These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of March&#160;31, 2022 and December 31, 2021 was approximately 311.6 million MXN and 413.1&#160;million MXN, respectively. The derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD. Preceding this contract we had a one-year cross-currency par forward contract with a term from November 3, 2020 to December 1, 2021 that matured in equal monthly amounts at a fixed forward rate of 24.26 MXN/USD.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Floating Interest Rate Risk</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,163&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</span></div><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.992%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.</span></div>As of March&#160;31, 2022, we expect an estimated $1.9&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $3.9&#160;million in deferred losses on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392202024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Disclosures</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1:  quoted prices in active markets for identical assets or liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Earn-out Liabilities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $53.5&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March 31, 2022, the estimated fair value of the total contingent earn-out is $1.6&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both March 31, 2022 and December 31, 2021, the estimated fair value of the contingent earn-out is $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit Vascular, Inc. ("Pursuit"). Pursuit's former equity holders were entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions). </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>January 6, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments, Foreign Exchange Contracts and Interest Rate Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our investments, which consist of corporate bonds, is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency par forward contract:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397130248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock', window );">investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]</a></td>
<td class="text">Investment Securities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Available-for-sale Securities</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds and are considered &#8220;investment grade&#8221; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of March 31, 2022 or December 31, 2021.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Non-Marketable Equity Securities</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we acquired approximately a 20.0% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the period ended March 31, 2022. We did not receive any dividend distributions from this investment during the period ended March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>investments in Debt and Marketable Equity Securities and Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511507595128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock', window );">Prepaids, other current assets and other noncurrent assets [Text Block]</a></td>
<td class="text">Prepaid Expenses and Other Current Assets and Other Assets<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,617&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaids, other current assets and other noncurrent assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391896920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories [Text Block]</a></td>
<td class="text">Inventories<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 3: Acquisitions).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397107384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment [Text Block]</a></td>
<td class="text">Property, Plant and Equipment<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458,614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $21.4 million and $16.3&#160;million for the three months ended March 31, 2022 and 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2022, property, plant and equipment and related depreciation expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391867400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets Disclosure [Text Block]</a></td>
<td class="text">Goodwill and Intangible Assets, Net<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of our goodwill (in thousands):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526,866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to Smiths Medical acquired on January 6, 2022.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other relates to measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">558,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,029&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,238,739&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended March&#160;31, 2022 and 2021, intangible asset amortization expense was $31.7 million and $5.8 million, respectively. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2022, intangible assets and related amortization expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067,548&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391916760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</a></td>
<td class="text">Accrued Liabilities and Other Long-Term Liabilities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Accrued liabilities consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired restructuring liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued transaction/integration costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $31.3&#160;million of estimated remediation costs related to a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div>Other long-term liabilities consist of the following (in thousands):&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397028648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes were accrued at an estimated effective tax rate of 31% and 12% for the three months ended March 31, 2022 and 2021, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the three months ended March 31, 2022 of $2.6&#160;million.    </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2021 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low taxed income ("GILTI"), FDII and tax credits. The effective tax rate during the three months ended March 31, 2021 included a discrete tax benefit of $1.8&#160;million related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391889784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term Debt [Text Block]</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Credit Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#8220;Lenders&#8221;) for $2.2&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $850.0&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $850.0&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $500.0&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $50.0&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $37.8 million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $15.8 million and $13.4 million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $8.7 million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $834.2 million and $836.6 million, respectively.   </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity Dates</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date for the Term Loan A and the Revolving Credit Facility is January 6, 2027, and the maturity date for the Term Loan B is January 6, 2029. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Terms</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus 0.50% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, plus 1.00%.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Term SOFR is the rate per annum equal to (a) Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of 0.10% for Base Rate Loans and between 0.10% to 0.25% for Term SOFR Loans based on the applicable interest period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility Commitment Fee</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Revolving Credit Facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Applicable Interest Margins</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of 0.75% per annum for Base Rate Loans and 1.75% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B has an initial applicable margin of 1.5% per annum for Base Rate Loans and 2.5% per annum for Term SOFR Loans.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: </span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.368%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.665%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.667%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.75 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principal Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to 2.50% of the original principal amount in each of the first two years, 5.00% in each of the third and fourth years and 7.50% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2022, we prepaid $16.0 million in principal payments on the Term Loan A principal balance.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Payments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantors and Collateral</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Covenants</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Leverage Ratio is defined, at any such date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $500.0&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Interest Coverage ratio is defined, at any such date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants as of March 31, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Credit Facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $150.0 million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on November 8, 2022, was terminated in connection with entering into the Credit Agreement on January 6, 2022. There were no borrowings outstanding under the Prior Credit Facility at that date or at December 31, 2021. The remaining unamortized deferred debt issuance costs related to the Prior Credit Facility were not material and were expensed in connection with its termination. See further details of the terms of the Prior Credit Facility in Note 11 in Part II, Item 8, of our 2021 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our long-term debt consist of the following (in thousands):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,016)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655,984&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,642,171&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $15.0 million and $13.0 million relating to the Term Loan A and the Term Loan B, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,684,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total interest expense related to our long-term debt (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392171640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies:<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies [Text Block]</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from the closing date to either the third or fourth anniversary of closing. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $53.5&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $55.1&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at March 31, 2022 is $54.7&#160;million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $1.6&#160;million (see Note 9: Fair Value Measurements).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $2.6&#160;million (see Note 9: Fair Value Measurements).</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments</span></div>&#160;&#160;&#160;&#160;We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391889784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Arrangement Disclosure [Text Block]</a></td>
<td class="text">Collaborative and Other Arrangements&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million and expires on November 30, 2022. As of March 31, 2022, we had satisfied the minimum purchase obligations under the Product Addendum.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511395480840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure</a></td>
<td class="text">Stockholders' Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shareholders Agreement</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owns approximately 10.5% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#8220;Shareholders Agreement&#8221;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least 5.0% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pursuant to the Shareholders Agreement who will stand for election to the Board at the 2022 Annual Meeting of Stockholders to be held in May 2022. This appointment expands the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treasury Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. During the three months ended March&#160;31, 2022, we did not purchase any shares of our common stock under our share purchase plan. As of March&#160;31, 2022, all of the $100.0 million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  </span></div><div><span><br/></span></div><div><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, we withheld 37,279 shares of our common stock from employee vested restricted stock units in consideration for $8.7 million in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. For the three months ended March 31, 2021, we withheld&#160;37,423&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$7.7 million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive (Loss) Income ("AOCI")</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of AOCI, net of tax, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,991)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(945)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,839)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,913)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392872296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The following table summarizes the preliminary purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated cash consideration for acquired assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,922,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary fair value of contingent consideration payable to Smiths</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of ICU Medical, Inc. common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Price per share (ICU's opening market price on the acquisition date)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of ICU shares issued to Smiths</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated consideration to be paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preliminary Purchase Price Allocation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212,950)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill - not tax deductible</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493,115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated Purchase Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,450&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preliminary identifiable intangible assets include $500.0&#160;million of customer relationships, $420.0&#160;million of developed technology, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately nine years, and, for each identifiable intangible asset is estimated as follows: eight years for customer relationships, ten years for developed technology, and six months for the trade mark. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preliminary accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397099768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended March&#160;31, 2022 (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Balance<br/>January 1, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Acquired Restructuring Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charges<br/>Incurred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency <br/>Translation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Balance<br/>March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance pay and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,796&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility closure expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,536&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,030)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,205&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392882248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text">The following table represents our revenues disaggregated by geography (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geography</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Foreign</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,046&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Contract with Customer, Asset and Liability [Table Text Block]</a></td>
<td class="text">The following table presents the changes in our contract balances for the three months ended March 31, 2022 and 2021 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:79.398%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contract Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,461)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of acquired deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,447)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,777)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grant recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(767)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other deferred revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,236)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance, January 1, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,921)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue recognized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software revenue deferred due to implementation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,794)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance, March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,888)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392937496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of our lease cost (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost &#8212; reduction of ROU asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,380&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,020&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Cash Flow, Supplemental Disclosures [Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental cash flow information related to our leases (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AssetsandLiabilitiesLeasesTableTextBlock', window );">Assets and Liabilities, Leases [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,847</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,786</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,391</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,177</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,980</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,545</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 years</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,513&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,336)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,592&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AssetsandLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities, Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AssetsandLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397039592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text">The following table presents the calculation of net earnings per common share (&#8220;EPS&#8221;) &#8212; basic and diluted (in thousands, except per share data):&#160; <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,068)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding (basic)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common and common equivalent shares outstanding (diluted)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,646&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.12&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8212; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No dilutive effect for the three months ended March 31, 2022;  therefore, zero incremental shares included for the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392876472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</a></td>
<td class="text">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.884%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Derivatives Designated as Cash Flow Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign Exchange Contracts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Rate Swaps</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Derivatives</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.692%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Recognized in Other Comprehensive Income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,163&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.992%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Derivatives designated as cash flow hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total derivatives designated as cash flow hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.</span></div>As of March&#160;31, 2022, we expect an estimated $1.9&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $3.9&#160;million in deferred losses on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511395389368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition date fair value estimate of earn-out</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions). </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earn-out Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of earn-out (included in income from operations as a separate line item)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued balance, March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smiths Medical Earn-out</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At Acquisition<br/>January 6, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuit Earn-out</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Simulation Input</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue/Gross Profit Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-Free Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Counter Party Risk</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,717&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,701&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;value&#160;measurements&#160;as of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total&#160;carrying<br/>value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted&#160;prices<br/>in&#160;active<br/>markets&#160;for<br/>identical<br/>assets&#160;(level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>other<br/>observable<br/>inputs&#160;(level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs&#160;(level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency par forward contract:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out liability - LT</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,069&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392863352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding <br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Holding<br/>Gains (Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,420&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-marketable equity method investment consists of the following (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391878152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaid expenses and receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,763&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance and property taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT/GST receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax charge</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,919&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,847&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent[TableTextBlock]</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets consist of the following (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.839%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pump lease receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spare parts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,617&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392204248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current [Table Text Block]</a></td>
<td class="text">Inventories consist of the following (in thousands):&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536,314&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 3: Acquisitions).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391866840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment consists of the following (in thousands):&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432,649&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, building and building improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments placed with customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,257&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905,104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458,614)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674,412&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391044616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill [Table Text Block]</a></td>
<td class="text">The following table presents the changes in the carrying amount of our goodwill (in thousands):<div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526,866&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Relates to Smiths Medical acquired on January 6, 2022.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other relates to measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill [Table Text Block]</a></td>
<td class="text">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life&#160;in&#160;Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">558,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">510,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">581,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">519,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,211,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,029&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,238,739&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144,029&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,094,710&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________ </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.054%"/><td style="width:0.1%"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Amortization Life in Years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-contractual customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-compete</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total amortized intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275,835&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,953&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internally developed software*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">301,193&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067,548&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392208488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities [Table Text Block]</a></td>
<td class="text">Accrued liabilities consist of the following (in thousands):&#160;<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incentive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-ST</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued sales taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranties and returns</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued freight</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired restructuring liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued transaction/integration costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued audit fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,195&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $31.3&#160;million of estimated remediation costs related to a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#8217;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.</span></div>Other long-term liabilities consist of the following (in thousands):&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability-LT</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward-starting interest rate swaps</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liability-LT</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Field service corrective action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,208&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,830&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391049400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text">The carrying values of our long-term debt consist of the following (in thousands):<div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of <br/>March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B &#8212; principal</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility &#8212; principal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,016)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total carrying value of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,655,984&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,642,171&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprised of $15.0 million and $13.0 million relating to the Term Loan A and the Term Loan B, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.837%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">801,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,684,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestExpenseOnLongTermDebtTableTextBlock', window );">Interest expense on long term debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total interest expense related to our long-term debt (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three months ended <br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitment fee &#8212; Revolving Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock', window );">Applicable Margin Based on Leverage Ratio</a></td>
<td class="text">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Term SOFR Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than 4.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than or equal to 2.00 to 1.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Based on Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestExpenseOnLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense on long term debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestExpenseOnLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397116536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">The components of AOCI, net of tax, were as follows (in thousands):<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized (Losses) Gains on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,946)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,641&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,991)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,335&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.976%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,381)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income before<br/>reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from AOCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,458)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(945)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,391)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,839)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,839&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,913)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511388541032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationConsiderationHoldbackLiability', window );">Business Combination, Consideration, Holdback liability</a></td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">15,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 17,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationConsiderationHoldbackLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration, Holdback liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationConsiderationHoldbackLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511388673000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">$ 57,701,000<span></span>
</td>
<td colspan="2" class="nump">$ 2,589,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_MinimumStockPriceTargetForEarnOutPayment', window );">Minimum Stock Price Target for Earn-out Payment</a></td>
<td class="nump">$ 300.00<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_RequiredShareHoldingOfStockIssuedAtAcquisition', window );">Required Share Holding Of Stock Issued At Acquisition</a></td>
<td class="nump">0.500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationConsiderationTransferredCash', window );">Business Combination, Consideration Transferred, Cash</a></td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="nump">2,500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent Earn-Out Liability, Noncurrent</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationConsiderationTransferredCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationConsiderationTransferredCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_MinimumStockPriceTargetForEarnOutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum Stock Price Target for Earn-out Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_MinimumStockPriceTargetForEarnOutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_RequiredShareHoldingOfStockIssuedAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Required Share Holding Of Stock Issued At Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_RequiredShareHoldingOfStockIssuedAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511396172728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Smiths Medical (Details)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="nump">$ 55,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="nump">$ 53,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | shares</a></td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Business Acquisition, Share Price | $ / shares</a></td>
<td class="nump">$ 230.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</a></td>
<td class="nump">$ 575,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</a></td>
<td class="nump">78,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</a></td>
<td class="nump">120,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">226,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</a></td>
<td class="nump">34,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="nump">210,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed', window );">business combination, recognized identifiable asset acquired and liability assumed,</a></td>
<td class="nump">57,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">925,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</a></td>
<td class="nump">9,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</a></td>
<td class="nump">379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</a></td>
<td class="nump">105,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</a></td>
<td class="nump">175,098<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable', window );">Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</a></td>
<td class="num">(24,332)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</a></td>
<td class="num">(85,739)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</a></td>
<td class="num">(212,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</a></td>
<td class="nump">1,059,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_BusinessCombinationGoodwillNonDeductible', window );">Business combination, goodwill- non deductible</a></td>
<td class="nump">1,493,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">2,552,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">420,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Trademarks and Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</a></td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationGoodwillNonDeductible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination, goodwill- non deductible</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationGoodwillNonDeductible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>business combination, recognized identifiable asset acquired and liability assumed,</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=icui_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=icui_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386194296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Business Acquisition, Pro Forma Revenue</a></td>
<td class="nump">$ 563,743<span></span>
</td>
<td class="nump">$ 594,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">543,122<span></span>
</td>
<td class="nump">318,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="num">(38,068)<span></span>
</td>
<td class="nump">23,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Business Acquisition, Pro Forma Net Income (Loss)</a></td>
<td class="num">(34,994)<span></span>
</td>
<td class="num">(1,994)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentAmortization', window );">Pro Forma Adjustment - Amortization</a></td>
<td class="nump">3,300<span></span>
</td>
<td class="nump">26,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentFinanceCosts', window );">Pro Forma Adjustment - Finance Costs</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">12,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentInventory', window );">Pro Forma Adjustment - Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ProFormaAdjustmentRelatedPartyLoans', window );">Pro Forma Adjustment - Related Party Loans</a></td>
<td class="nump">81,000<span></span>
</td>
<td class="nump">$ 31,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember', window );">Acquisition-related Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business Acquisition, Transaction Costs</a></td>
<td class="nump">13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">214,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">$ 40,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Finance Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ProFormaAdjustmentRelatedPartyLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pro Forma Adjustment - Related Party Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ProFormaAdjustmentRelatedPartyLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonrecurringAdjustmentAxis=us-gaap_AcquisitionRelatedCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511395334440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Restructuring (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Restructuringstrategictransactionandintegration', window );">Restructuring, strategic transaction and integration</a></td>
<td class="nump">$ 33,900<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Restructuringstrategictransactionandintegration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, strategic transaction and integration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Restructuringstrategictransactionandintegration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511396119704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Strategic Transaction and Integration Liability (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">$ 664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">3,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">9,205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</a></td>
<td class="nump">7,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">3,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">7,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</a></td>
<td class="nump">5,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Facility Closing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring Charges</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</a></td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve</a></td>
<td class="nump">1,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities</a></td>
<td class="nump">$ 1,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents liabilities associated with restructuring or exit activities of the acquiree, existing at the acquisition date (present liabilities of the acquiree).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397109288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Transaction and Integration (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_StrategicTransactionandIntegration', window );">Strategic Transaction and Integration</a></td>
<td class="nump">$ 30.7<span></span>
</td>
<td class="nump">$ 2.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_StrategicTransactionandIntegration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Strategic Transaction and Integration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_StrategicTransactionandIntegration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386230040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregated Revenue by Geography (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 543,122<span></span>
</td>
<td class="nump">$ 318,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">86,204<span></span>
</td>
<td class="nump">34,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember', window );">Other foreign countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">109,127<span></span>
</td>
<td class="nump">55,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=icui_ForeignMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">195,331<span></span>
</td>
<td class="nump">90,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 347,791<span></span>
</td>
<td class="nump">$ 227,351<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_OtherforeigncountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=icui_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=icui_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386114040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Disaggregated Revenue by Product Line (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 543,122<span></span>
</td>
<td class="nump">$ 318,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember', window );">Infusion Consumables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">140,521<span></span>
</td>
<td class="nump">126,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember', window );">Infusion Systems [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">87,012<span></span>
</td>
<td class="nump">84,334<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_IVSolutionsMember', window );">IV Solutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">88,480<span></span>
</td>
<td class="nump">94,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_CriticalCareMember', window );">Critical Care [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12,157<span></span>
</td>
<td class="nump">13,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesSmithsMedicalMember', window );">Infusion Consumables-Smiths Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">66,290<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_VascularAccessMember', window );">Vascular Access</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">79,008<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_VitalCareMember', window );">Vital Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 69,654<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_IVSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_IVSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_CriticalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_CriticalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_InfusionConsumablesSmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_InfusionConsumablesSmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_VascularAccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_VascularAccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_VitalCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_VitalCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385621832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Contract Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">$ (7,461)<span></span>
</td>
<td class="num">$ (6,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="num">(58,236)<span></span>
</td>
<td class="num">(8,888)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TimingAxis=icui_ShortTermMember', window );">Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">35,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TimingAxis=icui_LongTermMember', window );">Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,245)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">5,574<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(3,447)<span></span>
</td>
<td class="num">(2,921)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member] | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">24,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember', window );">Equipment revenue [Member] | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">4,299<span></span>
</td>
<td class="nump">1,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(4,777)<span></span>
</td>
<td class="num">$ (1,794)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member] | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember', window );">Software revenue [Member] | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(2,266)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember', window );">Government Grant Revenue | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">12,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (Decrease) in Deferred Revenue</a></td>
<td class="nump">1,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred Revenue, Additions</a></td>
<td class="num">(767)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue | Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember', window );">Other deferred revenue | Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInDeferredRevenueRollForward', window );"><strong>Movement in Deferred Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInDeferredRevenueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInDeferredRevenueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_ShortTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_ShortTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_LongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_LongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_EquipmentrevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_EquipmentrevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_SoftwarerevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_SoftwarerevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_GovernmentGrantRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=icui_OtherDeferredRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392900824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Text (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Optiontoextendinyears', window );">Lessee, Operating Lease, Option to Extend</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lessee, Operating Lease, Term of Contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Optiontoextendinyears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Optiontoextendinyears</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Optiontoextendinyears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391066360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 5,178<span></span>
</td>
<td class="nump">$ 2,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Finance Lease, Interest Expense</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Finance Lease, Right-of-Use Asset, Amortization</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term Lease, Cost</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost</a></td>
<td class="nump">$ 5,380<span></span>
</td>
<td class="nump">$ 3,020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511393111400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Cash Flow, Operating Activities, Lessee (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating Lease, Payments</a></td>
<td class="nump">$ 6,548<span></span>
</td>
<td class="nump">$ 2,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Finance Lease, Interest Payment on Liability</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</a></td>
<td class="nump">1,493<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386231208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Assets and Liabilities, Lessee (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 92,027<span></span>
</td>
<td class="nump">$ 39,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">20,786<span></span>
</td>
<td class="nump">9,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">73,391<span></span>
</td>
<td class="nump">33,971<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 94,177<span></span>
</td>
<td class="nump">$ 42,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.06%<span></span>
</td>
<td class="nump">4.98%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 2,545<span></span>
</td>
<td class="nump">$ 2,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance Lease, Liability, Current</a></td>
<td class="nump">669<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">1,923<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,592<span></span>
</td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance Lease, Weighted Average Remaining Lease Term</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance Lease, Weighted Average Discount Rate, Percent</a></td>
<td class="nump">4.28%<span></span>
</td>
<td class="nump">4.28%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391033368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</a></td>
<td class="nump">$ 18,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months</a></td>
<td class="nump">20,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Lessee, Operating Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">17,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Lessee, Operating Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">12,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Lessee, Operating Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">11,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">7,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Lessee, Operating Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">18,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Lessee, Operating Lease, Liability, Payments, Due</a></td>
<td class="nump">106,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(12,336)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">94,177<span></span>
</td>
<td class="nump">$ 42,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Finance Lease, Liability, Payments, Remainder of Fiscal Year</a></td>
<td class="nump">577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance Lease, Liability, Payments, Due Next Twelve Months</a></td>
<td class="nump">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance Lease, Liability, Payments, Due Year Two</a></td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance Lease, Liability, Payments, Due Year Three</a></td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance Lease, Liability, Payments, Due Year Four</a></td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">Finance Lease, Liability, Payments, Due Year Five</a></td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Finance Lease, Liability, Payments, Due after Year Five</a></td>
<td class="nump">426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance Lease, Liability, Payment, Due</a></td>
<td class="nump">2,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Finance Lease, Liability, Undiscounted Excess Amount</a></td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance Lease, Liability</a></td>
<td class="nump">$ 2,592<span></span>
</td>
<td class="nump">$ 2,710<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511396163192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="num">$ (38,068)<span></span>
</td>
<td class="nump">$ 23,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (for basic calculation)</a></td>
<td class="nump">23,646,000<span></span>
</td>
<td class="nump">21,149,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">546,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">23,646,000<span></span>
</td>
<td class="nump">21,695,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">EPS - basic</a></td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (In dollars per share)</a></td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511394464424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Details 1) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">546,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">23,646,000<span></span>
</td>
<td class="nump">21,695,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="nump">$ 1.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (1.61)<span></span>
</td>
<td class="nump">$ 1.09<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386306056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 231,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember', window );">other currencies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">85,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_MXN', window );">Mexico, Pesos</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">58,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">42,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CZK', window );">Czech Republic, Koruny</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">23,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 22,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Srt_MultipleCurrencyAxisAxis=icui_OtherCurrenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_MXN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_MXN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CZK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CZK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386446504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>MXN ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>MXN ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member', window );">Hedge 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="nump">21.60<span></span>
</td>
<td class="nump">21.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Derivative Asset, Notional Amount</a></td>
<td class="nump">$ 311,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 413,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember', window );">Hedge 3 [Member] [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeForwardExchangeRate1', window );">Derivative, Forward Exchange Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeForwardExchangeRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual rate at which a foreign currency can be purchased or sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeForwardExchangeRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=icui_Hedge3MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511396149528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Interest Rate Swaps (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 231,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestRateSwapEndingNotionalValue', window );">Interest Rate Swap Ending Notional Value</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.32%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DerivativeVariableRateFloor', window );">derivative variable rate floor</a></td>
<td class="num">(0.0015)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestRateSwapEndingNotionalValue', window );">Interest Rate Swap Ending Notional Value</a></td>
<td class="nump">$ 46,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Derivative, Fixed Interest Rate</a></td>
<td class="nump">1.17%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_DerivativeVariableRateFloor', window );">derivative variable rate floor</a></td>
<td class="nump">0.0035<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_DerivativeVariableRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>derivative variable rate floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_DerivativeVariableRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestRateSwapEndingNotionalValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Rate Swap Ending Notional Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestRateSwapEndingNotionalValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385795128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">$ 36,314<span></span>
</td>
<td class="nump">$ 1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">7,629<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">7,629<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">28,685<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">895<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">7,744<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">7,629<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">895<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative Asset</a></td>
<td class="nump">28,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">28,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">28,570<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386372088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">$ 33,163<span></span>
</td>
<td class="num">$ (402)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">3,112<span></span>
</td>
<td class="num">(402)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income (Loss), before Tax</a></td>
<td class="nump">$ 30,051<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386145592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months', window );">Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</a></td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="num">(2,279)<span></span>
</td>
<td class="num">$ (841)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Trading Revenue | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="num">(2,543)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Cost of Sales [Member] | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="num">(513)<span></span>
</td>
<td class="num">(841)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract | Interest Expense | Cash Flow Hedging [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion', window );">Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion</a></td>
<td class="num">$ (249)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_TradingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_TradingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511396191352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_OwnershipRequirementForEarnoutPayment', window );">Ownership requirement for Earnout Payment</a></td>
<td class="nump">0.500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember', window );">Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_OwnershipRequirementForEarnoutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership requirement for Earnout Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_OwnershipRequirementForEarnoutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511390966904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="nump">$ 55,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_CurrencyTranslationOnEarnOut', window );">Currency translation on earn-out</a></td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_CurrencyTranslationOnEarnOut">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Currency translation on earn-out</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_CurrencyTranslationOnEarnOut</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511388683064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 57,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">CONTINGENT EARN-OUT LIABILITY</a></td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385611384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Liability Measurement Inputs (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | MeasurementinputadjustedEBITDAvolatility [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | Measurement Input, Discount Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member', window );">Pursuit Vascular, Inc. [Member] | Measurement Input, Market Price of Risk [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.0131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical | Measurement Input, Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input</a></td>
<td class="nump">0.3700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_PursuitVascularInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=icui_MeasurementinputadjustedEBITDAvolatilityDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=icui_MeasurementinputadjustedEBITDAvolatilityDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=icui_MeasurementInputMarketPriceofRiskDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=icui_MeasurementInputMarketPriceofRiskDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385392200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">$ 53,717<span></span>
</td>
<td class="nump">$ 20,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">14,864<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember', window );">Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">57,701<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember', window );">Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">58,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">7,629<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember', window );">Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">28,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">53,717<span></span>
</td>
<td class="nump">20,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">14,864<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">7,629<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">28,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Earn-out liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="nump">57,701<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Liabilities, Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure', window );">Nonfinancial Liabilities Fair Value Disclosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial Liabilities Fair Value Disclosure</a></td>
<td class="nump">57,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeAssetsAtFairValue', window );">Interest Rate Derivative Assets, at Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonfinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonfinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=icui_EarnoutliabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilitiesTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511397051352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain (Loss) on Sale of Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386153976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investment securities</a></td>
<td class="nump">$ 14,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">17,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Debt Securities, Available-for-sale, Amortized Cost, Current</a></td>
<td class="nump">14,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">17,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,040<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=icui_AvailableforsaleDebtSecurityCurrentMember', window );">Available-for-sale Debt Security Current [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Debt Securities, Available-for-sale, Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain', window );">Long-term Investments [Domain]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent', window );">Debt Securities, Available-for-sale, Noncurrent</a></td>
<td class="nump">2,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">$ 2,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=icui_AvailableforsaleDebtSecurityCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=icui_AvailableforsaleDebtSecurityCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=icui_LongtermInvestmentsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391070600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">$ 3,209<span></span>
</td>
<td class="nump">$ 3,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity Method Investment, Aggregate Cost</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385573224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaids and Other Current Assets Prepaids and Other Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other Prepaid Expense, Current</a></td>
<td class="nump">$ 29,647<span></span>
</td>
<td class="nump">$ 14,763<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsAndOtherAssets', window );">Deferred Costs and Other Assets</a></td>
<td class="nump">9,795<span></span>
</td>
<td class="nump">12,746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Prepaidinsuranceandpropertytaxes', window );">Prepaid insurance and property taxes</a></td>
<td class="nump">19,716<span></span>
</td>
<td class="nump">6,310<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Prepaidothertaxes', window );">Prepaid Taxes</a></td>
<td class="nump">3,981<span></span>
</td>
<td class="nump">4,156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Deferredtaxcharge', window );">Deferred tax charge</a></td>
<td class="nump">4,241<span></span>
</td>
<td class="nump">4,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsCurrent', window );">Derivative Asset, Current</a></td>
<td class="nump">7,629<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositAssets', window );">Deposit Assets</a></td>
<td class="nump">1,345<span></span>
</td>
<td class="nump">1,343<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets, Current</a></td>
<td class="nump">3,919<span></span>
</td>
<td class="nump">2,227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 80,273<span></span>
</td>
<td class="nump">$ 46,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Deferredtaxcharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax charge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Deferredtaxcharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidinsuranceandpropertytaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid insurance and property taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidinsuranceandpropertytaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Prepaidothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid other taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Prepaidothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost assets and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385640968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets Noncurrent(Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Lessor, Operating Lease, Payments to be Received</a></td>
<td class="nump">$ 27,336<span></span>
</td>
<td class="nump">$ 25,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SpareParts', window );">Spare parts</a></td>
<td class="nump">32,031<span></span>
</td>
<td class="nump">28,538<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">3,209<span></span>
</td>
<td class="nump">3,238<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Debt Issuance Costs, Noncurrent, Net</a></td>
<td class="nump">6,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset</a></td>
<td class="nump">2,545<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other Assets, Miscellaneous, Noncurrent</a></td>
<td class="nump">4,315<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">OTHER ASSETS</a></td>
<td class="nump">104,617<span></span>
</td>
<td class="nump">$ 63,743<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">28,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">28,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember', window );">Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="nump">$ 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SpareParts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Spare parts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SpareParts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511396143720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Inventory, Raw Materials, Net of Reserves</a></td>
<td class="nump">$ 232,451<span></span>
</td>
<td class="nump">$ 135,528<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Inventory, Work in Process, Net of Reserves</a></td>
<td class="nump">74,427<span></span>
</td>
<td class="nump">36,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory, Finished Goods, Net of Reserves</a></td>
<td class="nump">229,436<span></span>
</td>
<td class="nump">118,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 536,314<span></span>
</td>
<td class="nump">$ 290,235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511388646392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 1,133,026<span></span>
</td>
<td class="nump">$ 905,104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(458,614)<span></span>
</td>
<td class="num">(436,739)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net property and equipment</a></td>
<td class="nump">674,412<span></span>
</td>
<td class="nump">468,365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and Equipment, Gross</a></td>
<td class="nump">432,649<span></span>
</td>
<td class="nump">321,078<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and Fixtures, Gross</a></td>
<td class="nump">10,646<span></span>
</td>
<td class="nump">7,670<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in Progress, Gross</a></td>
<td class="nump">123,448<span></span>
</td>
<td class="nump">72,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember', window );">Land, Buildings and Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">289,866<span></span>
</td>
<td class="nump">243,377<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember', window );">Molds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">60,499<span></span>
</td>
<td class="nump">60,463<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember', window );">Computer Equipment and Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">112,661<span></span>
</td>
<td class="nump">102,979<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember', window );">Instruments Placed with Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment, cost</a></td>
<td class="nump">$ 103,257<span></span>
</td>
<td class="nump">$ 97,384<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_MoldsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=icui_InstrumentsPlacedwithCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392208488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment Text (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 21.4<span></span>
</td>
<td class="nump">$ 16.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386107304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Goodwill Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">GOODWILL</a></td>
<td class="nump">$ 1,526,866<span></span>
</td>
<td colspan="2" class="nump">$ 43,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, Acquired During Period</a></td>
<td class="nump">1,493,115<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill, Purchase Accounting Adjustments</a></td>
<td class="num">(7,128)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Goodwill, Foreign Currency Translation Gain (Loss)</a></td>
<td class="num">$ (2,560)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385513544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Intangibles Table (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 1,211,577<span></span>
</td>
<td class="nump">$ 275,835<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">144,029<span></span>
</td>
<td class="nump">112,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">1,067,548<span></span>
</td>
<td class="nump">162,953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">27,162<span></span>
</td>
<td class="nump">25,358<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross (Excluding Goodwill)</a></td>
<td class="nump">1,238,739<span></span>
</td>
<td class="nump">301,193<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">INTANGIBLE ASSETS, net</a></td>
<td class="nump">$ 1,094,710<span></span>
</td>
<td class="nump">$ 188,311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 28,012<span></span>
</td>
<td class="nump">$ 27,429<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">17,213<span></span>
</td>
<td class="nump">16,764<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 10,799<span></span>
</td>
<td class="nump">$ 10,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 10,281<span></span>
</td>
<td class="nump">$ 10,412<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">6,256<span></span>
</td>
<td class="nump">6,196<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 4,025<span></span>
</td>
<td class="nump">$ 4,216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer-Related Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 558,579<span></span>
</td>
<td class="nump">$ 57,316<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">47,757<span></span>
</td>
<td class="nump">33,004<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 510,822<span></span>
</td>
<td class="nump">$ 24,312<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 5,425<span></span>
</td>
<td class="nump">$ 425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">2,424<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 3,001<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 18,265<span></span>
</td>
<td class="nump">$ 18,260<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">5,045<span></span>
</td>
<td class="nump">4,731<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 13,220<span></span>
</td>
<td class="nump">$ 13,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 581,915<span></span>
</td>
<td class="nump">$ 152,893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">62,220<span></span>
</td>
<td class="nump">49,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 519,695<span></span>
</td>
<td class="nump">$ 103,487<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-Lived Intangible Assets, Accumulated Amortization</a></td>
<td class="nump">3,114<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 5,986<span></span>
</td>
<td class="nump">$ 6,744<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511391908600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets Text (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 31.7<span></span>
</td>
<td class="nump">$ 5.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385827384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets 5-Year Amortization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">$ 104,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</a></td>
<td class="nump">132,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Two</a></td>
<td class="nump">132,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Four</a></td>
<td class="nump">124,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">123,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, Year Five</a></td>
<td class="nump">116,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</a></td>
<td class="nump">333,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 1,067,548<span></span>
</td>
<td class="nump">$ 162,953<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386074904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AccruedSalariesAndBenefits', window );">Salaries and benefits</a></td>
<td class="nump">$ 47,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,304<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Incentive compensation</a></td>
<td class="nump">19,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,107<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease, Liability, Current</a></td>
<td class="nump">20,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Sales taxes</a></td>
<td class="nump">7,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Restructuring accrual</a></td>
<td class="nump">2,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_UnfavorablecontractliabilityST', window );">UnfavorablecontractliabilityST</a></td>
<td class="nump">40,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,646<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedothertaxes', window );">Accrued other taxes</a></td>
<td class="nump">1,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accrued Professional Fees</a></td>
<td class="nump">16,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedlegalfees', window );">Legal accrual</a></td>
<td class="nump">3,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Outsidesalescommissions', window );">Distribution Fees</a></td>
<td class="nump">21,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,645<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Warranties and returns</a></td>
<td class="nump">31,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Accruedfreight', window );">Accrued freight</a></td>
<td class="nump">10,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,194<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">15,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,099<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">261,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,195<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Liability, Defined Benefit Plan, Current</a></td>
<td class="nump">2,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AcquiredRestructuringLiabilityCurrent', window );">Acquired restructuring liability, current</a></td>
<td class="nump">6,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AccruedTransactionCosts', window );">Accrued transaction costs</a></td>
<td class="nump">8,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_AccruedAuditFees', window );">Accrued audit fees</a></td>
<td class="nump">3,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">54,700<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TimingAxis=icui_ShortTermMember', window );">Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">31,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember', window );">Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative Liability, Current</a></td>
<td class="nump">$ 895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedAuditFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued audit fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedAuditFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedSalariesAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued salaries and benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedSalariesAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AccruedTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued transaction costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AccruedTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedfreight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued freight</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedfreight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedlegalfees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued legal fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedlegalfees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Accruedothertaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued other taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Accruedothertaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_AcquiredRestructuringLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired restructuring liability, current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_AcquiredRestructuringLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Outsidesalescommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Outside sales commissions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Outsidesalescommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_UnfavorablecontractliabilityST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>UnfavorablecontractliabilityST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_UnfavorablecontractliabilityST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.Y.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123377177&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_ShortTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_ShortTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385226696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities Long-term liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease, Liability, Noncurrent</a></td>
<td class="nump">$ 73,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent', window );">Accrued Employee Benefits</a></td>
<td class="nump">1,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRentCurrentAndNoncurrent', window );">Accrued Rent</a></td>
<td class="nump">1,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Liabilitiesforcontracts', window );">Liabilities for contracts</a></td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue', window );">Interest Rate Derivative Liabilities, at Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance Lease, Liability, Noncurrent</a></td>
<td class="nump">1,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other Accrued Liabilities, Noncurrent</a></td>
<td class="nump">9,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">OTHER LONG-TERM LIABILITIES</a></td>
<td class="nump">134,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">54,700<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">54,700<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract with Customer, Liability, Noncurrent</a></td>
<td class="nump">22,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TimingAxis=icui_LongTermMember', window );">Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">23,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityContingencyLineItems', window );"><strong>Product Liability Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">23,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember', window );">Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative Liability, Noncurrent</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Liabilitiesforcontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities for contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Liabilitiesforcontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRentCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRentCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateDerivativeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateDerivativeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.Y.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TimingAxis=icui_LongTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TimingAxis=icui_LongTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511395301560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Effective tax rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Income Tax Rate</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385831320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TotalSeniorSecuredCreditFacility', window );">TotalSeniorSecuredCreditFacility</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">1,684,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_RevolverSubLimits', window );">Revolver Sub limits</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">37,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioCalculationCeilingSubtractedAmount', window );">Leverage Ratio Calculation Ceiling Subtracted Amount</a></td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">850,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">834,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">15,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 834,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jan.  06,  2027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="nump">$ 850,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">850,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">13,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">$ 836,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jan.  06,  2029<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt Issuance Costs, Gross</a></td>
<td class="nump">$ 8,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioCalculationCeilingSubtractedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leverage Ratio Calculation Ceiling Subtracted Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioCalculationCeilingSubtractedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_RevolverSubLimits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revolver Sub limits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_RevolverSubLimits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TotalSeniorSecuredCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>TotalSeniorSecuredCreditFacility</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TotalSeniorSecuredCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511390228184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Interest Rate Terms (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestPercentageAddedToFederalFundsRate', window );">Interest Percentage Added to Federal Funds Rate</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_InterestPercentageAddedToBaseRate', window );">Interest Percentage Added to Base Rate</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans', window );">Ter SOFR Interest Rate % Adjustment for Base Rate Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans', window );">Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</a></td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member', window );">greaterthan 4to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member', window );">lessthan4to1butgreaterthan3to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member', window );">lessthanorequal3to1butgreaterthan2point5to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member', window );">lessthanorequalto2point5to1butgreaterthan2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member', window );">lessthanorequalto2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of Credit Facility, Commitment Fee Percentage</a></td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | greaterthan 4to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthan4to1butgreaterthan3to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequal3to1butgreaterthan2point5to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequalto2point5to1butgreaterthan2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A | lessthanorequalto2to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B | greaterthan2point75to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B | lessthan2point75to1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems', window );"><strong>Applicable Margin Based on Leverage Ratio [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginBaseRateLoans', window );">Applicable Margin Base Rate Loans</a></td>
<td class="nump">0.0125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ApplicableMarginTermSOFRLoans', window );">Applicable Margin Term SOFR Loans</a></td>
<td class="nump">0.0225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBaseRateLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Base Rate Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBaseRateLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginBasedOnLeverageRatioLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Based on Leverage Ratio [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginBasedOnLeverageRatioLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ApplicableMarginTermSOFRLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Applicable Margin Term SOFR Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ApplicableMarginTermSOFRLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestPercentageAddedToBaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Percentage Added to Base Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestPercentageAddedToBaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_InterestPercentageAddedToFederalFundsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Percentage Added to Federal Funds Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_InterestPercentageAddedToFederalFundsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TerSOFRInterestRateAdjustmentForBaseRateLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ter SOFR Interest Rate % Adjustment for Base Rate Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TerSOFRInterestRateAdjustmentForBaseRateLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_Greaterthan400to100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqual300To100ButGreaterThan250to100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThanOrEqualTo200To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_GreaterThan275To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_GreaterThan275To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LeverageRatioLevelAxis=icui_LessThan275To100Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LeverageRatioLevelAxis=icui_LessThan275To100Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392849464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Terminated Credit Agreement (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 150.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of Credit Facility, Expiration Date</a></td>
<td class="text">Nov.  08,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit, Current</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386083896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Table (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 1,684,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Line of Credit Facility, Fair Value of Amount Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="num">(28,016,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt, Long-term and Short-term, Combined Amount</a></td>
<td class="nump">1,655,984,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt, Current</a></td>
<td class="nump">13,813,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term Debt, Excluding Current Maturities</a></td>
<td class="nump">1,642,171,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 834,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">4.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanAxis=icui_TermLoanBMember', window );">Term Loan B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</a></td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="nump">5.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanAxis=icui_TermLoanBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanAxis=icui_TermLoanBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392951512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Obligations Schedule of Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_LOngTermObligationsDisclosureAbstract', window );"><strong>LOng-Term Obligations Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Long-Term Debt, Maturity, Remainder of Fiscal Year</a></td>
<td class="nump">$ 6,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">Long-Term Debt, Maturity, Year One</a></td>
<td class="nump">29,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Long-Term Debt, Maturity, Year Two</a></td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Long-Term Debt, Maturity, Year Three</a></td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Long-Term Debt, Maturity, Year Four</a></td>
<td class="nump">72,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Long-Term Debt, Maturity, Year Five</a></td>
<td class="nump">672,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Long-Term Debt, Maturity, after Year Five</a></td>
<td class="nump">801,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term Debt, Gross</a></td>
<td class="nump">$ 1,684,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_LOngTermObligationsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>LOng-Term Obligations Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_LOngTermObligationsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392937656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Interest Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Interest Expense, Debt, Excluding Amortization</a></td>
<td class="nump">$ 10,017,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of Debt Issuance Costs and Discounts</a></td>
<td class="nump">1,643,000<span></span>
</td>
<td class="nump">72,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Line of Credit Facility, Commitment Fee Amount</a></td>
<td class="nump">351,000<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="nump">$ 12,011,000<span></span>
</td>
<td class="nump">$ 128,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511395296072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Obligations Principal Payment (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermAPrincipalPaymentFirst2Years', window );">Term A principal payment % First 2 Years</a></td>
<td class="nump">0.0250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermAPrincipalPaymentYear3And4', window );">Term A Principal Payment % Year 3 and 4</a></td>
<td class="nump">0.0500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermAPrincipalPaymentInYear5', window );">Term A Principal Payment % in Year 5</a></td>
<td class="nump">0.0750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TermLoanBPrincipalPayment', window );">Term Loan B Principal Payment %</a></td>
<td class="nump">0.0025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="nump">$ 16,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentFirst2Years">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term A principal payment % First 2 Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentFirst2Years</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentInYear5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term A Principal Payment % in Year 5</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentInYear5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermAPrincipalPaymentYear3And4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term A Principal Payment % Year 3 and 4</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermAPrincipalPaymentYear3And4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TermLoanBPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Loan B Principal Payment %</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TermLoanBPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511386096344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies Contingency (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualComponentAmount', window );">Product Liability Accrual, Component Amount</a></td>
<td class="nump">54,700<span></span>
</td>
<td class="nump">$ 55,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember', window );">SmithsMedical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">53,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember', window );">Foreign Infusion System Supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossST', window );">Contingent Consideration, Gross ST</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_ContingentConsiderationGrossLT', window );">Contingent Consideration, Gross LT</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember', window );">International Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems', window );"><strong>Business Acquisition, Contingent Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_Contingentconsiderationgross', window );">contingent consideration gross</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossLT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross LT</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossLT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_ContingentConsiderationGrossST">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Gross ST</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_ContingentConsiderationGrossST</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_Contingentconsiderationgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>contingent consideration gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_Contingentconsiderationgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionContingentConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionContingentConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualComponentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recorded amount of the accrual for a material component of a product liability contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.Y.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualComponentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_SmithsMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_ForeignInfusionSystemSupplierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=icui_InternationalDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511395415144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaborative and Other Arrangements (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Purchase Commitment, Remaining Minimum Amount Committed</a></td>
<td class="nump">$ 29.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511392334008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_TreasuryStockPurchasePlan', window );">Treasury Stock Purchase Plan</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares</a></td>
<td class="nump">37,279<span></span>
</td>
<td class="nump">37,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment, Tax Withholding, Share-based Payment Arrangement</a></td>
<td class="nump">$ 8,743<span></span>
</td>
<td class="nump">$ 7,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SmithsGroupOwnershipAcquisitionSharesIssued', window );">Smiths Group Ownership % Acquisition Shares Issued</a></td>
<td class="nump">0.105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_icui_SmithsGroupOwnershipRequiredForBoardRepresentation', window );">Smiths Group Ownership % Required for Board Representation</a></td>
<td class="nump">0.050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SmithsGroupOwnershipAcquisitionSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Smiths Group Ownership % Acquisition Shares Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SmithsGroupOwnershipAcquisitionSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_SmithsGroupOwnershipRequiredForBoardRepresentation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Smiths Group Ownership % Required for Board Representation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_SmithsGroupOwnershipRequiredForBoardRepresentation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_icui_TreasuryStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">icui_TreasuryStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>icui_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140511385712424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (628)<span></span>
</td>
<td class="num">$ (628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,913)<span></span>
</td>
<td class="num">$ (19,269)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (1,522)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,752)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="nump">$ 18,641<span></span>
</td>
<td class="nump">18,641<span></span>
</td>
<td class="num">$ (8,391)<span></span>
</td>
<td class="num">(8,391)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,991)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,839)<span></span>
</td>
<td class="num">(19,045)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,381)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,839<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,210)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive income (loss), net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>icui-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:icui="http://www.icumed.com/20220331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="icui-20220331.xsd" xlink:type="simple"/>
    <context id="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic4143f4321de483daeaf8422585b5992_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic739b9e6cfbd49928ba2becb10737a7b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5d868d49505419592afffab42bf0eb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64868371845d4e76bc447e71919e1983_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibfc64c489cf04a69892f2bb79d05265d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6984b38e57b4cb9b7db8552e7a3fcaa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86236b5f9d4c43f5b952f83a321739b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee98598f2d5949e89f38dd5e926233ef_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17a81a7b494f4b9389f3416497deb3e2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d11403464e048ae8378f62edfc53cea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idb961a439cc448229c94512348851dab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ffc6e2664094fdf93f1f351c76c317c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3fe8dbdded6c47e5abc6e9b101c5276c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i691612597ddd469aa1e76c59b67248a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77dbdeb976b5481f9ae92bbf1102665e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9cbe5a67bda441529efd0b011401173b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia69c8c17a24744f9be803234128f6c24_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic3a542e87e2f471ba2bf2af24b497b2e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idbec71a052e34a628bdbc7874d90f523_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee88159d0ccf4a36be2cea91faa46dd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i83d7811e874b43c3ac9eedf4ade5ff94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaaa3308af1304da2922818b5e5b2203a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4bf3dd823004949bb668180e422e8b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70d5d4b789c14217a4637b71e3935b05_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9709296c43fd4879b1cc1f464dfaac3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6de1955a7159499e9b68b9b0daa91296_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie23ec980b5784615a4b1e1be6c1805d9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if1dae3bb26454570acfeaff45f3e5b66_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia4e2dc9a5e24485b8f9b458a7172bbff_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5cd3a8fb34fc4f0f9340555ab6074ee6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib569fc18582645668995f72d04a72816_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58b4154cd7374229b9e379d211fbefc5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">icui:CommonStockSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i894ed5cd7131488eb00a9af8903195f4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i463ae5afe8854c50a81194644b397891_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i766a662d646644049de578ec36ca4f87_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i93e818396f3f49a2ad987c721bf7dd83_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic9086cf89d1247ba9e8c0d33a92d5450_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ida794f824cb94242bde5116941247684_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id513614e0fb644d7b5f9986414615ea1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9c19a0416554eb991a114156f302300_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">icui:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3e0f9607f3f64f179b6cf6d4462adc77_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6bb7b402883540419226d3c255ed0ce0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonrecurringAdjustmentAxis">us-gaap:AcquisitionRelatedCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i31bdd76ac7d94b7da503fd63b93ae400_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7330ec69856e4bedab9881611ec4c66f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idced1370c58d496699456e82e999c739_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4421707804146808e8d82bd497823f1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id248bc190fef460ab54156ad628a9a09_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2b01fe971840481cbc0118ca73113ed3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic31670f3190f4250afa50c949a969ee7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic6940ef2009e4c4896a32c8c4aaf68d6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i82d850d6caf542d5bb4c6d576c8debea_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i05a0e8abbc6647928fbf299a5ca9c5bc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icca9ac7dfc3a4aa489ff4d89527fdae9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:IVSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic80e0a0251974b428f96f3f717f4d8c6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i677c8e8ff77c48aa8ce2231709909edf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:CriticalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c2efe33dc8d4acd88c30e7d87d93647_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i60182e4c96d44b05a31dbc6f360895df_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:InfusionConsumablesSmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i910b191cc2064df1a370ea5673a067f8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i99f317b22200400aa27ba28ee92de705_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VascularAccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4fa0894a784543158f3f2b1d7c4de28c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica2afa04d4254f6bb80cb6e3672895e9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:VitalCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i15c0bb3aed1b4706bc6fac56eab2c4cd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i38ee104e0e7f45abbbb082a302c3fd84_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0b4f448345b34a609c7840e89139cedb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if6ffb2785f52491bb1b6d09817f187a4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:OtherforeigncountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie5f91818e98e47c78b2642f077b41076_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id6b42d6a2aae43fb9961ff4e802256f1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">icui:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib52844df4caf4174aa01d6d15e5ce18a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i06dca36adccb4e6aa29a97ea62498b09_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i461675ccf5e5457c93bc148a02ebef8f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94c6563557f14f0fa17a7b159d6942ec_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic115301640614d36b47d9f6973156033_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i31ba1716c4654d44b41229c3a3ba3502_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica6df5554552455890bb3e503c4ecaf7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i10d0c665e84f4c42842d8354c9c251b1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ice75ec9db3e341b6aef90d3334be1eb0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i67d2154781164924b275843b993212d9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieffb1189d545486bb1d18d7d6120aa94_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:EquipmentrevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i747977f101ff4d60a6662e14aeccca04_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id9e71644be0d416286bfb1eca80a5bed_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:SoftwarerevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaaa7a333a6924010b053423c65083d92_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i590611035a394a67b144447f0765cc48_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:GovernmentGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i66742bd27a76437d802c35ce2d1bb3f2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6c8dc12807f14595a91b904cd714ee48_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">icui:OtherDeferredRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic2dd7ec8ea2a4048a06ea268924bf23a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if5b1cec7abee4f76b35a418a82f45396_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8646fd65464c418fae83a8e61e4c8e4b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i62db31deb9084936bafdeb3f3f63c809_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:MXN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7963d1971572480fbd840e0d5474ceb0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic373291ce2a54c54bc47f9dc50e82a5e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CZK</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5be466fa5bc14021acd2af7f71cc4898_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2aca8fbd4d9f46bd8abdb6dfa1bc52fa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:Srt_MultipleCurrencyAxisAxis">icui:OtherCurrenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic788c207f74e4b2dafcf30292f3548ad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2cae28aee9a248c6992bfec3cecde803_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78dc0822a7604ba0b14a6be54c13e439_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">icui:Hedge3MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7df84c8e6ce6476ba122f96383a99201_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib6f1ae97aae0424a80ff8ef2c5fe28de_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie951b51b46c24f91a76523e2ca109cf7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1565ea9c18f0446cac5355139ceb7865_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5480e0d4b9e94e3890f7f73f6ed47c70_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i315729be48514840b0d36c895155ff5e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib8b0233d309c4ffcb68ad6044df3947b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9e7790dee9054ceca551b75f9663ebea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1f4262eb928148c0bbdb719d4842c46e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i47c493e4a240482e95f73b4965a6f972_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i92d5fc92c6d7403f858073017410d73b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i442353a0995745d69a88c9e06d2b2e2b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f57e3739bad4f56b45c5af9ecd59b05_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ebbac56dc4f40cab230df979062a6fb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if96528d11b19404186843078164bf0ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9cb96a5a627a4f2c9fbf16b433a2a039_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32b4f49688b3453dabe1cbce3dac596e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if45f73643f964e8dad36acddabd4f6b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic809f3d4de8e4c4fa7ac38f6e35822f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i112e5d0a75164fdeb157a57239a63582_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fa3affafd794a8aba01a0642e492edc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0aeb03074de41f4a5d5dadadbbef2d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idc5567182ccf4bf2afb2d97a18d3f46e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b68c68d4340458b97c555caf230716e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic64816f8cccb4c3aa043d7bda0ab7443_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1428c27386ca455990cd6a0836006bf5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59c249ecf14641feac25b572b32ac6c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55bf118e00554d2e9a4e30260c8c7917_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a0ebabf35b94de9b3494c8f98c35fcb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i75dee15445a241d39eb89a15ed0d7674_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6f597ec7d6d94442ad8c9951a802383c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2d6c5a747f3646a5b3e9c6bcbaa397f8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4c6a7c98f99c45a0af8e8a18126938ea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iadccd508c3834cc2a5379622d5278846_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:TradingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i768b7317377646e18a4f32bd2ab2443d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i296eba7b2d0d407894537da13b4266d5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c66699e81d84448b3ba8cae1a7e7d61_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i030a14b9f87541e5a345d6f3f9d9e08d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib28660aeb4894aeabf3989dbe4367892_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a11d8ef901545fcbe623f7dd7ff571b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i099b2a7d616d421c860d4ddb8052bdab_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:ForeignInfusionSystemSupplierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i27fd8cbeeab3426e97107930d3deb563_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i591e5151200040c0933b61638412feac_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i52f666ba7ecd4b1e858ed6eed44de97d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia1b57ff5dbf448208328e971b35a3f90_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id4ad65ae063d4e49821ad5b4dece8ece_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iacc7d2919e7140fa9c80f0f1d09a1728_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27bd3a8f9e2b4c90a09dc353bf7cbd60_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id15440599eac41b2b8dcbf173de1a069_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i73db172d800a49ca831d1f3440d0a9a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i01dc0feea8d540698b9fa442d8af1726_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:SmithsMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia760ade7301b4ae091a97fbf0f60bae8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementinputadjustedEBITDAvolatilityDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae19c16d454a4da888fb439fac3a5955_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2eba1326445642438ae8479679188e72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id1ddc2565fbb4bc9ac3f95f9e98205b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:PursuitVascularInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">icui:MeasurementInputMarketPriceofRiskDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i97a07c4fb7834238809f74bc245a07e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i625f2e9aec314e25b0c0699f19c11778_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d39ec8bd177421d91c1d78701f1ac51_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4b2dd58641ec4c47944780cf820a3c80_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i893e8eee099341c480fec838d774cb74_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6c3fa86ba23d4ca99c7c1d8b7d588cce_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i08573f64c1804db985e0aed112395314_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia840f694db644720be6253993494b8e0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i62a390f242ec4b708b42188ba1ed533a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie8af3b131bc14d17a7571c2fdcc1af47_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1c78732ffce9481d84d10a6eed768479_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id600755f8bb64800a5c3f7106c241dcf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56220f4e4fce4161bc7b4edbede836a0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i92b9167994c04c478ad5b2e150315812_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibf032587ff8047c4b9bb91de60bb0fa0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i055211e4c3454a24b54386b6a7b21511_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i97d55547e25c4f90a6a7c87dd4a11427_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id97f8182fd794fdaa58639212799a600_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9d2d55b60f2e4d11a4d5ea598a1837be_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibc848f2b140a428c9e22a6befc519c3d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1419702164fa4c2a834cca8d8c248f20_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ida0534e7808d42c69fc2180af5749efe_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia01d6c13756c4351b7acb497ed3f5adb_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic3b4f8d61bc94efd8c535988f345c281_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c455c5698b743659c9158cd90d076a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i163dcce9674d46a2b3445bb6740cef0b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf12885b0a9c40079ede306096232146_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i18ee0f7fc4e048ad942066fc6d02bb35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic4c21c453adc4f41a028e77788e381cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9346449d62a4bae80c04e42368902d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15baeddeabd64f0793f301a17f103c2f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic019a3f7c2aa41b3b60c36d8dc1afbdc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i007e0b709a7948e9bfd7a77dfd33edca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">icui:EarnoutliabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf8727c5088147f1815d1cbf94b178ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e231f7074be46edac627e3736610412_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff209c9c312842e6a5aa213e04c2dd43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib96b6effe9a345e6809e9a0242de4c6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:LiabilitiesTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i744f21c9656746cd8b7b2215b75ac43f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:AvailableforsaleDebtSecurityCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iafc15da5318940b5a790f399b28e9e5a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iab0337d3ad564247a1200aceefee3a92_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:AvailableforsaleDebtSecurityCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">icui:LongtermInvestmentsDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9bd1e48a37ce464490eb88d4e81041c1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3e5193042f2c45bd83248a95c20e923d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i708212e3ab134bbaab535bc663a5a479_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id0ba8683ccfb439d8c9bf26272861771_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandBuildingsAndImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i190b17e0f2b041758e8c0431e71dcc64_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id29aa22c8f0840b08bc18688167f63d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:MoldsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iddf2d2aa8b564efc876aa1ba23936f52_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icfb0aaca7e4e4381ac74739e433b7861_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c8a50a910984b9e86610a127c140e86_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c3826af64dd4f7db3fecffa7b173fc5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">icui:InstrumentsPlacedwithCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic439ddf48ef245c5b7e4afa06b2ebd93_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if65da200e05c4e4b9a561174b1bc7c23_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i731b7502508d4f8c8b50e49d76dc37ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1e9016dd7b774b169ec2614f61542be9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i71b6f20b81f44312800477e6da74fd8f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib7e4ab57206c488b97acd961e65966ff_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i912753928ea843239807436aa78d567d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3aec3bdfaced4372b17ea0347c016398_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iabdeca4cff6a4718b4f1dd649c39be64_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia17f985170954eb48428d61f36b19859_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if65467afecf74a8b93960ba983aa3d59_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id6b397229737456d84db63d3bf2f90df_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i514d9e8e7edd4fa28d63ef9fccb34cd1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97a46089acbd4ff2aaeb2d2252ab6eb1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7205011397d3426281ae4bd434b15c77_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5eb56f1821864a0db13d3ee2043d7dcd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide038f68482143e7bc6cead2e03b3248_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66bc748b1f3449e4a5e0f34ba0a23593_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i02924cdb80304d2fbd0a1fd268de89a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibfc7fd5a9dbe4432b60326ce95161345_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4e310a8c7f034cd7853abf6100bc499e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5230a8d671ee4f5ab0953b698bff8639_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic17f4375ba33447ab41447690f328232_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if248896a740349349b9dc2c70a6c7362_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf4da5fb2b8244bca91159e192d1b9ee_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TimingAxis">icui:LongTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i99c31a1bbc5e49dfba0d6f77e03b2107_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icedd39ede0a346b7935ed0db37bd69b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i78ebe3443d494bd490f9f07d5202134d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9ae4f3915f574485829c8127bbdd1797_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i78b84b5657084d8e998eb611076dc5ab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:Greaterthan400to100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icab58ddd66a140bc97118bd0a1be6cef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1d03299aace54ed7ac0e3ac6f5fe2d8c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo400To100ButGreaterThan300To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i148b265b5e2742bd83a80cbf70e476da_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i121a2aae16c14453b205c42847a26f54_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqual300To100ButGreaterThan250to100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if626b886e63044aaa9c6735867a954ec_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic46418b7be58471cb3d15195cc4f5e2e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo250To100ButGreaterThan200To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ibc6ce78ff0d54018b0f911617adafb8c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i57b48a056c4f4370adbb6f193d7b4dd9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThanOrEqualTo200To100Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6e374be09b9f4b79a626d3ea4af57397_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:GreaterThan275To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6781406cb9184964ac659cf86bf513a4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="icui:LeverageRatioLevelAxis">icui:LessThan275To100Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="icui:TermLoanAxis">icui:TermLoanBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9088e8033ac42c7978c4207a0f3bf01_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if1cdbdaa242848b79d2fbe0b9504e9ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa110691e734492ebd77f89f72327112_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0afb2c7772cc49b1a684427d27a6856b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i338ce135c3964ade933cbd32298f936b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i85d6a1b5b0fc46539828a1892118c0d4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1994924f97d2435894c33f53b4e7eb17_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6e7b56bfd8ed46c2a062213becf7ccad_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i48b83546156b4d78be0e3b72137bad96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a79558ef22f4c09ac5459ea71f37b04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i567486d5838948dd8530f75bf634afcd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i480060d5d0174855bf349ac2611a425d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i95227b0013004393b99c2f868c8b0457_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icd1bc723546d4451bd24a0afcc9a5ad0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i63067cc116cb4e2baece3c78ca5225f7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i942bbd8143694f56aeaf956c380440e7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1114e70a57024459b1dd8837d9a8d9f3_I20220106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="i04278caae1d04e05aee4473287d6eb1f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ide3f1af499ed4114bc7d8f8c83ec901a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000883984</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">icui:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="mxn">
        <measure>iso4217:MXN</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY18yLTEtMS0xLTIzMzk5_e1d9cbd7-31e6-434e-b157-9255bec4036e">0000883984</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY18zLTEtMS0xLTIzMzk5_ea6837fc-0e5b-493a-9db3-be70afdd413c">ICU MEDICAL INC/DE</dei:EntityRegistrantName>
    <dei:AmendmentFlag
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY180LTEtMS0xLTIzMzk5_cc0b3c27-66e9-474f-8b3b-2ed8d15cc1c4">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY181LTEtMS0xLTIzMzk5_ec6e2553-4a0b-4e3c-b5ad-506865f7ded1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY182LTEtMS0xLTIzMzk5_3551e7a1-b29f-4f14-8803-952e9c735a99">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80L2ZyYWc6ZDJhNzA2NzcxZTIxNGE1OGFmNmMzYjRiNDJjZWE5NzQvdGFibGU6MzllNDU2NWY4YmNkNGNiMThjMDE0ODE5YzYxOTQ0M2MvdGFibGVyYW5nZTozOWU0NTY1ZjhiY2Q0Y2IxOGMwMTQ4MTljNjE5NDQzY183LTEtMS0xLTIzMzk5_f16f2ce0-566b-46e8-9094-e5c2bf958900">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgx_24da2f6b-28fe-4499-be59-fd82103b8368">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6YmU1YjU3NmVjMDA1NDM5NTg1YmQ3YjdkNDU2MWVlMWMvdGFibGVyYW5nZTpiZTViNTc2ZWMwMDU0Mzk1ODViZDdiN2Q0NTYxZWUxY18wLTAtMS0xLTIzMzk5_c3c50f52-5bc7-416f-b536-ae784b679d32">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xMjQ_ee345c25-b38c-44de-b69d-cc2e49e2d458">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NTkwM2YyY2ZjNjc3NDQ3NWJjOTA5YmJhNTRlNWZkNzIvdGFibGVyYW5nZTo1OTAzZjJjZmM2Nzc0NDc1YmM5MDliYmE1NGU1ZmQ3Ml8wLTAtMS0xLTIzMzk5_2983145d-5490-4bbb-88f6-25e9dea36e2e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgy_6bb60dbd-2938-412a-9e56-001861cd3e96">001-34634</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6MjYxMjQwY2NkZjk3NDNiZGIxZGE1OWEwZjg1ZDcxYjQvdGFibGVyYW5nZToyNjEyNDBjY2RmOTc0M2JkYjFkYTU5YTBmODVkNzFiNF8wLTAtMS0xLTIzMzk5_5e364189-edfd-4cc5-a200-701d730035d4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6MjYxMjQwY2NkZjk3NDNiZGIxZGE1OWEwZjg1ZDcxYjQvdGFibGVyYW5nZToyNjEyNDBjY2RmOTc0M2JkYjFkYTU5YTBmODVkNzFiNF8wLTItMS0xLTIzMzk5_f12d48e6-8e6f-473d-aea9-922be618afab">33-0022692</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTAtMS0xLTIzMzk5_5c90fe01-88b9-4bba-b09f-2d6e4d9e3293">951 Calle Amanecer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTItMS0xLTIzMzk5_a184e1b1-16c8-4672-9881-239fb024b539">San Clemente</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTQtMS0xLTIzMzk5_6e892a67-ea43-4cee-b98b-c6df98115b67">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDQ5NGNjMDc4OGE1NDhiYmEzZmRhZjczZjhmODQ2ZjkvdGFibGVyYW5nZTo0NDk0Y2MwNzg4YTU0OGJiYTNmZGFmNzNmOGY4NDZmOV8wLTYtMS0xLTIzMzk5_7aada6c0-f8a4-4845-847c-bddbff8f6e87">92673</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgz_044219fb-a125-4a2f-baf6-61280d3ae459">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTg0_582ebb86-d879-4d52-a2b7-5b5ed9fa99fe">366-2183</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTg1_3cf8bf95-d13c-4849-aa1b-ecca538b466c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTg2_f2e576ee-f32b-4094-9634-b304225482f5">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6Y2NiZDc4MzkyMGZhNGVmZjhlNTYzNmUzZTc1YTdjZDEvdGFibGVyYW5nZTpjY2JkNzgzOTIwZmE0ZWZmOGU1NjM2ZTNlNzVhN2NkMV8wLTAtMS0xLTIzMzk5_365c3c9f-78ff-41ca-9136-a2659856d791">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6Y2NiZDc4MzkyMGZhNGVmZjhlNTYzNmUzZTc1YTdjZDEvdGFibGVyYW5nZTpjY2JkNzgzOTIwZmE0ZWZmOGU1NjM2ZTNlNzVhN2NkMV8yLTQtMS0xLTIzMzk5_43a7d8d2-ed8e-4cbe-a799-c2e3111b8917">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6Y2NiZDc4MzkyMGZhNGVmZjhlNTYzNmUzZTc1YTdjZDEvdGFibGVyYW5nZTpjY2JkNzgzOTIwZmE0ZWZmOGU1NjM2ZTNlNzVhN2NkMV80LTQtMS0xLTIzMzk5_47126e9f-b371-4d39-af07-7fb24e011a63">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGV4dHJlZ2lvbjo0Njk4ZWM4YWNkZDI0MjRjOGMwNDYzZDlkZmEzZWVkNV8xOTgw_e98cc6b4-6f99-4254-935b-48bab9018489">false</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NzljOTllYzM1YjZjNDgyNmExOWNjMTk0ZmEwZGFhZWQvdGFibGVyYW5nZTo3OWM5OWVjMzViNmM0ODI2YTE5Y2MxOTRmYTBkYWFlZF8xLTAtMS0xLTIzMzk5_34b8a5a5-c15b-4271-8d7f-0f1183a177be">Common stock, par value $0.10 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NzljOTllYzM1YjZjNDgyNmExOWNjMTk0ZmEwZGFhZWQvdGFibGVyYW5nZTo3OWM5OWVjMzViNmM0ODI2YTE5Y2MxOTRmYTBkYWFlZF8xLTEtMS0xLTIzMzk5_a79f54e8-8a7d-4522-aab6-f83240cf3000">ICUI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NzljOTllYzM1YjZjNDgyNmExOWNjMTk0ZmEwZGFhZWQvdGFibGVyYW5nZTo3OWM5OWVjMzViNmM0ODI2YTE5Y2MxOTRmYTBkYWFlZF8xLTItMS0xLTIzMzk5_d5e90568-6f4a-4b3e-94e7-058411612d97">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ic4143f4321de483daeaf8422585b5992_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xL2ZyYWc6NDY5OGVjOGFjZGQyNDI0YzhjMDQ2M2Q5ZGZhM2VlZDUvdGFibGU6NDM0YjhkNjg5OWYxNDBhZWJlYzQwYjIwOGYyM2JiYTIvdGFibGVyYW5nZTo0MzRiOGQ2ODk5ZjE0MGFlYmVjNDBiMjA4ZjIzYmJhMl8xLTItMS0xLTIzMzk5_8765f4c4-0972-4cf4-8e03-71ab48b64668"
      unitRef="shares">23896032</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0xLTEtMS0yMzM5OQ_8f223e2a-c7a3-45c2-b8c9-c02f9bc85e8b"
      unitRef="usd">329428000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0zLTEtMS0yMzM5OQ_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
      unitRef="usd">552827000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0xLTEtMS0yMzM5OQ_042a1c10-7f68-468c-a5f2-ec21530c78c3"
      unitRef="usd">14864000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0zLTEtMS0yMzM5OQ_7efa49ea-e092-413e-8751-a78ed1981b91"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0xLTEtMS0yMzM5OQ_5cac9912-3b11-491d-bed4-d202c212cdb0"
      unitRef="usd">344292000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0zLTEtMS0yMzM5OQ_ced62afb-b606-4297-99ef-c3702478fb1a"
      unitRef="usd">567247000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmVmODBiYTVkMTE4ZjQyNTc4Y2VjYjBhYzc3YTE4NWQwXzY4_56a5c0c1-5b15-4de7-b108-bffac7f1fcc5"
      unitRef="usd">6921000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmVmODBiYTVkMTE4ZjQyNTc4Y2VjYjBhYzc3YTE4NWQwXzgy_aa5a6e39-1e86-4eb9-880f-e855d2a8d8cf"
      unitRef="usd">7038000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0xLTEtMS0yMzM5OQ_1783ed44-61fa-423e-b6d9-30b2616498d6"
      unitRef="usd">202897000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0zLTEtMS0yMzM5OQ_3144b2c3-7246-4a9a-b321-858926ddc79b"
      unitRef="usd">105894000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0xLTEtMS0yMzM5OQ_2e259d8f-d9d4-49de-aa52-8a8d0dcf7509"
      unitRef="usd">536314000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0zLTEtMS0yMzM5OQ_5cd22cf8-6283-40e8-bbc5-1bc602267a07"
      unitRef="usd">290235000</us-gaap:InventoryNet>
    <us-gaap:PrepaidTaxes
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0xLTEtMS0yMzM5OQ_0f6960d9-049a-4b33-bec9-ed2473bdc25b"
      unitRef="usd">10219000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0zLTEtMS0yMzM5OQ_850e73c3-d686-46ed-ba31-c5a05b4446a4"
      unitRef="usd">19586000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMS0xLTEtMjMzOTk_29221140-b63d-4ea3-9114-83edc7057327"
      unitRef="usd">80273000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMy0xLTEtMjMzOTk_98e9d6c1-3d9c-47ba-acef-9005f92f14af"
      unitRef="usd">46847000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMS0xLTEtMjMzOTk_6bbcbeff-3570-4869-8170-4039168b08b9"
      unitRef="usd">1173995000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMy0xLTEtMjMzOTk_455e6497-8c50-4f7b-930c-dbbd2cdcd547"
      unitRef="usd">1029809000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMS0xLTEtMjMzOTk_bf574f23-40f6-4f51-b7f2-6ebaa3c93511"
      unitRef="usd">674412000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMy0xLTEtMjMzOTk_d1006863-ea7d-4d08-acaa-0dd139ce00e6"
      unitRef="usd">468365000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMS0xLTEtMjMzOTk_7783218e-7891-4209-9c51-2efacc89438e"
      unitRef="usd">92027000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMy0xLTEtMjMzOTk_f3b68358-a167-4d1b-8af5-9ec10e8f8a00"
      unitRef="usd">39847000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTgtMS0xLTEtMjMzOTk_a37bf520-05d4-4da8-b0e4-b06d7a0bf503"
      unitRef="usd">2539000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTgtMy0xLTEtMjMzOTk_a01b21fa-ae9d-464d-b712-a89be39bf466"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:Goodwill
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMS0xLTEtMjMzOTk_aea7c300-2ee8-42bc-8f8e-68c24d5e3cad"
      unitRef="usd">1526866000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMy0xLTEtMjMzOTk_cc8b8dfd-f6dc-4ec6-ade4-50b9cede901b"
      unitRef="usd">43439000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMS0xLTEtMjMzOTk_4c928e13-9c1a-4c81-b7a8-a2b122c2b383"
      unitRef="usd">1094710000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMy0xLTEtMjMzOTk_1d960f4e-b520-4e13-ac47-3d43057e8c38"
      unitRef="usd">188311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjEtMS0xLTEtMjMzOTk_63e8dce3-e5ce-431f-ba91-47d9fbee08f8"
      unitRef="usd">77566000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjEtMy0xLTEtMjMzOTk_118ed157-f4cb-439b-8e84-4893d6863033"
      unitRef="usd">42604000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMS0xLTEtMjMzOTk_292a04ec-19b5-459d-ba96-0e8d914e07cc"
      unitRef="usd">104617000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMy0xLTEtMjMzOTk_7aee2232-f5cc-4422-ac0b-acde2a7b22b0"
      unitRef="usd">63743000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMS0xLTEtMjMzOTk_4d10a56b-609a-4723-af01-73eb394bf29f"
      unitRef="usd">4746732000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMy0xLTEtMjMzOTk_536c1a7f-db16-4a10-bfbb-c97cfb71f07d"
      unitRef="usd">1880738000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMS0xLTEtMjMzOTk_777b6f19-85c7-4931-bf62-9926a0d98a98"
      unitRef="usd">200991000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMy0xLTEtMjMzOTk_32d6c330-d912-4473-bc54-f1f72227b1fa"
      unitRef="usd">81128000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMS0xLTEtMjMzOTk_77184d0d-a829-4821-aeeb-495f082192dd"
      unitRef="usd">261820000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMy0xLTEtMjMzOTk_d7e34423-5f9a-44e2-9011-cd54a0587ee2"
      unitRef="usd">118195000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjktMS0xLTEtMjMzOTk_75053216-cfe1-41e6-a2b2-a4a8436babaa"
      unitRef="usd">13813000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjktMy0xLTEtMjMzOTk_90f9957f-bf72-46ea-bc54-612412e6684a"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMS0xLTEtMjMzOTk_05f5df22-0b2f-41fd-ab63-39121102b451"
      unitRef="usd">17491000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMy0xLTEtMjMzOTk_4fb9c3bb-8931-450f-b3cf-01bdf5d961d5"
      unitRef="usd">1454000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMS0xLTEtMjMzOTk_67f92a58-6c0d-46f4-b834-c384f08e9d0c"
      unitRef="usd">494115000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMy0xLTEtMjMzOTk_0598d5f2-f50a-4a33-ac25-fbef7e76a68e"
      unitRef="usd">200777000</us-gaap:LiabilitiesCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMS0xLTEtMjMzOTk_8aabeb50-7166-4149-916b-cd6a192197c4"
      unitRef="usd">57701000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMy0xLTEtMjMzOTk_73a62e42-584c-4dce-9927-9c26f4e79261"
      unitRef="usd">2589000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzUtMS0xLTEtMjMzOTk_4ccd8e6a-00a4-4d67-b64a-46a3acaf57db"
      unitRef="usd">1642171000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzUtMy0xLTEtMjMzOTk_0940c759-8b82-4e41-bf73-bebc2e62c37b"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzYtMS0xLTEtMjMzOTk_0bfad877-863b-465c-8708-1f2d9fca50df"
      unitRef="usd">134208000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzYtMy0xLTEtMjMzOTk_6b8d70db-f3d1-4394-a8bb-e5dabb598e55"
      unitRef="usd">41830000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMS0xLTEtMjMzOTk_37c176c3-80df-4330-9217-8342e772413b"
      unitRef="usd">220628000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMy0xLTEtMjMzOTk_a21ce225-4244-42ec-a068-e469ba3a1a67"
      unitRef="usd">1490000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMS0xLTEtMjMzOTk_b2b2179e-2d19-4e9f-a0ee-59e7d72f05cd"
      unitRef="usd">19007000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMy0xLTEtMjMzOTk_5d1b87c2-8fa3-4722-b2ef-4a2b0a6fbfa6"
      unitRef="usd">18021000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMS0xLTEtMjMzOTk_7bdb1601-8a35-4347-b103-d518694bc2d1"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMy0xLTEtMjMzOTk_73e25217-2337-4482-8f2c-9f7a801092f0"
      unitRef="usd">0</us-gaap:CommitmentsAndContingencies>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl8zMw_376fb228-85a8-4e9c-84e3-6f7ccc2f109c"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl81Nw_20e20338-a95c-46e6-8fef-1ed9e025c1a3"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_2f42a07f-0c52-4bf8-815d-321b0670a44f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_4741798e-0a03-4611-acaf-4a12eb78e72b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_980eb8e6-fc2a-4a46-95e5-0b43fd260535"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjo1MzQ5OWExNzFmYzQ0ZDM1ODYwOTI2YmZkOWEwNTI4Nl85MQ_deddc23b-2ffc-4ddd-93a9-f9e415474685"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMS0xLTEtMjMzOTk_6d16ef22-2c67-4b58-b749-32f510187024"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMy0xLTEtMjMzOTk_e9fe34ae-66d8-4800-81fe-6664927fd088"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM18xOQ_e03f9b58-29c5-43e1-b6aa-00fc74555a55"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM180Ng_68664b0d-d8a1-4ddc-a8d4-807781be40dd"
      unitRef="shares">80000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM182Ng_257315c0-fbcb-4157-b8e2-b72f8390054e"
      unitRef="shares">23897000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM184Nw_cfb7c5b6-6b8c-41d6-98c0-490ded8cc89a"
      unitRef="shares">21280000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM18xMjE_8a126408-28b2-4164-a02f-b7ad1a1c122c"
      unitRef="shares">23884000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjpkZGI1N2JkM2M4Mzg0NjM0OGU4MGQ5MTE5MGYzZWVmM18xNDI_a68b9cb1-e6d9-4703-b141-b3b64807d47d"
      unitRef="shares">21280000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMS0xLTEtMjMzOTk_e48ee132-beec-4002-8c2c-174fb31b3d5f"
      unitRef="usd">2390000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMy0xLTEtMjMzOTk_e0b25fae-b7d7-48dd-8dfd-d1c3160c65c1"
      unitRef="usd">2128000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMS0xLTEtMjMzOTk_ae026f59-c364-4c1c-8fcb-542e9417ef0c"
      unitRef="usd">1306264000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMy0xLTEtMjMzOTk_3f6dcf20-b952-4de0-a9ee-232417604dbb"
      unitRef="usd">721412000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:TreasuryStockShares
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjphMTEwYzZhOTQwMjc0MjdiYjlkNzVlNzVkZWIxMjE3N18yOQ_a065c0f7-8fef-403e-8497-7be8c12a6321"
      unitRef="shares">12684</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMC0xLTEtMjMzOTkvdGV4dHJlZ2lvbjphMTEwYzZhOTQwMjc0MjdiYjlkNzVlNzVkZWIxMjE3N18zNg_9509bcca-1e4c-4fb2-9867-20451623f3e3"
      unitRef="shares">119</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMS0xLTEtMjMzOTk_7f1801cc-1268-4115-ba5f-93c4d613a90e"
      unitRef="usd">2843000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMy0xLTEtMjMzOTk_1dbdf55a-a861-400c-aae6-f31012cdc0ee"
      unitRef="usd">27000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMS0xLTEtMjMzOTk_4afae006-708a-4552-9dbb-0da7dc8f336b"
      unitRef="usd">873719000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMy0xLTEtMjMzOTk_95ae1fef-bd2e-4aa7-85d3-b39bcaf0be5e"
      unitRef="usd">911787000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMS0xLTEtMjMzOTk_b0537436-48f3-420e-89d5-a1b4fa47c940"
      unitRef="usd">-628000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMy0xLTEtMjMzOTk_854504f5-7b4b-4a6e-a397-62f066a793aa"
      unitRef="usd">-19269000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMS0xLTEtMjMzOTk_4881f416-8c20-42c2-95e5-f911c4732a75"
      unitRef="usd">2178902000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMy0xLTEtMjMzOTk_329d35b3-51f6-4be3-bbcb-f409487a5d01"
      unitRef="usd">1616031000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMS0xLTEtMjMzOTk_6779b994-fdab-4501-be16-8cac7df2be1f"
      unitRef="usd">4746732000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMy0xLTEtMjMzOTk_46bef57c-5157-447f-a499-70c305544b3d"
      unitRef="usd">1880738000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMi0xLTEtMS0yMzM5OQ_3fbc241c-9c48-4539-beec-1a8c32ec3b88"
      unitRef="usd">543122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMi0zLTEtMS0yMzM5OQ_3a491be6-cb0a-4de0-9503-2da593b368fa"
      unitRef="usd">318046000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMy0xLTEtMS0yMzM5OQ_55cb87c4-1ab2-4a42-85bd-aa6c8b9528fd"
      unitRef="usd">374295000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMy0zLTEtMS0yMzM5OQ_1cccb4db-64c0-4efb-9b91-8bdaea293cd4"
      unitRef="usd">205366000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNC0xLTEtMS0yMzM5OQ_5ff8df05-7037-420f-bad0-09cfa8a09b00"
      unitRef="usd">168827000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNC0zLTEtMS0yMzM5OQ_ff5f40f2-a9b3-481e-a193-65d38bd9a390"
      unitRef="usd">112680000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNi0xLTEtMS0yMzM5OQ_33cf3920-3c24-473b-9c0f-d48d1a6815bc"
      unitRef="usd">153212000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNi0zLTEtMS0yMzM5OQ_38faddea-0d7c-479e-bfd4-b61ef51548af"
      unitRef="usd">72391000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNy0xLTEtMS0yMzM5OQ_60ac384e-c89b-4589-ac33-9e3926d3c143"
      unitRef="usd">23871000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfNy0zLTEtMS0yMzM5OQ_f4e57751-9437-4339-8fec-5ed6236ece8d"
      unitRef="usd">10709000</us-gaap:ResearchAndDevelopmentExpense>
    <icui:Restructuringandstrategictransaction
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfOC0xLTEtMS0yMzM5OQ_90f03014-f1b6-4223-accb-b8cf5bd0bc95"
      unitRef="usd">33905000</icui:Restructuringandstrategictransaction>
    <icui:Restructuringandstrategictransaction
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfOC0zLTEtMS0yMzM5OQ_a952656f-724f-449a-988c-39fca1742f24"
      unitRef="usd">2883000</icui:Restructuringandstrategictransaction>
    <icui:Contractsettlement
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTAtMS0xLTEtMjMzOTk_44e76da9-6d34-4a0b-a267-32b75ebc2f5c"
      unitRef="usd">0</icui:Contractsettlement>
    <icui:Contractsettlement
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTAtMy0xLTEtMjMzOTk_ecbee636-88d9-482d-a8ad-9b281b923eaf"
      unitRef="usd">127000</icui:Contractsettlement>
    <us-gaap:OperatingExpenses
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTEtMS0xLTEtMjMzOTk_7747b104-5a9b-4b0d-a75d-51fd57047b8b"
      unitRef="usd">210988000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTEtMy0xLTEtMjMzOTk_e0143547-c67b-471a-8fc2-5b005593d8ca"
      unitRef="usd">86110000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTItMS0xLTEtMjMzOTk_eca3d082-59a7-4584-9933-b43c30bb99ce"
      unitRef="usd">-42161000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTItMy0xLTEtMjMzOTk_389c79ea-d2f6-4d8c-86ee-30dfe40a1ed0"
      unitRef="usd">26570000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTQtMS0xLTEtMjMzOTk_c2dec322-b84d-4ff8-ba88-2ee045e1d26f"
      unitRef="usd">13644000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTQtMy0xLTEtMjMzOTk_902aa5bc-3cfc-445e-9a60-a4b750c7bf22"
      unitRef="usd">161000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTUtMS0xLTEtMjMzOTk_de0b792b-48ac-40ac-991c-8540eb3b1ae0"
      unitRef="usd">1004000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTUtMy0xLTEtMjMzOTk_069cbdd6-e804-43a8-b619-5ea36bd617c7"
      unitRef="usd">683000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTYtMS0xLTEtMjMzOTk_ec36d0a1-efa1-4ee1-bb1a-bc16336b529e"
      unitRef="usd">-54801000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTYtMy0xLTEtMjMzOTk_8e3985ff-8adb-434a-aa39-49e2213c1571"
      unitRef="usd">27092000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTctMS0xLTEtMjMzOTk_ebf6c258-c750-4c02-93ea-d1c11b0cb8da"
      unitRef="usd">-16733000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTctMy0xLTEtMjMzOTk_8e0edcb1-8c48-49f4-9c57-1375f73a5ebb"
      unitRef="usd">3361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTgtMS0xLTEtMjMzOTk_68615dee-bd61-407d-ba81-912725b657c6"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMTgtMy0xLTEtMjMzOTk_a83511bf-c74f-410e-8362-a0f722e110f8"
      unitRef="usd">23731000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjAtMS0xLTEtMjMzOTk_d643da38-127c-4a2a-9be9-912b4ada2242"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjAtMy0xLTEtMjMzOTk_f7fbcb2d-8fee-4d87-af34-a810a61cc269"
      unitRef="usdPerShare">1.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjEtMS0xLTEtMjMzOTk_673f2412-0a1f-47ba-8474-52baee72ec1e"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjEtMy0xLTEtMjMzOTk_71c6f6b4-e451-45c4-a29b-a673a70e9fd7"
      unitRef="usdPerShare">1.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjMtMS0xLTEtMjMzOTk_2f69072f-b445-4602-8c3d-ea4a700ac797"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjMtMy0xLTEtMjMzOTk_6e80a370-1273-4167-8f19-35ac97d3fdd3"
      unitRef="shares">21149000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjQtMS0xLTEtMjMzOTk_25b50bc0-f558-4484-b792-f3321eaa5651"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xOS9mcmFnOmQwMDRlMDZjMjI5YzRlMzBhMDUzNDQ4ZTU4YmZkNzQyL3RhYmxlOmIyNmFhM2VhM2MxNzQxZTlhMzE2NjM5MmVkMDRkZThlL3RhYmxlcmFuZ2U6YjI2YWEzZWEzYzE3NDFlOWEzMTY2MzkyZWQwNGRlOGVfMjQtMy0xLTEtMjMzOTk_32c11b28-52ed-4c71-9572-fed88200fb80"
      unitRef="shares">21695000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfMi0xLTEtMS0yMzM5OQ_e30f038c-4e60-420c-9b66-1ae118369f42"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfMi0zLTEtMS0yMzM5OQ_bc2f94f8-f61e-47b9-a2f5-451ae607ddb1"
      unitRef="usd">23731000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmI2NWRlNDgyNDkxODQ1MGViZWI2YzIwZDIwMzI2ZDYwXzQ5_c71799e3-addd-417b-992f-fa60aa282d42"
      unitRef="usd">7312000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmI2NWRlNDgyNDkxODQ1MGViZWI2YzIwZDIwMzI2ZDYwXzU2_46bc91c1-4ce1-4aee-8179-b47ff74af45c"
      unitRef="usd">298000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0xLTEtMS0yMzM5OQ_ad73e19d-7673-4a81-9da0-c4ac9e914a62"
      unitRef="usd">23572000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNC0zLTEtMS0yMzM5OQ_917f932b-5b3d-4d2f-9c2f-cc274baaa3b9"
      unitRef="usd">-945000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOjRjYjBiOTE1ODFkNjRmNTlhZDA2MzFlMzlmMDEzM2FlXzYx_5ae28854-c01c-4be4-bc48-a3f4dec29c67"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOjRjYjBiOTE1ODFkNjRmNTlhZDA2MzFlMzlmMDEzM2FlXzYx_875b80e6-a08a-4a11-b282-fb831edf7891"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0xLTEtMS0yMzM5OQ_837799f1-9ea9-4634-a49c-ff4ab6ecf4ac"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNS0zLTEtMS0yMzM5OQ_f8533d45-bfd3-44d3-b729-b65381a0a6e3"
      unitRef="usd">-7458000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmQwYzAxZjQyNWFlNzQ1ODI4MzNjNGQxYjIwOGU3OTIyXzM5_dea1ebe9-32c3-4049-994e-6b9827379c5f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0wLTEtMS0yMzM5OS90ZXh0cmVnaW9uOmQwYzAxZjQyNWFlNzQ1ODI4MzNjNGQxYjIwOGU3OTIyXzM5_f1909a64-a1d0-4bee-b1f5-ae68e185e5c8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0xLTEtMS0yMzM5OQ_e22c59d8-e4b2-4410-b9e9-ab6e701cb923"
      unitRef="usd">-15000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNi0zLTEtMS0yMzM5OQ_171c88d8-8eca-4210-931f-171c3c58a23b"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNy0xLTEtMS0yMzM5OQ_199310b0-a349-447e-b15b-3cb8dd6a919b"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfNy0zLTEtMS0yMzM5OQ_03026bca-26e4-4ba1-95df-6e9ee59be9d4"
      unitRef="usd">-8391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfOC0xLTEtMS0yMzM5OQ_4407822f-708b-488a-b3ec-6b4d431c9247"
      unitRef="usd">-19427000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yMi9mcmFnOmIyNWQ1ZDUzMGZlNTQ3ZmI4ZGYzZWRkMzgyNzM5ZGNjL3RhYmxlOmFlZTJkZWI3OTE0NzQwYzhhMDMyNTlhZWJiMDllY2NkL3RhYmxlcmFuZ2U6YWVlMmRlYjc5MTQ3NDBjOGEwMzI1OWFlYmIwOWVjY2RfOC0zLTEtMS0yMzM5OQ_4cfe52a6-d4f5-42da-810c-9e90d32c0657"
      unitRef="usd">15340000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic739b9e6cfbd49928ba2becb10737a7b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0yLTEtMS0yMzM5OQ_dbbf0bb8-f702-4be4-a3ff-e831d4de5ea3"
      unitRef="shares">21280000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib5d868d49505419592afffab42bf0eb7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi00LTEtMS0yMzM5OQ_19a67c00-7d8f-4d28-899b-1a887ec35746"
      unitRef="usd">2128000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i64868371845d4e76bc447e71919e1983_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi02LTEtMS0yMzM5OQ_2585f28a-05ca-4c98-94fc-8d83ea6b6eb7"
      unitRef="usd">721412000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfc64c489cf04a69892f2bb79d05265d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi04LTEtMS0yMzM5OQ_f24147ad-822d-42f5-9a96-2dcbca3829a6"
      unitRef="usd">-27000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6984b38e57b4cb9b7db8552e7a3fcaa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0xMC0xLTEtMjMzOTk_cbf8028a-1970-4dd2-b816-f87f151dec52"
      unitRef="usd">911787000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i86236b5f9d4c43f5b952f83a321739b1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0xMi0xLTEtMjMzOTk_3d2a07a1-5191-4b1c-af1e-8602da137f2c"
      unitRef="usd">-19269000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMi0xNC0xLTEtMjMzOTk_faaeec9f-0b18-4a07-89c7-88bcfaf20e84"
      unitRef="usd">1616031000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="iee98598f2d5949e89f38dd5e926233ef_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy0yLTEtMS0yMzM5OQ_a542b5f5-db3f-4805-88e5-37dc893b2471"
      unitRef="shares">154000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i17a81a7b494f4b9389f3416497deb3e2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy00LTEtMS0yMzM5OQ_5b9fdaa4-ab69-4ccf-8587-486e1838811c"
      unitRef="usd">12000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy02LTEtMS0yMzM5OQ_a368e7b8-352b-43bd-9301-97af3dabc3cb"
      unitRef="usd">-2965000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i8d11403464e048ae8378f62edfc53cea_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy04LTEtMS0yMzM5OQ_dd433c8e-4eb0-4dda-a33e-9cbe86490b92"
      unitRef="usd">5927000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfMy0xNC0xLTEtMjMzOTk_f547756c-0211-4f33-93d4-8456cd523488"
      unitRef="usd">2974000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="iee98598f2d5949e89f38dd5e926233ef_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNC0yLTEtMS0yMzM5OQ_f50d8223-8a83-4f14-9c05-e4b8584cf69d"
      unitRef="shares">37000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8d11403464e048ae8378f62edfc53cea_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNC04LTEtMS0yMzM5OQ_12cf78d0-2890-47af-9470-7c5d818efa52"
      unitRef="usd">8743000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNC0xNC0xLTEtMjMzOTk_fdb4057d-2737-4c6a-98ab-0b91eca8f9f6"
      unitRef="usd">8743000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS0yLTEtMS04MzA3NQ_8bc2d8df-aa61-4bde-aedc-a2bd552fdcec"
      unitRef="shares">2500000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i17a81a7b494f4b9389f3416497deb3e2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS00LTEtMS04MzA3OA_1bd5497e-fa44-472f-a8f1-0d1131b55e82"
      unitRef="usd">250000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS02LTEtMS04MzA4MA_8fcbb2dd-dae0-4f1b-b151-402131153d27"
      unitRef="usd">575725000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS0xNC0xLTEtODMwODM_5295b2bd-238b-42eb-bbdb-18510c5fa585"
      unitRef="usd">575975000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic4324773da6c46838da16563bbe0f6e1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS02LTEtMS0yMzM5OQ_24c1eddb-d054-42ef-b976-1bc9ad849744"
      unitRef="usd">12092000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNS0xNC0xLTEtMjMzOTk_eee8091c-9d30-4cfd-b8b1-60c0103ade4d"
      unitRef="usd">12092000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idb961a439cc448229c94512348851dab_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNi0xMi0xLTEtMjMzOTk_d32a77a0-9692-4ca1-b623-abdc2f4a2150"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNi0xNC0xLTEtMjMzOTk_33df5c6f-99be-4069-8ecc-5bf1816ac6d7"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i8ffc6e2664094fdf93f1f351c76c317c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNy0xMC0xLTEtMjMzOTk_49d42a08-a466-44de-b41f-0a638dae1032"
      unitRef="usd">-38068000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfNy0xNC0xLTEtMjMzOTk_6fcf52fe-a256-4ad2-8e22-76537ef4d81d"
      unitRef="usd">-38068000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3fe8dbdded6c47e5abc6e9b101c5276c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0yLTEtMS0yMzM5OQ_868063ad-dcc9-48f6-93f3-21c3c6fe4755"
      unitRef="shares">23897000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i691612597ddd469aa1e76c59b67248a2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC00LTEtMS0yMzM5OQ_734dd19f-ca29-47f8-b9db-4041e6294197"
      unitRef="usd">2390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i77dbdeb976b5481f9ae92bbf1102665e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC02LTEtMS0yMzM5OQ_680efe93-def8-4eb6-99be-16b85255ed39"
      unitRef="usd">1306264000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9cbe5a67bda441529efd0b011401173b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC04LTEtMS0yMzM5OQ_5b6ac48f-42b3-4895-af4b-1cdb86dc5a59"
      unitRef="usd">-2843000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia69c8c17a24744f9be803234128f6c24_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0xMC0xLTEtMjMzOTk_ae08fd93-d436-4670-9da3-c7520e47db86"
      unitRef="usd">873719000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic3a542e87e2f471ba2bf2af24b497b2e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0xMi0xLTEtMjMzOTk_db52fbcb-5d34-4252-b18f-e6b866d9170f"
      unitRef="usd">-628000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmE4MTg2YjUzOTQyMjQyMDg4ZTdiMjg2MzY2NzI1OTYxL3RhYmxlcmFuZ2U6YTgxODZiNTM5NDIyNDIwODhlN2IyODYzNjY3MjU5NjFfOC0xNC0xLTEtMjMzOTk_cf24cf8c-d52e-462a-a5ec-5195f7affdef"
      unitRef="usd">2178902000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idbec71a052e34a628bdbc7874d90f523_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0yLTEtMS0yMzM5OQ_c474737c-590e-4f9d-9b78-e8cea9348fd7"
      unitRef="shares">21058000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iee88159d0ccf4a36be2cea91faa46dd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi00LTEtMS0yMzM5OQ_ffe6356f-afef-4fdf-8297-4fe7bd283f72"
      unitRef="usd">2106000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i83d7811e874b43c3ac9eedf4ade5ff94_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi02LTEtMS0yMzM5OQ_eebd16b2-29ae-4422-9400-5b92ed393cfa"
      unitRef="usd">693068000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaaa3308af1304da2922818b5e5b2203a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi04LTEtMS0yMzM5OQ_39d93d85-b6a1-48b1-be1b-d206a627aa3a"
      unitRef="usd">-39000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib4bf3dd823004949bb668180e422e8b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0xMC0xLTEtMjMzOTk_286dc9e5-6ba2-4214-b986-b3f1f3395fd6"
      unitRef="usd">808652000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70d5d4b789c14217a4637b71e3935b05_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0xMi0xLTEtMjMzOTk_a2e0e79b-1b0a-4643-8ce9-2f226abe628b"
      unitRef="usd">-1522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMi0xNC0xLTEtMjMzOTk_2b96084d-0b7a-49e5-b21a-92772ae4ad24"
      unitRef="usd">1502265000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i6de1955a7159499e9b68b9b0daa91296_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy0yLTEtMS0yMzM5OQ_9595d7eb-0d26-4b75-b6c6-51a5ad27e3e8"
      unitRef="shares">198000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie23ec980b5784615a4b1e1be6c1805d9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy00LTEtMS0yMzM5OQ_75cb80c3-82d7-4275-956c-47de21ddf0ce"
      unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="if1dae3bb26454570acfeaff45f3e5b66_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy02LTEtMS0yMzM5OQ_b907134e-2059-4201-af09-18eacd67a6e6"
      unitRef="usd">2496000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ia4e2dc9a5e24485b8f9b458a7172bbff_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy04LTEtMS0yMzM5OQ_16cb27ab-ef69-4a4e-88d5-62d4a7854abf"
      unitRef="usd">2352000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfMy0xNC0xLTEtMjMzOTk_ef21eb33-1611-4825-9b8d-1fed631a4cfe"
      unitRef="usd">4864000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i6de1955a7159499e9b68b9b0daa91296_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNC0yLTEtMS0yMzM5OQ_a1094a7d-5645-4f75-b7bf-67f34e72337d"
      unitRef="shares">37000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia4e2dc9a5e24485b8f9b458a7172bbff_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNC04LTEtMS0yMzM5OQ_ef9b0ce5-fa5d-41a5-96a5-939b1e4870e8"
      unitRef="usd">7723000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNC0xNC0xLTEtMjMzOTk_390929dc-aeae-494b-8355-b53f96f22eeb"
      unitRef="usd">7723000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if1dae3bb26454570acfeaff45f3e5b66_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNS02LTEtMS0yMzM5OQ_8fc503bf-0241-44ac-a0cc-a6e64cf99dd7"
      unitRef="usd">6022000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNS0xNC0xLTEtMjMzOTk_fd00b81a-e5c4-4ccc-b0b1-6c150c862ba3"
      unitRef="usd">6022000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5cd3a8fb34fc4f0f9340555ab6074ee6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNi0xMi0xLTEtMjMzOTk_064082bd-c97e-4dc3-aebd-4b5d88d61a60"
      unitRef="usd">-8391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNi0xNC0xLTEtMjMzOTk_f1ed6d2b-84e2-49d8-9746-0b659c3ed1af"
      unitRef="usd">-8391000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ib569fc18582645668995f72d04a72816_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNy0xMC0xLTEtMjMzOTk_fdaf1d9f-ff78-4000-aae2-0464231f5974"
      unitRef="usd">23731000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfNy0xNC0xLTEtMjMzOTk_9c17b1e6-a66d-458e-be11-7b529355d9dc"
      unitRef="usd">23731000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i58b4154cd7374229b9e379d211fbefc5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0yLTEtMS0yMzM5OQ_32215ebd-d0d5-448f-a79d-e881cb8f98ae"
      unitRef="shares">21219000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i894ed5cd7131488eb00a9af8903195f4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC00LTEtMS0yMzM5OQ_8c772c7c-1779-4d6f-bd14-e001ce7eaad4"
      unitRef="usd">2122000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i463ae5afe8854c50a81194644b397891_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC02LTEtMS0yMzM5OQ_9038bd54-36b1-476e-ab07-b0c599246d10"
      unitRef="usd">701586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i766a662d646644049de578ec36ca4f87_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC04LTEtMS0yMzM5OQ_add666bf-4c63-4d3d-9768-300ffe1cd513"
      unitRef="usd">-5410000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i93e818396f3f49a2ad987c721bf7dd83_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0xMC0xLTEtMjMzOTk_781519fc-042e-4121-b83d-e524a53e2de1"
      unitRef="usd">832383000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic9086cf89d1247ba9e8c0d33a92d5450_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0xMi0xLTEtMjMzOTk_4fcf2971-be2e-4d70-ba2d-56e1d52501dd"
      unitRef="usd">-9913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yNS9mcmFnOmQ1MzljNTVmZjlhYTQ2MzM5ZjFmZWUzMDkwNjEyOWNkL3RhYmxlOmMzNWVkZDgwYjQ1YjQyYzhiYjBlYjRjMWRjZTBhOWY3L3RhYmxlcmFuZ2U6YzM1ZWRkODBiNDViNDJjOGJiMGViNGMxZGNlMGE5ZjdfOC0xNC0xLTEtMjMzOTk_35c8822e-532f-4528-8b4e-7b8faa799458"
      unitRef="usd">1520768000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMy0xLTEtMS0yMzM5OQ_dbf4a617-b6e9-4832-9789-90cc160185e6"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMy0zLTEtMS0yMzM5OQ_8c040a25-f314-4be9-90a0-9afff6d3fc69"
      unitRef="usd">23731000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNS0xLTEtMS0yMzM5OQ_4220f00f-5221-4d42-a0f9-cb0f58911359"
      unitRef="usd">53138000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNS0zLTEtMS0yMzM5OQ_d6ca2aee-c333-494b-979c-8c126f865cc3"
      unitRef="usd">22155000</us-gaap:DepreciationDepletionAndAmortization>
    <icui:AmortizationOfInventoryStepUp
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0xLTEtMS03ODM5OA_aa5c395e-8aea-4407-9a7b-a641ca38c906"
      unitRef="usd">14370000</icui:AmortizationOfInventoryStepUp>
    <icui:AmortizationOfInventoryStepUp
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0zLTEtMS03ODM5OA_79b14498-4c5b-4bf2-8491-1525df7c1ef6"
      unitRef="usd">0</icui:AmortizationOfInventoryStepUp>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0xLTEtMS0yMzM5OQ_ac23e570-2dd9-4522-9705-772fa0cad30f"
      unitRef="usd">5286000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNi0zLTEtMS0yMzM5OQ_6a0c6ca9-d992-4f74-9c49-ac4c1df76204"
      unitRef="usd">2372000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNy0xLTEtMS0yMzM5OQ_0f4bf77e-c595-4ccb-adb2-a352906bab6d"
      unitRef="usd">-548000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNy0zLTEtMS0yMzM5OQ_3845bcd5-43f4-4717-a4eb-53d7448d55da"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOC0xLTEtMS0yMzM5OQ_ea700709-3f50-4433-bcb3-48cf77a43e4c"
      unitRef="usd">726000</icui:ProvisionForWarrantyAndReturns>
    <icui:ProvisionForWarrantyAndReturns
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOC0zLTEtMS0yMzM5OQ_b4cf7dac-988e-42d4-a221-3deccce9a4fe"
      unitRef="usd">209000</icui:ProvisionForWarrantyAndReturns>
    <us-gaap:ShareBasedCompensation
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOS0xLTEtMS0yMzM5OQ_de0e882c-84c4-4c24-985e-05ba06d2307e"
      unitRef="usd">12092000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfOS0zLTEtMS0yMzM5OQ_f58b1c1a-1049-4d50-87ac-eafd82cb44cb"
      unitRef="usd">6022000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTAtMS0xLTEtMjMzOTk_15773f4e-1211-4224-a952-467bd70089b6"
      unitRef="usd">-596000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTAtMy0xLTEtMjMzOTk_bf50ed2d-9beb-424d-8286-77e75523d2d8"
      unitRef="usd">-659000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTEtMS0xLTEtMjMzOTk_e8740504-80b3-42a6-a6a1-8ecd5c14daff"
      unitRef="usd">130000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:InvestmentIncomeAmortizationOfPremium
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTEtMy0xLTEtMjMzOTk_822541fc-21ba-449b-a3a4-d3aa98a9afb7"
      unitRef="usd">168000</us-gaap:InvestmentIncomeAmortizationOfPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTItMS0xLTEtMjMzOTk_a7962df2-2e03-43f5-9ede-55dbd1d37b4a"
      unitRef="usd">1643000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTItMy0xLTEtMjMzOTk_f845f838-e0fb-467c-94ad-ba26bd7c3cbf"
      unitRef="usd">72000</us-gaap:AmortizationOfFinancingCosts>
    <icui:Sparepartsusage
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTUtMS0xLTEtMjMzOTk_bb5b7c01-e1b1-4bc8-a924-c006d22e389e"
      unitRef="usd">2223000</icui:Sparepartsusage>
    <icui:Sparepartsusage
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTUtMy0xLTEtMjMzOTk_9a5b75e0-25cb-422d-a30e-c6ae4e2aa2c3"
      unitRef="usd">2825000</icui:Sparepartsusage>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTYtMS0xLTEtMjMzOTk_5538607d-2de2-4e75-958e-6eedb13c44e4"
      unitRef="usd">1649000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTYtMy0xLTEtMjMzOTk_1a24d51b-4588-4652-95a6-23e221403e21"
      unitRef="usd">1287000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTgtMS0xLTEtMjMzOTk_547ac486-31d6-4d46-9e6b-3ffd10cc9f0d"
      unitRef="usd">-22489000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTgtMy0xLTEtMjMzOTk_f0cb7ef0-e054-4836-a098-5e06ec201852"
      unitRef="usd">-1506000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTktMS0xLTEtMjMzOTk_7769c256-008b-4001-8327-abb2483ce6a0"
      unitRef="usd">36170000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMTktMy0xLTEtMjMzOTk_5c4c0810-6e7e-4d86-b850-417484c5c250"
      unitRef="usd">-13208000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjAtMS0xLTEtMjMzOTk_85c6fff0-5fc6-489f-a342-187c572d4b27"
      unitRef="usd">-2607000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjAtMy0xLTEtMjMzOTk_78f91aa2-37c2-41d7-be86-a7fadca70ede"
      unitRef="usd">742000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjEtMS0xLTEtMjMzOTk_76b599e9-0f50-4970-830d-ded4bdb09afe"
      unitRef="usd">14371000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjEtMy0xLTEtMjMzOTk_16c7e48e-2509-4497-8df8-fbfcf6febf03"
      unitRef="usd">3463000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjItMS0xLTEtMjMzOTk_86ffedd2-b4ed-42dc-a5da-3e7a85211f4a"
      unitRef="usd">19504000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjItMy0xLTEtMjMzOTk_b04766a0-b3fe-49ba-8cc1-abe6edcad626"
      unitRef="usd">2411000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjMtMS0xLTEtMjMzOTk_8f70a698-d4f3-4317-9037-40dded42fa37"
      unitRef="usd">-19238000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjMtMy0xLTEtMjMzOTk_7563bed5-c22a-4673-8123-47d0b738fa46"
      unitRef="usd">-19965000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjQtMS0xLTEtMjMzOTk_5c2385c1-67a5-420e-bc16-1005803c0f88"
      unitRef="usd">-26102000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjQtMy0xLTEtMjMzOTk_56b527f6-15bb-42b5-b404-af36caf1b650"
      unitRef="usd">1439000</icui:IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjUtMS0xLTEtMjMzOTk_23d77972-5f21-4a31-b8bf-073bd2049bc3"
      unitRef="usd">-1342000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjUtMy0xLTEtMjMzOTk_b4ef3e32-5153-4fd3-b73e-4e84f608b38e"
      unitRef="usd">51320000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjctMS0xLTEtMjMzOTk_c9008c86-830b-4cd8-94d3-8212002bb762"
      unitRef="usd">23606000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjctMy0xLTEtMjMzOTk_4e9fa866-6e22-497e-a5a2-944351f62186"
      unitRef="usd">14028000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjgtMS0xLTEtMjMzOTk_9c51ff8f-e1f0-4bfb-a9b5-b15e3b13482a"
      unitRef="usd">900000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjgtMy0xLTEtMjMzOTk_bb42ae96-55b0-4c0b-9f11-046b5244345d"
      unitRef="usd">55000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjktMS0xLTEtMjMzOTk_7d586f35-dfc3-4e72-a0c6-b259b197c6ea"
      unitRef="usd">1844164000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMjktMy0xLTEtMjMzOTk_7d82e179-84b3-47fe-8b14-529438d0e576"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzAtMS0xLTEtMjMzOTk_9992a60b-ba78-4fb2-841f-e000cc25d4dd"
      unitRef="usd">2387000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzAtMy0xLTEtMjMzOTk_f1c0f719-7170-4b74-a54f-3e442f04520c"
      unitRef="usd">1874000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzItMS0xLTEtMjMzOTk_1804271f-67eb-4fbf-9b5f-f5092964db8a"
      unitRef="usd">1993000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzItMy0xLTEtMjMzOTk_9d9e3efc-7e11-4098-8995-80b4eb7b7516"
      unitRef="usd">10034000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzMtMS0xLTEtMjMzOTk_767c577e-141a-4f15-bdf4-06e1141c82a2"
      unitRef="usd">3500000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzMtMy0xLTEtMjMzOTk_81e29548-ed66-4859-9e02-2969b94a96a2"
      unitRef="usd">7000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzQtMS0xLTEtMjMzOTk_6cb2b965-e3f6-470a-9843-ee6c262ed42c"
      unitRef="usd">-1867750000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzQtMy0xLTEtMjMzOTk_c867fc16-2dcb-4fe2-9337-582d1d1078f6"
      unitRef="usd">-18881000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzYtMS0xLTEtMjMzOTk_a334ff59-e2ed-4c6c-be60-7783f892a8e2"
      unitRef="usd">1672698000</icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts>
    <icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzYtMy0xLTEtMjMzOTk_7d14c37d-9095-4afa-9e53-683f1c3f16b1"
      unitRef="usd">0</icui:ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzctMS0xLTEtMjMzOTk_fe6d2992-9779-4b2c-b85c-fb0e3154300b"
      unitRef="usd">16000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzctMy0xLTEtMjMzOTk_c0aba7c9-8342-4457-9609-c2c47f4c78b5"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMS0xLTEtNzc0MTI_abd0fe19-0c32-4df2-b1dd-591609187153"
      unitRef="usd">1852000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMy0xLTEtNzc0MTI_c48e58d7-cf82-4277-b393-8d330a153556"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMS0xLTEtMjMzOTk_7f732b21-747f-4663-b211-d45767e2cf2d"
      unitRef="usd">2974000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzgtMy0xLTEtMjMzOTk_c3b800ed-0177-445f-b43f-a8f80842e7a4"
      unitRef="usd">4864000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzktMS0xLTEtMjMzOTk_5b01dae7-517d-42b4-b5f1-66418146edf7"
      unitRef="usd">160000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfMzktMy0xLTEtMjMzOTk_7a2a070d-387c-4a8c-9c1d-6812e6fac5ea"
      unitRef="usd">141000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDAtMS0xLTEtMjMzOTk_813d3c86-a3ef-41ea-a207-6218148ae034"
      unitRef="usd">8743000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDAtMy0xLTEtMjMzOTk_bf4dc73d-7da2-4a86-8523-f2deb3ef983f"
      unitRef="usd">7723000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDEtMS0xLTEtMjMzOTk_7975406f-caba-42e9-b2ad-9922af618158"
      unitRef="usd">1648917000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDEtMy0xLTEtMjMzOTk_6ccf6b31-8bb8-41b7-be29-d6598eb72a70"
      unitRef="usd">-3000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDItMS0xLTEtMjMzOTk_c92e3fde-e47a-49eb-9f91-66d7c235ca14"
      unitRef="usd">-3224000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDItMy0xLTEtMjMzOTk_3853d05f-2562-4302-8395-1a3bcb87e902"
      unitRef="usd">-1287000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDMtMS0xLTEtMjMzOTk_9fcdc25e-927c-46bc-9d1f-1cf2e08ab92d"
      unitRef="usd">-223399000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDMtMy0xLTEtMjMzOTk_03c00b39-0957-4a41-9ceb-a1c751e1be91"
      unitRef="usd">28152000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMS0xLTEtMjMzOTk_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
      unitRef="usd">552827000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMy0xLTEtMjMzOTk_d475e045-ba25-4c52-b01b-ecadd868009e"
      unitRef="usd">396097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDUtMS0xLTEtMjMzOTk_2bc899dd-032f-44cd-8e62-b7bbb5147b21"
      unitRef="usd">329428000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDUtMy0xLTEtMjMzOTk_fe531192-9bff-4151-b884-f9fc031824fc"
      unitRef="usd">424249000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMy0xLTEtMS0yMzM5OQ_9645d35c-d331-4d3d-832a-9d97bf75aa8b"
      unitRef="usd">5178000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMy0zLTEtMS0yMzM5OQ_3047d636-6539-4f69-b062-53add204054d"
      unitRef="usd">1068000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTEtMS0xLTEtODMxMDk_848fa656-f247-4b39-982a-8af23082484f"
      unitRef="usd">1594776000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTItMS0xLTEtODMxMTE_bc76399b-95f8-4fd3-a4ab-a1656a45fc39"
      unitRef="usd">1844164000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTMtMS0xLTEtODMxMTM_2459d989-7193-42d6-8ae9-cb0a12179474"
      unitRef="usd">575975000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <icui:ContingentConsiderationAllAcquisitions
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTQtMS0xLTEtODMxMTU_e6224a78-6aaf-46ed-913b-e599e44b4b72"
      unitRef="usd">55158000</icui:ContingentConsiderationAllAcquisitions>
    <icui:GoodwillAcquiredDuringPeriodAllAcquisitions
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTUtMS0xLTEtODMxMTc_15c0d975-1d12-41fa-a8ae-96606ddbde86"
      unitRef="usd">1485987000</icui:GoodwillAcquiredDuringPeriodAllAcquisitions>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjBkZTE2MGNmNjBlMjRhZDc4Y2VlNjNhY2ViZjNmYTExL3RhYmxlcmFuZ2U6MGRlMTYwY2Y2MGUyNGFkNzhjZWU2M2FjZWJmM2ZhMTFfMTYtMS0xLTEtODMxMTk_a320e858-4802-4c37-8a94-abf6a589c046"
      unitRef="usd">605466000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8zNC9mcmFnOmZhNjQ1NzMxZTU4OTRkMWNhZmM2Nzg0NTJkODZiNmQzL3RleHRyZWdpb246ZmE2NDU3MzFlNTg5NGQxY2FmYzY3ODQ1MmQ4NmI2ZDNfMTczOQ_21a8361f-7e51-4a13-a353-ac23411292eb">Basis of Presentation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S.") and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and reflect all adjustments, consisting of only normal recurring adjustments, which are, in the opinion of management, necessary for a fair statement of the consolidated results for the interim periods presented. Results for the interim period are not necessarily indicative of results for the full year. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules&#160;and regulations. The condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report on Form&#160;10-K of ICU Medical,&#160;Inc., ("ICU") a Delaware corporation, filed with the SEC for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are engaged in the development, manufacturing and sale of innovative medical products used in infusion therapy and critical care applications.&#160;We sell the majority of our products through our direct sales force and through independent distributors throughout the U.S. and internationally.&#160;We also sell certain products on an original equipment manufacturer basis to other medical device manufacturers. All subsidiaries are wholly owned and are included in the condensed consolidated financial statements.&#160;All intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical 2020 Limited ("Smiths Medical"), see Note 3: Acquisitions. Our condensed consolidated statement of operations includes the results of operations for Smiths Medical from January 7, 2022 through March 26, 2022, which is the current end of their 4-4-5 accounting period.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8zNy9mcmFnOmNmYzk2NzQ5NzllYTRjYjJhMGYyYTQ5Yjc3YTc5MDRiL3RleHRyZWdpb246Y2ZjOTY3NDk3OWVhNGNiMmEwZjJhNDliNzdhNzkwNGJfMTc4OA_58c85ef3-c865-4e16-8ee9-1214a851813e">New Accounting Pronouncements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional guidance for a limited period of time to ease the potential burden for reference rate reform on financial reporting. Due to concerns about structural risks of interbank offered rates and, particularly, the risk of cessation of the London Interbank Offered Rate ("LIBOR"), regulators around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction-based and less susceptible to manipulation. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued as a result of reference rate reform. Optional expedients may be applied to contracts that are modified as a result of the reference rate reform. Modifications of contracts within the scope of Topic 470, Debt, should be accounted for by prospectively adjusting the effective interest rate. Modifications of contracts within the scope of ASC 842, Leases, should be accounted for as a continuation of the existing contracts with no reassessments of the lease classification and the discount rate (incremental borrowing rate). Exceptions to Topic 815, Derivatives and Hedging, results in not having a dedesignation of a hedging relationship if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. In November 2021, we entered into two forward-starting swaps whereby the variable leg of the swap referenced LIBOR. These swaps were amended in early 2022 to transition to an alternative reference rate (see Note 8: Derivatives and Hedging Activities). The amendments in this ASU allow for certain expedients that will allow us to assume that our hedged interest payments are probable of occurring regardless of any expected modification in their terms related to reference rate reform and will allow us to continue hedge accounting for a cash flow hedge for which the hedged interest rate risk changes if the hedge is highly effective under ASC 815, Derivatives and Hedging, or the optional expedient under this ASU is elected. The impact of this ASU on our contracts has not been and is not expected to be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI3NQ_e14d21ea-d6d6-4f6d-8910-b63c30b19f9b">Acquisitions&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired 100.0% of the equity interests in Smiths Medical, the holding company of Smiths Group plc's global medical device business, from Smiths Group International Holdings Limited (&#x201c;Smiths&#x201d;). The acquisition of Smiths Medical aligns with our strategic growth plans, enabling us to broaden our product offerings to include syringe and ambulatory infusion devices, vascular access, and vital care products and to strengthen and expand our global market reach.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash consideration for the acquisition was $1.9&#160;billion, which was financed with existing cash balances and proceeds from the credit agreement entered into on January 6, 2022 (see Note 17: Long-Term Debt). We also issued share consideration to Smiths of 2.5&#160;million shares of our common stock. The fair value of the common shares issued to Smiths was determined based on the closing market price of our common stock on the acquisition date. Smiths may be entitled to an additional $100.0&#160;million in cash consideration contingent on our common stock achieving certain price targets for certain periods after closing in accordance with the terms of the Share Sale and Purchase Agreement (the "Purchase Agreement"). In the event that (a) on or prior to the third anniversary of closing the 30-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share or (b) on or prior to the fourth anniversary of closing the 45-day volume-weighted average price for our common stock, as defined in the Purchase Agreement, equals or exceeds $300.00 per share (each a "Price Target"), and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved, then Smiths will be entitled to receive the additional $100.0&#160;million in cash consideration. The fair value of the contingent consideration was determined using an option pricing model, specifically the Monte Carlo Simulation. In the analysis, the determinants of payout are simulated in a risk neutral framework over a large number of simulation paths. The fair value of the contingent consideration is then calculated as the average present value across all simulated paths. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Preliminary Purchase Price Allocation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the preliminary purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash consideration for acquired assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preliminary fair value of contingent consideration payable to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of ICU Medical, Inc. common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Price per share (ICU's opening market price on the acquisition date)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of ICU shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated consideration to be paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preliminary Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Preliminary identifiable intangible assets include $500.0&#160;million of customer relationships, $420.0&#160;million of developed technology, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately nine years, and, for each identifiable intangible asset is estimated as follows: eight years for customer relationships, ten years for developed technology, and six months for the trade mark. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Preliminary accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The above purchase price and purchase price allocation are preliminary and subject to future revision as the acquired assets and liabilities assumed are dependent upon the finalization of the related valuations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The identifiable intangible assets and other long-lived assets acquired have been valued as Level 3 assets at fair value. The estimated fair value of identifiable intangible assets were developed using the income approach and are based on critical estimates, judgments and assumptions derived from: analysis of market conditions; discount rate; discounted cash flows; royalty rates; customer retention rates; and/or estimated useful lives. Certain other intangible assets were valued using a cost to replace method, estimating the labor and non-labor costs required to replace the asset under the premise that it was not part of the transaction. Property, plant and equipment was valued with the consideration of remaining economic lives. The raw materials inventory was valued at historical cost and adjusted for any obsolescence which we estimate to approximate replacement cost, the work in process was valued at estimated sales proceeds less costs to complete and costs to sell, and finished goods inventory was valued at estimated sales proceeds less costs to sell. The prepaid expenses and other current assets and assumed liabilities were recorded at their carrying values as of the date of the acquisition, as their carrying values approximated their fair values due to their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unaudited Pro Forma Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Smiths Medical is included in our consolidated results beginning on January 7, 2022. Total revenues and net loss attributable to Smiths Medical for the period from January 7, 2022 to March 31, 2022 were $214.9&#160;million and $40.4&#160;million, respectively. The following unaudited pro forma financial information presents the combined results of operations of ICU and Smiths Medical as if the acquisition had occurred on January 1, 2021. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place on the date indicated or of results that may occur in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma results presented above include the impact of the following adjustments: incremental amortization expense on intangible assets acquired of $3.3&#160;million and $26.3&#160;million for the three months ended March 31, 2022 and 2021, respectively, incremental interest expense, including amortization of debt discount and debt issuance costs, on the Credit Facilities of $0.8&#160;million and $12.6&#160;million for the three months ended March 31, 2022 and 2021, respectively; and a $18.8&#160;million expense related to the increase in fair value of inventory for the three months ended March 31, 2021. In addition, there were non-recurring adjustments directly attributable to the business combination, including acquisition-related cost of $13.5&#160;million for the three months ended March 31, 2021 and adjustments related to the extinguishment of related party loans receivable and payable equal to $81.0&#160;million and $31.0&#160;million for the three months ended March 31, 2022 and 2021, respectively. The unaudited pro forma results include IFRS to U.S. GAAP adjustments for Smiths Medical historical results and adjustments for accounting policy alignment, which were materially similar to the Company. Any differences in accounting policies were adjusted to reflect the accounting policies of the Company in the unaudited pro forma results presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Acquisition&lt;/span&gt;&lt;/div&gt;During November 2021, we acquired a small foreign infusion systems supplier and paid an initial gross cash payment of approximately $15.4&#160;million. In addition to the initial cash consideration, total consideration for the acquisition includes an additional holdback of $0.5&#160;million, to be paid two years from the completion date of the acquisition, and also a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March 31, 2022, the total consideration which includes the acquisition date fair value of the contingent consideration was $17.1&#160;million.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMjE5OTAyMzI5MTQ3NQ_df51bb94-188d-4283-a074-a336868dea78"
      unitRef="number">1.000</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <icui:BusinessCombinationConsiderationTransferredCash
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfNDU3_67561b3a-03de-4ac0-b34e-16ee5f9c9b41"
      unitRef="usd">1900000000</icui:BusinessCombinationConsiderationTransferredCash>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfNDg1_152fee50-3b7b-46a1-9480-f2bebe5d63b7"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfNjEx_df257995-1e34-4357-93e8-823ee4591a89"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <icui:MinimumStockPriceTargetForEarnOutPayment
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzM0Nw_a60198f5-b1c6-4065-971b-f7bc979da013"
      unitRef="usd">300.00</icui:MinimumStockPriceTargetForEarnOutPayment>
    <icui:MinimumStockPriceTargetForEarnOutPayment
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzM1Ng_75baa589-4b06-4e54-99d9-2b08b8fa4831"
      unitRef="usd">300.00</icui:MinimumStockPriceTargetForEarnOutPayment>
    <icui:RequiredShareHoldingOfStockIssuedAtAcquisition
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzM4MQ_45a57194-7035-49da-81d6-e03b105e3abd"
      unitRef="number">0.500</icui:RequiredShareHoldingOfStockIssuedAtAcquisition>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ1NDQwOA_df257995-1e34-4357-93e8-823ee4591a89"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE1NA_2ba0a110-907d-4f2a-9130-a9374a759614">The following table summarizes the preliminary purchase price and the preliminary allocation of the purchase price related to the assets acquired and liabilities assumed (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated cash consideration for acquired assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,922,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preliminary fair value of contingent consideration payable to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of ICU Medical, Inc. common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Price per share (ICU's opening market price on the acquisition date)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of ICU shares issued to Smiths&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated consideration to be paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Preliminary Purchase Price Allocation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,059,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill - not tax deductible&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated Purchase Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Preliminary identifiable intangible assets include $500.0&#160;million of customer relationships, $420.0&#160;million of developed technology, and $5.0&#160;million of trade mark. The estimated weighted-average amortization period for the total identifiable intangible assets is approximately nine years, and, for each identifiable intangible asset is estimated as follows: eight years for customer relationships, ten years for developed technology, and six months for the trade mark. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Preliminary accrued liabilities includes, among other things, accrued warranty reserves, accrued restructuring initiatives, accrued salaries and related benefits, deferred revenue and accrued sales and use taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMS0yLTEtMS04MzI3NA_181805dd-3781-4540-b0e5-083b85c79c34"
      unitRef="usd">53520000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNC0yLTEtMS04MzI2Nw_1b98de30-e654-4aed-b80b-3f8b7c968b57"
      unitRef="shares">2500000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNS0yLTEtMS04MzI3MA_802380c5-f7b1-4aa8-8592-affce38a2d6e"
      unitRef="usdPerShare">230.39</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNi0yLTEtMS04MzI3Mg_d2835194-0bac-4314-b0e8-504c71ccaf3a"
      unitRef="usd">575975000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfNy0yLTEtMS04MzI3Ng_2797d3bc-c144-400e-b488-4a5f356bcd5f"
      unitRef="usd">2552450000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTAtMi0xLTEtODMyNzg_c7ba5276-0f44-4a9e-8cdd-a33491541828"
      unitRef="usd">78791000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTEtMi0xLTEtODMyODA_3b0c9b52-fa5b-43ae-a1bb-5194c141229f"
      unitRef="usd">120497000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTItMi0xLTEtODMyODI_54609cfd-a8c2-45b8-b7c1-4c4e6d67124e"
      unitRef="usd">226996000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTMtMi0xLTEtODMyODQ_ca24f570-d6b3-4130-af6e-cb5441039d34"
      unitRef="usd">34554000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTQtMi0xLTEtODMyODY_526f943b-c626-4026-b457-96b8d689629e"
      unitRef="usd">210000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTUtMi0xLTEtODMyODg_fb01adf1-8c5a-4772-ab0b-df8b02c2dac2"
      unitRef="usd">57225000</icui:BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTYtMi0xLTEtODMyOTA_5ddd5e2c-2ac8-43da-8715-902be9efd2b8"
      unitRef="usd">925000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTctMi0xLTEtODMyOTI_7a436072-16cd-4d6c-8e0c-1f18f57deb8e"
      unitRef="usd">9303000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTgtMi0xLTEtODMyOTQ_e41b01db-27d9-41fc-8c8c-9a4aecb5ab33"
      unitRef="usd">379000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMTktMi0xLTEtODMyOTY_982bc8a0-247c-472b-8554-36cbb7908798"
      unitRef="usd">105291000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjAtMi0xLTEtODMyOTg_7e8045ad-65d9-43f2-a2d1-c0eeb5dfe169"
      unitRef="usd">175098000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjEtMi0xLTEtODMzMDA_028f10fc-edf4-4323-af7c-4d1d1cc56854"
      unitRef="usd">24332000</icui:BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjItMi0xLTEtODMzMDI_8fa25786-7aa2-40b0-88d3-33b34f653819"
      unitRef="usd">85739000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjMtMi0xLTEtODMzMDQ_071509ec-5359-4b8e-8a59-b516498c10a6"
      unitRef="usd">212950000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjQtMi0xLTEtODMzMDY_502bc63f-d89e-4f45-86a5-81347fdccf3b"
      unitRef="usd">1059335000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <icui:BusinessCombinationGoodwillNonDeductible
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjUtMi0xLTEtODMzMTE_55f2d3d9-f95a-464c-96ee-7a21412cf89e"
      unitRef="usd">1493115000</icui:BusinessCombinationGoodwillNonDeductible>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjcxZmE0MzlkMzg1ODRjOTViYWU0YTIxNjBiNDZkMmJjL3RhYmxlcmFuZ2U6NzFmYTQzOWQzODU4NGM5NWJhZTRhMjE2MGI0NmQyYmNfMjYtMi0xLTEtODMzMTM_b612703d-875b-4d76-9453-198bd7bbaeeb"
      unitRef="usd">2552450000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="id513614e0fb644d7b5f9986414615ea1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzA3OA_e36172e7-bbf2-4211-8eca-88a506b56595"
      unitRef="usd">500000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib9c19a0416554eb991a114156f302300_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzA5NA_fe196299-f3b9-4845-aa97-122796b37394"
      unitRef="usd">420000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i3e0f9607f3f64f179b6cf6d4462adc77_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzExMA_6427010d-2844-47a6-916a-4aed2f18d459"
      unitRef="usd">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Revenues
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzEyNA_eb05f855-535c-4dae-900f-a25d2fa03c25"
      unitRef="usd">214900000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE0MA_2344cfda-77f9-499c-8993-d1d3325fc2f8"
      unitRef="usd">40400000</us-gaap:ProfitLoss>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE1NQ_414b78de-55e4-4510-9120-c6baf288df5f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMi0xLTEtMS04MzM0Mw_37784eca-0656-4409-a1ce-ed77faed6b18"
      unitRef="usd">563743000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMi0zLTEtMS04MzM0OQ_12b0c390-692c-4f04-8e8c-e0d7b2232fd4"
      unitRef="usd">594144000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMy0xLTEtMS04MzM1MQ_bc66edc2-e78b-4bfb-a83f-a07927bc0300"
      unitRef="usd">-34994000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RhYmxlOjUyY2NjNDIzZTE1ZjQ5YmJhYjY5MDcxMDRkZjUzMmQyL3RhYmxlcmFuZ2U6NTJjY2M0MjNlMTVmNDliYmFiNjkwNzEwNGRmNTMyZDJfMy0zLTEtMS04MzM1Mw_224f3387-1694-494b-8ed5-7e95a997060e"
      unitRef="usd">-1994000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <icui:ProFormaAdjustmentAmortization
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE1Nw_7e8307c3-1345-4e18-9e6a-9ff7cde80c57"
      unitRef="usd">3300000</icui:ProFormaAdjustmentAmortization>
    <icui:ProFormaAdjustmentAmortization
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE3MQ_0e5fe162-117a-402e-8126-16a39f39a953"
      unitRef="usd">26300000</icui:ProFormaAdjustmentAmortization>
    <icui:ProFormaAdjustmentFinanceCosts
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzE4Ng_0ae874b8-67e0-4b7e-8bd9-4e7c7948a896"
      unitRef="usd">800000</icui:ProFormaAdjustmentFinanceCosts>
    <icui:ProFormaAdjustmentFinanceCosts
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzIwMA_13d7574a-f942-4d7e-b3f0-59a54a88d47d"
      unitRef="usd">12600000</icui:ProFormaAdjustmentFinanceCosts>
    <icui:ProFormaAdjustmentInventory
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI0NQ_4cccac38-7511-4b7c-b4de-316cc23bc3a3"
      unitRef="usd">18800000</icui:ProFormaAdjustmentInventory>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i6bb7b402883540419226d3c255ed0ce0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI1OQ_914b7600-9341-4896-aa3e-85605b761ddf"
      unitRef="usd">13500000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <icui:ProFormaAdjustmentRelatedPartyLoans
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzIxNQ_82930ed9-2de4-49b7-a050-41b3b54954f6"
      unitRef="usd">81000000</icui:ProFormaAdjustmentRelatedPartyLoans>
    <icui:ProFormaAdjustmentRelatedPartyLoans
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzIzMA_63d12b5f-32e9-4b3a-afc7-b5a690809f72"
      unitRef="usd">31000000</icui:ProFormaAdjustmentRelatedPartyLoans>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTQ1NA_6b4c85c3-ffb7-4bda-825e-e8298df6436a"
      unitRef="usd">15400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <icui:BusinessCombinationConsiderationHoldbackLiability
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3NzMyMA_53350510-0360-4b90-a193-ee14041e935c"
      unitRef="usd">500000</icui:BusinessCombinationConsiderationHoldbackLiability>
    <icui:Contingentconsiderationgross
      contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTQ4Mg_e5d004d0-089a-45c5-a2c3-1dc8c3670d9d"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTUwOQ_95ab2223-8b08-4c26-a98c-e0d307b40d8b"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTY0OTI2NzQ3MTUzNg_a485c9e3-9c4e-4ffd-acb2-10b61373296b"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV85MS9mcmFnOjI0Yzk3MjVjMThiMjRjZThiZWJkYjZmZmYzMzZmYzAwL3RleHRyZWdpb246MjRjOTcyNWMxOGIyNGNlOGJlYmRiNmZmZjMzNmZjMDBfMTA5OTUxMTY3MzI2MQ_a0e022d3-5500-4d4d-9278-3d23125b8e39"
      unitRef="usd">17100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMjgzNA_62ae63d3-0e54-4f7e-b5c8-9cebcc439ce5">Restructuring, Strategic Transaction and Integration&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Restructuring, strategic transaction and integration expenses were $33.9 million and $2.9 million for the three months ended March 31, 2022 and 2021, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended March 31, 2022, restructuring charges were $3.2&#160;million and were related to severance costs. Restructuring charges during the three months ended March 31, 2021 were not material.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Balance&lt;br/&gt;January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Acquired Restructuring Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Charges&lt;br/&gt;Incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Currency &lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Balance&lt;br/&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance pay and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility closure expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Strategic Transaction and Integration Expenses&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;We incurred and expensed $30.7 million and $2.9 million in strategic transaction and integration expenses during the three months ended March 31, 2022 and 2021, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three months ended March 31, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 (see Note 3: Acquisitions) which primarily included legal expenses, bank fees, a United Kingdom stamp tax and employee costs. The strategic transaction and integration expenses for the three months ended March 31, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTM3_772855e5-2615-44ca-b426-9a1af396916d"
      unitRef="usd">33900000</icui:Restructuringstrategictransactionandintegration>
    <icui:Restructuringstrategictransactionandintegration
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTY0OTI2NzQ0NDUxMA_f6221196-f3ad-4757-9d88-25bb0b7edc4e"
      unitRef="usd">2900000</icui:Restructuringstrategictransactionandintegration>
    <us-gaap:RestructuringCosts
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfNjcz_89662d79-c2a8-4a70-bd7e-af98a5ee5a25"
      unitRef="usd">3200000</us-gaap:RestructuringCosts>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMjg0Mg_2b6d94d2-7189-45c0-b531-e37990df7ba1">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.041%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Balance&lt;br/&gt;January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Acquired Restructuring Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Charges&lt;br/&gt;Incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Currency &lt;br/&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Balance&lt;br/&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance pay and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility closure expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i31bdd76ac7d94b7da503fd63b93ae400_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0xLTEtMS0yMzM5OQ_5fb7a51f-cf46-45cc-8be1-385f631e9353"
      unitRef="usd">499000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities
      contextRef="i7330ec69856e4bedab9881611ec4c66f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0zLTEtMS04Mzk3OQ_16fc140f-618a-4800-b2c8-9715ae5de449"
      unitRef="usd">5796000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities>
    <us-gaap:RestructuringCharges
      contextRef="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0zLTEtMS0yMzM5OQ_ae5d1006-6792-4acf-8b96-246132d70691"
      unitRef="usd">3222000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS01LTEtMS0yMzM5OQ_315f2a5b-4d56-45d4-8be0-a24dcc00ae55"
      unitRef="usd">2030000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i9b36d2757d1f4ea0bec51dc0ee246a6a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS03LTEtMS0yMzM5OQ_72272bb4-0ea2-4f24-ba80-34b99bfca905"
      unitRef="usd">147000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i7330ec69856e4bedab9881611ec4c66f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMS0xMS0xLTEtMjMzOTk_85dfcbea-3658-4f65-9504-0ad8669256b1"
      unitRef="usd">7340000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idced1370c58d496699456e82e999c739_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0xLTEtMS0yMzM5OQ_02f92040-4cdd-4963-b15e-41fd07b1eb82"
      unitRef="usd">165000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities
      contextRef="ie4421707804146808e8d82bd497823f1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0zLTEtMS04Mzk4Ng_46ac9ba0-368e-4a8f-ba83-d7871e494a77"
      unitRef="usd">1740000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities>
    <us-gaap:RestructuringCharges
      contextRef="id248bc190fef460ab54156ad628a9a09_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0zLTEtMS0yMzM5OQ_75482fc1-dc9a-4db6-9168-02c413d4dab1"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="id248bc190fef460ab54156ad628a9a09_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy01LTEtMS0yMzM5OQ_45807a4e-2437-4e41-8ba3-f7a4f3decd44"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="id248bc190fef460ab54156ad628a9a09_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy03LTEtMS0yMzM5OQ_e9211f30-f7db-4999-9efc-c733ae0306f0"
      unitRef="usd">40000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="ie4421707804146808e8d82bd497823f1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfMy0xMS0xLTEtMjMzOTk_57cbe14a-07d7-4e99-b169-8d350c62f157"
      unitRef="usd">1865000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0xLTEtMS0yMzM5OQ_3d61e44a-c319-4664-ab4d-365d728e80c3"
      unitRef="usd">664000</us-gaap:RestructuringReserve>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0zLTEtMS04NDI4Mg_461b3893-8b5c-4849-aed2-bbc49716adcd"
      unitRef="usd">7536000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities>
    <us-gaap:RestructuringCharges
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0zLTEtMS0yMzM5OQ_abd0e571-f8eb-4f61-94f9-a0ea776cbebb"
      unitRef="usd">3222000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC01LTEtMS0yMzM5OQ_0c005458-b4d0-4603-97c4-1cf742afe906"
      unitRef="usd">2030000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC03LTEtMS0yMzM5OQ_0c5e5624-077e-495e-bf1d-49482b7c7d64"
      unitRef="usd">187000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RhYmxlOmRjOTU3MThjMWQzYzRkOWRhZGMwOTg4M2EzNDIzMjdkL3RhYmxlcmFuZ2U6ZGM5NTcxOGMxZDNjNGQ5ZGFkYzA5ODgzYTM0MjMyN2RfNC0xMS0xLTEtMjMzOTk_415ed4b6-b625-4b6b-8805-50f0f926f234"
      unitRef="usd">9205000</us-gaap:RestructuringReserve>
    <icui:StrategicTransactionandIntegration
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTU2MQ_fe2a0716-a130-4425-90fc-88b7fae12cce"
      unitRef="usd">30700000</icui:StrategicTransactionandIntegration>
    <icui:StrategicTransactionandIntegration
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80MC9mcmFnOmUzNzk4MzdhMWY1YzQwYzRhOWM1MDZlNzFkYTNhNzIyL3RleHRyZWdpb246ZTM3OTgzN2ExZjVjNDBjNGE5YzUwNmU3MWRhM2E3MjJfMTY5NQ_fba94c5e-ac10-493c-9e27-02cb43e42e0d"
      unitRef="usd">2900000</icui:StrategicTransactionandIntegration>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RleHRyZWdpb246YjE1MmM3NjJiODI1NGQ3Njg4NmQxMDFkZTE4Y2M2MDVfMzMyNA_acc53ce4-cc1d-4e6e-a97c-ca2c3e090ba1">Revenue&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Following our acquisition of Smiths Medical, our primary product lines are Infusion Consumables, Infusion Systems, IV Solutions, Critical Care, Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical. The vast majority of our sales of these products are made on a stand-alone basis to hospitals and distributors. Revenue is typically recognized upon transfer of control of the products, which we deem to be at point of shipment. However, for purposes of revenue recognition for our software licenses and renewals, we consider the control of these products to be transferred to a customer at a certain point in time; therefore, we recognize revenue at the start of the applicable license term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Payment is typically due in full within 30 days of delivery or the start of the contract term.  Revenue is recorded in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We offer certain volume-based rebates to our distribution customers, which we record as variable consideration when calculating the transaction price. Rebates are offered on both a fixed and tiered/variable basis. In both cases, we use information available at the time and our historical experience with each customer to estimate the most likely rebate amount. We also provide chargebacks to distributors that sell to end customers at prices determined under a contract between us and the end customer. Chargebacks are the difference between the prices we charge our distribution customers and the contracted prices we have with the end customer which are processed as credits to our distribution customers. In estimating the expected value of chargeback amounts in order to determine the transaction price, we use information available at the time, including our historical experience.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;We also warranty products against defects and have a policy permitting the return of defective products, for which we accrue and expense at the time of sale using information available at that time and our historical experience. We also provide for extended service-type warranties, which we consider to be separate performance obligations. We allocate a portion of the transaction price to the extended service-type warranty based on its estimated relative selling price, and recognize revenue over &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the period the warranty service is provided. Our revenues are recorded at the net sales price, which includes an estimate for variable consideration related to rebates, chargebacks and product returns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue disaggregated&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents our revenues disaggregated by product line (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Product line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Consumables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Critical Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Infusion Systems-Smiths Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vascular Access-Smiths Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vital Care-Smiths Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Infusion Systems-Smiths Medical, Vascular Access-Smiths Medical and Vital Care-Smiths Medical represent our newly integrated product lines following our acquisition of Smiths Medical on January 6, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table represents our revenues disaggregated by geography (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the changes in our contract balances for the three months ended March 31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of acquired deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of March 31, 2022, revenue from remaining performance obligations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Recognition Timing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&amp;lt; 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&amp;gt; 12 Months&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Other deferred revenue includes pump development programs, purchased training and extended warranty.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:Revenues
      contextRef="i2b01fe971840481cbc0118ca73113ed3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMi0xLTEtMS04MzEyOA_40dc05e8-0786-4dba-a9a8-df2d7792b2c3"
      unitRef="usd">140521000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic31670f3190f4250afa50c949a969ee7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMi0zLTEtMS04MzEzMw_60cd8eb9-ad10-4ee1-8f0e-157b5f13f416"
      unitRef="usd">126370000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic6940ef2009e4c4896a32c8c4aaf68d6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMy0xLTEtMS04MzEzMQ_f65cccb0-11a5-4964-9a22-c9569bfad6f0"
      unitRef="usd">87012000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i82d850d6caf542d5bb4c6d576c8debea_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfMy0zLTEtMS04MzEzMw_14e8f2ce-16a7-4e0d-a86e-06544e41bef1"
      unitRef="usd">84334000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05a0e8abbc6647928fbf299a5ca9c5bc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNC0xLTEtMS04MzEzMQ_d612b1ce-1094-4a60-8624-31ecee1be940"
      unitRef="usd">88480000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icca9ac7dfc3a4aa489ff4d89527fdae9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNC0zLTEtMS04MzEzMw_9aa238c1-9adf-4740-b994-03c1dafca09b"
      unitRef="usd">94176000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic80e0a0251974b428f96f3f717f4d8c6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNS0xLTEtMS04MzEzMQ_cee7db62-213e-414f-9198-3c3ae3e1b5c9"
      unitRef="usd">12157000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i677c8e8ff77c48aa8ce2231709909edf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNS0zLTEtMS04MzEzMw_9902a678-8d3b-4566-88bf-dc28109f24af"
      unitRef="usd">13166000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c2efe33dc8d4acd88c30e7d87d93647_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNi0xLTEtMS04MzEzMQ_e2b05fb4-f435-4bf5-80cc-c301af4cfce7"
      unitRef="usd">66290000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60182e4c96d44b05a31dbc6f360895df_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNi0zLTEtMS04MzEzMw_31f8706a-12ae-4f2d-89f3-ec0c7aea9fa1"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i910b191cc2064df1a370ea5673a067f8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNy0xLTEtMS04MzEzMQ_0a858e39-a9ac-4c84-8218-8ef253f7b352"
      unitRef="usd">79008000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99f317b22200400aa27ba28ee92de705_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfNy0zLTEtMS04MzEzMw_d48b8a67-c9c1-4614-8ccf-88d8dede9d24"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fa0894a784543158f3f2b1d7c4de28c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOC0xLTEtMS04MzEzMQ_ae3d6a76-5bb2-4ffc-b62e-5634e4a6d192"
      unitRef="usd">69654000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica2afa04d4254f6bb80cb6e3672895e9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOC0zLTEtMS04MzEzMw_8036b460-14c4-4b9e-b441-846d11505e3a"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOS0xLTEtMS04MzEzMQ_386255d7-daf3-4139-a7d8-54a833cc6060"
      unitRef="usd">543122000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmRjY2Q0YTdmOGY1NTRlM2VhMWY2Y2ZlZmIyNjhmY2NiL3RhYmxlcmFuZ2U6ZGNjZDRhN2Y4ZjU1NGUzZWExZjZjZmVmYjI2OGZjY2JfOS0zLTEtMS04MzEzMw_8926fd47-1c05-41d7-92b9-e668d15e4163"
      unitRef="usd">318046000</us-gaap:Revenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RleHRyZWdpb246YjE1MmM3NjJiODI1NGQ3Njg4NmQxMDFkZTE4Y2M2MDVfMzMyNg_a40c2172-49de-4853-b5ea-d21666ce61b3">The following table represents our revenues disaggregated by geography (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geography&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i15c0bb3aed1b4706bc6fac56eab2c4cd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfMi0xLTEtMS0yMzM5OQ_1f6c808b-c281-42bb-8370-ccf9394d9a4f"
      unitRef="usd">86204000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i38ee104e0e7f45abbbb082a302c3fd84_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfMi0zLTEtMS0yMzM5OQ_c9d809e4-398d-4c4c-a882-c1f54649929d"
      unitRef="usd">34800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0b4f448345b34a609c7840e89139cedb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNi0xLTEtMS0yMzM5OQ_0e439acd-1439-4640-bdae-cafe4f2661e0"
      unitRef="usd">109127000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if6ffb2785f52491bb1b6d09817f187a4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNi0zLTEtMS0yMzM5OQ_eee8e11d-be24-4095-b112-46aa2c4aaa69"
      unitRef="usd">55895000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5f91818e98e47c78b2642f077b41076_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNy0xLTEtMS0yMzM5OQ_cf6f63f4-e480-4658-923f-b39a4fc78918"
      unitRef="usd">195331000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id6b42d6a2aae43fb9961ff4e802256f1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfNy0zLTEtMS0yMzM5OQ_40d05e28-f372-48d6-bc32-04d988fa639a"
      unitRef="usd">90695000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib52844df4caf4174aa01d6d15e5ce18a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOC0xLTEtMS0yMzM5OQ_aba0d283-709c-4616-95af-ccc1d88ed42f"
      unitRef="usd">347791000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06dca36adccb4e6aa29a97ea62498b09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOC0zLTEtMS0yMzM5OQ_cdd26749-c5cd-4b49-a88e-299895dd261b"
      unitRef="usd">227351000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOS0xLTEtMS0yMzM5OQ_1f85bb72-2c94-47e6-98fb-51bd5a1dd211"
      unitRef="usd">543122000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmI2N2E5MmVmMWU0NjRhYmRhMTg4NzQ4ZDc1NDliMjQwL3RhYmxlcmFuZ2U6YjY3YTkyZWYxZTQ2NGFiZGExODg3NDhkNzU0OWIyNDBfOS0zLTEtMS0yMzM5OQ_108f4e5f-5c4b-4788-a74d-8d310dece1b5"
      unitRef="usd">318046000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RleHRyZWdpb246YjE1MmM3NjJiODI1NGQ3Njg4NmQxMDFkZTE4Y2M2MDVfMzMzMg_a6548c83-825d-4692-b9f5-7f076558ee6a">The following table presents the changes in our contract balances for the three months ended March 31, 2022 and 2021 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of acquired deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,777)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grant recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other deferred revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,921)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software revenue deferred due to implementation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMS0xLTEtMS0yMzM5OQ_eefb4029-bc4e-4394-bfcb-e6674b1e40b6"
      unitRef="usd">7461000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i461675ccf5e5457c93bc148a02ebef8f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMi0xLTEtMS04MTA5OA_7e1c2971-cd3e-4497-b7ba-f3249fc43641"
      unitRef="usd">51245000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i94c6563557f14f0fa17a7b159d6942ec_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMi0xLTEtMS0yMzM5OQ_d574f580-bb79-4415-987a-9f84b0fa1214"
      unitRef="usd">-5574000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i94c6563557f14f0fa17a7b159d6942ec_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMy0xLTEtMS0yMzM5OQ_7600c79a-c037-4844-85ba-836dedf17108"
      unitRef="usd">3447000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ic115301640614d36b47d9f6973156033_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNC0xLTEtMS0yMzM5OQ_7f6d8c58-d20f-40ba-9f6a-ab13bd8ab059"
      unitRef="usd">-4299000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="ic115301640614d36b47d9f6973156033_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNS0xLTEtMS0yMzM5OQ_28438e1a-5a3f-4606-9679-567ef5199a0d"
      unitRef="usd">4777000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i31ba1716c4654d44b41229c3a3ba3502_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNy0xLTEtMS04MTI1Nw_12cb65cc-a1f8-4eb9-a99f-1362b07c308a"
      unitRef="usd">2266000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i31ba1716c4654d44b41229c3a3ba3502_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOC0xLTEtMS04MTI2OQ_4a1d6990-5f78-4eec-8aa6-7de941dbdc7f"
      unitRef="usd">-171000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="ica6df5554552455890bb3e503c4ecaf7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOS0xLTEtMS04MTI4OQ_00299f29-7c20-45ef-b4c3-2b89bbe9a03f"
      unitRef="usd">767000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ica6df5554552455890bb3e503c4ecaf7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTAtMS0xLTEtODEyOTY_e1467b11-14bd-442a-a079-0ea569781efe"
      unitRef="usd">-1683000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfNi0xLTEtMS0yMzM5OQ_cafe84c3-efa9-4b66-9d57-fd0d8bd99344"
      unitRef="usd">58236000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOC0xLTEtMS0yMzM5OQ_f16a8104-4b10-4da6-a3f0-3b6bf7eb2ba3"
      unitRef="usd">6430000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i10d0c665e84f4c42842d8354c9c251b1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfOS0xLTEtMS0yMzM5OQ_bf7862e7-6ed6-431f-87f0-c947c76c41ec"
      unitRef="usd">-461000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="i10d0c665e84f4c42842d8354c9c251b1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTAtMS0xLTEtMjMzOTk_b4cc4456-fb84-4caa-ac77-dc9cea8d1650"
      unitRef="usd">2921000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ice75ec9db3e341b6aef90d3334be1eb0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTEtMS0xLTEtMjMzOTk_28f12a81-b9f9-4f9c-a289-effbdaa522ec"
      unitRef="usd">-1796000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:DeferredRevenueAdditions
      contextRef="ice75ec9db3e341b6aef90d3334be1eb0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTItMS0xLTEtMjMzOTk_8783e9c8-83df-412e-a511-c65b63d4f8f4"
      unitRef="usd">1794000</us-gaap:DeferredRevenueAdditions>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOmZmZmQ1ZjhjZDVmNDQ5Yzg4ZTdmYmEyNTllYmU1MDk0L3RhYmxlcmFuZ2U6ZmZmZDVmOGNkNWY0NDljODhlN2ZiYTI1OWViZTUwOTRfMTMtMS0xLTEtMjMzOTk_cedcd825-a864-4558-84f2-18d1c835e2d3"
      unitRef="usd">8888000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i67d2154781164924b275843b993212d9_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMi0xLTEtMS04MjQ5Nw_2ef70f3c-86ad-41b5-8372-0cba0accb962"
      unitRef="usd">24100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ieffb1189d545486bb1d18d7d6120aa94_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMi0zLTEtMS04MzE1Mw_9a995d4e-7b47-48b8-8c0c-57b8b077219f"
      unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i747977f101ff4d60a6662e14aeccca04_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMy0xLTEtMS04MjQ5NA_709cc06f-5369-4300-888f-e5f43fefd23c"
      unitRef="usd">7700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id9e71644be0d416286bfb1eca80a5bed_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfMy0zLTEtMS04MzE1Mw_3efd7fe6-a972-4bd6-8d4e-022a0ab617e4"
      unitRef="usd">2600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="iaaa7a333a6924010b053423c65083d92_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNC0xLTEtMS04MzE0Nw_865aafd3-443f-4fd8-98a3-8b59f9433831"
      unitRef="usd">1300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i590611035a394a67b144447f0765cc48_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNC0zLTEtMS04MzE1Mw_605501a7-e1fa-46f1-8056-444b295abd24"
      unitRef="usd">12800000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i66742bd27a76437d802c35ce2d1bb3f2_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNS0xLTEtMS04MzE0Nw_39fa94c0-e8e7-46ff-bd19-979c8b1b7da9"
      unitRef="usd">2100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6c8dc12807f14595a91b904cd714ee48_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNS0zLTEtMS04MzE1Mw_2fde12a0-34a6-45f8-b826-5b7bd89995e6"
      unitRef="usd">7600000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ic2dd7ec8ea2a4048a06ea268924bf23a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNi0xLTEtMS04MzE0Nw_c77f6531-6cdb-41be-8b3c-d9fab8079925"
      unitRef="usd">35200000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="if5b1cec7abee4f76b35a418a82f45396_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80My9mcmFnOmIxNTJjNzYyYjgyNTRkNzY4ODZkMTAxZGUxOGNjNjA1L3RhYmxlOjQ1YzkwNmViYzdlYzQ1MWQ5YmQ4OTY4ZTM4MzY1YzY5L3RhYmxlcmFuZ2U6NDVjOTA2ZWJjN2VjNDUxZDliZDg5NjhlMzgzNjVjNjlfNi0zLTEtMS04MzE1Mw_1d1eb42e-26fb-44dd-9094-74270fd8becd"
      unitRef="usd">23000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc4OQ_f64cd80a-a7d2-454a-a8a8-8ee32f2ad8b1">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Our operating lease assets are separately stated in operating lease right-of-use ("ROU") assets and our financing lease assets are included in other assets on our condensed consolidated balance sheets. Our lease liabilities are included in accrued liabilities, and other long-term liabilities on our condensed consolidated balance sheets. We have elected not to recognize an ROU asset and lease liability for leases with terms of twelve months or less.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Lease ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Most of our leases do not provide an implicit rate, therefore we use our incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term based on the information available at commencement date. Our lease ROU assets exclude lease incentives and initial direct costs incurred. Our lease terms include options to extend when it is reasonably certain that we will exercise that option. All of our leases have &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;stated lease payments, which may include fixed rental increases. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our leases are for corporate, research and development and sales and support offices, distribution facilities, device service centers and certain equipment. Our leases have original lease terms of one year to fifteen years, some of which include options to extend the leases for up to an additional five years. For all of our leases, we do not include optional periods of extension in our current lease terms for the exercise of options to extend is not reasonably certain.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on our finance leases is included in other income (expense), net in our condensed consolidated statements of operations. The reduction of the operating and finance ROU assets is included as noncash lease expense in selling, general and administrative expenses in our condensed consolidated statements of operations.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,847&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,786&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i8646fd65464c418fae83a8e61e4c8e4b_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMTUzNg_b1c47139-ec37-43ca-ab79-8353480edbe0">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <icui:Optiontoextendinyears
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMTYxNQ_a99a23b1-4ce9-41dc-a2af-aa24bb629c66">P5Y</icui:Optiontoextendinyears>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc5Nw_345be884-a828-4a51-950b-f370773687df">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of our lease cost (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost &#x2014; reduction of ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMi0xLTEtMS0yMzM5OQ_69fb02c5-b413-44a0-8dbd-640dfd4bcd53"
      unitRef="usd">5178000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMi0zLTEtMS0yMzM5OQ_d3bc3b59-9eb1-4ab3-96e9-5211ceaab2c2"
      unitRef="usd">2835000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNC0xLTEtMS0yMzM5OQ_471d7d60-4214-4ba4-8b18-d1a572a491ba"
      unitRef="usd">29000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNC0zLTEtMS0yMzM5OQ_d5b91a9b-dea2-4975-bcca-2c1f441f7e9d"
      unitRef="usd">31000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNi0xLTEtMS0yMzM5OQ_0c0a830c-ec29-4e7e-81e0-276cb537718d"
      unitRef="usd">170000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfNi0zLTEtMS0yMzM5OQ_7d4a2215-49e0-4252-8f35-67fd81bff0dc"
      unitRef="usd">151000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:ShortTermLeaseCost
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfOC0xLTEtMS0yMzM5OQ_76a08417-26ad-49c5-b885-372af069f729"
      unitRef="usd">3000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfOC0zLTEtMS0yMzM5OQ_83e17a58-3392-41a9-a9c7-ed452879a3b9"
      unitRef="usd">3000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMTItMS0xLTEtMjMzOTk_3604a48f-146a-4683-b463-fb6c594eb275"
      unitRef="usd">5380000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjczMThjZmU2MjdhYjQ2YmU5ODQ2NDRmYjFlMTVhNGZiL3RhYmxlcmFuZ2U6NzMxOGNmZTYyN2FiNDZiZTk4NDY0NGZiMWUxNWE0ZmJfMTItMy0xLTEtMjMzOTk_a63dfc14-77b1-4921-9001-763f870dd3df"
      unitRef="usd">3020000</us-gaap:LeaseCost>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc5MQ_fbb9351b-c126-483e-bc9b-68b1ee12a555">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental cash flow information related to our leases (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfMy0xLTEtMS0yMzM5OQ_4bf075f5-8695-4ce0-b939-99840f644130"
      unitRef="usd">6548000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfMy0zLTEtMS0yMzM5OQ_5ecc1aea-e107-44a4-a232-6a36c0c0fb92"
      unitRef="usd">2821000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNC0xLTEtMS0yMzM5OQ_4d61fc76-63d9-46bb-b1b0-3d9c1eda5986"
      unitRef="usd">29000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNC0zLTEtMS0yMzM5OQ_b37b1485-cabd-4cde-950e-7078be95e5e8"
      unitRef="usd">31000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNy0xLTEtMS0yMzM5OQ_78e018c8-9aa9-4525-9218-327d42749456"
      unitRef="usd">1493000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfNy0zLTEtMS0yMzM5OQ_ca8a6739-ecf1-4f1e-88dd-75a5ace9f970"
      unitRef="usd">1095000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfOC0xLTEtMS0yMzM5OQ_ddf271f7-e297-45d9-998a-dea13e55902e"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjA1ZTg1ZDRmOTEwNzRjYWU4MThkMzI0ODMyMDhiYzRmL3RhYmxlcmFuZ2U6MDVlODVkNGY5MTA3NGNhZTgxOGQzMjQ4MzIwOGJjNGZfOC0zLTEtMS0yMzM5OQ_96625c64-aed2-4671-81a5-e68bbfa11a97"
      unitRef="usd">184000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <icui:AssetsandLiabilitiesLeasesTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjgwMA_87704c09-d761-4db5-a10b-44595ab1f4c7">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our operating leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,847&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,786&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,391&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,980&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the supplemental balance sheet information related to our finance leases (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:AssetsandLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMi0xLTEtMS0yMzM5OQ_e376585a-6b59-4fbf-9bce-64eabb1c0a85"
      unitRef="usd">92027000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMi0zLTEtMS0yMzM5OQ_e190b40d-381b-497a-babf-ae03f3fe2642"
      unitRef="usd">39847000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNC0xLTEtMS0yMzM5OQ_920d74e3-0359-4397-a215-cb05f4be0e0a"
      unitRef="usd">20786000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNC0zLTEtMS0yMzM5OQ_5bdbb41d-1665-434d-a580-f53ca321eb4b"
      unitRef="usd">9009000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNS0xLTEtMS0yMzM5OQ_4d6081ef-358c-4f7a-8b9c-0ee08147ad05"
      unitRef="usd">73391000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNS0zLTEtMS0yMzM5OQ_49394f29-d90e-4e2d-b9b0-5fad47dbe982"
      unitRef="usd">33971000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNi0xLTEtMS0yMzM5OQ_8e4e24ad-53ce-4c53-bbbe-a5b42cc0d2e7"
      unitRef="usd">94177000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfNi0zLTEtMS0yMzM5OQ_345f80b9-cd40-487e-9467-d910a77913be"
      unitRef="usd">42980000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfOS0xLTEtMS0yMzM5OQ_bddd6176-34ef-4f5a-a034-bb7227bf3f23">P6Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfOS0zLTEtMS0yMzM5OQ_a1f38bb1-646a-4581-a635-6b0d22b55daf">P5Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMTItMS0xLTEtMjMzOTk_68ec5617-132f-46da-8f93-349e4be40791"
      unitRef="number">0.0406</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjM5ZTFkMGQwOWRlMjRlNmM5ZWYxMTVjNDczNGIzMDU5L3RhYmxlcmFuZ2U6MzllMWQwZDA5ZGUyNGU2YzllZjExNWM0NzM0YjMwNTlfMTItMy0xLTEtMjMzOTk_765b009b-b4c8-4cd5-bc4d-597f65783cd1"
      unitRef="number">0.0498</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMi0xLTEtMS0yMzM5OQ_73dd0add-c2ad-442e-8649-88491506f0d5"
      unitRef="usd">2545000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMi0zLTEtMS0yMzM5OQ_da716474-4f82-454c-8dfd-fde0c4b45724"
      unitRef="usd">2673000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNC0xLTEtMS0yMzM5OQ_282d04d6-27b1-467d-a591-17c7d3f5e6ba"
      unitRef="usd">669000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNC0zLTEtMS0yMzM5OQ_613b5616-ad3a-4598-a353-2874dc320c30"
      unitRef="usd">643000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNS0xLTEtMS0yMzM5OQ_fe49c5dc-66b5-4a89-bf05-5f80737d5604"
      unitRef="usd">1923000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNS0zLTEtMS0yMzM5OQ_76146ae9-65d7-47c3-80df-f10f6ab8d800"
      unitRef="usd">2067000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNi0xLTEtMS0yMzM5OQ_ba1cc55d-3810-4f6f-9389-019d8ceb6ee0"
      unitRef="usd">2592000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfNi0zLTEtMS0yMzM5OQ_3ffad43e-6fac-4a16-9ac2-09e344c54cdc"
      unitRef="usd">2710000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfOS0xLTEtMS0yMzM5OQ_5335968c-3bca-417e-9a9b-010f1105c87f">P5Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfOS0zLTEtMS0yMzM5OQ_e729b08a-9c6b-4e0c-9fa3-3a3cc6014531">P5Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMTItMS0xLTEtMjMzOTk_2ee22b7f-b4b6-4fa8-97a5-0025980baf59"
      unitRef="number">0.0428</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOjRlNjJlMTRiNTY2NTQ4OGQ4ODgxOTg4NDY2NjhhZDY3L3RhYmxlcmFuZ2U6NGU2MmUxNGI1NjY1NDg4ZDg4ODE5ODg0NjY2OGFkNjdfMTItMy0xLTEtMjMzOTk_7e60268c-b1ca-4846-bf8e-0090ffd214c8"
      unitRef="number">0.0428</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RleHRyZWdpb246NmRjNzY4YmY3YWQ3NDMyOWE1ZjJkMmJlOTU1ZmM3ODBfMjc5NQ_904fa11b-f72a-4b1b-8b4a-da0cd74ca173">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2022, the maturities of our operating and finance lease liabilities for each of the next five years are approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMS0xLTEtMS0yMzM5OQ_4c36bf70-4ee3-44ec-a9bf-92b429c9e7fc"
      unitRef="usd">18934000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMS0zLTEtMS0yMzM5OQ_a4bc9b1c-fbc4-462b-aadf-c417d71c13e4"
      unitRef="usd">577000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMi0xLTEtMS0yMzM5OQ_7647cdb2-94e1-4051-b639-30ecb015d3bc"
      unitRef="usd">20911000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMi0zLTEtMS0yMzM5OQ_295fbfdc-9e69-462f-97be-e61fd40bd094"
      unitRef="usd">770000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMy0xLTEtMS0yMzM5OQ_f7206f07-cfcd-4c85-9315-09a0f8ee7325"
      unitRef="usd">17106000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMy0zLTEtMS0yMzM5OQ_84913190-6f2d-485f-9a07-b1ec8d17efef"
      unitRef="usd">464000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNC0xLTEtMS0yMzM5OQ_98af8bb2-58a0-4768-b14e-92e334ee1c7c"
      unitRef="usd">12481000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNC0zLTEtMS0yMzM5OQ_a8c14ab8-1d14-4e80-9ba2-d99ee0a6e6de"
      unitRef="usd">267000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNS0xLTEtMS0yMzM5OQ_b527685b-4b34-49b6-aa75-061110407e61"
      unitRef="usd">11121000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNS0zLTEtMS0yMzM5OQ_a89a3e1c-fc39-4ea5-bbbb-b834b582e553"
      unitRef="usd">213000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNi0xLTEtMS0yMzM5OQ_a1d99bf9-cd29-4df5-ba11-c5ecf8e17ccf"
      unitRef="usd">7839000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNi0zLTEtMS0yMzM5OQ_5230eeeb-ba07-46c7-a98e-271b3938b0c1"
      unitRef="usd">189000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNy0xLTEtMS0yMzM5OQ_a923b01d-6e21-490e-9b3f-6e4f52c06b46"
      unitRef="usd">18121000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfNy0zLTEtMS0yMzM5OQ_fcde7786-3d67-4b04-83af-cb6b0def28cd"
      unitRef="usd">426000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOC0xLTEtMS0yMzM5OQ_6f4d0931-e196-4fa5-b68f-d62fbdbeeda9"
      unitRef="usd">106513000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOC0zLTEtMS0yMzM5OQ_12a40c52-1a20-41f7-bc49-e5efaef3d64e"
      unitRef="usd">2906000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOS0xLTEtMS0yMzM5OQ_30fb9752-7e83-407d-9cae-ae382dbbfc9c"
      unitRef="usd">12336000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfOS0zLTEtMS0yMzM5OQ_c5013e13-c7d0-465b-9ed6-12fe7b96a8d4"
      unitRef="usd">314000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMTAtMS0xLTEtMjMzOTk_c492ddbe-02a7-4232-b894-b7e425fba1d5"
      unitRef="usd">94177000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80Ni9mcmFnOjZkYzc2OGJmN2FkNzQzMjlhNWYyZDJiZTk1NWZjNzgwL3RhYmxlOmZhNDcwZThmNDZlYTRkZDlhNzFiNmExNDhiOGQ2YjgwL3RhYmxlcmFuZ2U6ZmE0NzBlOGY0NmVhNGRkOWE3MWI2YTE0OGI4ZDZiODBfMTAtMy0xLTEtMjMzOTk_646de9e5-79e3-4502-984e-17763181e111"
      unitRef="usd">2592000</us-gaap:FinanceLeaseLiability>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfMTA2Nw_33f93164-5589-47d9-b5d1-545a90513b54">Net Income Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period plus dilutive securities. Dilutive securities include outstanding common stock options and unvested restricted stock units, less the number of shares that could have been purchased with the proceeds from the exercise of the options, using the treasury stock method. Options and restricted stock units that are anti-dilutive are not included in the treasury stock method calculation. Due to the net loss for the three months ended March 31, 2022, any potentially common shares were not included in the computation of diluted earnings per share as they would have had an anti-dilutive effect, therefore basic and diluted net loss per share are equal for the period. There were nil and 12,080 anti-dilutive securities for the three months ended March&#160;31, 2022 and March 31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No dilutive effect for the three months ended March 31, 2022;  therefore, zero incremental shares included for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfNzEy_b9a4f335-621b-4460-b1be-69e2623836dc"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfNzE5_1d6e8e13-2ac9-479c-a3b8-1deb2f7ae2d8"
      unitRef="shares">12080</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RleHRyZWdpb246MWNhYThjNjFjZWMzNDQ0NzkyN2Y2NTg2OWU0NzgwZWFfMTA3Mw_479232cd-e50d-4d4a-a82c-a799096c7935">The following table presents the calculation of net earnings per common share (&#x201c;EPS&#x201d;) &#x2014; basic and diluted (in thousands, except per share data):&#160; &lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding (basic)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common and common equivalent shares outstanding (diluted)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EPS &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No dilutive effect for the three months ended March 31, 2022;  therefore, zero incremental shares included for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMi0xLTEtMS0yMzM5OQ_e30f038c-4e60-420c-9b66-1ae118369f42"
      unitRef="usd">-38068000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMi0zLTEtMS0yMzM5OQ_bc2f94f8-f61e-47b9-a2f5-451ae607ddb1"
      unitRef="usd">23731000</us-gaap:ProfitLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMy0xLTEtMS0yMzM5OQ_2f69072f-b445-4602-8c3d-ea4a700ac797"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfMy0zLTEtMS0yMzM5OQ_6e80a370-1273-4167-8f19-35ac97d3fdd3"
      unitRef="shares">21149000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNC0xLTEtMS0yMzM5OQ_6f3c3278-2c49-40a5-8fed-b46413215cb6"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNC0zLTEtMS0yMzM5OQ_4ed15e00-dc35-4c32-8479-156eed48a518"
      unitRef="shares">546000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNS0xLTEtMS0yMzM5OQ_9449efea-7c2e-47a4-8893-256729786cd2"
      unitRef="shares">23646000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNS0zLTEtMS0yMzM5OQ_47f4b78a-5d8b-4ded-996e-f6fdf8a67b1a"
      unitRef="shares">21695000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNi0xLTEtMS0yMzM5OQ_e18e41b6-00b5-4051-a0c6-a90442b74a13"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNi0zLTEtMS0yMzM5OQ_a651cd08-8950-49f4-9a9f-c7462a50330d"
      unitRef="usdPerShare">1.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNy0xLTEtMS0yMzM5OQ_625d60c6-7179-4281-8e9f-8295149d204b"
      unitRef="usdPerShare">-1.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV80OS9mcmFnOjFjYWE4YzYxY2VjMzQ0NDc5MjdmNjU4NjllNDc4MGVhL3RhYmxlOjRiNTBjMzZjZjlhZDRlOGE4YjlmYjliNWZhZDI5MTU1L3RhYmxlcmFuZ2U6NGI1MGMzNmNmOWFkNGU4YThiOWZiOWI1ZmFkMjkxNTVfNy0zLTEtMS0yMzM5OQ_70b7b7a2-74c7-4aea-9548-d79fef2efc28"
      unitRef="usdPerShare">1.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTA5OTUxMTY2MTk5OA_70d5005d-4e92-4a5a-95ba-3844e77b26c9">Derivatives and Hedging Activities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hedge Accounting and Hedging Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The purposes of our cash flow hedging programs are to manage the foreign currency exchange rate risk on forecasted revenues and expenses denominated in currencies other than the functional currency of the operating unit, and to manage floating interest rate risk associated with future interest payments on the variable-rate term loans issued in January 2022. We do not issue derivatives for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. The derivative &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;instruments we utilize, including various foreign exchange contracts and interest rate swaps, are designated and qualify as cash flow hedges. Our derivative instruments are recorded at fair value on the condensed consolidated balance sheets and are classified based on the instrument's maturity date. We record gains or losses from changes in the fair values of the derivative instruments as a component of other comprehensive income (loss) and we reclassify those gains or losses into earnings in the same line item associated with the forecasted transaction and in the same period during which the hedged transaction affects earnings. If the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, we reclassify the gain or loss on the related derivative instrument from accumulated other comprehensive loss into earnings immediately.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Exchange Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated revenues and expenses to minimize the effect of foreign exchange rate movements on the related cash flows. These contracts are agreements to buy or sell a quantity of a currency at a predetermined future date and at a predetermined exchange rate. Our foreign exchange forward contracts hedge exposures principally denominated in Mexican Pesos, Euros, Czech Koruna and Japanese Yen, and have varying maturities with an average term of approximately twelve months. The total notional amount of these outstanding derivative contracts as of March&#160;31, 2022 was $231.8&#160;million, which included the notional equivalent of $58.7&#160;million in Mexican Pesos, $42.4&#160;million in Euros, $23.5&#160;million in Czech Koruna, $22.2&#160;million in Japanese Yen and $85.0&#160;million in other foreign currencies, with terms currently through July 2023. We did not have such derivative contracts as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cross-currency Par Forward Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into cross-currency par forward contracts to hedge a portion of our Mexico forecasted expenses denominated in Mexican Pesos ("MXN"). These contracts are agreements to exchange cash flows from one currency to another at specified intervals over the contract term with all exchanges occurring at the same predetermined rate. In November 2021, we entered into a one-year cross-currency par forward contract with a term from December 1, 2021 to December 1, 2022. The total notional amount of this outstanding derivative as of March&#160;31, 2022 and December 31, 2021 was approximately 311.6 million MXN and 413.1&#160;million MXN, respectively. The derivative instrument matures in equal monthly amounts at a fixed forward rate of 21.60 MXN/USD. Preceding this contract we had a one-year cross-currency par forward contract with a term from November 3, 2020 to December 1, 2021 that matured in equal monthly amounts at a fixed forward rate of 24.26 MXN/USD.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Floating Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, in anticipation of entering into the new senior secured credit facilities in January 2022, which includes a variable-rate term loan A and a variable-rate term loan B (see Note 17: Long-Term Debt), we entered into two forward-starting interest rate swaps. In February 2022, certain terms under the agreements were amended to reflect the transition from LIBOR to the Secured Overnight Financing Rate ("SOFR"), an alternative reference rate. Under the interest rate swap agreements we exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional amount. Effective March 30, 2022, the term loan A swap, as amended, has an initial notional amount of $300.0&#160;million, reducing to $150.0&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2027. We will pay a fixed rate of 1.32% and will receive the greater of 3-month USD SOFR or (0.15)%. Effective March 30, 2022, the term loan B swap, as amended, has an initial notional amount of $750.0&#160;million, reducing to $46.9&#160;million evenly on a quarterly basis excluding its final maturity on March 30, 2026. We will pay a fixed rate of 1.17% and will receive the greater of 3-month USD SOFR or 0.35%. These swaps effectively convert the relevant portion of the floating-rate term loans to fixed rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Condensed Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.&lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2022, we expect an estimated $1.9&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $3.9&#160;million in deferred losses on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ1MzEzMA_8e1b6382-8002-4d5d-8810-b2b2733058f3"
      unitRef="usd">231800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i62db31deb9084936bafdeb3f3f63c809_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTIwOA_0ebe66e7-0066-40e9-8f9b-8f9e3a1726c4"
      unitRef="usd">58700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7963d1971572480fbd840e0d5474ceb0_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTIzOA_12139ed2-cc00-4084-b6b6-40806186a98d"
      unitRef="usd">42400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic373291ce2a54c54bc47f9dc50e82a5e_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTI1Mw_c6c80125-f9f6-4bbd-acc5-5460fd72b08e"
      unitRef="usd">23500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5be466fa5bc14021acd2af7f71cc4898_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ3Mzg5Mg_1e804189-42ff-4305-80cc-f8cc068c1257"
      unitRef="usd">22200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2aca8fbd4d9f46bd8abdb6dfa1bc52fa_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI4NTI4Mw_65dc9e3c-149a-4632-a003-471402c9afed"
      unitRef="usd">85000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ic788c207f74e4b2dafcf30292f3548ad_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjE5OTAyMzI1OTMzMA_74194547-e97b-4872-9b4f-6752a77510f0"
      unitRef="mxn">311600000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2cae28aee9a248c6992bfec3cecde803_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ0NjE0Nw_86d48bda-8dbf-4423-aa06-20f00e166b81"
      unitRef="mxn">413100000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="ic788c207f74e4b2dafcf30292f3548ad_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ0NTM5Mw_3b2cb24c-e4e9-495e-848b-79a14c6e62c3"
      unitRef="number">21.60</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeForwardExchangeRate1
      contextRef="i78dc0822a7604ba0b14a6be54c13e439_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTYwNw_a942e684-65e1-446c-8861-bbddee89887b"
      unitRef="number">24.26</us-gaap:DerivativeForwardExchangeRate1>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODczOA_68927ab9-4e10-45eb-ab6b-afacd6a693bd"
      unitRef="usd">300000000</us-gaap:DerivativeNotionalAmount>
    <icui:InterestRateSwapEndingNotionalValue
      contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc1NA_25daaa1f-93fc-4656-aadd-8381d70f31d0"
      unitRef="usd">150000000</icui:InterestRateSwapEndingNotionalValue>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc3Ng_d7f2c780-e613-4d1a-9338-153e63fa8e5d"
      unitRef="number">0.0132</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeVariableRateFloor
      contextRef="ice4f52a2d82e4013bf866a6fa2b52be1_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc3MA_ef9fb7c7-8ac8-4663-beef-d75111c3a3ee"
      unitRef="number">-0.0015</icui:DerivativeVariableRateFloor>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc4Mw_47a2d649-a5e9-4018-8698-c66cf6012083"
      unitRef="usd">750000000</us-gaap:DerivativeNotionalAmount>
    <icui:InterestRateSwapEndingNotionalValue
      contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODc5OQ_14675f44-4e24-4964-93d1-40abfbbf812a"
      unitRef="usd">46900000</icui:InterestRateSwapEndingNotionalValue>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331"
      decimals="6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODgxNA_1d66db6a-d2c3-44a3-80c3-4fe82ca9a8f8"
      unitRef="number">0.0117</us-gaap:DerivativeFixedInterestRate>
    <icui:DerivativeVariableRateFloor
      contextRef="i7df84c8e6ce6476ba122f96383a99201_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2ODgyMQ_11e26ce4-d102-4130-a254-c09d2ce0163a"
      unitRef="number">0.0035</icui:DerivativeVariableRateFloor>
    <us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjcwNw_8fd39ba7-435e-4867-9c48-cec8e3d5a659">The following table presents the fair values of our derivative instruments included within the Condensed Consolidated Balance Sheets (in thousands):&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.753%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.884%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Cash Flow Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Condensed Consolidated Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Derivatives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized the following gains (losses) on our derivative instruments designated as cash flow hedges (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Recognized in Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table presents the effects of our derivative instruments designated as cash flow hedges on the Condensed Consolidated Statements of Operations (in thousands):</us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ib6f1ae97aae0424a80ff8ef2c5fe28de_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNC0yLTEtMS04MzU0Ng_3256bd52-5a9e-47d7-8cf3-a1d406ddc3c6"
      unitRef="usd">7629000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ie951b51b46c24f91a76523e2ca109cf7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNC00LTEtMS04MzU0OQ_1af4af92-f88c-4773-9005-d1828cac0601"
      unitRef="usd">0</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i1565ea9c18f0446cac5355139ceb7865_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNC02LTEtMS04MzU1MQ_29f2c7a7-fefc-458a-9b91-f4344f75c7f5"
      unitRef="usd">7629000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i5480e0d4b9e94e3890f7f73f6ed47c70_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNS0yLTEtMS04MzU1Mw_6688674e-d8d1-42ac-8b5c-9ba5373c8b34"
      unitRef="usd">115000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i315729be48514840b0d36c895155ff5e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNS00LTEtMS04MzU1NQ_0f67c0d4-345b-409b-ac2a-dcfca8eae063"
      unitRef="usd">28570000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ib8b0233d309c4ffcb68ad6044df3947b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNS02LTEtMS04MzU1Nw_3cd90c71-07d7-4a22-bbd5-5ff0d3fddfff"
      unitRef="usd">28685000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssets
      contextRef="i9e7790dee9054ceca551b75f9663ebea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNi0yLTEtMS04MzU1OQ_d4888f22-9b68-4253-874e-619f8dfe6e5d"
      unitRef="usd">7744000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNi00LTEtMS04MzU2MQ_58b5cae2-2b50-4e26-a043-d33308ae36ad"
      unitRef="usd">28570000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfNi02LTEtMS04MzU2NA_58c7e185-b8fc-46e2-8b20-360b83f4fed0"
      unitRef="usd">36314000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i1f4262eb928148c0bbdb719d4842c46e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOC0yLTEtMS04MzU3Mw_f252ae29-3f95-445d-8790-ba45ffeeeb38"
      unitRef="usd">895000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i47c493e4a240482e95f73b4965a6f972_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOC00LTEtMS04MzU3OA_3bc701ab-a985-4528-980a-fd2ac25728b1"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i92d5fc92c6d7403f858073017410d73b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOC02LTEtMS04MzU4MA_a1abe308-8ffb-4c6e-b7f9-bed2b545454d"
      unitRef="usd">895000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i442353a0995745d69a88c9e06d2b2e2b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOS0yLTEtMS04MzU4Ng_9503b47a-1701-4d7e-99aa-51336d06074a"
      unitRef="usd">27000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i3f57e3739bad4f56b45c5af9ecd59b05_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOS00LTEtMS04MzU4OA_12126381-4737-4071-a42a-15301dca546e"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i2ebbac56dc4f40cab230df979062a6fb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfOS02LTEtMS04MzU5MA_31e3c070-2e49-48d2-963f-37cea040b673"
      unitRef="usd">27000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="i9e7790dee9054ceca551b75f9663ebea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTAtMi0xLTEtODM1OTI_54825a12-3d6b-44af-bc7f-5c230b8209cb"
      unitRef="usd">922000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTAtNC0xLTEtODM1OTQ_a39f4399-9ec9-490c-a43a-7d7b094f5469"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTAtNi0xLTEtODM1OTc_c77c5648-4a86-42d5-9d02-066e7ddb5ff2"
      unitRef="usd">922000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="if96528d11b19404186843078164bf0ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTMtMi0xLTEtODM1Njc_8430a7c1-665d-4ceb-907a-39785af36d75"
      unitRef="usd">1061000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i9cb96a5a627a4f2c9fbf16b433a2a039_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTMtNC0xLTEtODM1Njk_6dd0ccb2-3710-4db0-86ee-132e08942960"
      unitRef="usd">0</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i32b4f49688b3453dabe1cbce3dac596e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTMtNi0xLTEtODM1NzE_f2f3f2fb-81af-46c0-842c-e9d9d27fd7bd"
      unitRef="usd">1061000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="if45f73643f964e8dad36acddabd4f6b0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTQtMi0xLTEtODM1Njc_09b82e8b-4e9f-4d4f-9f98-91c8f8b9fd5e"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ic809f3d4de8e4c4fa7ac38f6e35822f1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTQtNC0xLTEtODM1Njk_658f2528-953d-43c3-9a11-5400b9cad6e5"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i112e5d0a75164fdeb157a57239a63582_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTQtNi0xLTEtODM1NzE_ac32061a-d3cb-47aa-a974-2afaba9cd8e1"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssets
      contextRef="i7fa3affafd794a8aba01a0642e492edc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTUtMi0xLTEtODM1Njc_83ea6f9e-1be8-437c-b286-4e999b31bd2b"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id0aeb03074de41f4a5d5dadadbbef2d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTUtNC0xLTEtODM1Njk_0e411063-22f0-4990-80bf-160052e41595"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTUtNi0xLTEtODM1NzE_11cfdddf-fdb2-436b-81b4-6a43adec4254"
      unitRef="usd">1061000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="idc5567182ccf4bf2afb2d97a18d3f46e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTctMi0xLTEtODM1NzY_55f2580b-d861-4876-82ec-5f7114ed6bf4"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i1b68c68d4340458b97c555caf230716e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTctNC0xLTEtODM1ODI_59680ec2-667b-47b9-8c40-9dc65881c276"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ic64816f8cccb4c3aa043d7bda0ab7443_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTctNi0xLTEtODM1ODQ_24e42a9b-e7d3-4d42-8924-c6efd04b2f65"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i1428c27386ca455990cd6a0836006bf5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTgtMi0xLTEtODM1OTk_7f7315be-0f9d-4c28-bb45-2e9af18e50b0"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i59c249ecf14641feac25b572b32ac6c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTgtNC0xLTEtODM1OTk_4a9a7e37-7ff4-4ec5-b7e5-89b4ae9412d6"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i55bf118e00554d2e9a4e30260c8c7917_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTgtNi0xLTEtODM1OTk_eebc4a6c-2190-4068-a169-817e0cfbd142"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilities
      contextRef="i7fa3affafd794a8aba01a0642e492edc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTktMi0xLTEtODM1OTk_470e1d5a-f4f9-459f-b53a-18608ced6d01"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id0aeb03074de41f4a5d5dadadbbef2d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTktNC0xLTEtODM1OTk_2356f414-f289-4750-8a0f-5fc3462d061a"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjU5MzRkNDBmODVkZTQ4MmY4NDYzYWMyNmI3YzhhNjQzL3RhYmxlcmFuZ2U6NTkzNGQ0MGY4NWRlNDgyZjg0NjNhYzI2YjdjOGE2NDNfMTktNi0xLTEtODM1OTk_2f4da109-33f9-4e03-bc65-0c32b343e2eb"
      unitRef="usd">1480000</us-gaap:DerivativeLiabilities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i8a0ebabf35b94de9b3494c8f98c35fcb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNS0yLTEtMS04MzYwMw_e7adad88-b269-47e2-9453-9d4d8f3c293c"
      unitRef="usd">3112000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i75dee15445a241d39eb89a15ed0d7674_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNS00LTEtMS04MzYxMA_1fc3776a-8625-4c46-b87c-4d1a138ff1a5"
      unitRef="usd">-402000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i6f597ec7d6d94442ad8c9951a802383c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNi0yLTEtMS04MzYwNg_7f0f6964-c2ef-49be-88b3-801b23ee8873"
      unitRef="usd">30051000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i2d6c5a747f3646a5b3e9c6bcbaa397f8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNi00LTEtMS04MzYxMA_06ca8e38-e654-450a-8f35-e9a71902c60d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNy0yLTEtMS04MzYwOA_6c085eea-db45-4f5b-96be-60522c2c5ebb"
      unitRef="usd">33163000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjM0ZjlkMjU3YTEzMzRiNDI5OWJlMzAxYTZhMDdmMmEwL3RhYmxlcmFuZ2U6MzRmOWQyNTdhMTMzNGI0Mjk5YmUzMDFhNmEwN2YyYTBfNy00LTEtMS04MzYxMA_ecf94a04-5677-472d-b2cf-9575fbbe0b12"
      unitRef="usd">-402000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMjcxNA_5d95e631-9ff5-46e9-aae0-671d217934c5">&lt;div style="margin-top:5pt;text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gain (Loss) Reclassified From Accumulated Other Comprehensive Income into Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Derivatives designated as cash flow hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of goods sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total derivatives designated as cash flow hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Represents location of gain reclassified from accumulated other comprehensive income into income as a result that a forecasted transaction is no longer probable of occurring.&lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2022, we expect an estimated $1.9&#160;million in deferred gains on the outstanding foreign exchange contracts and an estimated $3.9&#160;million in deferred losses on the interest rate swaps will be reclassified from accumulated other comprehensive loss to net income during the next 12 months concurrent with the underlying hedged transactions also being reported in net income.</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i4c6a7c98f99c45a0af8e8a18126938ea_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS00LTEtMS04MzYxMg_1266cadf-5323-4fce-bdba-8694b38b8fe1"
      unitRef="usd">2543000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="iadccd508c3834cc2a5379622d5278846_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS02LTEtMS04MzYxNg_3fbd8d2c-26bc-4a79-b8bf-a66f07841706"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i768b7317377646e18a4f32bd2ab2443d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS04LTEtMS0yMzM5OQ_ed734df9-cfe2-4bba-98bd-3edea3c86130"
      unitRef="usd">513000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i296eba7b2d0d407894537da13b4266d5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNS0xMC0xLTEtMjMzOTk_9ce5a11f-3441-4374-bcce-a036a92002f6"
      unitRef="usd">841000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i9c66699e81d84448b3ba8cae1a7e7d61_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNy00LTEtMS04MzYxNA_895e30e7-ede7-4063-bbce-bf1a2bea5f50"
      unitRef="usd">249000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i030a14b9f87541e5a345d6f3f9d9e08d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNy02LTEtMS04MzYxNg_280d3a8f-eb6f-4fee-9bf8-421f81841e77"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="ib28660aeb4894aeabf3989dbe4367892_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNi04LTEtMS0yMzM5OQ_0e3f4793-78de-4c59-9968-69f5d2823e20"
      unitRef="usd">2279000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
      contextRef="i6a11d8ef901545fcbe623f7dd7ff571b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RhYmxlOjA3ZDczNTQ5MTVjMzQ5NTc5NzZhNzA4NzJkOGZlMGM0L3RhYmxlcmFuZ2U6MDdkNzM1NDkxNWMzNDk1Nzk3NmE3MDg3MmQ4ZmUwYzRfNi0xMC0xLTEtMjMzOTk_343bfd8b-666c-4e61-957e-efd4aa93230a"
      unitRef="usd">841000</us-gaap:DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion>
    <us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ2OTUwMA_815659aa-73c1-4802-9112-c19bd0c4e14d"
      unitRef="usd">1900000</us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81Mi9mcmFnOmE1YzBjOWE4ODdhZTRmYzlhMDdkMDg2NzMzMWNhNzU4L3RleHRyZWdpb246YTVjMGM5YTg4N2FlNGZjOWEwN2QwODY3MzMxY2E3NThfMTY0OTI2NzQ1OTk1NQ_8728b9e9-24b1-4f85-8f4f-4ddfbdef394b"
      unitRef="usd">3900000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDcyNw_18d08f4e-13b5-4c1e-ab2c-b43d61c88eb4">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1:  quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2:  inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3:  unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Earn-out Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical with a combination of cash consideration and share consideration issued at closing. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving certain Price Targets from the closing date to either the third or fourth anniversary of closing (see Note 3: Acquisitions for additional information) and provided Smiths beneficially owns at least 50.0% of the shares of common stock issued at closing at the time the Price Target is achieved. The initial estimated fair value of the earn-out was determined to be $53.5&#160;million. The initial fair value of the earn-out was determined using a Monte Carlo simulation model. The model utilized several assumptions including volatility and the risk-free interest rate. The assumed volatility is based on the average of the historical volatility of our common stock price and the implied volatility of certain at-the-money traded options. The risk-free interest rate is equal to the yield on U.S. Treasury securities at constant maturity for the period commensurate with the term of the earn-out. At each reporting date subsequent to the acquisition, we will remeasure the earn-out liability and recognize any changes in its fair value in our consolidated statements of operations. If the probability of achieving the Price Targets during their respective measurement periods is significantly greater than initially anticipated, the realization of an additional liability and related expense will have a significant impact on our consolidated financial statements in the period recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March 31, 2022, the estimated fair value of the total contingent earn-out is $1.6&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out payment shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of both March 31, 2022 and December 31, 2021, the estimated fair value of the contingent earn-out is $2.6&#160;million. The estimated fair value of the contingent earn-out is calculated using a probability-weighted cash flow model based on historical revenue streams and the likelihood that the revenue targets will be met.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the fourth quarter of 2019, we recognized an earn-out liability related to the acquisition of Pursuit Vascular, Inc. ("Pursuit"). Pursuit's former equity holders were entitled up to $50.0 million in additional cash consideration contingent upon the achievement of certain sales and gross profit targets for specific customers. The earn-out was calculated as a percentage of gross profit achieved during the earn-out period against a pre-determined target gross profit, not to exceed $50.0 million. During the earn-out period, we used a Monte Carlo simulation model to determine the fair value of the earn-out liability. The Monte Carlo simulation model utilized multiple input variables to determine the value of the earn-out liability including historical volatility, a risk-free interest rate, counter party credit risk and projected future gross profit (see the simulation input table below related to Pursuit). The historical volatility was based on the median of ICU and a certain peer group. The risk-free interest rate was equal to the yield, as of the valuation date, of the zero-coupon U.S. Treasury bill that was commensurate with the term of the earn-out. The counter party credit risk was based on a synthetic credit rating of B1. As of June 30, 2021, the earn-out measurement period ended. Based on the actual sales and gross profit achieved during the measurement period, we calculated the actual earn-out amount to be $26.3&#160;million. The $26.3&#160;million earn-out calculation was finalized and accepted by Pursuit's former equity holders and was paid out in the fourth quarter of 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contingent earn-out liabilities are separately stated on our condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smiths Medical Earn-out&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At Acquisition&lt;br/&gt;January 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pursuit Earn-out&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue/Gross Profit Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Counter Party Risk&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments, Foreign Exchange Contracts and Interest Rate Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value of our investments, which consist of corporate bonds, is estimated using observable market-based inputs such as quoted prices, interest rates and yield curves or Level 2 inputs. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The fair value of our Level 2 foreign exchange contracts, including forward contracts and cross-currency par forward contracts, is estimated using observable market inputs such as known notional value amounts, spot and forward exchange rates. These inputs relate to liquid, heavily traded currencies with active markets which are available for the full term of the derivative.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our Level 2 interest rate swaps is estimated using a pricing model that reflects the terms of the contracts, including the period to maturity, and relies on observable market inputs such as known notional value amounts and USD interest rate curves.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency par forward contract:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1NTU5OQ_9a09cdb2-06bb-4585-8475-9a7aba67e6dd"
      unitRef="usd">100000000</icui:Contingentconsiderationgross>
    <icui:OwnershipRequirementForEarnoutPayment
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMjE5OTAyMzI3MTU2OA_4d629360-625c-4917-917c-f00753a570e2"
      unitRef="number">0.500</icui:OwnershipRequirementForEarnoutPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1NTg1Ng_3d306c79-1c9b-49a5-9923-67084caf3f23"
      unitRef="usd">53500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjc0Mw_9fe422a3-3638-4458-a052-e3d4a4b27dbb"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjc3MA_bba804e3-eb3f-4fe5-9116-5bf3d451957b"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjc5Nw_a309faad-e2ff-4e4b-aab8-e853a2051a45"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i099b2a7d616d421c860d4ddb8052bdab_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY0OTI2NzQ1Mjg1NQ_d235c744-c670-4713-8ff6-65b1618dde6a"
      unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="i27fd8cbeeab3426e97107930d3deb563_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTI5MQ_a227bd7a-8cae-406c-a0ec-186f9414a721"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i591e5151200040c0933b61638412feac_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMTY5Nw_95e6f607-5af7-4801-8a95-4ef78ed6b8c4"
      unitRef="usd">2600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <icui:Contingentconsiderationgross
      contextRef="i52f666ba7ecd4b1e858ed6eed44de97d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMjA5NA_74846702-71e7-423c-9190-5c7ef4239d3e"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <icui:Contingentconsiderationgross
      contextRef="i52f666ba7ecd4b1e858ed6eed44de97d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMjM4NA_fafb815b-6658-45a0-8abb-0ceabec38d82"
      unitRef="usd">50000000</icui:Contingentconsiderationgross>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia1b57ff5dbf448208328e971b35a3f90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMzMyMw_6e2cedfa-1c22-42f6-87ef-489ef098cbcb"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia1b57ff5dbf448208328e971b35a3f90_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfMzMzMQ_b3aae195-8094-4266-8b80-c1f786f840b7"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDcyOQ_83efbcb1-2bc1-488f-93ae-d796da16fc6f">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide a reconciliation of the Level 3 earn-out liabilities measured at estimated fair value (in thousands):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition date fair value estimate of earn-out&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;$53.5 million relates to our acquisition of Smiths Medical and $1.6 million relates to our acquisition of a small foreign infusions systems supplier in the fourth quarter of 2021 (see Note 3: Acquisitions). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Earn-out Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of earn-out (included in income from operations as a separate line item)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accrued balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfMS0yLTEtMS0yMzM5OQ_ccbcaaef-7df5-42ec-ae01-7d258a93874c"
      unitRef="usd">2589000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfMi0yLTEtMS04MzIxNw_274e9ec4-ba8e-4efd-a0f8-ec0f2bb56983"
      unitRef="usd">55158000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <icui:CurrencyTranslationOnEarnOut
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfNC0yLTEtMS04MzIyMA_f0fb2d1d-245d-4cc7-9ee2-dfe376475ba6"
      unitRef="usd">46000</icui:CurrencyTranslationOnEarnOut>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id4ad65ae063d4e49821ad5b4dece8ece_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmE1MDA5NzhiZjc1MzQxMWU4ZWRiZGIxZjU2YmUwNDEzL3RhYmxlcmFuZ2U6YTUwMDk3OGJmNzUzNDExZThlZGJkYjFmNTZiZTA0MTNfNC0yLTEtMS0yMzM5OQ_20cebdb6-5591-42eb-8b2a-4a3e6479aba8"
      unitRef="usd">57701000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iacc7d2919e7140fa9c80f0f1d09a1728_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjlmZDc3MzFiOTc4MzRjNTJhMzc4MmFmYTAyYjNhYWE5L3RhYmxlcmFuZ2U6OWZkNzczMWI5NzgzNGM1MmEzNzgyYWZhMDJiM2FhYTlfMS0yLTEtMS0yMzM5OQ_348df728-4d45-4cd9-8d79-e4e37d5c33fa"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
      contextRef="i27bd3a8f9e2b4c90a09dc353bf7cbd60_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjlmZDc3MzFiOTc4MzRjNTJhMzc4MmFmYTAyYjNhYWE5L3RhYmxlcmFuZ2U6OWZkNzczMWI5NzgzNGM1MmEzNzgyYWZhMDJiM2FhYTlfMy0yLTEtMS0yMzM5OQ_15258ccf-2772-4c38-919c-a9004ab4e2ef"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id15440599eac41b2b8dcbf173de1a069_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjlmZDc3MzFiOTc4MzRjNTJhMzc4MmFmYTAyYjNhYWE5L3RhYmxlcmFuZ2U6OWZkNzczMWI5NzgzNGM1MmEzNzgyYWZhMDJiM2FhYTlfNC0yLTEtMS0yMzM5OQ_da8e3bbc-6cdc-472e-b344-24199bb871f6"
      unitRef="usd">26300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDczMQ_e9e3c5a2-3edc-42cf-bf7e-f3078c92dae2">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide quantitative information about Level 3 inputs for fair value measurement of our earn-out liabilities related to Smiths Medical and Pursuit:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smiths Medical Earn-out&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At Acquisition&lt;br/&gt;January 6, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pursuit Earn-out&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Simulation Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue/Gross Profit Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Counter Party Risk&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i73db172d800a49ca831d1f3440d0a9a8_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmI3MjMzYzU4ZGI4MzRmOGU4OGVhOWJjN2RjYTE3OGY3L3RhYmxlcmFuZ2U6YjcyMzNjNThkYjgzNGY4ZTg4ZWE5YmM3ZGNhMTc4ZjdfMS0yLTEtMS04MzIyMg_960cac72-3506-41ff-af35-63772787a0f5"
      unitRef="number">0.3700</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i01dc0feea8d540698b9fa442d8af1726_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOmI3MjMzYzU4ZGI4MzRmOGU4OGVhOWJjN2RjYTE3OGY3L3RhYmxlcmFuZ2U6YjcyMzNjNThkYjgzNGY4ZTg4ZWE5YmM3ZGNhMTc4ZjdfMi0yLTEtMS04MzIyNA_d67cb770-b9d1-459d-b3fe-df522b731627"
      unitRef="number">0.0131</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ia760ade7301b4ae091a97fbf0f60bae8_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfMS0yLTEtMS0yMzM5OQ_7e778632-87f2-4f73-b645-2092aa5554c8"
      unitRef="number">0.2500</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="iae19c16d454a4da888fb439fac3a5955_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfMi0yLTEtMS0yMzM5OQ_52621628-1009-41bc-ab8a-cfbec2ee6f35"
      unitRef="number">0.1250</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i2eba1326445642438ae8479679188e72_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfMy0yLTEtMS0yMzM5OQ_32d53bc7-949b-4410-b88a-03bc526009a1"
      unitRef="number">0.0009</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="id1ddc2565fbb4bc9ac3f95f9e98205b2_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjI2ZDM2MjhiMDQ4MTQwNzRiYmM0NGVjZmY4NTFjYjdlL3RhYmxlcmFuZ2U6MjZkMzYyOGIwNDgxNDA3NGJiYzQ0ZWNmZjg1MWNiN2VfNC0yLTEtMS0yMzM5OQ_f9898db2-5b9a-43b3-bfef-0458be6bc7a2"
      unitRef="number">0.0310</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RleHRyZWdpb246Mjg3MTIxNTMwZTMxNDMwOWI3NzE3Y2NmZDI2MzU2YmRfNDc1Mw_e8e14955-5fd7-429f-b3da-f8cc01a2da44">Our assets and liabilities measured at fair value on a recurring basis consisted of the following Level 1, 2 and 3 inputs as defined above (in thousands):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;value&#160;measurements&#160;as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&#160;carrying&lt;br/&gt;value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted&#160;prices&lt;br/&gt;in&#160;active&lt;br/&gt;markets&#160;for&lt;br/&gt;identical&lt;br/&gt;assets&#160;(level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;other&lt;br/&gt;observable&lt;br/&gt;inputs&#160;(level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&#160;(level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency par forward contract:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out liability - LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC0xLTEtMS0yMzM5OQ_7df11abb-67e5-4138-9f44-88cf689fc47e"
      unitRef="usd">14864000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC0zLTEtMS0yMzM5OQ_797b65c9-320d-4d58-a553-ff001ba17ae0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i97a07c4fb7834238809f74bc245a07e1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC01LTEtMS0yMzM5OQ_77679704-4f21-4fb9-b376-9e42fc0658bd"
      unitRef="usd">14864000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i625f2e9aec314e25b0c0699f19c11778_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNC03LTEtMS0yMzM5OQ_b75d803e-487b-49cf-b2cb-963e6e64981e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS0xLTEtMS0yMzM5OQ_c81cbdf4-f6ac-4ec8-bc00-0b93031c6f67"
      unitRef="usd">2539000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS0zLTEtMS0yMzM5OQ_7209081d-a6cf-4747-ae9c-f9b7e9790d72"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i97a07c4fb7834238809f74bc245a07e1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS01LTEtMS0yMzM5OQ_b6f76ab9-cce6-478c-85df-213f38bb36a5"
      unitRef="usd">2539000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i625f2e9aec314e25b0c0699f19c11778_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNS03LTEtMS0yMzM5OQ_74f060d0-b9cd-4aed-8ef6-54beee40c735"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i1565ea9c18f0446cac5355139ceb7865_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy0xLTEtMS04MzIyOA_8fd3670c-54fb-482d-965e-7433df5f6a4f"
      unitRef="usd">7629000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i4d39ec8bd177421d91c1d78701f1ac51_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy0zLTEtMS04MzIzMA_85ce1af8-7def-4f2d-a62f-18c9d3c2803c"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i4b2dd58641ec4c47944780cf820a3c80_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy01LTEtMS04MzIzMg_df76a9b3-ce20-442b-af05-3d3f501e6609"
      unitRef="usd">7629000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i893e8eee099341c480fec838d774cb74_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfNy03LTEtMS04MzIzNA_75b60856-4469-4175-a5c3-b9e991853ba5"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ib8b0233d309c4ffcb68ad6044df3947b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0xLTEtMS04MzIyOA_b062c29b-db8b-403f-a58c-46f52b86025b"
      unitRef="usd">115000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i6c3fa86ba23d4ca99c7c1d8b7d588cce_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0zLTEtMS04MzIzMA_1690ddea-903b-4aac-b76c-00f23c761993"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i08573f64c1804db985e0aed112395314_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC01LTEtMS04MzIzMg_6ca6caea-60f8-4056-bcb6-87a07da2fc4e"
      unitRef="usd">115000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ia840f694db644720be6253993494b8e0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC03LTEtMS04MzIzNA_e03ed455-3c10-45ab-9b9d-fe9d0cbf2dbd"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ib8b0233d309c4ffcb68ad6044df3947b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0xLTEtMS0yMzM5OQ_30a08faa-1010-48fb-943d-b0a19effde8a"
      unitRef="usd">28570000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i6c3fa86ba23d4ca99c7c1d8b7d588cce_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC0zLTEtMS0yMzM5OQ_10640e7d-56c2-4e2d-832a-25de704067ab"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="i08573f64c1804db985e0aed112395314_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC01LTEtMS0yMzM5OQ_4c35908f-a4c5-4673-9f9a-7bd489650455"
      unitRef="usd">28570000</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:InterestRateDerivativeAssetsAtFairValue
      contextRef="ia840f694db644720be6253993494b8e0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOC03LTEtMS0yMzM5OQ_dd2f0071-5615-4ff1-bb8a-53d60855d709"
      unitRef="usd">0</us-gaap:InterestRateDerivativeAssetsAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS0xLTEtMS0yMzM5OQ_50df29c7-2786-4f2d-a44c-2d4f0564fb3a"
      unitRef="usd">53717000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9c7bf42d52f54c2ebfbb2d19c3869aa3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS0zLTEtMS0yMzM5OQ_eefce338-0e6f-4804-b95b-7feb49f284b0"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i97a07c4fb7834238809f74bc245a07e1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS01LTEtMS0yMzM5OQ_0bc137c2-c9d3-418b-b32b-728e43827939"
      unitRef="usd">53717000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i625f2e9aec314e25b0c0699f19c11778_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfOS03LTEtMS0yMzM5OQ_44690fb7-356e-430f-9d65-640a493271f7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i62a390f242ec4b708b42188ba1ed533a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItMS0xLTEtMjMzOTk_d02c9ad0-52f7-4942-b5a3-44e01ed1f49b"
      unitRef="usd">57701000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ie8af3b131bc14d17a7571c2fdcc1af47_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItMy0xLTEtMjMzOTk_c9755067-e075-4aa1-ae96-d14f4bd692ff"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i1c78732ffce9481d84d10a6eed768479_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItNS0xLTEtMjMzOTk_6f548230-489b-4cde-aad7-28fb6a486f13"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="id600755f8bb64800a5c3f7106c241dcf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTItNy0xLTEtMjMzOTk_532db989-2c66-4c13-956a-ce1bd5e6f643"
      unitRef="usd">57701000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i92d5fc92c6d7403f858073017410d73b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtMS0xLTEtMjMzOTk_31953381-bf13-4036-b1eb-2c1b6d79c693"
      unitRef="usd">895000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i56220f4e4fce4161bc7b4edbede836a0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtMy0xLTEtMjMzOTk_0e0ba769-9404-4a84-a7c2-6afae49617d5"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i92b9167994c04c478ad5b2e150315812_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtNS0xLTEtMjMzOTk_17c19670-666f-4a9e-8454-331169d6b7dc"
      unitRef="usd">895000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ibf032587ff8047c4b9bb91de60bb0fa0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTQtNy0xLTEtMjMzOTk_35d9d43e-aa87-487f-9131-1d1f8084d5cd"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i055211e4c3454a24b54386b6a7b21511_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtMS0xLTEtMjMzOTk_9a731a0a-a5a5-43d8-83c9-cc1729d1f3d0"
      unitRef="usd">27000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i97d55547e25c4f90a6a7c87dd4a11427_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtMy0xLTEtMjMzOTk_529d5569-e4bf-4784-a107-06b79f88380a"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="id97f8182fd794fdaa58639212799a600_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtNS0xLTEtMjMzOTk_526b2a70-0f1a-4505-a7ea-bbf446f2db7d"
      unitRef="usd">27000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i9d2d55b60f2e4d11a4d5ea598a1837be_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTUtNy0xLTEtMjMzOTk_b3e6f7c3-2e70-40e3-b8d4-14c99cb64f91"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ibc848f2b140a428c9e22a6befc519c3d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtMS0xLTEtMjMzOTk_8684e2ea-4921-4aa7-9f14-dcb857406be7"
      unitRef="usd">58623000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i1419702164fa4c2a834cca8d8c248f20_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtMy0xLTEtMjMzOTk_9a2b0da5-e67d-44d5-ba31-73e1f1ee9fe8"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ida0534e7808d42c69fc2180af5749efe_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtNS0xLTEtMjMzOTk_2d7887f4-1b8c-4495-80c0-5d0ebb77c040"
      unitRef="usd">922000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ia01d6c13756c4351b7acb497ed3f5adb_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjQ0YzRkMWJiOTlmMjQ3YjY5MTUyMjc1MzA1ZTE0NjNkL3RhYmxlcmFuZ2U6NDRjNGQxYmI5OWYyNDdiNjkxNTIyNzUzMDVlMTQ2M2RfMTYtNy0xLTEtMjMzOTk_181f2382-abf0-4ee8-99a9-a5df814f4d4a"
      unitRef="usd">57701000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC0xLTEtMS0yMzM5OQ_3136e164-c092-42f4-a181-7579a5f36f79"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic3b4f8d61bc94efd8c535988f345c281_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC0zLTEtMS0yMzM5OQ_b345c25f-4e75-4b22-a0a0-da1a9f3e1b73"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i7c455c5698b743659c9158cd90d076a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC01LTEtMS0yMzM5OQ_4b842840-e817-4cca-b8c4-8055e4a4bd93"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i163dcce9674d46a2b3445bb6740cef0b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNC03LTEtMS0yMzM5OQ_bea6fd45-4108-484f-9345-db577f958012"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS0xLTEtMS0yMzM5OQ_6619f4d1-d318-4fac-b3fa-e53070032911"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ic3b4f8d61bc94efd8c535988f345c281_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS0zLTEtMS0yMzM5OQ_0fa0bf22-a27e-4d14-9913-19fe3eab26bf"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i7c455c5698b743659c9158cd90d076a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS01LTEtMS0yMzM5OQ_df3af80f-c011-4fdc-b591-0f29ab9216ff"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i163dcce9674d46a2b3445bb6740cef0b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNS03LTEtMS0yMzM5OQ_fd23906e-09ec-414a-bb40-4e51eddb53b1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i32b4f49688b3453dabe1cbce3dac596e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy0xLTEtMS0yMzM5OQ_1a63f93f-faf1-4f66-a829-b92f50e89cbb"
      unitRef="usd">1061000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ibf12885b0a9c40079ede306096232146_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy0zLTEtMS0yMzM5OQ_35f0fc63-54e1-496e-aa38-861d0652c73e"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="i18ee0f7fc4e048ad942066fc6d02bb35_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy01LTEtMS0yMzM5OQ_9bc8ded2-9ed3-49ab-abac-28e93d57b179"
      unitRef="usd">1061000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure
      contextRef="ic4c21c453adc4f41a028e77788e381cf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfNy03LTEtMS0yMzM5OQ_6d2ad885-05de-494e-b43c-5593c5bd7f9d"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS0xLTEtMS0yMzM5OQ_981e575a-0bbe-44cc-9aab-77e4336801ea"
      unitRef="usd">20101000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic3b4f8d61bc94efd8c535988f345c281_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS0zLTEtMS0yMzM5OQ_da5a80f0-197b-4db5-ae13-97fb2c39dd6d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7c455c5698b743659c9158cd90d076a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS01LTEtMS0yMzM5OQ_168c3e8d-dd6d-4b84-9326-4b939455009f"
      unitRef="usd">20101000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i163dcce9674d46a2b3445bb6740cef0b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfOS03LTEtMS0yMzM5OQ_9761c711-2efc-4b6c-bc29-956d2efd0244"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ie9346449d62a4bae80c04e42368902d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItMS0xLTEtMjMzOTk_44fc35a2-f844-4543-a2b6-d62075d93916"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i15baeddeabd64f0793f301a17f103c2f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItMy0xLTEtMjMzOTk_cf9ac7d1-5f32-439a-84b2-ff7b9f97c017"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ic019a3f7c2aa41b3b60c36d8dc1afbdc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItNS0xLTEtMjMzOTk_5f628ffb-adf8-4fa0-bcce-5f4668737968"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i007e0b709a7948e9bfd7a77dfd33edca_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTItNy0xLTEtMjMzOTk_8ad53b31-1060-4315-8fc9-ab2c532bf450"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ibf8727c5088147f1815d1cbf94b178ca_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtMS0xLTEtMjMzOTk_6339e884-595f-4b92-986a-e5c67437c806"
      unitRef="usd">4069000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="i2e231f7074be46edac627e3736610412_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtMy0xLTEtMjMzOTk_2b2e0609-37f3-4e01-9e11-9eb61835c870"
      unitRef="usd">0</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="iff209c9c312842e6a5aa213e04c2dd43_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtNS0xLTEtMjMzOTk_aef20ce2-a027-4dc7-aebe-fb27b153334c"
      unitRef="usd">1480000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <us-gaap:NonfinancialLiabilitiesFairValueDisclosure
      contextRef="ib96b6effe9a345e6809e9a0242de4c6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81NS9mcmFnOjI4NzEyMTUzMGUzMTQzMDliNzcxN2NjZmQyNjM1NmJkL3RhYmxlOjM3MTU2MDYyMDI2MDQ3Mjc4MDFhYzNmYzZiZGNkMzlkL3RhYmxlcmFuZ2U6MzcxNTYwNjIwMjYwNDcyNzgwMWFjM2ZjNmJkY2QzOWRfMTYtNy0xLTEtMjMzOTk_62b1ca87-83f9-4b34-a72f-75c581681bf9"
      unitRef="usd">2589000</us-gaap:NonfinancialLiabilitiesFairValueDisclosure>
    <icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzcyOQ_3a476142-e608-4c35-a01d-dc40c919b04c">Investment Securities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Available-for-sale Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our available-for-sale investment securities currently consist of short-term and long-term corporate bonds and are considered &#x201c;investment grade&#x201d; and are carried at fair value. We assess our investment in available-for-sale debt securities for impairment each reporting period. If an unrealized loss exists, we determine whether any portion of the decline in fair value below the amortized cost basis is credit-related by reviewing several factors, including, but not limited to, the extent of the fair value decline and changes in the financial condition of the issuer. We record an impairment for credit-related losses through an allowance, limited to the amount of the unrealized loss. If we either intend to sell or it is more likely than not we will be required to sell the debt security before its anticipated recovery, any allowance is written off and the amortized cost basis is written down to fair value through a charge against net earnings. Unrealized gains and non-credit-related unrealized losses are recorded, net of tax, in other comprehensive income (loss). We did not have any investments in available-for-sale debt securities in unrealized loss positions as of March 31, 2022 or December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost of the debt securities are adjusted for the amortization of premiums computed under the effective interest method. Such amortization is included in other income, net in our condensed consolidated statements of operations. Realized gains and losses are accounted for on the specific identification method. There have been no realized gains or losses on the disposal of these investments. The scheduled maturities of the debt securities are between 2022 and 2024. All short-term investment securities are callable within one year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding &lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding&lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Non-Marketable Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, we acquired approximately a 20.0% non-marketable equity interest in a nonpublic company and entered into a three-year distribution agreement where we have the exclusive rights to market, sell and distribute the company's products in exchange for a cash payment of $3.3&#160;million. In addition, we were granted an exclusive license for all of the seller's intellectual property. At the expiration of the distribution agreement we have the right but not the obligation to acquire the remaining interest in the business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the equity method of accounting for investments when we determine we have a significant influence, but not a controlling interest in the investee. We determine whether we have significant influence by considering key factors such as ownership interest, representation on the board of directors, participation in policy making decisions, business relationship and material intra-entity transactions, among other factors. Our equity method investment is reported at cost and adjusted each period for our share of the investee's income or (loss) and dividend paid, if any. We eliminate any intra-entity profits to the extent of our beneficial interest. We record our share of the investee's income or (loss) on a one quarter lag. We report our proportionate share of the investee's income or (loss) resulting from this investment in other income, net in our condensed consolidated statements of operations. The carrying value of our equity method investment is reported in other assets on our condensed consolidated balance sheets (see Note 11: Prepaid Expenses and Other Current Assets and Other Assets). We assess our equity method investments for impairment on an annual basis or whenever events or circumstances indicate that the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;carrying value of the investment may not be recoverable. Our recorded share of the investee's loss was not material for the period ended March 31, 2022. We did not receive any dividend distributions from this investment during the period ended March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock>
    <us-gaap:GainLossOnSaleOfInvestments
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzczMg_70e451e9-b798-45f6-bd24-775ab1f0e357"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfInvestments>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzcyNA_ccf1d6be-d280-4338-a363-033d03d7156c">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term and long-term investments in available-for-sale securities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding &lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Holding&lt;br/&gt;Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMi0xLTEtMS0yMzM5OQ_9d90fb84-4902-42f3-8aec-87a1f29e941b"
      unitRef="usd">14864000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="i744f21c9656746cd8b7b2215b75ac43f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMi0zLTEtMS0yMzM5OQ_4d87cf6e-1440-45a8-955f-8d5b2cfdacab"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMi01LTEtMS0yMzM5OQ_2f255641-5a36-4fb6-a72e-9557b3156555"
      unitRef="usd">14864000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMy0xLTEtMS0yMzM5OQ_b55f3161-1527-436a-8496-cb044e1a2a83"
      unitRef="usd">2539000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMy0zLTEtMS0yMzM5OQ_4d41f952-6f95-4194-b21d-b5ab9d47f733"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMy01LTEtMS0yMzM5OQ_a08cb36e-ff05-4f90-8d38-a79ac14f9d16"
      unitRef="usd">2539000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfNC0xLTEtMS0yMzM5OQ_34bb2e48-100c-45a7-95f2-facf397c73ce"
      unitRef="usd">17403000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iafc15da5318940b5a790f399b28e9e5a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfNC0zLTEtMS0yMzM5OQ_621ca732-e511-4306-88ec-3dd47d38db0c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfNC01LTEtMS0yMzM5OQ_1fb6d314-550e-43b1-a589-4bb1712cdbc2"
      unitRef="usd">17403000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOC0xLTEtMS0yMzM5OQ_351bbaad-8c08-402b-ade7-b495e599e3a6"
      unitRef="usd">14420000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="iab0337d3ad564247a1200aceefee3a92_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOC0zLTEtMS0yMzM5OQ_2052d82b-71af-4fb1-9230-410b4c643e2e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOC01LTEtMS0yMzM5OQ_6bb817f2-00b7-49cb-b2d2-186d9383d8d2"
      unitRef="usd">14420000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent
      contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOS0xLTEtMS0yMzM5OQ_573f660b-980b-42f0-b0ff-7843c9f1594b"
      unitRef="usd">4620000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOS0zLTEtMS0yMzM5OQ_49fff893-cccf-45f0-8df2-cca1c768d4d2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfOS01LTEtMS0yMzM5OQ_a442b1d6-6378-4946-94f8-a68c84e33392"
      unitRef="usd">4620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMTAtMS0xLTEtMjMzOTk_acc22656-87b8-449d-b30d-8d3692cf4b76"
      unitRef="usd">19040000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i162df0449fd244ebbfe076a2e3ef5a1b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMTAtMy0xLTEtMjMzOTk_1ac5f598-4a1b-4da2-8d4b-9a7981327ba2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOmFlOGFmYzY4ZmQ3ODRjODI4ZGQzMzEwNzU0ZmM3NWFkL3RhYmxlcmFuZ2U6YWU4YWZjNjhmZDc4NGM4MjhkZDMzMTA3NTRmYzc1YWRfMTAtNS0xLTEtMjMzOTk_bcf578ef-596b-454b-8e21-813f65275201"
      unitRef="usd">19040000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMTY0OTI2NzQ0OTI1MQ_00da0b00-04d3-439b-9624-cfbb14b9483b"
      unitRef="number">0.200</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMTY0OTI2NzQ0OTI1Nw_61a2a7f0-8ce3-45a3-a341-d12144f8a4f9"
      unitRef="usd">3300000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RleHRyZWdpb246MzA2OWJkYmM4ZjMxNGQzNjkwMzM5NjA1OTA5Y2Y0OWVfMzcyNw_d8a2a0f3-8547-45d3-84bc-20d06e10714b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our non-marketable equity method investment consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOjk1NTY2M2UyODI2ZDQ0Njk4OWVkN2Y0OTgxNDIxOGI5L3RhYmxlcmFuZ2U6OTU1NjYzZTI4MjZkNDQ2OTg5ZWQ3ZjQ5ODE0MjE4YjlfMS0yLTEtMS0yMzM5OQ_02780a0f-9c4e-4bc6-971c-d101256092f0"
      unitRef="usd">3209000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV81OC9mcmFnOjMwNjliZGJjOGYzMTRkMzY5MDMzOTYwNTkwOWNmNDllL3RhYmxlOjk1NTY2M2UyODI2ZDQ0Njk4OWVkN2Y0OTgxNDIxOGI5L3RhYmxlcmFuZ2U6OTU1NjYzZTI4MjZkNDQ2OTg5ZWQ3ZjQ5ODE0MjE4YjlfMS00LTEtMS0yMzM5OQ_3c23d4ad-c82a-4cc2-9d78-fe64eb2384dc"
      unitRef="usd">3238000</us-gaap:EquityMethodInvestments>
    <icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RleHRyZWdpb246NDgwODViNmQzMjM1NDI0MWI0MTU1YWJiNmNkMzY2YmNfMjE3_af41bfd3-c5be-4749-8a0c-3cfb20cdaefe">Prepaid Expenses and Other Current Assets and Other Assets&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RleHRyZWdpb246NDgwODViNmQzMjM1NDI0MWI0MTU1YWJiNmNkMzY2YmNfMjE5_04711f52-7b84-42f9-836c-015a49ef04f9">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaid expenses and receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance and property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT/GST receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax charge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMS0yLTEtMS0yMzM5OQ_37a85796-4375-4ee5-adaf-ff6c16f63dc3"
      unitRef="usd">29647000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMS00LTEtMS0yMzM5OQ_250dd83f-b294-4cc3-ac0a-500825dcccdb"
      unitRef="usd">14763000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMi0yLTEtMS0yMzM5OQ_76f1bbf9-0fde-44db-b32e-cf15d41ad711"
      unitRef="usd">9795000</us-gaap:DeferredCostsAndOtherAssets>
    <us-gaap:DeferredCostsAndOtherAssets
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMi00LTEtMS0yMzM5OQ_8775c730-fceb-4f76-afed-d1d140d2783b"
      unitRef="usd">12746000</us-gaap:DeferredCostsAndOtherAssets>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMy0yLTEtMS0yMzM5OQ_b4f765ee-5c5c-4c4f-9607-a2d41f2a379a"
      unitRef="usd">19716000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidinsuranceandpropertytaxes
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfMy00LTEtMS0yMzM5OQ_075df269-d88f-4615-90a2-bd320ad19f9a"
      unitRef="usd">6310000</icui:Prepaidinsuranceandpropertytaxes>
    <icui:Prepaidothertaxes
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNC0yLTEtMS0yMzM5OQ_c26951f0-d6b9-4aee-bed7-30039703d92b"
      unitRef="usd">3981000</icui:Prepaidothertaxes>
    <icui:Prepaidothertaxes
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNC00LTEtMS0yMzM5OQ_13c3c3b3-9054-40da-be81-08624a65bd9f"
      unitRef="usd">4156000</icui:Prepaidothertaxes>
    <icui:Deferredtaxcharge
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNS0yLTEtMS0yMzM5OQ_93df0e43-412d-4c35-90ce-ed253f6a1a9e"
      unitRef="usd">4241000</icui:Deferredtaxcharge>
    <icui:Deferredtaxcharge
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNS00LTEtMS0yMzM5OQ_c40f904b-6bf4-4b32-959a-ebe0e2fddf25"
      unitRef="usd">4241000</icui:Deferredtaxcharge>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNi0yLTEtMS0yMzM5OQ_98fc1e78-abb2-4f5d-ab28-c7311de11afc"
      unitRef="usd">7629000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DerivativeAssetsCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNi00LTEtMS0yMzM5OQ_1cf03c64-453c-423a-a196-9635ac2ad52f"
      unitRef="usd">1061000</us-gaap:DerivativeAssetsCurrent>
    <us-gaap:DepositAssets
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNy0yLTEtMS0yMzM5OQ_34f43121-542c-4184-ba7d-112a71f61360"
      unitRef="usd">1345000</us-gaap:DepositAssets>
    <us-gaap:DepositAssets
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfNy00LTEtMS0yMzM5OQ_fbf8bfc1-188b-49de-bf8d-f1a9529808ed"
      unitRef="usd">1343000</us-gaap:DepositAssets>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOC0yLTEtMS0yMzM5OQ_8d70f0e6-2d3e-4a28-b640-8683d78a9dc7"
      unitRef="usd">3919000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOC00LTEtMS0yMzM5OQ_7976f15d-26de-4107-bd40-a3448abdb8a2"
      unitRef="usd">2227000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOS0yLTEtMS0yMzM5OQ_82155472-01df-4ba9-9b78-c5322d439fd7"
      unitRef="usd">80273000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmIwYzg1MGJjZDk0ODQ1ZTZhMDU4ZDc4Nzk0MDhhN2JkL3RhYmxlcmFuZ2U6YjBjODUwYmNkOTQ4NDVlNmEwNThkNzg3OTQwOGE3YmRfOS00LTEtMS0yMzM5OQ_0eb52cd9-a2e3-48e1-a8a9-0fe663a9b368"
      unitRef="usd">46847000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RleHRyZWdpb246NDgwODViNmQzMjM1NDI0MWI0MTU1YWJiNmNkMzY2YmNfMjIx_bf40d2ba-65e2-4156-904e-98b46843ce40">&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pump lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spare parts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMS0yLTEtMS0yMzM5OQ_fdf3e217-644f-4c56-a915-adb73abe87f4"
      unitRef="usd">27336000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMS00LTEtMS0yMzM5OQ_a5773a27-1bed-4f16-8403-00e36490e561"
      unitRef="usd">25941000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <icui:SpareParts
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMi0yLTEtMS0yMzM5OQ_6435a784-83c8-47be-933f-2a331961c7b8"
      unitRef="usd">32031000</icui:SpareParts>
    <icui:SpareParts
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMi00LTEtMS0yMzM5OQ_99f071b1-af08-4a05-bedc-404f4e5f0748"
      unitRef="usd">28538000</icui:SpareParts>
    <us-gaap:EquityMethodInvestments
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMy0yLTEtMS0yMzM5OQ_102f1282-7749-49d2-98bf-cf397f7c39e3"
      unitRef="usd">3209000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfMy00LTEtMS0yMzM5OQ_27dc79c7-a88b-422d-8335-e924751737c5"
      unitRef="usd">3238000</us-gaap:EquityMethodInvestments>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS0yLTEtMS02MzMxOA_34427584-d48c-4db0-96cc-f1e21e10f1b2"
      unitRef="usd">6496000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS00LTEtMS02MzMwOA_919ef840-72b8-4802-a243-e3112ca255d1"
      unitRef="usd">2827000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNC0yLTEtMS0yMzM5OQ_04581712-74ae-44a3-a093-240ffc69f26e"
      unitRef="usd">2545000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNC00LTEtMS0yMzM5OQ_75dde50e-e2c9-4af5-b5a5-030a4b33bbc8"
      unitRef="usd">2673000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ie43ab84d6c1a438ea5e125f66b6cd8bd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNy0yLTEtMS02MzMxOA_d9457157-2fc4-4141-a426-c3822f527455"
      unitRef="usd">28570000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i9bd1e48a37ce464490eb88d4e81041c1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNy00LTEtMS02MzMwOA_fdeb18c2-9719-4d1f-bec9-526dca86d5cc"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfOC0yLTEtMS03OTYzNw_c94bf1c5-f517-4103-a52e-71b206291de1"
      unitRef="usd">115000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i3e5193042f2c45bd83248a95c20e923d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfOC00LTEtMS03OTYzNw_b5c56686-86c0-48c7-8808-5f2ccb8a01f3"
      unitRef="usd">0</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS0yLTEtMS0yMzM5OQ_66cbb7ef-2f2a-4c7c-8a94-30de64f1f9e1"
      unitRef="usd">4315000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNS00LTEtMS0yMzM5OQ_f0887d8e-295e-4dd5-aa0c-c44ba927f5ce"
      unitRef="usd">526000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNi0yLTEtMS0yMzM5OQ_da6aef28-855a-4692-9451-6d7e7262962f"
      unitRef="usd">104617000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82MS9mcmFnOjQ4MDg1YjZkMzIzNTQyNDFiNDE1NWFiYjZjZDM2NmJjL3RhYmxlOmQ4N2MxNDNmOTQ1ZTQ1ZDQ4YzU5NDQ2NGMzMzRmZTgxL3RhYmxlcmFuZ2U6ZDg3YzE0M2Y5NDVlNDVkNDhjNTk0NDY0YzMzNGZlODFfNi00LTEtMS0yMzM5OQ_96ac44e0-ae13-4877-a55b-3eec03ddfae4"
      unitRef="usd">63743000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RleHRyZWdpb246YWU3ZTliYWRiMmQwNGI2OTg0ZjEyZDM2NDBlZmQ4NzFfMzc3_f24dd6cc-1d72-41d8-b6fb-f2bb9e2d93e8">Inventories&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Inventories are stated at the lower of cost or net realizable value with cost determined using the first-in, first-out method. Inventory costs include material, labor and overhead related to the manufacturing of our products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended March 31, 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RleHRyZWdpb246YWU3ZTliYWRiMmQwNGI2OTg0ZjEyZDM2NDBlZmQ4NzFfMzgw_139a9b76-5efb-4b97-9905-ec380cca48fa">Inventories consist of the following (in thousands):&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended March 31, 2022, inventories increased significantly due to the acquisition of Smiths Medical. All acquired inventory was recorded at fair value on January 6, 2022 in accordance with ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMS0xLTEtMS0yMzM5OQ_6a4e5fd4-59b8-4350-839c-ed9336c10463"
      unitRef="usd">232451000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMS0zLTEtMS0yMzM5OQ_488d68ca-ccae-43cf-8393-bae1e47c402c"
      unitRef="usd">135528000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMi0xLTEtMS0yMzM5OQ_ecf1bb07-fe12-41c7-89a5-2d7b83948ec8"
      unitRef="usd">74427000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMi0zLTEtMS0yMzM5OQ_59fa85d2-99db-439d-93d9-0b4e2314f5f7"
      unitRef="usd">36490000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMy0xLTEtMS0yMzM5OQ_90119c71-8c6a-4a5d-836c-cc19c28ce16f"
      unitRef="usd">229436000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfMy0zLTEtMS0yMzM5OQ_1fa03e02-89ec-4b80-8dd6-5c8af6b8fab8"
      unitRef="usd">118217000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfNC0xLTEtMS0yMzM5OQ_9bde016e-ef9a-40d4-bbe4-b3803d221918"
      unitRef="usd">536314000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82NC9mcmFnOmFlN2U5YmFkYjJkMDRiNjk4NGYxMmQzNjQwZWZkODcxL3RhYmxlOjUwN2Y2OTQwMDdjMjQxNzBiMzk0NDNkNjUyMTYzNjU1L3RhYmxlcmFuZ2U6NTA3ZjY5NDAwN2MyNDE3MGIzOTQ0M2Q2NTIxNjM2NTVfNC0zLTEtMS0yMzM5OQ_2d9bdf43-2278-4672-a6ff-a50a518a010a"
      unitRef="usd">290235000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfNDkz_d71573cb-6610-4f10-a63c-e4cd504bf1cb">Property, Plant and Equipment&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458,614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $21.4 million and $16.3&#160;million for the three months ended March 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended March 31, 2022, property, plant and equipment and related depreciation expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfNDg4_97c44bf9-1b1a-4097-ac29-885ceead391b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment consists of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, building and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments placed with customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(458,614)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMS0xLTEtMS0yMzM5OQ_3494bb0a-9bf7-450f-b137-acbbc1d194a7"
      unitRef="usd">432649000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMS0zLTEtMS0yMzM5OQ_91e476d4-a43f-4ffe-9727-6f8982372a99"
      unitRef="usd">321078000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i708212e3ab134bbaab535bc663a5a479_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMi0xLTEtMS0yMzM5OQ_e241b2af-f20c-44b5-a93c-a6054be19b10"
      unitRef="usd">289866000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id0ba8683ccfb439d8c9bf26272861771_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMi0zLTEtMS0yMzM5OQ_269492f3-96dc-4b87-85f2-729f42220e02"
      unitRef="usd">243377000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i190b17e0f2b041758e8c0431e71dcc64_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMy0xLTEtMS0yMzM5OQ_c9bd8619-fb76-4a5a-b4cd-80511e07e222"
      unitRef="usd">60499000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id29aa22c8f0840b08bc18688167f63d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMy0zLTEtMS0yMzM5OQ_805567fb-a7f8-4141-9bcc-bb4faf35486c"
      unitRef="usd">60463000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iddf2d2aa8b564efc876aa1ba23936f52_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNC0xLTEtMS0yMzM5OQ_e90c9ce5-a867-4f45-b5d9-b1d28d7756f2"
      unitRef="usd">112661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icfb0aaca7e4e4381ac74739e433b7861_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNC0zLTEtMS0yMzM5OQ_3fd11332-1975-42e2-bb0e-7870be3a6197"
      unitRef="usd">102979000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNS0xLTEtMS0yMzM5OQ_5409e4c8-dad7-4d2f-ab7e-dd1c35f5c411"
      unitRef="usd">10646000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNS0zLTEtMS0yMzM5OQ_5d436fbf-1027-431f-a208-487668ab110a"
      unitRef="usd">7670000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6c8a50a910984b9e86610a127c140e86_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNi0xLTEtMS0yMzM5OQ_a8e4f429-bef3-4ca3-8647-ee145d45b681"
      unitRef="usd">103257000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4c3826af64dd4f7db3fecffa7b173fc5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNi0zLTEtMS0yMzM5OQ_654729d2-d683-42f6-b93a-502c3bdbdc31"
      unitRef="usd">97384000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNy0xLTEtMS0yMzM5OQ_30b59439-058a-4f72-8796-4b3135df506e"
      unitRef="usd">123448000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfNy0zLTEtMS0yMzM5OQ_22d889f1-74c1-46ed-95b6-db0f45fc2021"
      unitRef="usd">72153000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOC0xLTEtMS0yMzM5OQ_44022310-3034-464e-9661-b3187c8053dc"
      unitRef="usd">1133026000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOC0zLTEtMS0yMzM5OQ_06740d1f-2552-46c8-8ca4-094a63d25b8b"
      unitRef="usd">905104000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOS0xLTEtMS0yMzM5OQ_cff48f52-ef3d-469b-a426-1a91a1ce4d0a"
      unitRef="usd">458614000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfOS0zLTEtMS0yMzM5OQ_395b0d84-ba7e-4093-bf89-578f364d7463"
      unitRef="usd">436739000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMTAtMS0xLTEtMjMzOTk_1d60c3da-f33c-4982-b88b-42b5ab0e0b93"
      unitRef="usd">674412000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RhYmxlOmVjMzM1ZDAyNTlkZDRmNjM5ZWRhODYyOGIxN2VmMGQ2L3RhYmxlcmFuZ2U6ZWMzMzVkMDI1OWRkNGY2MzllZGE4NjI4YjE3ZWYwZDZfMTAtMy0xLTEtMjMzOTk_8ee91103-b80b-46c6-9095-9d6e3458836e"
      unitRef="usd">468365000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfMzAx_178857e3-83ac-4d96-b9cf-41b005c0a5b9"
      unitRef="usd">21400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV82Ny9mcmFnOmU0MjZmMmExZDBmMzRhNDBiNjBhYjk0YmFkOTU1NzJkL3RleHRyZWdpb246ZTQyNmYyYTFkMGYzNGE0MGI2MGFiOTRiYWQ5NTU3MmRfMzk2_f80568ef-b8f4-49ea-bddd-5f6a5eb654c3"
      unitRef="usd">16300000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTExOA_671db673-1d82-4801-8bbe-bdfa96c4df79">Goodwill and Intangible Assets, Net&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the carrying amount of our goodwill (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to Smiths Medical acquired on January 6, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Other relates to measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&#160;in&#160;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;558,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;510,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,067,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,238,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with definite lives are amortized on a straight-line basis over their estimated useful lives. During the three months ended March&#160;31, 2022 and 2021, intangible asset amortization expense was $31.7 million and $5.8 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the quarter ended March 31, 2022, intangible assets and related amortization expense increased significantly due to the acquisition of Smiths Medical (see Note 3: Acquisitions).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTEyMQ_bb01cdc5-bde6-4bcd-9029-77296f38124b">The following table presents the changes in the carrying amount of our goodwill (in thousands):&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,560)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Relates to Smiths Medical acquired on January 6, 2022.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Other relates to measurement period adjustments related to a 2021 acquisition of a small foreign infusion systems supplier.&lt;/span&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfMS0yLTEtMS0yMzM5OQ_8ce3c81b-c2c2-419a-ae11-46c9173333c3"
      unitRef="usd">43439000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfMi0yLTEtMS0yMzM5OQ_efb1cf55-dc23-4b0d-ad38-741faacc109e"
      unitRef="usd">1493115000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfMy0yLTEtMS0yMzM5OQ_429ad652-269a-477f-acdf-df4c84655cbf"
      unitRef="usd">-7128000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfNC0yLTEtMS0yMzM5OQ_12b30994-6f32-46b6-966a-9210be75a4c4"
      unitRef="usd">-2560000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjUxYmU5OTI5NDAyYjQyZGVhYjg4YTc5ZjUxMDRiMTg4L3RhYmxlcmFuZ2U6NTFiZTk5Mjk0MDJiNDJkZWFiODhhNzlmNTEwNGIxODhfNS0yLTEtMS0yMzM5OQ_5513e417-073c-427b-a667-dc00bf0c170f"
      unitRef="usd">1526866000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTEzMg_d9c10c84-e33a-4cbd-8f78-aed4fa90712c">Intangible assets, carried at cost less accumulated amortization and amortized on a straight-lined basis, were as follows (in thousands):&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life&#160;in&#160;Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;558,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;510,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;581,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;519,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,211,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,067,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,238,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,094,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________________________ &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Internally developed software will be amortized when the projects are complete and the assets are ready for their intended use.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Life in Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:23pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Customer contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-contractual customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total amortized intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;275,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Internally developed software*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;301,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;188,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic439ddf48ef245c5b7e4afa06b2ebd93_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi0yLTEtMS0yMzM5OQ_3057c2aa-a21b-48f3-a69a-2d2ece93273c">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if65da200e05c4e4b9a561174b1bc7c23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi00LTEtMS0yMzM5OQ_90b2f3bc-8daa-4ea3-bb21-99b2ec2109d8"
      unitRef="usd">28012000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if65da200e05c4e4b9a561174b1bc7c23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi02LTEtMS0yMzM5OQ_7a12b2ae-c6b5-498c-af0f-7bd629c6f201"
      unitRef="usd">17213000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if65da200e05c4e4b9a561174b1bc7c23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMi04LTEtMS0yMzM5OQ_47f1455a-dc14-46a4-857e-036f86f83e4c"
      unitRef="usd">10799000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i731b7502508d4f8c8b50e49d76dc37ee_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy0yLTEtMS0yMzM5OQ_89a45bcf-01d2-421e-8f39-13003b22f78e">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy00LTEtMS0yMzM5OQ_bb43f8ab-755c-453f-ac5f-c2ee477ff0c6"
      unitRef="usd">10281000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy02LTEtMS0yMzM5OQ_d562f244-4bc3-4722-9da8-3a1095c6a505"
      unitRef="usd">6256000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i644fce9cbdb94b4cbdba02c8bbfaa47b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMy04LTEtMS0yMzM5OQ_88b50a9b-4301-4533-9265-5983f4c98e61"
      unitRef="usd">4025000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1e9016dd7b774b169ec2614f61542be9_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC0yLTEtMS0yMzM5OQ_70bc1165-303e-4ba8-8d44-aa1a85fc6d18">P8Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i71b6f20b81f44312800477e6da74fd8f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC00LTEtMS0yMzM5OQ_97431411-1dc2-4512-859c-dc2e97652827"
      unitRef="usd">558579000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i71b6f20b81f44312800477e6da74fd8f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC02LTEtMS0yMzM5OQ_70734105-825b-467f-a254-fce1d1684ce8"
      unitRef="usd">47757000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i71b6f20b81f44312800477e6da74fd8f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNC04LTEtMS0yMzM5OQ_bb4629cf-e55f-472a-a80f-940d54a2ecef"
      unitRef="usd">510822000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib7e4ab57206c488b97acd961e65966ff_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS0yLTEtMS0yMzM5OQ_e3b6eac6-1e19-4900-bc2e-e712351de569">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS00LTEtMS0yMzM5OQ_18863699-0165-4841-8e50-0c00d656401b"
      unitRef="usd">5425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS02LTEtMS0yMzM5OQ_8a5bd8f1-5dca-429f-924d-e17a38f2e27b"
      unitRef="usd">2424000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8ca8d4f19b3948c0b5d0e9a65b010398_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNS04LTEtMS0yMzM5OQ_ff6bfa70-b501-4b11-ae08-f2089f02d6ec"
      unitRef="usd">3001000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i912753928ea843239807436aa78d567d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi0yLTEtMS0yMzM5OQ_d0744d3c-1b44-45a0-b332-9b293a607d83">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3aec3bdfaced4372b17ea0347c016398_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi00LTEtMS0yMzM5OQ_906c93ac-1067-4478-b279-b8e885fbb9ca"
      unitRef="usd">18265000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3aec3bdfaced4372b17ea0347c016398_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi02LTEtMS0yMzM5OQ_f4af65a7-7b71-443d-a660-b8de286bc428"
      unitRef="usd">5045000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3aec3bdfaced4372b17ea0347c016398_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNi04LTEtMS0yMzM5OQ_90eadf72-92be-4ef4-a8c6-7f308161aa78"
      unitRef="usd">13220000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iabdeca4cff6a4718b4f1dd649c39be64_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy0yLTEtMS0yMzM5OQ_ec2724c3-a322-4f6f-a921-d06bde0197c0">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia17f985170954eb48428d61f36b19859_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy00LTEtMS0yMzM5OQ_0a09ca50-8040-4018-9ea8-ce7ae646fb42"
      unitRef="usd">581915000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia17f985170954eb48428d61f36b19859_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy02LTEtMS0yMzM5OQ_f3238abd-553a-4e87-bb50-f1d78f51ee02"
      unitRef="usd">62220000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia17f985170954eb48428d61f36b19859_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfNy04LTEtMS0yMzM5OQ_3f4de97d-06ea-4d3a-a9ad-0fdf63599b37"
      unitRef="usd">519695000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if65467afecf74a8b93960ba983aa3d59_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC0yLTEtMS0yMzM5OQ_60b9b9cf-64c6-46fc-9cba-33715b72acf3">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id6b397229737456d84db63d3bf2f90df_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC00LTEtMS0yMzM5OQ_03cd97b4-6205-4978-951e-8e96c9a81e88"
      unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id6b397229737456d84db63d3bf2f90df_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC02LTEtMS0yMzM5OQ_d979fed4-b324-41e0-b096-f7dbffb11531"
      unitRef="usd">3114000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id6b397229737456d84db63d3bf2f90df_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOC04LTEtMS0yMzM5OQ_bb0e230c-5cd1-4e86-9e91-650a1b43091c"
      unitRef="usd">5986000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOS00LTEtMS0yMzM5OQ_19300e01-ffbe-4ad3-9dc4-9663d63215dd"
      unitRef="usd">1211577000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOS02LTEtMS0yMzM5OQ_1298261d-596e-4bee-a472-ff4b0b57b74e"
      unitRef="usd">144029000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfOS04LTEtMS0yMzM5OQ_ca7f6501-1923-4e81-b410-c88e92f8ae13"
      unitRef="usd">1067548000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTEtNC0xLTEtMjMzOTk_73d87545-5cff-449f-8dcc-ae235f5d78db"
      unitRef="usd">27162000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTEtOC0xLTEtMjMzOTk_cbff7ad8-3657-49dd-9462-78154ddaa485"
      unitRef="usd">27162000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTMtNC0xLTEtMjMzOTk_3e1afa61-517f-4ceb-ba46-3ac4db5db0f0"
      unitRef="usd">1238739000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTMtNi0xLTEtMjMzOTk_11a87a3b-0832-4aa2-9a90-e854cd117f1d"
      unitRef="usd">144029000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOjFiMGYyYzgwMTY2NDRmMDk5NTM3MjQwZDMxZmZlMTAwL3RhYmxlcmFuZ2U6MWIwZjJjODAxNjY0NGYwOTk1MzcyNDBkMzFmZmUxMDBfMTMtOC0xLTEtMjMzOTk_467c71f3-0b15-4080-bb79-146af76aae1a"
      unitRef="usd">1094710000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i514d9e8e7edd4fa28d63ef9fccb34cd1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi0yLTEtMS0yMzM5OQ_addd357d-b42b-4e51-8c75-fbd281e636f5">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi00LTEtMS0yMzM5OQ_17308bb4-933c-4c31-b692-81c4056137da"
      unitRef="usd">27429000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi02LTEtMS0yMzM5OQ_67d35e14-dc35-4e89-90c4-edcd5c8ab8c1"
      unitRef="usd">16764000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i58bf397cce9f4fdb9485d50382dc0bd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMi04LTEtMS0yMzM5OQ_486f8af7-894c-4eab-ab84-bee821386605"
      unitRef="usd">10665000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i97a46089acbd4ff2aaeb2d2252ab6eb1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy0yLTEtMS0yMzM5OQ_84cd81d4-4651-4f8f-8432-711cfc639e79">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7205011397d3426281ae4bd434b15c77_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy00LTEtMS0yMzM5OQ_3ef8ee79-8ff6-42f7-a733-3920b4d549b3"
      unitRef="usd">10412000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7205011397d3426281ae4bd434b15c77_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy02LTEtMS0yMzM5OQ_2f4232b8-3f62-4df4-a865-cfb7097cbbc7"
      unitRef="usd">6196000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7205011397d3426281ae4bd434b15c77_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMy04LTEtMS0yMzM5OQ_d0a238b7-ca7a-4d1e-8933-63870e05eb29"
      unitRef="usd">4216000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5eb56f1821864a0db13d3ee2043d7dcd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC0yLTEtMS0yMzM5OQ_47b3c378-3e4d-4ecf-8090-a1b27e7d643c">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ide038f68482143e7bc6cead2e03b3248_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC00LTEtMS0yMzM5OQ_01ed2a9f-2e80-4bf3-bb01-3683b0dac7c1"
      unitRef="usd">57316000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ide038f68482143e7bc6cead2e03b3248_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC02LTEtMS0yMzM5OQ_9aab2dcd-6944-411e-8cbf-007873d286ba"
      unitRef="usd">33004000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ide038f68482143e7bc6cead2e03b3248_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNC04LTEtMS0yMzM5OQ_d59f2dc9-ba97-4ede-bbcb-9927b9f6ad86"
      unitRef="usd">24312000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i66bc748b1f3449e4a5e0f34ba0a23593_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS0yLTEtMS0yMzM5OQ_c3e1a33a-8e74-4b41-8b6c-ddd29b565645">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i02924cdb80304d2fbd0a1fd268de89a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS00LTEtMS0yMzM5OQ_a33e3712-8e68-44a2-a20b-18d1829bfe46"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i02924cdb80304d2fbd0a1fd268de89a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS02LTEtMS0yMzM5OQ_429570e9-3c98-480d-9549-45259db6573b"
      unitRef="usd">425000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i02924cdb80304d2fbd0a1fd268de89a3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNS04LTEtMS0yMzM5OQ_158aac85-e536-4752-9c06-6e4234e3a65d"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibfc7fd5a9dbe4432b60326ce95161345_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi0yLTEtMS0yMzM5OQ_6e5a8aa9-2e71-4e92-947a-4acdd6ab3f85">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4e310a8c7f034cd7853abf6100bc499e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi00LTEtMS0yMzM5OQ_8421c14e-edea-4547-ae70-d657ed0d8078"
      unitRef="usd">18260000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4e310a8c7f034cd7853abf6100bc499e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi02LTEtMS0yMzM5OQ_d06e33b4-8ff0-4566-8408-5217bff920f6"
      unitRef="usd">4731000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4e310a8c7f034cd7853abf6100bc499e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNi04LTEtMS0yMzM5OQ_9865a5c7-aa36-4fdd-8fc3-c44e433c5b5e"
      unitRef="usd">13529000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5230a8d671ee4f5ab0953b698bff8639_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy0yLTEtMS0yMzM5OQ_504d5d6c-a3f6-4f0c-ae3c-e6edc71c5e30">P13Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic17f4375ba33447ab41447690f328232_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy00LTEtMS0yMzM5OQ_4f20865b-775d-442c-9ad2-0d3afbf76297"
      unitRef="usd">152893000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic17f4375ba33447ab41447690f328232_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy02LTEtMS0yMzM5OQ_ec4d7501-2850-42c0-98c1-ba76b0ffb22a"
      unitRef="usd">49406000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic17f4375ba33447ab41447690f328232_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfNy04LTEtMS0yMzM5OQ_b1f0f36d-57cb-4e21-ae99-d36e08ce9295"
      unitRef="usd">103487000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if248896a740349349b9dc2c70a6c7362_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC0yLTEtMS0yMzM5OQ_4f600ed9-530e-4fc9-a701-55b58d96c97c">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC00LTEtMS0yMzM5OQ_6d6f14d6-99d3-4b4e-ac8b-47d020b5f2da"
      unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC02LTEtMS0yMzM5OQ_ea019936-3b98-4d67-bd32-fbc358237f62"
      unitRef="usd">2356000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7c8f028437bf4764af20ef5d6bf0c8b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOC04LTEtMS0yMzM5OQ_3801a529-6ce8-4cb7-bbdb-75e4fd4db39b"
      unitRef="usd">6744000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOS00LTEtMS0yMzM5OQ_c8e93ef4-35ee-47f2-a6ab-6582de6477e3"
      unitRef="usd">275835000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOS02LTEtMS0yMzM5OQ_4a7c3572-4ae3-4c31-ac4f-0b578ee2b22b"
      unitRef="usd">112882000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfOS04LTEtMS0yMzM5OQ_a885609a-fc90-4e4a-98f6-dd87690441e7"
      unitRef="usd">162953000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTEtNC0xLTEtMjMzOTk_cd29d848-7b2c-4361-ab16-37a4d5b1a8e7"
      unitRef="usd">25358000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTEtOC0xLTEtMjMzOTk_14c9b66a-b936-4f34-9720-4d9fb98d2111"
      unitRef="usd">25358000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTMtNC0xLTEtMjMzOTk_d1a31317-8a36-4ce4-95de-609bf8b175c4"
      unitRef="usd">301193000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTMtNi0xLTEtMjMzOTk_5e7a9daa-fefa-4e4b-9a2f-367943689fb7"
      unitRef="usd">112882000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmE0YjFkYjNlZjlhNTQwOGZhODZiYTNlY2EyNTY5NGQ1L3RhYmxlcmFuZ2U6YTRiMWRiM2VmOWE1NDA4ZmE4NmJhM2VjYTI1Njk0ZDVfMTMtOC0xLTEtMjMzOTk_dc6f41dc-92b8-4715-81c6-8f5e8688403a"
      unitRef="usd">188311000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfODY1_01391e8e-3387-457c-a6d8-c98850f15267"
      unitRef="usd">31700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfOTA1_39e2e9e6-7ae3-43e0-8eb9-bb7c5fecd8f3"
      unitRef="usd">5800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RleHRyZWdpb246YTUyMzhhOTkyYjFlNDgxMThiZGUyZjA1YzUxZmFlZDJfMTEzMQ_71564848-afad-4b87-92f8-a1aa7bf44894">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 estimated annual amortization for our intangible assets for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;333,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMC0yLTEtMS0yMzM5OQ_580c4739-a809-4ac2-bb16-e571c48fdc55"
      unitRef="usd">104564000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMS0yLTEtMS0yMzM5OQ_a922e47a-f5fc-46a9-8929-bd72ff32671d"
      unitRef="usd">132855000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMi0yLTEtMS0yMzM5OQ_2cffa45b-5c39-46e4-b823-dd0a6583eec7"
      unitRef="usd">132216000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfMy0yLTEtMS0yMzM5OQ_caeb0eaf-4393-492d-a87d-78d3f0f68993"
      unitRef="usd">124744000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNC0yLTEtMS0yMzM5OQ_50ef94b2-786e-4dd4-978b-b07b40b54708"
      unitRef="usd">123989000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNS0yLTEtMS0yMzM5OQ_5185cdd2-9805-4830-bce6-25d856e16ceb"
      unitRef="usd">116092000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNi0yLTEtMS0yMzM5OQ_6256cb18-f186-4712-93cf-9945b3d11887"
      unitRef="usd">333088000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83MC9mcmFnOmE1MjM4YTk5MmIxZTQ4MTE4YmRlMmYwNWM1MWZhZWQyL3RhYmxlOmZlNTIyMTE3MjgxYzQzMmZhYTQ4NTQwM2NlODk3MjljL3RhYmxlcmFuZ2U6ZmU1MjIxMTcyODFjNDMyZmFhNDg1NDAzY2U4OTcyOWNfNy0yLTEtMS0yMzM5OQ_3a0194b3-7d31-4e34-beb9-0d14f383d73f"
      unitRef="usd">1067548000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RleHRyZWdpb246OWYxMDQ5MDRhYzlmNDE3YTg5MTY2YTk5MDBlMzBlNmNfMjEx_d06b09b4-da9e-4fb8-8e8e-3f64fa9ae217">Accrued Liabilities and Other Long-Term Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Accrued liabilities consist of the following (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired restructuring liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued transaction/integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued audit fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes $31.3&#160;million of estimated remediation costs related to a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.&lt;/span&gt;&lt;/div&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RleHRyZWdpb246OWYxMDQ5MDRhYzlmNDE3YTg5MTY2YTk5MDBlMzBlNmNfMjA3_e6b88f8b-d9ef-47a0-97d6-84902ffdf76d">Accrued liabilities consist of the following (in thousands):&#160;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-ST&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued sales taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legal accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranties and returns&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued freight&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired restructuring liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued transaction/integration costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued audit fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Defined benefit plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;___________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes $31.3&#160;million of estimated remediation costs related to a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail.&lt;/span&gt;&lt;/div&gt;Other long-term liabilities consist of the following (in thousands):&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward-starting interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liability-LT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Field service corrective action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <icui:AccruedSalariesAndBenefits
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMS0xLTEtMS0yMzM5OQ_70f052fd-af62-406d-8ee3-bc8acf05f6c4"
      unitRef="usd">47604000</icui:AccruedSalariesAndBenefits>
    <icui:AccruedSalariesAndBenefits
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMS0zLTEtMS0yMzM5OQ_58de87eb-5653-41e6-b7e4-3850081d378e"
      unitRef="usd">27304000</icui:AccruedSalariesAndBenefits>
    <us-gaap:AccruedBonusesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMi0xLTEtMS0yMzM5OQ_7041382c-5270-4395-8ed9-bb09a409f3a6"
      unitRef="usd">19930000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMi0zLTEtMS0yMzM5OQ_349c8e42-f502-405e-9dd5-b2279bee2797"
      unitRef="usd">33107000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfNC0xLTEtMS0yMzM5OQ_8ebd40c4-bd6e-4f8e-b444-6aeef148ed34"
      unitRef="usd">20786000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfNC0zLTEtMS0yMzM5OQ_7dcadc56-55da-46b3-bb04-344bbd2daeec"
      unitRef="usd">9009000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOC0xLTEtMS0yMzM5OQ_64ac18e5-7c79-41ac-b571-9bba34b47a70"
      unitRef="usd">7491000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOC0zLTEtMS0yMzM5OQ_4b0d0de4-e958-43db-bd85-881d93375a20"
      unitRef="usd">1980000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOS0xLTEtMS0yMzM5OQ_96252081-fff5-4082-9fde-1ae218ca05fc"
      unitRef="usd">2430000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfOS0zLTEtMS0yMzM5OQ_d26720bf-9ba2-4bef-a854-1cb77251bbdc"
      unitRef="usd">664000</us-gaap:RestructuringReserveCurrent>
    <icui:UnfavorablecontractliabilityST
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTEtMS0xLTEtMjMzOTk_ad7ce96d-9689-4ce9-aa72-76adc1e2b10c"
      unitRef="usd">40870000</icui:UnfavorablecontractliabilityST>
    <icui:UnfavorablecontractliabilityST
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTEtMy0xLTEtMjMzOTk_fc695162-215c-4cff-8011-67cbc97d58d8"
      unitRef="usd">12646000</icui:UnfavorablecontractliabilityST>
    <icui:Accruedothertaxes
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTItMS0xLTEtMjMzOTk_29386317-7cab-438a-89e5-ca88575e266d"
      unitRef="usd">1653000</icui:Accruedothertaxes>
    <icui:Accruedothertaxes
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTItMy0xLTEtMjMzOTk_95bf1b1f-c64f-4a7a-aadc-f82f67800efc"
      unitRef="usd">4337000</icui:Accruedothertaxes>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTMtMS0xLTEtMjMzOTk_c81f4ff5-b1d5-48da-98be-eda5c9d4035b"
      unitRef="usd">16608000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTMtMy0xLTEtMjMzOTk_ed4ab9cb-3637-4064-a457-100888dc905d"
      unitRef="usd">773000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <icui:Accruedlegalfees
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTQtMS0xLTEtMjMzOTk_d3ed3b21-1972-49a0-bcea-dee35e255940"
      unitRef="usd">3216000</icui:Accruedlegalfees>
    <icui:Accruedlegalfees
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTQtMy0xLTEtMjMzOTk_9ac9c3a3-9954-469e-af91-309eaa02b9a6"
      unitRef="usd">3897000</icui:Accruedlegalfees>
    <icui:Outsidesalescommissions
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTYtMS0xLTEtMjMzOTk_4ea4563b-cf87-4b15-b6d4-d79736e4a425"
      unitRef="usd">21084000</icui:Outsidesalescommissions>
    <icui:Outsidesalescommissions
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTYtMy0xLTEtMjMzOTk_995f60e1-875e-40a4-9e92-d6d69cdc622e"
      unitRef="usd">5645000</icui:Outsidesalescommissions>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTctMS0xLTEtMjMzOTk_9d38b1fd-b994-47ff-8159-3613d8fd4da8"
      unitRef="usd">31857000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTctMy0xLTEtMjMzOTk_7020271a-bf7b-4ba3-afb3-d01a138c407b"
      unitRef="usd">532000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <icui:Accruedfreight
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTgtMS0xLTEtMjMzOTk_b021a9c0-1d82-4835-8f83-ec6ea957122d"
      unitRef="usd">10285000</icui:Accruedfreight>
    <icui:Accruedfreight
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMTgtMy0xLTEtMjMzOTk_546bf1ac-b8b4-4c06-8abc-bbb346a835e2"
      unitRef="usd">9194000</icui:Accruedfreight>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjAtMS0xLTEtNjk5NzE_7828cc00-8d9b-47da-8647-0203a13ad0cc"
      unitRef="usd">895000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i3e5193042f2c45bd83248a95c20e923d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjAtMy0xLTEtNjk5NzE_f4b54162-c523-4261-869b-0476c06329e9"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesCurrent>
    <icui:AcquiredRestructuringLiabilityCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjEtMS0xLTEtMjMzOTk_bf95e6f0-f251-4532-8165-48b9ee7961f1"
      unitRef="usd">6775000</icui:AcquiredRestructuringLiabilityCurrent>
    <icui:AcquiredRestructuringLiabilityCurrent
      contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjEtMy0xLTEtMjMzOTk_aed28218-dfa7-43bf-b802-cf148c4f31ce"
      unitRef="usd">0</icui:AcquiredRestructuringLiabilityCurrent>
    <icui:AccruedTransactionCosts
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMS0xLTEtODQwNDU_8fc8ee01-c2ee-4021-9fad-897faf282da4"
      unitRef="usd">8982000</icui:AccruedTransactionCosts>
    <icui:AccruedTransactionCosts
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMy0xLTEtODQwNjY_9d6142cd-8ef4-430e-a40a-28c9902386b8"
      unitRef="usd">0</icui:AccruedTransactionCosts>
    <icui:AccruedAuditFees
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjUtMS0xLTEtODQwNTI_e0c12b3f-3e41-4985-a2e0-b5bf37693b33"
      unitRef="usd">3187000</icui:AccruedAuditFees>
    <icui:AccruedAuditFees
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjUtMy0xLTEtODQwNTk_f751be3b-0144-48be-ac11-0b809393fa3a"
      unitRef="usd">1008000</icui:AccruedAuditFees>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMS0xLTEtODIwOTI_3b2b21c7-04e1-4199-b747-70023e1de5b2"
      unitRef="usd">2796000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMy0xLTEtODIwOTk_55fffe9a-8ab0-4744-bea6-b49300f77068"
      unitRef="usd">0</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjMtMS0xLTEtMjMzOTk_fc4be422-e752-4b5e-96f9-3b267c6b099c"
      unitRef="usd">15371000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjMtMy0xLTEtMjMzOTk_fa12a7e3-35d0-4530-86fa-cee03d8bd7fe"
      unitRef="usd">8099000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMS0xLTEtMjMzOTk_08e57882-9ba1-4428-a13f-cd77e57f3bcc"
      unitRef="usd">261820000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOmUxOWJkNTBkNTMyNzQ1MTE5Y2RjN2Y2ZDc0NTc3YTI1L3RhYmxlcmFuZ2U6ZTE5YmQ1MGQ1MzI3NDUxMTljZGM3ZjZkNzQ1NzdhMjVfMjQtMy0xLTEtMjMzOTk_3b00ee63-673b-495c-8dca-0c8da16be919"
      unitRef="usd">118195000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="ic2dd7ec8ea2a4048a06ea268924bf23a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RleHRyZWdpb246OWYxMDQ5MDRhYzlmNDE3YTg5MTY2YTk5MDBlMzBlNmNfMTA5OTUxMTYyODk2NA_7f62d86c-72c3-4618-818a-d6893665b4c8"
      unitRef="usd">31300000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMy0xLTEtMS0yMzM5OQ_ccbf8ffb-e267-4576-8ef6-f942626e6984"
      unitRef="usd">73391000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMy0zLTEtMS0yMzM5OQ_7d320084-a07b-40b9-ac1a-14ea162e1f39"
      unitRef="usd">33971000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNC0xLTEtMS0yMzM5OQ_8b50e06b-8ea9-437a-bc4f-46db64c562c4"
      unitRef="usd">1272000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNC0zLTEtMS0yMzM5OQ_540b8f3b-153e-4f45-8ff9-632db695689b"
      unitRef="usd">1369000</us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNS0xLTEtMS0yMzM5OQ_7a655156-842d-47ec-b21c-93eff91a1984"
      unitRef="usd">1231000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <us-gaap:AccruedRentCurrentAndNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNS0zLTEtMS0yMzM5OQ_25d49aa2-e50c-4d8c-a9e7-5cf1ee14909c"
      unitRef="usd">1262000</us-gaap:AccruedRentCurrentAndNoncurrent>
    <icui:Liabilitiesforcontracts
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNi0xLTEtMS0yMzM5OQ_ba4e51c3-ff9e-4f51-877f-04aa4e95614d"
      unitRef="usd">168000</icui:Liabilitiesforcontracts>
    <icui:Liabilitiesforcontracts
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfNi0zLTEtMS0yMzM5OQ_7fd80eb2-19d0-478f-bf23-1c9a3defdcef"
      unitRef="usd">202000</icui:Liabilitiesforcontracts>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0xLTEtMS02NDA2Mg_80190eee-1b2a-4de7-8638-d1805f7792c1"
      unitRef="usd">0</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:InterestRateDerivativeLiabilitiesAtFairValue
      contextRef="ic0ac7a7c0982447ba048c5eb2590b89f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0zLTEtMS02NDA2Mg_ba4defc8-17de-4ade-b01c-9f7ff745c0eb"
      unitRef="usd">1480000</us-gaap:InterestRateDerivativeLiabilitiesAtFairValue>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ib1f1c44876a242d58926d2c6cfd7d32a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0xLTEtMS03ODk2MQ_9721fce2-dbe7-4843-8807-1441f6dbdc92"
      unitRef="usd">27000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i3e5193042f2c45bd83248a95c20e923d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0zLTEtMS03ODk2MQ_986fbcf4-3964-46f2-8516-28a8d02626c3"
      unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0xLTEtMS0yMzM5OQ_d8e00191-1db4-40b2-8101-c452d3c60e21"
      unitRef="usd">1923000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOC0zLTEtMS0yMzM5OQ_529d5d04-1908-4473-bd22-352188847d08"
      unitRef="usd">2067000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOS0xLTEtMS0yMzM5OQ_338bab05-d1eb-44d4-9224-2905251a64ff"
      unitRef="usd">22828000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfOS0zLTEtMS0yMzM5OQ_ec42d63d-5974-4d40-954a-8e71a5f1e00b"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="if5b1cec7abee4f76b35a418a82f45396_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTItMS0xLTEtODE3ODE_c8d08913-dddc-49c2-97bd-70b8ea80a30e"
      unitRef="usd">23385000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="idf4da5fb2b8244bca91159e192d1b9ee_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTItMy0xLTEtODE3ODg_d6228173-00e9-464c-8163-a714357e4e2e"
      unitRef="usd">0</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTAtMS0xLTEtMjMzOTk_d01014b7-f265-4c70-afd3-96292443d9a0"
      unitRef="usd">9983000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTAtMy0xLTEtMjMzOTk_3eaf2698-57ae-48c8-bf0c-5faede01e4ee"
      unitRef="usd">1479000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTEtMS0xLTEtMjMzOTk_1a229b70-ef5c-40a7-974e-823c014560a6"
      unitRef="usd">134208000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83My9mcmFnOjlmMTA0OTA0YWM5ZjQxN2E4OTE2NmE5OTAwZTMwZTZjL3RhYmxlOjdmYTg1M2I5ZDAxNjQ4Zjg5Zjg4OGViNjQ3Y2UzY2ExL3RhYmxlcmFuZ2U6N2ZhODUzYjlkMDE2NDhmODlmODg4ZWI2NDdjZTNjYTFfMTEtMy0xLTEtMjMzOTk_f27e5418-30aa-45b8-ba6a-68debcf4257d"
      unitRef="usd">41830000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTk5Ng_af02782b-5b44-467a-bac5-88e31cd823d0">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes were accrued at an estimated effective tax rate of 31% and 12% for the three months ended March 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2022 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, section 162(m) excess compensation, foreign-derived intangible income ("FDII") and tax credits and the following discrete items recognized during the interim period:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the three months ended March 31, 2022 of $2.6&#160;million.    &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The effective tax rate for the three months ended March 31, 2021 differs from the federal statutory rate of 21% principally because of the effect of the mix of U.S. and foreign incomes, state income taxes, global intangible low taxed income ("GILTI"), FDII and tax credits. The effective tax rate during the three months ended March 31, 2021 included a discrete tax benefit of $1.8&#160;million related to excess tax benefits recognized on stock option exercises and the vesting of restricted stock units during the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfOTY_fa82219b-e2ac-4533-9c2b-1d0d5c30761f"
      unitRef="number">0.31</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTkx_3b53aa66-7f3a-47d4-8b73-0ccb3a494655"
      unitRef="number">0.12</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMzU1_793958d3-869e-4377-9a74-cf5f4ed46593"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfNzg5_012bf9e5-3135-459e-be57-e782138aa3a0"
      unitRef="usd">2600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTE3MA_98b6ef9c-40f0-4739-b205-bb184c819ead"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83Ni9mcmFnOjFkYWNhNWQzMzI4MjRmZmM5MDIyZmNmZWY1ZjZjNGI3L3RleHRyZWdpb246MWRhY2E1ZDMzMjgyNGZmYzkwMjJmY2ZlZjVmNmM0YjdfMTUyNQ_3409a25c-23ba-4b2a-aa30-3aff82e980bf"
      unitRef="usd">1800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMzA5OA_303eed1e-04df-4941-b732-7d840e02cd22">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, in connection with the acquisition of Smiths Medical, we entered into a Credit Agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, Wells Fargo Securities, LLC, Barclays Bank PLC and certain other financial institutions (the &#x201c;Lenders&#x201d;) for $2.2&#160;billion of senior secured credit facilities. The senior secured credit facilities include (i) a five-year Tranche A term loan of $850.0&#160;million (the "Term Loan A"), (ii) a seven-year Tranche B term loan of $850.0&#160;million (the "Term Loan B") and (iii) a five-year revolving credit facility of $500.0&#160;million (the "Revolving Credit Facility"), with separate sub-limits of $50.0&#160;million for letters of credit and swingline loans (collectively, the "Senior Secured Credit Facilities"). We used the proceeds from borrowings under the Term Loan A and the Term Loan B (collectively, the "Term Loans") to fund a portion of the cash consideration for the purchase of Smiths Medical and the related fees and expenses incurred in connection with the acquisition. We did not incur borrowings under the Revolving Credit Facility on the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;closing date of the acquisition. The proceeds from any future borrowings under the Revolving Credit Facility may be used for working capital and other general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with entering into the Credit Agreement, during the period ended March 31, 2022, we incurred $37.8 million in debt discount and issuance costs, which were allocated to the Term Loan A, the Term Loan B and the Revolving Credit Facility based on lender commitment amounts relative to each type of fees paid. The lender and third-party discount and issuance costs allocated to the Term Loan A and the Term Loan B were $15.8 million and $13.4 million, respectively, and are reflected as a direct deduction from the face amount of the corresponding term loans on the condensed consolidated balance sheet. These costs are being amortized to interest expense over the respective terms of the loans using the effective interest method. The issuance costs allocated to the Revolving Credit Facility were $8.7 million, which are capitalized and included in prepaid expenses and other current assets and other assets on our condensed consolidated balance sheets. These costs are being amortized to interest expense over the term of the Revolving Credit Facility using the straight-line method. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net funds received from the Term Loan A and the Term Loan B, after deducting debt issuance costs, were $834.2 million and $836.6 million, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity Dates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity date for the Term Loan A and the Revolving Credit Facility is January 6, 2027, and the maturity date for the Term Loan B is January 6, 2029. Pursuant to the terms and conditions of the Credit Agreement, the maturity dates of the Term Loans and the Revolving Credit Facility may be extended upon our request, subject to the consent of the Lenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Terms&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, the Term Loans and borrowings under the Revolving Credit Facility denominated in U.S. dollars bear interest, at our option, on either: (1) the Base Rate, as defined below, plus the applicable margin, as indicated below ("Base Rate Loans") or (2) the Adjusted Term Secured Overnight Financing Rate ("Adjusted Term SOFR"), as defined below, plus the applicable margin, as indicated below ("Term SOFR Loans"). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Base Rate is defined as the highest of (a) the Prime Rate, (b) the Federal Funds Rate plus 0.50% and (c) Adjusted Term SOFR (as defined below) for a one-month period plus, in each case, plus 1.00%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjusted Term SOFR is the rate per annum equal to (a) Term SOFR plus (b) the Term SOFR Adjustment. Term SOFR is the forward-looking term rate based on SOFR and is calculated separately for Term SOFR Loans and Base Rate Loans, as specified in the Credit Agreement. The Term SOFR Adjustment is a percentage per annum of 0.10% for Base Rate Loans and between 0.10% to 0.25% for Term SOFR Loans based on the applicable interest period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facility Commitment Fee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Revolving Credit Facility has a per annum commitment fee at an initial rate of 0.25% which is applied to the available amount of the Revolving Credit Facility. Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the commitment fee will be determined by reference to the leverage ratio in effect from time to time as set forth in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Applicable Interest Margins&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan A and borrowings under the Revolving Credit Facility have an initial applicable margin of 0.75% per annum for Base Rate Loans and 1.75% per annum for Term SOFR Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan B has an initial applicable margin of 1.5% per annum for Base Rate Loans and 2.5% per annum for Term SOFR Loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan B will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.665%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.75 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principal Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the Term Loans are due on the last day of each calendar quarter commencing on June 30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan A will amortize in nineteen consecutive quarterly installments in an amount equal to 2.50% of the original principal amount in each of the first two years, 5.00% in each of the third and fourth years and 7.50% in the fifth year, with a final payment of the remaining outstanding principal balance due on the maturity date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan B matures in twenty-seven consecutive quarterly installments in an amount equal to 0.25% of the original principal amount, with a final payment of the remaining outstanding principal balance due on the maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may borrow, prepay and re-borrow amounts under the Revolving Credit Facility, in accordance with the terms and conditions of the Credit Agreement, with all outstanding amounts due at maturity. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During March 2022, we prepaid $16.0 million in principal payments on the Term Loan A principal balance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Payments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest payments on Base Rate Loans are payable quarterly in arrears on the last business day of each calendar quarter and the applicable maturity date. Interest periods on Term SOFR Loans will be determined, at our option, as either one, three or six months and will be payable on the last day of each interest period and the applicable maturity date. In the case of any interest periods of more than three months' duration, the interest payment will be payable on each day prior to the last day of such interest period that occurs at three-month intervals.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The commitment fee on the Revolving Credit Facility is payable quarterly in arrears on the third business day following the last day of each calendar quarter and at the maturity date. The commitment fee is included in interest expense in our condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantors and Collateral&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Credit Agreement are unconditionally guaranteed, on a joint and several basis, by ICU Medical, Inc. and certain of our existing subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains affirmative and negative covenants, including certain financial covenants. The negative covenants include restrictions regarding the incurrence of liens and indebtedness, certain merger and acquisition transactions, asset sales and other dispositions, other investments, dividends, share purchases and payments affecting subsidiaries, changes in nature of business, fiscal year or organizational documents, prepayments and redemptions of subordinated and other junior debt, transactions with affiliates, and other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial covenants include the Senior Secured Leverage Ratio and the Interest Coverage Ratio, both defined below, and pertain to the Term Loan A and the Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Senior Secured Leverage Ratio is defined, at any such date, as the ratio of: (a) all Funded Debt, as defined in the Credit Agreement, that is secured by a lien on any asset or property minus the lesser of (i) all unrestricted cash and cash equivalents and (ii) $500.0&#160;million, to (b) Consolidated EBITDA, as defined in the Credit Agreement, for the most recently completed four fiscal quarters, calculated on a pro forma basis. The maximum Senior Secured Leverage Ratio is 4.50 to 1.00 until June 30, 2024. Thereafter, the maximum Senior Secured Leverage Ratio is 4.00 to 1.00, with limited permitted exception.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Interest Coverage ratio is defined, at any such date, as the ratio of Consolidated EBITDA, as defined in the Credit Agreement, to Consolidated Interest Expense, as defined in the Credit Agreement, paid or payable in cash, for the most recently completed four fiscal quarters. The minimum Interest Coverage ratio is 3.00 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We were in compliance with all financial covenants as of March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary events of default, including, among others: non-payments of principal and interest; breach of representations and warranties; covenant defaults; cross-defaults and cross-acceleration to certain other material indebtedness; the existence of bankruptcy or insolvency proceedings; certain events under ERISA; material judgments; and a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the administrative agent and the Lenders are entitled to take various actions, including, without limitation, the acceleration of all amounts due and the termination of commitments under the Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2017 Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On November 8, 2017, we entered into a five-year senior secured revolving credit facility with various lenders for $150.0 million, with Wells Fargo Bank, National Association as the administrative agent, swingline lender and issuing lender (the "Prior Credit Facility"). The Prior Credit Facility, which was set to mature on November 8, 2022, was terminated in connection with entering into the Credit Agreement on January 6, 2022. There were no borrowings outstanding under the Prior Credit Facility at that date or at December 31, 2021. The remaining unamortized deferred debt issuance costs related to the Prior Credit Facility were not material and were expensed in connection with its termination. See further details of the terms of the Prior Credit Facility in Note 11 in Part II, Item 8, of our 2021 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of our long-term debt consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,642,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprised of $15.0 million and $13.0 million relating to the Term Loan A and the Term Loan B, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,684,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total interest expense related to our long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee &#x2014; Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <icui:TotalSeniorSecuredCreditFacility
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0NDk2MQ_cd2997d2-1fc2-4605-9c9c-93fcbf6be46b"
      unitRef="usd">2200000000</icui:TotalSeniorSecuredCreditFacility>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0Njg4Nw_de2ec5cb-5d69-4841-86e0-07240b46133a"
      unitRef="usd">850000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0NjkwMw_f427e247-4449-46a2-8409-2ab0f4c5b1d9"
      unitRef="usd">850000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i99c31a1bbc5e49dfba0d6f77e03b2107_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ0NjkxOQ_2dcaab8f-7a39-4d1c-8d9b-f6098d7d90b6"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <icui:RevolverSubLimits
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ5NTkwMA_197d8327-2714-4f68-9cfb-33ac1f4c709d"
      unitRef="usd">50000000</icui:RevolverSubLimits>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODE5MQ_ea89d7c3-42ad-41e0-93a2-76237b1bbd13"
      unitRef="usd">37800000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODIyMg_89297a6b-dbf8-4e57-9446-8ded46d7892c"
      unitRef="usd">15800000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODI0Mg_ce17cd52-50dd-4224-a8de-a1cfcdfee288"
      unitRef="usd">13400000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i99c31a1bbc5e49dfba0d6f77e03b2107_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODI2Mg_49ab5d22-0a1b-45b4-9abe-8ea6907b732b"
      unitRef="usd">8700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODI4MQ_0a9d1ba0-a4c5-4ad2-a023-fd8d7a2fecd6"
      unitRef="usd">834200000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMwMg_87ab9c0e-3123-47a7-81e3-89f5f662b9d2"
      unitRef="usd">836600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwMjQ3Ng_f1b2ead5-5e4d-4c31-99a8-078b14b8ac78">2027-01-06</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwMjQ5Mw_31767190-0354-449d-b4a1-82779b63432b">2029-01-06</us-gaap:DebtInstrumentMaturityDate>
    <icui:InterestPercentageAddedToFederalFundsRate
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxMTg1NA_1242d266-1dcc-40db-8d4e-4a85220a5069"
      unitRef="number">0.0050</icui:InterestPercentageAddedToFederalFundsRate>
    <icui:InterestPercentageAddedToBaseRate
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxMjMyNQ_f2fd6db0-164b-4565-b8a2-cd5316276197"
      unitRef="number">0.0100</icui:InterestPercentageAddedToBaseRate>
    <icui:TerSOFRInterestRateAdjustmentForBaseRateLoans
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxNjYyNQ_a3c57553-49ad-42e0-bee8-baafbca29f49"
      unitRef="number">0.0010</icui:TerSOFRInterestRateAdjustmentForBaseRateLoans>
    <icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans
      contextRef="i78ebe3443d494bd490f9f07d5202134d_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxNjYzMg_5c0edb43-83b7-4b22-802f-10b830005011"
      unitRef="number">0.0010</icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans>
    <icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans
      contextRef="i8646fd65464c418fae83a8e61e4c8e4b_I20220331"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxNjYzOQ_98f069c5-2670-49e6-bfb8-bb295a070cad"
      unitRef="number">0.0025</icui:TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwMDIxOA_bc96ce56-4806-4e9e-886c-ed91b9386087"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwNjM1NA_817e02a6-9ffe-4615-8751-fa592af6a9cd"
      unitRef="number">0.0075</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwOTUxMw_2969fc52-b1c5-452b-95ab-1136a9151a35"
      unitRef="number">0.0175</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxMw_9874ab50-1e71-4492-a486-802fd2fe3072">Effective on the first Adjustment Date, as defined in the Credit Agreement, occurring subsequent to our quarter ending June 30, 2022, the applicable margin for the Term Loan A and borrowings under the Revolving Credit Facility will be determined by reference to the leverage ratio in effect from time to time as set forth in the following table: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Term SOFR Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than 4.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 4.00 to 1.0 but greater than 3.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 3.00 to 1.0 but greater than 2.50 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.50 to 1.0 but greater than 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than or equal to 2.00 to 1.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</icui:ApplicableMarginBasedOnLeverageRatioTableTextBlock>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i9ae4f3915f574485829c8127bbdd1797_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMS0xLTEtMS04Mzg4Nw_693a765b-23b5-4e5d-acde-2056b73e3d1e"
      unitRef="number">0.0225</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i9ae4f3915f574485829c8127bbdd1797_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMS0yLTEtMS04Mzg4OQ_4e84fd85-191f-4b51-a3be-04b0e8eb3c68"
      unitRef="number">0.0125</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i78b84b5657084d8e998eb611076dc5ab_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMS0zLTEtMS04Mzg5NA_1fd2c4c4-485b-4eae-bcca-ef8b2a6f8053"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="icab58ddd66a140bc97118bd0a1be6cef_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMi0xLTEtMS04Mzg5Mg_1a4ff9a9-8716-4790-b269-7a2ef68d2b4e"
      unitRef="number">0.0200</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="icab58ddd66a140bc97118bd0a1be6cef_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMi0yLTEtMS04Mzg4OQ_3fd089f3-d72b-4402-86c4-ff0373484d89"
      unitRef="number">0.0100</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i1d03299aace54ed7ac0e3ac6f5fe2d8c_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMi0zLTEtMS04Mzg5NA_6c1dc68c-f80c-4416-9972-e6cbddf95851"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i148b265b5e2742bd83a80cbf70e476da_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMy0xLTEtMS04Mzg5Mg_d102ce6f-0f47-49d0-bb94-d4f8182193ef"
      unitRef="number">0.0175</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i148b265b5e2742bd83a80cbf70e476da_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMy0yLTEtMS04Mzg4OQ_49273537-080a-442c-aef6-0f8e5aa122dc"
      unitRef="number">0.0075</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i121a2aae16c14453b205c42847a26f54_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfMy0zLTEtMS04Mzg5NA_9017b65b-6bcf-4011-bc89-ccfcdee248ec"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="if626b886e63044aaa9c6735867a954ec_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNC0xLTEtMS04Mzg5Mg_51e122a7-ffea-4437-bc90-d0b596de4828"
      unitRef="number">0.0150</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="if626b886e63044aaa9c6735867a954ec_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNC0yLTEtMS04Mzg4OQ_55a1395a-c21e-46e9-af08-00b1e61a2159"
      unitRef="number">0.0050</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ic46418b7be58471cb3d15195cc4f5e2e_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNC0zLTEtMS04Mzg5NA_d646ab30-f806-4cd6-97c0-303a6720d9ff"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="ibc6ce78ff0d54018b0f911617adafb8c_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNS0xLTEtMS04Mzg5Mg_1ec187c5-a110-46b7-9966-7ae5a810abe7"
      unitRef="number">0.0125</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="ibc6ce78ff0d54018b0f911617adafb8c_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNS0yLTEtMS04Mzg4OQ_25d18833-566c-4529-94bf-edde0484cff5"
      unitRef="number">0.0025</icui:ApplicableMarginBaseRateLoans>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i57b48a056c4f4370adbb6f193d7b4dd9_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjE4MjE2NjU5MGQ3NDQ0NTk4OWJmYmZmZWYxNGEzMWUwL3RhYmxlcmFuZ2U6MTgyMTY2NTkwZDc0NDQ1OTg5YmZiZmZlZjE0YTMxZTBfNS0zLTEtMS04Mzg5NA_0dadb25f-0422-4f64-bb0f-4390721f9ad1"
      unitRef="number">0.0015</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMjE5OTAyMzMyMzA5NQ_45351cf6-bb9b-44dc-904a-abfe3094bfe9"
      unitRef="number">0.015</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUwOTgxMg_c952e26d-420c-4096-b089-f29c7a38ee54"
      unitRef="number">0.025</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i6e374be09b9f4b79a626d3ea4af57397_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMS0xLTEtMS04Mzg5OQ_066fbb1c-c4bc-480c-bea7-81c618e67e5f"
      unitRef="number">0.0250</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i6e374be09b9f4b79a626d3ea4af57397_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMS0yLTEtMS04MzkwMg_19b34d78-6250-401d-9ddb-42ecc531bf21"
      unitRef="number">0.0150</icui:ApplicableMarginBaseRateLoans>
    <icui:ApplicableMarginTermSOFRLoans
      contextRef="i6781406cb9184964ac659cf86bf513a4_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMi0xLTEtMS04MzkwNA_d531fe92-7e2b-435c-8e6a-295ad9366382"
      unitRef="number">0.0225</icui:ApplicableMarginTermSOFRLoans>
    <icui:ApplicableMarginBaseRateLoans
      contextRef="i6781406cb9184964ac659cf86bf513a4_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmRlNGE4YzJkZjdhYTQ3ZTc4OTNjN2UzNDBkYzQ5YWE5L3RhYmxlcmFuZ2U6ZGU0YThjMmRmN2FhNDdlNzg5M2M3ZTM0MGRjNDlhYTlfMi0yLTEtMS04MzkwNw_f4bff7e1-5a10-4ee2-9d70-9b4c43b348b0"
      unitRef="number">0.0125</icui:ApplicableMarginBaseRateLoans>
    <icui:TermAPrincipalPaymentFirst2Years
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUxOTc1NQ_1ed2f298-34d9-437d-8404-4018bdff9d7b"
      unitRef="number">0.0250</icui:TermAPrincipalPaymentFirst2Years>
    <icui:TermAPrincipalPaymentYear3And4
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUyMDQyMQ_50f14474-7d4f-49dc-a956-03fd9ba918cf"
      unitRef="number">0.0500</icui:TermAPrincipalPaymentYear3And4>
    <icui:TermAPrincipalPaymentInYear5
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUyMDU0NA_6e5a5a31-bdb7-48e7-9f38-aefe01dc64c8"
      unitRef="number">0.0750</icui:TermAPrincipalPaymentInYear5>
    <icui:TermLoanBPrincipalPayment
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMjE5OTAyMzMzNjU2Mg_3c046f9d-68f0-4a83-b406-7e3aa3e269e3"
      unitRef="number">0.0025</icui:TermLoanBPrincipalPayment>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMyNw_fdde98a1-c220-4704-9006-1c237b608997"
      unitRef="usd">16000000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <icui:LeverageRatioCalculationCeilingSubtractedAmount
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzUyNjEyMg_65c10a84-359b-49f8-b768-a3eb9c3313d6"
      unitRef="usd">500000000</icui:LeverageRatioCalculationCeilingSubtractedAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTky_806f0a40-7cdc-4f31-b7b2-4f785abff735"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMjE5OTAyMzI5ODU1Mg_cfe22a44-1830-4eb7-a87c-c6ce362e5ffb">2022-11-08</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTY0OTI2NzQ4NjUyOQ_3fc51293-be74-414b-8ba1-3abd9cdc9ecf"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxNA_9a010423-41d2-4941-b09f-bdaabf501ab9">The carrying values of our long-term debt consist of the following (in thousands):&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of &lt;br/&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving Credit Facility &#x2014; principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total carrying value of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,655,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,642,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprised of $15.0 million and $13.0 million relating to the Term Loan A and the Term Loan B, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i6a91358f8598428bbb1e48dd761a428f_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfMy0xLTEtMS04Mzg3MQ_15559a9c-a695-4575-91a8-f6c2972a9471"
      unitRef="number">0.0444</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfMy0zLTEtMS04Mzc1MA_4d3a19af-b931-49d4-abda-57d0f01965bd"
      unitRef="usd">834000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i0c719bd4e13d4d6097944c2edd581a71_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNC0xLTEtMS04Mzg3Mw_6ecdac8f-24b9-441e-b3f9-7b54d4a93c19"
      unitRef="number">0.0511</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNC0zLTEtMS04MzgxNw_68bbed7f-9116-4f16-9d41-83e575429665"
      unitRef="usd">850000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ib9088e8033ac42c7978c4207a0f3bf01_D20220101-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNS0xLTEtMS04Mzg3Ng_66a693fb-db3b-48e5-9314-fd32e8dd4b79"
      unitRef="number">0</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNS0zLTEtMS04MzgxOQ_ac9083a0-487e-4fd8-997f-fb581d067a21"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNi0zLTEtMS04MzgyMQ_50c13a0b-2e0e-456e-8831-8cf898c9d608"
      unitRef="usd">-28016000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfNy0zLTEtMS04MzgyMw_2db4fc10-cccf-4848-99d8-e8bc612bd7fe"
      unitRef="usd">1655984000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfOC0zLTEtMS04MzgyNQ_f27cab39-da5d-4066-819a-885da14bc79b"
      unitRef="usd">13813000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmU2ZjVlNTI4OTU2YjQyNzBhYzc1OTBkNzg0ZjkwYzg4L3RhYmxlcmFuZ2U6ZTZmNWU1Mjg5NTZiNDI3MGFjNzU5MGQ3ODRmOTBjODhfOS0zLTEtMS04MzgyNw_5e50d798-26b7-4488-bc51-e7dfa5e39f32"
      unitRef="usd">1642171000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="icedd39ede0a346b7935ed0db37bd69b1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODM0OQ_2595807e-e119-4196-aba1-8ad4d4bd6876"
      unitRef="usd">15000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ia7ea40aea9364ff593a1a4a2332b13d4_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODM2NA_e4f4ec59-f53d-41f7-a98d-99c9cac26992"
      unitRef="usd">13000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxNQ_4017ad6f-74fd-4136-bea7-9660e2c3a366">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the aggregate amount of principal repayments of our long-term debt (including any current portion) for each of the next five years is approximately (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;801,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,684,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMC0yLTEtMS04Mzc1NA_92656462-d7f6-4317-8533-b1d0dcd66ea2"
      unitRef="usd">6375000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMS0zLTEtMS00NjYyOA_d24c6138-3328-466f-b9c2-58e5a28a3bde"
      unitRef="usd">29750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMi0yLTEtMS04Mzc1OQ_ce9e26c4-c7cd-4a1a-88cc-bcd86af64c61"
      unitRef="usd">51000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfMy0yLTEtMS04Mzc2MQ_99c6c9ed-7919-4670-9bfb-70d0c01007e9"
      unitRef="usd">51000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNC0yLTEtMS04Mzc2Mw_426c2adc-e638-449d-b9c0-7f736f35795e"
      unitRef="usd">72250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNS0yLTEtMS04Mzc2NQ_468e4d9b-4e45-469a-9832-e61bfd2cd4e0"
      unitRef="usd">672500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNi0yLTEtMS04Mzc2Nw_e9eb6289-4028-4dbc-ab52-cd20ad5f91b2"
      unitRef="usd">801125000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOmIyNTI4ZTUxNWMyMzRiYjdhODdhODQyNjY1MmIxYjhkL3RhYmxlcmFuZ2U6YjI1MjhlNTE1YzIzNGJiN2E4N2E4NDI2NjUyYjFiOGRfNy0yLTEtMS04Mzc2OQ_d4591164-3735-4190-870b-c11265e3f314"
      unitRef="usd">1684000000</us-gaap:DebtInstrumentCarryingAmount>
    <icui:InterestExpenseOnLongTermDebtTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RleHRyZWdpb246ZGVkYzQzMDE1NmRkNDQzNGJlMzgyNTk3MjQxM2E2ZDhfMTA5OTUxMTcxODMxNg_662225ab-5ac7-4449-a7e5-b383b9f0cbc3">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total interest expense related to our long-term debt (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitment fee &#x2014; Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</icui:InterestExpenseOnLongTermDebtTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMi0xLTEtMS04Mzc3Mw_b4b330c3-5b8d-4d46-a40e-431fc2e7cef9"
      unitRef="usd">10017000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMi0zLTEtMS04Mzc4Mg_800743a1-8022-4c4d-aed7-f56132151671"
      unitRef="usd">0</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMy0xLTEtMS04Mzc3Ng_566a8440-6b2d-463f-b5ed-107127817bde"
      unitRef="usd">1643000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfMy0zLTEtMS04Mzc4Mg_d805010a-e9ad-406c-b951-645885639d27"
      unitRef="usd">72000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNC0xLTEtMS04Mzc3OA_0d55d2ae-d972-4f17-bd41-c98f46773d94"
      unitRef="usd">351000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNC0zLTEtMS04Mzc4Mg_96a6906c-3c4b-46f5-8c88-6cc368bfc4c9"
      unitRef="usd">56000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:InterestExpenseDebt
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNS0xLTEtMS04Mzc4MA_6b7b5160-7aa0-449e-bb6f-5b9908c9b651"
      unitRef="usd">12011000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV83OS9mcmFnOmRlZGM0MzAxNTZkZDQ0MzRiZTM4MjU5NzI0MTNhNmQ4L3RhYmxlOjExMTdkOTBlNjcwNzQ4NDE4M2VkNjlkYWJhMzg5NjljL3RhYmxlcmFuZ2U6MTExN2Q5MGU2NzA3NDg0MTgzZWQ2OWRhYmEzODk2OWNfNS0zLTEtMS04Mzc4Mg_05149d4c-5323-42d0-bd54-2ada18f67022"
      unitRef="usd">128000</us-gaap:InterestExpenseDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMTQwNA_0b4ffe30-467d-4094-aba7-ee28c4f7ffce">Stockholders' Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shareholders Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the completion of the Smiths Medical acquisition on January 6, 2022, Smiths owns approximately 10.5% of the total outstanding shares of our common stock (see Note 3: Acquisitions). At closing, in connection with the issuance of the share consideration, we entered into a Shareholders Agreement (the &#x201c;Shareholders Agreement&#x201d;) with Smiths. The Shareholders Agreement imposes certain restrictions on Smiths including prohibiting certain transfers of the shares of our common stock issued (i) for 6 months following the closing of the acquisition transaction and (ii) to certain of our competitors and certain other parties, as well as customary standstill limitations. The Shareholders Agreement also permits Smiths to designate one individual for election to our Board of Directors (the "Board") so long as Smiths beneficially owns at least 5.0% of the total outstanding shares of our common stock. On February 1, 2022, our Board appointed a new director designated by Smiths &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;pursuant to the Shareholders Agreement who will stand for election to the Board at the 2022 Annual Meeting of Stockholders to be held in May 2022. This appointment expands the size of our Board from eight to nine members. See our Current Report on Form 8-K filed on February 1, 2022 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In August 2019, our Board approved a share purchase plan to purchase up to $100.0 million of our common stock. This plan has no expiration date. During the three months ended March&#160;31, 2022, we did not purchase any shares of our common stock under our share purchase plan. As of March&#160;31, 2022, all of the $100.0 million available for purchase was remaining under the plan. We are currently limited on share purchases in accordance with the terms and conditions of our Credit Agreement (see Note 17: Long-Term Debt).  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022, we withheld 37,279 shares of our common stock from employee vested restricted stock units in consideration for $8.7 million in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. For the three months ended March 31, 2021, we withheld&#160;37,423&#160;shares of our common stock from employee vested restricted stock units in consideration for&#160;$7.7 million&#160;in payments made on the employees' behalf for their minimum statutory income tax withholding obligations. Treasury stock is used to issue shares for stock option exercises and restricted stock grants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive (Loss) Income ("AOCI")&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of AOCI, net of tax, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <icui:SmithsGroupOwnershipAcquisitionSharesIssued
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMjE5OTAyMzI2MTMwNA_aed12629-8966-4fa8-a03e-6e7d622e8bce"
      unitRef="number">0.105</icui:SmithsGroupOwnershipAcquisitionSharesIssued>
    <icui:SmithsGroupOwnershipRequiredForBoardRepresentation
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMjE5OTAyMzI2MTM4MQ_2a4da476-0839-4813-9967-478b4e4669af"
      unitRef="number">0.050</icui:SmithsGroupOwnershipRequiredForBoardRepresentation>
    <icui:TreasuryStockPurchasePlan
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMTQ3_a0fcfa77-3af0-415d-923c-96db35254a4d"
      unitRef="usd">100000000</icui:TreasuryStockPurchasePlan>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMzcz_ee094dca-716e-4c7b-a0f2-ee3337594020"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfNjI0_88bc6a89-95df-42b3-ac8a-64a0368c0296"
      unitRef="shares">37279</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfNzE5_96465006-62d8-4ff2-96dc-d6e8540282ec"
      unitRef="usd">8700000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfODg3_f0e8ac51-d499-4ada-8f13-265bea85aee0"
      unitRef="shares">37423</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1185e80495c24587bfb17cca57d64f93_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfOTgy_95ea2367-f5e3-46fe-a10b-b8ddc7762ced"
      unitRef="usd">7700000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RleHRyZWdpb246NWYzZTdjNWE5MWU2NGQ0NmFlMGM2NmZkZjFiZDA0ZDlfMTQxNA_1a4dd690-56cf-4ba4-9c34-60d92cc76515">The components of AOCI, net of tax, were as follows (in thousands):&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized (Losses) Gains on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.125%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income before&lt;br/&gt;reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(945)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if1cdbdaa242848b79d2fbe0b9504e9ca_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS0yLTEtMS0yMzM5OQ_4e613981-fd67-4eb5-8035-a54ba8b92509"
      unitRef="usd">-19045000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaa110691e734492ebd77f89f72327112_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS00LTEtMS0yMzM5OQ_7c114136-1e63-4ee5-a8b8-cd04d38f176c"
      unitRef="usd">-237000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0afb2c7772cc49b1a684427d27a6856b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS02LTEtMS0yMzM5OQ_4aeb03ca-2217-47bb-89f7-bcbc461017d3"
      unitRef="usd">13000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMS04LTEtMS0yMzM5OQ_47c44f01-a161-4058-a450-3cee8c0f6c73"
      unitRef="usd">-19269000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi0yLTEtMS0yMzM5OQ_a7cfb0fe-b92c-45e2-8feb-2623f9a895fe"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi00LTEtMS0yMzM5OQ_f02d0c93-8013-4165-9d26-755b5bdf3944"
      unitRef="usd">25782000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi02LTEtMS0yMzM5OQ_8960598d-21c5-4240-8c9e-9f19cfd108f8"
      unitRef="usd">15000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i338ce135c3964ade933cbd32298f936b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMi04LTEtMS0yMzM5OQ_83c595f2-fbda-48b7-b283-f210adba7c29"
      unitRef="usd">20851000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy0yLTEtMS0yMzM5OQ_cb9c15b2-d5a1-4f29-b5d6-11ea2e83074b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy00LTEtMS0yMzM5OQ_1e9c7f0f-7b38-4cac-8b44-9e3011d8e9cb"
      unitRef="usd">-2210000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy02LTEtMS0yMzM5OQ_260fbda5-8236-478a-bdfd-b5af3a4fa596"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i338ce135c3964ade933cbd32298f936b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfMy04LTEtMS0yMzM5OQ_e7bae5fd-4592-4824-b42a-6d8a5aaea760"
      unitRef="usd">-2210000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia2ba2fc34747473ebe5acab74c99d77d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC0yLTEtMS0yMzM5OQ_45b429eb-484b-4dbd-b3a1-288ef0dbf6c5"
      unitRef="usd">-4946000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib8ec7f4c78fe427baac4cfa80a52a803_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC00LTEtMS0yMzM5OQ_77b56c02-9cd3-4e23-bab1-5e75c83fbf69"
      unitRef="usd">23572000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3703fa6705e5442a9858f0bc0003ad84_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC02LTEtMS0yMzM5OQ_98d679c0-7f9c-48c0-be72-97f24bbc585e"
      unitRef="usd">15000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i338ce135c3964ade933cbd32298f936b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNC04LTEtMS0yMzM5OQ_4d5c7ae6-a1a5-487d-a598-9c8ef7dd8203"
      unitRef="usd">18641000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i85d6a1b5b0fc46539828a1892118c0d4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS0yLTEtMS0yMzM5OQ_2b735417-2162-4f79-8d6f-e80ecda4e62b"
      unitRef="usd">-23991000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1994924f97d2435894c33f53b4e7eb17_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS00LTEtMS0yMzM5OQ_045ea32c-a90a-4c5c-b2a2-2e683440a002"
      unitRef="usd">23335000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6e7b56bfd8ed46c2a062213becf7ccad_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS02LTEtMS0yMzM5OQ_75997a99-3c97-4943-8d20-21637360294c"
      unitRef="usd">28000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id4ad65ae063d4e49821ad5b4dece8ece_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOjQ1ZjY3Mzc2ZDFiOTQ5ODhhNmJiZTljMDBlZDlhMTgxL3RhYmxlcmFuZ2U6NDVmNjczNzZkMWI5NDk4OGE2YmJlOWMwMGVkOWExODFfNS04LTEtMS0yMzM5OQ_3e1ca7ae-9183-4e3f-828d-62c5e6bdc35c"
      unitRef="usd">-628000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i48b83546156b4d78be0e3b72137bad96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS0yLTEtMS0yMzM5OQ_02cb4440-3f92-4f71-b71a-7244437942b6"
      unitRef="usd">-4381000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0a79558ef22f4c09ac5459ea71f37b04_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS00LTEtMS0yMzM5OQ_5c2e5490-5bab-4eae-9a68-6f30b2e812b5"
      unitRef="usd">2784000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i567486d5838948dd8530f75bf634afcd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS02LTEtMS0yMzM5OQ_8e23ae93-f6ab-4f4a-bdce-39567ebab46d"
      unitRef="usd">75000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9709296c43fd4879b1cc1f464dfaac3c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMS04LTEtMS0yMzM5OQ_ce5ed612-4394-4af9-b6dd-636d9bfc8e95"
      unitRef="usd">-1522000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi0yLTEtMS0yMzM5OQ_68a376a4-6736-49af-a4a9-ef7309cdc574"
      unitRef="usd">-7458000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi00LTEtMS0yMzM5OQ_63d11792-53b1-4317-88e9-8f6396173a59"
      unitRef="usd">-306000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi02LTEtMS0yMzM5OQ_a930aa91-1168-4b1b-8281-149e7f112a98"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i480060d5d0174855bf349ac2611a425d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMi04LTEtMS0yMzM5OQ_32760467-8042-4cad-851e-7da5b0f61cfb"
      unitRef="usd">-7752000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy0yLTEtMS0yMzM5OQ_8f8eac25-dffc-49b4-b594-0f2caf1c7dc3"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy00LTEtMS0yMzM5OQ_4769da29-2b54-4e86-ba80-32fa86e28ac2"
      unitRef="usd">-639000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy02LTEtMS0yMzM5OQ_7302bc55-6b1d-462c-9fdc-dd679425fd46"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i480060d5d0174855bf349ac2611a425d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfMy04LTEtMS0yMzM5OQ_fbc4d984-e07e-4dc5-b507-cfb3465257a0"
      unitRef="usd">-639000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3eb20008ff714915b27dfb4a4278a1bb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC0yLTEtMS0yMzM5OQ_d3b29a11-bcc6-4d01-8707-440a3579d05e"
      unitRef="usd">-7458000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i85040b34fe78463fa30cbaccfe9dc5fc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC00LTEtMS0yMzM5OQ_9b9a5b1e-1b65-4c1e-b957-602d3a45270f"
      unitRef="usd">-945000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2cf5485cc8174b2687a38eec0d3b7faf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC02LTEtMS0yMzM5OQ_52aa1409-f5f5-49c3-80e0-f6885883fe6f"
      unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i480060d5d0174855bf349ac2611a425d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNC04LTEtMS0yMzM5OQ_fbac193b-2492-4edd-beaf-2964118ed2bc"
      unitRef="usd">-8391000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i95227b0013004393b99c2f868c8b0457_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS0yLTEtMS0yMzM5OQ_31b0f158-b080-44ac-be4d-b16c3847996b"
      unitRef="usd">-11839000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icd1bc723546d4451bd24a0afcc9a5ad0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS00LTEtMS0yMzM5OQ_a33ee7f0-a833-41cc-9deb-06a957aec12e"
      unitRef="usd">1839000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i63067cc116cb4e2baece3c78ca5225f7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS02LTEtMS0yMzM5OQ_aac215b7-ca24-482a-b72f-afe9ad46fbbc"
      unitRef="usd">87000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i942bbd8143694f56aeaf956c380440e7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84Mi9mcmFnOjVmM2U3YzVhOTFlNjRkNDZhZTBjNjZmZGYxYmQwNGQ5L3RhYmxlOmYyNjM5ZWRjZWEwNjQ0NDQ5ZWJiNDRiM2YwYzZmZjkyL3RhYmxlcmFuZ2U6ZjI2MzllZGNlYTA2NDQ0NDllYmI0NGIzZjBjNmZmOTJfNS04LTEtMS0yMzM5OQ_89e5ced8-4b51-4fc9-8aff-a13522bf8da0"
      unitRef="usd">-9913000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMzM0OA_81194a40-fb9a-4945-bcea-7dd96ec757d0">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business.&#160;Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Off-Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products.&#160;There is no maximum limit on the indemnification that may be required under these agreements.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 6, 2022, we acquired Smiths Medical. Total consideration for the acquisition includes a potential earn-out payment of $100.0&#160;million in cash contingent on our common stock achieving a certain volume-weighted average price from the closing date to either the third or fourth anniversary of closing. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $53.5&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to being acquired, during 2021, Smiths Medical received a Warning Letter from the FDA following an inspection of Smiths Medical&#x2019;s Oakdale, Minnesota Facility. The Warning Letter cited, among other things, failures to comply with FDA's medical device reporting requirements and failures to comply with applicable portions of the Quality System Regulation. A provision for the estimated costs related to the field service corrective action was recorded on the opening acquired balance sheet of Smiths Medical in the amount of $55.1&#160;million. The initial estimate recorded was based on a probability-weighted estimate of the costs required to settle the obligation. The actual costs to be incurred are dependent upon the scope of the work necessary to achieve regulatory clearance and could differ from the original estimate. The estimated field service corrective action recorded at March 31, 2022 is $54.7&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During November 2021, we acquired a small foreign infusion systems supplier. Total consideration for the acquisition includes a potential earn-out payment of up to $2.5&#160;million, consisting of (i) a cash payment of $1.0&#160;million contingent on the achievement of certain revenue targets for the annual period ending December 31, 2022 and, separately, (ii) a cash payment of $1.5&#160;million contingent on certain product-related regulatory certifications obtained by May 26, 2024. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $1.6&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During August 2021, we entered into an agreement with one of our international distributors whereby that distributor would not compete with us in a specific territory for a three-year period that will end in September 2024. The terms of the agreement include a contingent earn-out payment. The contingent earn-out shall not exceed $6.0&#160;million, which will be earned based on certain revenue targets over a twelve-month measurement period determined by the highest four consecutive quarters commencing over a two-year period starting on the closing date of the agreement and provided that the distributor is in compliance with its obligations under the agreement. As of March&#160;31, 2022, the estimated fair value of the contingent earn-out is $2.6&#160;million (see Note 9: Fair Value Measurements).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;We have non-cancelable operating lease agreements where we are contractually obligated to pay certain lease payment amounts (see Note 6: Leases).</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <icui:Contingentconsiderationgross
      contextRef="ida794f824cb94242bde5116941247684_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0ODYxMA_8d3f3082-4909-47a7-87c8-5d08f5c83696"
      unitRef="usd">100000000</icui:Contingentconsiderationgross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i5dc12fe8f6254cb6a80e3ae364e79c9b_I20220331"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0ODYyOQ_d196577a-58dd-464b-9a58-47118f0a1186"
      unitRef="usd">53500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i1114e70a57024459b1dd8837d9a8d9f3_I20220106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ1MDQ2OQ_421905b3-44c3-4090-a33d-7806ed409ee2"
      unitRef="usd">55100000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <us-gaap:ProductLiabilityAccrualComponentAmount
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTA5OTUxMTYzNjg2NA_ba3d3e07-40c3-4349-9fec-6a368564e990"
      unitRef="usd">54700000</us-gaap:ProductLiabilityAccrualComponentAmount>
    <icui:Contingentconsiderationgross
      contextRef="i2cbf394f8a7041faac97e278f848a931_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzM0Nw_53eaee76-e1f7-4529-ac7e-2d4b4757b42f"
      unitRef="usd">2500000</icui:Contingentconsiderationgross>
    <icui:ContingentConsiderationGrossST
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzM3NA_23a98fc8-df36-4439-bbbd-95a22ac38acd"
      unitRef="usd">1000000</icui:ContingentConsiderationGrossST>
    <icui:ContingentConsiderationGrossLT
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzQwMQ_29dede25-0318-40b8-8e39-69f91899ce25"
      unitRef="usd">1500000</icui:ContingentConsiderationGrossLT>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i099b2a7d616d421c860d4ddb8052bdab_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY0OTI2NzQ0NzQ1OQ_fb81e433-c185-4139-b1d7-aa8747179284"
      unitRef="usd">1600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <icui:Contingentconsiderationgross
      contextRef="i04278caae1d04e05aee4473287d6eb1f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTI3Mw_3081a915-3ce7-40ab-b0ce-89858451f327"
      unitRef="usd">6000000</icui:Contingentconsiderationgross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ide3f1af499ed4114bc7d8f8c83ec901a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84NS9mcmFnOmJkMDM4N2RmNDhiZTQwMWJhNDljMDgwYTQ5ZWFlY2IwL3RleHRyZWdpb246YmQwMzg3ZGY0OGJlNDAxYmE0OWMwODBhNDllYWVjYjBfMTY3OQ_ff60f0a6-b9a3-4fd8-885b-ca708f957112"
      unitRef="usd">2600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84OC9mcmFnOjZjODE3MTU5Yzg0OTQ4YTJhZTE3YTMwMDViMjM4YTEyL3RleHRyZWdpb246NmM4MTcxNTljODQ5NDhhMmFlMTdhMzAwNWIyMzhhMTJfMTQxOA_02458c38-15e3-401a-9401-9cbd06390267">Collaborative and Other Arrangements&#160;&#160;&#160;&#160;On February 3, 2017, we entered into two Manufacturing and Supply Agreements ("MSAs") whereby (i) Pfizer will manufacture and supply us with certain agreed upon products for an initial five-year term with a one-time two-year option to extend and (ii) we will manufacture and supply Pfizer certain agreed upon products for a term of five or ten years depending on the product, also with a one-time two-year option to extend. The MSAs provide each party with mutually beneficial interests and both of the MSAs are to be jointly managed by both Pfizer and ICU. The initial supply price, which will be annually updated, is in full consideration for all costs associated with the manufacture, documentation, packaging and certification of the products. On January 1, 2021, we amended our MSA with Pfizer, whereby we manufacture and supply certain agreed upon products to Pfizer. The amendments included a change to the term of the agreement to end on December 31, 2024 with Pfizer's unilateral election to extend through December 31, 2025. Other changes to the terms of the MSA included (i) amendments to our level of supply of products to Pfizer, (ii) certain changes to our manufacturing lines, (iii) updates to our supply price with added volume price tiers for annual periods and (iv) certain minimum purchase requirements for certain products. On February 1, 2022, effective as of January 1, 2022, upon our request, Pfizer executed a Product Addendum (the "Product Addendum") to our MSA, whereby Pfizer manufactures and supplies to us certain agreed upon products. The Product Addendum includes the supply of additional product to us subject to certain time and pricing terms and conditions. The Product Addendum includes a minimum purchase obligation of $29.6&#160;million and expires on November 30, 2022. As of March 31, 2022, we had satisfied the minimum purchase obligations under the Product Addendum.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV84OC9mcmFnOjZjODE3MTU5Yzg0OTQ4YTJhZTE3YTMwMDViMjM4YTEyL3RleHRyZWdpb246NmM4MTcxNTljODQ5NDhhMmFlMTdhMzAwNWIyMzhhMTJfMTY0OTI2NzQ0MzgyOQ_c2247560-5ddf-4525-86f4-7d845272dd83"
      unitRef="usd">29600000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0zLTEtMS0yMzM5OQ_7efa49ea-e092-413e-8751-a78ed1981b91"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0zLTEtMS0yMzM5OQ_7efa49ea-e092-413e-8751-a78ed1981b91"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMy0xLTEtMjMzOTk_cc8b8dfd-f6dc-4ec6-ade4-50b9cede901b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMy0xLTEtMjMzOTk_cc8b8dfd-f6dc-4ec6-ade4-50b9cede901b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMy0xLTEtMjMzOTk_7aee2232-f5cc-4422-ac0b-acde2a7b22b0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMy0xLTEtMjMzOTk_7aee2232-f5cc-4422-ac0b-acde2a7b22b0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMy0xLTEtMjMzOTk_1dbdf55a-a861-400c-aae6-f31012cdc0ee"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMy0xLTEtMjMzOTk_1dbdf55a-a861-400c-aae6-f31012cdc0ee"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMy0xLTEtMjMzOTk_d7e34423-5f9a-44e2-9011-cd54a0587ee2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMy0xLTEtMjMzOTk_d7e34423-5f9a-44e2-9011-cd54a0587ee2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMy0xLTEtMjMzOTk_a21ce225-4244-42ec-a068-e469ba3a1a67"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMy0xLTEtMjMzOTk_a21ce225-4244-42ec-a068-e469ba3a1a67"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMy0xLTEtMjMzOTk_5d1b87c2-8fa3-4722-b2ef-4a2b0a6fbfa6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMy0xLTEtMjMzOTk_5d1b87c2-8fa3-4722-b2ef-4a2b0a6fbfa6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMy0xLTEtMjMzOTk_0598d5f2-f50a-4a33-ac25-fbef7e76a68e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMy0xLTEtMjMzOTk_0598d5f2-f50a-4a33-ac25-fbef7e76a68e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMy0xLTEtMjMzOTk_f3b68358-a167-4d1b-8af5-9ec10e8f8a00"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMy0xLTEtMjMzOTk_f3b68358-a167-4d1b-8af5-9ec10e8f8a00"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0zLTEtMS0yMzM5OQ_5cd22cf8-6283-40e8-bbc5-1bc602267a07"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0zLTEtMS0yMzM5OQ_5cd22cf8-6283-40e8-bbc5-1bc602267a07"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMy0xLTEtMjMzOTk_73a62e42-584c-4dce-9927-9c26f4e79261"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMy0xLTEtMjMzOTk_73a62e42-584c-4dce-9927-9c26f4e79261"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMy0xLTEtMjMzOTk_73e25217-2337-4482-8f2c-9f7a801092f0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMy0xLTEtMjMzOTk_73e25217-2337-4482-8f2c-9f7a801092f0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0zLTEtMS0yMzM5OQ_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0zLTEtMS0yMzM5OQ_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMy0xLTEtMjMzOTk_4fb9c3bb-8931-450f-b3cf-01bdf5d961d5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMy0xLTEtMjMzOTk_4fb9c3bb-8931-450f-b3cf-01bdf5d961d5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMy0xLTEtMjMzOTk_536c1a7f-db16-4a10-bfbb-c97cfb71f07d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMy0xLTEtMjMzOTk_536c1a7f-db16-4a10-bfbb-c97cfb71f07d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMy0xLTEtMjMzOTk_e0b25fae-b7d7-48dd-8dfd-d1c3160c65c1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMy0xLTEtMjMzOTk_e0b25fae-b7d7-48dd-8dfd-d1c3160c65c1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMy0xLTEtMjMzOTk_329d35b3-51f6-4be3-bbcb-f409487a5d01"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMy0xLTEtMjMzOTk_329d35b3-51f6-4be3-bbcb-f409487a5d01"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMy0xLTEtMjMzOTk_98e9d6c1-3d9c-47ba-acef-9005f92f14af"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMy0xLTEtMjMzOTk_98e9d6c1-3d9c-47ba-acef-9005f92f14af"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0zLTEtMS0yMzM5OQ_850e73c3-d686-46ed-ba31-c5a05b4446a4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0zLTEtMS0yMzM5OQ_850e73c3-d686-46ed-ba31-c5a05b4446a4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMy0xLTEtMjMzOTk_95ae1fef-bd2e-4aa7-85d3-b39bcaf0be5e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMy0xLTEtMjMzOTk_95ae1fef-bd2e-4aa7-85d3-b39bcaf0be5e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMy0xLTEtMjMzOTk_455e6497-8c50-4f7b-930c-dbbd2cdcd547"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMy0xLTEtMjMzOTk_455e6497-8c50-4f7b-930c-dbbd2cdcd547"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMy0xLTEtMjMzOTk_1d960f4e-b520-4e13-ac47-3d43057e8c38"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMy0xLTEtMjMzOTk_1d960f4e-b520-4e13-ac47-3d43057e8c38"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0zLTEtMS0yMzM5OQ_3144b2c3-7246-4a9a-b321-858926ddc79b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0zLTEtMS0yMzM5OQ_3144b2c3-7246-4a9a-b321-858926ddc79b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMy0xLTEtMjMzOTk_32d6c330-d912-4473-bc54-f1f72227b1fa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMy0xLTEtMjMzOTk_32d6c330-d912-4473-bc54-f1f72227b1fa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMy0xLTEtMjMzOTk_3f6dcf20-b952-4de0-a9ee-232417604dbb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMy0xLTEtMjMzOTk_3f6dcf20-b952-4de0-a9ee-232417604dbb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMS0xLTEtMjMzOTk_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMS0xLTEtMjMzOTk_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMy0xLTEtMjMzOTk_e9fe34ae-66d8-4800-81fe-6664927fd088"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMy0xLTEtMjMzOTk_e9fe34ae-66d8-4800-81fe-6664927fd088"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMy0xLTEtMjMzOTk_46bef57c-5157-447f-a499-70c305544b3d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMy0xLTEtMjMzOTk_46bef57c-5157-447f-a499-70c305544b3d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMy0xLTEtMjMzOTk_854504f5-7b4b-4a6e-a397-62f066a793aa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMy0xLTEtMjMzOTk_854504f5-7b4b-4a6e-a397-62f066a793aa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0zLTEtMS0yMzM5OQ_ced62afb-b606-4297-99ef-c3702478fb1a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0zLTEtMS0yMzM5OQ_ced62afb-b606-4297-99ef-c3702478fb1a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMy0xLTEtMjMzOTk_d1006863-ea7d-4d08-acaa-0dd139ce00e6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMy0xLTEtMjMzOTk_d1006863-ea7d-4d08-acaa-0dd139ce00e6"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">December&#160;31, 2021 balances were derived from audited consolidated financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNS0zLTEtMS0yMzM5OQ_7efa49ea-e092-413e-8751-a78ed1981b91"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTktMy0xLTEtMjMzOTk_cc8b8dfd-f6dc-4ec6-ade4-50b9cede901b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjItMy0xLTEtMjMzOTk_7aee2232-f5cc-4422-ac0b-acde2a7b22b0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDQtMy0xLTEtMjMzOTk_1dbdf55a-a861-400c-aae6-f31012cdc0ee"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjgtMy0xLTEtMjMzOTk_d7e34423-5f9a-44e2-9011-cd54a0587ee2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzctMy0xLTEtMjMzOTk_a21ce225-4244-42ec-a068-e469ba3a1a67"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzgtMy0xLTEtMjMzOTk_5d1b87c2-8fa3-4722-b2ef-4a2b0a6fbfa6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzItMy0xLTEtMjMzOTk_0598d5f2-f50a-4a33-ac25-fbef7e76a68e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTYtMy0xLTEtMjMzOTk_f3b68358-a167-4d1b-8af5-9ec10e8f8a00"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOC0zLTEtMS0yMzM5OQ_5cd22cf8-6283-40e8-bbc5-1bc602267a07"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzQtMy0xLTEtMjMzOTk_73a62e42-584c-4dce-9927-9c26f4e79261"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzktMy0xLTEtMjMzOTk_73e25217-2337-4482-8f2c-9f7a801092f0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNC0zLTEtMS0yMzM5OQ_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMzAtMy0xLTEtMjMzOTk_4fb9c3bb-8931-450f-b3cf-01bdf5d961d5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjMtMy0xLTEtMjMzOTk_536c1a7f-db16-4a10-bfbb-c97cfb71f07d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDItMy0xLTEtMjMzOTk_e0b25fae-b7d7-48dd-8dfd-d1c3160c65c1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDctMy0xLTEtMjMzOTk_329d35b3-51f6-4be3-bbcb-f409487a5d01"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTAtMy0xLTEtMjMzOTk_98e9d6c1-3d9c-47ba-acef-9005f92f14af"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfOS0zLTEtMS0yMzM5OQ_850e73c3-d686-46ed-ba31-c5a05b4446a4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDUtMy0xLTEtMjMzOTk_95ae1fef-bd2e-4aa7-85d3-b39bcaf0be5e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTMtMy0xLTEtMjMzOTk_455e6497-8c50-4f7b-930c-dbbd2cdcd547"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjAtMy0xLTEtMjMzOTk_1d960f4e-b520-4e13-ac47-3d43057e8c38"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNy0zLTEtMS0yMzM5OQ_3144b2c3-7246-4a9a-b321-858926ddc79b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMjctMy0xLTEtMjMzOTk_32d6c330-d912-4473-bc54-f1f72227b1fa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDMtMy0xLTEtMjMzOTk_3f6dcf20-b952-4de0-a9ee-232417604dbb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8yOC9mcmFnOjBkYTc2NmU3MzM2YjRjOTRhZmRiZDZlZTc5ZmZhYzBjL3RhYmxlOjYwNGM5MzY5ZWQwZTQ0NmNiZjM5ZjM0N2QxNTVmODc1L3RhYmxlcmFuZ2U6NjA0YzkzNjllZDBlNDQ2Y2JmMzlmMzQ3ZDE1NWY4NzVfNDQtMS0xLTEtMjMzOTk_ce63ce15-8ce2-4f54-aa06-6b57ea6ca776"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDEtMy0xLTEtMjMzOTk_e9fe34ae-66d8-4800-81fe-6664927fd088"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDgtMy0xLTEtMjMzOTk_46bef57c-5157-447f-a499-70c305544b3d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNDYtMy0xLTEtMjMzOTk_854504f5-7b4b-4a6e-a397-62f066a793aa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfNi0zLTEtMS0yMzM5OQ_ced62afb-b606-4297-99ef-c3702478fb1a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RhYmxlOjM4OGUyOWJjYWYxMzQ1Y2ZhZTJmNDI2Yjg1ZjE1OTYyL3RhYmxlcmFuZ2U6Mzg4ZTI5YmNhZjEzNDVjZmFlMmY0MjZiODVmMTU5NjJfMTUtMy0xLTEtMjMzOTk_d1006863-ea7d-4d08-acaa-0dd139ce00e6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjgzNDNhNTAyY2YxYzQ2NWE4YWRmZDcyZmY2OTk0ZmNlL3NlYzo4MzQzYTUwMmNmMWM0NjVhOGFkZmQ3MmZmNjk5NGZjZV8xNi9mcmFnOmVmZTcxMjExZWQ2NDQ2OGI5ZDYwMWIwMWM5YzQ5MmViL3RleHRyZWdpb246ZWZlNzEyMTFlZDY0NDY4YjlkNjAxYjAxYzljNDkyZWJfMzUz_bc78e210-8e7c-47c9-b77a-cffeb227a453"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>108
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MN^I080=#>3*K9LBW$!Y)@,RNF %Y#2#/V,MM3O9AO.'+-:(I 2Q\UB/S-&.
MH"\!TUCY(\^1<)D],N/R&US^NW"1Y[V@NZ+*OY3M2,Y9-L]%6@J+@NCGI:_
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M^BVXCU0#<"L@L)FN.;3K656!K"N2D\7->G;S97HS.9'_L*H29*[M-@DZO.I
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MP=L>*&N [U=2FN>.O4]4]\?I?U!+ P04    " #FB:E4E^>U/2X%  #8$0
M&    'AL+W=O<FMS:&5E=',O<VAE970T+GAM;)5877.B/!3^*QEG+]J9MI*
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M#"AK@/M+*<UN8@_H?HGFOP!02P,$%     @ YHFI5*O.GQK, @  1@<  !@
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MLC$,;X^(T"R#B23ZQ\);?S@.W*(I31+/:2#M@$??!3R)%']3@"X:"5:@"E;
M;9N%FGDSJ-!9QU$:QE9L2ZR#5P\D: <[.@R[-\40B#<+()N>U28J2^!=&X[1
M([!:ML<OIV;1JE>8E)"@,KVAIO,_F)QZ@9M4T',H1AV4BY)HFGC*:]IQC@Z7
M?BU"5CJMR YTIV79>E[ZBVUJEW2C* HCSUJ(.AQ&PSC\D_/\N2C+4T@3VL%'
M.12@$-MK0P#GX;9C[Y%.HJD/7U&'KV@87]^ZXT"]:IJ->RYN[W+P!D <1#3N
MKY;QWDLD&R96YMT:B<S11?L2QN[J[OV=F7EKI7?](OQ\V;Z%T]VF?2GH>RI6
M126AC%O"+8-/";A%M._9M%\4K\VK*@NN%-^8CVN6PNAK _A]R;EZ^Z(?L'O;
MZ?Q_4$L#!!0    ( .:)J53Y#,<=7P4  )$,   8    >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&ULG5=M;]LV$/XKA 8,+>#:CI.^($T".&F+95O7(&[6#T4_
MT-+)8DN1*E_B9+]^SY&R''=IMNY++(EWQ^<>/G>\'*VM^^(;HB!N6FW\<=&$
MT!U.)KYLJ)5^;#LR6*FM:V7 JUM-?.=(5LFIU9/9=/ILTDIEBI.C].W"G1S9
M&+0R=.&$CVTKW>TI:;L^+O:*S8=+M6H"?YB<''5R10L*5]V%P]MDB%*IEHQ7
MU@A']7$QWSL\/6#[9/"GHK6_\RPXDZ6U7_CEO#HNI@R(-)6!(TC\7-,9:<V!
M .-K'[,8MF3'N\^;Z&]2[LAE*3V=6?U!5:$Y+EX4HJ):1ATN[?H7ZO-YRO%*
MJWWZ*]:][;009?3!MKTS$+3*Y%]YT_/P7QQFO<,LX<X;)92O9) G1\ZNA6-K
M1..'E&KR!CAE^% 6P6%5P2^<G$JOO+"UN'#DR03)7!T>30)BL\6D[..<YCBS
M[\39%V^M"8T7KTU%U:[_!)@&8+,-L-/9@P'?2C<6^WLC,9O.9@_$VQ\2W4_Q
M]K\3[YU;2:/^2OF-Q)DUWFI5R2P-4^WDSWR\44::4DDM%OA(T&'PXN-\Z8.#
MDCX]@.A@0'20$!W\"/7BXWNZ">)4V_++I_N.X?_$?-\0Y%_:MI/F5IF5B$;&
M2@6JA#*!G&I%:7%NQN-+.5"#EWI@P6]9:.0UB261$>@#G70I3-K 5; F2#@T
MZ3V:P-MU3B%(I\F+%1ER4NM;7J<N0Q ! *], I383BG,6R KI7A47(T7X^)Q
M.J8N.A^E"2+8Y.4B1^451ZNH4[[)FQ<75$:G@NHM7M^4C30KPNFWK?*IKSSZ
M^:<7L]GTY>+U67K:>_FXCU9SXQ" *F3U&868<A\E>I1/:6$7:Y")X?:@X8+=
M'"_L.*P;58(-1Z--IK93IE=9*PU:'UN.A*&2O$=G%.BU0HI:*K>E?9/3SO'@
MD-%]?'+@Q<UI=OAK*\_GPRJ@:BPN'S1E?,@C#" 4\E*F O_<-7GS;_>J(ZBY
M)2[3,W(!_1\.^9;8U%1M;4!0$I7RI;8^(D;/5@I?ZECUXC$F@L)_U]Y#BKM'
M6_>+<"O@K>R1E6U58*>[&O,1AW>OR,:IK'ZD;GQCHZZPL>#KDS. S^=H\OV4
M4OC'"=\;B)$PKY[M'0'F72XYQCSS>4F==9".$7R%B;WID]_X*,_/KL1;XL/5
M(W%NRO$(18:/7&/B%6FY9CF 7'CW#;-6&M$'C"B700BL 4'<]N%;4KLDMVG<
M>V/Q@9*VR*P@] %?1=>8![HL?!1!K-%48RX>).>E3II3QMCKK, VX\4QVBJ6
M("'Z' ZBBZF4F0O9W:8 )9<]FY>\N>PZG92<C@V(,!7HA*.5GRU,;U,M1[>-
M'AIGXZI)'ROEN!4PJ"1_Z(WWV)B@3*CC_*$8"#TXM8S!NB$&1J'<X-#%DF,J
M/9/@L%HS1]K;#*OLBVF DHH)^E0K:$$+^AI5(NX.;Y1&$W1^2,$R#P-=(%J5
MM&,*"N;8Q\>E5Y5"J;.VP=*ZL5P[=FVX<$SN"=\*ZP?TGK=)R?97#T!J+M>L
M8%RDQLLR=^QM29)6F'-D:EKOC/@5R+DG/LN3 /HIWV7@@)O  A6+F:/7,AM,
MQ>]P9TB/BMW5XO$(!)/X@QO2_J&8<Q"O>E&\PSE_)[>=%HQIV/673$^-S_=0
MWQUW3;A$OL%8.]L.23W/20U2PM"#=C/;YIKN#I6WX-N%44!J_66 ^^'@R<&3
MISMM+O7S\7WSR>3.F(B[=96&82^2:YX8AZ_#O#W/8^;6/ _K  HU>J&IANMT
M_/QI(5P>@/-+L%T:.I<V8(1-CPV:'CDVP#I?#9L7WF#X+^3D;U!+ P04
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M"G,=L2>';YA8;Q9=<['A7U.U#KN$2IFC]+A5V9S&%TU.P<QM'Y?>6>'*\-!
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M9J33M&<P GS?L_*!H(CN) U!:15S 3I@S*19=V(CK47T;P7557NK>H]HM+>
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M=N&/:X7QW](&/%\:X],78M#]1.?U?P!02P,$%     @ YHFI5% F?$YE P
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M)R63A2B-5"738G4^N(S>7B4TWTWX*L7.])X96;)4ZAN]_)R=#T(")'*16I+
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M]W*CWK4GSAUK=[F+,PH=)OP-:/>UNS^^]->F^^G^\AF^1S(8EHL5EH;#V63
MM+_0]2]65>X2%:=8''+<XT9P-&TT >,KI6S[0@JZ6_6+_P%02P,$%     @
MYHFI5*FK=9_J!P  +14  !D   !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
MM5AM;]LX$OXKA*]W2 #5ME[\HEP2(&UW<0M<KT7:O7XX[ =:HFVBDJ@EJ3BY
M7W_/D)(BV8FQQ6$1(++(>9]GAB->'Y3^;O9"6/98%I6YF>RMK:]F,Y/M1<G-
M5-6BPLY6Z9);O.K=S-1:\-PQE<4LFL^7LY++:G)[[=8^Z]MKU=A"5N*S9J8I
M2ZZ?WHE"'6XFX:1;N)>[O:6%V>UUS7?BB["_UI\UWF:]E%R6HC)254R+[<WD
M+KQZEQ"](_BW% <S^,W(DXU2W^GEE_QF,B>#1"$R2Q(X'@_BO2@*$@0S?F]E
M3GJ5Q#C\W4G_V?D.7S;<B/>J^"9SN[^9K"<L%UO>%/9>'?XA6G\6)"]3A7'_
MV<'3QB#.&F-5V3+#@E)6_LD?VS@,&-;S5QBBEB%R=GM%SLH/W/+;:ZT.3!,U
MI-$/YZKCAG&RHJ1\L1J[$GSV]I\"+AEV\2]EA;F\GEG(I)U9UO*_\_S1*_PQ
M^Z@JNS?LIRH7^9A_!EMZ@Z+.H'?168$?N9ZR. Q8-(^B,_+BWL'8R8O/._B?
MNXVQ&ACX[8S,I)>9.)G)JS*-$2)@GVJAN975CG5:OHI'R]X5*OO^VTNQ/"N6
MZN_*U#P3-Q,4F!'Z04PZ^[\)8,T*#0@()K>, ]!:\VHG4"&62<,X*XB4<;Q5
MF:@)]%/VJ=%,]6:V%+#>@D$+9D3-L2>*)V8LGCEX3^@U(?NMVKYM\'(QN?_T
MZ^2R%U+E3$''5E:\RE[4 6N*)F]%V[W0W2:*DE@S!>A4!@3X950A<V?(AA>0
M"!,)V\9[XF47DF]D(:T4IPIXEND&/P<T@3?2:2Y4M7M+81P)^3%#D(H]?Q#,
M=1;L5\HRJ]"A,K6KY'\%Y08Q\EXZW6.SGQAZJ5\SJ':[9V00K-@R>Q %))>^
MI!R5@4:'@6>9Y@6A72QZ*W+7K'+R#9XS!R@ Y8$7C7"JL+AM; ,>8$J63=E*
MK/D300KJ'Q P(O/K+FH 5Z9*[&<>=Q2A*5J L213-;U?N7)QJ;5ZD+D+B2SK
M0F;2,L);0(+1?Q74'P0C8!$S,JF=8%ZPC=(H2T*49SCL9;8GH)-)M$34C=;P
M$='WU.0MAX5%@7W-BRX.LO6&,R-+67#MO1E%2%;^B'-GQ0,'U:80KSC\C,5!
M4L2C@V&[0358T8GCLX406PFO<HD,D4P#CLZ!H4"/A1;2*$6RQY"'Z"P"@@Y[
M@5BZBL<A;%0%,Y]8)K3%"0Q'8# ">I!% 0ZA,TDR:56U'>$..^-<.32WY3_&
M0!?UDC_U)FWE(^BT3Y)+& GI0"H>:RHA!_%7<.4L[U'J,D:MV349:HG#A(WA
M-XB31SMIR92NE8<(89QKV$L1S\4#1H[:98W>#2_:7)BF!@<A=BLSZ@^YA %R
MT[C<;WG6-P[(D%3Y:,7TI(P*[85T$1>_-](I&1GG0JK0.-$6BU%F*?3P\4D0
M"!6BN;4"&:5W*#2J=-79@OU5%/1Q,2X&34U[=";DN21:*-T">U[LE&& 8?PX
M[P$!I:W3L29PXPB0*G?F.I5N")-MGR30(JI#M\@*,JK''*DZ,1MI)6VGP)VR
MK]2/4+B^Y*TKOK9I^9)'&=:(G.M, S=<*;$+AWW5&*3&7%Y!FA9]'Q4TFKAY
M@OZ%@V-[(.$-6P3A:HUG%*SC!?O9'6AB2/*WOZRC,/H[P@"?!1:B%)/*.4K4
M=N.G3YC\?":$JSD+%R'[L@<,V^/HF3G&WU=E>]STYL7K.9YQ,(_F[)?.AJ[@
MVC-L.S3&U=KI\8L5@ME%RWH9L$K8/KDO'X*N/91]]'T$0> 3-_*3DO4\0E"M
M=$8-FN70,$ZHJ#)N]JW'G4\P"?,[>L(N8#M144=W\GA.K86:!C78CMS\7RZ<
MQ1YUC*([F)RA6Q"/C@PM"J<%8!^TUA_"Y7L27'.9NVKBI6HJ.\X?V5)"<N-/
M2?+C9 RX&N"[-Q4%JE5Y/-D9P&D9+)(6]:/2.&8] M8; O\;@O_]<#KL)KL-
M%;6W&<?BGN;4YZD'VX7<^>!?'5<CB0Z#)(W=<YX>52)M=]4%@G7R@\D;#7/G
M$G@2JE$J W(+,_9H-J)#1YJ,TN8&%.3[SF'MHSN4NH\:]D%@F-B@$-N5DXYD
M3EJ4?B'(;U@:H1>L* UIL$Y6[.YT^*5$S8/5>DGDP7R>LD]G!N%5',1IR.(X
M2%=AVX2.OP;&PM,$79-,2*(@17_ZYCZ#1?[V#L<WONK9O:"K@?X;B7TEG2?^
M+J<+?U:QQ31M?YV(^M %]YZFOQ,9R72^9'_%(UWC\2?!XJ@,_DQ0'.%^?,R\
M#(@(Q;QPS^4J?@4.RR45[C*)SR(A#-(HAISY<M7B8.3Y,<2"11JYYRK\HQ@X
M<F\Q37H$+/\8 HXD)--H[?+O'B\%.? -E..KI_WPVQ[5^O"T.G64.IC@$-B>
M<A5][3_/66XDY36^>1YEZ3^JC_O_R8U!YT/[ZB.5(RU0X7!!32Y(XX0F !0:
MUF*JZ#0,V0IC!-X3S!-!".PGRX3>%RR,@F0=LFCIZ)<L#(,0@(I"8D7#6&'"
M22$WI2K!,(815),:(DI [Q/N<_6Y&]NA(5B0A""%+KH"H4^ZQM\9M,/(!33'
M\?*27<1A<MG*&30)CY.7;F!F@RNL4NB=NZ@SS&7;WV;UJ_U=X)V_ GLF]Q>)
MR#G&;H/\;<$ZGZX6$U\NW8M5M;L0VRAK5>E^[@5'T(D ^UNE;/=""OH;TMO_
M 5!+ P04    " #FB:E47&M_"T\$   H"P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Q-2YX;6S-5FUOVS80_BL';1@<P+4LV7&=Q#$0]P7KAW9!TZT?BF*@
MI;-%A!)5DHKC_?K=4;(BNW;0]=,"Q**HN^>>>XY'<K;1YMYFB X><U78ZR!S
MKKP,0YMDF L[T"46]&6E32X<O9IU:$N#(O5.N0KCX7 2YD(6P7SFYV[-?*8K
MIV2!MP9LE>?";!>H].8ZB(+=Q$>YSAQ/A/-9*=9XA^[/\M;06]BBI#+'PDI=
M@,'5=7 372[&;.\-_I*XL9TQ<"9+K>_YY5UZ'0R9$"I,'",(>CS@*U2*@8C&
MMP8S:$.R8W>\0W_K<Z=<EL+B*ZT^R]1EU\$T@!17HE+NH][\CDT^YXR7:&7]
M+VQJV]$X@*2R3N>-,S'(95$_Q6.C0\=A.CSA$#<.L>==!_(L7PLGYC.C-V#8
MFM!XX%/UWD1.%ER4.V?HJR0_-_] =7]7)#I'N$4#=YDP>#D+'4&S09@T,(L:
M)CX!,X+WNG"9A3=%BNF^?TB46E[QCM<B?A;PO3 #&$5]B(=Q_ S>J,USY/%&
M)_#>"%/(8FV?LH0O-TOK#"V+K\_@CUO\L<<?_P<=X<LG?'2P4#JY_WI,TY^
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M@6/<'50FM7E0? 7B+\L\H<$! <*L$.LJ:"4)DO>B @VSUM*D[4?>.2$C]I,
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M3#KR/XTKS./NO7,:]__W\(OQ<-O#NT.MAU] U-81NF]WC^>B[W'U46]XV7I
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MD)IH^R.Z2KYRSEV,KI3'%6DT$-Z ]PN'A&A^L(+NL_?%_P%02P,$%     @
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M*+?.D+0D.[>\,=C(LK @50$?W1X-7+7&H'*PLA:=A1<?M$/[<AXZ<N>-PGR
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M&D_+V03,, N'C=-=F#]K[2C18=G0SP<T7H#N-YIH'S;>P/B#9/4O4$L#!!0
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M**8RB,*0.'D2<"V+;)N/MY%K[@/!)X:(D!QYSNN$_5#ZKV&6!VE2,'B4Z0'
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MEY)AGN3I":=>:W;XKYMC^O]JCDK;#;L^J#<7,1X6=Y5_NWY_S:4_@M "_VR
M!S/R VF>!E^Z"_OBKGT.>B"689J>[LO I=7Q.B"[;^C_J&/Z?DWONU2S@QG5
MH*OB) Y?6F>H'U?C[CCLS_L9=Z?>_REP=BIE/&@LV722ON39ZOKIVPMDVSCQ
M-I9X?L9ES3\LZ(("GY?6TEX(#L9?H.5?4$L#!!0    ( .:)J509=Z9=01$
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M!4E$E6X]H>#0UCD0*;22G"AYAXY#<*(83Y"D-.S@='S</]YN"'UXI8SRIXW
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M7T.UKKH2NJIMOEW#?K]$@&UC;8G.6Q?VG@>%\U)20A_7J?4#2O7[!.[EB6,
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M6%7X+D1BJU47L33&F?JA"RAEA]YG\*KT@.M\4BNRAAX K]9)? 2*WG;2Q7#
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M+]V?7J80&RZ:?5W!Y%N'BNG.B:]FMX[G6K3'MB:DP]_P=#@Z+].)<6N>SMW
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MW3ND?:"%O?MP.IW<9-I8Z\19VZ&P?_W-V&E)65KI^% 2>QZ_>4_.UTI_-Q6
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M'#24+_18"<MGJ)BL%%W7SW#*!9A:=IJ*4H_.X;Y6C$';Z\NLOO!I<+;RV$<
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M&]9XYV+*.J!]):7936R"X18W_P=02P,$%     @ YHFI5(8@R&EE!0  &@\
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M<DD"^#T30F\G9*"_#B_^ U!+ P04    " #FB:E4\K"MD#T#   0!P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q]56U/VS 0_BNG;)I:J6M>6DJ!
MMA+=F,8'4$79]@&AR4TNC85C=[9#V7[]SDZ:E0'-A^1LWSWWW/GN,MDJ_6 *
M1 M/I9!F&A36;D[#T*0%ELSTU08EG>1*E\S24J]#L]'(,F]4BC")HE%8,BZ#
MV<3O+?1LHBHKN,2%!E.5)=._YRC4=AK$P6[CAJ\+ZS;"V63#UKA$^VVST+0*
M6Y2,ER@-5Q(TYM/@/#Z=#YV^5_C.<6OV9'"1K)1Z<(O+;!I$CA *3*U#8/1Y
MQ$\HA ,B&K\:S*!UZ0SWY1WZ%Q\[Q;)B!C\I\8-GMI@&XP RS%DE[(W:?L4F
MGB.'ERIA_!NVM>[H)("T,E:5C3$Q*+FLO^RIR<.>P3AZPR!I#!+/NW;D67YF
MELTF6FU!.VU"<X(/U5L3.2[=I2RMIE-.=G9V3?=^*5-5(BQ0P[)@&J%SRU8"
M37<26G+A%,.T@9O7<,D;< .X4M(6!BYDAMES^Y"HM?R2';]Y<A#PBND^#.(>
M)%&2', ;M/$./-[@#;P+IB67:[,7[=WYREA-Y7%_ '_8X@\]_O -_"5U358)
M!)7#2U\]F#/#4V R@\]<5!8SN//)AEM\LC 7*GVX?RWMA[W>%@BY$M1AY ^L
M!Z0>-2BM 4N'*1-I)9AO!&(FZ=9QQVY#[*@ 2CHR]?5_>#=.DNCL8K'T4GS6
M!2?$R9GK@(9_UO#O<$DN5&5HT_0 GU+<6 ]:HV54EMU3N"TT(I1U=:"K#G^E
M[A6#J\*.4,9T@=?%^!XZ@W$O&HV[)":#WO$@AA^^Q3#[R!Y1T\0 694K\D,!
M[?,W0,/'6*+CDM'QC+L.8S0<01+WXN%)G7P:!V PK32WG*PZ\;\PCTCUA;O&
MB0N^$?%7Q1^9H#2_ZKI)T;[ST<D14%[_RR=%&_='L8LU[L?),XU=GI_I1"?P
M\_#CP[E6M;F+%/.<)B&5B?8585_>!_5:6K3-=N;4:$0J5[9_4"MW-1II(%LF
M=N'2EJB<[0Z6[IVKK/]:)X5[4ZI$O?:SV% J*VGK@=7NMN/^O)YR_]3K?P4Q
M77-I0&!.IE'_^"@ 7<_?>F'5QL^\E;(T0;U8T"\+M5.@\UPINULX!^U/</87
M4$L#!!0    ( .:)J53;&\(MY00  )L-   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;+57;6_;-A#^*P<O&&) BRWY-9EC('::MD"+!7&V?BB*@9;.
M$E&*]$@JSO;K=Z1D64X3+2LV?[!(ZN[XW/&Y.VJV4_JKR1 M/.9"FLM.9NWV
MHM<S<88Y,V=JBY+>;)3.F:6I3GMFJY$E7BD7O:C?'_=RQF5G/O-KMWH^4X45
M7.*M!E/D.=-_+E"HW64G[.P7[GB:6;?0F\^V+,45VE^WMYIFO=I*PG.4ABL)
M&C>7G:OP8C%R\E[@-XX[TQB#\V2MU%<W>9]<=OH.$ J,K;/ Z/& 2Q3"&2(8
M?U0V._663K$YWEN_\;Z3+VMF<*G$)Y[8[+(S[4""&U8(>Z=V[[#RQP.,E3#^
M'W:5;+\#<6&LRBME0I!S63[98Q6'URA$E4+D<9<;>937S++Y3*L=:"=-UMS
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MM^R_>3N1\B\AY7"'CPXN&UW>?WTN^2>]^<M\;CM9XBJBVVK1/& T0<!C"#I
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MCA90$%O:^&B\ =TWFF@?#S[ ^!^R^ E02P,$%     @ YHFI5+C/4BTZ P
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M]9+O4$EMZ"^C&.5P30_IX$9DLI!.HCT#']//6BB8PH\_3.(H_ADJ(U4F*U'
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MT87$+Y=T T3#!/1]KK7;OK""]DYY^1]02P,$%     @ YHFI5,#(G=1B P
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M_T ;AR*C+Q&YJKYAW^SU'$A*I471@)%!P7C]2[XW@?@90-  @A< C(P=$#:
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M6VS[J30;<#T30A\FQD#[1V+V'U!+ P04    " #FB:E4]F:(@[(%  !!&P
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M>8,J;V#S!O^5MY'A;6,M'\@383GI6[ B<&@#&WUXFH]"- [0U'UJUK'';!+
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MQDBU.@4^$H0KF<.=$<J*KM:J@"O%^WSH[!<@.+Y$$K*R)_ )[F\OX?CH!(Y
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M2  K'H?V5>W_ACR@5*"O0I-^DGT^U^T0/S961?EB5! )F7WS7WDB3A8PVK"
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M+I7%&C-]W&!5#SJ9@.,KI>RQD3@H_B>8_0]02P,$%     @ YHFI5(&#?N1
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M Q%UC*:! EB052*>Z.8[% 5YRM^<)ES_HDUNVY#&\Q47-"W$,H,TSO(K>2M
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M0K"LW%R2."%<-9#_SQD3NQV5H%FO'?\'4$L#!!0    ( .:)J52[*^ U.0(
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MOQ;X)M&*S*1U@R6.(\YVB.MHY:8'IC9&K;(A5/^+"\G5+E$Z&7\"50.!SF]
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MYVJLZL2KME]-)"M-YUPRJ?JP&6;JI@2N ]3^BC&YG^@#FKLW_@-02P,$%
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M0Y2]53E0?%UT&W.N=.]2O*YT/PK"&.CU!>=J-S !Z@YW\A]02P,$%     @
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M4T34S<R4;2#M C._%D(_=VPET1:"R3]02P,$%     @ YHFI5)L5%B'< @
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M"69\)81^Z-@2H:KP)G\ 4$L#!!0    ( .:)J53J2MI7)04  ),=   9
M>&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;+59VV[;.!#]%<+H0PMD(_'B6^$8
M2.(-&J#9#9)M^E#L R/1-E%=O"0=I\!^_%*7B(I%,;(W>DDD>68X/#,\/)1F
MNU3\E&O&%'B.HT2>#=9*;3Y[G@S6+*;R--VP1/^R3$5,E;X5*T]N!*-A[A1'
M'O+]D1=3G@SFL_S9K9C/TJV*>,)N!9#;.*;BUP6+TMW9  Y>'MSQU5IE#[SY
M;$-7[)ZI;YM;H>^\*DK(8Y9(GB9 L.79X!Q^7@S]S"&W>.!L)VO7()O*8YK^
MS&ZNP[.!GV7$(A:H+ 35_Y[8)8NB+)+.XY\RZ* :,W.L7[]$O\HGKR?S2"6[
M3*/O/%3KL\%D $*VI-M(W:6[+ZR<T#"+%Z21S/^"76GK#T"PE2J-2V>=0<R3
MXC]]+H&H.4#2XH!*!]35 9<.N*L#*1U(CDPQE1R'!55T/A/I#HC,6D?++G(P
M<V\]?9YD=;]70O_*M9^:+YC@3S3#'ESQA"8!IQ&X3J026UU=)4'-H/Z8)B'X
MPL(53U;@/*L=5YQ)\!NX>@#ILLWK.@FB;<A"\)VK-4_ 99K(-.(A5?K9!8WT
M^ S<Y_W^<<$4Y9'\I&-^NU^ CQ\^@0] ^_RU3K=2#R]GGM( 9-/P@G*R%\5D
M4<MD;Z@X!1B> .0C9'&_=+LO6%"Y0XO[HOOH>^Z>KEI5.E25#N7Q\)NEDR?@
MBG(!'FBT9>#'5VT(KA6+Y=^.87 U#,Z'(6]WR+F43-E@+R*,\@@9TSS-\0A#
M,O.>ZN@VK: _@I71J^Q(E1TY*+L3<+D50C>;+<TBU+"6P'B$IGM9-HW:LQQ6
M60Z[9OF5TT<><?7+EN"P,?8T:]17^35M()GX]OQ&57XC9WZW@FTH#\'OSWH_
MD:Q8WG^J-1,O<!;H2O#CAL6/3+@::UP-.NZS?R?5,)/WZY!)EPYI&K5WR+3*
M<NK,L@"[.\C0-P3O]PDSK.TD\$"@_TB3H!WK,EP=1S09389[:%O,6KH=&N:$
MR)GJ>1"(K=YR7A9CMG5U =UP)L2]@F[H#W;FOXI9G!T.F_PVF38P;QJU86XH
M$+HYL.CP&N*N^1OB@J->@39D!<=' /U&AX^;'3[>A[IIT\[GT) >=+.>%L5:
M\B::T8,U358LDUI*:)7M L.0%9SVB3HRY(7\_RT^RA"O2'M,]L6'Q:J=M9$A
M/=29])P[.VJR6'-KMQBU- *JB40WU;4V O@7O.NVCPPYHE[)$1ER1.\H#E$G
M=6BQ<K21(4?D)D=7E0Z5!LB0)^J5/)$A3]29/#M) V0A1;B_25F,VE:+H4UT
M)&WJ.API&I!A5=0KJV+#JK@SJW83#;A)GDW18#%JJ0<V](K=]/KVNN@F*+#A
M2]SOJ;IVK.Y\KNXL*,J03D%AL6DK@R%2[";2ZT0QP:0"=U0Q<+^C&Q<$AO7P
ML%>L#=%A]_FVTSN,D>4X,AS[^_ VS=K@-?2(WY<>L457-E-=E&:C#JD:@L2=
M3]-.O8.;A^0&DI9S=*ORQ89%L?LDW>S5]U8ZQ! MZ?7L30Q/DD//WJ[78"Z9
M6;X$ZZQ$B6%6XE:BUL(<*FZ(X5?2J\HDM3>0AZI,]^HE30EI(QJ+65L)#.$2
MM\RTEN!(74,,^Y)>928Q/$J..:.[5H)+0I9EZ*PRB2%1XB91QTKH)F>(84/2
MJZ8<&JH;'J,IW2NA#&G?H,JWW4T3RR;AU3Z 99\K;ZA8\42"B"VUFW\ZUN43
MQ1? XD:EF_R;V&.J5!KGEVM&0R8R _W[,DW5RTWVF:WZ#CO_#U!+ P04
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M9KBYY<K<B%!:!_-](81^,>P!Y1VK]P=02P,$%     @ YHFI5'20X] X P
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M-W;(_@$N!;C3?FS[4* ]/70&E#;O VF+5 T'4: -HM#.H[L%N S@S_JQ'\\
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M:%#6 -?W4IKSP 9HV_+U_U!+ P04    " #FB:E4?N@%_"T$  "H#@  &0
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MA0"N+X30SX/"0-V<COX'4$L#!!0    ( .:)J50%-\:E @,  #@(   9
M>&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;)56VU+;,!#]%8W+=.@,Q;9\2:!)
M9H ,+0]T,ES* ],'Q=XD&F0IE>0$_KXKV[@A-^A++*WVG#TK:;7I+95^,C,
M2YX+(4W?FUD[/_5]D\V@8.98S4'BRD3I@EF<ZJEOYAI87H$*X=,@2/V"<>D-
M>I5MI <]55K!)8PT,651,/UR#D(M^U[HO1IN^'1FG<$?].9L"K=@[^<CC3._
M9<EY =)P)8F&2=\["T^'7>=?.?SBL#0K8^(R&2OUY"97>=\+G" 0D%G'P/"S
M@ L0PA&AC#\-I]>&=,#5\2O[994[YC)F!BZ4>."YG?6]KD=RF+!2V!NU_ %-
M/HGCRY0PU2]9UKYQQR-9::PJ&C J*+BLO^RYV8<50#?8 : -@*X!PG@'(&H
MT3H@V@&(&T!<[4R=2K4/0V;9H*?5DFCGC6QN4&UFA<;TN73'?FLUKG+$V<&5
M7("T2G,PY' (EG%AOI"OY/YV2 X/OI #PB6YFZG2,)F;GF\QID/Z6<-_7O/3
M'?S73!^3*#PB-*!T"_QB/WP(60L/W\)]S+1-E[;ITHHO>B?=%S+D)A/*E!K(
MX]G86(TW\/>>"%$;(:HBQ.]%."(W;$FNF07-F3!'Y"<6L9J0&S"@%[!U+VOJ
MM*)V!;L8T(C&"6:^6-VS3;<P2A+:;=W>*(];Y?%'E3]@K;J#'VF5@?F8]IH\
M61'5B6/:69.^Z16E\4FP77G2*D\^JOR22X[5D)/O2N4?$YYL2*+T)([2->6;
M;F'8I6%GN_2TE9[NE7ZG+!/;5*4;9YQ$:13&:ZHVW>A)0*/DK=MPOXC'<-_-
M[WAKAFZ;6_?_:.O,]H.PXJ$8@_[\*4R#;Z^ECV^[8!+O(ED"5FR.-;7 0YYH
M51!6YMSB)%/2*,%SYB83+M$?"X\8BP9L5-@=MR7IK[R=!>AIU8,,DI72UE7?
M6NLV=X%MKFH':_:SSNFPL\5^WFW:HO^/ONZI^#9.N31$P 1#!<<=O%RZ[E/U
MQ*IY]7*/E<4^4 UGV-I!.P=<GRAE7R<N0/MG8? 74$L#!!0    ( .:)J53%
M'E+A3 0  -4/   9    >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;+U7;6_;
M-A#^*X17#"V01B+UZLXQD-C+%J 9@J;=/@3[P$BT350279**TW^_(R7+LB1K
M08'TBRU1]_+<'?GP;K83\JO:,*;1<YX5ZF*RT7K[P7%4LF$Y5>=BRPKXLA(R
MIQI>Y=I16\EH:I7RS"&N&SHYY<5D/K-K=W(^$Z7.>,'N)%)EGE/Y_8IE8G<Q
MP9/]PB>^WFBSX,QG6[IF]TQ_V=Y)>',:*RG/6:&X*)!DJXO))?ZP),0H6(F_
M.=NIUC,RH3P*\=6\W*07$]<@8AE+M#%!X>^)+5B6&4N XUMM=-+X-(KMY[WU
M:QL\!/-(%5N([!^>ZLW%))Z@E*UHF>E/8O<GJP,*C+U$9,K^HETE&X!P4BHM
M\EH9$.2\J/[I<YV(ED+LGE @M0+I*&#_A()7*WA=!>^$@E\K^#8S52@V#TNJ
MZ7PFQ0Y)(PW6S(--IM6&\'EAZGZO)7SEH*?G=Q*VD-3?$2U2]/NWDF^AJ!J]
M73)->:;>H??HR_T2O7WS#KU!O$"?-Z)4(*MFC@;WQHB3U*ZN*E?DA*M;*L^1
MA\\0<0D94%^,JR]9TJCC8W4'@FXB)TWDQ-KS_B?R,W2740CY. $/'T$<W6B6
MJW]'G'F-,\\Z\T\X^RPTS="VG6RV]W6&$J'T4#XKFZ&U:0[PTQQCSW-).'.>
MVHGKRTW= +M^(W:$V6\P^Z.8+Y.DS,N,:I;"20)623@U9W4(:64I:"%X[P=Q
MB/T.TB$Y+XR\Z3#4H($:C$+]"PAR.+E#8(,>B##R?4PZ6/MB?AA[87 LMAQ'
M]H#'MD_8Q!>.6KFER0:69.>8GJ$_I%"#1S'L@_=(Z$\[,?;%/(+=*!XN1]3
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MI!& [RLA]/[%.&@F^?E_4$L#!!0    ( .:)J52G6;JC.@(  !(%   9
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M<FMS:&5E=',O<VAE970X,"YX;6R=5MMNVS@0_15"6RP2H(FLJR]K&W"LW6Z
M!#6:M'TH]H&6QA:W%.F25-S\?8>4K+J)8@1]D<C#.<,SI&9&T[U47W4)8,CW
MB@L]\TIC=A/?UWD)%=67<@<"5S925=3@5&U]O5- "T>JN!\.!JE?42:\^=1A
M*S6?RMIP)F"EB*ZKBJK'*^!R/_,"[P!\8-O26,"?3W=T"W=@/NY6"F=^YZ5@
M%0C-I" *-C-O$4RRL;5W!I\8[/71F-A(UE)^M9/K8N8-K"#@D!OK@>+K 9;
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M3^^\<"%XE/^<,;G'2C(#^7S"N5A?9 V4)\8N_P-02P,$%     @ YHFI5)=
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M?*D[[5+45\+OJ=BE18DRMH5TSE4(2U/4MZSU@^2'ZE9PS:7D>?5SSR@40!G
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M"EU1)M%W&F_!A#YH('.?8Y\$C0+%?NB:P8<E^- *_HIQRB-X]9(*FUSWB7=
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M+119+_3#W+Y6J%V W<^4HMW$):C?O\%O4$L#!!0    ( .:)J52#"YV%V@,
M ! /   9    >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;+5746_;-A!^[GX%
M(?2A!;+(I&W9*6P#B;-V&1(LB-/M8=@#+9UMHA3ID93=_ON1DB+:L\0V0V+
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M8D120"2=8KK8HJ3-4P9PTM!S\I2:/&%?CGYH_)"A],"#6%CZ/#4 H<8("#4
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M3X^WX7>! OJ\$=!7RNP:% "?-P+X2IE=@P+8\SKL3"RJZW7GLYAG.BT/>QY
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M+IXJFW=I&+EV_6\A#793-USA?0?*.N#WI91F;]@$U0TZ_@M02P,$%     @
MYHFI5&8HJ'V0 @  L 8  !D   !X;"]W;W)K<VAE971S+W-H965T.3,N>&UL
MG95A;]HP$(;_RBE:I5;J2 @$4!4B05FU2JV&VG73-.V#20ZPZMB9[93VW]=V
M0LJVA$WC _'9=^\]/CN7>"?DH]HB:GC.&5=3;ZMU<>'[*MUB3E1/%,C-REK(
MG&ACRHVO"HDD<T$Y\\,@&/DYH=Q+8C>WE$DL2LTHQZ4$5>8YD2]S9&(W]?K>
M?N*.;K;:3OA)7) -WJ-^*);26'ZCDM$<N:*"@\3UU)OU+^83Z^\<OE#<J8,Q
MV)VLA'BTQG4V]0(+A Q3;16(>3SA)3)FA0S&SUK3:U+:P,/Q7OW*[=WL9444
M7@KVE69Z._4F'F2X)B73=V+W$>O]1%8O%4RY?]A5OE'@05HJ+?(ZV!#DE%=/
M\ES7X2 @['<$A'5 Z+BK1(YR031)8BEV(*VW4;,#MU47;> HMX=RKZ59I29.
M)S>";]Y_1IG#IQ6C&V)+I6 I*4]I01@LR8LY @VG"]2$,G46^]JDM<%^6J>8
M5RG"CA0#N!5<;Q5\X!EFO\;[!K=A#O?,\_"HX"V1/1CTSR$,PO#A?@&G[\Z.
MR Z:4@R<[*!#=H$K#0NJ4B94*1&^SU9*2W-M?AP1'S;B0R<^[!!W)9Y!T12V
MJ M[ E=4*@TA?$,B55MY*^5^=83V+7M*@EX01K'_U$(4-431OQ#]>=0GC@0&
M0'@&PS:@J!6H@V?4\(S^EX?R"BEJ@QFUPHP[:,8-S?CO-#>"<)BW(;6!C%M!
M.L]ITI!,CI*X:WG-S54L;>YS6**D(J/IGN;\#; -JU(?'5#U1X'[_<;E'W21
M'.7&]4H%J2BYKAI*,]NTXUG5A=[<JUYNWM --7V$X=J$!KVQN3&RZH^5H47A
M>M)*:-/AW'!K/BDHK8-97PNA]X9-T'RDDE=02P,$%     @ YHFI5*9YW])^
M P  A T  !D   !X;"]W;W)K<VAE971S+W-H965T.30N>&ULQ5=;;YLP%/XK
M%MK#)G4%0T+:*8G4IKMT:J5JV>5AVH,#3K!F;&:;9OWW.S84Z )(T[KU);&-
MSW>^<^&SF>^E^JXS2@WZF7.A%UYF3/'*]W62T9SH8UE0 4^V4N7$P%3M?%TH
M2E)GE',_#(+8SPD3WG+NUF[4<BY+PYF@-PKI,L^)NCNG7.X7'O;N%SZP76;L
M@K^<%V1'U]1\*FX4S/P&)64Y%9I)@13=+KPS_&H5!M; [?C,Z%YWQLB&LI'R
MNYU<I@LOL(PHIXFQ$ 3^;NF*<FZ1@,>/&M1K?%K#[O@>_8T+'H+9$$U7DG]A
MJ<D6WHF'4KHE)3<?Y/X=K0.:6KQ$<NU^T;[:.YMY*"FUD7EM# QR)JI_\K-.
M1,< </H-PMH@_-U@,F 0U0:1"[1BYL*Z((8LYTKND;*[ <T.7&Z<-43#A"WC
MVBAXRL#.+%<RSYF!NAB-B$C12@K#Q(Z*A%'=F=VAYQ?4$,;U"_02?5I?H.?/
M7J!GB GT,9.E!EL]]PTPLKA^4GL_K[R' ]XC= T>,HU>BY2F#^U]B*0))[P/
MYSP<!;PFZAA%^ B%01CV\%F-F[\GXA@%<9_Y SI1D]W(X44#>.>EAA6MT5GR
MHV2:V<X]:K-J[%"SE"KB>OKK%>Q&EX;F^MN(]TGC?>*\3P9KV^_G"+U5$DBM
M/_95K,*,':85@=LE#H)@[M_V,)DV3*9_Q>2JETF%.>TRF0XQB1LF\2B3&R73
M,C'HBI$-X\S<06D251)NRY(74EB.9[DLA>FC%!]0FDYF'4Y5D\4'*9Q.\1#S
M6<-\-LI\#>]IIJ]IRA+"1[KCI,$[>8+>/&V\GXY&D[1^D@=^=K8A^E)_>M@-
M03#8F3AH!3 89=+D >J_88*,Y^&H[9Q>N0L.&R0:;%K<46D\2A*.+#B0!+H4
MV]*=H.L[#:5 Z[(H.*-JI"(X;)V$3] 1N!5+'#UR3]2 W72'P]EN=1/_"^&L
M07_OT $RK73B?Z&=^$_$$[?JB<?E\W%?ED,UQ?$@QU8G\;A07@I#546-<'3!
MM%%L4QHY^I*TJHF?0C9QJYOXL843'RIG/-B78:N;X7_4S=I7]\@,#UO![]QS
M<ZIV[OJO(0]P6E=7WF:U^<0X<Q=KO]U>?9_ 17''A$:<;L$T.)Y!>E1UY:\F
M1A;NUKR1!N[@;IC!9Q)5=@,\WTII[B?60?/AM?P%4$L#!!0    ( .:)J505
MDLM@)P(  #$$   9    >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;'U436_;
M, S]*X310PL$<>*LW5HX!O*!8CL4#1)T.PP[*#9C"]5')M%-MU\_2G:"#%AV
ML42*?'R/HIP?K'OU#2+!NU;&3Y.&:/^0IKYL4 L_M'LT?+*S3@MBT]6IWSL4
M54S2*LU&H[M4"VF2(H^^E2MRVY*2!E<.?*NU<+_FJ.QAFHR3HV,MZX:"(RWR
MO:AQ@_2R7SFVTA-*)34:+ZT!A[MI,AL_S"<A/@9\E7CP9WL(2K;6O@;C2S5-
M1H$0*BPI( A>WG"!2@4@IO&SQTQ.)4/B^?Z(_ABULY:M\+BPZINLJ)DFGQ*H
M<"=:16M[^(R]GMN 5UKEXQ<.?>PH@;+U9'6?S RT--TJWOL^G"5DXPL)69^0
M1=Y=H<AR*4@4N;,'<"&:T<(F2HW93$Z:<"D;<GPJ.8\*5J/$UCH1F@/"5/!,
M#3J8.2=,C=Q^\G"]1!)2^1NX FG@22K%'?5Y2LP@X*1E7VW>5<LN5'L2;@B3
M\0"R49:];)9P?77S-TK*_$\BLI.(+,).+L ^NUH8^5N$>Q[ @JE9)2O173M+
M6CGT+*1SV!T\2B-,*86"#3M[D=]G6T^.I^3'?QA-3HPFD=&'"XQ6K2L;'A8F
MH[6D4&$ :PRO1)J:.VBD;C7,M&T-]4&$U;\ZVA6ZCX7"$WLKLOOA79Z^G=-+
MSR8@/"9N="V-!X4[3AL-/]XFX+H![0RR^S@46TL\8G';\)M&%P+X?&<M'8TP
M9Z>_1/$'4$L#!!0    ( .:)J50X>)_?&P,  '@(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#DV+GAM;)U646_:,!#^*Z>HDUJ)D9  @0J0@'9;'ZHB:->'
M:0\F,8G5Q$YMIY1I/WZV$S)*0]2-!V)?[CY_GWV^RVC+^).(,9;PFB94C*U8
MRNS2MD40XQ2)-LLP56\VC*=(JBF/;)%QC$(3E":VZSA].T6$6I.1L2WX9,1R
MF1"*%QQ$GJ:([V8X8=NQU;'VAB6)8JD-]F24H0BOL'S(%ES-[ HE)"FF@C *
M'&_&UK1S.1]J?^/PG>"M.!B#5K)F[$E/;L*QY6A".,&!U A(/5[P'">)!E(T
MGDM,JUI2!QZ.]^A?C':E98T$GK/DD80R'EL#"T*\07DBEVS[#9=Z>AHO8(DP
M_[ M?1T+@EQ(EI;!BD%*:/%$K^4^' 2X_HD MPQP/QK@E0&>$5HP,[*ND$23
M$6=;X-I;H>F!V1L3K=00JD]Q);EZ2U2<G%P_YT3NX/P*2T02<0%G0"C<QRP7
MB(9B9$NUB':U@Q)P5@"Z)P ]N&54Q@*N:8C#M_&V(E<Q=/<,9VXCX"WB;? Z
M+7 =UWU87<'YV86($<=UY.8?Q^HT8+TAZE5;Z1EPKWDK?TS70G*5GC\;,+L5
M9M=@=D]@WJN;*7*^@Y5DP1,L<A[$*FEAD2!:=S8%6M^@Z0O\,NDX^C>R7VI8
M]"H6O486Q>)+G%7+<Q9QE+:435<*0B.8YC)FG/S"X:'C-&4YE75,>__$M%\Q
M[3<SU8?Y6=_K$!9HI\J-A"GGB$98CUM@' 0\$AG'. E!U4&X1Z^%@26AEG*W
M3DB$3)7Y#2=3;58PZ1TH\'S7'U8"BH2L\^JZ7KU,OY+I-\HLI;6.J9?Z3F]
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M*2"N+RGEAQ-I(/^F-/H&4$L#!!0    ( .:)J53F)QNK*@,  /(2   -
M>&PO<W1Y;&5S+GAM;-U876O;,!3]*T8=HX-1Q_'BQFL<V *%P38*[</>BA++
MB4"6/%GIDO[ZZ5J.\U'=TO5A2^:06KI'Y]PCZ;H6&=5F+=CM@C$3K$HAZXPL
MC*D^AF$]6["2UA>J8M(BA=(E-;:KYV%=:4;S&DBE"/N]7A*6E$LR'LEE>5V:
M.IBII309&72AP-V^Y!F)D@\D<'(3E;.,W)^__;E4YNI-X.YG[\_.>O?OK@[C
MYPWPCH1>T<$+1"]ZN*[%,.ED7WHS'+0Z+DJ^?)&O9VQAPD/$U;XM1P_;C1F/
M"B6W^Q,3%[#ZM&3! Q49F5#!IYH#JZ E%VL7[D-@IH32@;&%81-&$*D?'1RY
M'M1,JU-RJ723VV5P?Z?M\ -@TP.#7(C.8)^XP'A446.8EM>VTPQN@D^@H&W?
MK2OK<*[I.NH/R);0W&R2J=(YTUV:B&Q"XY%@!=C1?+Z NU%5"* QJK2-G-.Y
MDK3QL&&T#2L[8T+<P@/UH]C37A4[.]>#?9-=TQIJFT[&=4!_5\UI[\KV7Z4;
M5/Q!F<]+.QW9]*'4V(UF!5\U_571&<#4(UR=5I58?Q)\+DOF)O_BA.,1W?""
MA=+\T6:#4IG9 -,D>&#:\-ENY)>FU1U;F4TYK0K<<_\$/?_==9XSR305NZ9M
M[1_S*K_:<7SYKRPW_U4.#7L]MF_)8S<Y. 63R2F8/(&:C-/C]]B>BX[.9-B^
MOW<."7M'A"X:P%$L(]_A:">V28/ID@O#9=M;\#QG\LE)P<H;.K4'^CU].SYG
M!5T*<]>!&=FVO[&<+\NT&W4#"]&.VK:_PO2BI#L'VEQ<YFS%\DG;U?-ITPQL
MPV9M+R <(M?-Y4<PCL/\"&!8'LP!QG$L+,__-)\A.A^'8=Z&7F2(<H8HQ[%\
MR*3Y8'G\G-1>_IFF:1PG";:BDXG7P01;MR2!KU\-\P8,+ ]D^K.UQG<;KY#G
MZP#;T^<J!)LI7HG83/&U!L2_;L!(4_]N8WF @>T"5CN0WY\':LK/B6/85<P;
M]@3C2)IB"-2BOT:3!%F=!#[^_<&>DCA.4S\"F-]!'&,(/(TX@CD #Q@2Q\U[
M\.!]%&[>4^'V5Z[Q;U!+ P04    " #FB:E4EXJ[',     3 @  "P   %]R
M96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:
MI7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$
MVV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_
M,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH
M^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( .:)J51?98XQS@8  +D_
M   /    >&PO=V]R:V)O;VLN>&ULQ9M=;]LV%(;_BN"K#>CF6-9GT11(XV8+
MD"9!$_2VH"7:)BJ1'BDE:7_]2-E>J91YL9L37\66%?DQ1?(Y/(=Z]ZCTMZ52
MWZ*GMI'F=++INNW;Z=14&]XR\Z?:<FD_62G=LLZ^U>NIV6K.:K/AO&N;:7QR
MDDU;)N3D_;O#M6[UU'^C.EYU0DE[T!WX(OBC^?FY>QL]"".6HA'=]]/)\+KA
MDZ@54K3B!Z]/)R>3R&S4X]]*BQ]*=JRYJ[1JFM/);/?!%ZX[4?UR^,Y!WK.E
M&8YT;/F969#3279B+[@2VG3#&</UF65\X/;DW;N^4Q>BZ;A>L([_I56_%7+M
M+F-_Q=3[&4,['/[N&O&M_C_-J%8K4?&%JOJ6RV[7CIHW#E":C=B:2219RT\G
MBX^7T>$T][/L]US6NY_863:OP?1;83_0E_5 24=TKF3-I>%U9%\9U8C:<M31
M!]8P6?'(@XP!9'Q$R*^Q!SD'D/.C0-XY'/NO'F0"(),C0HY:,@60Z3$AYQYD
M!B"S8T(F'F0.(/-C0J8>9 $@"UK(#\P($ZE5=*NYL:<.9WSUV$K 5M*R75NA
MG565ZF5GG6$)E;2O*S>@.^,SSD[0''Y"W(*]$9(;8^]RNQ1R=T+$9!V=&<-'
MIH&J(7;-9VXZW5==KVU;OK&]4%N0M:BB>\VD83XFDLV,V#:?^0.7/8]^N[;1
MCOG=QT)ZF1'[Y8HSPTV("OED1BR4:WO=2UFIED>W7$=W&Z;Y:%P@C\R(1;+@
M6CPP%PM&%W98R$JPQM*Z7O@\ D,FF1&KY(()'7UAC>USG^Q-[NTT. S>A3!5
MHXR/B5PR(Y;)I7RP ]B=%-WQR@[B3H3[(W+)C%@FUB%;)NI= ]YT&]LGSWNM
M';2;"WU,I)49L5=<6\K.+H'XR"(QLDA,;!$KMZU=>WT?FN[C/[W8NG\8X2%[
MQ,3V^$NI^E$TS8!W:<,$N78$.\69T4H%+E6([6&C!=W;&.M*L&$5'!XC,3))
M3&R2_7Q]SYZ>]3XDDIA8)%=*KO^XY[J-;I:-6.]CF$#+(:'$Y"N3MA7#%+B;
M8&Q4[>)";LWRK"F13V+RI4G3L*72._/]G C/M(VSUOX<&".?Q,0^<5-,]]VG
M0>*(J5<A*(8>K8QC)(Z86!PPAAZG0I!+YL0N^2^&OF?VBT<#>(XD,B>6R"&(
M#F A:<R)I1&*HH.0,+]%K T838^['A+)G%@D,)H>8R*5S(E5\D(T';CG2"5S
M8I7 <'K<F$@E\U=8FNS#Z6 3(K',R5<DH; ZB(G$,B<6"PRO1W<Z06))B,42
M#*]_;<H$22:AEDPXE U0(N<DQ,[9A5]!+&29A-@R. [SD_\)K*,06P9C^NG_
M!%DF(;8,QO0+  G23$*L&8R9^9A(,PFQ9G#P/>J;R#@)L7$PYJAO(N,DQ,9Y
MGO\?-A8<],/7?BT2&2=]I:6,C1_9>JWY>BBA'8XN?4PDG92\N (PQY5=9)WT
ME8HK+G.B[2T?BWSA8R(+I:]3;+GG3S926_".B6:DR!2Y)Z5.E>T7L2$N6+8G
MELV>ZYR93731J,<WT8V-?-E0.3VK_')+BF23$LMFC[G/&[OYQNN#;_Q$<HID
MDQ++9H_YB;EYW 5JH=N--),2:R:<M A1(LNDY!5\0!G-_,TDR#(9L65P<F6T
MYP59)B.V#,;T0XL,628CM@S&],/>#%DF.VI&S0][,^2;C-@W&#/W,9%^LF-6
M^[\6/B;<-W;,:O]XI"/]9,3ZP9BCD8XDE!%+"&..1CJR4$9L(8SIC_0<62@G
MMA#&]$=ZCBR4$UOHA=QY(/3(D85R8@N%,8=\FX/U,9&%<F(+[1.!GWBW46[M
M?8#>MZB/B2R4$UL(ER+\>3-'%LJ)+;0OM>\6%]=*5CO&0^?T,9&%<F(+C2HF
MH8$#=RT3N^>EDDF@#9%[\N-4=@Y) Q\3N2<_:F7''S@%<D]![!Z,Z0<<!7)/
M<<QM:.,M]<@]!;%[,*8?<!3(/06Q>X+EO,!T5"#S%,3F"4$.-;[.U?@:'Q.9
MIR#?4?!S6U_T<;7BPU-P4<>>(I=H]S&1>0KJ]%NX.AJZZ<A!!77Z+8CI*A,V
M*.[\+&$!GYTA=E 8TQUP9;3134<.*H@=] )F(!0ND8-*8@>%,>_LE>N^&3T-
M62('E4?98+#OFZ-:3XD<5!([*(QYJX6LQ);Y\V:)'%22/[@)-O5&YSXFLE!)
M_N@FV-4[ONG(0B6QA0[;2@+S>8FT4Q)K9\]E7=ZW?3,41_>+2-5N]6@&0MHI
M!^U,AY/-^W<U7PG)ZVO[%<8>KUA3W>K(_7%7FL5)ZAXS6?5-<VZ/W<@KQ>K#
MD^>'I^;?_PM02P,$%     @ YHFI5+0I?LS" @  "CD  !H   !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<\W:O6ZC0!A&X5NQN(#@^9]9Q:FV2;O*#5C.
MV(YB&PM8;7+W:SF%?= 6VT2\%1H0'Z=ZA& >?]7#>GSK3L/^[3PL/HZ'T[!J
M]N-X_M&VPV9?C^OAH3O7T^7*MNN/Z_&R['?M>;UY7^]J:Y?+V/;W,YJGQ_N9
MBY?/<_V?B=UV^[:I/[O-[V,]C?\8W/[I^O=A7^O8+%[6_:Z.JZ;].-Q.#^WU
M8!XNDYO%\^NJZ9]?3=/.'6019.</<@AR\P=Y!/GY@P*"POQ!$4%Q_J"$H#1_
M4$90GC^H(*C,'V26E'$ID#3!6D!K0ZZ-@->&8!L!L0W)-@)F&Z)M!-0V9-L(
MN&T(MQ&0VY!N(V"W(=Y&0&]+O:V WI9Z6P&][>1E6T!O2[VM@-Z6>EL!O2WU
MM@)Z6^IM!?2VU-L*Z&VIMQ70VU)O*Z"WH]Y.0&]'O9V WHYZ.P&]W>1CB8#>
MCGH[ ;T=]78">COJ[03T=M3;">CMJ+<3T-M1;R>@MZ?>7D!O3[V]@-Z>>GL!
MO3WU]@)Z^\G';@&]/?7V GI[ZNT%]/;4VPOH[:FW%]#;4V\OH'>@WD% [T"]
M@X#>@7H' ;T#]0X">@?J'03T#I.?E0)Z!^H=!/0.U#L(Z!VH=Q#0.U#O(*!W
MI-Y10.](O:. WI%Z1P&](_6. GI'ZAT%]([4.PKH'2>;303TCM0["N@=J7<4
MT#M2[RB@=Z+>24#O1+V3@-Z)>B<!O1/U3@)Z)^J=!/1.U#L)Z)VH=Q+0.TTV
M"PKHG:AW$M [4>\DH'>FWEE [TR]LX#>F7IG ;TS]<X">F?JG07TSM0["^B=
MJ7<6T#M3[RR@=YYL]A;0.U/O+*!WH=Y%0.]"O8N WH5Z%P&]"_4N GH7ZET$
M]"[4NPCH7:AW$="[4._RG7H/X^>A#K>>KS6?_YU4CY=[Z^WQU^77R0D[5YS;
M^XKAZ2]02P,$%     @ YHFI5(S%)I]. @  )S<  !,   !;0V]N=&5N=%]4
M>7!E<UTN>&ULS=M-;MLP$(;AJQC:!I8BDJ*H(LZF[;;-HA=0)3H6K#^03.K<
MOK2<!&B1&@U<H._&@DUROA$'>':^^?8T6[\Z#/WH-\DNA/E#EOEF9X?:I]-L
MQ[BRG=Q0A_C5W6=SW>SK>YN)ZVN=-=,8[!C6X5@CN;WY9+?U0Q]6GP_Q9]]-
MXR9QMO?)ZN-IXS%KD]3SW'=-'>)Z]CBVOZ6LGQ/2>'+9XW?=[*_BAB1[,^&X
M\N> YW-?'ZUS76M7=[4+7^HA[LH.?>;#4V]]>K[$&SU.VVW7V'9J'H9X)/6S
MLW7K=]:&H4]/1:_.)X=XP_;TF5^<OY0Y%QAWWKEI]G%BSKX_[F4DQ]/K.1:R
M+G3G7_$U,9:^^/WL<=JM;?\R.U[OC\GMEWGX;'E<?L>_SOBU_CO[$) ^)*0/
M!>FC@/2A(7V4D#X,I(\*TD=^36F$(FI.(36GF)I34,TIJN845G.*JSD%UIPB
MJZ#(*BBR"HJL@B*KH,@J*+(*BJR"(JN@R"HHLDJ*K)(BJZ3(*BFR2HJLDB*K
MI,@J*;)*BJR2(JNBR*HHLBJ*K(HBJZ+(JBBR*HJLBB*KHLBJ*+(6%%D+BJP%
M1=:"(FM!D;6@R%I09"THLA8460N*K)HBJZ;(JBFR:HJLFB*KILBJ*;)JBJR:
M(JNFR%I29"TILI8464N*K"5%UI(B:TF1M:3(6E)D+2FR&HJLAB*KH<AJ*+(:
MBJR&(JNAR&HHLAJ*K(8B:T61M:+(6E%DK2BR5A19*XJL%476ZG_*^GV:]O\X
M?GFF0]V-+_G9\O^XVY]02P$"% ,4    " #FB:E4!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .:)
MJ52HVO7M[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    ( .:)J5297)PC$ 8  )PG   3              "
M <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ YHFI5+A:>A=&
M!0  @!4  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    ( .:)J52E0'MHQ0@  &@E   8              "
M@8H-  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #FB:E4
MT**742\#  !+"@  &               @(&%%@  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ YHFI5)?GM3TN!0  V!$  !@
M     ("!ZAD  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M .:)J53(-ZWI+@,  !X)   8              " @4X?  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    " #FB:E4J\Z?&LP"  !&!P  &
M            @(&R(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ YHFI5+":C2K&!@  $"   !@              ("!M"4  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( .:)J532I&X)00D  /DD
M   8              " @; L  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    " #FB:E4^0S''5\%  "1#   &               @($G-@
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ YHFI5+()$C<.
M!@  J0X  !D              ("!O#L  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    " #FB:E4HC^K\U,-  "N(P  &0
M@($!0@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( .:)
MJ510)GQ.90,  #$(   9              " @8M/  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ YHFI5/DBX#3A"   81<  !D
M         ("!)U,  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    " #FB:E4J:MUG^H'   M%0  &0              @($_7   >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( .:)J51<:W\+3P0  "@+
M   9              " @6!D  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ YHFI5!ZS(;E&"P  _B   !D              ("!YF@
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #FB:E4-KM<
M4P<.  "2*0  &0              @(%C=   >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    ( .:)J52K]60UL @   (7   9
M  " @:&"  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
MYHFI5'W):+*B P  &@@  !D              ("!B(L  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    " #FB:E4&TWBPW4#   <!P  &0
M            @(%ACP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    ( .:)J50@?$EXX@,  )P(   9              " @0V3  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ YHFI5'8BF;5;!@
MD0\  !D              ("!)I<  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    " #FB:E4EL04@_<$  !["@  &0              @(&X
MG0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( .:)J53]
M8@3H<@,   X)   9              " @>:B  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ YHFI5!EWIEU!$0  438  !D
M     ("!CZ8  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .:)J52QRDM=#@,  &0&   9              "
M@7+2  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ YHFI
M5!']X+SQ P  T0D  !D              ("!M]4  'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6Q02P$"% ,4    " #FB:E4AB#(:64%   :#P  &0
M        @('?V0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0
M   ( .:)J53RL*V0/0,  ! '   9              " @7O?  !X;"]W;W)K
M<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ YHFI5-L;PBWE!   FPT
M !D              ("![^(  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q0
M2P$"% ,4    " #FB:E40*" XPH&  "5$   &0              @($+Z
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( .:)J53(IO!'
M-P,  $$(   9              " @4SN  !X;"]W;W)K<VAE971S+W-H965T
M,S8N>&UL4$L! A0#%     @ YHFI5$4>T,RZ P  DP@  !D
M ("!NO$  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " #F
MB:E4#,I0]1T#  !/!@  &0              @(&K]0  >&PO=V]R:W-H965T
M<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( .:)J52XSU(M.@,  ,8&   9
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M970T,RYX;6Q02P$"% ,4    " #FB:E4X5_M-OX"  !;"0  &0
M    @($I$0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (
M .:)J51*40)("@0  %0,   9              " @5X4 0!X;"]W;W)K<VAE
M971S+W-H965T-#4N>&UL4$L! A0#%     @ YHFI5/9FB(.R!0  01L  !D
M             ("!GQ@! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"
M% ,4    " #FB:E4CJ1O8+\#  !K#0  &0              @(&('@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( .:)J50%5VX]8 (
M .4%   9              " @7XB 0!X;"]W;W)K<VAE971S+W-H965T-#@N
M>&UL4$L! A0#%     @ YHFI5%M'+@'@ P  ,Q   !D              ("!
M%24! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " #FB:E4
M@8-^Y$ "   [!0  &0              @($L*0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4P+GAM;%!+ 0(4 Q0    ( .:)J538?MR0# ,  (\*   9
M      " @:,K 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%
M  @ YHFI5"UQ4!^4 P  N X  !D              ("!YBX! 'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " #FB:E4V"G?Q 8%  "['0
M&0              @(&Q,@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+
M 0(4 Q0    ( .:)J52[*^ U.0(  - %   9              " @>XW 0!X
M;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ YHFI5,D^*=2M
M @  AP<  !D              ("!7CH! 'AL+W=O<FMS:&5E=',O<VAE970U
M-2YX;6Q02P$"% ,4    " #FB:E473+=0,$"  !O!P  &0
M@(%"/0$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( .:)
MJ53L3 K( P0  .T.   9              " @3I  0!X;"]W;W)K<VAE971S
M+W-H965T-3<N>&UL4$L! A0#%     @ YHFI5/8* UF] P  ;Q   !D
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M=#8R+GAM;%!+ 0(4 Q0    ( .:)J53(=]!\U0(  .T)   9
M  " @015 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @
MYHFI5.I*VE<E!0  DQT  !D              ("!$%@! 'AL+W=O<FMS:&5E
M=',O<VAE970V-"YX;6Q02P$"% ,4    " #FB:E41;6[TO@"   5"0  &0
M            @(%L70$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4
M Q0    ( .:)J51#49M%OP,  /0-   9              " @9M@ 0!X;"]W
M;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ YHFI5" /T@=1!
M3!(  !D              ("!D60! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX
M;6Q02P$"% ,4    " #FB:E44FS]8H4#  # "@  &0              @($9
M:0$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( .:)J52,
MX=/%(0,  &\)   9              " @=5L 0!X;"]W;W)K<VAE971S+W-H
M965T-CDN>&UL4$L! A0#%     @ YHFI5'20X] X P  10X  !D
M     ("!+7 ! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .:)J51.DM6_F@,  *(+   9              "
M@<2$ 0!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ YHFI
M5'[H!?PM!   J X  !D              ("!E8@! 'AL+W=O<FMS:&5E=',O
M<VAE970W-BYX;6Q02P$"% ,4    " #FB:E4!3?&I0(#   X"   &0
M        @('YC $ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0
M   ( .:)J53%'E+A3 0  -4/   9              " @3*0 0!X;"]W;W)K
M<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ YHFI5*=9NJ,Z @  $@4
M !D              ("!M90! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q0
M2P$"% ,4    " #FB:E4![-S=D@#  #<"   &0              @($FEP$
M>&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( .:)J50JBYG2
MO 8  #TF   9              " @:6: 0!X;"]W;W)K<VAE971S+W-H965T
M.#$N>&UL4$L! A0#%     @ YHFI5)= +(E" @  .@4  !D
M ("!F*$! 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4    " #F
MB:E4< ,93<,"  !I"0  &0              @($1I $ >&PO=V]R:W-H965T
M<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    ( .:)J50Z^FM&LP4  /<6   9
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M970X."YX;6Q02P$"% ,4    " #FB:E4KX9(ZW<"  "W!0  &0
M    @('DOP$ >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    (
M .:)J506D$X/Y0,  !4/   9              " @9+" 0!X;"]W;W)K<VAE
M971S+W-H965T.3 N>&UL4$L! A0#%     @ YHFI5&L#@Y2A @  Y <  !D
M             ("!KL8! 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q02P$"
M% ,4    " #FB:E4L+!NNL4"  !-!P  &0              @(&&R0$ >&PO
M=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( .:)J51F**A]D (
M + &   9              " @8+, 0!X;"]W;W)K<VAE971S+W-H965T.3,N
M>&UL4$L! A0#%     @ YHFI5*9YW])^ P  A T  !D              ("!
M2<\! 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX;6Q02P$"% ,4    " #FB:E4
M%9++8"<"   Q!   &0              @('^T@$ >&PO=V]R:W-H965T<R]S
M:&5E=#DU+GAM;%!+ 0(4 Q0    ( .:)J50X>)_?&P,  '@(   9
M      " @5S5 0!X;"]W;W)K<VAE971S+W-H965T.38N>&UL4$L! A0#%
M  @ YHFI5%E0'_YW!0  7QH  !D              ("!KM@! 'AL+W=O<FMS
M:&5E=',O<VAE970Y-RYX;6Q02P$"% ,4    " #FB:E4YB<;JRH#  #R$@
M#0              @ %<W@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .:)
MJ527BKL<P    !,"   +              "  ;'A 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( .:)J51?98XQS@8  +D_   /              "  9KB 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #FB:E4M"E^S,("   *.0  &@
M            @ &5Z0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #FB:E4C,4FGTX"   G-P  $P              @ &/[ $ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     :0!I -8<   .[P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>286</ContextCount>
  <ElementCount>443</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>91</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - DEI Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DEIDocument</Role>
      <ShortName>DEI Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome</Role>
      <ShortName>Condensed Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Paranthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity Statement</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - New Accounting Pronouncements:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - Business Combinations and Asset Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions</Role>
      <ShortName>Business Combinations and Asset Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Revenue (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/RevenueNotes</Role>
      <ShortName>Revenue (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Leases (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LeasesNotes</Role>
      <ShortName>Leases (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128107 - Disclosure - Net Income Per Share:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2132108 - Disclosure - Derivative Financial Instruments (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes</Role>
      <ShortName>Derivative Financial Instruments (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2140109 - Disclosure - Fair Value Measures and Disclosures (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes</Role>
      <ShortName>Fair Value Measures and Disclosures (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2147110 - Disclosure - Investment Securities (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesNotes</Role>
      <ShortName>Investment Securities (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2152111 - Disclosure - Prepaids and Other Current Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</Role>
      <ShortName>Prepaids and Other Current Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2156112 - Disclosure - Inventories:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/Inventories</Role>
      <ShortName>Inventories:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2159113 - Disclosure - Property and Equipment:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2163114 - Disclosure - Goodwill and Intangible Assets (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes</Role>
      <ShortName>Goodwill and Intangible Assets (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2169115 - Disclosure - Accrued Liabilities (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesNotes</Role>
      <ShortName>Accrued Liabilities (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2173116 - Disclosure - Income Taxes:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2175117 - Disclosure - Long-Term Obligations (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsNotes</Role>
      <ShortName>Long-Term Obligations (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2184118 - Disclosure - Commitments and Contingencies:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2186119 - Disclosure - Collaborative and Other Arrangements (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</Role>
      <ShortName>Collaborative and Other Arrangements (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2189120 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Business Combinations and Asset Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables</Role>
      <ShortName>Business Combinations and Asset Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2316303 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RevenueNotes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesNotes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2329305 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Fair Value Measures and Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables</Role>
      <ShortName>Fair Value Measures and Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2348308 - Disclosure - Investment Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesTables</Role>
      <ShortName>Investment Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InvestmentSecuritiesNotes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - Prepaids and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables</Role>
      <ShortName>Prepaids and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2357310 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/Inventories</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2360311 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipment</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2364312 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2370313 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesNotes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2376314 - Disclosure - Long-Term Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTables</Role>
      <ShortName>Long-Term Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsNotes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2390316 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.icumed.com/role/Equity</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Business Combinations and Asset Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Smiths Medical (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails</Role>
      <ShortName>Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Restructuring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails</Role>
      <ShortName>Restructuring, Strategic Transaction and Integration Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Strategic Transaction and Integration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/StrategicTransactionandIntegrationDetails</Role>
      <ShortName>Strategic Transaction and Integration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails</Role>
      <ShortName>Revenue Disaggregated Revenue by Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails</Role>
      <ShortName>Revenue Disaggregated Revenue by Product Line (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Revenue Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/RevenueContractLiabilitiesDetails</Role>
      <ShortName>Revenue Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Leases Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesTextDetails</Role>
      <ShortName>Leases Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LeasesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails</Role>
      <ShortName>Leases Cash Flow, Operating Activities, Lessee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - Leases Assets and Liabilities, Lessee (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails</Role>
      <ShortName>Leases Assets and Liabilities, Lessee (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - Leases Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LeasesMaturityDetails</Role>
      <ShortName>Leases Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShareTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Net Income Per Share (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/NetIncomePerShareDetails1</Role>
      <ShortName>Net Income Per Share (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/NetIncomePerShareTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails</Role>
      <ShortName>Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/DerivativeFinancialInstrumentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails</Role>
      <ShortName>Derivative Financial Instruments Interest Rate Swaps (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails</Role>
      <ShortName>Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - Fair Value Measures and Disclosures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails</Role>
      <ShortName>Fair Value Measures and Disclosures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2445428 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Liability Measurement Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2446429 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails</Role>
      <ShortName>Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - Investment Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesDetails</Role>
      <ShortName>Investment Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InvestmentSecuritiesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2450431 - Disclosure - Investment Securities Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InvestmentSecuritiesTableDetails</Role>
      <ShortName>Investment Securities Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2451432 - Disclosure - Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityMethodInvestmentsDetails</Role>
      <ShortName>Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails</Role>
      <ShortName>Prepaids and Other Current Assets Prepaids and Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2455434 - Disclosure - Other Assets Noncurrent(Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/OtherAssetsNoncurrentDetails</Role>
      <ShortName>Other Assets Noncurrent(Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2458435 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/InventoriesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2461436 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - Property and Equipment Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/PropertyandEquipmentTextDetails</Role>
      <ShortName>Property and Equipment Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2465438 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails</Role>
      <ShortName>Goodwill and Intangible Assets Goodwill Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2466439 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails</Role>
      <ShortName>Goodwill and Intangible Assets Intangibles Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2467440 - Disclosure - Goodwill and Intangible Assets Text (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails</Role>
      <ShortName>Goodwill and Intangible Assets Text (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2468441 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails</Role>
      <ShortName>Goodwill and Intangible Assets 5-Year Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2471442 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2472443 - Disclosure - Accrued Liabilities Long-term liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails</Role>
      <ShortName>Accrued Liabilities Long-term liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2474444 - Disclosure - Income Taxes Effective tax rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails</Role>
      <ShortName>Income Taxes Effective tax rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2477445 - Disclosure - Long-Term Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsDetails</Role>
      <ShortName>Long-Term Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/LongTermObligationsTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2478446 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails</Role>
      <ShortName>Long-Term Obligations Interest Rate Terms (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2479447 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails</Role>
      <ShortName>Long-Term Obligations Terminated Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2480448 - Disclosure - Long-Term Obligations Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsTableDetails</Role>
      <ShortName>Long-Term Obligations Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2481449 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails</Role>
      <ShortName>Long-Term Obligations Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2482450 - Disclosure - Long-Term Obligations Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails</Role>
      <ShortName>Long-Term Obligations Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2483451 - Disclosure - Long-Term Obligations Principal Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails</Role>
      <ShortName>Long-Term Obligations Principal Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2485452 - Disclosure - Commitments and Contingencies Contingency (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails</Role>
      <ShortName>Commitments and Contingencies Contingency (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2488453 - Disclosure - Collaborative and Other Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails</Role>
      <ShortName>Collaborative and Other Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2491454 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.icumed.com/role/EquityTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="icui-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2492455 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Equity Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="icui-20220331.htm">icui-20220331.htm</File>
    <File>icui-20220331.xsd</File>
    <File>icui-20220331_cal.xml</File>
    <File>icui-20220331_def.xml</File>
    <File>icui-20220331_lab.xml</File>
    <File>icui-20220331_pre.xml</File>
    <File>icui-ex31133122.htm</File>
    <File>icui-ex31233122.htm</File>
    <File>icui-ex32133122.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="959">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>114
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "icui-20220331.htm": {
   "axisCustom": 4,
   "axisStandard": 20,
   "contextCount": 286,
   "dts": {
    "calculationLink": {
     "local": [
      "icui-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "icui-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "icui-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "icui-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "icui-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "icui-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 683,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 6,
    "total": 6
   },
   "keyCustom": 65,
   "keyStandard": 378,
   "memberCustom": 41,
   "memberStandard": 50,
   "nsprefix": "icui",
   "nsuri": "http://www.icumed.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - DEI Document",
     "role": "http://www.icumed.com/role/DEIDocument",
     "shortName": "DEI Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - New Accounting Pronouncements:",
     "role": "http://www.icumed.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - Business Combinations and Asset Acquisitions",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions",
     "shortName": "Business Combinations and Asset Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Restructuring, Strategic Transaction and Integration (Notes)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes",
     "shortName": "Restructuring, Strategic Transaction and Integration (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Revenue (Notes)",
     "role": "http://www.icumed.com/role/RevenueNotes",
     "shortName": "Revenue (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Leases (Notes)",
     "role": "http://www.icumed.com/role/LeasesNotes",
     "shortName": "Leases (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128107 - Disclosure - Net Income Per Share:",
     "role": "http://www.icumed.com/role/NetIncomePerShare",
     "shortName": "Net Income Per Share:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132108 - Disclosure - Derivative Financial Instruments (Notes)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes",
     "shortName": "Derivative Financial Instruments (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140109 - Disclosure - Fair Value Measures and Disclosures (Notes)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes",
     "shortName": "Fair Value Measures and Disclosures (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147110 - Disclosure - Investment Securities (Notes)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesNotes",
     "shortName": "Investment Securities (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152111 - Disclosure - Prepaids and Other Current Assets (Notes)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes",
     "shortName": "Prepaids and Other Current Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156112 - Disclosure - Inventories:",
     "role": "http://www.icumed.com/role/Inventories",
     "shortName": "Inventories:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159113 - Disclosure - Property and Equipment:",
     "role": "http://www.icumed.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163114 - Disclosure - Goodwill and Intangible Assets (Notes)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes",
     "shortName": "Goodwill and Intangible Assets (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169115 - Disclosure - Accrued Liabilities (Notes)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesNotes",
     "shortName": "Accrued Liabilities (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2173116 - Disclosure - Income Taxes:",
     "role": "http://www.icumed.com/role/IncomeTaxes",
     "shortName": "Income Taxes:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2175117 - Disclosure - Long-Term Obligations (Notes)",
     "role": "http://www.icumed.com/role/LongTermObligationsNotes",
     "shortName": "Long-Term Obligations (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2184118 - Disclosure - Commitments and Contingencies:",
     "role": "http://www.icumed.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2186119 - Disclosure - Collaborative and Other Arrangements (Notes)",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes",
     "shortName": "Collaborative and Other Arrangements (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2189120 - Disclosure - Equity",
     "role": "http://www.icumed.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Business Combinations and Asset Acquisitions (Tables)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables",
     "shortName": "Business Combinations and Asset Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Restructuring, Strategic Transaction and Integration (Tables)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables",
     "shortName": "Restructuring, Strategic Transaction and Integration (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316303 - Disclosure - Revenue (Tables)",
     "role": "http://www.icumed.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Leases (Tables)",
     "role": "http://www.icumed.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329305 - Disclosure - Net Income Per Share (Tables)",
     "role": "http://www.icumed.com/role/NetIncomePerShareTables",
     "shortName": "Net Income Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Derivative Financial Instruments (Tables)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Fair Value Measures and Disclosures (Tables)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables",
     "shortName": "Fair Value Measures and Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348308 - Disclosure - Investment Securities (Tables)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesTables",
     "shortName": "Investment Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - Prepaids and Other Current Assets (Tables)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables",
     "shortName": "Prepaids and Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357310 - Disclosure - Inventories (Tables)",
     "role": "http://www.icumed.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2360311 - Disclosure - Property and Equipment (Tables)",
     "role": "http://www.icumed.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Income",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
     "shortName": "Condensed Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364312 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370313 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2376314 - Disclosure - Long-Term Obligations (Tables)",
     "role": "http://www.icumed.com/role/LongTermObligationsTables",
     "shortName": "Long-Term Obligations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2390316 - Disclosure - Equity (Tables)",
     "role": "http://www.icumed.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:ContingentConsiderationGrossST",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
     "shortName": "Business Combinations and Asset Acquisitions Foreign Infusion Distributor(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "icui:BusinessCombinationConsiderationHoldbackLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Business Combinations and Asset Acquisitions (Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
     "shortName": "Business Combinations and Asset Acquisitions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "icui:MinimumStockPriceTargetForEarnOutPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical (Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
     "shortName": "Business Combinations and Asset Acquisitions Smiths Medical (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ida794f824cb94242bde5116941247684_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)",
     "role": "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
     "shortName": "Business Combinations and Asset Acquisitions Smiths Medical Pro Forma (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Restructuringstrategictransactionandintegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Restructuring, Strategic Transaction and Integration Restructuring (Details)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails",
     "shortName": "Restructuring, Strategic Transaction and Integration Restructuring (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:Restructuringstrategictransactionandintegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Restructuring, Strategic Transaction and Integration Liability (Details)",
     "role": "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails",
     "shortName": "Restructuring, Strategic Transaction and Integration Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Strategic Transaction and Integration (Details)",
     "role": "http://www.icumed.com/role/StrategicTransactionandIntegrationDetails",
     "shortName": "Strategic Transaction and Integration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:StrategicTransactionandIntegration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Revenue Disaggregated Revenue by Geography (Details)",
     "role": "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
     "shortName": "Revenue Disaggregated Revenue by Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i15c0bb3aed1b4706bc6fac56eab2c4cd_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Revenue Disaggregated Revenue by Product Line (Details)",
     "role": "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails",
     "shortName": "Revenue Disaggregated Revenue by Product Line (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i2b01fe971840481cbc0118ca73113ed3_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Revenue Contract Liabilities (Details)",
     "role": "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
     "shortName": "Revenue Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Leases Text (Details)",
     "role": "http://www.icumed.com/role/LeasesTextDetails",
     "shortName": "Leases Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "icui:Optiontoextendinyears",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Leases (Details)",
     "role": "http://www.icumed.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Leases Cash Flow, Operating Activities, Lessee (Details)",
     "role": "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails",
     "shortName": "Leases Cash Flow, Operating Activities, Lessee (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - Leases Assets and Liabilities, Lessee (Details)",
     "role": "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
     "shortName": "Leases Assets and Liabilities, Lessee (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:AssetsandLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - Leases Maturity (Details)",
     "role": "http://www.icumed.com/role/LeasesMaturityDetails",
     "shortName": "Leases Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Net Income Per Share (Details)",
     "role": "http://www.icumed.com/role/NetIncomePerShareDetails",
     "shortName": "Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Comprehensive Income (Paranthetical)",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Paranthetical)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Net Income Per Share (Details 1)",
     "role": "http://www.icumed.com/role/NetIncomePerShareDetails1",
     "shortName": "Net Income Per Share (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
     "shortName": "Derivative Financial Instruments Foreign Exchange Forward Contracts(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i2aca8fbd4d9f46bd8abdb6dfa1bc52fa_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Derivative Financial Instruments (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
     "shortName": "Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ic788c207f74e4b2dafcf30292f3548ad_I20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "mxn",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Derivative Financial Instruments Interest Rate Swaps (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
     "shortName": "Derivative Financial Instruments Interest Rate Swaps (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ice4f52a2d82e4013bf866a6fa2b52be1_I20220331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - FV of Derivative Instruments Included Within Consolidated Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - Cash Flow Hedge Activity Included in Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "role": "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
     "shortName": "Derivative Financial Instruments Derivative Instruments and Hedging Activities - Amounts Affecting Consolidated Statements of Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - Fair Value Measures and Disclosures (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
     "shortName": "Fair Value Measures and Disclosures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "8",
      "lang": "en-US",
      "name": "icui:OwnershipRequirementForEarnoutPayment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
     "shortName": "Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Pursuit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "icui:CurrencyTranslationOnEarnOut",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia07fbd83d23f4cf19c3ef9ca4c01d58c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
     "shortName": "Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "idbec71a052e34a628bdbc7874d90f523_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders' Equity Statement",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity Statement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "idbec71a052e34a628bdbc7874d90f523_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia760ade7301b4ae091a97fbf0f60bae8_I20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445428 - Disclosure - Fair Value Measures and Disclosures Liability Measurement Inputs (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
     "shortName": "Fair Value Measures and Disclosures Liability Measurement Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "ia760ade7301b4ae091a97fbf0f60bae8_I20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446429 - Disclosure - Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)",
     "role": "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
     "shortName": "Fair Value Measures and Disclosures Assets and Liabilities by Balance Sheet Grouping (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - Investment Securities (Details)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesDetails",
     "shortName": "Investment Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450431 - Disclosure - Investment Securities Table (Details)",
     "role": "http://www.icumed.com/role/InvestmentSecuritiesTableDetails",
     "shortName": "Investment Securities Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451432 - Disclosure - Equity Method Investments (Details)",
     "role": "http://www.icumed.com/role/EquityMethodInvestmentsDetails",
     "shortName": "Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentAggregateCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - Prepaids and Other Current Assets Prepaids and Other Assets (Details)",
     "role": "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails",
     "shortName": "Prepaids and Other Current Assets Prepaids and Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455434 - Disclosure - Other Assets Noncurrent(Details)",
     "role": "http://www.icumed.com/role/OtherAssetsNoncurrentDetails",
     "shortName": "Other Assets Noncurrent(Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458435 - Disclosure - Inventories (Details)",
     "role": "http://www.icumed.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461436 - Disclosure - Property and Equipment (Details)",
     "role": "http://www.icumed.com/role/PropertyandEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - Property and Equipment Text (Details)",
     "role": "http://www.icumed.com/role/PropertyandEquipmentTextDetails",
     "shortName": "Property and Equipment Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465438 - Disclosure - Goodwill and Intangible Assets Goodwill Table (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails",
     "shortName": "Goodwill and Intangible Assets Goodwill Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466439 - Disclosure - Goodwill and Intangible Assets Intangibles Table (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
     "shortName": "Goodwill and Intangible Assets Intangibles Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467440 - Disclosure - Goodwill and Intangible Assets Text (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails",
     "shortName": "Goodwill and Intangible Assets Text (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468441 - Disclosure - Goodwill and Intangible Assets 5-Year Amortization (Details)",
     "role": "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails",
     "shortName": "Goodwill and Intangible Assets 5-Year Amortization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471442 - Disclosure - Accrued Liabilities (Details)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "icui:AccruedSalariesAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiabilityNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472443 - Disclosure - Accrued Liabilities Long-term liabilities (Details)",
     "role": "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
     "shortName": "Accrued Liabilities Long-term liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccruedEmployeeBenefitsCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474444 - Disclosure - Income Taxes Effective tax rate (Details)",
     "role": "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails",
     "shortName": "Income Taxes Effective tax rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:TotalSeniorSecuredCreditFacility",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2477445 - Disclosure - Long-Term Obligations (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsDetails",
     "shortName": "Long-Term Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:TotalSeniorSecuredCreditFacility",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestPercentageAddedToFederalFundsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478446 - Disclosure - Long-Term Obligations Interest Rate Terms (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
     "shortName": "Long-Term Obligations Interest Rate Terms (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:InterestPercentageAddedToFederalFundsRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479447 - Disclosure - Long-Term Obligations Terminated Credit Agreement (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails",
     "shortName": "Long-Term Obligations Terminated Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation:",
     "role": "http://www.icumed.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation:",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2480448 - Disclosure - Long-Term Obligations Table (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsTableDetails",
     "shortName": "Long-Term Obligations Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2481449 - Disclosure - Long-Term Obligations Schedule of Maturities (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails",
     "shortName": "Long-Term Obligations Schedule of Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:InterestExpenseOnLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2482450 - Disclosure - Long-Term Obligations Interest Expense (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails",
     "shortName": "Long-Term Obligations Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "icui:InterestExpenseOnLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermAPrincipalPaymentFirst2Years",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2483451 - Disclosure - Long-Term Obligations Principal Payment (Details)",
     "role": "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails",
     "shortName": "Long-Term Obligations Principal Payment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "icui:TermAPrincipalPaymentFirst2Years",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i9b0029b2767d4a81bf2f11c76dac300a_D20220101-20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "icui:ContingentConsiderationGrossST",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2485452 - Disclosure - Commitments and Contingencies Contingency (Details)",
     "role": "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
     "shortName": "Commitments and Contingencies Contingency (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i04278caae1d04e05aee4473287d6eb1f_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "icui:Contingentconsiderationgross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2488453 - Disclosure - Collaborative and Other Arrangements (Details)",
     "role": "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails",
     "shortName": "Collaborative and Other Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:TreasuryStockPurchasePlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2491454 - Disclosure - Equity (Details)",
     "role": "http://www.icumed.com/role/EquityDetails",
     "shortName": "Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "icui:TreasuryStockPurchasePlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "i1f219d65d2dc4abc830b7ab0f8df0f99_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2492455 - Disclosure - Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Equity Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "icui-20220331.htm",
      "contextRef": "id4ad65ae063d4e49821ad5b4dece8ece_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 91,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_CZK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Czech Republic, Koruny",
        "terseLabel": "Czech Republic, Koruny"
       }
      }
     },
     "localname": "CZK",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_MXN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mexico, Pesos",
        "terseLabel": "Mexico, Pesos"
       }
      }
     },
     "localname": "MXN",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "verboseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.icumed.com/role/DEIDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "icui_AccruedAuditFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued audit fees",
        "label": "Accrued audit fees",
        "terseLabel": "Accrued audit fees"
       }
      }
     },
     "localname": "AccruedAuditFees",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AccruedSalariesAndBenefits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued salaries and benefits",
        "label": "Accrued salaries and benefits",
        "terseLabel": "Salaries and benefits"
       }
      }
     },
     "localname": "AccruedSalariesAndBenefits",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AccruedTransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued transaction costs",
        "label": "Accrued transaction costs",
        "terseLabel": "Accrued transaction costs"
       }
      }
     },
     "localname": "AccruedTransactionCosts",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedfreight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued freight",
        "label": "Accrued freight",
        "terseLabel": "Accrued freight"
       }
      }
     },
     "localname": "Accruedfreight",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedlegalfees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued legal fees",
        "label": "Accrued legal fees",
        "terseLabel": "Legal accrual"
       }
      }
     },
     "localname": "Accruedlegalfees",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Accruedothertaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued other taxes",
        "label": "Accrued other taxes",
        "terseLabel": "Accrued other taxes"
       }
      }
     },
     "localname": "Accruedothertaxes",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AcquiredRestructuringLiabilityCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired restructuring liability, current",
        "label": "Acquired restructuring liability, current",
        "terseLabel": "Acquired restructuring liability, current"
       }
      }
     },
     "localname": "AcquiredRestructuringLiabilityCurrent",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_AmortizationOfInventoryStepUp": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Inventory Step-up",
        "label": "Amortization of Inventory Step-up",
        "terseLabel": "Amortization of Inventory Step-up"
       }
      }
     },
     "localname": "AmortizationOfInventoryStepUp",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ApplicableMarginBaseRateLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Base Rate Loans",
        "label": "Applicable Margin Base Rate Loans",
        "terseLabel": "Applicable Margin Base Rate Loans"
       }
      }
     },
     "localname": "ApplicableMarginBaseRateLoans",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio [Line Items]",
        "label": "Applicable Margin Based on Leverage Ratio [Line Items]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio [Line Items]"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioLineItems",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio [Table]",
        "label": "Applicable Margin Based on Leverage Ratio [Table]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio [Table]"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioTable",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ApplicableMarginBasedOnLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Based on Leverage Ratio",
        "label": "Applicable Margin Based on Leverage Ratio [Table Text Block]",
        "terseLabel": "Applicable Margin Based on Leverage Ratio"
       }
      }
     },
     "localname": "ApplicableMarginBasedOnLeverageRatioTableTextBlock",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ApplicableMarginTermSOFRLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Applicable Margin Term SOFR Loans",
        "label": "Applicable Margin Term SOFR Loans",
        "terseLabel": "Applicable Margin Term SOFR Loans"
       }
      }
     },
     "localname": "ApplicableMarginTermSOFRLoans",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_AssetsandLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities, Leases [Table Text Block]",
        "label": "Assets and Liabilities, Leases [Table Text Block]",
        "terseLabel": "Assets and Liabilities, Leases [Table Text Block]"
       }
      }
     },
     "localname": "AssetsandLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_AvailableforsaleDebtSecurityCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available-for-sale Debt Security Current [Member]",
        "label": "Available-for-sale Debt Security Current [Member]",
        "terseLabel": "Available-for-sale Debt Security Current [Member]"
       }
      }
     },
     "localname": "AvailableforsaleDebtSecurityCurrentMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_BusinessCombinationConsiderationHoldbackLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration, Holdback liability",
        "label": "Business Combination, Consideration, Holdback liability",
        "terseLabel": "Business Combination, Consideration, Holdback liability"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationHoldbackLiability",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationConsiderationTransferredCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Cash",
        "label": "Business Combination, Consideration Transferred, Cash",
        "terseLabel": "Business Combination, Consideration Transferred, Cash"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredCash",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationGoodwillNonDeductible": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination, goodwill- non deductible",
        "label": "Business combination, goodwill- non deductible",
        "terseLabel": "Business combination, goodwill- non deductible"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillNonDeductible",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "business combination, recognized identifiable asset acquired and liability assumed,",
        "label": "business combination, recognized identifiable asset acquired and liability assumed,",
        "terseLabel": "business combination, recognized identifiable asset acquired and liability assumed,"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumed",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable",
        "label": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable",
        "negatedTerseLabel": "Business Combinations, Identified Assumed Liabilities Recognized, Income tax payable"
       }
      }
     },
     "localname": "BusinessCombinationsIdentifiedAssumedLiabilitiesRecognizedIncomeTaxPayable",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CommonStockSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Shares [Member]",
        "label": "Common Stock Shares [Member]",
        "terseLabel": "Common Stock Shares [Member]"
       }
      }
     },
     "localname": "CommonStockSharesMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Software [Member]",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computer Equipment and Software [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ContingentConsiderationAllAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent consideration all Acquisitions",
        "label": "Contingent consideration all Acquisitions",
        "negatedTerseLabel": "Contingent consideration all Acquisitions"
       }
      }
     },
     "localname": "ContingentConsiderationAllAcquisitions",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContingentConsiderationGrossLT": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Gross LT",
        "label": "Contingent Consideration, Gross LT",
        "terseLabel": "Contingent Consideration, Gross LT"
       }
      }
     },
     "localname": "ContingentConsiderationGrossLT",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContingentConsiderationGrossST": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Gross ST",
        "label": "Contingent Consideration, Gross ST",
        "terseLabel": "Contingent Consideration, Gross ST"
       }
      }
     },
     "localname": "ContingentConsiderationGrossST",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Contingentconsiderationgross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contingent consideration gross",
        "label": "contingent consideration gross",
        "terseLabel": "contingent consideration gross"
       }
      }
     },
     "localname": "Contingentconsiderationgross",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ContractassetandliabilitybalancesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Line Items]",
        "terseLabel": "Contract asset and liability balances [Line Items]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesLineItems",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_ContractassetandliabilitybalancesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract asset and liability balances [Table]",
        "label": "Contract asset and liability balances [Table]",
        "terseLabel": "Contract asset and liability balances [Table]"
       }
      }
     },
     "localname": "ContractassetandliabilitybalancesTable",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Contractsettlement": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "contract settlement",
        "label": "contract settlement",
        "terseLabel": "contract settlement"
       }
      }
     },
     "localname": "Contractsettlement",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_CriticalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Critical Care [Member]",
        "label": "Critical Care [Member]",
        "terseLabel": "Critical Care [Member]"
       }
      }
     },
     "localname": "CriticalCareMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_CurrencyTranslationOnEarnOut": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency translation on earn-out",
        "label": "Currency translation on earn-out",
        "negatedTerseLabel": "Currency translation on earn-out"
       }
      }
     },
     "localname": "CurrencyTranslationOnEarnOut",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Deferredtaxcharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax charge",
        "label": "Deferred tax charge",
        "terseLabel": "Deferred tax charge"
       }
      }
     },
     "localname": "Deferredtaxcharge",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_DerivativeVariableRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "derivative variable rate floor",
        "label": "derivative variable rate floor",
        "terseLabel": "derivative variable rate floor"
       }
      }
     },
     "localname": "DerivativeVariableRateFloor",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "developed technology",
        "label": "developed technology [Member]",
        "terseLabel": "developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document And Entity Information [Abstract]",
        "label": "Document And Entity Information [Abstract]",
        "terseLabel": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.icumed.com/20220331",
     "xbrltype": "stringItemType"
    },
    "icui_EarnoutliabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-out liability [Member]",
        "label": "Earn-out liability [Member]",
        "terseLabel": "Earn-out liability [Member]"
       }
      }
     },
     "localname": "EarnoutliabilityMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_EquipmentrevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment revenue [Member]",
        "label": "Equipment revenue [Member]",
        "terseLabel": "Equipment revenue [Member]"
       }
      }
     },
     "localname": "EquipmentrevenueMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ForeignInfusionSystemSupplierMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Infusion System Supplier",
        "label": "Foreign Infusion System Supplier [Member]",
        "terseLabel": "Foreign Infusion System Supplier"
       }
      }
     },
     "localname": "ForeignInfusionSystemSupplierMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_ForeignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign [Member]",
        "label": "Foreign [Member]",
        "terseLabel": "Foreign [Member]"
       }
      }
     },
     "localname": "ForeignMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_GoodwillAcquiredDuringPeriodAllAcquisitions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, acquired during period - All acquisitions",
        "label": "Goodwill, acquired during period - All acquisitions",
        "terseLabel": "Goodwill, acquired during period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriodAllAcquisitions",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_GovernmentGrantRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Grant Revenue",
        "label": "Government Grant Revenue [Member]",
        "terseLabel": "Government Grant Revenue"
       }
      }
     },
     "localname": "GovernmentGrantRevenueMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_GreaterThan275To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "greater than 2.75 to1.00",
        "label": "greater than 2.75 to1.00 [Member]",
        "terseLabel": "greaterthan2point75to1"
       }
      }
     },
     "localname": "GreaterThan275To100Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Greaterthan400to100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "greaterthan4.00to1.00",
        "label": "greaterthan4.00to1.00 [Member]",
        "terseLabel": "greaterthan 4to1"
       }
      }
     },
     "localname": "Greaterthan400to100Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 2 [Member]",
        "label": "Hedge 2 [Member]",
        "terseLabel": "Hedge 2 [Member]"
       }
      }
     },
     "localname": "Hedge2Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Hedge3MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge 3 [Member]",
        "label": "Hedge 3 [Member] [Member]",
        "terseLabel": "Hedge 3 [Member] [Member]"
       }
      }
     },
     "localname": "Hedge3MemberMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_IVSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IV Solutions [Member]",
        "label": "IV Solutions [Member]",
        "terseLabel": "IV Solutions [Member]"
       }
      }
     },
     "localname": "IVSolutionsMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in the carrying amount as of the balance sheet date of payments made for taxes. Also includes the net change during the reporting period in the account that represents the temporary difference that results from income (loss) that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase Decrease in income taxes, including excess tax benefits and deferred income taxes",
        "terseLabel": "Income taxes, including excess tax benefits and deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_InfusionConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Consumables [Member]",
        "label": "Infusion Consumables [Member]",
        "terseLabel": "Infusion Consumables [Member]"
       }
      }
     },
     "localname": "InfusionConsumablesMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InfusionConsumablesSmithsMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Consumables-Smiths Medical",
        "label": "Infusion Consumables-Smiths Medical [Member]",
        "terseLabel": "Infusion Consumables-Smiths Medical"
       }
      }
     },
     "localname": "InfusionConsumablesSmithsMedicalMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InfusionSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infusion Systems [Member]",
        "label": "Infusion Systems [Member]",
        "terseLabel": "Infusion Systems [Member]"
       }
      }
     },
     "localname": "InfusionSystemsMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InstrumentsPlacedwithCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments Placed with Customers [Member]",
        "label": "Instruments Placed with Customers [Member]",
        "terseLabel": "Instruments Placed with Customers [Member]"
       }
      }
     },
     "localname": "InstrumentsPlacedwithCustomersMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InterestExpenseOnLongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense on long term debt",
        "label": "Interest expense on long term debt [Table Text Block]",
        "terseLabel": "Interest expense on long term debt"
       }
      }
     },
     "localname": "InterestExpenseOnLongTermDebtTableTextBlock",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_InterestPercentageAddedToBaseRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Percentage Added to Base Rate",
        "label": "Interest Percentage Added to Base Rate",
        "terseLabel": "Interest Percentage Added to Base Rate"
       }
      }
     },
     "localname": "InterestPercentageAddedToBaseRate",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_InterestPercentageAddedToFederalFundsRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Percentage Added to Federal Funds Rate",
        "label": "Interest Percentage Added to Federal Funds Rate",
        "terseLabel": "Interest Percentage Added to Federal Funds Rate"
       }
      }
     },
     "localname": "InterestPercentageAddedToFederalFundsRate",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_InterestRateSwapEndingNotionalValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Swap Ending Notional Value",
        "label": "Interest Rate Swap Ending Notional Value",
        "terseLabel": "Interest Rate Swap Ending Notional Value"
       }
      }
     },
     "localname": "InterestRateSwapEndingNotionalValue",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_InternationalDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Distributor",
        "label": "International Distributor [Member]",
        "terseLabel": "International Distributor"
       }
      }
     },
     "localname": "InternationalDistributorMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "investments in Debt and Marketable Equity Securities and Equity Method Investments",
        "label": "investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]",
        "terseLabel": "investments in Debt and Marketable Equity Securities and Equity Method Investments [Text Block]"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndEquityMethodInvestmentsTextBlock",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_LOngTermObligationsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LOng-Term Obligations Disclosure [Abstract]",
        "label": "LOng-Term Obligations Disclosure [Abstract]",
        "terseLabel": "LOng-Term Obligations Disclosure [Abstract]"
       }
      }
     },
     "localname": "LOngTermObligationsDisclosureAbstract",
     "nsuri": "http://www.icumed.com/20220331",
     "xbrltype": "stringItemType"
    },
    "icui_LessThan275To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than 2.75:1.00",
        "label": "less than 2.75 to1.00 [Member]",
        "terseLabel": "lessthan2point75to1"
       }
      }
     },
     "localname": "LessThan275To100Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqual300To100ButGreaterThan250to100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal 3.00 to 1.00 but greater than 2.50to1.00",
        "label": "less than or equal 3.00 to 1.00 but greater than 2.50to1.00 [Member]",
        "terseLabel": "lessthanorequal3to1butgreaterthan2point5to1"
       }
      }
     },
     "localname": "LessThanOrEqual300To100ButGreaterThan250to100Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo200To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 2.00 to 1.00",
        "label": "less than or equal to 2.00 to 1.00 [Member]",
        "terseLabel": "lessthanorequalto2to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo200To100Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo250To100ButGreaterThan200To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 2.50 to1.00 but greater than 2.00 to1.00",
        "label": "less than or equal to 2.50 to1.00 but greater than 2.00 to1.00 [Member]",
        "terseLabel": "lessthanorequalto2point5to1butgreaterthan2to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo250To100ButGreaterThan200To100Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LessThanOrEqualTo400To100ButGreaterThan300To100Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "less than or equal to 4.00 to 1.00 but greater than 3.00 to100",
        "label": "less than or equal to 4.00 to 1.00 but greater than 3.00 to100 [Member]",
        "terseLabel": "lessthan4to1butgreaterthan3to1"
       }
      }
     },
     "localname": "LessThanOrEqualTo400To100ButGreaterThan300To100Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LeverageRatioCalculationCeilingSubtractedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Calculation Ceiling Subtracted Amount",
        "label": "Leverage Ratio Calculation Ceiling Subtracted Amount",
        "terseLabel": "Leverage Ratio Calculation Ceiling Subtracted Amount"
       }
      }
     },
     "localname": "LeverageRatioCalculationCeilingSubtractedAmount",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LeverageRatioLevelAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Level",
        "label": "Leverage Ratio Level [Axis]",
        "terseLabel": "Leverage Ratio Level [Axis]"
       }
      }
     },
     "localname": "LeverageRatioLevelAxis",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_LeverageRatioLevelDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Level [Domain]",
        "label": "Leverage Ratio Level [Domain]",
        "terseLabel": "Leverage Ratio Level [Domain]"
       }
      }
     },
     "localname": "LeverageRatioLevelDomain",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Liabilitiesforcontracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liabilities for contracts",
        "label": "Liabilities for contracts",
        "terseLabel": "Liabilities for contracts"
       }
      }
     },
     "localname": "Liabilitiesforcontracts",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_LongTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term",
        "label": "Long Term [Member]",
        "terseLabel": "Long Term"
       }
      }
     },
     "localname": "LongTermMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_LongtermInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Investments [Domain]",
        "label": "Long-term Investments [Domain]",
        "terseLabel": "Long-term Investments [Domain]"
       }
      }
     },
     "localname": "LongtermInvestmentsDomain",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MeasurementInputMarketPriceofRiskDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Market Price of Risk [Domain]",
        "label": "Measurement Input, Market Price of Risk [Domain]",
        "terseLabel": "Measurement Input, Market Price of Risk [Domain]"
       }
      }
     },
     "localname": "MeasurementInputMarketPriceofRiskDomain",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MeasurementinputadjustedEBITDAvolatilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MeasurementinputadjustedEBITDAvolatility [Domain]",
        "label": "MeasurementinputadjustedEBITDAvolatility [Domain]",
        "terseLabel": "MeasurementinputadjustedEBITDAvolatility [Domain]"
       }
      }
     },
     "localname": "MeasurementinputadjustedEBITDAvolatilityDomain",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_MinimumStockPriceTargetForEarnOutPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Stock Price Target for Earn-out Payment",
        "label": "Minimum Stock Price Target for Earn-out Payment",
        "terseLabel": "Minimum Stock Price Target for Earn-out Payment"
       }
      }
     },
     "localname": "MinimumStockPriceTargetForEarnOutPayment",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_MoldsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molds [Member]",
        "label": "Molds [Member]",
        "terseLabel": "Molds [Member]"
       }
      }
     },
     "localname": "MoldsMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Optiontoextendinyears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Optiontoextendinyears",
        "label": "Optiontoextendinyears",
        "terseLabel": "Lessee, Operating Lease, Option to Extend"
       }
      }
     },
     "localname": "Optiontoextendinyears",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "icui_OtherCurrenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "other currencies",
        "label": "other currencies [Member]",
        "terseLabel": "other currencies"
       }
      }
     },
     "localname": "OtherCurrenciesMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_OtherDeferredRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other deferred revenue",
        "label": "Other deferred revenue [Member]",
        "terseLabel": "Other deferred revenue"
       }
      }
     },
     "localname": "OtherDeferredRevenueMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_OtherforeigncountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign countries [Member]",
        "label": "Other foreign countries [Member]",
        "terseLabel": "Other foreign countries [Member]"
       }
      }
     },
     "localname": "OtherforeigncountriesMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_Outsidesalescommissions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outside sales commissions",
        "label": "Outside sales commissions",
        "terseLabel": "Distribution Fees"
       }
      }
     },
     "localname": "Outsidesalescommissions",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_OwnershipRequirementForEarnoutPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership requirement for Earnout Payment",
        "label": "Ownership requirement for Earnout Payment",
        "terseLabel": "Ownership requirement for Earnout Payment"
       }
      }
     },
     "localname": "OwnershipRequirementForEarnoutPayment",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_Prepaidinsuranceandpropertytaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid insurance and property taxes",
        "label": "Prepaid insurance and property taxes",
        "terseLabel": "Prepaid insurance and property taxes"
       }
      }
     },
     "localname": "Prepaidinsuranceandpropertytaxes",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Prepaidothertaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid other taxes",
        "label": "Prepaid other taxes",
        "terseLabel": "Prepaid Taxes"
       }
      }
     },
     "localname": "Prepaidothertaxes",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaids, other current assets and other noncurrent assets",
        "label": "Prepaids, other current assets and other noncurrent assets [Text Block]",
        "terseLabel": "Prepaids, other current assets and other noncurrent assets [Text Block]"
       }
      }
     },
     "localname": "PrepaidsOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "icui_ProFormaAdjustmentAmortization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Amortization",
        "label": "Pro Forma Adjustment - Amortization",
        "terseLabel": "Pro Forma Adjustment - Amortization"
       }
      }
     },
     "localname": "ProFormaAdjustmentAmortization",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProFormaAdjustmentFinanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Finance Costs",
        "label": "Pro Forma Adjustment - Finance Costs",
        "terseLabel": "Pro Forma Adjustment - Finance Costs"
       }
      }
     },
     "localname": "ProFormaAdjustmentFinanceCosts",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProFormaAdjustmentInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Inventory",
        "label": "Pro Forma Adjustment - Inventory",
        "terseLabel": "Pro Forma Adjustment - Inventory"
       }
      }
     },
     "localname": "ProFormaAdjustmentInventory",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProFormaAdjustmentRelatedPartyLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro Forma Adjustment - Related Party Loans",
        "label": "Pro Forma Adjustment - Related Party Loans",
        "terseLabel": "Pro Forma Adjustment - Related Party Loans"
       }
      }
     },
     "localname": "ProFormaAdjustmentRelatedPartyLoans",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance of long-term debt, net of lender debt issuance costs",
        "label": "Proceeds from issuance of long-term debt, net of lender debt issuance costs",
        "terseLabel": "Proceeds from issuance of long-term debt, net of lender debt issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebtNetOfLenderDebtIssuanceCosts",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ProvisionForWarrantyAndReturns": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provision for warranty and returns",
        "label": "Provision for warranty and returns",
        "terseLabel": "Provision for warranty and returns"
       }
      }
     },
     "localname": "ProvisionForWarrantyAndReturns",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_PursuitVascularInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pursuit Vascular, Inc. [Member] [Member]",
        "label": "Pursuit Vascular, Inc. [Member]",
        "terseLabel": "Pursuit Vascular, Inc. [Member]"
       }
      }
     },
     "localname": "PursuitVascularInc.Member",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_RequiredShareHoldingOfStockIssuedAtAcquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Required Share Holding Of Stock Issued At Acquisition",
        "label": "Required Share Holding Of Stock Issued At Acquisition",
        "terseLabel": "Required Share Holding Of Stock Issued At Acquisition"
       }
      }
     },
     "localname": "RequiredShareHoldingOfStockIssuedAtAcquisition",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_Restructuringandstrategictransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring and strategic transaction expenses",
        "label": "Restructuring and strategic transaction",
        "terseLabel": "Restructuring, strategic transaction and integration"
       }
      }
     },
     "localname": "Restructuringandstrategictransaction",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Restructuringstrategictransactionandintegration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, strategic transaction and integration",
        "label": "Restructuring, strategic transaction and integration",
        "terseLabel": "Restructuring, strategic transaction and integration"
       }
      }
     },
     "localname": "Restructuringstrategictransactionandintegration",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_RevolverSubLimits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver Sub limits",
        "label": "Revolver Sub limits",
        "terseLabel": "Revolver Sub limits"
       }
      }
     },
     "localname": "RevolverSubLimits",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_ShortTermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term",
        "label": "Short Term [Member]",
        "terseLabel": "Short Term"
       }
      }
     },
     "localname": "ShortTermMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SmithsGroupOwnershipAcquisitionSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smiths Group Ownership % Acquisition Shares Issued",
        "label": "Smiths Group Ownership % Acquisition Shares Issued",
        "terseLabel": "Smiths Group Ownership % Acquisition Shares Issued"
       }
      }
     },
     "localname": "SmithsGroupOwnershipAcquisitionSharesIssued",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_SmithsGroupOwnershipRequiredForBoardRepresentation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smiths Group Ownership % Required for Board Representation",
        "label": "Smiths Group Ownership % Required for Board Representation",
        "terseLabel": "Smiths Group Ownership % Required for Board Representation"
       }
      }
     },
     "localname": "SmithsGroupOwnershipRequiredForBoardRepresentation",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_SmithsMedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SmithsMedical",
        "label": "SmithsMedical [Member]",
        "terseLabel": "SmithsMedical"
       }
      }
     },
     "localname": "SmithsMedicalMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SoftwarerevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Software revenue [Member]",
        "label": "Software revenue [Member]",
        "terseLabel": "Software revenue [Member]"
       }
      }
     },
     "localname": "SoftwarerevenueMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_SpareParts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spare parts",
        "label": "Spare parts",
        "terseLabel": "Spare parts"
       }
      }
     },
     "localname": "SpareParts",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Sparepartsusage": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sparepartsusage",
        "label": "Sparepartsusage",
        "terseLabel": "Sparepartsusage"
       }
      }
     },
     "localname": "Sparepartsusage",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_Srt_MultipleCurrencyAxisAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "srt_MultipleCurrencyAxis",
        "label": "srt_MultipleCurrencyAxis [Axis]",
        "terseLabel": "srt_MultipleCurrencyAxis [Axis]"
       }
      }
     },
     "localname": "Srt_MultipleCurrencyAxisAxis",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_Srt_MultipleCurrencyAxisDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "srt_MultipleCurrencyAxis [Domain]",
        "label": "srt_MultipleCurrencyAxis [Domain]",
        "terseLabel": "srt_MultipleCurrencyAxis [Domain]"
       }
      }
     },
     "localname": "Srt_MultipleCurrencyAxisDomain",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_StrategicTransactionandIntegration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Transaction and Integration",
        "label": "Strategic Transaction and Integration",
        "terseLabel": "Strategic Transaction and Integration"
       }
      }
     },
     "localname": "StrategicTransactionandIntegration",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/StrategicTransactionandIntegrationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TerSOFRInterestRateAdjustmentForBaseRateLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans",
        "label": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans",
        "terseLabel": "Ter SOFR Interest Rate % Adjustment for Base Rate Loans"
       }
      }
     },
     "localname": "TerSOFRInterestRateAdjustmentForBaseRateLoans",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentFirst2Years": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A principal payment % First 2 Years",
        "label": "Term A principal payment % First 2 Years",
        "terseLabel": "Term A principal payment % First 2 Years"
       }
      }
     },
     "localname": "TermAPrincipalPaymentFirst2Years",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentInYear5": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A Principal Payment % in Year 5",
        "label": "Term A Principal Payment % in Year 5",
        "terseLabel": "Term A Principal Payment % in Year 5"
       }
      }
     },
     "localname": "TermAPrincipalPaymentInYear5",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermAPrincipalPaymentYear3And4": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A Principal Payment % Year 3 and 4",
        "label": "Term A Principal Payment % Year 3 and 4",
        "terseLabel": "Term A Principal Payment % Year 3 and 4"
       }
      }
     },
     "localname": "TermAPrincipalPaymentYear3And4",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Axis]",
        "terseLabel": "Term Loan [Axis]"
       }
      }
     },
     "localname": "TermLoanAxis",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TermLoanBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B",
        "label": "Term Loan B [Member]",
        "terseLabel": "Term Loan B"
       }
      }
     },
     "localname": "TermLoanBMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermLoanBPrincipalPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B Principal Payment %",
        "label": "Term Loan B Principal Payment %",
        "terseLabel": "Term Loan B Principal Payment %"
       }
      }
     },
     "localname": "TermLoanBPrincipalPayment",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TermLoanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Domain]",
        "label": "Term Loan [Domain]",
        "terseLabel": "Term Loan [Domain]"
       }
      }
     },
     "localname": "TermLoanDomain",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans",
        "label": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans",
        "terseLabel": "Term SOFR Adjustment Interest Rate Adjustment Term SOFR Loans"
       }
      }
     },
     "localname": "TermSOFRAdjustmentInterestRateAdjustmentTermSOFRLoans",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "icui_TimingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing",
        "label": "Timing [Axis]",
        "terseLabel": "Timing [Axis]"
       }
      }
     },
     "localname": "TimingAxis",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "icui_TimingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing [Domain]",
        "label": "Timing [Domain]",
        "terseLabel": "Timing [Domain]"
       }
      }
     },
     "localname": "TimingDomain",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_TotalSeniorSecuredCreditFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TotalSeniorSecuredCreditFacility",
        "label": "TotalSeniorSecuredCreditFacility",
        "terseLabel": "TotalSeniorSecuredCreditFacility"
       }
      }
     },
     "localname": "TotalSeniorSecuredCreditFacility",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_TreasuryStockPurchasePlan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock Purchase Plan",
        "label": "Treasury Stock Purchase Plan",
        "terseLabel": "Treasury Stock Purchase Plan"
       }
      }
     },
     "localname": "TreasuryStockPurchasePlan",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_UnfavorablecontractliabilityST": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UnfavorablecontractliabilityST",
        "label": "UnfavorablecontractliabilityST",
        "terseLabel": "UnfavorablecontractliabilityST"
       }
      }
     },
     "localname": "UnfavorablecontractliabilityST",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "icui_VascularAccessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vascular Access",
        "label": "Vascular Access [Member]",
        "terseLabel": "Vascular Access"
       }
      }
     },
     "localname": "VascularAccessMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "icui_VitalCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vital Care",
        "label": "Vital Care [Member]",
        "terseLabel": "Vital Care"
       }
      }
     },
     "localname": "VitalCareMember",
     "nsuri": "http://www.icumed.com/20220331",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r129",
      "r169",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r189",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r301",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r129",
      "r169",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r189",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r301",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r309",
      "r335",
      "r396",
      "r399",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r629",
      "r632",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r309",
      "r335",
      "r396",
      "r399",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r629",
      "r632",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r190",
      "r368",
      "r371",
      "r581",
      "r628",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r190",
      "r368",
      "r371",
      "r581",
      "r628",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r309",
      "r335",
      "r386",
      "r396",
      "r399",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r629",
      "r632",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r309",
      "r335",
      "r386",
      "r396",
      "r399",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r629",
      "r632",
      "r670",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails",
      "http://www.icumed.com/role/LeasesTextDetails",
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r142",
      "r147",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r368",
      "r372",
      "r631",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r368",
      "r372",
      "r631",
      "r656",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r142",
      "r147",
      "r278",
      "r397",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r47",
      "r568"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r7",
      "r27",
      "r194",
      "r195"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses, Current",
        "terseLabel": "Incentive compensation"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrentAndNoncurrent": {
     "auth_ref": [
      "r597",
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them.",
        "label": "Accrued Employee Benefits",
        "terseLabel": "Accrued Employee Benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r21",
      "r591",
      "r613"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax liability"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r23",
      "r591",
      "r613"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "INCOME TAX LIABILITY"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "terseLabel": "Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities [Member]"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r597",
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accrued Professional Fees",
        "terseLabel": "Accrued Professional Fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRentCurrentAndNoncurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r592",
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements.",
        "label": "Accrued Rent",
        "terseLabel": "Accrued Rent"
       }
      }
     },
     "localname": "AccruedRentCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r71",
      "r77",
      "r84",
      "r85",
      "r86",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r45",
      "r252"
     ],
     "calculation": {
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r70",
      "r77",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r74",
      "r76",
      "r77",
      "r616",
      "r637",
      "r640"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r84",
      "r85",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r73",
      "r77",
      "r84",
      "r85",
      "r86",
      "r130",
      "r131",
      "r132",
      "r471",
      "r633",
      "r634",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r68",
      "r77",
      "r84",
      "r85",
      "r86",
      "r471",
      "r532",
      "r533",
      "r534",
      "r535",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquisitionRelatedCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of acquisition-related costs allocated to (included in) reported pro forma earnings (supplemental pro forma information).",
        "label": "Acquisition-related Costs [Member]",
        "terseLabel": "Acquisition-related Costs"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r404",
      "r405",
      "r406",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Adjustments to Additional Paid in Capital, Other"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r400",
      "r401",
      "r409",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r196",
      "r220",
      "r221",
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r96",
      "r116",
      "r322",
      "r542"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Debt Issuance Costs amortization"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r116",
      "r322",
      "r330",
      "r331",
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of Debt Issuance Costs and Discounts"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r116",
      "r239",
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r126",
      "r177",
      "r182",
      "r188",
      "r215",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r466",
      "r472",
      "r522",
      "r566",
      "r568",
      "r589",
      "r611"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r12",
      "r63",
      "r126",
      "r215",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r466",
      "r472",
      "r522",
      "r566",
      "r568"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "TOTAL CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r203",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r200",
      "r204",
      "r224",
      "r596"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r202",
      "r224"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r202",
      "r224"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Noncurrent",
        "terseLabel": "Long-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r486",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r395",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r395",
      "r398",
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails",
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionContingentConsiderationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Contingent Consideration [Line Items]",
        "terseLabel": "Business Acquisition, Contingent Consideration [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business Acquisition, Transaction Costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Business Acquisition, Share Price"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r434",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r434",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Business Acquisition, Pro Forma Revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r449",
      "r450",
      "r453"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business Combination, Consideration Transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r449",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "negatedTerseLabel": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r447",
      "r449",
      "r450",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Business Combination, Consideration Transferred, Liabilities Incurred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r448",
      "r451",
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r448",
      "r452"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "terseLabel": "Contingent Earn-Out Liability, Noncurrent"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combination Disclosure"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities": {
     "auth_ref": [
      "r439",
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents liabilities associated with restructuring or exit activities of the acquiree, existing at the acquisition date (present liabilities of the acquiree).",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restructuring Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestructuringLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r119",
      "r120",
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Capital Expenditures Incurred but Not yet Paid"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "totalLabel": "TOTAL CASH, CASH EQUIVALENTS AND INVESTMENT SECURITIES"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r113",
      "r118",
      "r122"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r113",
      "r529"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Cash Flow, Supplemental Disclosures [Text Block]"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect [Abstract]"
       }
      }
     },
     "localname": "CashPeriodIncreaseDecreaseExcludingExchangeRateEffectAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r460",
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaborative Arrangement Disclosure [Text Block]"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r57",
      "r277",
      "r598",
      "r620"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r286",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies [Text Block]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, shares outstanding",
        "periodStartLabel": "Common stock, shares outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r568"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.10 par value - Authorized-80,000 shares; Issued 23,897 shares at March 31,2022 and 21,280 shares at December 31, 2021 and outstanding 23,884 shares at March 31, 2022 and 21,280 shares at December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r80",
      "r82",
      "r83",
      "r93",
      "r602",
      "r624"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in Progress, Gross"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r356",
      "r357",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "negatedPeriodEndLabel": "Contract with Customer, Liability",
        "negatedPeriodStartLabel": "Contract with Customer, Liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r356",
      "r357",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Contract with Customer, Liability, Noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue": {
     "auth_ref": [
      "r25",
      "r348"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.",
        "label": "Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value",
        "verboseLabel": "Convertible preferred stock, $1.00 par value Authorized-500 shares; Issued and outstanding - none"
       }
      }
     },
     "localname": "ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r98",
      "r126",
      "r215",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r522"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer Contracts [Member]"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer-Related Intangible Assets [Member]"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Debt, Current"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r22",
      "r324",
      "r593",
      "r610"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term Debt, Gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r53",
      "r319",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt Instrument, Interest Rate During Period"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r54",
      "r309",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsPrincipalPaymentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r55",
      "r125",
      "r129",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r328",
      "r329",
      "r330",
      "r331",
      "r348",
      "r349",
      "r350",
      "r351",
      "r540",
      "r541",
      "r543",
      "r544",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r313",
      "r325",
      "r328",
      "r329",
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "terseLabel": "Debt, Long-term and Short-term, Combined Amount"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "auth_ref": [
      "r203",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Current",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost, Current"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent": {
     "auth_ref": [
      "r203",
      "r224"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Noncurrent",
        "terseLabel": "Debt Securities, Available-for-sale, Noncurrent"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r209",
      "r225",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost assets and assets classified as other.",
        "label": "Deferred Costs and Other Assets",
        "terseLabel": "Deferred Costs and Other Assets"
       }
      }
     },
     "localname": "DeferredCostsAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt Issuance Costs, Gross"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r46",
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Debt Issuance Costs, Noncurrent, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r412",
      "r413"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred Income Tax Assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r412",
      "r413"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "DEFERRED INCOME TAXES"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.",
        "label": "Deferred Revenue, Additions",
        "negatedTerseLabel": "Deferred Revenue, Additions"
       }
      }
     },
     "localname": "DeferredRevenueAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositAssets": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.",
        "label": "Deposit Assets",
        "terseLabel": "Deposit Assets"
       }
      }
     },
     "localname": "DepositAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r116",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentTextDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r116",
      "r172"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r479",
      "r480",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Derivative Asset, Notional Amount"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsCurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Current",
        "terseLabel": "Derivative Asset, Current"
       }
      }
     },
     "localname": "DerivativeAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Noncurrent",
        "terseLabel": "Derivative Asset, Noncurrent"
       }
      }
     },
     "localname": "DerivativeAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed interest rate related to the interest rate derivative.",
        "label": "Derivative, Fixed Interest Rate",
        "terseLabel": "Derivative, Fixed Interest Rate"
       }
      }
     },
     "localname": "DerivativeFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeForwardExchangeRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual rate at which a foreign currency can be purchased or sold.",
        "label": "Derivative, Forward Exchange Rate",
        "terseLabel": "Derivative, Forward Exchange Rate"
       }
      }
     },
     "localname": "DerivativeForwardExchangeRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r66",
      "r487",
      "r488",
      "r493",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r505",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r484",
      "r487",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r484",
      "r487",
      "r493",
      "r497",
      "r498",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion": {
     "auth_ref": [
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of gain reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion",
        "negatedTerseLabel": "Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Derivative Liability, Current"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Derivative Liability, Noncurrent"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r480",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r478",
      "r481",
      "r482",
      "r484",
      "r485",
      "r490",
      "r493",
      "r500",
      "r501",
      "r503",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsForeignExchangeForwardContractsDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed Technology Rights [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA [Member]"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r94",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r150",
      "r152",
      "r157",
      "r158",
      "r159",
      "r163",
      "r164",
      "r508",
      "r509",
      "r603",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "EPS - basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r94",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r152",
      "r157",
      "r158",
      "r159",
      "r163",
      "r164",
      "r508",
      "r509",
      "r603",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted (In dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of Exchange Rate on Cash [Abstract]",
        "terseLabel": "Effect of Exchange Rate on Cash [Abstract]"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations": {
     "auth_ref": [
      "r529"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash balances in continuing operations held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Income Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r127",
      "r415",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxesEffectivetaxrateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance [Member]"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r84",
      "r85",
      "r86",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r146",
      "r166",
      "r217",
      "r347",
      "r352",
      "r404",
      "r405",
      "r406",
      "r419",
      "r420",
      "r507",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r538",
      "r633",
      "r634",
      "r635",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Equity Method Investment, Aggregate Cost"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity Method Investment, Ownership Percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r43",
      "r178",
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityMethodInvestmentsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments [Table Text Block]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FacilityClosingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Facility Closing [Member]",
        "terseLabel": "Facility Closing [Member]"
       }
      }
     },
     "localname": "FacilityClosingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r511",
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r511",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r315",
      "r328",
      "r329",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r512",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Disclosures"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r315",
      "r387",
      "r388",
      "r393",
      "r394",
      "r512",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r315",
      "r328",
      "r329",
      "r387",
      "r388",
      "r393",
      "r394",
      "r512",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r315",
      "r328",
      "r329",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r512",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r515",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r515",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "terseLabel": "CONTINGENT EARN-OUT LIABILITY"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationPursuitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r315",
      "r328",
      "r329",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r119",
      "r120",
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair Value of Assets Acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r486",
      "r490",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r547",
      "r553",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Finance Lease, Interest Expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r549",
      "r556"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Finance Lease, Interest Payment on Liability"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r546",
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance Lease, Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance Lease, Liability, Current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "terseLabel": "Finance Lease, Liability, Payment, Due"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "Finance Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Finance Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Finance Lease, Liability, Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Finance Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r548",
      "r556"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Finance Lease, Principal Payments"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r547",
      "r553",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r559",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r558",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial Liabilities Fair Value Disclosure"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Five"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Four"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Year Two"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r240",
      "r241",
      "r244",
      "r248",
      "r582",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r244",
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r240",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r244",
      "r582"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssets5YearAmortizationDetails",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": {
     "auth_ref": [
      "r504"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months",
        "terseLabel": "Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months"
       }
      }
     },
     "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
        "label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractAssetFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r66",
      "r387",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading of derivative or nonderivative instruments whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange [Member]",
        "terseLabel": "Foreign Exchange"
       }
      }
     },
     "localname": "ForeignExchangeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and Fixtures, Gross"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfInvestments": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.",
        "label": "Gain (Loss) on Sale of Investments",
        "terseLabel": "Gain (Loss) on Sale of Investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r231",
      "r232",
      "r568",
      "r588"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "GOODWILL"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, Acquired During Period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Goodwill, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r235",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Goodwill, Purchase Accounting Adjustments"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsGoodwillTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r97",
      "r126",
      "r177",
      "r181",
      "r184",
      "r187",
      "r189",
      "r215",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r522"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross Profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r484",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r177",
      "r181",
      "r184",
      "r187",
      "r189",
      "r587",
      "r599",
      "r605",
      "r626"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r254",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r127",
      "r416",
      "r417",
      "r418",
      "r424",
      "r427",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r128",
      "r145",
      "r146",
      "r175",
      "r414",
      "r425",
      "r428",
      "r627"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "PROVISION FOR INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "negatedTerseLabel": "Increase (Decrease) in Deferred Revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Increase (Decrease) in Other Operating Assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive securities"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r238",
      "r242"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "INTANGIBLE ASSETS, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r88",
      "r171",
      "r539",
      "r542",
      "r604"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r101",
      "r320",
      "r327",
      "r330",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r102",
      "r321",
      "r330",
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Interest Expense, Debt, Excluding Amortization"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r504"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.",
        "label": "Interest Rate Derivative Assets, at Fair Value",
        "terseLabel": "Interest Rate Derivative Assets, at Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateDerivativeLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.",
        "label": "Interest Rate Derivative Liabilities, at Fair Value",
        "terseLabel": "Interest Rate Derivative Liabilities, at Fair Value"
       }
      }
     },
     "localname": "InterestRateDerivativeLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsInterestRateSwapsDetails",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories [Text Block]"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r227"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory, Finished Goods, Net of Reserves"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r6",
      "r60",
      "r568"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r36",
      "r227"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Inventory, Raw Materials, Net of Reserves"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r35",
      "r227"
     ],
     "calculation": {
      "http://www.icumed.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Inventory, Work in Process, Net of Reserves"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeAmortizationOfPremium": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of purchase premium on nonoperating securities.",
        "label": "Investment Income, Amortization of Premium",
        "terseLabel": "Bond premium amortization"
       }
      }
     },
     "localname": "InvestmentIncomeAmortizationOfPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LandBuildingsAndImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Real estate held and additions or improvements to real estate held and structures used in the conduct of business.",
        "label": "Land, Buildings and Improvements [Member]",
        "terseLabel": "Land, Buildings and Improvements [Member]"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r560",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost [Table Text Block]"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due after Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Five"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Four"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Three"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Due Year Two"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lessee, Operating Lease, Term of Contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesTextDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Lessee, Operating Leases [Text Block]"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r564"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Lessor, Operating Lease, Payments to be Received"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r126",
      "r215",
      "r522",
      "r568",
      "r595",
      "r618"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r119",
      "r120",
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r52",
      "r126",
      "r215",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r467",
      "r472",
      "r473",
      "r522",
      "r566",
      "r567",
      "r568"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "TOTAL CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-term Debt, Noncurrent",
        "terseLabel": "OTHER LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesTotalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of total liabilities, when it serves as a benchmark in a concentration of risk calculation. Sum of all reported liabilities as of the balance sheet date.",
        "label": "Liabilities, Total [Member]",
        "terseLabel": "Liabilities, Total [Member]"
       }
      }
     },
     "localname": "LiabilitiesTotalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Line of Credit Facility, Commitment Fee Amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of Credit Facility, Commitment Fee Percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsInterestRateTermsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Line of Credit Facility, Expiration Date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r20",
      "r590"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of Credit, Current"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTerminatedCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r22",
      "r314",
      "r326",
      "r328",
      "r329",
      "r593",
      "r614"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Long-term Debt, Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r129",
      "r289",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Long-Term Debt, Maturity, after Year Five"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r129",
      "r289",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "Long-Term Debt, Maturity, Year One"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r129",
      "r289",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "Long-Term Debt, Maturity, Year Five"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r129",
      "r289",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "Long-Term Debt, Maturity, Year Four"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r129",
      "r289",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "Long-Term Debt, Maturity, Year Three"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r129",
      "r289",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "Long-Term Debt, Maturity, Year Two"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "Long-Term Debt, Maturity, Remainder of Fiscal Year"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsScheduleofMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term Debt, Excluding Current Maturities"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Long-term Debt [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r55",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r13",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and Equipment, Gross"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Measurement Input, Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilityMeasurementInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInDeferredRevenueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Deferred Revenue [Roll Forward]",
        "terseLabel": "Movement in Deferred Revenue [Roll Forward]"
       }
      }
     },
     "localname": "MovementInDeferredRevenueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r113",
      "r114",
      "r117"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r4",
      "r78",
      "r81",
      "r86",
      "r91",
      "r117",
      "r126",
      "r135",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r156",
      "r177",
      "r181",
      "r184",
      "r187",
      "r189",
      "r215",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r509",
      "r522",
      "r600",
      "r622"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Income Attributable to Parent"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r133",
      "r134",
      "r137",
      "r138",
      "r147",
      "r148",
      "r149",
      "r198",
      "r199",
      "r218",
      "r219",
      "r378",
      "r379",
      "r380",
      "r381",
      "r407",
      "r421",
      "r422",
      "r423",
      "r506",
      "r523",
      "r524",
      "r525",
      "r565",
      "r583",
      "r584",
      "r585",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "NON-CASH INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonfinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations not classified as financial liabilities. Includes, but is not limited to, accounts payable and accrued liabilities, commitments, obligations, and other liabilities.",
        "label": "Nonfinancial Liabilities Fair Value Disclosure",
        "terseLabel": "Nonfinancial Liabilities Fair Value Disclosure"
       }
      }
     },
     "localname": "NonfinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "OTHER INCOME (EXPENSE), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonrecurringAdjustmentAxis": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Axis]",
        "terseLabel": "Nonrecurring Adjustment [Axis]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonrecurringAdjustmentDomain": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
        "label": "Nonrecurring Adjustment [Domain]",
        "terseLabel": "Nonrecurring Adjustment [Domain]"
       }
      }
     },
     "localname": "NonrecurringAdjustmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "TOTAL OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r177",
      "r181",
      "r184",
      "r187",
      "r189"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r554",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails",
      "http://www.icumed.com/role/LeasesMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating Lease, Liability, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating Lease, Liability, Noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r550",
      "r556"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating Lease, Payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r545"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Amortization Expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r559",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating Lease, Weighted Average Discount Rate, Percent"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r558",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating Lease, Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesAssetsandLiabilitiesLesseeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r51"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other Accrued Liabilities, Noncurrent"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r61",
      "r568"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other Assets, Current"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r486",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other Assets, Miscellaneous, Noncurrent"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/OtherAssetsNoncurrentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r72",
      "r74",
      "r465",
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r69",
      "r74",
      "r526",
      "r527",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other Comprehensive (Loss) Income, Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Axis]",
        "terseLabel": "Other Comprehensive Income Location [Axis]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in other comprehensive income.",
        "label": "Other Comprehensive Income Location [Domain]",
        "terseLabel": "Other Comprehensive Income Location [Domain]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresLiabilitiesRecurringBasisUnobservableInputReconciliationHospiraDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r77",
      "r84",
      "r85",
      "r87",
      "r531",
      "r533",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r84",
      "r85",
      "r92",
      "r213",
      "r531",
      "r536",
      "r538",
      "r601",
      "r623"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "terseLabel": "Other Comprehensive Income (Loss), before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesCashFlowHedgeActivityIncludedinAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r70",
      "r74"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment, net of taxes of $0 for all periods"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r67",
      "r75",
      "r528",
      "r537"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r79",
      "r82",
      "r84",
      "r85",
      "r87",
      "r92",
      "r347",
      "r531",
      "r536",
      "r538",
      "r601",
      "r623"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive income (loss), net of Tax",
        "totalLabel": "Other comprehensive income (loss), net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r72",
      "r74"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Other Comprehensive Income (Loss), Other Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r72",
      "r75",
      "r465"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeParanthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r486",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other Noncash Income (Expense)"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities [Member]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r8",
      "r11",
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other Prepaid Expense, Current"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents [Member]"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r111",
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "terseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of Debt Issuance Costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "terseLabel": "Payment, Tax Withholding, Share-based Payment Arrangement"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r104",
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to Acquire Businesses, Gross"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Intangible assets additions"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r201"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchases of investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r21",
      "r383",
      "r384",
      "r385",
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "terseLabel": "Liability, Defined Benefit Plan, Current"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Convertible preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Convertible preferred stock, authorized shares"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Convertible preferred stock, issued shares"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Convertible preferred stock, outstanding shares"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r10",
      "r40",
      "r41"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsPrepaidsandOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesFVofDerivativeInstrumentsIncludedWithinConsolidatedBalanceSheetDetails",
      "http://www.icumed.com/role/FairValueMeasuresandDisclosuresAssetsandLiabilitiesbyBalanceSheetGroupingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r9",
      "r11",
      "r229",
      "r230"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from Issuance of Debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sale of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of asset"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r106",
      "r403"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityAccrualComponentAmount": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recorded amount of the accrual for a material component of a product liability contingency.",
        "label": "Product Liability Accrual, Component Amount",
        "terseLabel": "Product Liability Accrual, Component Amount"
       }
      }
     },
     "localname": "ProductLiabilityAccrualComponentAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails",
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Liability Contingency [Line Items]",
        "terseLabel": "Product Liability Contingency [Line Items]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductLiabilityContingencyTable": {
     "auth_ref": [
      "r277",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.",
        "label": "Product Liability Contingency [Table]",
        "terseLabel": "Product Liability Contingency [Table]"
       }
      }
     },
     "localname": "ProductLiabilityContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails",
      "http://www.icumed.com/role/AccruedLiabilitiesLongtermliabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r51",
      "r287",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Warranties and returns"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r78",
      "r81",
      "r86",
      "r112",
      "r126",
      "r135",
      "r145",
      "r146",
      "r177",
      "r181",
      "r184",
      "r187",
      "r189",
      "r215",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r465",
      "r468",
      "r469",
      "r475",
      "r476",
      "r509",
      "r522",
      "r605"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net Income",
        "totalLabel": "NET INCOME"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r45",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r256",
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment [Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r44",
      "r251"
     ],
     "calculation": {
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment, cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r253",
      "r568",
      "r608",
      "r619"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.icumed.com/role/PropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "PROPERTY AND EQUIPMENT, net",
        "totalLabel": "Net property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r95",
      "r222"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": {
     "auth_ref": [
      "r24",
      "r594",
      "r615"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.",
        "label": "Purchase Commitment, Remaining Minimum Amount Committed",
        "terseLabel": "Purchase Commitment, Remaining Minimum Amount Committed"
       }
      }
     },
     "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CollaborativeandOtherArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r77",
      "r84",
      "r85",
      "r87",
      "r531",
      "r535",
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "terseLabel": "Repayments of Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r411",
      "r580",
      "r672"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r258",
      "r260",
      "r263",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r116",
      "r257",
      "r266",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r259",
      "r260",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationRestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r260",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Restructuring Reserve",
        "periodStartLabel": "Restructuring Reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r21",
      "r260",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Restructuring accrual"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r260",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r352",
      "r408",
      "r568",
      "r617",
      "r636",
      "r640"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r146",
      "r217",
      "r404",
      "r405",
      "r406",
      "r419",
      "r420",
      "r507",
      "r633",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r168",
      "r169",
      "r180",
      "r185",
      "r186",
      "r190",
      "r191",
      "r193",
      "r367",
      "r368",
      "r581"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r365",
      "r366",
      "r370",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RevenueContractLiabilitiesDetails",
      "http://www.icumed.com/role/RevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r89",
      "r126",
      "r168",
      "r169",
      "r180",
      "r185",
      "r186",
      "r190",
      "r191",
      "r193",
      "r215",
      "r291",
      "r292",
      "r293",
      "r296",
      "r297",
      "r298",
      "r300",
      "r302",
      "r304",
      "r305",
      "r522",
      "r605"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyGeographyDetails",
      "http://www.icumed.com/role/RevenueDisaggregatedRevenuebyProductLineDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUES:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsDetails",
      "http://www.icumed.com/role/LongTermObligationsTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r557",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r557",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesCashFlowOperatingActivitiesLesseeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r597",
      "r621"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.",
        "label": "Sales and Excise Tax Payable",
        "terseLabel": "Sales taxes"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r77",
      "r536",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InvestmentSecuritiesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information about a contingent payment arrangement including the terms that will result in payment and the accounting treatment that will be followed if such contingency occurs, including the potential impact on earnings per share if the contingency is to be settled in shares of common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CommitmentsandContingenciesContingencyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsForeignInfusionDistributorDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails",
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalProFormaDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r55",
      "r129",
      "r328",
      "r330",
      "r348",
      "r349",
      "r350",
      "r351",
      "r540",
      "r541",
      "r544",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/NetIncomePerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r240",
      "r243",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r236",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r17",
      "r37",
      "r38",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LongTermObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent[TableTextBlock]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PrepaidsandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r45",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r269",
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r264",
      "r265",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r193",
      "r262",
      "r271",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r555",
      "r562"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term Lease, Cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r3",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r193",
      "r236",
      "r255",
      "r262",
      "r271",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r59",
      "r84",
      "r85",
      "r86",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r146",
      "r166",
      "r217",
      "r347",
      "r352",
      "r404",
      "r405",
      "r406",
      "r419",
      "r420",
      "r507",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r538",
      "r633",
      "r634",
      "r635",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement",
      "http://www.icumed.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r166",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r25",
      "r26",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Stock Issued During Period, Shares, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r347",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r59",
      "r347",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Stock Issued During Period, Value, Acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r347",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Stock Issued During Period, Value, New Issues"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/EquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r126",
      "r197",
      "r215",
      "r522",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Stockholders' Equity Attributable to Parent",
        "periodStartLabel": "Stockholders' Equity Attributable to Parent"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r85",
      "r126",
      "r130",
      "r131",
      "r132",
      "r136",
      "r144",
      "r215",
      "r217",
      "r352",
      "r404",
      "r405",
      "r406",
      "r419",
      "r420",
      "r463",
      "r464",
      "r474",
      "r507",
      "r522",
      "r531",
      "r532",
      "r538",
      "r634",
      "r635",
      "r679"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "TOTAL STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "STOCKHOLDERS' EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r124",
      "r334",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r352",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and Trade Names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/BusinessCombinationsandAssetAcquisitionsSmithsMedicalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks [Member]"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/GoodwillandIntangibleAssetsIntangiblesTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingRevenueMember": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about trading revenue have been included.",
        "label": "Trading Revenue [Member]",
        "terseLabel": "Trading Revenue"
       }
      }
     },
     "localname": "TradingRevenueMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsandHedgingActivitiesAmountsAffectingConsolidatedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r58",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofStockholdersEquityStatement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r58",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r58",
      "r353",
      "r354"
     ],
     "calculation": {
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury Stock, at cost (12,684 and 119 shares, respectively)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r259",
      "r260",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/RestructuringStrategicTransactionandIntegrationLiabilityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r151",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails",
      "http://www.icumed.com/role/NetIncomePerShareDetails1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r150",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding (for basic calculation)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.icumed.com/role/CondensedConsolidatedStatementsofIncome",
      "http://www.icumed.com/role/NetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB TOPIC 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123377177&loc=d3e11281-110244"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12524-110249"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "c",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8,17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r673": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r674": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r675": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r676": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r677": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r678": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>115
<FILENAME>0000883984-22-000030-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000883984-22-000030-xbrl.zip
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MIA((+X3C+FC4H40B6!J8'H[/S0Z<H$*6*3DA&5->^1",(708*D$LXK(D9QG
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MR]=W.J/C3Z#Y-Z8#%(N+R,>M9WIG_1O[SG1&@]+&\R]"\1T;SX@(*!P@>J
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M%(+)W,M$!U*JPP++^]."6IJS05GV#60^^*R"]4"1/4D$!5E;6>?AMV^-/<]
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MI4 $!B:'#(^9U3=T=?.&5-%GE JP,B:YJM0%58XH ?UJE!<V4P+K'J7Z]5&
MF_FJTAI)?D2GHF:5RC947E(B0&EJ*BE TNK1KWYC=/6F5+4TD0-YTQ0XY:O
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M0+!DUI=K?HG\3L+[J#$X'4_&;0O;OZ+$EUEX9S0ZQ>''A<.31 <G%>CQ&GF
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M">=-^&EMPJNP9L5=')SOXE0?1!5--_4'^G.QVW_/Q[;5&]OC\3@E7DG6^,9
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MXE1)Q]=2<'M=JCN3P>S<KJPBE[:-9D6^'T6>M>H(HM1@2X# -&Y_6FE@"$9
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M-UH3JPA#:&V="UJGZ,XW7?.)8F4UN3Q/7];D>]+D&9KGXIISR0GP6CA '91
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M>&V=XCJ'54IE^03<%IWN/XWM$BXX/VKX*2VV]$<VBWR@N@SD:5Z5H$9#ZBU
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MGI8#Z:+$:>U(GZ8+:7<Y[WN<QM2CM)?*+G7]=BH].6%HZ?:3O2)?BS \FKA
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MD@8HO7+0KJU31>L(W=D'?",562$OS!/5^=+\,UGGEZOSI[,VD9*.A73S'&I
M-4EI\# #P?@@O.":IX)D*<!-B++J&"U7YZM[-^B:P5;H7M B/7P""0@W.^U4
MHC(QP<;&=AMTWO^@A-=? GKJ+OJR:-_+XW'LQGB\.3PTO8%.7[L9OR?.6]P-
MXJ-QSQ55[X:#B\WB-.<I6<9N\6Z.(4JMC3<, H$X!Q11!13B!EC'-5)Q^86E
M:^M,U 5\A-'06=-+)GM9TZNCZ;,9B8CFV%,,F*064&=]NO,@@+(XVH5>*,Q1
M48--YB(,]WM;^7NQR*W&RVX^JKO'>)^,/<O GO=7E%NP3GJN 80ZU7_D AA.
MHW7*-=%6!R:<21Y^3G$=B7Q4]WBU>!E1/]=I<0[\N;T"SSJ5%(56, 6DD1A0
M3].MR711R1N+/<>6"%-:X$_U@HFK3!^FR9!_D(B23KH>-0J5FAOYDH,[\XEE
MP-'N?-R/"=I)(8#DQ$06P2R0 DH0U]6I8#6#+J008EK'L$IW)K/;HIIL(NOQ
M/>GQ#*W@1CH!G0&!.)1*+%"@I3' ,Z>-84IZQM;6*:I'@*Z0&C\!IT1Y%9N>
M@E6SM(I-ES$IUWLI$XSF,\,089'@E@ 9V4,$(P*!PBAR#$*Q%P)31**-$Y>Q
MSN^>B"&[*"JKS$NKVY25>8G*/,,L-$;68\P Q93&7]X"#;D$GG)E--%(<U'$
M%*LJI3!X NZ*'WPB!V \X/6D;.$L X?FDZD8;"*'4!Y@AQ2@7H6(0]X#IKQP
M @?(;$K7K>H0EA6,EQT5U5/DY=U0RHJ\)$6>S;OOD)'"8B"#)JFD" 8&^V@G
M:&R@YL$$S5-UZ7I<QPHI\A-P540^T6IV6XUV=YKM_7NLYV;*__Y'>SCQ-:3^
MS,Z+)9.,S>'A86]R&)%HO#%PW\.^;#1W\KEL*:AT12X5D\J 0 2D)M'6(50
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M$5F()I6E@F M6!$W*V1=P;("61;6K15RISQ=O"C+UY+QHH)X,1OVAI4CS!#
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M&GO*:OT0:CW+H+1BF#,>@, T $J5!DI*"X@*5B-!<<"TJ'<LY^L=5TVK5XY
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M'A2?4A".3#*6X#3YGL.=6N1=)!4.,IHX1@!&"0Z0L4H[296@*:<2KD-UY[P
M&10R=.=5RJN45RFOTH/3H&4&J64:5'4:-!?)YKV74"$+E",04!L<,-(@P*&-
M,D"T\]15D <]@7BV(F=0X6KY7C"\UBNJA->+:Z/#4)OHDQS,ED\!\BKE5<JK
ME%<IKU)>I;Q*E;&TG%$<:4J4M91*C)55E*$B'PM#3IL;6UH%(]R\3 B;!1]\
M,QR/VW[2"5U]DJVETJRE*PJ-.(*U$!H"Q16.UI)&P'!,@#;.XD U1@Q&:TG6
M.9U/PY\U^[%H=ND^E.LT^]5P%+LXV#P>C?S GG9'<7C3[FT,7/%7O_"DO-:]
M04*!C5%O'&?]<NQ*!H9E ,.L&X40%YCE 2AE/*"0*R"]M8"9@"3BVG(G*@@,
M3R!B)<I_K1]5(\>I9-=_7J6\2GF5\BKE55KE5;I1)JL0+/>8<PH5#2XH$E @
M+'%U2Y"PMR_[$'G%#^L[D^O2R/7I?"%EJAS%&DJ@*>> 4N>!H2@ J'F*XO,(
M$KRV3F0=<EF-=!M9CS/:/I)5NN<$2!EM[QMM9UT9/-C </! 8Q;15CL,I,<8
M",Z(\($ZB5RUT+:D8)#BN\4SP:KBT+BZX.]+W4]ICNJUEA[9_1I!]5I2IH<.
M!+E;->G5*:M\9<HC$KQTQCGON*7",VTBZU0F IUE$0VGE947\ -O%GFKBDM6
MT^Q&G>/)>*(':?(RZI6%>IWYY.&22\B)=L!9JP"5@8-H*A" D266!T\%8VOK
MF-2EFD\@OCKUE6^JJP]\X+1<S*D:L"]>P?[&PU]-J)TGF%PACC!3PCE'N=(:
M^8BN3!DN,)4:+XJSN8+]4M%UM@"K(-0YI *P&D=T%4$"HYP!%%+D.584*9%2
MQQ$UGWTJ@VL&UPRN]P&N0D0*Z],M2,.H1$%IK[ QT8*'F'/F,[A6 EQG;[)&
MYNJ#5R3.9\15Z@V?!B$@;B3#C'E'U-HZJA/(ZYC/UP#+ )L!-@/LK<=](_^H
M-9YI+HS3E"*&E0\.&IB*K2 DB+D>8:]QBV:H72K4SI9+889K2V4 %!L"J%0,
MZ$ -0-89R9UEFJG$8^6=TKYGF,LP5SF8NP'*::ZLM$AH3 6E(7(1"0DF%&$9
MN,4T\\A*@-O<,;OV4 :7B"0E'% N(%!.$V %P]!3D3!N;5T*4A=(91J9\37C
MZ\/02$LTH]A+X7&@ AF-3< Z8&JH$@;_PE"_ 8W,8'HS,)V]*608#L8:P!Q)
M^:48!@9%YNBC5<ZY4TC L+;.\5V.T#.092"K')#=I)9(P$@YSAQVEFIC)8%&
M: .#= $&I3)1K :VS48(V;C5V" M< S[2!2Q!IIY"QA2+ @=@O,AF<%(R+J"
M\VEC,E6\8023ZXV/^OHT3:+_-2CGEKGES5MF\<LML_CEED^S91:_W#*+7V[Y
M-%MF\<LML_CEED^S91:_W#*+7V[Y-%MF\<LML_CEED^S91:_W#*+7V[Y-%MF
M\<LML_CEED^S91:_W#*+7V[Y-%MF\<LM'UK\_IIHT_?Q7]?[NOYW_'7QCDN1
MT]8/)GZT-HT47__;C/Y:_QZZO<C;BJ^X:' >Q!W[V-='8__\XL&+BR[V!D6\
M>/&F%X=Z]+DW -,P[><I)>1, '?Q?=.77WSKN<G^<Z6>"4G^O[7OJG7^Q=-7
MT;/B=L3%5/WT&I'/)"+7O@R?H5N^1BB^U3M_U5GQ#!*ZA+XRIDKO*WU&R6W[
M<__SJN#M/O7^^\JCO(H5Z>NRY'49?8TX(.2*])4_P_+Z5R]_ZCG=N&AP?B$'
MT^)VX-7;Q@H5&+KZ2M$OQG1MEEVUR/"GFUN5;OQ-D]9.IZ&XBE?&7,2FH^&W
MZ6.\FO.R$?N:[KOI?L%<WNJ> [U!\7A3'_4F\?D\46FBNB.OQ\>CTV)JL@3]
MF)AM/]'Q25=,3$./!K'GBQ0R>PISLV'M\>%Q7T_.IZ<HH3A5KLMU%(MGWBQ6
M_VV1:?M5TZOW.807V.=N^Y57-[W)?=5JK_(T"_HBN>T7&?*3FKJ-P^'Q8'(/
M8E_QIBNQ6-WA+!THJ33GJA6U^(\>'.O1:6U:U0(]=-7.)UW5PAEO!=*084^H
MYE@:9ZR0@CH% \.DR,\!$<Y5+7Z=J:-UUO[XX<O>UN=ONP?O4/PYW3W;[^T>
MO.SO'FP?M#YN'^QU7^YW/NZ2N4P=9RVT]W'[2V?K9:^]]2'^_.>@\_H_O=;K
M^/AUZV3O=;O?>MV(W^]"JS=7U<)20041%C %/:!!.:",D,!+Z[4B5(94E1BC
M.F3S>8A6)TO'377U@>N%+1=SJH;LB^=!NO'P5Q-JY_,@>2\E8LI!:P/5A!N/
MDWZBH#7ESO%%<?9IYD&Z-W2=K6H1@N>$\0!T\ &DZJ) 8B7B(R^,PY($@8LT
M2)!G<,W@FL'U0<!5$B<D0C[25D.))=HJ[UW$6>=9"(IF<*T$N,Y6M?#>.,0-
M!ECI2%TIQD!%/ /,*)PJ6A ;]-HZ5^3*,I097C.\9GB]EV3$6FM"H-0!$4B=
MQ@ICB:1AGIF4NU-?CZ]/+1GQO6'I;-D*HIPB3C)@N$: 2H. \<@ AR'7'(NX
M@A%+R7Q.]QM7\\TPEF&L.N.^ 8H9:@)Q3F("(554&<-YA#'H(_'PTHC,$BN!
M;',U*W JNZ,\ ]QH#"A&%!@E.3 DH$"(8L&EFA50UCE;Y43$&5\SOE8.7V]"
M$P5TS%$CI+(HJJG0E!-A!/+1E&,&LE)H8D;:$I%VIJ"%QAYZH0Q !FI .25
M6J\ #AAS;7PZ'DQE)AF>Q]G,(S/.K3#.W:3"HX **VXI"8[*J"[(6A2BMKB@
MM24V\\AJH-ML20ML%(>2.I JD ":&*7!2 .%A<#:4^TP+= -XCKF+#/)NY:T
M^&WUH$KAX=4SWQR/CU/44FT8:B,_GHQZ=N+3U$?=K>F!J_D3/[*]<=%@^NSP
M*(G+0@&--RVOM%!8TQ637+7(I:OG^F:12]QYI!C3 K%HS"NO#)=&&>BT5BCB
M\Z>M%%P&X_] \6"Q$D-IO;W;.A[%J7L;1S%TTW"F.,+BI7&&X9O \.E<O))B
MBCGA#8 .<Q"MA>2RM!PPI%E$8.&)EQ&%U?R!S^WJ^E2H.-H3U=XK@F$P\59)
M:)B0E".FJ4$>1?O"(@F94V6I[@?=/_99<V^IN;.Q,()9(Z&--B%V E <-5<Q
M;@$5SF/D7(#61\V=#X3)BOM8%#<@ISTQ!G/**!-0V^!U")0%XIGA-]]S-]S!
M\7ARZ >3<7?XXS)=ND?7')S?H"MN_633J$3-G@W$, H*1*B/B\94U.RX?#I
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MXPAZ>@79ZT;_P)SX!34)R$-@,;:7 1:_\C:^69O]=NV/!HB.C8+A1=]&TY$
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M'KK6D>?^:<%T*I\]Z<_TR)K<Y8OO*=GBE>]JAEOTI0?L\K'>3J^,"^A"/UB
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MEM]E9)U0>NW7\3K^S>\XO?ZEO[KS5XW%;#VCZ:T>NZ2T]D^37OAF2 V3O5.
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MO<TCL+IP2FR*E'($,8(QRJR6*,LDCQ/%$R[XV@:/X_7KP!9$M^V%I><B/2I
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M>GSIRA%0";^+/>A%[[SW)-KMEEZ4Z4WLET(^0Z?W.[DWR)O6A#4WGYAY_JQ
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MYUT.;3MK7>R<M=Y_[K0.FN??MO]QX^CYYGX,?8-[SHYHFF;,!W#&"4\08[%
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M:D6)A3'IV?FZLS9]GJZJSIM.[GY/N=O489*B441SS#7QX(@2HKU5C! 6 WO
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M@?8O$SJO VTO7[IN3B&U"D<K')U_$=!'ECZK</0Y<'2*M.<BGX$K1#P6@*.
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M)$L<1:XQ0*;0R%"6D&,Y6 ZC"&,*W,>(91BOUQU/>M)3H._8\(-TG 9IJ;5
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M>&*5O_H\8;7IA+!<[$)GZAB3-8@[*9$)0J$4<- N&,-X3@C3RY3-(:YVYZ+
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ME>FTJW<7LYDA1O;P)?3VYW_5&&"M598Q9J6A'!/LL& <D%@*K%DPM,* E\*
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M;/R]5?Q$_O-G+?] Z']FL((K]=R6@;_Y>'0\1A&"/;9_#AWFV@,\IUO[XH9
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MEL;Y)F^V-T];:S]P=%'*J!#&4B*.HT$Z&9?_BLP21:7G2ZM"KUQ7VWDX4V:
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M7PFOE%&5S<-:,T>"L@F5U2]/A[U;WAH:E9N)SB+TZQVZ>MB:LF7%0UY8Z-!
M\X-.O$9OC8)T!M<%0:X/?>0E:0H>BH#(U7C,M:O6P>_#26*KM/84 W/AD3L:
M;/*)86IH8H)K&QZP:JT-!O&X6KKNM7215KN10R2*$\/!NT31*(>X5A09QQ.2
M2E"KE" XX:551LC*M"Q-;;1L@1G?7&UX>AI0;R/5-D9CP='UTACJ4O3,1Q^
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M[EW%O9<I+C4T_V*?SBJ+M&75^B[!.L\Q6"=X(:0BFGJ?N$O4)D>#49;H !K
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MDG&'%;I%-!G34<>)3 ZX5NG).0+J^JIRX8J'YHHF!ZY(-CE-1"Z2(C3*#>M
MJCJ'L <;)GJF@[XL *EQ)E$W+R6G"L.K#)3?AVUD(CJCM9E@XKFPD#/PK[GA
MM^.>Q8# Z\/VX3C^&4;NM[..-IA_\A4/G8@<N3"N8RW7M[@X\B+? !SE%ZH\
MGY.&!YL<V#)_>JR)[T=?:25'PQS?,,6]5=!@%?!UOLAZ,571%] )LM(Q(0]'
M@NW/>ILN#D+)"#(5NG( 4[*5[,Q7K566_;F/+\+4<^V;P]\'F.1!YR-,UC(^
MC;8U[W&]@E#MR^CE7(06P1X=S@6CN*SUU.X!.[A6K$EM\%^V[5/KMXW!"1AK
M<9@A=_0A.[ZN^9N,+9I_CH!2&)ZR6L9D<H&=5W607V_\/14@Y(=Y>RZ1 1?A
M]/S %6]-H/_$N&?3L0=YY3>(Q[/$B5P**[C$N:98,ZJS.\,Q85DR>.'J',5.
MNC=$/VV>-(]W9:0^AF01\92"GI,DTJ#A@,5D8L)&>^?S;:5<OZP!Y92A5&CF
MJ=/,:?/#KF/61@+&M,:&H]R>!VFG,?($;&N9-,=.+4(SY\ SQJ7\8L;8'#/6
M&9EQ(1?.R([=RO%UE?F5/Y]'J!)L*UN\>ZG12,D%COU'XK\G(N?AU(Z_.?_#
M9%I?E7UU=E];Q^"%B4"]D./ZPG3(GK.=RGDWV(M@7,S[#6YP^7%/A0PF,JQ&
M<!"VN].,/H<+T[#PG.L?;'_8U2PF@'S8:E<5;-()&6;!M%,&SH/(Y&6:K6>P
M6IQ1N9%V*I;O@(I;:42U[CYR75<5Y2:/?*P%CE(@+^:CD495I4A<Z _\HT*:
MWA%,.PS^?-FX_,[PHNJ*M5)^%FU:E7Z$S>K8PT%\.?[EKYE:)]67_IH>[H(J
M@M69U&__-5>-9U29?KI8SWKUUDPIR_H]3=<I8Y>^C=?)#=\3[/*'_NZ;OYLL
MX>N:J86&O:),_S6JQ-_@HQ?4$*Z#3A^F7NY<)&I%*G-IK"=3-4\?=9^#JX-Q
MJRW8\+Y_="X@U\[28$=757?1RV#!0K+S=6)7K%3UU<A]JUK5"ZS_@:I1+[CP
MZYA.6.56VRQ0EKA/Q'B0VL9;[C$)0M?7DH30%3:='KI,]0W5J[I,]<$;TMS<
M$*W3O?:W?4_@N;^:7S[S;U\^MK^]V_KU;3^K5)^/6YMO3F?+5%?SV_S!MM_]
M<] Z_0QK?//KV\Y>Y]N[?WY\W7][T-KYUOZVLX&;.ZV46P#,M +P8(^#\960
M"DF Z14]LA$48Q6HR '?6G&?6P$(O>16 %>SUP-WV+Q)1\BI0ABRZL[Y0,P_
MD=5=QUY,*)9C;3.KJ6/5]$ZJA\CUVS6-+#TC'UXTW#:6>DY&7!R>>GYIMC.J
M8 :FT83QO557)PU%&"Q-&+3/A &L#6SZXUVJ>#31<^2LCCFR)2"+DT;1XT2=
M$]+HG&$MUHC0I7_<'?5E>_#.S@MBR+CB>5U/L/:UWFGKM4?6T'[!;?SC(;"X
M#EH8'>#.^?EM=[--OGTT+$AZ#21MO9Y"TI/FQF["R=%  J)<!,2]5\C$2%%(
MD2G)E7!6OGC%YX,%_[RN.OT8->:5\+1,QP3?13OZJ[[W!)HU+MT'L\RM66W@
MOTYY.&Z#%&"72Q9XY$938H-P'* ]:OBO=L]@PW!QSSP-.3)VSU#LHPM.(B$,
MR>X9A[2C%G'+(H@18T%3!XU<K2E\ZSYB2V2]IZW)EVF4::S$-,;M]AY3)[VY
MN^J_'J"WW@*.R=^VUEO4,?D '?0NRW?Y?[DPWEDF01VF6T4?Y["=F;25F7*[
M.03J_Y%UN>"W+RMX,YBK>//[6*K+RY3^>57^]$R9I1(+46(A2BS$ZAB)-XJ%
M("46HL1"W$<LA/<J4$-,5(3C9(W7..%$ C:6**HK8QN76(B[,K;W.WD.K'GZ
MMKV]X^&Y'_=;.__L-4_A]X.W!U_SG/=;>U^_O!&SQO;VEV\_8.S3YI<M,-9A
MC>^:I'GPYA1^/_GZY=M><_.?=I.^W?NZT[DH%H)Q'1*<,.*!YU9=P2 =E$&1
M1Z:"\(PEF\/0UQB^K'3#8PN&6!&KZ5K7@X_A;JQN%POJ[70>X5D@\!^C<C%5
ME9E1;\ZJP/]YM=\ZG78<:=_(#VFT07V>NR$H\0[+A/]<NH59G4RDCGN#+3;!
M,\%<4MX%B:L[-HQ5?<>&K^%T72"5H*:;K>[G;EU2.89Q)]]IX$_M7S&@G*Y8
M,/\ZF'\RA_E$4*&]3X@J10'SF<YI^1Y9@S&WCD<:4]UBB="_'D_,P],T"*:N
M[![2'BA7=G>T-4]&C 0B.,?"F&@])XXZ';Q+1+$0B<6R[F=S'>E1K(A5E"@7
M7-D%JR-SSB/I@T=<T8@<XQQ13HQQ3BN2Y-U8$>7*KDRC3..*N[+S/B"3G;%7
MKCS9@R0[;U3M,C>ZX?>F"GR@U0,+95+ _&=<464G^KUN^[]'<;"3-_P99S_G
MR@;11.:%I8C%+ PH&!I@2$:4&%;:&QILI+-],(RSR1!L)!PJYXR98&D*6- 8
MG5>)/O9LZ?\>Y09"P^I"=;+#8,.ZZ@)DE#0]:A2;"Y%-.%$FZ]",:@9?F%T]
M48?H@MO,4=&':W8@7Y5.L#,+>C.3PG,QPOVV\]'SZV%$9W:K]# J/8PNZ&%T
M94^B&>R6425NHZ#>1FXML<$E+9U//CEK<G_"BY]S)>:/ .C11#(HO<X9O8-(
M!J;Y\B,9]+I:<-@%(QD>U,.S6,3!I_,R?I4#80%WVE,-OM@83H875<)_IAWY
M4H(QKG/9MQJ4<[$;[#]G]1L?.M_K=N$9]^A@7&QCK]<R6['@B*)!@Y7'#<@I
M1@))C',<L#567USOCBZA7<R$+[*"CD??4WL4YK_%FOO-TZ^GG_FW=UO99WBP
M_>XSWWX'S_ORSWZ+?MS_NO.&;;_[RN;"_/?]2?.TM=_:V?OQ-:_QW5?^;><[
M__;EC?AZT&3?WK7VFCN>?]L/DY$'=;K8]UTCL;=>@9DHL$2<I 0*)Q-(,J6H
MTLKB)%Z\8FK]400>/ #G_,_M 'J5\MD66_#'7/OV;:Y]^Q'LW!(2<+=0BTGP
M.,5H=1 <2Z.=299SP%Z; (+EQ5"[C.[P!6IO!;73-0Y.6AN[02KOE,+(F4 0
MV'0!.98B"DE0ZA0CDJK<P8LM*Y_J28#IM/?\L3C*QNTW9CUDC\F*IEH\EGR
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M.A@38UE2GEK+B6-.8L]DT,$3FUQ8..*E0-2]0]1L\VB1)-4I.61#JFI 8>3
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MA>:;ULZGQA]UANQ1#']>1#'WP.*7+*8WC V"7S8:(UG<.CJ D?RT\#4.8VI
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M_7_-O#DCS>ISNWI2TXLPS(3HA(XZ.JZ2=IIH;T7('?NXX.[%W7)0->++]A#
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MD:W-1WAP#C/$"$8,,PY$QB,R4A($@D0KK[%@(7=H:Q/&VIC6E8_2F-SA&@-
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M-=/2=V(6>GV8WGYQV+(5?./"R8>L$/QT/J*3F2P9S>R[Z;;34<S/H=\/7;C
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M"Y^Y%,%]R8UG+Q:G+J+/IM4!8#]+G9ZR-GRDG]K %3VPW:"(I \GK'D*5_1
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M?02QS@A&_^^%^HT/;)=VW6'P@R;8ILL)N[T]^)8/S8[[]>IPX5+N[9_4MLO
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M[%3,05[#._Y*X.SZ7/!XI$!&0J.VQHC:#S)<>O$D2,83O%L;7@^ N',=Q (
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MQ3PG]%])@"^MFD3H]0%%? 8H#9S @I5#EY@#2BL!"\$NJG,@72VO.-$)<YI
M<N&O;^4L3E7\-EO#L,PT=85E)U'J.0JQ%6Q!R31>8=4#T03-!3R$_(:)5]MQ
M$6R3;@LA&TZ]+>L=T!S;[5ZKV0?&(H>-4:F_/S?3N&F]O_]/J]YOB$&C4VW9
M$BUD,:P.Z[:L]@?]3K_=:8Q:S=[9S]W'M+"*2@8D1!Q*PA%R<2H7U#H=+,"H
M.J#UO?3N9'4*MSBQIAEOT4CN2,1@+0P1B2= P2#G*&)%]H*T$_+J_)6(D#(>
M,&Z&(6HT(O1;@ASI1+ +-C+\Y0C9$K&@"THE"3A95J))U"Y1+SFD7?):$4V[
M>,S4>Q9ER1'9VON6Z(YLC1IBU!X,I--N--I#N^> (6WW6](>U!NBE.@_7J*W
M4(J/NO51772KPX%H5=LC!S31?F=8M46OWA\-.KU&HXD&]3-)\</.8#7RWS=(
M!#V((ZU.T7LTY6XA14_T.L#;6TZ_-^JUG1&&T7OP'YQG/FP.[/;Z1+E5I3T,
MJGTH;JNA\?CI_M I78$/E 1\VJ.(H<KE!O[O 5F8B6NLQNEL<GQER.$/;ZXY
M.\=+0&-*)1TOHOT"0DTHSBBQ^\IZAX\0X2V"U=I2H]ZP#*E?D#*D9OW5.A3[
M >5)'MQW$%)FMY'37KS:I(]7NB7*__OSX_6;UOLOOW7^]^\QF'J_MO_WR[\F
M_^_+F];_?GE___[Z=_?]G^_ALS?S1:$#;VF__V)_^_#%@S5^[8#0FKR?OO7>
M?W$F[_^^O/_PQ\W\_=_P&8X$^_+KMX^7_P&CH=.W6_UJHR,Q1-D0U0'\MSJP
MATZ]VQK4F]TEEM)IU+NBY0R:HWJ[+9O-_DC(KFWW&DZG+1J]T7)MDG$)I%GQ
MI*M\C<&32Y3VEE2ZFB4]#IT\-+$5\+ #3W6;@W:K[F#&T\"N-[KMNB/!;EK/
MH#_ZUELY#"FAL84*9*.W;,R"&@R:II^,D(F%G KB6+<8W)E;EQG7.S][?WL9
MG;U,K5ATQ'\: 3A"UO.GZ2)\AQ$O 48L*;Z:$ZJD:8H#ZW1C-F?]-((] CQ@
MW1P5?97-@49VE0N5M.8>S#CK..!D:H?>2X[8>_G@IM2^']\3;P!T:]P2YL3!
M:RQ\=Z1BVH;!H'Y9L4 ?#C;?-%O4"-PTZU@*&YW(F,)-RTP3)5^&TI<CEVJ0
MR,\@(Y4#,PS0"\$F "V%LHD#\7\&\*@W5V559#+1TPH&^.N;J]_R*00*3)0S
MN&C,L8,<;W:&II%349;.*/%6!0&%I_,"1!0%L/58EUYQ,GQZ/Q7+">P$D4V5
MC,V$_56,-4;FW*'ZJ&F^NF7D[JH>[QS.G&+>@4.>&8 +OYA/7DDQ^5ZNPY,'
M$03 RRNI' A\%=.*\J1@$-6>( O3F4(:F_*V)**"3X;Q8IRA;6[XO]%:=-%/
M'&+<U%.Y6AGVQY.0<M@75^G4%$/ES43F;B(#:[)]4Y M.P\\CP#TP%SW\'D%
M'?AK&1@J$J(A9[PRX-H^@],@RXSH!_ +1J?T21,%%3$YN#7.;U6?QR[:]LP]
MC+!-I!C!7;:/*: VEB_,$C"J41?+I9'A"@LN><:IE'^F!K@<C73&",$NCW7P
M "$)G@#?  1:T90FOZ%7@K!"Y718EW DWX%MG>,5G"U^#-Q600-N)\-7M9Z!
MLU&&M"Z#$-CN0\C+*+NTC31"3QDZZ2UCQS#ET%0+J%=$R?!/5>Z@WT;,CKTC
M+KE;&,LX9<?G=1Y]O;#6&Q=+!NGI5>MURVJ]LEHO=^T%TW$?UUF7^''F%-TZ
MN757B79J*YFKZ+.< DL#)O:>=\NI=OP],/+#\%;^>,,QBS^^_WN,=0!VL]GN
M=;KU:L=Q1I@*U*GVNZ-VM>?T<81BTW'ZK;.?FX-'79<H1>2WF8L2#_Z9IJ^U
MZBQ]<ZYS*_.:4]T>"$C KVCDDL=>+JL$J_WRBU+JASEH!NUE!\TC0=33$X6]
M'R<*UYYP-'JV$W)?5@>3D@G57A%>XE.P)U&8O5B3$%GQ_WD<J7MG/W]A!^N(
M>M"P;T?\O">AMDI"/P3S&RP7 3:#+A/5I"0MC4&?81)%FD]=@KH\CUSB1V_3
MUB%76@>F9SYGS4,^ILU#"N*]*E1]]CH7%YH161&3Z[- IC3E"2554"&Z<#@4
MZ_^9^*HD1SL@T":1?D2E/3YU259E OK"HA@^R(J-A(T17>'/\7U^@ 8K5>;
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M"A@W\H"P$B46 8M]&6LRQ)G63#^(P5A/G3U&OI$01+K*S8?K]5.52$_L2:=
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M8/3HE.AQ7.QYM=9.%]2K]3H%Y]2WTO,H;C:6/C7VY5'B6>?X.YEFI'V/>G^
MI-KL/TW-.E)2?58=_1#1HU6BQW%Q\@=$[0%P\L\RDN2-7BQ\^"[V?;B:5KM4
MM$H]?+T>7F+'<3'OPU;#@7E39;I*8LLJ5VE$O,A&<&!&_UCE$YVH7MXM]:Y2
M+5_O'2^QXY 9>_$V?"A/GIBY@\GNV-N"FBQRKO6)&3A8@==H7I2*;&GFE#A2
MRL3RR5-.P<J*^G=A%1Y;RDSKB:&<4\R8*7.QM@D"]4K$.EJY>Q2I6.?O@BAZ
MJ<N3J-(P6"X4>X(V?&RD?-Y[N:V"?(I4_*P6UK'AU+9JQPGCU<%)A^)M^%">
M/+'8WHUJPJ4MLQ,+UYVW-I>KQQV,*4-UNW!.'C>.' &W/NRXTD?5?AW-I0JV
MU2RC2B<?,2BC2B6.G #C/L#@1]Z[Q<-,T[;&XEL9!<D!JU'?6A4_15=$&0%Y
M1A?7">/5$8B( PR O):^'+FQ=4Y#AK#](/<L_VXI<;CZ6UG\4&KW#ZD)6P?"
MCA0SCH!A'Z!._T$"L_8,O7X'.KSJ>MD"W'2"!'MHZG,<FSZV31A[YS Z(MK_
M$4; Z6#E]Z5)E9AY %+I']1F^.>U38RSQL,_'K8/=IQ^K/NRT3$YWX\Y-P9]
MO\-T]607'D<XG0F:NV9/A#_F8<BJ12--9>6QN[]<7G["V3QNQ&.DO$C_E,<4
MK/@Q9X_YNLD]C07R PJ8))$:2$.#?"T["4/IVW,:T:2G+"]]FYM"@T-W_8F:
M<B@M--5X)BZVV.;1&#3T)IV#$(?8&;]BR6^VEZ3C:W@4 /7E-DZ ?D$@[NS-
M5%>KNG)CK2V.8X+S"\]./!KVR_,8%_:K^O\SP&8SCV?3"6R6/\8^.?Q&6I!L
M3-T8,^OPS\.,YE*D$XUX\9@_TU-AL74YSI)4W=VC"<V8'6;SK'@F@7'M%4MU
MWU?CE-TXX4U4TE5":GBO?FG;P#H)VM1:'[&AEG63]VE UN+Q%;8(ZM"ON[3#
M&::5=+HF;1&12,^YCES >(&S'=4LJ71&1H*#BX9PO6K2,HXU<M4<##U..'T8
M)W09$PC4RQ\XR\ZI>MTT#=?YG[/'Y[0,>F<__X"6^[3BJIGSJT<)W/BCA 8R
MX$R!9(IW=M## U8V_$^F<,&P>$1$S?WW5QT\97/G..2;AY=%+U]MV)Q_N8LR
M7/B/;=<_&-3:C<Y/9S]OW:V_TZOU>[MO@-^O]3K-)ZWZ6+/^SHGOM=WI'\Y>
MNZU-5ST(;?=0GOS>60W-QM*S>^X8/SBN60U'TL=_LULI!R \'7";S#\H ;<(
MN!?6%9EC)?"> +R?-@=>\23?H3QYT-&<13Q:5_SP@(6YZUR1E<[PHD'DQ?,=
M?T^^[<W.W6B#@5&\9*%=AH!*1#X)1&YV:]LVERT1N43DXB%RN_;$;HF'@L='
MF9B[X>4V:LWB7>X> '&8(?5#>?+AT+^ZB#:&+V9!1+'*5SP-^4YF0X;1!6S\
M2L4\ZME/Q!"P,(G7_V15\&4?@:EV*Q\N,O\["3,'X%A6AZ$47ZMB!)M]);Q[
M,8_._I&/+[F^7KS3AK<OGGWM"4>C9SLA4[HC[8 [R+SBP+Q+""$*LQ=K$LK1
M_YS]G\?CLKVSG[]0D"X8H8D:X^3P__L/\?.J:RQ<N'-M:'+_B2F-YAKC/XVR
MNKX-%( Y -O-8J?\ Y6HXN@DBDA,TZP4UU_(M*A83D*Y""#N[F,<U4Z1X+$7
M#(4'2U')&.^THC\-? 32>([9$[X:BQ3-),Z8C^>8T>(D=ARE608KH"MEL]=L
M/R-TK0=>_NQ7^_'!#)$'+_Z><EDFX@X+]J1OO6BTF[6.CK@_B@V6@0A^BD5(
MOR\:W5HC70>6:31KO9^VQY>:914D">*IZ1RW\RB6TQ-+Y5"'WC:-8_]Y&R#2
M:W46ZT](W.@TGR-HWQT\;=7'$@R>(\FDW.OS[+57WWC5@[!5#N7),G&C3-PH
MSJV4B1MEXD:9N'$PP"L3-_8OH8\J<6/1EBQ#A"<4(NSW:O7B19'*4'>)QUOB
M<;OVQ''=)1Z7>%R<<S=K!1PX4F9L[.1N6V7"1IFPL:>$C6+%?@XFKKT8<MI#
M3'L"^Y*AY8EP+*V[P$OP1\ET9IV?O?O]T]E+"UX)A(VE\I$$YB P%.N$+FP8
MB^_I=]@,+XJ%YV'\ED*I\-.H G^,\#>PJ]B%;^?T@^ >GN=E*).'-XSQ.$"S
M*OPPBXY;&T:)%\&X%"'N]VN]702(V[6V&1_NU)I/"0\7)*RZ;7#X=^L6DZAR
M<Y\*>H*GL8M]L+#-P]0&^ ^^TT 9L2[W6L2]EA'K0OK#RXAU82%_C"&P,F)=
M1JS+B/7! *^,6.]?0A]%Q'J5@5M&1TXH.M+OEQT&2CP^?#P>M(L8"BKQN,3C
M[<Y]WJD]>1I!X5'XA"/5Y]W:%C-BRBAU<<R 0WFRC%+O8"S JHB3(W]<A!K^
MQCB8-]>Q:HX=V_"J4-BQ!2=,1O!'0L,*.*0,3WT:P2$/-<IZ%;K$H:PK %1!
MCO"\];>Y$Y>1S1./P)5[+2.;Q_1D&=DL(YO%N94RLEE&-LO(YL$ KXQL[E]"
M'T-D<[516;K23\B5WFB6(:$2CX\ CUO'WG.ZQ.-3P./S>FU0J!!8&=K<56BS
M6/=:AC:/[,DRM/G]^UX=<XH\? 3#C3\LR%E;[A3\"*@*'K]<K,FMWDY=A-E[
MJB+V3B*B^0@,GM1@> M$* .>AQ28*_=:!CR/Z<DRX%D&/(MS*V7 LPQXE@'/
M@P%>&?#<OX0^AH#GIE9HZ7(_(9=[MUOV<"WQ^/#Q^+_^3[_9:"YZ6DM4+E'Y
MX%#Y^%GR-FL<HAZ_^E[]::G!__ 0X-/B!06+S&&09=/XB1M9 OX1)5Z,W5DQ
MLB;LOQ*7AS[C1_D?UBQ<74R!]&(=BN-@B1@&=Q@'G,%J.,'7$K-9&'QSIR*6
MWCP?_8-E]09&83"E56POB# HY,#S>BMQ"& 0-FU%A0*E[^AO_TI$&*^J4OR^
M6SR]@=GM<F!V ?9R> .SMXQK_RXB._%$:%V"L(Y.,JR] ()-P]AEM/J(HJKE
M7LMH]3$]64:KRVAU<6ZEC%:7T>HR6GTPP"NCU?N7T,<0K=[0MBPC(R<4&>D-
MRL&Y)1X?/AZ7P>H2E8\$E8^?)9?!ZKVKN\?WY$/UJH<3DWY81S_ND/1!%)[^
M[L:JGO?QV%P9<SJDV$BYUS+F=$Q/EC&G,N94G%LI8TYES*F,.1T,\,J8T_XE
M]%'$G!XUETK?Y@GY-KN#6O>X?9LE'I\"'I?AIA*5CP25CY\EE^&FO6NZQ_?D
MD==&KM7;RQ#4WD-0OX1!%&%?V+'K1WJ7^T"4Y::R!U2/]G:KEKN6 .Q!5US%
M&A/X.4 76?<RE%:K46O\1(^T.K7V3Q6DBYFTL1C6FS/BZUZ_B/KY%1[K_6M]
MSVS3>_C)TGS3#6AU@>CS.\9FQCPC-9[ A4[<* Y">N[FZK>E<REB4R]_9;UH
MM&I-7<EG 9Q\%*H6_ U/>FX\MR*NQR:  B=P$CNN4G$Q'#N44]@3U84"+*(X
MNE!;R4]IQ<+B<$9/J4-'R6P&(+ G L $'#U,Z&OX/;X&-^H"9&UB9JX_\O@5
M^-T$L E>, H)K2SY;08[B/$MM(&:]4Z.A3VGPZ^^6@T"0I:Q]&4H/-P+O!Y@
M!SS/N@=P&Q='[PWER ,D@D/#SD+@D5-\4AW']77O:!Y("[M6^^27T^+)%!EL
M5(%O1Y&,K>%< <L #SR*M9>7211C@64.BB#UX(W$:/EW=X&7(&WB]E(@'2@;
MO96 @?ZX8OW"%T*'NG2FK@]W$E(ENW6.AEZS?G'[RW^)Z>SBDO[9N'AIO0$D
M\"/YW.QW[9&*S9"WW/9C[=WWI01M5*ZL42-%B7*F\(DF.I1[+1-(CNG),H&D
M3" ISJV4"21E DF90'(PP"L32/8OH8\A@42;5V6^R"D&)QN=5CE/N$3DPT?D
M7K/6+O&XQ.-#Q^-^O=8_;CS.W!<[S!8YC*'"C4:CB+E >X!$.5KXQ^?.%"L]
MH.A).FG82>JP4Q817I51P*?:X4CARG)>@;!>@)[32V/[*J">)NH\F'-0L>XG
MKCU)@^*.L3X\_*+9K]73E>&#2'CPI8I%#Z4O1VX<5>"Y3JUA/N=@7I'M9N%\
M,0V S_S-'RCHU;+H73P1L0%+$;F.D6NTD!=AG@A^XR4(WA>=VB"# 6)&8'^U
MAK0<@AC>PW%SZW;--\;[4]#:Y$[)[B$8BJ%+Z1((C G<6T2GH80!^,506G!+
MOG2.;O;S9QE)<L7C;5[+.^D%,TJ-T-'ZST0:USI87X@4J6* ;C%MH:AY JMW
M?]!Y @HIRS2!,DV@W&N9)G \3Y9I F6:0'%NI4P3*-,$RC2!@P%>F2:P?PE]
M#&D"RKHJLP1.,2C5;-4&Q0M;E,'5$H^WC+_5:[T2CTL\/G@\/OJDK5-.$@!I
M6\!4IC))X,B>/.@D@=.;C]TIYV,78"_/-A^[8-DO.IBZ8?++^KX>V^>]/*F=
M!D:)]1:-1)%&H]9/,T5TAPM8<2'+9/&TM:5/8"O4L $XR$3MW.S[P4OCRKDL
M$VXRP6]5&339BMA?(PE#S*O0;YN%P9_2CJ,#;?CP649QF*C>%A7K%IL\R+%K
M6U^,9D$(DQL@AS'3UE*CA\,Z<A$S)A:N(4JO(5ZX!M>XAA0MJ87*BU;+2+'"
M9U\TC0\V[JAC=/7)=^PYT$8:.=!BQE@X+@SF/DG!6GD@C0-&%Z'-;]S@LI$$
M8T+XMM1]?/Z0*H,.OYV)N97X,^$BCURU"T%-=Q:6'\[-7F/X$2 3<'_8,.W:
M#]:LMND)&NN8[P_/;%M+)/NG@]NM>,HA$\AV)]644S>2=)^!>Z*VLR5;5_K+
M9N^E4RQJ-T32F&[WH"JFDHRS'Z?*F"?'\+7>4,4:"O^K-9+XI[!^\UU\P[]A
MCTXPA<.!0F3%XAL=2$YG7C"7*1MYWN,W'CB^N39M!IA4%&#R,WRO6HS).S=(
M(A-*<$)\\3^#:.:& K2?41+A"K>J#=OYV3]O;L]>4CIQ-4AB[)XV Z.45_PT
M C3FAF4!IA4"UJMW VA1@72TW@E[I5^$<IS EH,0H0\[(*,X6I&F7#"9NUK%
M0N,IQ#3W6QG''O5H.\R#%%%7!(GL@ #V@YBQ":L#&-I1"FU-19LSKIKU6//'
ME-@J0&V L#9Z+H%/UHW: NZQMVXW!VHCH>F#"HJV>P[S%$5$Y12R&EVQ-2?V
MPNSF17']26KM&E&\W?45S,FS!+'-P:&D>L3]@165)B#?7;UF*IP S,,@#"E_
M/[+(E4:_N@JQRZ=U.89W(6&SD)R1J/.3*4HTT"R(Y$<H^TF/I^7('W0G7(^[
M&W/'8]5Y&,1OX-V1XL_KCX3-53RX2P$P2%U.BQM(^Y3F"IBHPFD(YXFB)+-E
MLN,QE_(E*R D?\E/C%L 8 2K7W4>P9$^!"#C&[U7UKO 'U>_R'!J7=.K?*5G
MD=_,GW,G5$07KF/R*;!#.L?(]6%3+@ >5*:8UF93!X,]N".Z$OA@2J=YN:T2
M<"P8V\AC[*98EO@)@GR&^,"XD.$8+,'(C'?5K#=Z^I;?:HP[QX?//I%G<^$[
MT/;689NZ4MW]ENOE2"4U<8Y>N!'NK7P_*]$KOR*^"8M,81_Q4Q'\0*7SQQ@;
M_-[X@!6R8OFR*)KFDTQ7/HQ+A\&S*!OF1<.H\U02L;=#XW13U:]9L0)CAP1N
MPCW#WH*M=<U:4U.ZT&_@@8[YP-2-;.EYPI=H@ZFS+XE]E\X),$0+4=5]CD$V
M@*$V$T",U#PZ:^D,OVV9+_&P!355K**A%G 5*SP;;:7W;G+XWN:'7WNFY>.O
M@=/:P_<V.WQ!:&5KA9QPY(OX]NS-IG?96OIT ^'=,A!>@+T\6R"\6#)T8V%F
MB$,E=6+D**RX@28?)L@HT<:P@(73Z!7'DJ,1RTUR=89JO$I+C;IH-!<'712]
MS\"30(R*Z I ;*Z(."[\.HRR'A(CZ="\ 32)$G*#:M V ;0ST%QM=T9B;BAM
M 1J^5NQY&_I?4_<;_OE;[;9&]Z'%*]]O5&&3*W?=\)G2DQO=YOGT)8IB&46Y
MK("*7@@(*X0CD\<:Q+6+-*(6.S][>WUSHXT$  D;L\KWO0):6[GW4Y=\;-;6
M+U?(;R2 5%IA%7.#"?<N3&2L-OI[,Q:I/45WCSZIBQQL&NU:!V'QAE$"KTYW
M52$'Z-B'A<GRY'XFP4R%,&1HNY'JPX(W=H<,! >ZC#C4Z5)'$OY1XN-R!C:H
M+!MJ\)+ITD_T6RTU,]C;S3X+*VD4BY7\<O/NRTW%0D[P''R@D?$!86(CX<J:
MO"DZV1[P=[WD6X>2ZS#9=?[G['&=!53 LQ\H,%=9)@_I@>_<OQ+705\-PO1*
MS&B8W&<9!4EHKXVW[X=*B^Y2_$.J>&D(1"SOA)<0@2>AY>6@;"LHAQK*%44_
MA,KLKB6Z" #EP>) SZOZ384^]*.$DE3@4]\2COPKX?%[4PF&-BZ0<A-X(L(H
M+KP^9)>N[MVE*-:Z#\*OY"%,-V4^BU.ET,^MOW5])#GV#2O?\C") !(1/)PY
M0#$0;X3V\VDTZR+KE<755\T8TY]1D-HE+WHP_)-Y%_E<YN2 -7T<:GU4@(VO
M@R0&3LGSS+*@@JERP\)@H](>^=VY;(49>G*1Q[B4TDHN]M"A#9%C$T$SAE7A
M3Y5@4'RE>TM_QRUC+T(S92,''1/XF.B484"Z[' &]8:2*8K)&/Y :@%*9YS'
M.X\F@!=5='H;Z$QN?U"/W:#"/QN!HJQT _Q1 +(IAVB:_E/,A%>'Z(@CXM@5
M(A4,_&]!+D5JYAY%I @\!F@ ^A/I<1QAW2TH]I)"'JPH8#M(I37K>@O3AF_S
MX=>LONOLC>DD28?<G\UFR_"7T^E>=+H]PYT*5OVUM.5T*,-<[GN#G+BM=MOP
M'L.S*Y/DF;VO'":))U**I?SFLNI$!QL*#SE7Q,F4VG,[2I2:]6 G1>M?PD^0
M8CA=X^/C-*#[1D;,IO4#51 (#@9%PUE &N@P0'R@^XQR:6 Q7QAL5H5D\6DM
MHF@T;7BW9MSAH7#<U11"-O?*8/-ERC*4#G><+ +3?DFN.P]$Q$G^W@&R8$#"
M0UP)J49"(VHW=5XLA2/-&<7*X%J/_&PZ+;T>YW^ZCLH3%M8(-),J5:,007@!
M0.TRRR5 $ZG?J1N,@6.]%,-_1P^?O<2\1DR!]A<7>KW-0J^5%\C<T_HD!URO
M4U]>[W/ZB^5 ]#EV,-0^1L[".+N5/H:&;Y$KPK7E?P1,\NPEPQ' 9DOI&!9S
M>DSE^Z0 .A(]A;4EG&,AFDZ\C)B+HX1&:K _=HNF.BC&<)=CY"F9'IU/#3%V
MYF)F4*UG#35;7I%JOJ!S<^* <<$J, \K6%,1)Q2?-]EJ+S5XC<M\[$>#!;!B
M/D!"SZW,H5E[K7KSH$:[(>NZYM8J\'9T6?#M")PTSJI37G-24WWAOECA\<<!
MONLAZX/S5"FTJ>;P&K)AEH08,63W!?K%.6%_M5:_R3%77ES-NHQ(()+(7$I5
M> RU*2.1W?91Y(XI82B*$I6":]ZE(CY$6M@OO#:F%^@QZ6G&$.&?BUX2!"7K
M*!LMF>V H)K$7A!\U7M3GMMH?6?3;<7EX;0Y[=?:]>:!-,YL]&N]?NMYEMVL
M>>CNVA@^X=$]=TE[W-=&*'A#Y/@/DQ2)2A1W^,STN$$_@L,Z]D=F*;ES'70S
MLPW/_3X(G/E_;W*?3^]<LL$::_MU%*7'X.,*/H'SM6A]#RB/!0RW) N_CYA&
M]'\'14QOW=B>/.G^%P[[)%)Z'& %Q)37K__Q^O7KZBZ =A@'W@5I'*"<N46S
M1H2.10T>K$]!$.Y?ZAP6YA"I[ )DAW'<=82RU*CI^SR#IY<VVBO31@NPEU/I
MG[32QZPJT"*C:LL.[B3\K<M\9L")!):G!4O>1NU,7.L+JUFW,VF[(^1DZ,>]
M9_^:<LZ1#W8J7-J!)1:]8.^H5<=8DJ4;(,Q]>#P(,>8&KV_7.G5<H%&KUZW$
MCUW/^E?B2ZM5)Y=;N\*.^"B6,R>X]RFDT<9G]6_0(2B)I"KLS?:MM);K*ECQ
M;H\"(_CNEKG.N2-'KG:(.6YD)U'$-4H 90$+6HZ$$V+.P]KRNK2-P=/*ZUY2
M'Q-5D&6F-.A8!):EK;C@E:[*HPMU+9?!'79R :+1'<5VK7Z%JNZ(LG+QK,U"
M,RL#7!CI>-%8$0!:4S7X0-V>&43&VAU*1$+O/].".H2*;.1+_)(99O0L><I]
M@.%CWO+:0O.=1WWYJVL.!;O.J;D%NL[C;'\[C @7#+F C0REY\H[R=P?N5(^
MQ+\ZB<$+, B#Z&2DI2R,)EQ(R%!!I(64%<IPI?R-4-J2<M&S3!;*1\_N[3%$
MX*"6"J-:2:0D0C("@>2B],N%E70T,$W7R,60=/S/AWNRXGOIW>FLCQJ(#<Y"
MO<,U56TL'3Z$M\"**'_@K%C+9\]MCP*'(P_SV-3!%S+@> V4E"3NJ&<5["NT
M$,IT=DS7 Y&'(46 9P4H&N0+DKT]H;LSOD3REW[")8>Z1MG#"8J8:!1:$P'/
M8TB'Q#0<(/&S9+UHPC\!& &(.0Z%83I?JMX[0Y+=L$PDY5=  \HRI/Q?(^])
M!^7@L;22F&6N2CW45P3$*J(H"54.R423() =+10E."QTQ6I\TT.S!A]VEU"T
M?B3N0.FCCW"=BN6.J.K%\SC)1(_4A!]H#%W.K4J1M,)A,B[ ART0BV+^Q"'&
M;$]FIA5N!'%X%F<[ 4&<> [MVH$;CC#S4E#^-'+Q$2LH&!<6&)@%9()#@P:+
M1*O[!3ARJG*W5;IFX !:1;@Q]42$9>&^/>=41<#L) )[B1(90HJD K&'<"K0
M43"M.=2S2.GAKW)NZ WT'?UN(22(;Z>S&VCD82>U#/1<_1FI5 GN P"4<RN!
M^V)8] :H")09JW%9L\X^N]%7).,X"",UT%/OB'*8+GT_H>1B#@/[6.(*/ZU7
M_TV04#J861T/"S)[20"S2)\E_K#8*0G?0!>;7N+A:D.K4RU_B[XKS[(H2IW.
M+W]C,*?C%,B7\5(."/,%XMM#*7TRBS1_T'2F# I=UT=T0;E*BXG8>?9.R7[<
M+0RS_8"0O$ 9,QM0W^$2RQHL"[(F,A^S'.[C1+2/^73_+ 4_31!=JM;CUL.4
MI$G,%=43SM;4NET&M)U-I/[Q8-L2:SZRK@ *P#M,V3U2=/E#<2 _\*LVZFNL
M=07IX3WJ>RVTIPF4;V64<?)[1EK8VH'Q1'7R5A):K:!++3AQCCNVHI(X1<L@
MZRBT\.*(,\B J25>K'6?1QIV8V$U*=Q&=R(LQ!%A6E"S>#P#P2M& Z7N*W7W
M.W#L'"SZ;$DV[U+F@1ZQ@SWUP\(\,AR$8AC<R<IBXCN96&E7I25WQ4:^#X./
M&Z5*"T5(6<E_6N"D'HUTJRDC.S7_BX4.58N_2YM1(:6;[^%5B5$,)5A7M<SC
M^L"[R8^3+9-$7/QE73I_@C$C5;;B[<>WG[G@5#ESN<^H9PFT<6QZ*:<$(NTW
M:KW.3\1M%AW:S5JGOOC-Z]0UD1XM#X(UFXQI! !O0Q?IUFO-SD]\3<L[2_>_
M &'ZG&Q<U4:'<YO1-86.,?S?%:5C@FL8,)/<)8MT'+J 4U1'HL#L:2<[&7</
M]X#[3EY&,#5W$BV6\3Z&W"\7VG7KNI(\(\Y,N4T<5_K#Q6HA^/F2@VKGS/CT
M0I[],N19@+T\8Z><'YNP/1C4^IW64_*UF]U:H_6T?.V'EAW4FH/-,J#+58]Y
MU?X/R8)O-@XTR?L<M!457(Q>;I."=[39_I\E9D)0[U:>(7)TB?UPJ$U2L@_N
M4.UC/%3G& _5/<9#]8[N4%_2Q*PC3LY>G6IK.B,^I4Z<3\HWLK/9NT4:J[TA
M9'8W5[L00[4W/#5&OQO-Q<FS.X7 =TS5+O'OV/&OV=CY5/<2^4KDV^S4[6:M
M4R+?WJ^A1+X2^4KD^Z&G[K9J_1+Y]GX-)XI\W7:M7F+?WN_A-+&OP!;O<37.
M>-P!E>;FK/,_97&H[8"PDOZ*AXK-3JVU)1ZNOO&G<KLCAV]KL+6<*>&[#7S;
MM6X)WV?D#X.MM?02OMO MUOKE?!]/OC62_%6/$UVAR ^K8#IZPT"IAMAW HH
M' C&=6OMI]E-/Y*@#Q>\_:=ZA$OPEN MP5N"MP1O"=Z"@K?>J#7V!^#3\JR^
M/GG/:FO[X'II>FZ3O-"N#4KX/B-\6UM;6B5\MX%OO?2LEI&7 X9OO^0/S\H?
MMM=62[_J5A#^K/M<7&6-*-Y*>6(.U?K6:E1I=6X!WB<7%Y3@W0R\3TSC*\&[
M&7-X8HYN"=X2O 4 ;\E["Q?\+Y!+=;'!QF._4ZFWJGE/"W;M! FV J+TV]/,
MR]XE:(J-[MW.4PVR70#G.0H*2K0NT?KG1J/]5$=DB=<%N<,2KU?@=:O^5 =P
MB=<%N<,2KU?@=;/Y5,=[B=<%N<,2KU?QZWZIAY1X?71XW6LT2GY=XO71X76_
MW=S:O5H O'Z.J=Z%G3?RWO7=:3*U/B6A/<%9+L<_X<FWWLIA2*-&TF%BD@8.
MXL!&'@:L9Y&D#] @5AR'@.,P9117K$\C>"E.5Y!V@@,3A/6)YPY:EPZ<T0&@
MZH&Q^8_/7NH9$N_A+2,<_Q/R+ _'NL51A/-L,C6-SHGX0SVYTQCWHR8=PA/#
M/]4T"#TVB*9AX))ZU@0/6^2I&GKTH#'IHEE_95UA8_HA-<J_XQ]_I(&&E^8(
MQUW,OS".8$P9>EFS+E>,8J99,!,!3 .>BD:NY!DD4X6Y,XVYYO +<ZIM'OIZ
M3N_"5?% 7IJ[DD[D53.TFZ<S?8BO^RU/_-#3!6_\.T#X?(+VH<'A1PT7Q'3V
M,#$I&L<*C=4\435W-C<H.*+!@TB?3.@X1>ZO1- LUF@> =4PT>K/C+'F 1$]
MD.KWCRQ<QO#]C"9\<&KG#6#*E">K,I4?] !S-2[91^Z'DP:3,*+Y(GK\L6)[
M=VIZ'(T'<A4$YCR&#2<XXPQ;Q \'V!>-BM5CA*;B&_%'."VFK<UP:'=,0YF(
M-UY+3]SC9"KX'Y[K9"Z?S<<5D2E5$)L]3_(P2) ^L"K@)*!_C,\:@XPBX?&(
M57,@KQY)[D9,4+Q!SX6-Z4E,;OZ.>?HQSEH>2CV)VLFX>VZT7HU5S4LOG@3)
M>/+@5.4,N#Z.?DI'C57P/D#7U*.K6:;2MSBJ>0Z;U8.21S1=.+?;Y<F?!:2B
M?[IPM2%-W[["D4]O<;YS03:^5ERM/DJV?QY7E<V<O$2^2-.R].;W0>+6X2H.
MCPY)]67,(\,2+6:R"?9Z2GP\ =I4\^$M$'/P( E:)M1TCNH]\)@7C5I+ST*I
MP3YC)#K@0-;, [U7T(R[3'_D<9OP<MQ%*E5IFJ8[)&W\17M0&^077+?;A1&9
MQHSN;,XE< ZIYJ1I#H"3LVGG'7/K?#14,;=91TV212/B1:M;:^KE\(N01FP2
M[[T#  #IDKP'B+5K[94/\A1R?A4_.3"6=&3V)"CQ82+S>\&]O<"Y4,;:?-O9
M@=3=Q.(;[H5WC\>3WX"W1O@Y\&M?CEQU5D>.)$UR-']8LSZ.1K#'6,T(1&;.
MTTT)KK!O4+T[Z_;-#X+,D^X=FNITT&:MN_+Y&0Z =!U# 8--,9B([^-@U>QF
M&&*=E;!-WSP3<WPMFQ.KKFE.IP#K:RI"%W6R1&K1;#X>B9%$52\.[*_+BYE7
M2>L9JV2&SPBT2!3E\!]U!/Q>S;9V_Q9ZU"L-=7=!")+Z: <1/NUY@6V.'^39
MCF35\>3!$4\>G//N'D.?M8<&@ 4)49A@/708^$"-:E;G PBFL"&C4&(MH#3@
M--I1.C)SY?86L015CZ7= =M$E88T]!&P%P.&V6L +-)/9+;;I^'72O"(W&(I
ML? %3>&_.!R8:,4:SK-[E<Y.;O0A]%[$N55@Y_\[ 4FG-$D'+^&ITJZQ0F;L
M0MQUNC],W&4\EO'GJ8*N6:_5-Y5*Q-U;:WARCDDJ!EZO]58^^P"E\@*/2Z5&
M:XTT7130S37R>9'(6$;#X<H)J>F$U$$Y(;4 >WG&":G[P*H-54E6@1LYZGTF
M#?A[-2J>:;Y>I=J0]6VBI*Q^8Q2,8G(CP>_EO?  &)FF@C\!YAG&A@ZJ=^'Z
MRA>C@A3*E63 Y3OU8%KDA_M<5B/>*BGQ@'U@:%GL.4/84>1&N>72,Z,6,!W"
M^QSV)K.ZIW\";S.5Q6DNW'0'KR5?V&ZTP-TIWSLS"':DDA;5V\5QF=7>KF(X
M(%<3 ^O#R__%6Q\!-@3WI'KQ!.UDBNCR-X9;%E3-)"12,D;;CP@V.%07/<"P
M12=Z^6HM$N3G; ,6Z,G;F%;0(:0XE"G>G5X-A/+.)S@WX,O.TX:#/_Q=YQE&
MCI_*9A^<YEYK-S9#@^^=+STXV*&J2S8ZL<8T_KO%&-DMAF\_]='=C0%?FS*U
M(FNJX'>XX5CPC4Y\<I!K/ ^"'\;YKTA]>"H$CJOAS6H(93IEIFV^VH38MIY%
MM"T5/@;=[UFCW.337G *#4L_I98VF^/DIJA8H/&COP1L<DQ*F:'!^3U-N(XT
MR?V DM7/FZU*M]Y]N>]6=<_8G*)$N"*=[;S1KM2;_1+ABG0I1XUP@TJG=U#X
M=@@8<][(0_01G4@["_V 0GT/0.<TGCPNHVJ-"AD&L&E'N>TQ,YH":!3,.K%6
MHH-Z09HQ[L)H.\XKZA1DQ$AY0^OK:@_\BD[!;_!:E?%8POXK<3G_*JI06!NS
M[M"[1M^$TCFQL2?GC4J_W:XTNNU#TD6?Q&,.]Y+V/K:SO*;CI:5#X-_GS:WL
MNJ,P5&[\6/ACEU(@T3I)Z_1/S4PY;U9:_=[F)%4P_>H$+@CX7F\+GE=>T(^^
MH$ZC=;#74_KPGM>'=X#J0"X,[*8=4:Q(VDF83[T]&<US,-B"Q/>O=9Z<:5"O
MU%L'91><V WU*_7V'@>X'3&W/F^=GO&V.LJT.U%UN+IHJ](IPTY%OZ1>I5Y>
M4M$OZ9Q(Z9#LND/@W.?M[Y16#R@%O5JO4_#C+S6KR,KZQ')AXRX:"-<?ZB%<
M+_M/;PF@@O.L1J7?[55ZG2WXULYA5/!$S9):2FK1U-*O]/N-DE1*4BE)98/8
M.U!+=W"BU/+PH(1\!X36WEJX_>?A_]NP/T0+.V\Q$*I(HZ\:?4VXJI%(%3_9
M]1F[M<XF'9R6>X(AYE1;M16-)X8BDMQHRDA=W\?%8-= [*\WV[C"+FU2XU@.
M-['!IB!_)2*,96@VJ#%R[G#1VZF+]?[OI4-MCW'->]>#/[PHP#XX<_:9P8O=
M@+HFJK^&]"KLO6/.*TB[X5N^E(YJ=ZTZM_N2FVG+;RY;,+KUM?H4P!RI36$#
MDWQ''M66$:R=]:UK3@ KFX7 RN&J_$U&FT<Q)AT6HOMJ 4^]QU[_<2AB.9YS
MYRT<HJ%ZB<,":HZ(1>W)(C>DUC,QW#9:QS1IPZ66N7XZFZ1KC,>@J0 R5J,Q
M'D1_U;01#6X<UN$ZJC-DUL<R!/ );LFD6C,/K"%W0H.735Q[0I_S= _=>2K%
M>%IY*#SJ+44G!6$64E,?<R['%;<B32>=U*Q+E0[+*]";>_U:/VTV><HTT7JY
MKFO2/FEEB7NOC#9L2#2 ;9I<5*]3Z40L!GSBCH">7_W@'A"5YY,8>*KFVJSJ
M#L6;483WP"27HT.9]M[9:#XBA42OHU*+U_,$7.$1%R@Y@7_BN*%(=X(S)/1Z
MGK'Y=1]85[BW/'-IDZYP^]_\0KSGT19MSV="/&GCQ>+&V_?/&Z6X\GC_O,.
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MYOK,BX7H[&G$Q9OKX^+[B7 7C W<2BR=J"C1@BBNB N@P9K) Q$L="P%_I]
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M>%\7D,(>%+VR\%UT#0.A.*)T)C)[7=@5EVA4W$M?I'0+7VJW\*7M%BY[G\0
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M4'[,DW)Y*TK)5<;PYAL_LE]#5;3&R9JCN.EJ;__;&U.18^<O8/YX4:@>Q8.
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MV##\W*,8S=*9",38@!+ 9^9_(64H7@,2/Z0T'UQJ(==G8&OO%HLG:F37R]B
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MK#,:'8\H8QOS<E>D8]KT^4"FIJDR:X821UVI*'@S[U_-#\,B'TY/#]68Q*Q
M,8<0/!/X$!A%@J"!>)F<330D9]HLB=R$:DQ]'!_.U:FCI#JSU3J</WW?^]GB
M&.?0#X QRVR8<$E9PA$1;DI(K/%'X,82'A2-1GAA8]YHNKKY/D\@4*PZ7U64
M>KV3#O9\#[_ZY?+N?K%B*P?*A0 *LB$B\;*M-C#B16E12Z-RD?DD79N Z&H\
M8SII[H$L1@7%U-OF>E)<O#N[8CGIVUI24,)+&1.QTGK$5OI>2)X)LP+-@G,L
ML#:3S6;X-B&1?>04:&T6-=!<U7.V5O6-JSJ>\^[\^Q[VN\/]B5')E#.!"(.
M;CSP<CA<!F(DY=&@+Q\;G=:[$;Q-..6^+\-47VWU.D^?@_*FF_E9Q(&7_; #
M(C().8YNE2F]L$N*WRDAB8C2ZR2YYK+1F0LWH-HHZT>_+P)5TU(=7_CC@2_'
M4/6+X7#PGV$")EO+$BTG.2 "2((XYA+1TC#J?'!4JHV<WPL7WDC5WTF&=VO!
MUBWM+;UC<+3G&Z1ZR2@SH$EVWA I<%PA!7RKF:764F%MF]+U:R%MQ) 'V\S[
M4$F6*@JJV=JGG-4!KV#U[]O9Y0-*)S(+(V4RQ"2EB70QXLA9()8S1X44)K@V
M2_V;H-N(18]=BU3?*:FLMH:$.DU4ES&7?9<L<4HR*'23HL")3SL@/($&EPW+
MNDV<?2.LC2CTV,5'[2ET7T4UY,[)B9FO3H[/N_+DS$D,$'"NS:5N& VG HSK
M%+ZR);'D KX7;4X'N!_>C=CVV+5)[=E67;4-:;B$]$TD)]BL<TF*3,1ROL:8
M#\4A%(%@-8N2<=>H;_5F^#:BF?[N:;:UZA[ U7KOCY<3-C@O:92& "W+^,)'
MXB3.VLI[P65TFC=JJ7<KM(W(])UEI.OJJRV-^D-([SH?NNE)N1U37/C$23:E
M;Y!*L31G5D2QX%,VGC'1ZB"*V]%M1";[_X!,VVBM3C+H(JQNUBUCTD5I2MN=
M'K$&7R,, WX65MOU!S]+Z63>7OO^1#"9?; 4!>0]!AR&XO,@2LTGV Q"6^XV
MZ[A>%=9&=/M.DM:/K-36E;MGR=-U,4G-F%6>"!I13#X8XLLV:":M#9YKRW*;
M_5*;8]RV=N&LUKH<$(X7A]W\;C[[_ GZ_5<05NTRWI7-QWUY>_JE58*94N.C
M*_V/M)3E5!N'ZO..@-))*@?!7>P9?GUMPQ8XGD"Y[[;DNEC[\%!:JWCFRL')
M#I+S2"=")LU=#L1F*<H!'T"<-;+,2Q"ERZY5_N\Z1*/J MF83E6U4WV/V&Z^
M3%X6J V!>0)03J'W)5X/)I',H2RO>R:A[4[\*T ]A0VKM1E32T=M=H&5$WUW
M#Y;'(;S^"GWL4 83RJ)E*5,DKT,/V"I-+'Y"7.122"EY:-1;^%9H3Z >N#I_
MJJJK&HM6PX1ED?+['EW5[L!/3[D^<4&#B:JLHBDD=@1.? )'N&7>)*T !]Z$
M03?">@K;46O3IYZ>JL]:'V!YCO>G^2?_M1P>4$X6QX&_F??7E"$J2EV,Y7@-
M6EJ3R* P#-.&)*WQ4XYR:=1^\[Z([UAK_%T0[D&T6Z_-($JD_%^J$H_\= 5\
M6/1=1.S+7A*E5'K]@[5OOH>^FZ?+2:63V/[UU[CG,<3_@')XG3/$Q80)ZR5E
MC##.RP;<R-%*4YSU,X-DA('0JG/A@X[S ;<,,R$M,SC;@82R^T4487).% =M
M=%)<YG%M&7[D9HKCY?NE4Z;;D*!U=NRJ7?XJ.D\]M\0XIXE,B:(8;"+:Y51.
MD,@Q/BA);^T1]\B]')\\2;<EP6.D< .H"$8$PCVZ@3(Q0UPY)"VI("(3(C@8
M5PKW<?<:/WV2;DN":B1=#7$WKP][=W8BPPN2N^H@QXF,W,J,TN#<"B)UDL09
MXPE-R5'#/16J3<)B6^1CRF<\(4(_*&$:-NQ=J_5[!0O?3>_5F/>*JVS?@/<V
M:)4:[9[U3T ;-8F@O38A$4M]())I08*3B0"E+ $Z=++1(N(ZBAH;S);7^N"_
M_(Z\[#L_7;4F+.>W]^@73++.T1HORZ&Q2/TL%''(.6(]=Y):)R)M8ZYNQS:F
M6.7>W+AJ\UA%E53=B[C$]>>\_ZO48LY+,<!Y8%JS:*.W) A>CL]QC-@42K<B
MI7BT.4??JE;[5G!CBAGJDZ624NJS!?VV;MB#]-M\GBX 6W:T+RVLJ"Z[G4+2
MQ(-*A'EI>%(J)-9JC\BMX,;DO-=G2R6E-'0V3G=A^[5.S%MX'3==;GOW8V.P
ME?R0:WM5%X)0]!23#*(<8<;*1D)'K*:*!!.4\X;GV*CRXB94%9:!K[[V\N33
MB<J*4F"49*T-D1R'ZYCRA"5)O;*9!MML#?@&7&/R3ZIQYHHEWUJJJ;?+/>(3
M>KA<TMFD&=[UO=\AY82A5VDTE''&Y!J(MQA_>6Z4,2 S\#:]QVJ-8%1E3\TX
M^"CZWG#V._F\_ A^@%]^^#]02P,$%     @ YHFI5 .P-:FTB   5OX% !4
M  !I8W5I+3(P,C(P,S,Q7V1E9BYX;6SLO5F76[>2+OA>O\+M>FT<8Q[.JE-W
MR9+E4K=L:4GR.77[A2L !%*\9I*Z)%.6[J_O (<<F&0FF=P@,RG58.=D[@\1
MWP8B C'\Q__X<C[XX3..)_W1\!\_BK_Q'W_ 81KE_O#L'S_^\>$E\S_^C__\
MMW_[C_^+L?_^^=WK'UZ,TL4Y#J<_/!\C3#'_\%=_^O&'?V6<_/E#&8_.?_C7
M:/QG_S,P]I^S_^CYZ-/7<?_LX_0'R:5<_>WX[QAM3,(*9G513!LLS"MC&#?*
M1:Y#X<7]WV=_%R7Q[+5@"H5F&K1A ;QDA3N3;(I*J_F'#OK#/_]>_Q%A@C_0
MXH:3V;?_^/'C=/KI[S_]]-=??_WM2QP/_C8:G_TD.5<_+?_ZQ\6??[GU]W^I
MV5^+$,)/L]]>_NFDO^X/Z6/%3__]V^OWZ2.> ^L/)U,8IJL'T./S]/(_O([&
M_#3_)?WII/_WR>R_?SU*,)VIY]XE_+#Q+^IW;/EGK/Z("<F4^-N72?[Q/__M
MAQ_FDH-Q&H\&^ [+#XLO_WCWZC;2_G#Z4^Z?_[3XFY]@,"#$LT^8?OV$__AQ
MTC__-,#ESSZ.L6Q$OUQR!64JG'^OG_;3WI@^$I!QNHC(Z*<XK 3O$..Z3]\?
M\^5GL8P%+@;3#A'?_NQ.\8[.H=^E@&]]= =H9Q_$SO$\XKA+J#<^]QK.)<A5
MA/4C^W4?S7]+H_.?9N">CX:9%HR9OIB,!OU<=]>?85 WCO<?$:>3^Q'39_99
MW6>YFK_9_[[%IU[#2\3H#_MUKWE-WRX^NJ+K%#E^F2+]%_G''_J9,%N).OF4
M TBK _<ABN@3Z@"0P1;?V^+SZQ*6BQB,THW'#>KV.;K4]P B#F8_[5U,V!G
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MSZ(6BF@0P%T,()O5E.3^]&*,$]I/+VJOJ)\OIK^/IO\3IW546<]QA2[K4B7
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MHK0&''M^,9F.SG'\#@?S>_N/_4^3Q9ENHX@00#,A5;V3Y(Y!).T'EX3G7A/
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M?0HV)O3*YH"EM_)9^[T\+_H3.#L;X]G,'ZZ$F7WXE=/CC8K)@V,& )CV)K(
MY-_ZF!R]Y4'IT&8SO0]91\5_[["^%,3EMS@NM9B2]K4W<="?/[9G4C8\>WI%
M2!%,QVI[2\M92MY9 ,Z%;77YL@6\PV\KG?)E0^E@ARII<-QLD,#<50-T8&IJ
M!A3M:F37,<]M8C'Q &BX=[I-^N1=J X51&G*C<[$?NR(R60\K264M4'UF_%[
MLM#[:6ZC1T=&%"^*19]).BB >$WG*<JHBI<@>-ZJCRH]X!IOZ+M5SFQ"<*Q8
M2'>J'74HX@X=EFMX:C.(!:+)LLG$%J!VB73LHO_;< X;W>A&4[?5WI&8#\8!
MD4/F+GB6;&T^3:8?\Q"([\8*K8MW(F\U:>4QZGY#Z.* JM]%NEW7SKP:EHLJ
MA_=?)_4,7'A,#B&!T[0]UM:+A(A6*V5F= [&4IQU8K4ASX;JF;4??SBSL$.Y
MCSH56M?]M'[YWQ?]3_78'\\/IP4D,CY-%$XP:<@@U0IKD'XV;*) )C=;ZFBW
MTN/ZSW_RBNQ ;)T7LXW*]"\8XTU$*J,,42#SQ<HZQ8X0V4@ 0TI@-6I8K7O:
M5,ZV[N.?O![W%]HAFE@M(R-7]F2]J9_]+'[]%4=G8_CT<;\T\5T>T%G4Z 'K
M6>T_9;/33GO/)6D%E%?.R**\%"D)F7)OMT<UCCD9YR!PCBP%0;QRB7A5HF0A
M)A1!B9"@3>SV0#&GVAO)%#1U)I6I_4I-M R"24R9(M'2'BAYFYD9QVLXU:G6
M[V@ZM;U@#QT<LH'>.T&6K%":=M]D:P4/.B8*H"^Z"%1M$FZ>1'!H'_5W)O;'
M$!QZ/Z7-MW[(<MNMA>,SST@&66( SHJ&PK1W@46#M8E[5(9G6@=N==F]E9>X
M$<:C#!/MI.11U\+N.$[P?DZBZY"670BV -5YK&@CG,/'BCI2UZB5K ]&!*T#
M5T(JILDC)DM>UFEE(=5+7,6SL\CC5M5ACY$ =P2,#JG_743<(KOEMU^>+?PL
M6<@O\YFS/$/BLV"T6F0QDY$C7/9.M\DTO\)P6 ^V(Z6LYJ\\3*)=AY)FX\/+
M:(S]LV$:70RGX_YE6VB0NA04AD%.Q&)>Y]?JR%G 5%311G.Y4KBS(0QQQT.>
MLBH[%6#7D:67<TC+AO A:$Q*LR2U8#K46II$GHB7/BK$DD/>;K3OC8]]\LI[
MN) ZK*B;L^9K[X_W/?#)<BXM2SYZ(HSD=;J69MQ$)%74U*6["BHGF/YV-OK\
MT^(3YUOKXIO9KCK3X]7SGK+^'BBUC15LAXK\+>*AU=5L%?M;\XBVT;_[UK02
M__-0I)"2_C][[73R",6'>L%6BN 9[H[_K7E8XPB@X )R]HE9;PS3,10&5@"3
MTF6NO9<AMFG(?K (H#7&&^[(8:U=Y+11F8R/K!FIR#LTQ:;8)ACTB". NVA]
M8P1P%\$>.@*(Q:C@HF)"&G)-$*MU4C)3'+(E]\5XW:8*ZDE$ /=1?V=B?PP1
MP+5I$:#0>.<LL]:Y.C'&,TC9,_)BZ.3-RF2W52;J::6'[:3:^]+#=A'QP5*#
MM@'US:6'[:2IK7*$'B+F@W' 2UM\S(X9'273(@GF51 ,Z$1S#D%(W"H)_S'J
M?M?TL.Y5OXMT6Z6'/1\-)Q?G=4M;1C)09@&*TSIGR=()ZDVF4 RMLF3/^!"<
MN\]GN?L1CR4K92?YKTL3VT]X7<?W-B2O:1EJ>V<65$YDECK%0N:J=EHLQ40I
MR^JDAJ>8\;>W*A\NM,[?S'^^'PTN9KV>%VAJ8-@5LC# ^-K^2106O./,<?3:
MZ))4VC)I<_6CG[[Z]A)6AY&]&9KG8Y)>@L%S&"]3U3 6HI"N3$J*:><S SHL
M&#<Z152"F[3=U-/;G_WDE;>GN#KL4+5I5U_70S]F)1+!8P8T[0VQCGR&XN@?
M@IQ%'45>'>*U_?EXU)D$ASLL]Q7K;<WKO33_3YBDBP&,GR5:[W(CB2)89SUG
M.:0Z(0$BBR +<S8[+Z2.?K4Y] 8]K_OT)Z_5O47681.J.:#^],9.8FSDW#BL
M6?I0F]< 6>J$*@%RX8RV=,9OI[Z;'_ST-;>'H&XKS;:Z4J'M8CJ&&OR_;'*V
M_R7*'1_:U;7)MKA7>V5SJ>O$.8PJ:,<+U"TOH2^.+!;C8N_^C]_'<%E\*M0.
M=##,@V6G[0B#6@4]N0J66L$#O>>2&2%JSX6:O)"R9NA4).Q*8-S.&-W^F?N&
MQG\;?9[%2%\-7V#!\?CRANG=:#!X.1K_!>/<RRIQI<&Q4NI ')<T XZ9B92R
MS0JTYVV&36V#[G";3DLZK,;..]=+@VN5I2C^11;+\XO)='2.X\L^]&2NDC=A
M@3,$.NLT&'(["LDAQ0+):9&-;-,K_4Y8I\F6[C31(&GNU3"-$2;X N?_OD7I
M7D!+9S0$)EVM)W<RL3"[-0A$:8/*VKA5I>W.5+D7VFG2I5N--.BJO0+G6<[S
M 5^]8+,G[A9FK FU1,XQ2)R^E5IF"\%YU:@*:0.BTR1()_)OT"7[[GW.T8$7
M'/?,A<()7"8WV9$ DO<B%V]D%FW,E!U.G =GI]S3@,>*&!VY/<P7<G0T<LV"
M1]KR-:B<E976M^HN_ZAZ(AWR+>E>,UT[_O<*8M'/Q=AL731,YD)N;BB>A41?
M^2!\D!*]$]M=:VWWO-;)+8?@0"OQ/MI4%\,# ,^)16X\TTG61MM:U"D\P1B/
M7CA]4JDNS31\7\;++I(^6+;#-J"^N8R7G32U5=K#0\1\N(R7",5G:UG2')F.
M&,GXJ[.U1>%%%\"PW<SQQZC[73->NE?]+M+M^EY]4TL8+:,@FYK9)&B1ID@&
M6'-W?4DBI@CH[XTN/X%..CM)?IM..CN(K>M$E_5-82"$$I6.3,22Z7P*A44)
MD@F'("7D:+>\:7_4G70>K,?]A=;U"_GKZ#..A[,ZH3$,I^]N G,) _I<UTG6
MADZ&K VB&U>IUM@&%;<TU^]ZRI-7:F<B[#H39E8JN1)AN;QO))?02LFRKAT3
M5'#,IU+O_:,L&)40;KL+I,W/>/)Z[4A\#:)3RV%6UR8[SVP%K6,QGM;F ];$
M'5UHJ5XS[DTV5L9DL.U0LA5 I^9)=2G_!L'L=;#F<\SPLO#S?H!-Y^K<"_$X
M\W4Z4>@6)-E?&PVNS>X'ZK5"B\:R4E0DH,(R$ J9=&B24P@!VS0V/Q)=[IFW
M<QRV[**$SMMFKLD5=,H'I1TR5$#.1TFT@<92\\P\%N%5"HIO9^H?,]^RD?Q'
M'0JO:\_M0_^\#IN;,38Z@XE@9 7U]C5JYDWD+&J5-?ABP&R77GGUF:=VYN\C
MLJZ3H^<PEJ?'%D#6G^5WZO 8Q_!>,KZMIST$U/7&>0.0D6 (DF:NU#OMHFQ-
MCT'FHTR97GSNLWXDFMIP K91U"YRZ?QD^S@:3S_@^/RRZ,B2[^8=L[Y.LRID
MEH04)*.?UKZY.>'J).Q-I]K-#S[PQ?3#Y3OJ2#A=GUJO1\.S:U"B3U&+E)D0
MB=:DN&<QU+3$;&.Q",*D[7IEW?S<)ZFF/41SB(%LKVOFU^0#?IGND3M^^T/V
MSA6_!]=J$^V0M4HRD!3I"[(?7%!*66V$=8KGW+O]<?NY9:_)&D5\/4^?FZ1Q
M_]-B@8MD A!2)\\CBTGD6GL +!JA&=F50O-D"Z0V24CW -LO9#G[K.EH+OS^
M\"O">-(+0@24.K/,M:Z,#LPC<&:5E61\6^/5=F;JVH\_O+/1I6IOABSW%E^#
M[.WY:M^0+0]3VNUFRZ[;U9NR--M[)>L$P2N6?? UOYP\9Q%X=9_1:P<YQ)9<
MO@O;:;"CD2X:1*/6KWXQ"UU[+9R5+ A>^SQG.MDBI^4'KA.WH=C56XNF6]Y!
M&RBU9\7^,G\,.67O8'@VSYS0(1KI8V0H:G<@G1P#SAU+(L1(!X.QKKN1>I>/
M/5:CI,YT.-I7EAVG"<U 7'8,O1]&Y\EAUP </AWL@2I85>(>\FNH3N$MD&OB
M:I4RT#^B8R'2[E4"&"/0&0A;M4%\'&J\([.K6RWN(K:.M?<;?.F?7RP]S=G@
M5DE/=KY.E$K>LX <F?*.E\AY]-O=-V^EOQN//FQRP8.%/^I"<AM-\@Y]]-]Q
M^FI(W^%;'+__".-]>N5N_*R]/?;M4*XX[CKX(CD7R@KRUJ4+:*-1W$2-OG!T
MO8V?NI\A^VPX[>=^[8OS&=]CNAC/ZL1_^9(&%P3N)1'L^>C\T\5TT=CP%QC7
MTH[)$L259<<MTD$M.!.V!EE+%,P+"<P%DVL9DG.-BA:[6L&^+L&>.)Z=U];5
M/6NT+_3AK'AZ9S59Q>32*,LB<L]-43;+-E.W.H%_>#?T*/Q=]4P.K_H& 9"W
MXU'I3U^/)I->$@A:*LFD)#%H&0+S,FM6K$'44)QP6_5RW)F$5QB^428]4 D-
M(AS_PO[9QRGF9Y]Q#&?X^T65WILR6^ODS<5T4F^P20 _PZ2?>J*$((M.K BA
MR*^'VF(F6I;)7/2*1VN@36AL)YC?**G:J;)!>N"L&+^&5V! HCD?#><PGTVG
MXWXD0<4!?AC-?D9P,;^%K_6/GXW'U?JM7TYZ6=(.*J5B+A7--,;$@@7:2#E(
M*TT)L;3I6[\_]F^4H0=6>H-DYPWOV(LJ6<RW7K6>4,$G'C7+J@X!#86D%6)@
MTEK'E0P82YL"]1V!?J.$;*G.#EL27HX-6Q'"?"<//$I,VC%N. D :M<28WUM
M=",+SX$GV^8B8BV<;Y1)^ZNFPRX(FT M>-VC]<F<2:&B<#K[.90ZI%BP&C/B
MA796G]K,M-D Z#MG'JR>C?T7'\Z:]^DCYHL!OBE[2FF1YQJR-#EDEG4I3#O#
M632AIN49H5SA1? VVU.WZSC4U>JC8.81*7#L:]N.]/#SU_4?,)\0B\8'#;FF
MIDHZ%A0P[^ELD$IRXQ-X5]KLOPT7=:RKYF-2M=OX8&>4:1 F6H_L=SA?%J1L
M@Z]I,=]]"(]3R_=H*+$55??4YS%X!T6:8$UB.2#AU%FR&,DC2X1?!\6M*(>\
M2&G-MWN* 9\LW791XR'2Q%_@N/\9*MR7_2$,4Q\&KX83LCMF4:C%Y&"2Z\<:
MF5HT)EXF+>[3E;R3Y^Y]M=W]ZE>NP:TSJBBN$O*HDR!'6 )$7CO5*_0E]CI!
ML&\WUB6$*YO: .>V%D38^B)HI0.]#>2>Z5BL4M8 Z#;W'VO [-]M=OF1OX\J
M06"PN*#TJ0C#LV&<UTG8]%XSJ/EZP@:;48-UT*K;['I$1Y@/NZ?N;W>6[4#6
M+4;$7N):Y&;26U@2"$;O)*W,:,G %L6<DY%\QP@.MVIWN(?J#SL(MIF>=Y?G
ML1W?FA?V_&(\QF'Z.COP SD_F%UDWM;2K2 #@Y@X4SP845)RTF^U#VR54'?]
MR4<;[[J/]D8=2+%# SHM,/2>#08+//W++D3;8-K"69M@^MO9Z/-/RV?-M;S\
M;J;EF7[OPG+X).:':V?42+2'4KNV=-:$2$>,-);X[(G/BO:XXJQ368;,\:X7
M^O&J^XYDY[;:WD6B+;3\VW__WK.1@&,$)FHMG4Z@6%#H6/0R<.#H(]PUR7UG
MK=(S#V>0=2?]577N*KH.K:]+#+_\\:[G;,[%&,\@HR%.5L^W#K<!:Y \ZBQ%
MNBN+96?UT3-/07V[BJ[%V_?\__M_:1')&ZXTX\5&6@0O+(!VS$0,H'A2-G>J
M/GKF*:AO5]%UF(%VB>'_>?L_>SR:I#,MPJ*0Y'^E.O$E!(92JU("]VJU;]1^
MZJ-GGH+Z=A5=U[V'WM<:%K*@^I\&>/V$GS>IMB$JA\!X5G7FI*0U<N&85 C"
MB0S*;M?9YJZG/&4?I5L1=MTH=A.P96.2+:#MU&GJ[N<=H?=4=YK91M][B+7S
M]D=W0_3:YXB +-')P70)F0&(0-:[(*B\* _[O=?'ZF%U%(7O(LVN%3UK9GQU
M(EW.>TYUDE5@QI?:L9(CB]$59D!Z7F+QX'=H [WZ\0=NIM2E]&_U@=Y+=(>H
MX+S[^J;9_=B!+L"VF]Z+2@ONM U!>Y"1WN*0@&PK4#Y ON>&J]T55O39>.<2
M\]D!TYR\WUC=)U!)>>Z2@SN#0(_T"FMQ!;B\$7P'4Q0]:8T)6J3:6H+\0ZEH
ME;1C,JO)/\3LBX,VLUCOQO4XKK-VX<'F:XZ]Y=[T4NM9[<"Z<N.653$FHZX;
M))VGUD0&IC;/]R*[H!UZWZ: ^4Y8I\2)?:7>((UHD3"P/(B?P^3CR\'HK__"
M?(:_DK1J)>:'T<]TOJ4!3";]TL?\XF+<'Y[]3ONZD+^-AM./DYZP*%$0I[T2
MMLZ'#2QP&YF-VF5TH%.Y*]3Z<.YT@__ID^P(>FPRY_>F#X\ZT?Z(@8&0-5/;
M&Q9]?5>R!J&$5MZU/J>.?NO>S=:SNSR/?>M^>PU75N"[_N3/F0](NZ<SHH:W
MO:S#5*5ET5K-@G/%^01<-JITO0O58XF [:3MC<S94^H-SJPK;,O$M@_T7R[\
MQVVP-4VWO@O=<5*MN]/E1I)TI(B#DR4G8U!'QF7BM>6J8L%$SQR9XB58XSG
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M3;'63HA$*XF^3L,#!J $"\:CC"J:LMILY[X=\3BSH_>0\-JM\ 'B:75R_;S
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M5R#K&)W6C/M&V:GN&,<W6H;2[&P4M32P9E>X[@$R(8J4) (JI\FNJ@T%I,S
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M#;N.4[D[U% [6U>(+$\Q1W(%:P=2Q.*-%V3O"Y>5LK+XH:X0#;NB!I;FFT=
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MI]1F4QQ6 RUN,FU]X=5*^'^3Y=<'4EG<%\OBOA W<OZQ>M:%D71*J) A>6-
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M1]I59?82O58B= M0['S%$>;.#:N+V>""'#!"OT+UZ=MD^96.TSQ)X7*#1_J
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MK?GAU;F+. ?JHF5'A3O0Q#4TDYE3Z#(XF3BHZDZ$;,A9=<H:)X(SO,UM\"=
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MJ[-;+DI,C;R.NAEMK;C:+\>H+6FVM<'.%CL^<YHR,WH;>B(&9KM!YL": /N
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M;E?BF13Z=(@H9R+  2)<=WH/&$0TQ# /4PE%''$1ARF)0JMDWOW!IT8&&]U
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M&/VL'.O'\K.H9DDHDCA5!!3&"6O2=&E$8QBE*8H1CH0@@8W/ZD>MJ7FJK55
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MDVX3.<N$<H?B,()A)!E$"::0)"&#%*><)"20:6S4H\E%^-0(J%4?U/J#/0/
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M0-J?SIG!HMK4_J>:WC\8SKNL+X%LSM#B>5ZU?O^NS*J9KR><Y3(E.0.9*!1
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M:^\7\H[JO/MEO1]L+A?YGB,&E&3_^W3-9E=LJ>JVZ!.)(4,X*X%.;<>O/-6
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M-J[!1IG:P+,U^VF$S#=!#JKJAV#^C:NYTM/UBLVE5%J9_:K<^_P$PXRK4A<
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MVC=GPA.Q,_D0KJ,-F>O@:>&;/ ;?IV/E*&PJPF[+ $W5:E*:;9Y&A!N23PE
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M.P"= ]X:AA\L\JW=O/T0N#.?#/.-OE;%MJMND-?SI^?U+A-#PY1#4F* H*0
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M1%SD>F:)X4#SB,R-!MY T;GA(/J%Y3KATAJ:VS["<.&Y3I8<A.BZ/1%8U\I
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M6E0T>Z:Q0R K;9.-NLE.WWBDY0Q-5)8Z+W506G(&X2T/N3_8XVWK'XN)8JB
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M=CT4.RG):3W1>CWMR^MQ__+CYN_7M]<WWY+/-S^2ZV]7-U\_)7>7__7I-J0
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M_SK[IN93^_'[=<ZFRZ8_09,&9UNZYUQ"("C" *8V1X@5&:"HE"G4A5+4J2W
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M/9(*F>4IE!(((KFA]90!PC,$1*E@P3(.5>9U7O>DE*'1^*;#1]"NWVD@W98
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M83GDLH 1 HMDV<YW)[) ;-[..A.D#IN9G\]M@9KWJO[O+5]4P8"14B7DD&M
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M"YHQ1 J@""8 *L0 35$!I*:Z%$0JCKT264Z+&=HKO]8R>;V08>H#I=O[?CU
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MB9XBU,Z(^,6D3UG=&H3>NZ&_J/,I/??"S"<O"&"<'7)[G)BID'_NM(U:5U"
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M?/ VWM#^6R%WT^5X^>.=^9S,V>1^*M7W_ZU^C!3/4I&I A2Z4 #"4@%>P@S
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M'D.CF-/EU7>TKCO57UWAWFF.W*BH!^0[)JIK08]1LMX'LJYKU3OI\M9%ZGT
M<ZA.[S5<Y$RC3VHY4KJ %!H"A(I NZ&8 5ZF". ,$4X9Y,:MBI)C9(0-C?0>
M/S\\WGU^_H_D]M/[*C;_^-O=I^>;9*H\4P%:$8:"2XD@!URA%$")$&!:EH 7
M K*2EX0I/EK.EFS2,\(;D=TA;%1*7AM]*V],K96-"+#;YR(6;!U_$UJSLVZ2
M3RV/9KQ\K!U(^LG$L@*'D8.U8[IS]M7N/9$I^OUX(2:SA?&:MSF)*8)%D6(%
M9&%S0$0FC NK%2!(Y#DIA1:"1Z'L$\('1^&[Y+*;Q1@])_343%S)/%?B^Y9,
ME&QU=P,['CFUH-8/69U28!CDU0*-,YFUC1%&;@_+KVK^.%>O;"SOOK^JZ4*M
M"\)J;8MLZQ10:.8 HM2P6"$)P#E&BA:42^BU&C\O:FC$56F:-*HFC:Z!C8Q:
M '9CJ#BP=<Q'@8AY$\]E,*+23(NX7DGELMF'%.)P1R!AO%;;D-,OS:B+$>(\
MRY7, "+$N#P,E8 JE@.!A,PA22ECJ<\:ZDC"T!9.SP_/MQ\3NSR]?;[_]&MR
M]W\?[SX]W3UY$L,1D(Y\< T\7=/ 6K<U!42,CYVU.^X;?R2EWQ?]G)%'[_?9
M"P.JT3R]LKEZ9//E8E06LL!I*H F(@<0$YO#3@N 2YE32'4&2^1<@68[[M"^
M\)5FMF*?:]C\$*?V=_4*ZSM^0Z\VW*-F3!@ /=6)<0'"KS#,L;FMQ6!V+N^O
M ,RQCGM%7T[\^HIEQ<<QX^-)55S )E V7B\Q2*C2!K4IMD%M8A88)5'&7= Z
MPRHON6;>RXJ3HH9&.K63/)E-OP C[B69;)4.6%.<1M=C37$U9KVL*7:TK"IT
MBDZ6%*U8Q%]2G!;7_Y*BU>R32XKV.P)\C[K4B)IO8ARW4_DTT\L_#1.MRY25
M,-<V_)"FI0 0&E"I*B#(,IFG0@G$E5/S44=Y0Z.-M<8[ 3X;[ELK'5(/S@%T
M!P<G+I0=L\G;H.CA+<5%LR<OZFI4_5PL=XQ:72^'8?ISR=QMVG/5/&X+/)HH
MOBJYFJ@';=M/WT]MM\>ZFOUFBR7CG+ "$I!Q20$L>0IXD6&0*L01+PA5Q&NS
MZ[+(H7'S6F-;<NWCQK&KVK3OJ.]YIO R\&Y>7EPXNUZ8.B'9:0D4=[SB'M>[
M++;?(WC.,!P=JW._\SI.FND/X^EXJ3Z.OREYV%3CPZI*:7VQ!_G^57W_FAA9
M]>AL7R)<L RJM !,805@)CD@98D (ZDF0C-$<J\C+C&5&S+/U=:!RKSCWC,W
M26UBLFOC.AQ\=56HJ ^ 'XOV/:T]\FU/,QI,R#&A[X2ZHRCX)B0?$]ISGX.H
M,L(^'/O?HX^;HL($IXHQ6 *!4@8@1M#6RB! Z93EB)5963JU\[P@9VAT?N!6
M75'>^1RP;MP: :Z.:3((*6^BNX!#5,XZ)ZM7^KE@\"&37+H\C!0^J]>F0=N#
MMDN.9[/BL))&HM22E3(#M&0(0$+,NE:F!.",IIQ!A*A;D]]+@H9&"UL]CU=A
M?K1P%EHW7H@!6,?$$(25-S%< B(J,YP5UBLU7#+YD!LN7N_?:^MYSFPIF*<?
M+WPV&<&<%3QC&8 %+^VN)0(T)\9EP$I*IE.%<J>CS4<C#^WU;Y1+:NW<.VKM
MP]7^AE\%0L>OM*/]7GVS3MH:W"]K?[3>^F2=-&*W/];I"R)4)3E>+S0;*YC@
M,K/5;XFBR/945H#Q' +$,YA3\_W.$ VN3W).ZM!>V+72H-'Z>.WNN:WE-P=N
MW_+HR':]41@!U.O*FUP"J;M")V<EOUW)DTM@M!8_N7AS&$4==D39U&^$ I5%
MGAM"DJ4","<*4$4T( B3E*<E2['7AM@Y04,CHD]WS\G]IW</O]TECW>?DZ>_
MWGZ^\V.<LY"ZD4P,H#KFE5,=F3JH3WD)B:CD<598KWQQR>1#BKAX?6B,<3[^
MQFQ3I9IJ1F6A92H*&SS0'$#."F +]P-B')=2*9&IU,M'.10P-!;8ZE=_*'TC
MB0?PN880PT'I/';HB$= O/"TT9$#A0=">HX0GC;Q.#1XYKIHI8L6C_/9A]G\
MA35MAD;:+/A+E:5 9XC;C6,,J$QS\Y57S/ROTHAYO=<.,H?VJI^NCF.43BJM
MUZVTKBY)=(2]&RE$1K1CGK@6S!BEAL[!TW59H2.Y;UU"Z!P0#N6"SMX:N>Y$
M71.0ER7C*"5 2ZP!A+H$M#3.!M-4(4&D@'XLU"YN: 3T;,]YGBE?<Y,([X9!
M%\!VHYUX$';,.!<*V40NQN@&2S_U(=Z@+*.;^<XU(&(4:+P58K::+A>/[(?-
MLC##FY_,5TKN'.\X55/%#"8RB$I@JV;9( <''-N\N93D$B*<E=#K[%:@'D,C
MH[4926-']3XUENP>8/(NS!)U\MPXK(<IZ9C<.IL-_][8UV$9MQ5VH"[]=KZ^
M#K"C1M=7#A=(KI/)[$]F[#6^X/O9BB_U:K+6Y+,2RBQ7C3(C2!E%MI4'+.PJ
MDF/COY&<@Q**4F%"<H6@%Y<ZB1TL=6Y5O$DVIB1Z-D_>S94<VYYHOO6T'2?"
MD1>CP]L7#5Z'K#_I>0$5E^/<1/=+:5YP'#&8W]VA>7#5<G4QPK9XCSW*E9M'
M"D!<2$ H1T#E7"O,&<:E5P/+]<!#(YVU7KXY;0U,;H018GS'E'#1[H#\M'TC
M(^>C-8/WG'^V;])QOMG![X-;R<YM5]KWJO[O_;0Z7[^IZ]-L@D"L.-54V0;/
M.8 00T!4)FR9+6'<A9R@/!U-U1>[U_WLU5K60;K3HTOK1_=(A^X>X[7RR4]K
M]7].QM.DKA>Q+4%5V^#===9E5MP8("+(O?6AC0!L2$M:#YQB]Z9U$=UWDUH/
M.$YTJ_6Y.]1C$!.V6(SUN.Z%^\$88=R2U<NJ2KJI)-H#ZG/U54T7XV^J[J';
M5"!\5//Q3'Y2RP?]S+Z/8,DYR4H*RHQIXW64&6"\8,"LC72II<JU;[9]/.6&
MY[GLVY;8QR?9L:YY6??L2VH#-^4XD]K&JF"Y35XW=OIZ0A&GW]6;>IM)[=PC
MZWD^ SR\^,!']A(C*MBSIQD?VF-OM0,9 66>ZL\.F^Z&WC[:[]/BX%!VSH7.
M2XR IO:T!<G-AX 6*: %E$1G1<&9=B[VY"IU:#3?Y!G;P/5>_;-:]^!3]'XS
MT4[,G>';=5AL"-!ZE(7J N*>BD/%@]JO2I0O9*VUHIP'ZZ]BE*]]>W6CO&\.
M(/MU'LRM_,_58FF?M/OI-_/G;/YC9&@=H51H4 CK[7.&@:T("D2:"<$+!7/E
M=)KNDJ"A4?HVG6NK; *2C;X>--,&KP-I1P*M8Y[N"2\/)HZ$6T_D&XR?']<Z
M@-)*KVWW]\>H#E;LD:C+]0&\N<XI- XY'T^K!\3X[[,OT_&_E+R71H#QX]GZ
M+-.Z+^'MELM_F%^8ATN..,&YI J#+-,,0(HRP+'QHK.,9I!"!KE4SBP;3:VA
M<3)?)]Z*K64WR7QCFYF=K7$)L]8EK#&O<FO6%9Q_V%]:"V\\:"G>;#N0_IO,
M8<>?B/\NT^?Q#7J3:>SIB]7G=/I]Y**CWOI)C">MOP]H=(3V/K?Q1P_;]K!E
M#M0+F_]C?0*^I# 7F&0 $VX^LS#3@'-!0,X81*E.(7'[S)X3,+0/YE:_P,("
M1PBZ1?^OP:7CCY /)-[!]W-V1PV@'PGI-0A^SL3#0/;9Z\+B$]_&"QL-G\W_
MSN9S-C4,,96?U7(UGRY&.<\)9!@!) H$(#,>-.6(@8)RDA<Y8HHXM=UVD#6T
M%WRC;94?^&>C;_5UG=<:^ZV[VV!V"U5$ J_[:$5ON/F%+"+AUU_4(A1'[[B%
M S*70A=M0_0:O7"PY3" X7)+F)MDQE3C+].[[^*KF5OU;C:MRBLT7_P",J4-
ME0)$"@U@EJ6 $VW^IE/."IV6N' * #M)&QJ_-LHF:VV3M;I^;E0[PFX^533<
M.J;6LY!UX&\Y81+5^6J7V*LGYF3\H5OF=E-07ZBI35<SGQSSMX59^L^K3T]U
M^O'C\RC/=(I2XY[A%"KCHZ4%("FE0!"2,YIBX[JY;R.URQH:AVRU3?;4;<[M
M)A^?O7H8M<+LX*/% Z]C(ND3-Z^^3['PZZWG4S".OMV>7)"YT.FI=8@^NSRY
MV'+0X<GIEC ?;;=2[D[[2"@%*5DJ )>\ % 5):#&*0.*R51E!<9YZE7 [K28
MH3'J?O7F&^MJ3%95*=AUAN5OS#C& 9TZS\#LYJ%=#U['C!H%-V\GK1V6J-[9
M&5&]NF7MYA[Z8Q>N#JQ$PY:VOG:SO%!<I)0@#'(F,^-Z,01H6F2 $)V7>5;0
MC'GU3=H;?6C4T"@7&.[>!\[MK0^&H^L0ERL2_O5A3ED<MQS,GH1^J[^<,NZH
MV,O)BZYHO7TBI?OCK,X O_T^7HQPP7F6E1I@EG, H42 "%D *A0MI*8B%4XM
M=7V$#NW5/G^R(EFKG?QA%?=\Z9TFP(T+8L/:,45$0#2L?;<C1/$;>5\2W']+
M;T<H3C;W=KWWNM*:.[OX>PN;YSF;+K0R#LMN;O)][</($<<R3;&A+,TU!E"3
M''"24E!0411$XH(Q&5)U,TR=H9'9IH;DN]WDF3V#DAV+;O8*(:V-"BO7&3B?
M;@S8WRQUS(W=3E!P"=#K<.VD.FB@2F]2./0Z^,[5%+UR5/^&1W?3Y7CYHUFT
M?U:OMAGC],O3TJS>%R.8"@1940"&A;1)3A2P5&J@*.$8"4@0<5KO71(T-$JM
M==V$,C;:)K6Z[OV16M%MI\&8F'5,<*%P>;53<L$BN+M2Z^"]-5MR,7&W]Y+3
M]6$>VV^*V<)X]?F&U]7R\WCQCP]S95Q#\_ZIQ?*S6;8VL0VF*2'<\ .&J  P
M+W- $4> <2XX2D5*I5=E4'?10Z.-'<V32O6;Q"J?6.V3M?J)U3\PJ.0Q*VX^
M5C=8=TPW,6'V]I[\$8OJ*7F([]4K\H?ET ,*&"&PA9/62BPWR]QG]MT.76^Y
MK0Q_-O5RC/<UXKS,<,D%R&5J%IXI$X!@K@"G-F4I*XA"7DG>[J*'1FT;S==1
M':-[]8IY]GIRQ]Z-P+I!M&M_Z1R8MF"G>=^,=]\L$A^5$3F-V#[&'Z^X7:/<
MQ??;1\H;EJ/.4OXC!/>&T..E+=PZDI#!4N44Y)I@6[2S (2) G"A4895*3*$
M1DO;+L%Q.VXSM!?]; 1T]\9LN\QY]W98@U5R7)0:(J!5*@"D1 ,J4 D*@D0F
MI4Q1X;=W&096'RWYU+(AEF"P'/<K@R#HF%RWUB<_6=5^OK'_;)(3'NT2:39-
M;I?+^9BOEM5YPN4LL?OE-G]Q-IG8R]8^1]1&& =0Q6YZL1Z^[P87!V:=:&9Q
M>$5HU=1OJCYP_VP&>&?(]<ML/OY7Q:G-FH<(96[-). <Y0"6 @.N. $\$U2G
M,-/8KT?%99%#>_6W&B^2/][/7MAXZKG$=(#9C1SB@M<Q:7CA%E#EU!6*R!5.
M+XKMN;JI*PS'E4V=[PQMX,F7[]:)D"E3*3->%4$L!9"7!%"I() DS3%#6!:I
MURF5G;&'1A=U[EZCG&_/SBUB;H00B$/';[X;! %M.H^,C=RA<SM^S\TYCPP[
M[LMY?$E@/Y47ZZ_5[_F#_C">,K,XGGYY-ULL%Z.<I%F&< $HA^8]Q4(!5A0*
M0)$SEADO7V=>B4QMPH;XXB;WB\6J:NA1J9BP'?T]NZ6TP>SV<L<"K^.W?5=-
M6R_W!(X1VZ$X8!*W"4J;P'Y;GSB8?M3PQ.6>X)B)4$HN; G<)U:U@VK2TW\\
MZ-_8_!^J6@D^*=&DK(]XD1>"0 &HYAS 5#! <YJ#4MON3(BDE&6>T0(_#8;&
M.&L#ZC+5"V."?7_&&\<L66Q4]XXZ>,Z-<W"B.\0[IJE]L*WVU3GXM?X6^:T%
MR=-EY$/B%6'HQ0YK>&K1=_0C#*0309+ @<+X\%>SOK4AF8>IE?:@]SJ.;MJ-
MCD@J-$1, Y%K F"9E8"C@@ ABCR7-%6IR-8=:-QHT$VPTYNXWWRF8_:S.B?&
M99#CQ>O,D)]] T]W(/8C/\>)<&.\B.#V0W-6X29(:\%]7X$[7OMF:_6;1L5W
M%Q'V)CD_P*(RFZ/H7NG,#XY##O.\.XRXWK'%5_O_=KQO1DS5"V^QG(^%X0#[
MBZJ2R>X/=JX<Y3GFD"D"6)F9%:/.)&!0,Z!5H;*<Y6E&O?+(K])F: Z>5>\F
ML7\F.UK>)%L#ZE]:MCO\V<X-?OQWW7RZT6)OL]0Q6W8]0=[T&078J*QZG4:]
MDFT4\ XY.,Z@ 25;[J=Z96M*/?U8+-7+]KBP- YD2H'Q%C/C/Y(,T)*9?XJ2
M$421\2&=]N/.BQ@:B:Z53!HM/?,\6[!LY[HX"'6^R=85.!XU5ZX&J:=2*_Y@
M^558:<6AM;#*Z3O[JZ?2JOE>&97V*P-H[NF5S97Y_^5BM6!?U*C(E%!2%Z!4
MHK1;A0QP6&K :88@*246S+U<Z,'@0Z.V _4\WME#U!RH[ HL.B:Q>#!XD-85
M</1$5ZZP^)'4&;M;Z>GPGOZ(Z8RV>Y1T[AH_,JJZP,]_C'Y_&G$F,2]P!C"5
MV/A8W% 0PQA0+)'.89'E*G>AH.V00R.>WS_=/]^]3YZ>;Y_OGMS>MQU\VLDF
MS.J.*<;-8.<WZ=C&EF-RS<7UDJOY1[7:JEZPG:%Z>:V.55^_3"=^$QA1FKV\
M& ]A.1/_>&3SA[D]/:?DW]ADI1[5_.FK>5U'&D-1*IP#Q8D$4&8,4)A"@$F!
MLIP1J(77,1 'F4-["6N5DX75^28Q!)9\L^IZ1GL<L':,Z<1%L.O(30W>4PV>
M4=@\H4FM<E+I;,]Y))76$:,S[A#%C<$XR.TWTN(.Q%$\Q>/6..=LWX\7%;7M
MG.04&BM9<@J@PH9]<J$ SXD&ME233@LF2NEU<.&RR*&1SXD#GVNE8YZF/8&]
M&QO%1;1C,KH>S*O/S)['I].SLB?$OND9V?,P7#H;VW)G4$\4LR(9R_'4R+!Y
M<&PJUWO;2_9=+48XPS@C6H*2E1F A<KLOAD!O*2"<T@R2*A'5Y1V:4,CGT;?
M9*-PM<&RV?RO=/;J\'$!;(?H2$P(.V:;OM'SZI 2#\7>>J1<@:9OEQ0W="[T
M2;DP2)^=4MSL.>B5XGA3 .M^5M]FDV_&BUSQC^.7\7(QXEDN<VC+*VF$ $R1
M )1D'-!4Z!0J2I1;*.?T\$/CU;6"B=$PF50J>A#!,7H.O'D5)AT396PX/(CP
M*EAZ8CX?>/R([JSUK<QV?%=_5'96XSWN.G]5V$JU6OO:F7[0]?'JVZD\437T
MEB^J-C C0U9:T9P!QJ0-FB$(B&V022#*D4Y+)%.OP[B>\H=&=QOU;6KCR3JY
M?ZQ5]US&^DZ,VYJV0[B[WJ&+@;3W&C<0KZ@+7E\=>EW]!@)TN!0.'2;P *+M
M*KQH#C-NWJ T9YAI:ARU5.8 :DJ,HY9K4!8ZTTP75!#H=?+PE)2A$=B[WS]_
MOOOTG-P^/=T]/_V[YPG#DSBZ,='5Z'3,-[5^FS/$G;!+*P9QSQ">E-3OX<$V
M8X].#;9>'-C%<CP=+]5'0R;RWGBVTR_C=8/Q1=6"::1YJ;D0')10%<:W*7-
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M/CRM\U&BX9G+HG6WNYW*IZ^S^=(NS>\WS787HY1 CLL2@2+/B/&!,L-MBA6
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MW5:KY?XG+ETF[<<_^7=77?%VL]UN_K2OA.^X'4'[_PN#<D5+HP GLK 3DQ+
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MI> ;##WA\M-F^R??V@6,_.*(\H[O-5R46+"R(!08Z)*SU+X5,;NR !))+;A
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MURXD?)JZ7EP[>4?7+N_;VKEV?C96T>XB97^W?/AR$I:FD/$<L0(8(EWC+V,
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MN3C]Z6^+Y=^G7P/ OVW^T<O%E^_+Z<GG]4^""7'[;Y?_C-'$Q T'HXH$I;&
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M_>XD\\!*,1F<$AF4=P&"+06T1YXMU\IK=Y/JJH05:6$#L!6F/YXLOOY,GTM
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MIML@^WQO>*X<$5TH0F:T-TQA$)RPD D/6EA+LDL]@>D!$CK!R#Y7&/4A]R8
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M\S#-!8]1-6ZIRE$PUIM2&@!8'08_W?:"DL NG<M$ IPDK4MR14.2T5)(Y>C
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M2LUP3%(('T 901*-1H++.8#4EFF!M0>P4["YSS7TCK2.C]PC >GNQ?606FT
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M65L&* :.(J0P3)G3@R1U0]6/DM[O1S/ME(AT%]_$N2C)AF8HA;:/RLQ!,"&
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M]Q'<[<5'3R[&/8N_N+OVE35."8TM""A%!%6T 5>GM ETD>>B&.(PO5R[T3G
M==!]_G?@S'"!#%RLKSTQ4< )[<!FD[.HX[OU,&,+NM$W[N$_(+(ZW.0<JJXV
MPZ6NIN)3O90:U/"=KW!$\W<?3^,8P<Q*CL;7RY@8Z]U,AL"8A>H):NM,*0,5
M/!_7"'Y,GS&?U0&Q'S M3N;3_\+\)I.*IV6*^68A"I%Q-SV\T=C5]C.R%*><
MA%Q2?>^]#E"4TM?G>I*PG <;AWGKJV=&GI59W06K=VIZ1P1  Y'4A:2OB96\
MV]>U9O5:Z>H5>Y@Y$X9"4Q7KM!R5"P1/!UJ.PCJ-.6$:UAOH2.BX)4M'Q.^0
M"GS>_@') *<G<Y+"V6KK+*V7TWA&^^$5KL-T-JCK\/3B1_0J=I3$. X'8HE"
M&23\J]K53E; ZVP!M8K6H3,Z#'/3/9;#<<_.7?WR_=IWFY-EPCT:(1(%":60
M<9!"@U,L R_,,\UU0CM,I=VNE#XKEV$7M#WL,@R@PC9]@A??IJL)DF!T,0&*
MI%-C.]["4'R)FD>63 RHAKGR?H"@D;M]!D7!TZ?\SBII%%E;WQI?+4[#=#XQ
M*N7-,W!&1%8?A O@8\E0O%;:.6M\/)I_>9.T-LS;00#H *K]M3'V5.!;3L['
M[ZLUGFY:\J:X_#.>1EQ.DG>R)&D@YT+2LCJ!3\BAA.1S2 *+34]Y@%T7:P\O
M!^AV,:"@V[1+;R^[YYPO1ED*QP1+$E1B""YR74>&Z.BP>"O$L4S2)54C#ZX8
M^>S;3SD- .V1+J,_+1>KU20K2>&XS'5BDR7GE/:G9\Z#R<S:0CLU#S1=_RG*
MFC-G>V*@>]O7[@H9^PB\:KM(U]LN3C:,>)&#]#: 8^0D*"48^,(]8-%H>$K:
M<]OI['MLE3;2;KVAI%^IM@./&UTY&YQ__#3A5FO!BX4BL Y"]YYL-+F2Q6;!
ME6+61[,C0.Y;9]RNNZ$A<K!D6P;)VT\3%W@M%;/@17W?1GM9\R8*R!HF(8RS
MW/F#0?*V&T@&ZY [/DAVE.S8('FJJ_3?%[,<0_K[Q6W9]_K4H4HQ.C"RRJJ^
M\>X<)P=0N2Q9"H(9U0DW.R\];D?<,% :5OX-^,D[M"WSB0^92ZS=R!O>.-+.
M2=X ]T6I8NC_V6&FQ^Y"Y;C-<X/YSX,IZGG?/1[AAG&$>\26;@LM>=E)T_'(
MZR4.#]7OKF\,D#_N2V8^F6&3,HW>%H;BO=/90\G1@S*![+RU HI+TEK+@E/#
ME&W]V+>%.Z#MX-O"7538T%%]^V8BD),1C54UZ"$V1(FUJ*7.5U8FA4PAS\!U
MP\_[MG G%'2\+=Q%)8TBZ^8=AG>,\_I2M7 V@)(N0Z"C"%A&#%)'P?VPE?K/
M[+9P)P#L?%NXBS;&CF _GD[7GU=_QCQ-879^:56<4E&H# :5K[D\#1%9[8*F
M36=XG9S9+4:]Y\/;P\,!NEOT*,@V[<Q5<!0+ESP;!B8&79_00"##3-\F[C.W
MK##WW[=_QSW+]E-.FT![C\M4=7="TOSKHN8'+P>P74T;U(:CTQ:\UI&LMC,0
M@[>0+?/<Y>320!-O]Z.W.5.W)UXZ%%KWK+RQ#\4=DCEU'.8D2L=U+A92\<2;
MH\U-.UJ R>1-!(&8;S]ZMV=2]];"#=\R[H.PP67?INF[=][DN^7%N,G?SJHO
M\:YL7N8[_UL2;XG)RWI_5M\PM9%B\'JPF**CC+)(<FF/90KWH+_AN\^>3>/0
MRFT(TC=W['U7?)?7,'6&79W5/U]/,BK)$T<(O&S>"M1 >SA!SHK\\&05RJ.U
M.W0GN^%[V3X /+PJQS[B_SR=3T_/MB]$OU].$WX*RQ-<OUXL?PW+^;NS]7E!
MU,3G+)6@H\4H4U^+EA8BBPZP=J8)X6EWQDYG>]<5&[ZGW?M0'T3:8T/H VY=
MVXWM_O?M"[IDR2N/YS.CK^?0)P6%9T60HV)K 5WV @(*"9Z98@4K1=EN4W!W
M6[?A^]:]X32@Y)_W=>N-)-01[E[O7>^(%[%/\SO.K:Q+,:DB'"';BOI<-IDQ
M;NL+@9AX,L5Q.<P4S\9O9153EO:< VLDJP,U&41#/FY02I)_H,G,_W</YZ!H
M._A6=A<5-A2<W+X!LLZF(BO=&>E,<$A>J_8!BHA:F\)3NNW6_?>M[+XHZ'@K
MNXM*&D76S;NDR'5BEA>(!1,HYAWXNB^5BL7E6*SVP\S >::WLCL!8.=;V5VT
M,79H<=]EHO.<VYP3:,;(6Y:*Y&12 >2!E:!,T.Z'O97=27=/W<KN(L@&[,QK
MBIW7^';Z%?,;4LK\9$H&>#N/Z9?O?P[_L5B^G 427MU!S-060O($DK.YAL\4
M4;$HP0EEZM-$EG;7(!9G!R*?V9WM(2?=4*IK&Y57C/T63B]W<-'(ZWSA(K4"
M53OU@U9U *2OS1Y>V-O],L,C\SY"Q[6$@P&F.S /UEX#X'QYMEHO3G'Y 6?;
MW,'GZ9?5N?4WD<?@@P(NZH3OP&Q]Q(:#MXD[YA0Q- P0'R&J6= =#H;;SS;W
MI)FQ';17^!5GBR_UG:+T>;Z8+4Z^GW.A4O!>R@C*% K&$\_@B79(B?&"NA!'
MNI.;]N 2XQZ@QT!+CR)NP!I]6E(\<QJ6?Z]3[3??5/%<H)Z1@^%ET& 9<Z!R
M4A!K]V-$XZ2W66<]3%'3HV2->T%_3(O4GW8:@-KC[6W9%Y]3)JM:7YGDNH#W
MFH&.3F7-HQ.W^]I;J> <#&ACY[WV4TX#0'MR7(C2*B9A"U@NJW>*"*[4-UV"
M8(XVC2TX3%G'<Y[?L@L&=IW?LHM"&@#8#F6 UT91O]G6HN0)^0.:HJ (P6JL
M)529]JFE;S&*PDOB7 Z;>MV/[H8+.@\!YQ&5V1!T#ZP"])R1EV$-1.8"*)8T
M?64D).8D[57Z3SA:P\6/5>+9!Y2/J-PV(;UA9U/+-0G&%R?)/Y;,<G*2F::=
MF@,455QF2=IBAJUVN)>LADLT>P;@GJIH$U<W=]/MS?37,#NKD>#T9$Z[2(J(
MTM&98!6C7:0\TIF0%:1H3:;8C#SS85ZN.XSNABL\!S6-_2FS(>A>\VGN/IP2
M+O,6%WU0]SZ=4AM9Z"^JM+Z&677C)UP(GWEBP.SF[?9HZEVX!*F]B6B+Y_9H
M#FR/?#5<C=JS@SL6&'ZTK;'M+=C^)GT*DE#JTV"3P!1G%!8 #ZZ0!Y43>!,B
M9&'09*VYE\,6< W)7:=M8O^QMTD?P/C!-LN;^5?Z_<7R^T1S#($;#]+6H>9:
M)0C%"? 98TH^FS)0H>T@['3:#NX?>COLI_H?#/\W;,+[)7X)T_SKMR\X7R']
M_KOU9UQN_VX2@]%*%4GRB1F4H1#)%9X@%[0H$Q;)CC8V;7AV.^T?_P^]?X:!
MS@^VO]XO%U]PN?[^?A9(5%L?]<NF;T]SI47@2+#'4J_D)3@N(YBBHC;%H+>J
M^?WT('O=[HS8/_0&Z@<;8]?U[":1>P3R_5P<D\)2M@)U?4R&CF''%<5L@5C'
M:%,4QOMP*X#O/A-D/Y*ZH?CY7'V.J+ ?S*Y?%=FL)BB)6E8*!$RT6XEQ\ QC
M+8#ASB3&A3K:,_=],-0-]3_$G>K1]?^#;8-7YRQ\"M_.?;V BO$Z#%RF:A,$
MR<$Q+2!DKH(NJ435?I+I#EO=ML3SO9L='PL_V,;8A#]7@U[.!:(9SSQ[!8+3
MJ:E*)H%$4X 'PW.64DC6OL]_+VO=-LCSO3MN Q,_V"8YSR!<_XN4%F?S]>I]
M^+XI'B5IB)HA .YB(.$4!V[SR(0*&9-UTKIAIS0?A<UNF^?Y7F^WAY4??B--
MHBO&"63@G*LOLZ"$F(P#X;TC)2:K7?M^V%V^NFV5?_#K\,/0T&!":74A <SG
M/%YC[IJ<YFEQBN1_7I@$Z:-(BA400I-&E'00>?# .6<E!^>+NU5FUSVCM"=-
MW0#\?"ZJQU39[DCU6Z3.\22L:YM<B\;\RD.\]G<;WW&B<B@VR%2'OM5^SZC!
M6\' 6H9)*1XT&[9Z;UC^NNV-?^Q;ZY[0\6-NG6LIB.NGGR;6(^<:BF$>%!I%
M3F$6$#$G%M 6[6WSV^9^WKIMF7_LB^H>4/%C;I??<#TQ1F>.&U,A20HAD[J0
M"SIOF;(A1PQIV!;7GACIU@?VCWWAO*N^&XP$_K18Y-^GLQD=@Z\PGZ5UO8*9
M9"XI@C$6-',,E-$1HD$+43LN4 N61;=!P5U7[(:VYW\Q?+BXV\RT//S0K-11
M,\\14MFT ]6Y:8%+,-)D5Y^TBG'8%W-Z>Q%8_! WM/UHZ@>:4?U^N7B]6)Z&
M8\^JOKWN6#.K'^5_G-G549>8##-@2ZKUP]E ])Y##$X(X=$&>[2P?,#9U?<-
M_+C0Q@?\BO,SG'C!C,TD@)!3J*6>) KA S!O&:-]6NC/8_47WB:NC3D6 V"J
M0UOA08IJX S?>>R,5IS').E@4#7CS10=2/49-<UBCKS8:-DP<SV?Y]STWJ!R
MZ+#T7?36 "X?&LR<'98HK &FZL1<Y<@[MM(!+Y(5XA$U&_:-IN<]+'TG%'0<
MEKZ+2AI%ULT1SZ)X%8PJD.MX+56GN7FN B#76=M0#!^X..*9#4O?"0 [#TO?
M11MC)U;NF_'M15&JCNQ#)Y"V'.T[[^JC9((;IPQGRH2G HOG.BQ])]T]-2Q]
M%T$V8&=^6\R76*^4IO.3%_D_SE;KVH*RV3#&V11,(K.+6M2^R'H7&PM(H8V.
M!IT<Z#6&AVEZ9J/0#SG'>E),LQ [WWNJH$'I'01A%*@4ZRMCUH))*8L2T @^
MS 7$8U2-:[#ZTGPG0.VAA@8@=6VG;09C8WZY6*TO9M"ZS*.*4H!7F0QO=IF"
M9RM RL@HAA'&^F&\[T?):A%4^VA_,90J&L#5XZGM$&/T14*23-5&'T9N@J$_
M(G<VHJ4].&RCUP\P#KCGR&X_Y30 M//DRFH25<I61@5<UTE%ALRZ]\6##RHR
M'FVAP&004%U0T)QSOJ=.%ST(N %@O%\NRG3]M@X@#DH:J46=XAHM*(\*0H@)
M+!IM7 GTYS"NT14-+8_7/0 <>PJY 7C<(Y)ZW+XK%Y4?O\[7T_7WS4UI2!=_
MO9IX;5-*2H(-DJ1EE(=0,[D8A TIN*#"T2:.=B&XY6&X!P#O&.IK$Z67UPJ_
MX7I;];W9?H@LH$\>4&R&K!<#,:8,W$87DD7![=&2F/>3V(8)'/G:<'^EC9WK
MO.#@6B!]NEBNI_^UD>7$J!HR$P/T/V+%!TX'@=40O'$RRTPLW1IK]4#:\_%U
MVC!G X*H;UFW!YO7)+EYPJT]MMP)QU4"X3*%,=QQ<)%%8"Z0[%)1476;5?/X
M.FU,Y#X^;/:6=7NPN1HSR% X:X0'I^JCXY+7YP?I#^D]A2<*DT>Y)V9VF_LX
M>"?Q\0&SGY3;0\MY!NU]6*Z_OUV0$S@1F#/9S0A<\DA&4]<FSL3!*A&<85YD
MON\!=6>Q-F9-'Q\]ATF]S>+2#TAR.DOKLYKP_4@B6^/)-%T++,*\3C'"DVUI
M[6^+->Y53+K7.CT4CQ[.7T_%HC<((<">@^D%$?%UVWUQ@5B%(1;K'+ 4<C5-
M&KQ0FK#+?6&,7*&!GECJ3.+A6<TG%GHU7:798G6VQ$\D_E_HW_Y]H@HWF44.
M6F:[G1'J>5:0K<Y)*E/L[?<_CR66>Z@=-ULZ#-;NIDX'UN(/83$_;>?.#V\R
M/UT;<']4FWD?AT<WFAQC,$9D*'DS"S5*BA>])T@7K[QE1HF1K$-?1O/J#NV!
M)3=AT-5.LQJ-"2E#S(YV6N %7)$,?,Y<%26,,\.T*.U(Z',QE;L@[.'ZYOYU
M]T-8R1N_?D#/4A_+'M^"/LW]T>UI\(5S23Y!U@1TA8K7I\ CI,*D3290B#S,
MI>+@]G03W-U8976AH/4-!4VO%#1Q5AKIC8)@G +%%=]>!!I'.Q$E9IZ[)?)V
M7/BY&,==X'(CRAY2$0W<<-U@;YNG-%)X25R 1U6?8ZL)B>AI*Q27<O$YE('>
MUKM+R[AW5L.BJR<-_!"GZ^5(]N.=K'>6//ZI^CC71S]1"7#,1I^!,TD!MJLO
MTXJ"$)+.KAADR@U3;=I:A+(=PQD,CT%F<*$.&#'<D8<K%%A9$HDCQV*';KQ\
MDLCG<OCN@JP](Y.===;BV;MA:H7+K[@MDM>R2%,B:%5342Q30%<+367A5J;L
MM1^H;NX)PEIIPNP9$$^=RP=HIP&P?:+?NR6R\Z+Y3%N1,66 R^JQ4EP/GE4/
M1G$6O"#NY#!YF =):LBN':KXQ1!:: !.OY)+MOB.^!&_XK+6.)SW29ADA$$O
M@'OT-0E5IU>; IBU,YQ<UUCD(&!Z@*!QH=23NA?]R[X!"+T.:>/]OIPM5B28
M<R8X$8HJ4R@5JJ\0F"<W(2)P72^RI0L<AWF?\5YRQ@U AX'/X7)O #R/&.FW
MEQ7.,;I,(:('1UL#E/860BD, M<\69$%OUUS,KP#]7:GAJ<CM "/YD7MIZ?6
ML'?.S$2(Z)5.EJ2R:<\) :+*H5;U" I^+%?V"/=[Y]0TZT#MJ?/'0+6/ O8&
MT1=<3A?YXSHLUP.8L<]A>8*K2;$&'3,"G%2U,2,Q<.CI'/<BA&2EE,H?P6QM
MJ6DH!3LXE/910 /VZ'WX7JO_5J\7RQOL3 JS.KFJZA!\;5I6->_"@3:#L9$5
MEL4P&;V'*!JW?6!P,/6BB 8 =9]]W62Q9UM=71:<3@PS6F?:&B40"A2G[>)Y
MUI"]M39ZS6PXPEW18R2.VWHPRE%XN*H:Q>!$% IP<ZZ/K\?Z$F,JX(1"<"Z*
MB#+2&7\$AWX7)VNP'H61G*P=%'"@D_7K/#?WTL -F5Q_A"$5#,EK!]S5;@T,
M B*S"8PQM+U0!&6';4L>DKMQVRD&!WIS &GS2O_I^^P#+N^[?W@/U_1[<G+\
M$K=2M+,N0?'5XD:1($HG@*E<"#7%*W:$.'"P$K>GU3!AG!=-X1:8G&O[4@FU
M^I]VC=#)&)X4NWTU]= PQR?7:BAETALH;LYX[%?<;1JI\VDY!W2!7?OWO50$
M/41/;]9DL\!K0M3+Q7P#D;]-UY]?DM>_.,7E)6R8]Q)9#&!5K5#C=7"0H3^B
MSG7@GN&HAREGZ4A@3W.H'EKFJG)=$IE>A0(I6 K%F2G@<ZV2)Q<" Q.2XJ Q
M!-%,NT'_>'I@I%6_NFK:'AW28W7] _JS2(/V1'6#D/6N2$>.<'*8M@]=1Q[-
MYO;:(U<JNJ%R1T<Q2:^FJW!RLJPOYY&.ZD7;E>2O,(Y1.YD-G>>2!*"TBW2>
M"T?GN6:LD#Q8&*9@HA-YS\,8[8*DV\:H?RTUD#R[5UJ; 0170>OW6RQFZ2S+
M/H)E-4<=*%:-K @@GY(DFG41 PV;W8/8L2^EAH?ET!IL^K@\J O@QB?T=V .
MFQ+H!J@L*+CSWM3W'BPHZ; V7$; 7&2D",TQ-8KO>HP3<Q+0!KUI:BW*UOL+
M"XZ118Z)^8":.7M[5-41#LKG<3[N@IM=SL>==#+BL;A:KNNTG/KPY[OE1UQ^
MG:9M*6^T!CTK$J++ 13R $Y(#2@BG?,B<)9C%TS1 M?P1-_=QM)#%(R+G_YT
MN^A1T&T 944'[3D'J_.B2YY]9G2H0S+U25!C&+C@ZY 00X=Y<9;G3N^O[X*6
MNV2, YE^-'L7)@>*>>S)9V_FY6Q%HO_X?57OH<YK:2V&%*Q"R(;SR@%)1X@,
MR;I8BC66ZVYIZWL_?G0 '*JS1:\"'!L"O_[GV?1+K;!8;JWG.0N1.QVYY2"T
MHWTAL9;/;MZ:+B$79$)%TPD#]W_^.!'00"#H081CH^#CHJQ_)]G=Y$!F%#YR
M!%>, *5J#;6)Q)!/*1B%*MQ^>>JA^ZO[/GZ<:KJ!,'"X !O(NSS@4+V]FKFN
MR>%V@3 < D&:\ V^QNDNDFE+QDOECYKM>]M&-T+OCN@@"FD 8.?T?\"ZV:;S
MD_>X+'4&Z#SANSB;;MF<Z)0URZ[>WOIZ1UP;-@3MQ)2<-2$PQLU0A0,=R&LR
MYMD3$???;/6HGK;S=%>RK*5/FY_%[W_"Q<DR?/E\V#"/71;H,<NW!T='3@)Z
MLH I)@Z8;:SO<K*:54Z@<ZTO(P25'S@)2-O/24[A)9>*W(MDZ@-O:(&7@*ZH
MPE$.4\;P_). N^!FIR3@+CH9.;?SD=2"-="XV-'UO=M-&D-X4:(/#$JM-U#.
MUE(&9.1R1DG&FEC 3D,0.N5V'B2CR:-Q#RTO^A;YV+C!D]LL7+PXJ3R37$A0
MP=9&;%' >Y]J([9DV1IDL5/;9S?</$3&>"FAGM2[Z%O6#?CJO_[YUQ?G8:PH
M%/:ZS"!O*'>9D^]7$&+6-G.;*809ICW@BH81(=*/0F\/P=A/NF/GB=ZM/V]B
M IR>S-/BC,[K*5YD/8-0I2#7$'*B'4/,DR0B X^IR**T8B(]Y3@_M<AX><-^
M8="K,,<&Q>LM"^>4*^\5)JD@"<5!^=I>E72B&-%%B5BRS[P3#&Y\['C)P@$4
MO[_ 1E3U%J'?)W_Y. DN&<:$@>2B(W *\L4+*F Z(JFQSEIY+(9;8?KCR>+K
MS^>?N#T.SK_9G 0;#%RM-TX/;/^ZWU."#?@"3V:=M+7!,X:0/!>@;,K@2A3@
M8T+N)?<I#-/9^HP3P_N$)(,HI & 77LF6A?4N3Y';G-]O\1 \&0,I2X"3<A%
ML$XE+?NFA]J,8??4Z\-O<7<7\C/,X)Y?[U6A#97#O6>)H;.X3W%UY#QN41@C
M5QHH?*&H&&V :$($GHK.4C+I[3!7@2WD<;%HXB]*X$)7YK%ZYR6#9"&;$KUV
M:IC1ML\_C[L+;G;*X^ZBDS9J]&Y6H@6)VEEKP!AK0>7D(*3LP&5&GF&6.MM.
MMYX_8C'G3KI]JIAS%T&W 91["E6<,,7%;$$K.OT53QR<]!R"LV@M!BYNOV+[
M#U#,N9-F.Q5S[B+FL=,P%[6(9'Y79Z>;!LGS# .*S(-D))=-34 *U=_C$M!(
M4Q]8]=[:I]RAQY<8'0B'ZNZ^HL[#!-D*'&Z5IBKAE> &O,R)7']+06=F$J*W
MI>@H1&%A)RCL7MM[Y++.@V&POP!'A\!?/RYF9U7\%]37^P1+L1]%?JY.\N,%
MO+,,+$.GM"I)IHZEW;<_NL5JSOU5?Y#@QE;[R^5T75.5+TET%X8K%H*KJJA-
M$I1U%/O3@0A,JQ11<J:3[J3WNY\]7G9V ,4?*+JQ-7_/R?7QE*(P0G&N;%U4
MIF?)$[$#.BBR85$B^% L_<&9<BKR'/*^_L ]ZXTS:?!XSL&A(AX;-7\-JW0V
M"\L7B>2SNNQ>\,8:QR#[A* $A>@QB +69.NX4-'=[J=_ "/W??HX(_D&0L3!
MXAM=_]/U#8NG361,6ZS]2J$.S \401$7*2#C5BM#/E WU=_\X$Y:M\]%ZP<(
MK8$+ER<O&CCC(6>7P#BMR8#Y J$R)83-9,&<\/%6"OV_;_3V25,-HI & '9Y
MV62T=II9#9S7UT"UK*]N9P6""]ICNI@4!QW=UF9><T^]/G2CMXN0F[[1N[@[
MN#9\]O [O$<^M+];NZZ4'_F>KLZ>4QP=8"@$+ZQ#AGD=LF,+ 8R<4ZW8<[RG
MVX9KYQ\<ZFBA,,^SB]%",<QJU]+Y"T!!FVQLU"!R"74PJ .?Z"OGN?-"H+.\
M6_ZSVWK/XR)N%V#<C)'[%WH;URPW+Q,T\R&PG" R[4 E46=R*UX?Y/%D;=%Q
MJ[ILG&=V'S>8BI^ZEMM%WFW@Y;YP(H;BLC&0%*.P+V*$D*PA;1=65 GH72=K
M^T-=R^VDV6[7<CN(>>SH^J'I$$I$KIP'DW@=R5@$!*QNFRN)QQ0#NB?=FT,'
M;!S[0FX7K749L+&#",=&P?WS(8+W)4H5@4<*$Q5]!U$$ =QB$"+D:#JFY?<?
ML''LV[A],7"X ,>&P)\67W$YW]23+\-\_>$F(S:A1Y>K7.@H)>^+CE*"-I.I
M]IYY&3NZJ(^MTN0=W;Z Z$V<8^-BTP;TZGSAFVQH(W,V0D!6M41<>@LNE7JI
M$$7!*#FWW:YK'UZCR>N[?3'1DR@;2)]=O.JS>:YG-=WHH_I22L7Z@(8A'QOK
M;:0J)!JG@#F=M1$Q:1SVI:9;!(USQ@P=I/2IA4;!M'T&"B]VG))H4!LH149B
MB!L(7"((BSI9B<'C,--IGR1MW&1*+P#H *K]M3'VZ77?Y;>5SDME$5 &<LQ+
MHBT72[W\=/\_>V^VY-:1I T^D?\3^W))4F(U9RA1)JJJI^<&%HL'B:XDP 8R
M*;&>?CR0^X),'. $3H#59FUJ427A>+A_X5OX@H4[F;QDN[FU>Q83'!4/!\AN
M.2(CIP;"'_,O=?G3YG9$JS$1V5D&2SR("IR.#**26057=-"[U0[<_N8TKFMK
M.W,(X_J0]Q7JM0B:2%=@B_8$5$FH+W7N810I$UB9RVJ Q*=4_0?)Y+%<]V#0
MU)+]^'FY.O\#5U]N2EX-.<?.@G%2$^UDR'WR NB?2B=M3OAP;>TV=7[_AR>7
M[SZR68[$J*F%_'ZY^'2'].A25#QEX#P1#R1S$'U2$+*)Q6#@.NTVO./^[TX8
M'HPCX@/8-+6$7[1;[V]J$ QG/G)"JN:<@!OJ])F4%:"5,4HO.<;=\@R[?W.:
MO,-1#'HCQG<02/ZR_+:9EO5N\2#)\OOR[.SM<O5G6.59EHE)1;:R%#J.LO5Z
M,*0KD^BJD1%5CK6I.-B%NIX?5?>$Q;*QC#K W5.%##=KI&8897(F,, 08ET<
MI:MRUY!B"<DJGK78:8C=**N_;LCJ.3,V#M+&D\IPB/E+B"TNAR3\AJOY,G\\
M#ZOS4?#V;I%6&-;X$U[^_T=W:>;1\,2#I[B^3O6V(H'?U'MZNDL:I3%QIV4J
M@S'W(FD]1\KCX&Y<Z1R*O3_&J\F^?XI7.6\23.N9-]G1W2F@3?5>M;$0$J,_
M"B6R"=XZV6BZTA:*>G;>QL'8*++H!UK/JVI+]MY;BF6L+XS.E!&\]77QH^.Y
M."TR;^.Q'6Y 1V\;Z\> #I'*. ;TYT4>L_;_A3T"AL=HA2G@BN>@D"GP%(D#
MJB!SED:8M@N41UCS,'J+VC'1-[Z4^NPL>%]]A/6OR_/]5IC?_<]'Z!;82LU(
M?0&7OW\[-E\GC"DE2,S5D2B10V1UJK7!K#AREQ]6F(UTR>[3<:A&>8]T%_##
M5UP1PQ>?+G_\=G5PBL@Y(U6IE52@4IV*EWC=XE=XT$KP;-NHDN?IFO:M\@ D
M/%05([*_9QVQR?L=H"2N_OO1M,13]+11$\)%GJP.((Q.9$>\H5C)!)!,*4OV
MA9-I.0DU0;_V9KD^?[!:O& NB6,&[<F+4EJI^H[.B*BBD;SWP+&A%GQ,4%>*
M88CL'RN&PQG>0WXQK#^_/5O^^?'B*UWVFCT-9S_-U^ELN;Y8W=5TRA=?W_@J
M<S(H64R=U4]^$2-O77-=T+0Q-+M2.&UW](C(:B*2J9_D7E6/?DTN_9TFT3NJ
M_O90Y+G+8"0=JN9-%:?SA#K^O^2,T2<B+.[VY+[K%Z?)&HZ(FW;\[4 _/>5_
MW20*?@GG%ROZ_P]5L)6$_3IHU=:ZE5I%%I'<LTB.GM39)Q]:V;S!Q$Z33VQB
M#]L*JFOOF4YT0*_^XQ\9SX_>1ED;9YH%@UPG#J16-DU)"IS,$@)&BK)B,B:V
M&8W=(N9^?_G2LDZK^=?*_<O:B**<XM8(\)S5W0790:1H$J)G*C'CBWG8F#*J
M<GF2J*Z<ZB$8>%J)',[XB;ND?P^+3Y<-P,I'35HU K&D;E!+%@)C%A+W,9(&
MT,;NM-1AIZ[HF\].C8>1A+@\E*,]P."J?(X[$\B]LG4@6J"_1$MA(=V/0B9.
M<R2CZW>:!;0[$*;NAMY39 ^%O@?_)A;[+^&O^9>+Z[K)S>YI091:YRKBG0./
M#$$ZRTHD;]OMUK:VD^#O?7IBT>\CN.487.PF:GFH F\?KP(7= 86(:9J(WDB
M#:BY B\55RR9$E*;9^<7")LZAS*NX6@AC:GS*!\VM)\O+_WW^>([AM5ZYCGW
M*%2&3)%:+<[VX# P,-((U,EH)W=K.WKRYWMT)_:4WG)45G:C:>Z'W;5J_T.Y
M?DN?E:Q2\$Y"=M[5BM<"@7M6VS;1*1NRCRV5S7.T]:AO#D-6([GTG/TX./,Q
M>M;CB!D/(X1644D0N1:)6$YV*<0 *&U&)Z/VOE4Z8,R,QWV@UF>MF1!9NR@U
M65R?*(ZW"3Q!%DPH,NM<IWNW41N/:9G: .TM\8=:X4 V=V!OWLX7M4SJ_67U
M,?TNKL]__NLK+M8XPQ0EW6P$PR3I2PP4YP5/3KI0COM"NHVUR?X]0]34%F8T
MZ(S%^,XP]/O\T^?S#^7O:]R\8+WZLER=S_]U68 79*Q[A>J B2!!&5G "Z<A
M^)09MUP9L=,<RH/P] R!7;T<CH6ML032 <YNFI1OM:V1KDY&R\"=)9^+LPS.
M>0VH92HY2<9]&T@]IJ6KE[]#T',@FSL RBWA7I?:!N@@1/J+RJ(Z_X&HMTI[
MXY5 T2I6&@*+T6O_&\!B/Z;V'.A<%^;<>'&OTOG\VU6I10WW#HZ$=O[":*'2
M?F=J%$LI:74(#H03M8HI6\*)M\ (@8J\8_9H.=,)Q%*_A>^UA&L]TZ$8%J*
M(#*=3FQ6=(H,5D576!9T+]H4FCY-3U\QU0#)/Q]3[<7N#DS04^[]U5D^+&X[
MHWSVGAL9ZG;77%>R<0A8R U+F0ZFO/;8WB7>3E]?T=8!H&H@C@Y ]L"W_Q!)
MM2\POUO\_%?Z7-_LWBY76RJX9BHGDYE4D+T3H)PA(^ZD ,8\ZFASMJF-^CJ
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M<^=%TKKRYQM :D\A](NJ&7&AY. <L,VT>)'JZ[:(@.B2+]P9Q\PQL=25Q]T
M08,8WAUN_A.KH<;\ZAO]TT^W\UENJJ?XC!>70XD.N*)#*A15V[H, 5V==,M1
M-BIF&TII5^\XXR%M9!'U#L':=[V\6)S_'L[Q-UREJIISD&@CW2D?A ;E R=F
ML@C<.J:9T0(;+:(92NDT@YR.#<%#1=0!!)^IOY@QZTJ(P0!SF8["?.6;EW6%
MI/0YTSESFW&;SQ"U$[#L"0!K+,9WAJ%',4KB(1N>"SAF/7F3PD-(20"7N<Y
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MNDU+_ N$3=L5>$R$C2FA#@!7]S8OOWS%<WSU:87WI@TR5U3,*8$7SH.214/
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METQY2=?-YEH$R[-TT@=FVH0>N]'7;6'#6" <74@=0H_4^N,S1<NLQ!(@26=
MF5#JKO8"!GTH+EB=8YMUOKM0UVVA0QO8'2R@DVO0/7#N]HZ_W'A.9.,IW,.:
M(T.=SQYUS8Y803HJ4E3 >08,4>089=&ES0OO49MO[T9#CZ? S30*;]%JT GK
MXKX4(<J<H7##@P[$!-M&J3U/URDUV0[!T:-M3N-)Y^0TFOXO#*N[#&BCWK9^
MIJVNV^UTDR@^$Z6R0GH00FQ*G".$9.KJDV1=T"5E\0,HON>218^G ?Z.M6:
MU$I],5JG<%;%-Y,V&!^D M0RUM"^+L4EKS9RE<AU<<*8-IP:@?A34J%#$#DD
M*=A"SAV$*\.._"LIF3_^Q+-O^,MR<?Z9K(IRWFE6MP#' $II#B[^_^5]6Y,3
M2;+F^_X7MXW[Y67-@&YFVXQN6."<L7V2Q<4#=*:0&$G5W>RO7P^5ZJZJRI0R
ME"G.F U6-)#AER\\W"/\HBJW3AG&)=.IT>2IH^@^IZYLIP/T4=H].RS7W?KY
MK^7,!&^"51IJ10Y)E5N(&3VX8L@E0%%HWTX PCMRSZFOV^F0>X@NSQ.PA$"<
M%6M3,ED!RZ: 8M'6,7,2A&=%NY"=+6U:#QY(\#EU@#LQ:'OK\RQA^W9YN9H5
MEV.6-H%6H>;T9T^;L][<&<E=82A'Z'_T#+WC/@%-&;2]M7F>F*6_.V-8@J^W
M)N@Y'2A*UGM@F4#FQ$M27DK3IHSZ,'K'?3&:-&;[:O/L,/NJT,HWK&8M'1JT
MX&/M>&N*)B<H2 B%1:%\886=/,GM):+'?7B:*GH/U^NT(;P=ZZZ=,5@R,.D-
M*,Y\'5SIP#"5A,DEBMRF1^< 24CNIP9B7^U,\\G@54JK2R)D'N+\8KZ9X^&3
M0)_ZU !7_YVH'.AZ__%:5WVJZW396O>_^\TUNK+0WD4>0>3:1D ' 2XI!=9$
M="5)+44;G[T?G4>_;%YUC5]_"#]J(0>M\7C]?4,DC>=!($5J'I&#*O6^(44)
M20BN2C398#/Q'$+PN!?Y#;'WZ#'T! H]%Y-W^##0)[_5Q.@U'/W9$WFD9IV=
M)+R16U7?<!R$*.M ;)$B3X%QUJ;[S&FMWFUEVQ/*N#-SLD26-,G!&A%!)9\A
M&/(RBO4B!FX%*ZUG@;Y$XUG9MCX(>[J;^J!J.Q=S=D1JQ],?:V+06J9I],0;
M"[;X.G=)$AQ *<<@,JW .,:ESIQ'UB;[X#06K:KZ>JE/X2*L:!U:X#4NL,PW
MZUGA2;$<,F 6Y$H$IBB2L1Z09! -ZIK>_A)X7ECCK,Q/'SA<FY\A93R!FXD=
M)Z^7B\OUC;1FKJ;86=2@LY>[MI\\(PBEI.%1:!1M\AGVDC-NFL(),#6<,B:
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MT$6@DVU&E3U/5S>L_0QWW /J9P)H>YJ1F$E&A14(HC:B8L)#S1\$K966-IK
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MULTD_41I*L/H:.R+H<_S;T3[UGDDF01!3B*P4/.[<HH0G/7 38DN),M,Q_J
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M0$;^@)*QS;#S<^NATDO;G7JH]!']!/"SK\V#M,$(*Q68G.N5FW+@(I. Q?)
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MKECF$3NV;NV_^)A]_EK#:W#A3PQ<GY?$RSX.[V^?4%0N]9'1"9E!9<_!19V
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M!-!/"HKV>1R[/ZB_Q+#&__4__C]02P,$%     @ YHFI5-K9S%=4"   ?"H
M !,   !I8W5I+65X,S$Q,S,Q,C(N:'1MY5I=<QHY%GW?7Z$AM9FXBH^F 6-C
MQU4.)A6V$GO6(9.9IRW14H/*ZE:/I 8SOW[OE9HO QZ\.Y40VP^8;EU)1]*Y
M]QX)G?]T==,=_/Y+CXQM(LDO7]Y]['=)J5*K?6UT:[6KP17Y,/CTD32K09T,
M-$V-L$*E5-9JO>L2*8VMS3JUVG0ZK4X;5:5'M<%M#9MJUJ12AE>99:6+<WP#
MGYRRBW^<_U2ID"L5Y0E/+8DTIY8SDAN1CLA7QLT=J50*JZ[*9EJ,QI:$01B2
MKTK?B0GUY598R2_F[9S7_/-YS75R/E1L=G'.Q(0(]K8DFB?U88N&C780Q4T^
M#$[B%HV/F_7F\9#&X3'[3QU UL#<US%V)OG;4B+2RIAC_YUF6&VW,GLV%<R.
M._4@^&?)F5Z<QRJUT)^&^OZK;V:C,<OO;85*,4H[;D@E7W5>'"FI=.=5X/[.
ML*02TT3(6>?G@4BX(==\2FY50M.?RP:6H6*X%K$W-.)/#I@ GGN<>LAM:$>*
ME,^'4 \1=.]^+(;"OGY5/P[.&O5J?1WV]P3<W K8(]U ^7UFK]N['?3?][N7
M@_[--;EY3[H?^KWWI/=;K_MET/^U!Z^@M'<+CG3[^<OE]8 ,;LCG7A?-BRD/
M0JPW^- CGR]OWUU>]SY7;G[[V/N=7'8'6!(&0?C-1WM04[\=3+],?A43?D?^
M145:)A'75L0S8L<4R-PZV05SBVNN<#RCC$'<J4@>PY*' ,2Q7J0,8DJGTCC.
MOA?MZ]4YZ&_?^]G:M(0GU19.0Y^,Z803S2>"3R%BV[$PY(^<:LNUG,'[3&E+
M5$K>*YUXZM2#RK^)BDF_^X5\XDQ$5)9]23^-JK!LIYO+MG5I<"'6EJ89>% _
M]!J'![?&[ZB!E84U3&;D+E53R=F(E_U2%PO,%$!(%61NZ %<D=!T1O+4ZIS#
M"""7N[0.BTY) D]:4$EB&L$K350B++'*VVT8I#SBQE ]0Y.$WG'H=Z5- ^\8
M@($NI=,$T <:1$*#!@"S%*H#$L8UF8Y%-"8FQX]E_2G7O&@$!Y ((T$LH.Z8
M"CN& 9J,1PX@MIL!-,5@F!.HQLAPMCH-+YZ[C1^'NYS$(@5V(-&6;"@#<<$<
MBO5*N4ACB%X4-2Y\CV3.H$U@W,K2EX&M B->!H1!KJ,/2+DD<\$C\Z!K\!?F
MQ',9+7()!L!@!31SW1F')Z)F3&*IIF9.;\U'PEA0WI90?.EQ \KR"DO-',P&
MVA=/U.;!$76PMJJO7YV$]?:9*:A8Z!H,2BJ.!3RZ]>X3JKEC%C!%#"5'!A .
M=!Y*8<9HCF8)!&0,ROC,A(FD,CG4PU"ME?04R[2*.(/7AKP!1C$.%/6TZ=U'
M8YJ..+F$*'B;2VZ*--Z@E7KK#3_RC]A(O<7\JR/7)O3*=>I)CCT1#)HKW/=<
M1%1/ZS+>[#*&+G'L#WT#+%"?;->"+XCO].B ^!XV<1ZNN(%=)"RX2\A_S<LR
M:H6(YF;_*IBTAQR85?3D98#*-30 (7(BC N\8,53UP[N&Y8A>S7L:RZIHVJA
M Y8D*Q<I 0L%A&_ 8I04S!U@F'QH!!-4"QR \&K%):(46\H-*@CGX\;)#1>F
ME>$ R$):P$H9:&D1Y9)B=H%A.1!+)0(UO*Y9E6/P;<C1$!( U.?L"0&_'IP\
M1P\8'HX'M*O'[4T/V#M:;CC"_G%V;W\ 'YH(AC2G1J444PLUX"(HIY'[5+,Y
M#\$S!!T**>P,U<FV;M$K'64=&[U#K9FNR'&7P>Z+ 66YSL ;C%-34:0T<P"<
M,!_Q%$22!*> $IZAMZ$);#H\\<$K1>92Q][4WR#LLV!^=#C,G\?^WH3*W 5(
MI 6/8U#&8@(+:K8HW(46VB/@^\?MHM<1'2I"L#9>6@]5;G<CV"<ET84UQWU#
M_-=[1#*<[TB<[W(_$X#'\10[V)]B/S@QV>$0<Q&2_9IO<@?/,PI1ZDJV$O0)
M@1B%AHJB7"-#5K+ZEE8392R\CW!7&0,^:*@X8"-O=E2)@>H0(A]8%\!A-\G=
M40R>TJ3Y M>11S6F9B&!,+@ZU^#,91TW'T5&F!$I[K@LSF4>V)?_[REZ>>[0
M>B9[4G<@S.:.5%X&/(R_JV1>QCZDXQ/TSX8&7T"CH,.MTF8A.=P+:#))A+6<
M/Y)=A@I$#98S ?A<(V^ \A#,#28+^(^[@;F?\C]R ?"=3^9IY,YJCIZPS7P&
M?#W />6E!"T)VE8 'W'_CV<*D>! H$(;+/9V4T[O,-E[;>G2O5/%[D!Z?OKV
M)%H6VS!_(K,E1E(&%0U?A,B=%"ZT-%0!'H+D+7O%84!NF#Q)8"_Y)W>#*5+3
MUG/*EQ<^#W"#=PFB(=80@LI #NZB)M#+_<I0\+#L<ZY()TI..";>E(Z*'TMT
M$6AYDDDUXU Z'2L?7>D:RX&5?XLJJ3Z)*];M"@N#(?"4ZPK,MJ29X9WYES/(
M YFDLXY(W9RY2F? X9%(*T-EK4HZ>(-B@LD$M$IQM<!QRA<7ERM.3ZOMH(WW
M*RRPT[)YQ\75BZJ[>E&S;+.L66T?MW:6!M7ZSK)'6VU60X_G[VVV76V')WLU
M6W,3X2<#IMMD-'U;:I0>+%DGS.Y)?>ZF*Q<W-J9<9=_><=V-F2OPA?7,60S]
M::-";A[.H#[1&3DMNQM*SVE8KU\U(:2XSY6+%VLCW).7 0ZT=.BSLN>DK-V(
MV3V@(DH"4&R9N&-B,H=W */=CP/=L> QZ=WS*,<C$W+CU?\F"6HNVC]^B0PW
M EQ_CW1RTFK\+^GD]*1Z&NPNWA*AYP;%)#9\]GR,(,5(PIT<67.>Q^?ZP57%
M3/F[FAW_@\:$;UQ>7&)Q(()E%3H$-+G=767;NNZ0E&N?_EZFNR%Z\5]02P,$
M%     @ YHFI5'2;;1-M"   GBT  !,   !I8W5I+65X,S$R,S,Q,C(N:'1M
M[5IO<QHW$W__? J5S)/&,W#\MS%V/(,QGC"3V*U#)NVKCCCM@<:ZTU72@>FG
M[THZ_AE(<)L^YFF<R6#NM%JMI-_N_E;H_(>KV^[@UY]Z9&QB07[Z=/F^WR6%
M4KG\N=XMEZ\&5^3=X,-[T@@J53)0--'<<)E042[W;@JD,#8F;9?+T^DTF-8#
MJ4;EP5W9JFJ4A90: F98X>+<OL%/H.SB/^<_E$KD2H99#(DAH0)J@)%,\V1$
M/C/0]Z14RJ6Z,ITI/AH;4JO4:N2S5/=\0GV[X4; Q5S/>=D_GY?=(.=#R687
MYXQ/"&=O"SQLG-"3$/\#&S:JE ZKS1#"4V#U%K1:U?"W*AI91G'?1YN9@+>%
MF">E,=CQVXU:<-),S=F4,S-N5RN5_Q:<Z,5Y)!.#XRGL[[]Z-1O*##R8$A5\
ME+3=E J^Z[PYE$*J]JN*^W=F6TH1C;F8M7\<\!@TN8$IN9,Q37XL:MR&D@;%
M(R^H^1^ -J%Y[G'J33Y!/8(G,)]"M6:-[CV,^9";UZ^JQY6S>C6HK9O]G 8W
MMAKL+=VP\GE6K]N[&_2O^]W.H'][0VZO2?==OW=-KOLWG9MNO_,>7V%K[PX=
MZ>[CI\[-@ QNR<=>UXKG2UZIV7Z#=SWRL7-WV;GI?2S=_O*^]ROI= >VI5:I
M;.[)=[7TVXWI%\FEXC0A'P)R*9,$A"B2$)3AT8R8,45(-UN'8NR.E9N;D5+&
M,-R5!$2F?5Q'E<[9>,(PE+5+Z)88:Y[)WZK!W.QO.GI]C\'/UM:EUK!KL+Z2
MSP(\,J83( HF'*:8J<R8:_)[1I4!)6;X/I7*$)F0:ZEB;VZU4OJ9R(CTNY_(
M!V \I*+H6_I)&"!03[\--K;DG?\3E-7^&93M-?HVF%U2C5N+FQC/R'TBIP+8
M"(I^K_,=9A(-2"12%M1/>4)H,B-98E0&:#^2&,=G<-<IB?$)8Y4@$0WQE2(R
MYH88Z>4V!!((06NJ9E8DIO> XZ[HU/B.H3$XI'!D",>P B%72'Y0+,'N: D#
M1:9C'HZ)SNS'LO\4%.1*[ 1BK@6R)$NXIMR,<8(ZA= 9:/6F:)ID.,T)=F-D
M.%M=AA?P%B[J!P9>LA.]0"*>(#XLU)9X*")T41R;U4H[3R(,8-32>_P>BHRA
M3L3<RN87$:_<!KT4(6/1;KU B"6<<R3I1T.CQS!7-Q2M1"90 #$L$6AN..WL
M":D>DTC(J9X#7,&(:X-%AR'4OO1VHY7%%9SJN3$;UKY M7#1.#"H#M:V]?6K
M5JUZ<J9S+.9LSL8E&44<']V&]PE5X*"%4.%# 18"!!#/0\'UV(I;L1ACLHW+
M]IEQ'0JI,^QGH[62PF,L51)+0'RMR1N$% /$J,=-[R$<TV0$I(.!\"X3H/-4
M7J>E:O,-'/E'JZ3:9/[5D=.)HX)*/,KM2,3&S17P>S!:JYXV9+0Y9(1#VKD_
M=@Z4L!QE.P/^O@!/CPX&\/7@Q&'^"C06T;CG+BU_'9I%RQA"FNG]N]C4/00$
M5SZ2)P,R4Z@ P^2$:Q=\40H2I\<63,NPO1KZ%0CJT)JS@27.BGE:L(T<0SC:
MHJ7@S)W?Z&RH.>-4<3L![CF+2T:)U91IRR.<FVM'.ERHEAK0((.IP79*D5+S
M,!/49AB<EC-BR4>PAV<WJZ0,OPW!"F(2P/[ 7H)^X6)X2#Y0/=GT@;U#YH8K
M[!]L]_8(]*()9Q;H5,N$VOQ"-3J)I=46_52Q.1+1-S@=<L'-S'*4;<-:OW2@
M=7CT+K4FND++71I[R">49BI%?]".4X6A5,P9X CZ"!*D2@+= EL@M?YF1;#X
M\-!'O^2IRQ\OX \/"?P^ ?0F5&0N2EID0!0A1>83W%.]A>HN.-$>4=\_;F>_
M#NO8$2.V]AQ[*#.SVX)]\A)=2(,M(**OEXMD."]-G/N"7PFTQT'5#O"=PY4=
M$ESS6.V1L(DH>^"14U;7LA6V3XC0EH/(,,R4Q<U*PM^B-9;:X/O0%IT1VH>*
M\B,X\F9'EP@= &/G(^G<<"PVP9W5V&.<)%O8=>2M&E.]8$<VZCJ' >;2D5N/
M/%7,B.#W(/*#FT?RQ;^]1"].XIVD>6!5+/EK9:P[1V9S[RHN8Z,-U:L(7X9)
MB]$GL*4-SKXPC2)O-U+I!4%Q+U!E''-C +Z0B(82*9!M9QSM<TK>H!]@W-<V
MK^!?6SW,G1=^SSB:[QPU2T)WOG/T4ID>9&7:$<A'D1]S1*D]2+"'$R$'A%5.
M+A85XA3HO64+GI\ZON"8M3O<GI_C/0FL>3'GCW:VA%/*L*.&133=">R<CV,7
M1"?2YJ*G+!KYBL[B&"O2/\!-)L]B6T\\7R+MP9:.'60=D<)P543(@(NP"#KW
M.T:.SJ)/VCR92#$!F[D3.LI_CE%Y4(8X%7(&V#H=2Q^)Z1KV$:O?A-8$._=]
M=9?KQ\^VQ5_Y;1H=9L23DI%IN_D(FKG1QM7(N?@0/0Y4"8T7--70GG\YPSR7
M"CIK\\29X#J=Y<J'TA@9._T3FRR1H.4W3=QPOCF_:W-Z$AP?N^LV!GW*L/G
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MW(MI6&(&PO3 BBQ6N0%A*@\G*<V4Q>N*3#@'7(9@"$=_R!)T@:R>KXI83.)
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M+.3F)9N*U8U?*Y6_Q;=3^5=<1_\ 4$L! A0#%     @ YHFI5")\W.\9I0(
M32T? !$              ( !     &EC=6DM,C R,C S,S$N:'1M4$L! A0#
M%     @ YHFI5'A] "W:&   ]"8! !$              ( !2*4" &EC=6DM
M,C R,C S,S$N>'-D4$L! A0#%     @ YHFI5$N3C93"&   !>D  !4
M         ( !4;X" &EC=6DM,C R,C S,S%?8V%L+GAM;%!+ 0(4 Q0    (
M .:)J50#L#6IM(@  %;^!0 5              "  4;7 @!I8W5I+3(P,C(P
M,S,Q7V1E9BYX;6Q02P$"% ,4    " #FB:E41:W@6#4K 0">] P %0
M        @ $M8 , :6-U:2TR,#(R,#,S,5]L86(N>&UL4$L! A0#%     @
MYHFI5'8.>^^)R   &38) !4              ( !E8L$ &EC=6DM,C R,C S
M,S%?<')E+GAM;%!+ 0(4 Q0    ( .:)J53:V<Q75 @  'PJ   3
M      "  5%4!0!I8W5I+65X,S$Q,S,Q,C(N:'1M4$L! A0#%     @ YHFI
M5'2;;1-M"   GBT  !,              ( !UEP% &EC=6DM97@S,3(S,S$R
M,BYH=&U02P$"% ,4    " #FB:E4P9W:$UH%   @)@  $P
M@ %T904 :6-U:2UE>#,R,3,S,3(R+FAT;5!+!08     "0 ) $T"  #_:@4
"   !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
